<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006832.pub2" GROUP_ID="NEUROMUSC" ID="089906101912293617" MERGED_FROM="" MODIFIED="2014-01-23 10:06:00 +0000" MODIFIED_BY="Ruth Brassington" NOTES="&lt;p&gt;This is ready for submission to the copy editor. I omitted see examples from the plain language summary. The dates need to be resolved: should the assessed as up to date date be Oct 2007? RACH&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2014-01-23 10:04:14 +0000" NOTES_MODIFIED_BY="Ruth Brassington" REVIEW_NO="122" REVMAN_SUB_VERSION="5.2.7 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="3.0">
<COVER_SHEET MODIFIED="2014-01-23 10:06:00 +0000" MODIFIED_BY="Ruth Brassington">
<TITLE MODIFIED="2012-08-28 14:29:23 +0100" MODIFIED_BY="Greet Hermans">Interventions for preventing critical illness polyneuropathy and critical illness myopathy</TITLE>
<CONTACT MODIFIED="2014-01-23 10:06:00 +0000" MODIFIED_BY="Ruth Brassington"><PERSON ID="3C2DB2A282E26AA20178986B03B6ADDB" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Greet</FIRST_NAME><LAST_NAME>Van den Berghe</LAST_NAME><POSITION>Professor of Medicine and Head of Department</POSITION><EMAIL_1>Greta.vandenberghe@med.kuleuven.be</EMAIL_1><ADDRESS><DEPARTMENT>Department of Intensive Care Medicine</DEPARTMENT><ORGANISATION>KU Leuven, University Hospitals</ORGANISATION><ADDRESS_1>Herestraat 49,3000</ADDRESS_1><CITY>Leuven</CITY><COUNTRY CODE="BE">Belgium</COUNTRY><PHONE_1>+3216344021</PHONE_1><FAX_1>+3216344015</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2014-01-23 10:06:00 +0000" MODIFIED_BY="Ruth Brassington"><PERSON ID="3C336E0A82E26AA20178986BE32576AE" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Greet</FIRST_NAME><LAST_NAME>Hermans</LAST_NAME><SUFFIX>MD PhD</SUFFIX><POSITION>Associate Professor</POSITION><EMAIL_1>Greet.Hermans@uz.kuleuven.be</EMAIL_1><ADDRESS><DEPARTMENT>Department of Cellular and Molecular Medicine</DEPARTMENT><ORGANISATION>KU Leuven</ORGANISATION><ADDRESS_1>Herestraat 49, 3000 Leuven</ADDRESS_1><CITY>Leuven</CITY><COUNTRY CODE="BE">Belgium</COUNTRY><PHONE_1>+3216344275</PHONE_1><FAX_1>+3216344230</FAX_1></ADDRESS></PERSON><PERSON ID="3C38FEE882E26AA20178986BD91B4A4E" ROLE="AUTHOR"><FIRST_NAME>Bernard</FIRST_NAME><LAST_NAME>De Jonghe</LAST_NAME><SUFFIX>MD</SUFFIX><POSITION>Full-time physician</POSITION><EMAIL_1>bdejonghe@chi-poissy-st-germain.fr</EMAIL_1><ADDRESS><DEPARTMENT>Réanimation Médico-Chirurgicale</DEPARTMENT><ORGANISATION>Centre Hospitalier de Poissy-Saint-Germain</ORGANISATION><ADDRESS_1>10 rue du Champ Gaillard, F-78300</ADDRESS_1><CITY>Poissy</CITY><COUNTRY CODE="FR">France</COUNTRY><PHONE_1>+33 (0) 39 27 52 05</PHONE_1><FAX_1>+33 (0) 1 39 27 44 46</FAX_1></ADDRESS></PERSON><PERSON ID="3C3D8E4482E26AA20178986B526DE8B9" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Frans</FIRST_NAME><LAST_NAME>Bruyninckx</LAST_NAME><POSITION>Clinical Neurophysiologist</POSITION><EMAIL_1>frans.bruyninckx@uz.kuleuven.ac.be</EMAIL_1><ADDRESS><DEPARTMENT>Physical Medicine and Rehabilitation</DEPARTMENT><ORGANISATION>KU Leuven, University Hospitals</ORGANISATION><ADDRESS_1>Herestraat 49, 3000</ADDRESS_1><CITY>Leuven</CITY><COUNTRY CODE="BE">Belgium</COUNTRY></ADDRESS></PERSON><PERSON ID="3C2DB2A282E26AA20178986B03B6ADDB" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Greet</FIRST_NAME><LAST_NAME>Van den Berghe</LAST_NAME><POSITION>Professor of Medicine and Head of Department</POSITION><EMAIL_1>Greta.vandenberghe@med.kuleuven.be</EMAIL_1><ADDRESS><DEPARTMENT>Department of Intensive Care Medicine</DEPARTMENT><ORGANISATION>KU Leuven, University Hospitals</ORGANISATION><ADDRESS_1>Herestraat 49,3000</ADDRESS_1><CITY>Leuven</CITY><COUNTRY CODE="BE">Belgium</COUNTRY><PHONE_1>+3216344021</PHONE_1><FAX_1>+3216344015</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2014-01-14 09:23:04 +0000" MODIFIED_BY="Angela Gunn">
<UP_TO_DATE>
<DATE DAY="4" MONTH="10" YEAR="2011"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="4" MONTH="10" YEAR="2011"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="20" MONTH="1" YEAR="2015"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2007"/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="2009"/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2009"/>
</DATES>
<WHATS_NEW MODIFIED="2014-01-17 09:52:33 +0000" MODIFIED_BY="Greet Hermans">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2014-01-17 09:52:24 +0000" MODIFIED_BY="Ruth Brassington">
<DATE DAY="13" MONTH="12" YEAR="2013"/>
<DESCRIPTION>
<P>We identified two new studies for inclusion based on searches to October 2011 and extensively revised the review including changes to inclusion criteria</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2014-01-17 09:52:33 +0000" MODIFIED_BY="Ruth Brassington">
<DATE DAY="4" MONTH="10" YEAR="2011"/>
<DESCRIPTION>
<P>Searches updated to October 2011 and integrated into the review. A further search to December 2013 revealed further studies currently awaiting assessment.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2013-01-09 20:59:52 +0000" MODIFIED_BY="Kate Jewitt">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2013-01-09 20:59:52 +0000" MODIFIED_BY="Ruth Brassington">
<DATE DAY="19" MONTH="8" YEAR="2012"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2014-01-23 10:04:14 +0000" MODIFIED_BY="Angela Gunn">
<SUMMARY MODIFIED="2014-01-17 09:53:09 +0000" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2013-11-27 09:29:36 +0000" MODIFIED_BY="[Empty name]">Interventions to reduce neuromuscular complications acquired during the acute phase of critical illness</TITLE>
<SUMMARY_BODY MODIFIED="2014-01-17 09:53:09 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Review question</B>
</P>
<P>We reviewed the evidence about the effect of treatments to prevent or reduce complications affecting the nerves or muscles during the severe, early phase of critical illness. These complications are called critical illness polyneuropathy or myopathy (CIP/CIM) and can affect nerves, muscles or both.</P>
<P>
<B>Background</B>
</P>
<P>CIP/CIM is a frequent complication of critical care. CIP/CIM causes weakness of limbs and of muscles used for breathing. These difficulties can make it difficult for the person to come off a ventilator and start rehabilitation. CIP/CIM can also mean a longer stay in the intensive care unit (ICU) and increases the risk of death. Recovery takes weeks or months and in severe cases it may be incomplete or absent. Prevention and treatment of CIP/CIM is therefore very important.</P>
<P>
<B>Study characteristics</B>
</P>
<P>We searched for all randomised controlled trials (RCTs) that looked at the effects of any treatment to prevent CIP/CIM in adults admitted to an ICU. We identified and analysed five trials that were suitable for inclusion in our review. These trials studied four treatments: intensive insulin therapy (IIT), corticosteroid therapy, early rehabilitation, and electrical muscle stimulation.</P>
<P>
<B>Key results and quality of the evidence</B>
</P>
<P>Two trials, with a total of 825 adults staying in ICU for one week or more, studied the effect of IIT versus conventional insulin therapy (CIT) on the incidence of CIP/CIM. IIT aimed to produce normal blood sugar levels (80 to 110 mg/dL) and CIT aimed to avoid high blood sugar (blood sugar over 215 mg/dL). Combining the results of both trials showed moderate quality evidence that IIT reduces CIP/CIM. There was high quality evidence that it reduced time spent on a ventilator, ICU stay and 180-day mortality but not 30-day mortality. There were more episodes of low blood sugar with IIT. Although there was not an increase in deaths within 24 hours of episodes of low blood sugar, low blood sugar remains a concern as it can damage the brain. Neither trial reported the degree of limb weakness or on physical rehabilitation. The results came from a subgroup of people who were in the ICU for a long time, which may also limit the conclusions.</P>
<P>The third trial compared corticosteroid therapy with a placebo in 180 people with acute respiratory distress syndrome (ARDS). Moderate quality evidence suggested no effect of corticosteroids on CIP/CIM (in 92 participants evaluated). High quality evidence showed no effect on 180-day mortality, new serious infections, blood glucose levels on day seven or episodes of suspected or probable pneumonia. There were fewer episodes of shock (a life-threatening condition where there is a lack of blood flow to vital organs).</P>
<P>The fourth trial was of on early rehabilitation in 104 participants in a medical ICU. There was moderate quality evidence of a reduction in CIP/CIM in the 82 participants who could be evaluated in the ICU. This effect was not significant when imputation to intention-to-treat analysis was performed. Early rehabilitation reduced the duration of mechanical ventilation but did not affect ICU stay or deaths. The trial reported no serious adverse events.</P>
<P>Finally, a trial compared the effect of EMS of the lower limbs to no stimulation. The trial included 140 participants but provided results for only 52 of them. It supplied very low quality evidence that EMS was without effect in preventing CIP/CIM. There was no effect on duration of mechanical ventilation or deaths. Because the EMS and control groups differed in type and severity of disease,   these findings may not be reliable. Results were even less significant when imputation to intention-to-treat analysis was performed. The study found no effect of EMS on duration of mechanical ventilation or deaths.</P>
<P>The evidence is up to date as of October 2011. We re-ran the search for studies in December 2013 and identified nine additional potentially eligible studies that we will assess in the next update of the review.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2014-01-17 09:52:59 +0000" MODIFIED_BY="Angela Gunn">
<ABS_BACKGROUND MODIFIED="2014-01-17 09:52:39 +0000" MODIFIED_BY="[Empty name]">
<P>Critical illness polyneuropathy or myopathy (CIP/CIM) is a frequent complication in the intensive care unit (ICU) and is associated with prolonged mechanical ventilation, longer ICU stay and increased mortality. This is an interim update of a review first published in 2009 (<A HREF="Hermans 2009">Hermans 2009</A>). It has been updated to October 2011, with further potentially eligible studies from a December 2013 search characterised as awaiting assessment.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2013-12-12 08:00:21 +0000" MODIFIED_BY="[Empty name]">
<P>To systematically review the evidence from RCTs concerning the ability of any intervention to reduce the incidence of CIP or CIM in critically ill individuals.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2014-01-17 09:52:46 +0000" MODIFIED_BY="Angela Gunn">
<P>On 4 October 2011, we searched the Cochrane Neuromuscular Disease Group Specialized Register, CENTRAL, MEDLINE, and EMBASE. We checked the bibliographies of identified trials and contacted trial authors and experts in the field. We carried out an additional search of these databases on 6 December 2013 to identify recent studies.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2014-01-13 23:02:23 +0000" MODIFIED_BY="[Empty name]">
<P>All randomised controlled trials (RCTs), examining the effect of any intervention on the incidence of CIP/CIM in people admitted to adult medical or surgical ICUs. The primary outcome was the incidence of CIP/CIM in ICU, based on electrophysiological or clinical examination. Secondary outcomes included duration of mechanical ventilation, duration of ICU stay, death at 30 and 180 days after ICU admission and serious adverse events from the treatment regimens.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2013-11-26 09:21:13 +0000" MODIFIED_BY="Ruth Brassington">
<P>Two authors independently extracted the data and assessed the risk of bias in included studies.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2014-01-17 09:52:57 +0000" MODIFIED_BY="[Empty name]">
<P>We identified five trials that met our inclusion criteria. Two trials compared intensive insulin therapy (IIT) to conventional insulin therapy (CIT). IIT significantly reduced CIP/CIM in the screened (n = 825; risk ratio (RR) 0.65, 95% confidence interval (CI) 0.55 to 0.77) and total (n = 2748; RR 0.70, 95% CI 0.60 to 0.82) population randomised. IIT reduced duration of mechanical ventilation, ICU stay and 180-day mortality, but not 30-day mortality compared with CIT. Hypoglycaemia increased with IIT but did not cause early deaths.</P>
<P>One trial compared corticosteroids with placebo (n = 180). The trial found no effect of treatment on CIP/CIM (RR 1.27, 95% CI 0.77 to 2.08), 180-day mortality, new infections, glycaemia at day seven, or episodes of pneumonia, but did show a reduction of new shock events.</P>
<P>In the fourth trial, early physical therapy reduced CIP/CIM in 82/104 evaluable participants in ICU (RR 0.62. 95% CI 0.39 to 0.96). Statistical significance was lost when we performed a full intention-to-treat analysis (RR 0.81, 95% CI 0.60 to 1.08). Duration of mechanical ventilation but not ICU stay was significantly shorter in the intervention group. Hospital mortality was not affected but 30- and 180-day mortality results were not available. No adverse effects were noticed.</P>
<P>The last trial found a reduced incidence of CIP/CIM in 52 evaluable participants out of a total of 140 who were randomised to electrical muscle stimulation (EMS) versus no stimulation (RR 0.32, 95% CI 0.10 to 1.01). These data were prone to bias due to imbalances between treatment groups in this subgroup of participants. After we imputed missing data and performed an intention-to-treat analysis, there was still no significant effect (RR 0.94, 95% CI 0.78 to 1.15). The investigators found no effect on duration of mechanical ventilation and noted no difference in ICU mortality, but did not report 30- and 180-day mortality.</P>
<P>We updated the searches in December 2013 and identified nine potentially eligible studies that will be assessed for inclusion in the next update of the review.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2014-01-17 09:52:59 +0000" MODIFIED_BY="[Empty name]">
<P>There is moderate quality evidence from two large trials that intensive insulin therapy reduces CIP/CIM, and high quality evidence that it reduces duration of mechanical ventilation, ICU stay and 180-day mortality, at the expense of hypoglycaemia. Consequences and prevention of hypoglycaemia need further study. There is moderate quality evidence which suggests no effect of corticosteroids on CIP/CIM and high quality evidence that steroids do not affect secondary outcomes, except for fewer new shock episodes. Moderate quality evidence suggests a potential benefit of early rehabilitation on CIP/CIM which is accompanied by a shorter duration of mechanical ventilation but without an effect on ICU stay. Very low quality evidence suggests no effect of EMS, although data are prone to bias. Strict diagnostic criteria for CIP/CIM are urgently needed for research purposes. Large RCTs need to be conducted to further explore the role of early rehabilitation and EMS and to develop new preventive strategies.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2014-01-17 09:55:46 +0000" MODIFIED_BY="Angela Gunn">
<BACKGROUND MODIFIED="2014-01-17 09:53:51 +0000" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2014-01-17 09:53:51 +0000" MODIFIED_BY="Ruth Brassington">
<P>Critical illness polyneuropathy (CIP) is an acute and primary axonal motor and sensory polyneuropathy. It occurs in critically ill individuals and is related to severe limb weakness and difficulty in weaning from a ventilator. The term CIP was first used in 1986 (<LINK REF="REF-Bolton-1986" TYPE="REFERENCE">Bolton 1986</LINK>). Later on it became apparent that in many individuals the disease primarily affected the muscles and the term myopathy in critical illness or critical illness myopathy (CIM), was introduced. It is now clear that the neuromuscular involvement during critical illness covers a spectrum of neuropathy and myopathy, and in many cases overlap syndromes are present.</P>
<P>Many clinical signs of CIP and CIM are similar and include flaccid weakness of the limbs. Weakness affects legs more often than arms. Although head, facial, tongue and jaw movement are relatively spared, facial muscles can be involved and ophthalmoplegia may occur. Involvement of the phrenic nerves and diaphragm may cause ventilator weaning problems. In CIP, distal loss of sensitivity to pain, temperature and vibration may also occur. Deep tendon reflexes are usually normal or reduced in pure CIM but may be absent in CIP.</P>
<P>Several diagnostic approaches are available. Muscle strength can be quantified using the Medical Research Council (MRC) sum-score (<LINK REF="REF-De-Jonghe-2002" TYPE="REFERENCE">De Jonghe 2002</LINK>). This score grades muscle weakness in six muscle groups between zero and five (<LINK REF="REF-Kleyweg-1991" TYPE="REFERENCE">Kleyweg 1991</LINK>) (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>). When added up, a cut-off of 48 may be used to indicate clinically relevant weakness (<LINK REF="REF-De-Jonghe-2002" TYPE="REFERENCE">De Jonghe 2002</LINK>). This tool was validated in individuals who are awake and co-operative using standard evaluation of consciousness. During the early unconscious phase of critical illness, such evaluation may often not be possible. Information from clinical examination is then limited. Electrophysiological testing may be used also during this early stage to confirm the diagnosis and to exclude other causes of weakness. Nerve conduction studies (NCS) show normal or near normal nerve conduction velocity, in contrast to Guillain-Barré syndrome, in which demyelination occurs. In CIP, NCS also typically show reduced nerve conduction amplitudes. Electromyography (EMG) often reveals abundant spontaneous electrical activity. EMG and NCS findings are not specific, however, and occur in CIP as well as in CIM and in other disorders. Therefore, differentiating between CIP and CIM using electrophysiological data is often only possible when individuals are fully co-operative and voluntary motor unit potential recruitment can be studied. Also, direct muscle stimulation can be helpful, although it is technically demanding. Co-existence of CIP and CIM can also make interpretation difficult. Ultimately, electrophysiological findings always need to be correlated with clinical findings. Finally, muscle biopsy can confirm muscle involvement and differentiate between the three subtypes of CIM: diffuse non-necrotising myopathy or CIM in the strict sense; thick filament myopathy; and acute necrotising myopathy.</P>
<P>Due to the difficulty in differentiating between CIP and CIM, and the frequent association of both, terminology used in the literature is often inconsistent and sometimes merely descriptive (for example 'ICU acquired paresis' and 'acquired neuromuscular disorders'), and both disorders are frequently grouped together as critical illness polyneuromyopathy or critical illness polyneuropathy and myopathy (CIP/CIM).</P>
<P>The incidence rates reported in the literature vary according to patient population, definition and timing of evaluation. For instance, in individuals with sepsis or systemic inflammatory response syndrome the incidence is 70% (<LINK REF="REF-Witt-1991" TYPE="REFERENCE">Witt 1991</LINK>), and rises up to 100% if complicated by multiple organ failure (MOF) (<LINK REF="REF-Tennil_x00e4_-2000" TYPE="REFERENCE">Tennilä 2000</LINK>). Among individuals in the intensive care unit (ICU) for at least seven days, 25% will develop weakness (<LINK REF="REF-De-Jonghe-2002" TYPE="REFERENCE">De Jonghe 2002</LINK>), and 49% to 84% electrophysiological abnormalities (<LINK REF="REF-Coakley-1998" TYPE="REFERENCE">Coakley 1998</LINK>; <LINK REF="STD-Hermans-2007" TYPE="STUDY">Hermans 2007</LINK>; <LINK REF="STD-Van-den-Berghe-2005" TYPE="STUDY">Van den Berghe 2005</LINK>).</P>
<P>
<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> outlines hypotheses on the pathophysiology of CIP/CIM. Many risk factors have been related to the incidence of CIP. Both prospective and retrospective trials have found sepsis, systemic inflammatory response syndrome (SIRS) and multiple organ failure to play a key part in the development of CIP. Many other factors have been incriminated, although results have not always been consistent. Factors identified as independent risk factors by prospective studies are: female sex (<LINK REF="REF-De-Jonghe-2002" TYPE="REFERENCE">De Jonghe 2002</LINK>), severity of illness (<LINK REF="REF-Bednar_x00ed_k-2005" TYPE="REFERENCE">Bednarík 2005</LINK>; <LINK REF="REF-de-Letter-2001" TYPE="REFERENCE">de Letter 2001</LINK>; <LINK REF="REF-Nanas-2008" TYPE="REFERENCE">Nanas 2008</LINK>), duration of organ dysfunction (<LINK REF="REF-De-Jonghe-2002" TYPE="REFERENCE">De Jonghe 2002</LINK>), renal failure and renal replacement therapy (<LINK REF="REF-Garnacho_x002d_Montero-2001" TYPE="REFERENCE">Garnacho-Montero 2001</LINK>), hyperglycaemia (<LINK REF="STD-Hermans-2007" TYPE="STUDY">Hermans 2007</LINK>; <LINK REF="REF-Nanas-2008" TYPE="REFERENCE">Nanas 2008</LINK>; <LINK REF="STD-Van-den-Berghe-2005" TYPE="STUDY">Van den Berghe 2005</LINK>), hyperosmolality (<LINK REF="REF-Garnacho_x002d_Montero-2001" TYPE="REFERENCE">Garnacho-Montero 2001</LINK>), parenteral nutrition (<LINK REF="REF-Garnacho_x002d_Montero-2001" TYPE="REFERENCE">Garnacho-Montero 2001</LINK>), serum albumin (<LINK REF="REF-Witt-1991" TYPE="REFERENCE">Witt 1991</LINK>), duration of ICU stay (<LINK REF="STD-Van-den-Berghe-2005" TYPE="STUDY">Van den Berghe 2005</LINK>; <LINK REF="REF-Witt-1991" TYPE="REFERENCE">Witt 1991</LINK>), vasopressor and catecholamine support (<LINK REF="STD-Hermans-2007" TYPE="STUDY">Hermans 2007</LINK>; <LINK REF="STD-Van-den-Berghe-2005" TYPE="STUDY">Van den Berghe 2005</LINK>), and central neurological failure (<LINK REF="REF-Garnacho_x002d_Montero-2001" TYPE="REFERENCE">Garnacho-Montero 2001</LINK>).</P>
<P>Data on the impact of corticosteroids on neuromuscular function are controversial. Many reports found CIM to occur in individuals treated with a combination of corticosteroids and neuromuscular blocking agents (NMBAs). However, most prospective studies could not identify corticosteroids as an independent risk factor for CIP (<LINK REF="REF-Garnacho_x002d_Montero-2001" TYPE="REFERENCE">Garnacho-Montero 2001</LINK>), CIP/CIM (<LINK REF="REF-Bednar_x00ed_k-2005" TYPE="REFERENCE">Bednarík 2005</LINK>; <LINK REF="REF-de-Letter-2001" TYPE="REFERENCE">de Letter 2001</LINK>; <LINK REF="REF-Nanas-2008" TYPE="REFERENCE">Nanas 2008</LINK>; <LINK REF="STD-Van-den-Berghe-2005" TYPE="STUDY">Van den Berghe 2005</LINK>), or CIM (<LINK REF="REF-Weber_x002d_Carstens-2010" TYPE="REFERENCE">Weber-Carstens 2010</LINK>), although two other prospective trials on weakness did (<LINK REF="REF-De-Jonghe-2002" TYPE="REFERENCE">De Jonghe 2002</LINK>; <LINK REF="REF-Herridge-2003" TYPE="REFERENCE">Herridge 2003</LINK>). In one study, corticosteroids were even found to be an independent protective factor for the occurrence of CIP/CIM (<LINK REF="STD-Hermans-2007" TYPE="STUDY">Hermans 2007</LINK>). Most prospective trials also could not identify NMBA use as an independent risk factor for CIP or CIP/CIM (<LINK REF="REF-Bednar_x00ed_k-2005" TYPE="REFERENCE">Bednarík 2005</LINK>; <LINK REF="REF-De-Jonghe-2002" TYPE="REFERENCE">De Jonghe 2002</LINK>; <LINK REF="REF-Nanas-2008" TYPE="REFERENCE">Nanas 2008</LINK>; <LINK REF="STD-Van-den-Berghe-2005" TYPE="STUDY">Van den Berghe 2005</LINK>), although other trials did (<LINK REF="REF-Garnacho_x002d_Montero-2001" TYPE="REFERENCE">Garnacho-Montero 2001</LINK>; <LINK REF="STD-Hermans-2007" TYPE="STUDY">Hermans 2007</LINK>). A recent randomised controlled trial (RCT) in severe acute respiratory distress syndrome (ARDS) did not show increased muscle weakness in participants randomised to an early, short course of NMBAs, compared with controls (<LINK REF="REF-Papazian-2010" TYPE="REFERENCE">Papazian 2010</LINK>).</P>
<P>Until recently, the only possible way to affect the incidence of CIP and CIM was by controlling risk factors. This includes aggressive treatment of sepsis and avoiding or limiting the use of corticosteroids and NMBAs to the lowest dose possible and the shortest time feasible.</P>
<SUBSECTION>
<HEADING LEVEL="2">Description of the interventions and how they might work</HEADING>
<SUBSECTION>
<HEADING LEVEL="3">Nutritional therapy</HEADING>
<P>Caloric deficit rapidly develops during critical illness due to the dysfunctional gastro-intestinal tract. This catabolic state is considered to contribute to muscle wasting and weakness. Whether addition of parenteral feeding can reverse this and improve muscle function is unclear (<LINK REF="REF-Berek-1997a" TYPE="REFERENCE">Berek 1997a</LINK>; <LINK REF="REF-Bolton-1984" TYPE="REFERENCE">Bolton 1984</LINK>; <LINK REF="REF-Waldhausen-1997" TYPE="REFERENCE">Waldhausen 1997</LINK>). Glutamine is relatively deficient in critically ill individuals, markedly reduced in muscle biopsies taken during critical illness and possibly pathogenically linked to CIM (<LINK REF="REF-Burnham-2005" TYPE="REFERENCE">Burnham 2005</LINK>; <LINK REF="REF-Weitzel-2009" TYPE="REFERENCE">Weitzel 2009</LINK>). Arginine is another conditionally essential amino acid, potentially crucial for maintaining body protein homeostasis in critical illness (<LINK REF="REF-Burnham-2005" TYPE="REFERENCE">Burnham 2005</LINK>). We therefore examined the effects of various feeding protocols such as enteral feeding, parenteral feeding and therapies such as protein and amino acid supplementation.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Antioxidant therapy</HEADING>
<P>Excess production of free oxygen radicals and diminished endogenous antioxidant mechanisms have been implicated in multiple organ failure and septic shock (<LINK REF="REF-Brealey-2002" TYPE="REFERENCE">Brealey 2002</LINK>). Muscle biopsies in critically ill individuals also show decreased levels of glutathione (GSH), an intracellular antioxidant (<LINK REF="REF-Hammarqvist-1997" TYPE="REFERENCE">Hammarqvist 1997</LINK>). Antioxidant therapy may therefore, improve outcome because of its ability to scavenge free oxygen radicals and replete GSH stores.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Hormonal therapy</HEADING>
<P>The loss of lean body mass in critical illness is associated with a disturbed balance between catabolic and anabolic hormones. Correcting this balance by hormonal therapy may therefore be beneficial. Testosterone derivates increase weight (<LINK REF="REF-Berger-1996" TYPE="REFERENCE">Berger 1996</LINK>), survival (<LINK REF="REF-Mendenhall-1993" TYPE="REFERENCE">Mendenhall 1993</LINK>), improve nitrogen balance (<LINK REF="REF-Michelsen-1982" TYPE="REFERENCE">Michelsen 1982</LINK>), and increase inspiratory muscle strength (<LINK REF="REF-Schols-1995" TYPE="REFERENCE">Schols 1995</LINK>), in various settings. Evidence of hypogonadism was found in males with CIP/CIM (<LINK REF="REF-Sharshar-2010" TYPE="REFERENCE">Sharshar 2010</LINK>). Therefore, the use of testosterone in critically ill males is theoretically attractive.</P>
<P>Basal growth hormone secretion is increased in acute critical illness but circulating levels of insulin-like growth factor 1 (IGF-1) are low secondary to resistance to growth hormone. This may contribute to increased protein turnover and negative nitrogen balance in this condition. Treatment with recombinant human growth hormone improves nitrogen balance (<LINK REF="REF-Gore-1991" TYPE="REFERENCE">Gore 1991</LINK>; <LINK REF="REF-Jeevanandam-1995" TYPE="REFERENCE">Jeevanandam 1995</LINK>; <LINK REF="REF-Pape-1991" TYPE="REFERENCE">Pape 1991</LINK>; <LINK REF="REF-Ponting-1988" TYPE="REFERENCE">Ponting 1988</LINK>; <LINK REF="REF-Voerman-1992" TYPE="REFERENCE">Voerman 1992</LINK>; <LINK REF="REF-Voerman-1995" TYPE="REFERENCE">Voerman 1995</LINK>; <LINK REF="STD-Ziegler-1990" TYPE="STUDY">Ziegler 1990</LINK>), which opens perspectives for clinical effects on muscle function.</P>
<P>Hyperglycaemia is possibly detrimental for the peripheral nerve in critical illness due to impairment of the microcirculation (<LINK REF="REF-Bolton-2005" TYPE="REFERENCE">Bolton 2005</LINK>; <LINK REF="REF-Witt-1991" TYPE="REFERENCE">Witt 1991</LINK>). Passive uptake of glucose with increased generation or deficient scavenging of reactive oxygen species may also have neurotoxic effects (<LINK REF="REF-Van-den-Berghe-2004" TYPE="REFERENCE">Van den Berghe 2004</LINK>). Avoiding hyperglycaemia by using insulin, on the other hand, might exert a protective effect on the neural mitochondrial function (<LINK REF="STD-Van-den-Berghe-2005" TYPE="STUDY">Van den Berghe 2005</LINK>), and also reduce organ damage by endothelial protection through diminished release of nitric oxide (<LINK REF="REF-Langouche-2005" TYPE="REFERENCE">Langouche 2005</LINK>).</P>
<P>Some rationale also exists for treatment with corticosteroids as these drugs may not only improve survival in some ICU subpopulations (for example, septic shock, ARDS and acute asthma) but could also reduce the duration and severity of multiple organ failure, a major determinant of CIP/CIM (<LINK REF="REF-Bollaert-1998" TYPE="REFERENCE">Bollaert 1998</LINK>; <LINK REF="REF-Boyer-2006" TYPE="REFERENCE">Boyer 2006</LINK>; <LINK REF="REF-Briegel-1999" TYPE="REFERENCE">Briegel 1999</LINK>; <LINK REF="REF-Chalwa-1999" TYPE="REFERENCE">Chalwa 1999</LINK>; <LINK REF="REF-Meduri-1998" TYPE="REFERENCE">Meduri 1998</LINK>; <LINK REF="REF-Rowe-2001" TYPE="REFERENCE">Rowe 2001</LINK>; <LINK REF="STD-Steinberg-2006" TYPE="STUDY">Steinberg 2006</LINK>). Furthermore, corticosteroids independently protected against CIP/CIM in one prospective trial (<LINK REF="STD-Hermans-2007" TYPE="STUDY">Hermans 2007</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Intravenous immunoglobulins</HEADING>
<P>Immune mechanisms may be implicated in the pathogenesis of CIP/CIM. In a retrospective study, early treatment of Gram-negative sepsis with immunoglobulins may have prevented CIP (<LINK REF="STD-Mohr-1997" TYPE="STUDY">Mohr 1997</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Physical therapy and rehabilitation programs</HEADING>
<P>Early physical therapy and mobilisation of critically ill individuals appear feasible and safe (<LINK REF="STD-Morris-2008" TYPE="STUDY">Morris 2008</LINK>). As duration of immobilisation is a risk factor for CIP/CIM, early mobilisation could affect its incidence, possibly by obviating disuse atrophy that undoubtedly dominates this disorder (<LINK REF="REF-Pandit-2006" TYPE="REFERENCE">Pandit 2006</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Electrical muscle stimulation</HEADING>
<P>Electrical muscle stimulation (EMS) increased exercise tolerance and muscle strength in several populations, such as chronic obstructive pulmonary disease (COPD) (<LINK REF="STD-Vivodtzev-2006" TYPE="STUDY">Vivodtzev 2006</LINK>), and chronic heart failure (<LINK REF="REF-Deley-2005" TYPE="REFERENCE">Deley 2005</LINK>; <LINK REF="REF-Nuhr-2004" TYPE="REFERENCE">Nuhr 2004</LINK>). In the setting of critical illness, EMS has been shown to preserve muscle mass (<LINK REF="STD-Gerovasili-2009b" TYPE="STUDY">Gerovasili 2009b</LINK>) and to exert a short-term systemic effect on the microcirculation (<LINK REF="STD-Gerovasili-2009a" TYPE="STUDY">Gerovasili 2009a</LINK>), which makes it a potentially interesting strategy.</P>
</SUBSECTION>
</SUBSECTION>
</CONDITION>
<IMPORTANCE MODIFIED="2014-01-15 23:20:45 +0000" MODIFIED_BY="Ruth Brassington">
<P>This review is important for several reasons. Two previous systematic reviews on CIP/CIM have been published (<LINK REF="REF-De-Jonghe-1998" TYPE="REFERENCE">De Jonghe 1998</LINK>; <LINK REF="REF-Stevens-2007" TYPE="REFERENCE">Stevens 2007</LINK>). The first review considered prospective cohort studies and focused on assessment and outcomes. The second review aimed to determine prevalence, risk factors and outcome. In the current systematic review, we aimed to specifically assess the effect of any intervention, studied in an RCT, on the incidence of CIP/CIM. In ICU, interventions to reduce mortality are obviously of paramount importance. However, in acute phase survivors, reduction of morbidity is also imperative. CIP/CIM is now recognised as a major complication of severe critical illness and its highly sophisticated management in the ICU. As both locomotor and respiratory muscles can be involved, CIP/CIM can significantly affect weaning from mechanical ventilation and recovery of physical autonomy. Therefore, interventions demonstrated to reduce the incidence of CIP/CIM are expected to have a beneficial effect on weaning and mechanical ventilation duration, muscle function and overall locomotor autonomy in the recovery phase as well as long-term functional disability. Improvement may take weeks in mild cases and months in severe cases. In more severe cases, recovery may be incomplete or not occur at all. Accumulating evidence points to CIP/CIM as an important contributor to profound long-term disability after ICU stay (<LINK REF="REF-Herridge-2011" TYPE="REFERENCE">Herridge 2011</LINK>).</P>
<P>Although less clearly investigated to date, other potential adverse consequences of CIP/CIM include negative psychological impact, higher residual mortality after the acute phase, and increased costs. No systematic review of interventions to prevent CIP/CIM is currently available. This review was first published in 2009 (<LINK REF="REF-Hermans-2009" TYPE="REFERENCE">Hermans 2009</LINK>), and this is the first update.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2013-11-26 09:18:36 +0000" MODIFIED_BY="[Empty name]">
<P>To systematically review the evidence from RCTs concerning the ability of any intervention to reduce the incidence of CIP or CIM in critically ill individuals. </P>
</OBJECTIVES>
<METHODS MODIFIED="2014-01-17 09:54:09 +0000" MODIFIED_BY="Angela Gunn">
<SELECTION_CRITERIA MODIFIED="2014-01-17 09:53:57 +0000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2013-12-12 08:05:28 +0000" MODIFIED_BY="[Empty name]">
<P>We included all RCTs in humans that compared the efficacy of any treatment used to prevent or reduce the incidence of CIP or CIM as a primary or secondary outcome to placebo, no treatment or a different treatment.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2013-06-15 15:05:46 +0100" MODIFIED_BY="[Empty name]">
<P>Adults (over 18 years)<I>
<B> </B>
</I>of either sex, admitted to a medical, surgical or mixed ICU.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2014-01-17 09:53:57 +0000" MODIFIED_BY="[Empty name]">
<P>We included in the review any form of<I> </I>intervention that has been related<B> </B>in the literature to a decreased risk of CIP or CIM or both. Interventions include:</P>
<UL>
<LI>nutritional interventions:</LI>
<UL>
<LI>enteral versus parenteral feeding; and</LI>
<LI>supplemental therapies such as protein and amino acid supplementation (glutamine and arginine);</LI>
</UL>
<LI>antioxidant therapy (for example, glutathione or n-acetyl cysteine);</LI>
<LI>hormone therapy: testosterone, oxandrolone, growth hormone, IGF-1, intensive insulin therapy (IIT) and glucocorticoids;</LI>
<LI>intravenous immunoglobulin;</LI>
<LI>physiotherapy;</LI>
<LI>EMS; and</LI>
<LI>rehabilitation programs.</LI>
</UL>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2014-01-16 10:01:34 +0000" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2014-01-13 23:03:02 +0000" MODIFIED_BY="[Empty name]">
<P>The primary outcome measure was the incidence of CIP/CIM during ICU stay. We extracted this outcome measure in ICU. As no internationally accepted criteria exist for this diagnosis, we defined CIP/CIM for the purpose of this review as weakness of the limbs or respiratory muscles, or as EMG documented peripheral polyneuropathy or myopathy for which causes other than CIP/CIM have been excluded.</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2014-01-16 10:01:34 +0000" MODIFIED_BY="[Empty name]">
<P>Secondary outcome measures included clinically relevant consequences from a possible reduction in the incidence of CIP/CIM and also any possible side effects of the therapy. The secondary outcomes are limited by their surrogate nature as outcome measures for CIP/CIM, as they can be influenced by other ICU complications.<BR/>(a) Duration of mechanical ventilation. This was defined as the time to actual and final liberation from the ventilator<BR/>(b) Duration of ICU stay<BR/>(c) Death at 30 days (after ICU admission)<BR/>(d) Death at 180 days (after ICU admission)<BR/>(e) Serious adverse events from the treatment regimens, which were fatal, life-threatening or required prolonged hospital stay (eg hypoglycaemia, hyperglycaemia, and organ failure)</P>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2014-01-17 09:54:06 +0000" MODIFIED_BY="Angela Gunn">
<ELECTRONIC_SEARCHES MODIFIED="2014-01-17 09:54:06 +0000" MODIFIED_BY="Angela Gunn">
<P>On 4 October 2011, we searched the Cochrane Central Register of Controlled Trials (CENTRAL) (2011, Issue 3 in <I>The Cochrane Library</I>), MEDLINE (January 1966 to September 2011) and EMBASE (January 1980 to September 2011). We used a combination of MeSH and keyword searching in these databases. The detailed search strategies are listed in the appendices: CENTRAL (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>), MEDLINE (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>), and EMBASE (<LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>). Shortly before publication, on 3 December 2013, we updated the electronic database searches. We screened titles and abstracts to identify any studies potentially eligible for inclusion. We have included these studies as <LINK TAG="AWAITING_STUDIES" TYPE="SECTION">Studies awaiting classification</LINK>, for full assessment in the next update of the review.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2013-12-12 08:06:34 +0000" MODIFIED_BY="[Empty name]">
<P>We reviewed the bibliographies of the RCTs identified and contacted trial authors and known experts in the field to identify additional unpublished data.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2014-01-17 09:54:09 +0000" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2013-11-26 12:22:18 +0000" MODIFIED_BY="Ruth Brassington">
<P>Two of the four review authors independently checked titles and abstracts identified from the searches. We obtained the full text of all potentially relevant studies and the authors decided which trials fit the inclusion criteria. If the two authors did not agree, the authors achieved consensus by discussion.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2013-12-12 08:06:51 +0000" MODIFIED_BY="Ruth Brassington">
<P>Two review authors independently extracted data. We obtained data on 'Risk of bias' criteria, baseline characteristics and relevant data for the primary and secondary outcome measures if available. When there were missing data we contacted the investigator whenever possible. We also sought information about participants who were randomised but excluded from analyses in the original trial publications and, if available, incorporated their data into the analysis.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2014-01-17 09:54:09 +0000" MODIFIED_BY="Ruth Brassington">
<P>Our 'Risk of bias' assessment took into account security of randomisation, allocation concealment, observer and participant blinding, completeness of follow-up, intention-to-treat analysis and explicit diagnostic criteria. Allocation concealment relates to the randomisation procedures, whereby investigators involved in participant allocation should not be able to influence how the groups are assembled. It involves concealment of the next allocation in the randomisation sequence, such that neither the investigator nor the participants can be aware of the next group assignment until after the decision about whether an individual is eligible for the trial has been finalised. We graded these items as low, unclear or high risk of bias according to the criteria formulated in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011a" TYPE="REFERENCE">Higgins 2011a</LINK>). If the information needed to make an assessment was not available, we graded the item as at an unclear risk of bias. For some items where there was insufficient information to form a judgement, we attempted to contact the study authors to obtain additional information about the trial design. Two review authors independently assessed the risk of bias. In the event of disagreement between the two authors, agreement was reached by consensus. One review author entered data into the Cochrane statistical package, Review Manager 5 (<LINK REF="REF-RevMan-2012" TYPE="REFERENCE">RevMan 2012</LINK>), and a second author checked the data entry.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2013-12-12 08:07:22 +0000" MODIFIED_BY="Ruth Brassington">
<P>We analysed and presented results according to the statistical guidelines of The Cochrane Collaboration as described in Chapter 9 of the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Deeks-2011" TYPE="REFERENCE">Deeks 2011</LINK>). The reliability of the various pieces of evidence obtained form part of the <LINK TAG="DISCUSSION" TYPE="SECTION">Discussion</LINK>. We analysed and presented trials of each intervention separately. We presented dichotomous outcome data as risk ratios (RRs) and risk differences (RD) with 95% confidence intervals (CIs). We presented continuous outcome data as mean differences (MDs) with 95% CIs. We used the fixed-effect model and where there was heterogeneity we repeated the analysis using the random-effects model.</P>
</EFFECT_MEASURES>
<BIAS_ASSESSMENT MODIFIED="2014-01-13 23:03:04 +0000" MODIFIED_BY="Ruth Brassington">
<P>There were too few included studies for a funnel plot to be appropriate.</P>
<SUBSECTION>
<HEADING LEVEL="3">'Summary of findings' tables</HEADING>
<P>We applied the Grading of Recommendations Assessment, Development and Evaluation (GRADE) assessment method to the studies included to determine the quality of evidence across outcomes. We used methods and recommendations described in Section 8.5 and Chapter 12 of the <I>Cochrane Handbook for Systematic Reviews of Interventions </I>(<LINK REF="REF-Higgins-2011a" TYPE="REFERENCE">Higgins 2011a</LINK>) using GRADEpro software. The GRADE method considers risk of bias, directness of evidence, unexplained heterogeneity or inconsistency of results, precision of effect and risk of publication bias as factors determining the quality of evidence (<LINK REF="REF-Atkins-2004" TYPE="REFERENCE">Atkins 2004</LINK>). We included all our primary and secondary outcomes for which data were available.</P>
</SUBSECTION>
</BIAS_ASSESSMENT>
<SENSITIVITY_ANALYSIS MODIFIED="2013-12-12 08:08:09 +0000" MODIFIED_BY="Ruth Brassington">
<P>We did not perform a sensitivity analysis excluding studies with the lowest quality as we could only pool data for two studies.</P>
<SUBSECTION>
<HEADING LEVEL="3">Risk of bias in the review process</HEADING>
<P>We have reported any discrepancies between the review and the published protocol (<LINK REF="STD-Hermans-2007" TYPE="STUDY">Hermans 2007</LINK>) in <LINK TAG="PRO_REV_DIFF" TYPE="SECTION">Differences between protocol and review</LINK>.</P>
</SUBSECTION>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2014-01-17 09:55:31 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;The number of papers found by the new, current strategies are&lt;/p&gt;&lt;p&gt;MEDLINE - 338&lt;/p&gt;&lt;p&gt;EMBASE - 405&lt;/p&gt;&lt;p&gt;NMD REGISTER - 9&lt;/p&gt;&lt;p&gt;CENTRAL - 159&lt;/p&gt;&lt;p&gt;The NMD Group is now following the Cochrane policy of giving the total number of references found by each database, the number of references after deduplication, the number of references selected for further review and the number meeting the inclusion criteria for the review.&lt;/p&gt;&lt;p&gt;The numbers given above are total references retrieved &lt;/p&gt;" NOTES_MODIFIED="2014-01-17 09:55:31 +0000" NOTES_MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2014-01-17 09:54:54 +0000" MODIFIED_BY="[Empty name]">
<P>The search strategy in 2009 identified 23 potentially relevant references, of which 14 were excluded. Nine trials fulfilled the selection criteria (<LINK REF="STD-Caruso-2005" TYPE="STUDY">Caruso 2005</LINK>; <LINK REF="STD-Hermans-2007" TYPE="STUDY">Hermans 2007</LINK>; <LINK REF="STD-Johnson-1993" TYPE="STUDY">Johnson 1993</LINK>; <LINK REF="STD-Pichard-1996" TYPE="STUDY">Pichard 1996</LINK>; <LINK REF="STD-Steinberg-2006" TYPE="STUDY">Steinberg 2006</LINK>; <LINK REF="STD-Takala-1999a" TYPE="STUDY">Takala 1999a</LINK>; <LINK REF="STD-Takala-1999b" TYPE="STUDY">Takala 1999b</LINK>; <LINK REF="STD-Van-den-Berghe-2005" TYPE="STUDY">Van den Berghe 2005</LINK>; <LINK REF="STD-Watters-1997" TYPE="STUDY">Watters 1997</LINK>). For this revision, we defined our inclusion criteria more clearly and more strictly, to consider only those trials that actually reported the incidence of CIP/CIM as a primary or secondary outcome. Therefore, we excluded studies that reported other neuromuscular outcomes but not the incidence of CIP/CIM (<LINK REF="STD-Caruso-2005" TYPE="STUDY">Caruso 2005</LINK>; <LINK REF="STD-Johnson-1993" TYPE="STUDY">Johnson 1993</LINK>; <LINK REF="STD-Pichard-1996" TYPE="STUDY">Pichard 1996</LINK>; <LINK REF="STD-Takala-1999a" TYPE="STUDY">Takala 1999a</LINK>; <LINK REF="STD-Takala-1999b" TYPE="STUDY">Takala 1999b</LINK>; <LINK REF="STD-Watters-1997" TYPE="STUDY">Watters 1997</LINK>). We also modified the search strategy to increase its sensitivity. The MEDLINE search in October 2011 revealed another 10 possibly relevant references, out of the 343 that were retrieved. We excluded eight of these: one was not an intervention trial (<LINK REF="STD-Brunello-2010" TYPE="STUDY">Brunello 2010</LINK>), another two trials were not performed in the ICU (<LINK REF="STD-Chiang-2006" TYPE="STUDY">Chiang 2006</LINK>; <LINK REF="STD-Toledo-2007" TYPE="STUDY">Toledo 2007</LINK>) and finally, five trials did not provide the incidence of CIP/CIM as a primary or secondary outcome (<LINK REF="STD-Burtin-2009" TYPE="STUDY">Burtin 2009</LINK>; <LINK REF="STD-Gerovasili-2009a" TYPE="STUDY">Gerovasili 2009a</LINK>; <LINK REF="STD-Gruther-2010" TYPE="STUDY">Gruther 2010</LINK>; <LINK REF="STD-Morris-2008" TYPE="STUDY">Morris 2008</LINK>; <LINK REF="STD-Zanotti-2003" TYPE="STUDY">Zanotti 2003</LINK>). Two trials remained that fulfilled the selection criteria (<LINK REF="STD-Routsi-2010" TYPE="STUDY">Routsi 2010</LINK>; <LINK REF="STD-Schweickert-2009" TYPE="STUDY">Schweickert 2009</LINK>). Our search of EMBASE up to October 2011 revealed another seven out of 408 retrieved studies, for possible inclusion. One trial was a subanalysis of the EMS trial (<LINK REF="STD-Karatzanos-2012" TYPE="STUDY">Karatzanos 2012</LINK>), and five others did not provide the incidence of CIP/CIM as a primary or secondary outcome (Alia 2010; <LINK REF="STD-Chen--2011" TYPE="STUDY">Chen 2011</LINK>; <LINK REF="STD-Martin-2011" TYPE="STUDY">Martin 2011</LINK>; <LINK REF="STD-Miao-2005" TYPE="STUDY">Miao 2005</LINK>; <LINK REF="STD-Routsi-2009" TYPE="STUDY">Routsi 2009</LINK>). One trial randomised body parts rather than participants (<LINK REF="STD-Rodriguez-2012" TYPE="STUDY">Rodriguez 2012</LINK>). Additionally, two out of the 159 references retrieved by CENTRAL were of potential interest. Both were excluded because of the absence of the incidence of CIP/CIM as a primary or secondary outcome (<LINK REF="STD-Huang-2006" TYPE="STUDY">Huang 2006</LINK>), or because the intervention was not investigated with the potential to reduce the incidence of CIP/CIM (<LINK REF="REF-Papazian-2010" TYPE="REFERENCE">Papazian 2010</LINK>). Searching the Cochrane Neuromuscular Disease Group Specialized Register produced another 10 hits which did not result in any new references. Other data sources revealed another four references which were all excluded because the studies were not performed in the ICU (<LINK REF="STD-Menadue-2010" TYPE="STUDY">Menadue 2010</LINK>; <LINK REF="STD-Salisbury-2010" TYPE="STUDY">Salisbury 2010</LINK>; <LINK REF="STD-Vivodtzev-2006" TYPE="STUDY">Vivodtzev 2006</LINK>) or did not present the incidence of CIP/CIM as a primary or secondary outcome (<LINK REF="STD-Gerovasili-2009a" TYPE="STUDY">Gerovasili 2009a</LINK>).</P>
<P>We excluded a total of 41 studies. Five trials fulfilling the inclusion criteria for this review remained (<LINK REF="STD-Hermans-2007" TYPE="STUDY">Hermans 2007</LINK>; <LINK REF="STD-Routsi-2010" TYPE="STUDY">Routsi 2010</LINK>; <LINK REF="STD-Schweickert-2009" TYPE="STUDY">Schweickert 2009</LINK>; <LINK REF="STD-Steinberg-2006" TYPE="STUDY">Steinberg 2006</LINK>; <LINK REF="STD-Van-den-Berghe-2005" TYPE="STUDY">Van den Berghe 2005</LINK>).</P>
<P>We updated the searches in December 2013 and identified nine trial reports that require further assessment (see <LINK TAG="CHARACTERISTICS_OF_AWAITING_STUDIES" TYPE="SECTION">Characteristics of studies awaiting classification</LINK>). We will assess these trials for inclusion in the next update of the review. We also identified two trial protocols from these searches (see <LINK TAG="CHARACTERISTICS_OF_ONGOING_STUDIES" TYPE="SECTION">Characteristics of ongoing studies</LINK>).</P>
<P>Two of the five included trials (<LINK REF="STD-Hermans-2007" TYPE="STUDY">Hermans 2007</LINK>; <LINK REF="STD-Van-den-Berghe-2005" TYPE="STUDY">Van den Berghe 2005</LINK>) were planned subgroup analyses of the secondary outcomes of two prior trials that compared treatment with IIT versus conventional insulin therapy (CIT) on mortality and morbidity outcomes in ICU (<LINK REF="REF-Van-den-Berghe-2001" TYPE="REFERENCE">Van den Berghe 2001</LINK>; <LINK REF="REF-Van-den-Berghe-2006a" TYPE="REFERENCE">Van den Berghe 2006a</LINK>). The two primary trials included 2748 participants randomised to IIT or CIT, of whom 1548 were in a surgical ICU following cardiac surgery (63%) or had medical/surgical complications after other surgery or trauma (37%) (<LINK REF="REF-Van-den-Berghe-2001" TYPE="REFERENCE">Van den Berghe 2001</LINK>), and 1200 were in a medical ICU, with a variety of conditions (<LINK REF="REF-Van-den-Berghe-2006a" TYPE="REFERENCE">Van den Berghe 2006a</LINK>). Between 13% and 17% of the participants had diabetes prior to admission. At day seven, 1923 participants in these primary trials had been discharged from the ICU or had died, leaving a total of 825 participants who were evaluable for 'screening' for CIP/CIM and were included in the two secondary trials (see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>). <LINK REF="STD-Van-den-Berghe-2005" TYPE="STUDY">Van den Berghe 2005</LINK> evaluated patients treated in the surgical ICU and included 405 participants who reached seven days of ICU care, from among the 1548 participants in the original surgical ICU randomisation. <LINK REF="STD-Hermans-2007" TYPE="STUDY">Hermans 2007</LINK> enrolled patients in the sister medical ICU study, and included 420 of the 1200 participants in the primary study. The investigators diagnosed CIP/CIM in these 825 participants by weekly electrophysiological examination. The neurophysiologist performing the EMG screening, who determined the presence or absence of diagnostic EMG changes, was blinded to the treatment group. Assessments of mortality and length of stay were not blinded. Significantly fewer participants treated with IIT in the original surgical ICU study (<LINK REF="REF-Van-den-Berghe-2001" TYPE="REFERENCE">Van den Berghe 2001</LINK>), but not in the medical study (<LINK REF="REF-Van-den-Berghe-2006a" TYPE="REFERENCE">Van den Berghe 2006a</LINK>), reached the CIP/CIM screening period because of the benefit of IIT in the first seven days, a possible source of bias in the subsequent results. Any bias as such originated from earlier ICU discharge in the intervention group and would be expected to reduce rather than inflate the effect. Both trials were single centre trials.</P>
<P>One trial compared therapy with corticosteroids versus placebo in 180 participants with unresolving ARDS (<LINK REF="STD-Steinberg-2006" TYPE="STUDY">Steinberg 2006</LINK>). Intravenous methylprednisolone was given at a starting dose of 2 mg/kg/day then gradually tapered over more than three weeks. During this trial, six adverse events of neuromyopathy were reported. This was followed by a retrospective chart review of all the 88 previously enrolled participants, ordered by the safety board. From then on, neuromyopathy was prospectively evaluated in the next 92 participants.</P>
<P>One trial randomised 104 critically ill medical individuals within 72 hours of mechanical ventilation to early physical and occupational therapy co-ordinated with daily interruption of sedatives, versus standard care (<LINK REF="STD-Schweickert-2009" TYPE="STUDY">Schweickert 2009</LINK>). The latter included the interruption of sedatives and physiotherapy as ordered by the treating physician. The participating sites did not usually order physiotherapy for individuals mechanically ventilated for less than two weeks. Participants were all living independently premorbidly and expected to be ventilated for at least one more day. CIP/CIM was evaluated using the MRC sum-score. For participants who never awakened, the authors of the study imputed a zero MRC score.</P>
<P>One trial randomised 140 participants on the second day of ICU stay to daily sessions of bilateral lower limb EMS versus control, without sham stimulation (<LINK REF="STD-Routsi-2010" TYPE="STUDY">Routsi 2010</LINK>). CIP/CIM was diagnosed using the MRC sum-score with a cut-off of 48. Only 24 EMS and 28 control participants were actually evaluable. The reasons for missing MRC data included death, impaired cognitive state or dropout because of prolonged neuromuscular blocking treatment or no EMS sessions received. In the evaluable participants, a significant baseline difference was present between EMS and control participants in their APACHE II score (EMS 16 ± 4, control 19 ± 5; MD -3.00, 95% CI -5.45 to -0.55), diagnostic categories on admission (P = 0.05) and the presence of comorbid renal disease (EMS 0%, control 21%; P = 0.03; RR 0.07, 95% CI 0 to 1.33) (<LINK REF="STD-Karatzanos-2012" TYPE="STUDY">Karatzanos 2012</LINK>), which possibly influences the significance of any results.</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2014-01-17 09:55:01 +0000" MODIFIED_BY="[Empty name]">
<P>The risk of bias for the individual trials is described in <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> and <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> provides a summary of review authors' judgements across all domains for all studies.</P>
<P>In four trials, we considered random sequence generation, allocation concealment, and blinding for the neuromuscular outcome to be at low risk of bias (<LINK REF="STD-Hermans-2007" TYPE="STUDY">Hermans 2007</LINK>; <LINK REF="STD-Schweickert-2009" TYPE="STUDY">Schweickert 2009</LINK>; <LINK REF="STD-Steinberg-2006" TYPE="STUDY">Steinberg 2006</LINK>; <LINK REF="STD-Van-den-Berghe-2005" TYPE="STUDY">Van den Berghe 2005</LINK>). In one trial, we considered sequence generation and allocation concealment to be at high risk of bias because the trialists used odd and even numbers for group assignments (<LINK REF="STD-Routsi-2010" TYPE="STUDY">Routsi 2010</LINK>). In <LINK REF="STD-Routsi-2010" TYPE="STUDY">Routsi 2010</LINK>, blinding for neuromuscular outcome data was also judged to be at high risk of bias because outcome assessors were not blinded to the participant allocation. We considered blinding for mortality at low risk of bias in all trials, as knowledge of the intervention is unlikely to affect this outcome (<LINK REF="REF-Higgins-2011b" TYPE="REFERENCE">Higgins 2011b</LINK>). Blinding for other secondary outcomes was at high risk of bias in two trials (<LINK REF="STD-Routsi-2010" TYPE="STUDY">Routsi 2010</LINK>; <LINK REF="STD-Schweickert-2009" TYPE="STUDY">Schweickert 2009</LINK>) and at low risk in the remaining trials. We judged completeness of follow-up for the neuromuscular outcome as at high risk of bias because of the substantial amount of imputed data in four trials (<LINK REF="STD-Hermans-2007" TYPE="STUDY">Hermans 2007</LINK>; <LINK REF="STD-Schweickert-2009" TYPE="STUDY">Schweickert 2009</LINK>; <LINK REF="STD-Steinberg-2006" TYPE="STUDY">Steinberg 2006</LINK>; <LINK REF="STD-Van-den-Berghe-2005" TYPE="STUDY">Van den Berghe 2005</LINK>). We also assigned a high risk of bias for this item to the EMS trial because of imbalance in the screened patients and because it was necessary to impute a large amount of data to perform an intention-to-treat analysis (<LINK REF="STD-Routsi-2010" TYPE="STUDY">Routsi 2010</LINK>). Attrition bias for mortality and for other secondary outcomes was low in all studies. One study lacked adequate diagnostic criteria (<LINK REF="STD-Steinberg-2006" TYPE="STUDY">Steinberg 2006</LINK>). In this trial, no clear predefined diagnostic criteria were used for either the retrospectively or prospectively evaluated participants. In the four other trials reporting data on our primary outcome measure, predefined electrophysiological or clinical criteria were used (<LINK REF="STD-Hermans-2007" TYPE="STUDY">Hermans 2007</LINK>; <LINK REF="STD-Routsi-2010" TYPE="STUDY">Routsi 2010</LINK>; <LINK REF="STD-Schweickert-2009" TYPE="STUDY">Schweickert 2009</LINK>; <LINK REF="STD-Van-den-Berghe-2005" TYPE="STUDY">Van den Berghe 2005</LINK>). We therefore graded them as at low risk of bias in this respect. In one trial, we identified an additional risk of bias as the trial was stopped due to a formal, but data-dependent, stopping rule (<LINK REF="STD-Van-den-Berghe-2005" TYPE="STUDY">Van den Berghe 2005</LINK>).</P>
<P>We used unpublished information derived from the authors to assess certain items for three trials (<LINK REF="STD-Hermans-2007" TYPE="STUDY">Hermans 2007</LINK>; <LINK REF="STD-Schweickert-2009" TYPE="STUDY">Schweickert 2009</LINK>; <LINK REF="STD-Van-den-Berghe-2005" TYPE="STUDY">Van den Berghe 2005</LINK>).</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2014-01-17 09:55:31 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Intensive insulin therapy versus conventional insulin therapy</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcome measure: occurrence of CIP/CIM</HEADING>
<P>Data on the incidence of CIP/CIM were available from both insulin trials for individuals in the ICU for at least seven days (<LINK REF="STD-Hermans-2007" TYPE="STUDY">Hermans 2007</LINK>; <LINK REF="STD-Van-den-Berghe-2005" TYPE="STUDY">Van den Berghe 2005</LINK>). In the individual studies, significantly fewer participants in the ongoing IIT group developed CIP/CIM compared to the CIT group. In <LINK REF="STD-Van-den-Berghe-2005" TYPE="STUDY">Van den Berghe 2005</LINK>, the RR was 0.52 (95% CI 0.39 to 0.69) and in <LINK REF="STD-Hermans-2007" TYPE="STUDY">Hermans 2007</LINK>, the RR was 0.77 (95% CI 0.62 to 0.96). Analysis of the whole surgical population who received CIT or IIT was performed as a post hoc intention-to-treat analysis (n = 1548) with negative imputation performed for participants who were not screened by EMG because they were no longer in the ICU on day seven. In the whole population IIT reduced the risk of CIP/CIM, as assessed by weekly EMG screenings (RR 0.49, 95% CI 0.37 to 0.66), but this analysis involved imputing data for 74% of the participants. A similar analysis in the medical population revealed an RR of 0.84 (95% CI 0.70 to 1.01), with imputation of 72% of the data.</P>
<P>A meta-analysis of the two insulin trials was possible, which comprised 389 participants treated with IIT and 436 participants treated with CIT. In the surgical trial, but not in the medical trial, significantly fewer IIT participants entered the screened phase. Any bias originated from earlier ICU discharge in the intervention group and would be expected to reduce rather than inflate the effect. Meta-analysis using a fixed-effect model showed a significant benefit of IIT in the 'screened' patients, with an RR of 0.65 (95% CI 0.55 to 0.77) (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>, <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>). As the statistical heterogeneity here is the result of clinical diversity, the fixed-effect analysis provides the best estimate of the intervention effect (<LINK REF="REF-Deeks-2011" TYPE="REFERENCE">Deeks 2011</LINK>). Use of a more conservative random-effects model, to account for heterogeneity, changes the RR to 0.64 (95% CI 0.44 to 0.94). With only two studies in the meta-analysis, however, a random-effects analysis provides poor estimates of the distribution of intervention effects (<LINK REF="REF-Deeks-2011" TYPE="REFERENCE">Deeks 2011</LINK>). Based on the current data, we cannot exclude a real or artificial difference in the effect size between medical and surgical patients.</P>
<P>We have also performed an analysis of practicality, as it is not possible to identify individuals upon admission to ICU as needing ICU for at least one week. We analysed data on the primary outcome measure as well as on the secondary outcome measures in the total randomised population (1360 IIT and 1388 CIT participants). As participants who were in the ICU for less than one week did not undergo an electrophysiological examination, we imputed data for them. For the purpose of the analysis, we categorised those who died as having CIP/CIM, whereas we categorised patients discharged early, and therefore not evaluated, as not having CIP/CIM. This showed that IIT had a significantly beneficial effect on CIP/CIM, with an RR of 0.70 (95% CI 0.60 to 0.82) (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>) but the effect was lost in the random-effects analysis (RR 0.65, 95% CI 0.38 to 1.11). This conclusion remained when we imputed data only for participants who had been discharged alive and did not make assumptions about the neuromuscular status of those who died early (fixed-effect model RR 0.60, 95% CI 0.49 to 0.73; random-effects model RR 0.58, 95% CI 0.33 to 1.02, analysis not shown).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcome measures</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Duration of mechanical ventilation</HEADING>
<P>For the insulin trials, the need for prolonged mechanical ventilation (a surrogate measure of neuromuscular weakness) was defined as mechanical ventilation for at least 14 days. The need for mechanical ventilation was significantly reduced in the IIT group compared to the CIT group, with an RR of 0.76 (95% CI 0.58 to 0.99) for <LINK REF="STD-Van-den-Berghe-2005" TYPE="STUDY">Van den Berghe 2005</LINK> and an RR of 0.74 (95% CI 0.59 to 0.94) for <LINK REF="STD-Hermans-2007" TYPE="STUDY">Hermans 2007</LINK>. In meta-analysis, IIT had a significant beneficial effect on the duration of mechanical ventilation, with an MD of -2.00 days (95% CI -2.93 to -1.07) for the total population randomised and an MD of -2.55 days (95% CI -4.60 to -0.51) for the population actually included at seven days or more of ICU stay (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>). In practical terms, only people surviving the ICU will benefit from an intervention that reduces CIP/CIM, and so we analysed data for ICU survivors (1181 participants with IIT and 1163 participants with CIT). IIT reduced the duration of mechanical ventilation in the ICU survivors as part of the total population randomised (MD -1.00, 95% CI -1.86 to -0.14) (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>), but not in the subpopulation of ICU survivors who were included with seven or more days of ICU admission.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Duration of ICU stay</HEADING>
<P>IIT significantly reduced the duration of ICU stay (<LINK REF="STD-Hermans-2007" TYPE="STUDY">Hermans 2007</LINK>; <LINK REF="STD-Van-den-Berghe-2005" TYPE="STUDY">Van den Berghe 2005</LINK>). The MD was -1.48 days (95% CI -2.43 to -0.54) for the total population randomised and MD -3.59 days (95% CI -5.70 to -1.48) in the screened population (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>). When we analysed only the population of ICU survivors, the statistical benefit remained in the total randomised group (MD -1.00 days, 95% CI -1.90 to -0.10), but not in the screened population (MD -2.18 days, 95% CI -4.66 to 0.30).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Death at 30 and 180 days</HEADING>
<P>In the insulin trials, there was no statistically significant effect on mortality at 30 days in the total population (RR 0.94, 95% CI 0.80 to 1.10) or in the screened population (RR 0.91, 95% CI 0.72 to 1.14) (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>). With a fixed-effect model, the meta-analysis showed a significant beneficial effect on 180-day mortality (total population RR 0.87, 95% CI 0.76 to 1.00, screened population RR 0.78, 95% CI 0.66 to 0.93). When we used a more conservative random-effects model to take into account the heterogeneity, this effect was lost in the total population (RR 0.83, 95% CI 0.60 to 1.13) but confirmed in the screened population (RR 0.79, 95% CI 0.63 to 0.98). However, this random-effects analysis is bound to provide poor estimates of the distribution of intervention effects, as there were only two studies in the meta-analysis (see primary outcome measure above).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Serious adverse events</HEADING>
<P>The insulin trials defined hypoglycaemia as blood glucose below 40 mg/dL and the occurrence of at least two hypoglycaemic events. The incidence of hypoglycaemia was significantly higher in the IIT than the CIT group in both the total patient population randomised (RR 6.27, 95% CI 4.15 to 9.49), as well as in the screened participants (RR 6.93, 95% CI 4.10 to 11.72) (<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>). There was no increase in death 24 hours after the last hypoglycaemic event in the total population randomised (RR 1.6, 95% CI 0.42-6.10).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Corticosteroids versus placebo</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcome measure: occurrence of CIP/CIM</HEADING>
<P>The steroid trial (<LINK REF="STD-Steinberg-2006" TYPE="STUDY">Steinberg 2006</LINK>) provided primary outcome data on clinical weakness. The trial involved 92 participants, of whom 48 received placebo and 44 received corticosteroids. There was no significant difference between the treatment groups according to the data that the trialists obtained prospectively (incidence of CIP/CIM in the placebo group was 11/48 (23%), and in the intervention group, 11/44 (25%); RR 1.09, 95% CI 0.53 to 2.26) (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>, <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>). We also performed an intention-to-treat analysis, by imputing data for the first 88 participants, whom the trial authors did not evaluate prospectively. For this purpose we used the retrospective data available for these participants. With imputed data there was also no significant effect (RR 1.27, 95% CI 0.77 to 2.08).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcome measures</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Duration of mechanical ventilation</HEADING>
<P>Not reported</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Duration of ICU stay</HEADING>
<P>Not reported</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Death at 30 and 180 days</HEADING>
<P>Steroids had no effect on mortality at 180 days (RR 0.99, 95% CI 0.64 to 1.52) (<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>). No data were available at 30 days, as the primary outcome measure of this trial was death at 60 days (which also showed no difference). Subanalyses, however, revealed increased mortality in the steroid-treated participants in the subgroup enrolled at least 14 days after the onset of ARDS at 60 days, as well as at 180 days.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Serious adverse events</HEADING>
<P>Treatment with corticosteroids appeared to have a protective effect on the occurrence of new episodes of shock (RR 0.41, 95% CI 0.17 to 1.01) (<LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>), and no significant effect on new serious infections (RR 0.68, 95% CI 0.42 to 1.11) or episodes of suspected or probable pneumonia (RR 0.44, 95% CI 0.18 to 1.09). Blood glucose levels reported in this trial on day seven were not significantly different in corticosteroid and placebo groups (MD 15.00 mg/dL, 95% CI -3.41 to 33.41) (<LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Early physical therapy versus control</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcome measure: occurrence of CIP/CIM</HEADING>
<P>The early physical therapy trial reported data on CIP/CIM at hospital discharge and included imputation using an MRC value of zero for non-survivors (<LINK REF="STD-Schweickert-2009" TYPE="STUDY">Schweickert 2009</LINK>). There was no significant difference in the incidence of CIP/CIM in the total randomised population at hospital discharge (15/49 in the intervention group versus 27/55 in the control group with significant weakness, RR 0.62, 95% CI 0.38 to 1.03, analysis not shown). We obtained further data about participants with weakness at ICU discharge through personal communication with the study authors. For the total population randomised to early therapy versus standard care (intention-to-treat analysis, imputing worst values for participants who were not evaluable), the RR for the intervention was not significant at ICU discharge (RR 0.81, 95% CI 0.60 to 1.08) (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>, <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>). For participants both randomised and actually screened (alive and co-operative), the RR of CIP/CIM at ICU discharge judged by weakness was 0.62 (95% CI 0.39 to 0.96) (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>, <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcome measures</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Duration of mechanical ventilation</HEADING>
<P>The early physical therapy trial (<LINK REF="STD-Schweickert-2009" TYPE="STUDY">Schweickert 2009</LINK>) reported a significant reduction in the duration of mechanical ventilation (median (IQR) 3.4 days (2.3 to 7.3) versus 6.1 days (4.0 to 9.6)).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Duration of ICU stay</HEADING>
<P>
<LINK REF="STD-Schweickert-2009" TYPE="STUDY">Schweickert 2009</LINK> showed that early physiotherapy had no effect on duration of ICU stay (intervention median 5.9 days (IQR 4.5 to 13.2); control median 7.9 days (IQR 6.1 to 12.9), P = 0.08).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Death at 30 and 180 days</HEADING>
<P>
<LINK REF="STD-Schweickert-2009" TYPE="STUDY">Schweickert 2009</LINK> did not report 30- or 180-day mortality, but hospital mortality was not significantly different.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Serious adverse events</HEADING>
<P>In one participant in the early physiotherapy group, desaturation &lt; 80% occurred, which was related to the intervention (<LINK REF="STD-Schweickert-2009" TYPE="STUDY">Schweickert 2009</LINK>). From the available data, no significant severe adverse events were observed from early physiotherapy (<LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Electrical muscle stimulation versus control</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcome measure: occurrence of CIP/CIM</HEADING>
<P>
<LINK REF="STD-Routsi-2010" TYPE="STUDY">Routsi 2010</LINK> reported the incidence of weakness in the 52 evaluable participants from among the 140 participants who were randomised to EMS or control groups. The evaluable treatment and control groups were not completely comparable. There were considerable differences in the baseline characteristics and severity of illness between the EMS and control groups (see <LINK TAG="STUDY_DESCRIPTION" TYPE="SECTION">Description of studies</LINK>). In this evaluable subset of participants, EMS had no effect on reducing the incidence of CIP/CIM (EMS 3/24, control 11/28; RR 0.32, 95% CI 0.10 to 1.01). After imputing worst values for the non-evaluated 88 participants, as in <LINK REF="STD-Schweickert-2009" TYPE="STUDY">Schweickert 2009</LINK>, the effect of EMS on CIP/CIM was even less significant (RR 0.94, 95% CI 0.78 to 1.15) (<LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcome measures</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Duration of mechanical ventilation</HEADING>
<P>EMS did not significantly reduce the duration of mechanical ventilation (<LINK REF="STD-Routsi-2010" TYPE="STUDY">Routsi 2010</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Duration of ICU stay</HEADING>
<P>
<LINK REF="STD-Routsi-2010" TYPE="STUDY">Routsi 2010</LINK> also found no effect for EMS on duration of ICU stay (mean (range): EMS 14 days (4 to 62) ; control 22 days (2 to 92), P = 0.11).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Death at 30 and 180 days</HEADING>
<P>
<LINK REF="STD-Routsi-2010" TYPE="STUDY">Routsi 2010</LINK> reported no difference in ICU mortality with EMS, but no data are available for mortality at 30 or 180 days.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Serious adverse events</HEADING>
<P>The EMS trial provided no systematic evaluation of adverse events (<LINK REF="STD-Routsi-2010" TYPE="STUDY">Routsi 2010</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2014-01-17 09:55:46 +0000" MODIFIED_BY="[Empty name]">
<P>Our review includes five studies examining the effects of four interventions on the incidence of CIP/CIM, although only one of these specifically evaluated this as a primary outcome (<LINK REF="STD-Routsi-2010" TYPE="STUDY">Routsi 2010</LINK>). This is a very small number of trials. One of the main reasons for this is that no clear and uniformly accepted diagnostic criteria for CIP/CIM exist. The literature reports various evaluations of peripheral or respiratory muscle force in the critically ill, such as maximal inspiratory pressure, hand grip force, quadriceps strength and thumb muscle force, but these lack a cut-off value that allows differentiation between weak and not weak individuals and therefore do not allow diagnosis of CIP/CIM. An arbitrary cut-off value is only described for the MRC sum-score, which is employed by two of the included studies. Several other trials only evaluated nitrogen metabolism and protein balance or muscle mass after various interventions, without any clinical or electrophysiological correlation. As these are not validated or accepted criteria for CIP/CIM, we excluded these studies from this review.</P>
<P>Two included trials evaluated the effect of IIT on CIP/CIM and studied a total of 825 participants (see <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>). One trial was in a surgical ICU and one trial in a medical ICU. Both were at the same single centre. IIT significantly reduced our primary outcome measure, incidence of CIP/CIM after at least one week in ICU (fixed-effect model RR 0.65, 95% CI 0.55 to 0.77; random-effects model RR 0.64, 95% CI 0.44 to 0.94). Baseline characteristics, including severity of illness, were well balanced between both treatment groups in this screened long-stay population of medical patients. Although no differences were identified in the surgical population, significantly fewer participants treated with IIT reached the CIP/CIM screening period because of the benefit of IIT in the first seven days. Any potential bias induced hereby originated from earlier ICU discharge in the intervention group and would be expected to reduce rather than inflate the effect. As ICU stay of at least seven days cannot be predicted accurately on admission, we also evaluated all outcome measures for the total population randomised to receive IIT or CIT. As participants discharged or dead within one week were not screened for CIP/CIM, we used imputation of positive results for those participants who died and negative results for those alive discharged. Meta-analysis then showed a significant beneficial effect in the total population randomised (RR 0.70, 95% CI 0.60 to 0.82). As we imputed a large amount of data, this analysis is prone to bias and imputation of data does have limitations. Furthermore, there is significant heterogeneity in the meta-analysis. This heterogeneity is due to clinical diversity, as methodology was identical in both ICUs. We performed a more conservative statistical analysis using a random-effects model to potentially take account of this heterogeneity. This showed that the effect was lost (RR 0.65, 95% CI 0.38 to 1.11). However, this type of analysis provides poor estimates of the width of the distribution of intervention effects when the meta-analysis includes only two studies. In participants discharged within one week, it is likely that no clinically relevant CIP/CIM was present. Participants who died within the first week clearly had a bad outcome. The trialists made the diagnosis of CIP/CIM using only the presence of abundant spontaneous electrical activity on electrophysiological examination, which is observed either in axonopathy or muscle necrosis, two important components of the neuromuscular involvement in individuals with CIP/CIM. On the other hand, some myopathies with muscle membrane inexcitability may therefore have been missed. The issues identified here might be addressed in future studies.</P>
<P>Concerning the secondary outcome measures, IIT had a beneficial effect on duration of mechanical ventilation, ICU stay and 180-day mortality in the total population randomised, as well as in the population screened for CIP/CIM, but had no beneficial effect on mortality at 30 days, which is likely to be too early to see the benefit of this intervention. When the analysis was redone taking account of heterogeneity, which was only present in the 180-day mortality analysis, the reduction in 180-day mortality was confirmed in the screened population but lost in the total population. Whether the reduction in duration of mechanical ventilation is the result of improved respiratory muscle force or other beneficial effects of IIT, such as reduced infections or reduced organ failure, remains unclear.</P>
<P>Hypoglycaemia and at least two hypoglycaemic events occurred more frequently in the IIT group than in the CIT group, in the total population randomised as well as in the screened participants. There was no increase in mortality within 24 hours of the hypoglycaemia. Although retrospective analysis from these trials did not show any long-lasting detrimental effects in participants developing hypoglycaemia (<LINK REF="REF-Van-den-Berghe-2006b" TYPE="REFERENCE">Van den Berghe 2006b</LINK>), this complication is a major concern when implementing IIT in ICU, as hypoglycaemia may not be easily recognised in critically ill individuals, and profound and prolonged hypoglycaemia can cause coma, epilepsy and neurological sequelae. Finally, pointing to the potential harm to overall outcome, there have been calls for caution to be used in implementing this treatment on a large scale but with methods and protocols that are different from the original setting (<LINK REF="REF-Finfer-2009" TYPE="REFERENCE">Finfer 2009</LINK>).</P>
<P>The third RCT compared corticosteroids with placebo in people with persisting ARDS (see <LINK REF="SOF-02" TYPE="SOF">Summary of findings table 2</LINK>). The trial randomised a total of 180 participants, but prospectively evaluated only 92 for the incidence of CIP/CIM. The results found no significant difference between steroids and placebo (RR 1.09, 95% CI 0.53 to 2.26). We performed an intention-to-treat analysis by imputing results for the first 88 participants, for which we used the retrospective data from the analysis of these participants in the trial. There was no significant difference in effect between steroid and placebo (RR 1.27, 95% CI 0.77 to 2.08). There were no significant differences in 180-day mortality, infection, pneumonia or glycaemia, although new episodes of shock occurred less frequently with corticosteroids (RR 0.41, 95% CI 0.17 to 1.01).</P>
<P>The third intervention involved early physical therapy versus control (<LINK REF="STD-Schweickert-2009" TYPE="STUDY">Schweickert 2009</LINK>) (see <LINK REF="SOF-03" TYPE="SOF">Summary of findings table 3</LINK>). Only 82 of the 104 randomised participants were available for measurement in ICU, being alive and co-operative. In this evaluated population, the intervention significantly reduced the risk of CIP/CIM (RR 0.62, 95% CI 0.39 to 0.96). To obtain a full intention-to-treat analysis, we imputed data and gave participants that were not evaluable a score of zero on the MRC scale. The intention-to-treat analysis did not confirm a significant treatment effect (RR 0.81, 95% CI 0.60 to 1.08). The trial reported a significant shortening of duration of mechanical ventilation with early physical therapy, but no effect on duration of ICU stay, hospital mortality, or severe adverse events.</P>
<P>Finally, one trial examined the effects of daily EMS sessions on the lower limbs on the incidence of CIP/CIM (see <LINK REF="SOF-04" TYPE="SOF">Summary of findings table 4</LINK>). Only 50 out of 140 participants were evaluable. In this subset of screened participants, there was no reduction in the incidence of CIP/CIM (RR 0.32, 95% CI 0.10 to 1.01). Importantly, there was an imbalance between intervention and control participants in this screened subset concerning severity of illness, diagnostic categories and renal disease as a comorbidity, some of which may have introduced significant bias in these results favouring the intervention arm. Imputation of worst values for participants not evaluable negated any significant treatment effect (RR 0.94, 95% CI 0.78 to 1.15). As we imputed a large amount of data, this analysis is also prone to substantial bias.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2014-01-13 23:03:53 +0000" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2014-01-13 23:03:53 +0000" MODIFIED_BY="[Empty name]">
<P>Moderate quality evidence from two large single-centre trials shows a significant benefit of intensive insulin therapy on the electrophysiological incidence of critical illness polyneuropathy/critical illness myopathy in individuals in the intensive care unit for at least one week, and on its most important associated problem of prolonged mechanical ventilation (high quality evidence). Whether this is the result of improved respiratory muscle force or other beneficial effects of intensive insulin therapy is unclear. No data are available concerning the effect of intensive insulin therapy on clinical weakness of peripheral muscles and physical rehabilitation. There were also significant reductions in prolonged intensive care unit stay and mortality rate at 180 days. Hypoglycaemia remains a major issue of concern and follow-up studies in which the treatment has been implemented on a large scale call for caution on overall outcome. In neither trial was critical illness polyneuropathy/critical illness myopathy a primary outcome measure and results derive from subgroup analysis, which may limit conclusions. Moderate quality evidence from one multicentre trial showed no evidence of an effect of corticosteroid treatment on critical illness polyneuropathy/critical illness myopathy, but the number of new events of shock was reduced. Moderate quality evidence from a single randomised controlled trial suggests possible benefit in preventing critical illness polyneuropathy/critical illness myopathy from an early rehabilitation strategy in the evaluable participants with associated reduction in the duration of mechanical ventilation. Finally, also very low quality evidence from a single study suggests no benefit from electrical muscle stimulation, and the data are prone to bias.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2013-12-19 13:11:39 +0000" MODIFIED_BY="[Empty name]">
<P>This review underlines the need for debate and consensus on criteria to define critical illness polyneuropathy/critical illness myopathy for the purpose of research. This is the first step towards the design of future high quality randomised trials on the subject. Several theoretically appealing interventions should be studied in randomised controlled trials. More particularly, further evaluation of early rehabilitation strategies and optimal timing during critical illness should be pursued. Possible preventive effects of electrical muscle stimulation should be further examined. Additional research is needed concerning the impact of hypoglycaemia in critically ill individuals and into strategies that minimise the risk for hypoglycaemia when implementing strict glycaemic control.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2014-01-17 09:55:50 +0000" MODIFIED_BY="Greet Hermans">
<P>We thank Jens de Groot for his advice concerning search strategies and Emmanuel Lesaffre for his statistical support. We also thank Jingjing Zhang for the translation. Greet Hermans is the recipient of a post doctoral fellowship from the Clinical Research Fund of the Leuven University Hospital and holds a research grant from the Flanders Research Foundation (FWO), Belgium (G.0399.12). Greet Van den Berghe receives funding from the Methusalem program of the Flemish Government (METH08/07) and holds a European Research Council Advanced Grant (AdvG-2012-321670) from the Ideas Program of the EU FP7.</P>
<P>The editorial base of the Cochrane Neuromuscular Disease Group is supported by the MRC Centre for Neuromuscular Diseases. The Cochrane Neuromuscular Disease Group Trials Search Co-ordinator developed and ran the searches.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2014-01-23 10:04:14 +0000" MODIFIED_BY="Greet Hermans">
<P>Greet Hermans and Greet Van den Berghe have been involved in trials included in the review.</P>
<P>Frans Bruyninckx and Bernard De Jonghe have no known conflicts of interest.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2013-11-22 10:12:30 +0000" MODIFIED_BY="Greet Hermans">
<P>Greet Van den Berghe initiated and supervised the project. Greet Hermans and Bernard De Jonghe independently extracted the data. Greet Hermans contacted corresponding authors for additional data and wrote the first draft. Bernard de Jonghe and Frans Bruyninckx commented on the first draft and made revisions. Greet Van den Berghe reviewed and commented on the revised draft prior to submission for formal review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2013-12-12 08:15:12 +0000" MODIFIED_BY="Ruth Brassington">
<P>During the process of updating the review, and after extensive discussion between the authors and the editorial board, it was decided to refine inclusion criteria in order to improve clarity and further reduce bias in the review. Therefore, the review includes only studies that report the incidence of CIP or CIM as a primary or secondary outcome.</P>
<P>We used the Cochrane 'Risk of bias' tool to assess studies, which was introduced after publication of our protocol. For this update we included 'Summary of findings' tables.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2013-06-22 19:49:14 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="MIX" ID="STD-Hermans-2007" MODIFIED="2012-10-30 10:13:11 +0000" MODIFIED_BY="[Empty name]" NAME="Hermans 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-10-30 10:13:11 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DA - 20061201&lt;/p&gt;" NOTES_MODIFIED="2012-10-30 10:13:11 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hermans G, Wilmer A, Meersseman W, Milants I, Wouters PJ, Bobbaers H, et al</AU>
<TI>Impact of intensive insulin therapy on neuromuscular complications and ventilator-dependency in MICU</TI>
<SO>American Journal of Respiratory Critical Care Medicine</SO>
<YR>2007</YR>
<VL>175</VL>
<NO>5</NO>
<PG>480-9</PG>
<IDENTIFIERS MODIFIED="2012-10-30 10:13:11 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-10-30 10:13:11 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="17138955"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Routsi-2010" MODIFIED="2013-06-21 20:46:03 +0100" MODIFIED_BY="Greet Hermans" NAME="Routsi 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-06-21 20:46:03 +0100" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Routsi C, Gerovasili V, Vasileiadis I, Karatzanos E, Pitsolis T, Tripodaki E, et al</AU>
<TI>Electrical muscle stimulation prevents critical illness polyneuromyopathy: a randomized parallel intervention trial</TI>
<SO>Critical Care (London, England)</SO>
<YR>2010</YR>
<VL>14</VL>
<NO>2</NO>
<PG>R74</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="20426834"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Schweickert-2009" MODIFIED="2012-01-16 09:06:12 +0000" MODIFIED_BY="Greet Hermans" NAME="Schweickert 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-01-16 09:04:52 +0000" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schweickert WD, Pohlman MC, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL, et al</AU>
<TI>Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial</TI>
<SO>Lancet</SO>
<YR>2009</YR>
<VL>373</VL>
<NO>9678</NO>
<PG>1874-82</PG>
<IDENTIFIERS MODIFIED="2012-01-16 09:04:39 +0000" MODIFIED_BY="Greet Hermans">
<IDENTIFIER TYPE="PUBMED" VALUE="19446324"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Steinberg-2006" MODIFIED="2012-10-30 10:22:47 +0000" MODIFIED_BY="[Empty name]" NAME="Steinberg 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-10-30 10:22:47 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DA - 20060420&lt;/p&gt;" NOTES_MODIFIED="2012-10-30 10:22:47 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, et al</AU>
<TI>Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome</TI>
<SO>New England Journal of Medicine</SO>
<YR>2006</YR>
<VL>354</VL>
<NO>16</NO>
<PG>1671-84</PG>
<IDENTIFIERS MODIFIED="2012-10-30 10:22:25 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-10-30 10:22:25 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16625008"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Van-den-Berghe-2005" MODIFIED="2012-10-30 10:24:21 +0000" MODIFIED_BY="[Empty name]" NAME="Van den Berghe 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-10-30 10:24:21 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DA - 20050426&lt;/p&gt;" NOTES_MODIFIED="2012-10-30 10:24:21 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ</AU>
<TI>Insulin therapy protects the central and peripheral nervous system of intensive care patients</TI>
<SO>Neurology</SO>
<YR>2005</YR>
<VL>64</VL>
<NO>8</NO>
<PG>1348-53</PG>
<IDENTIFIERS MODIFIED="2012-10-30 10:24:21 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-10-30 10:24:21 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15851721"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Berard-2000" MODIFIED="2013-12-12 08:23:35 +0000" MODIFIED_BY="[Empty name]" NAME="Berard 2000" YEAR="2000">
<REFERENCE MODIFIED="2013-12-12 08:23:35 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DA - 20001211&lt;/p&gt;" NOTES_MODIFIED="2013-12-12 08:23:35 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bérard MP, Zazzo JF, Condat P, Vasson MP, Cynober L</AU>
<TI>Total parenteral nutrition enriched with arginine and glutamate generates glutamine and limits protein catabolism in surgical patients hospitalized in intensive care units</TI>
<SO>Critical Care Medicine</SO>
<YR>2000</YR>
<VL>28</VL>
<NO>11</NO>
<PG>3637-44</PG>
<IDENTIFIERS MODIFIED="2013-11-28 15:57:01 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-28 15:57:01 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE=" 11098966"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bouletreau-1985" MODIFIED="2013-11-28 15:57:57 +0000" MODIFIED_BY="[Empty name]" NAME="Bouletreau 1985" YEAR="1985">
<REFERENCE MODIFIED="2013-11-28 15:57:57 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bouletreau P, Patricot MC, Saudin F, Guiraud M, Mathian B</AU>
<TI>Effects of intermittent electrical stimulations on muscle catabolism intensive care patients</TI>
<SO>JPEN. Journal of Parenteral and Enteral Nutrition</SO>
<YR>1987</YR>
<VL>11</VL>
<NO>6</NO>
<PG>552-5</PG>
<IDENTIFIERS MODIFIED="2013-11-28 15:57:57 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-28 15:57:57 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="3501482"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brunello-2010" MODIFIED="2012-08-28 15:27:59 +0100" MODIFIED_BY="Greet Hermans" NAME="Brunello 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-08-28 15:27:59 +0100" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brunello AG, Haenggi M, Wigger O, Porta F, Takala J, Jakob SM</AU>
<TI>Usefulness of a clinical diagnosis of ICU-acquired paresis to predict outcome in patients with SIRS and acute respiratory failure</TI>
<SO>Intensive Care Medicine</SO>
<YR>2010</YR>
<VL>36</VL>
<NO>1</NO>
<PG>66-74</PG>
<IDENTIFIERS MODIFIED="2012-01-16 09:28:41 +0000" MODIFIED_BY="Greet Hermans">
<IDENTIFIER TYPE="PUBMED" VALUE="19760204"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Burtin-2009" MODIFIED="2013-06-13 12:18:22 +0100" MODIFIED_BY="Greet Hermans" NAME="Burtin 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-13 12:18:22 +0100" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Burtin C, Clerckx B, Robbeets C, Ferdinande P, Langer D, Troosters T, et al</AU>
<TI>Early exercise in critically ill patients enhances short-term functional recovery</TI>
<SO>Critical Care Medicine</SO>
<YR>2009</YR>
<VL>37</VL>
<NO>9</NO>
<PG>2499-505</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="19623052"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Caruso-2005" MODIFIED="2014-01-16 00:33:02 +0000" MODIFIED_BY="Greet Hermans" NAME="Caruso 2005" YEAR="2005">
<REFERENCE MODIFIED="2014-01-16 00:33:02 +0000" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Caruso P, Denari SD, Ruiz SA, Bernal KG, Manfrin GM, Friedrich C, et al</AU>
<TI>Inspiratory muscle training is ineffective in mechanically ventilated critically ill patients</TI>
<SO>Clinics (Sao Paulo, Brazil)</SO>
<YR>2005</YR>
<VL>60</VL>
<NO>6</NO>
<PG>479-84</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="16358138"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen--2011" MODIFIED="2013-06-13 12:18:38 +0100" MODIFIED_BY="Greet Hermans" NAME="Chen  2011" YEAR="2011">
<REFERENCE MODIFIED="2013-06-13 12:18:38 +0100" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chen F, Wang J, Jiang Y</AU>
<TI>Influence of different routes of nutrition on the respiratory muscle strength and outcome of elderly patients in respiratory intensive care unit</TI>
<SO>Chinese Journal of Clinical Nutrition</SO>
<YR>2011</YR>
<VL>19</VL>
<NO>1</NO>
<PG>7-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chiang-2006" MODIFIED="2012-08-28 15:29:18 +0100" MODIFIED_BY="Greet Hermans" NAME="Chiang 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-08-28 15:29:18 +0100" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chiang LL, Wang LY, Wu CP, Wu HD, Wu YT</AU>
<TI>Effects of physical training on functional status in patients with prolonged mechanical ventilation</TI>
<SO>Physical Therapy</SO>
<YR>2006</YR>
<VL>86</VL>
<NO>9</NO>
<PG>1271-81</PG>
<IDENTIFIERS MODIFIED="2012-01-16 09:28:41 +0000" MODIFIED_BY="Greet Hermans">
<IDENTIFIER TYPE="PUBMED" VALUE="16959675"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fl_x00e4_ring-2003" MODIFIED="2013-11-28 16:02:02 +0000" MODIFIED_BY="[Empty name]" NAME="Fläring 2003" YEAR="2003">
<REFERENCE MODIFIED="2013-11-28 16:02:02 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fläring UB, Rooyackers OE, Wernerman J, Hammarqvist F</AU>
<TI>Glutamine attenuates post-traumatic glutathione depletion in human muscle</TI>
<SO>Clinical Science</SO>
<YR>2003</YR>
<VL>104</VL>
<NO>3</NO>
<PG>275-82</PG>
<IDENTIFIERS MODIFIED="2013-11-28 16:02:02 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-28 16:02:02 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="12605586"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gamrin-2000" MODIFIED="2013-12-12 08:23:52 +0000" MODIFIED_BY="[Empty name]" NAME="Gamrin 2000" YEAR="2000">
<REFERENCE MODIFIED="2013-12-12 08:23:52 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gamrin L, Essén P, Hultman E, McNurlan MA, Garlick PJ, Wernerman J</AU>
<TI>Protein-sparing effect in skeletal muscle of growth hormone treatment in critically ill patients</TI>
<SO>Annals of Surgery</SO>
<YR>2000</YR>
<VL>231</VL>
<NO>4</NO>
<PG>577-86</PG>
<IDENTIFIERS MODIFIED="2013-11-28 16:54:07 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-28 16:54:07 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="10749620"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gerovasili-2009a" MODIFIED="2013-01-08 16:16:34 +0000" MODIFIED_BY="Greet Hermans" NAME="Gerovasili 2009a" YEAR="2009">
<REFERENCE MODIFIED="2012-01-16 09:28:43 +0000" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gerovasili V, Tripodaki E, Karatzanos E, Pitsolis T, Markaki V, Zervakis D, et al</AU>
<TI>Short-term systemic effect of electrical muscle stimulation in critically ill patients</TI>
<SO>Chest</SO>
<YR>2009</YR>
<VL>136</VL>
<NO>5</NO>
<PG>1249-56</PG>
<IDENTIFIERS MODIFIED="2012-01-16 09:28:41 +0000" MODIFIED_BY="Greet Hermans">
<IDENTIFIER TYPE="PUBMED" VALUE="19710290"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gerovasili-2009b" MODIFIED="2013-01-08 16:16:30 +0000" MODIFIED_BY="Greet Hermans" NAME="Gerovasili 2009b" YEAR="2009">
<REFERENCE MODIFIED="2012-08-28 15:29:41 +0100" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gerovasili V, Stefanidis K, Vitzilaios K, Karatzanos E, Politis P, Koroneos A, et al</AU>
<TI>Electrical muscle stimulation preserves the muscle mass of critically ill patients: a randomized study</TI>
<SO>Critical Care (London, England)</SO>
<YR>2009</YR>
<VL>13</VL>
<NO>5</NO>
<PG>R161</PG>
<IDENTIFIERS MODIFIED="2012-01-16 09:28:41 +0000" MODIFIED_BY="Greet Hermans">
<IDENTIFIER TYPE="PUBMED" VALUE="19814793"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gruther-2010" MODIFIED="2013-06-15 20:44:33 +0100" MODIFIED_BY="Greet Hermans" NAME="Gruther 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-06-15 20:44:33 +0100" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gruther W, Kainberger F, Fialka-Moser V, Paternostro-Sluga T, Quittan M, Spiss C, et al</AU>
<TI>Effects of neuromuscular electrical stimulation on muscle layer thickness of knee extensor muscles in intensive care unit patients: a pilot study</TI>
<SO>Journal of Rehabilitation Medicine</SO>
<YR>2010</YR>
<VL>42</VL>
<NO>6</NO>
<PG>593-7</PG>
<IDENTIFIERS MODIFIED="2012-01-16 09:28:41 +0000" MODIFIED_BY="Greet Hermans">
<IDENTIFIER TYPE="PUBMED" VALUE="20549166"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hsieh-2006" MODIFIED="2013-12-12 08:24:04 +0000" MODIFIED_BY="[Empty name]" NAME="Hsieh 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-12-12 08:24:04 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hsieh LC, Chien SL, Huang MS, Tseng HF, Chang CK</AU>
<TI>Anti-inflammatory and anticatabolic effects of short-term beta-hydroxy-beta-methylbutyrate supplementation on chronic obstructive pulmonary disease patients in intensive care unit</TI>
<SO>Asia Pacific Journal of Clinical Nutrition</SO>
<YR>2006</YR>
<VL>15</VL>
<NO>4</NO>
<PG>544-50</PG>
<IDENTIFIERS MODIFIED="2013-11-28 16:54:54 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-28 16:54:54 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="17077073"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Huang-2006" MODIFIED="2012-08-28 15:30:08 +0100" MODIFIED_BY="Greet Hermans" NAME="Huang 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-08-28 15:30:08 +0100" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Huang CJ, Lin HC</AU>
<TI>Association between adrenal insufficiency and ventilator weaning</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2006</YR>
<VL>173</VL>
<NO>3</NO>
<PG>276-80</PG>
<IDENTIFIERS MODIFIED="2012-01-16 09:28:41 +0000" MODIFIED_BY="Greet Hermans">
<IDENTIFIER TYPE="PUBMED" VALUE="16272449"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Johnson-1993" MODIFIED="2013-06-13 12:18:47 +0100" MODIFIED_BY="Greet Hermans" NAME="Johnson 1993" YEAR="1993">
<REFERENCE MODIFIED="2013-06-13 12:18:47 +0100" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Johnson D, Gallagher C, Cavanaugh M, Yip R, Mayers I</AU>
<TI>The lack of effect of routine magnesium administration on respiratory function in mechanically ventilated patients</TI>
<SO>Chest</SO>
<YR>1993</YR>
<VL>104</VL>
<NO>2</NO>
<PG>536-41</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="8339645"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Karatzanos-2012" MODIFIED="2014-01-14 14:34:15 +0000" MODIFIED_BY="Greet Hermans" NAME="Karatzanos 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-01-14 14:34:15 +0000" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Karatzanos E, Gerovasili V, Zervakis D, Tripodaki ES, Apostolou K, Vasileiadis I, et al</AU>
<TI>Electrical muscle stimulation: an effective form of exercise and early mobilization to preserve muscle strength in critically ill patients</TI>
<SO>Critical Care Research and Practice</SO>
<YR>2012</YR>
<VL>2012</VL>
<PG>432752</PG>
<IDENTIFIERS MODIFIED="2013-12-13 07:38:39 +0000" MODIFIED_BY="Greet Hermans">
<IDENTIFIER TYPE="PUBMED" VALUE="22545212"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Knox-1996" MODIFIED="2013-11-28 16:42:45 +0000" MODIFIED_BY="[Empty name]" NAME="Knox 1996" YEAR="1996">
<REFERENCE MODIFIED="2013-11-28 16:42:45 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Knox JB, Wilmore DW, Demling RH, Sarraf P, Santos AA</AU>
<TI>Use of growth hormone for postoperative respiratory failure</TI>
<SO>American Journal of Surgery</SO>
<YR>1996</YR>
<VL>171</VL>
<NO>6</NO>
<PG>576-80</PG>
<IDENTIFIERS MODIFIED="2013-11-28 16:42:45 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-28 16:42:45 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="8678203"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kuhls-2007" MODIFIED="2013-11-28 16:44:35 +0000" MODIFIED_BY="[Empty name]" NAME="Kuhls 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-11-28 16:44:35 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kuhls DA, Rathmacher JA, Musngi MD, Frisch DA, Nielson J, Barber A, et al</AU>
<TI>Beta-hydroxy-beta-methylbutyrate supplementation in critically ill trauma patients</TI>
<SO>Journal of Trauma</SO>
<YR>2007</YR>
<VL>62</VL>
<NO>1</NO>
<PG>125-31</PG>
<IDENTIFIERS MODIFIED="2013-11-28 16:44:35 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-28 16:44:35 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE=" 17215743"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Martin-2011" MODIFIED="2013-11-28 16:45:23 +0000" MODIFIED_BY="Greet Hermans" NAME="Martin 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-11-28 16:45:23 +0000" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martin AD, Smith BK, Davenport PD, Harman E, Gonzalez-Rothi RJ, Baz M, et al</AU>
<TI>Inspiratory muscle strength training improves weaning outcome in failure to wean patients: a randomized trial</TI>
<SO>Critical Care (London, England)</SO>
<YR>2011</YR>
<VL>15</VL>
<NO>2</NO>
<PG>R84</PG>
<IDENTIFIERS MODIFIED="2013-11-28 16:45:23 +0000" MODIFIED_BY="Ruth Brassington">
<IDENTIFIER MODIFIED="2013-11-28 16:45:23 +0000" MODIFIED_BY="Ruth Brassington" TYPE="PUBMED" VALUE="21385346"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Menadue-2010" MODIFIED="2012-08-28 15:30:26 +0100" MODIFIED_BY="Greet Hermans" NAME="Menadue 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-08-28 15:30:26 +0100" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Menadue C, Alison JA, Piper AJ, Flunt D, Ellis ER</AU>
<TI>Bilevel ventilation during exercise in acute on chronic respiratory failure: a preliminary study</TI>
<SO>Respiratory Medicine</SO>
<YR>2010</YR>
<VL>104</VL>
<NO>2</NO>
<PG>219-27</PG>
<IDENTIFIERS MODIFIED="2012-01-16 09:28:41 +0000" MODIFIED_BY="Greet Hermans">
<IDENTIFIER TYPE="PUBMED" VALUE="19804963"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miao-2005" MODIFIED="2013-06-15 20:44:59 +0100" MODIFIED_BY="Greet Hermans" NAME="Miao 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-06-15 20:44:59 +0100" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miao LJ, Wang J, Liu H, Cheng Z</AU>
<TI>Role of enteral nutrition combined with parenteral nutrition in supporting mechanical ventilation of patients with chronic obstructive pulmonary disease accompanied by respiratory failure</TI>
<SO>Chinese Journal of Clinical Rehabilitation</SO>
<YR>2005</YR>
<VL>9</VL>
<NO>31</NO>
<PG>27-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mohr-1997" MODIFIED="2013-11-28 16:49:00 +0000" MODIFIED_BY="[Empty name]" NAME="Mohr 1997" YEAR="1997">
<REFERENCE MODIFIED="2013-11-28 16:49:00 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Department of Anaesthesiology, Critical Care and Emergency Medicine, University of Goettingen, Germany mmohr@gwdgdeFAU - Mohr, M&amp;#182;&lt;/p&gt;" NOTES_MODIFIED="2013-11-28 16:49:00 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mohr M, Englisch L, Roth A, Burchardi H, Zielmann S</AU>
<TI>Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis</TI>
<SO>Intensive Care Medicine</SO>
<YR>1997</YR>
<VL>23</VL>
<NO>11</NO>
<PG>1144-9</PG>
<IDENTIFIERS MODIFIED="2013-11-28 16:49:00 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-28 16:49:00 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="9434920"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Morris-2008" MODIFIED="2012-08-28 15:30:52 +0100" MODIFIED_BY="Greet Hermans" NAME="Morris 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-08-28 15:30:52 +0100" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Morris PE, Goad A, Thompson C, Taylor K, Harry B, Passmore L, et al</AU>
<TI>Early intensive care unit mobility therapy in the treatment of acute respiratory failure</TI>
<SO>Critical Care Medicine</SO>
<YR>2008</YR>
<VL>36</VL>
<NO>8</NO>
<PG>2238-43</PG>
<IDENTIFIERS MODIFIED="2012-01-16 09:50:12 +0000" MODIFIED_BY="Greet Hermans">
<IDENTIFIER TYPE="PUBMED" VALUE="18596631"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nava-1998" MODIFIED="2013-11-28 16:55:26 +0000" MODIFIED_BY="[Empty name]" NAME="Nava 1998" YEAR="1998">
<REFERENCE MODIFIED="2013-11-28 16:55:26 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nava S</AU>
<TI>Rehabilitation of patients admitted to a respiratory intensive care unit</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>1998</YR>
<VL>79</VL>
<NO>7</NO>
<PG>849-54</PG>
<IDENTIFIERS MODIFIED="2013-11-28 16:55:25 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-28 16:55:25 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="9685104"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Paddon_x002d_Jones-2005" MODIFIED="2013-12-12 08:24:35 +0000" MODIFIED_BY="[Empty name]" NAME="Paddon-Jones 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-12-12 08:24:35 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Paddon-Jones D, Wolfe RR, Ferrando AA</AU>
<TI>Amino acid supplementation for reversing bed rest and steroid myopathies</TI>
<SO>Journal of Nutrition</SO>
<YR>2005</YR>
<VL>135</VL>
<NO>7</NO>
<PG>1809-12S</PG>
<IDENTIFIERS MODIFIED="2013-11-28 17:33:08 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-28 17:33:08 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15987870"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Pichard-1996" MODIFIED="2013-06-13 12:19:37 +0100" MODIFIED_BY="Greet Hermans" NAME="Pichard 1996" YEAR="1996">
<REFERENCE MODIFIED="2013-06-13 12:19:37 +0100" MODIFIED_BY="Greet Hermans" NOTES="&lt;p&gt;DA - 19960627&lt;/p&gt;" NOTES_MODIFIED="2013-06-13 12:19:37 +0100" NOTES_MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pichard C, Kyle U, Chevrolet JC, Jolliet P, Slosman D, Mensi N</AU>
<TI>Lack of effects of recombinant growth hormone on muscle function in patients requiring prolonged mechanical ventilation: a prospective, randomized, controlled study</TI>
<SO>Critical Care Medicine</SO>
<YR>1996</YR>
<VL>24</VL>
<NO>3</NO>
<PG>403-13</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="8625627"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Porta-2005" MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="[Empty name]" NAME="Porta 2005" YEAR="2005">
<REFERENCE MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Porta R, Vitacca M, Gilè LS, Clini E, Bianchi L, Zanotti E, et al</AU>
<TI>Supported arm training in patients recently weaned from mechanical ventilation</TI>
<SO>Chest</SO>
<YR>2005</YR>
<VL>128</VL>
<NO>4</NO>
<PG>2511-20</PG>
<IDENTIFIERS MODIFIED="2013-11-28 16:50:48 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-28 16:50:48 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16236917"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Rodriguez-2012" MODIFIED="2013-06-15 20:46:46 +0100" MODIFIED_BY="Greet Hermans" NAME="Rodriguez 2012" YEAR="2011">
<REFERENCE MODIFIED="2013-06-15 20:46:46 +0100" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rodriguez PO, Setten M, Maskin LP, Bonelli I, Vidomlansky SR, Attie S, et al</AU>
<TI>Muscle weakness in septic patients requiring mechanical ventilation: protective effect of transcutaneous neuromuscular electrical stimulation</TI>
<SO>Journal of Critical Care</SO>
<YR>2012</YR>
<VL>27</VL>
<NO>3</NO>
<PG>319 e1-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="21715139"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Routsi-2009" MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Greet Hermans" NAME="Routsi 2009" YEAR="2010">
<REFERENCE MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Routsi C, Gerovasili V, Zevakis D, Karatzanos E, Papadopoulos E, Pitsolis T, et al</AU>
<TI>Electrical muscle stimulation prevents critical illness polyneuromyopathy in ICU patients</TI>
<SO>Intensive Care Medicine. Conference: 22nd Annual Congress of the European Society of Intensive Care Medicine, ESICM Vienna, Austria</SO>
<YR>2009</YR>
<VL>35</VL>
<PG>s133</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Salisbury-2010" MODIFIED="2012-08-28 15:31:30 +0100" MODIFIED_BY="Greet Hermans" NAME="Salisbury 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-08-28 15:31:30 +0100" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Salisbury LG, Merriweather JL, Walsh TS</AU>
<TI>Rehabilitation after critical illness: could a ward-based generic rehabilitation assistant promote recovery?</TI>
<SO>Nursing in Critical Care</SO>
<YR>2010</YR>
<VL>15</VL>
<NO>2</NO>
<PG>57-65</PG>
<IDENTIFIERS MODIFIED="2012-01-16 09:28:41 +0000" MODIFIED_BY="Greet Hermans">
<IDENTIFIER TYPE="PUBMED" VALUE="20236432"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sevette-2005" MODIFIED="2013-11-28 16:51:07 +0000" MODIFIED_BY="[Empty name]" NAME="Sevette 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-11-28 16:51:07 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sevette A, Smith RC, Aslani A, Kee AJ, Hansen R, Barratt SM, et al</AU>
<TI>Does growth hormone allow more efficient nitrogen sparing in postoperative patients requiring parental nutrition? A double-blind placebo-controlled randomised trial</TI>
<SO>Clinical Nutrition</SO>
<YR>2005</YR>
<VL>24</VL>
<NO>6</NO>
<PG>943-55</PG>
<IDENTIFIERS MODIFIED="2013-11-28 16:51:07 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-28 16:51:07 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16083996"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Takala-1999a" MODIFIED="2013-06-15 20:45:31 +0100" MODIFIED_BY="Greet Hermans" NAME="Takala 1999a" YEAR="1999">
<REFERENCE MODIFIED="2013-06-15 20:45:31 +0100" MODIFIED_BY="Greet Hermans" NOTES="&lt;p&gt;DA - 19990914&lt;/p&gt;" NOTES_MODIFIED="2013-06-15 20:45:31 +0100" NOTES_MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, et al</AU>
<TI>Increased mortality associated with growth hormone treatment in critically ill adults</TI>
<SO>New England Journal of Medicine</SO>
<YR>1999</YR>
<VL>341</VL>
<NO>11</NO>
<PG>785-92</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="10477776"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Takala-1999b" MODIFIED="2013-06-13 12:19:53 +0100" MODIFIED_BY="Greet Hermans" NAME="Takala 1999b" YEAR="1999">
<REFERENCE MODIFIED="2013-06-13 12:19:53 +0100" MODIFIED_BY="Greet Hermans" NOTES="&lt;p&gt;DA - 19990914&lt;/p&gt;" NOTES_MODIFIED="2013-06-13 12:19:53 +0100" NOTES_MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, et al</AU>
<TI>Increased mortality associated with growth hormone treatment in critically ill adults</TI>
<SO>New England Journal of Medicine</SO>
<YR>1999</YR>
<VL>341</VL>
<NO>11</NO>
<PG>785-92</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="10477776"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tj_x00e4_der-2004" MODIFIED="2014-01-13 23:07:06 +0000" MODIFIED_BY="[Empty name]" NAME="Tjäder 2004" YEAR="2004">
<REFERENCE MODIFIED="2014-01-13 23:07:06 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tjäder I, Rooyackers O, Forsberg AM, Vesali RF, Garlick PJ, Wernerman J</AU>
<TI>Effects on skeletal muscle of intravenous glutamine supplementation to ICU patients</TI>
<SO>Intensive Care Medicine</SO>
<YR>2004</YR>
<VL>30</VL>
<NO>2</NO>
<PG>266-75</PG>
<IDENTIFIERS MODIFIED="2013-11-28 17:23:47 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-28 17:23:47 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="14722645"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Toledo-2007" MODIFIED="2012-01-16 09:49:54 +0000" MODIFIED_BY="Greet Hermans" NAME="Toledo 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-01-16 09:49:54 +0000" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Toledo A, Borghi-Silva A, Sampaio LM, Ribeiro KP, Baldissera V, Costa D</AU>
<TI>The impact of noninvasive ventilation during the physical training in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD)</TI>
<SO>Clinics (Sao Paulo, Brazil)</SO>
<YR>2007</YR>
<VL>62</VL>
<NO>2</NO>
<PG>113-20</PG>
<IDENTIFIERS MODIFIED="2012-01-16 09:49:50 +0000" MODIFIED_BY="Greet Hermans">
<IDENTIFIER TYPE="PUBMED" VALUE="17505694"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vivodtzev-2006" MODIFIED="2013-06-15 20:45:50 +0100" MODIFIED_BY="Greet Hermans" NAME="Vivodtzev 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-15 20:45:50 +0100" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vivodtzev I, Pépin JL, Vottero G, Mayer V, Porsin B, Lévy P, et al</AU>
<TI>Improvement in quadriceps strength and dyspnea in daily tasks after 1 month of electrical stimulation in severely deconditioned and malnourished COPD</TI>
<SO>Chest</SO>
<YR>2006</YR>
<VL>129</VL>
<NO>6</NO>
<PG>1540-8</PG>
<IDENTIFIERS MODIFIED="2012-01-16 09:28:41 +0000" MODIFIED_BY="Greet Hermans">
<IDENTIFIER TYPE="PUBMED" VALUE="16778272"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Watters-1997" MODIFIED="2013-06-13 12:19:11 +0100" MODIFIED_BY="Greet Hermans" NAME="Watters 1997" YEAR="1997">
<REFERENCE MODIFIED="2013-06-13 12:19:11 +0100" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Watters JM, Kirkpatrick SM, Norris SB, Sharmji FM, Wells GA</AU>
<TI>Immediate postoperative enteral feeding results in impaired respiratory mechanics and decreased mobility</TI>
<SO>Annals of Surgery</SO>
<YR>1997</YR>
<VL>226</VL>
<NO>3</NO>
<PG>369-77</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="9339943"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Zanotti-2003" MODIFIED="2013-06-13 12:18:56 +0100" MODIFIED_BY="Greet Hermans" NAME="Zanotti 2003" YEAR="2003">
<REFERENCE MODIFIED="2013-06-13 12:18:56 +0100" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zanotti E, Felicetti G, Maini M, Fracchia C</AU>
<TI>Peripheral muscle strength training in bed-bound patients with COPD receiving mechanical ventilation: effect of electrical stimulation</TI>
<SO>Chest</SO>
<YR>2003</YR>
<VL>124</VL>
<NO>1</NO>
<PG>292-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="12853536"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ziegler-1990" MODIFIED="2013-12-12 08:24:51 +0000" MODIFIED_BY="[Empty name]" NAME="Ziegler 1990" YEAR="1990">
<REFERENCE MODIFIED="2013-12-12 08:24:51 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ziegler TR, Young LS, Ferrari-Baliviera E, Demling RH, Wilmore DW</AU>
<TI>Use of human growth hormone combined with nutritional support in a critical care unit</TI>
<SO>JPEN. Journal of Parenteral and Enteral Nutrition</SO>
<YR>1990</YR>
<VL>14</VL>
<NO>6</NO>
<PG>574-81</PG>
<IDENTIFIERS MODIFIED="2013-11-28 16:52:55 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-28 16:52:55 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="2273531"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Check these&lt;/p&gt;" NOTES_MODIFIED="2014-01-17 10:44:18 +0000" NOTES_MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Abokhabar-2012" MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Greet Hermans" NAME="Abokhabar 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Abokhabar H, Abouelela A, Abdelkarim I</AU>
<TI>Effect of electrical muscle stimulation in prevention of ICU acquired muscle weakness and facilitation of weaning from mechanical ventilation</TI>
<SO>Intensive Care Medicine</SO>
<YR>2012</YR>
<VL>38</VL>
<PG>S132</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Alia-2011" MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Greet Hermans" NAME="Alia 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alía I, de la Cal MA, Esteban A, Abella A, Ferrer R, Molina FJ, et al</AU>
<TI>Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2011</YR>
<VL>171</VL>
<NO>21</NO>
<PG>1939-46</PG>
<IDENTIFIERS MODIFIED="2013-12-12 12:47:20 +0000" MODIFIED_BY="Greet Hermans">
<IDENTIFIER TYPE="PUBMED" VALUE="22123804"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brunner-2013" MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Greet Hermans" NAME="Brunner 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brunner R, Rinner W, Haberler C, Kitzberger R, Sycha T, Herkner H, et al</AU>
<TI>Early treatment with IgM-enriched intravenous immunoglobulin does not mitigate critical illness polyneuropathy and/or myopathy in patients with multiple organ failure and SIRS/sepsis: a prospective, randomized, placebo-controlled, double-blinded trial</TI>
<SO>Critical Care (London, England)</SO>
<YR>2013</YR>
<VL>17</VL>
<NO>5</NO>
<PG>R213</PG>
<IDENTIFIERS MODIFIED="2013-12-12 13:04:03 +0000" MODIFIED_BY="Greet Hermans">
<IDENTIFIER TYPE="PUBMED" VALUE="24088271"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Devost-2011" MODIFIED="2014-01-13 23:08:51 +0000" MODIFIED_BY="Greet Hermans" NAME="Devost 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-01-13 23:08:51 +0000" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Devost A-A, Boilard G, Vovodtzev, Saey D, Mainguy V, Maltais F, et al</AU>
<TI>Efficiency of neuromuscular electrical stimulation to prevent ICU-acquired weakness in mechanically ventilated patients</TI>
<SO>Intensive Care Medicine</SO>
<YR>2011</YR>
<PG>S13</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Files-2013" MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Greet Hermans" NAME="Files 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Files D, Morris P, Shrestha S, Dhar S, Young M, Hauser J, et al</AU>
<TI>Randomized, controlled pilot study of early rehabilitation strategies in acute respiratory failure</TI>
<SO>Critical Care</SO>
<YR>2013</YR>
<VL>17</VL>
<NO>Suppl 2</NO>
<PG>P540</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gerovasili-2011" MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Greet Hermans" NAME="Gerovasili 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Gerovasili V, Karatzanos L,  Zervakis D, Dimopoulos S, Tripodaki E-S, Pitsolis T, et al</AU>
<TI>Electrical muscle simulation is an effective form of excercise and early rehabilitation in ICU patients</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2011</YR>
<VL>183</VL>
<PG>A3740</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hermans-2013" MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Greet Hermans" NAME="Hermans 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hermans G, Casaer MP, Clerckx B, Güiza F, Vanhullebusch T, Derde S, et al</AU>
<TI>Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial</TI>
<SO>The Lancet Respiratory Medicine</SO>
<YR>2013</YR>
<VL>1</VL>
<NO>8</NO>
<PG>621-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-12-12 09:58:45 +0000" MODIFIED_BY="Greet Hermans"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mikaeili-2012" MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Greet Hermans" NAME="Mikaeili 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mikaeili H, Yazdchi M, Barazandeh F, Ansarin K</AU>
<TI>Euglycemic state reduces the incidence of critical illness polyneuropathy and duration of ventilator dependency in medical intensive care unit</TI>
<SO>Bratislavské Lekárske Listy</SO>
<YR>2012</YR>
<VL>113</VL>
<NO>10</NO>
<PG>616-9</PG>
<IDENTIFIERS MODIFIED="2013-12-12 12:55:38 +0000" MODIFIED_BY="Greet Hermans">
<IDENTIFIER TYPE="PUBMED" VALUE="23094903"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Paternostro_x002d_Sluga-2012" MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Greet Hermans" NAME="Paternostro-Sluga 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Greet Hermans" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Paternostro-Sluga T, Hiesmayr M, Janda D, Senekowitsch S</AU>
<TI>Early neuromuscular electrical stimulation for intensive care unit patients: effect on muscle strength and urinary nitrogen excretion</TI>
<SO>The Journal of Injury, Function, and Rehabilitation</SO>
<YR>2012</YR>
<VL>4</VL>
<NO>10 Suppl</NO>
<PG>S310</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Greet Hermans">
<STUDY DATA_SOURCE="PUB" ID="STD-Kho-2012" MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Ruth Brassington" NAME="Kho 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Ruth Brassington" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kho ME, Truong AD, Brower RG, Palmer JB, Fan E, Zanni JM, et al</AU>
<TI>Neuromuscular electrical stimulation for intensive care unit-acquired weakness: protocol and methodological implications for a randomized, sham-controlled, phase II trial</TI>
<SO>Physical Therapy</SO>
<YR>2012</YR>
<VL>92</VL>
<NO>12</NO>
<PG>1564-79</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="22421734"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Parry-2012" MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Ruth Brassington" NAME="Parry 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Ruth Brassington" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Parry SM, Berney S, Koopman R, Bryant A, El-Ansary D, Puthucheary Z, et al</AU>
<TI>Early rehabilitation in critical care (eRiCC): functional electrical stimulation with cycling protocol for a randomised controlled trial</TI>
<SO>BMJ Open</SO>
<YR>2012</YR>
<VL>2</VL>
<NO>5</NO>
<PG>e001891</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="22983782"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Atkins-2004" MODIFIED="2014-01-16 00:45:02 +0000" MODIFIED_BY="Greet Hermans" NAME="Atkins 2004" TYPE="JOURNAL_ARTICLE">
<AU>Atkins D, Eccles M, Flottorp S, Guyatt GH, Henry D, Hill S, et al; GRADE Working Group</AU>
<TI>Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group</TI>
<SO>BMC Health Services Research</SO>
<YR>2004</YR>
<VL>4</VL>
<NO>1</NO>
<PG>38</PG>
<IDENTIFIERS MODIFIED="2013-09-30 21:18:40 +0100" MODIFIED_BY="Greet Hermans">
<IDENTIFIER TYPE="PUBMED" VALUE="15615589"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bednar_x00ed_k-2005" MODIFIED="2013-12-12 08:25:27 +0000" MODIFIED_BY="[Empty name]" NAME="Bednarík 2005" TYPE="JOURNAL_ARTICLE">
<AU>Bednarík J, Vondracek P, Dusek L, Moravcova E, Cundrle I</AU>
<TI>Risk factors for critical illness polyneuromyopathy</TI>
<SO>Journal of Neurology</SO>
<YR>2005</YR>
<VL>252</VL>
<NO>3</NO>
<PG>343-51</PG>
<IDENTIFIERS MODIFIED="2013-11-28 17:57:18 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-28 17:57:18 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15791390"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Berek-1997a" MODIFIED="2013-11-29 17:03:26 +0000" MODIFIED_BY="Greet Hermans" NAME="Berek 1997a" TYPE="OTHER">
<AU>Berek K, Margreiter J, Willeit J, Berek A, Schmutzhard E, Mutz N</AU>
<TI>Critical illness polyneuropathy--only due to parenteral nutrition?</TI>
<SO>Intensive care medicine</SO>
<YR>1997</YR>
<VL>23</VL>
<NO>8</NO>
<PG>923-4</PG>
<IDENTIFIERS MODIFIED="2013-11-29 17:03:26 +0000" MODIFIED_BY="Ruth Brassington">
<IDENTIFIER MODIFIED="2013-11-29 17:03:26 +0000" MODIFIED_BY="Ruth Brassington" TYPE="PUBMED" VALUE="9310818"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Berger-1996" MODIFIED="2013-11-29 17:00:59 +0000" MODIFIED_BY="[Empty name]" NAME="Berger 1996" TYPE="JOURNAL_ARTICLE">
<AU>Berger JR, Pall L, Hall CD, Simpson DM, Berry PS, Dudley R</AU>
<TI>Oxandrolone in AIDS-wasting myopathy</TI>
<SO>AIDS</SO>
<YR>1996</YR>
<VL>10</VL>
<NO>14</NO>
<PG>1657-62</PG>
<IDENTIFIERS MODIFIED="2013-11-29 17:00:59 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-29 17:00:59 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="8970686"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bollaert-1998" MODIFIED="2013-11-29 17:01:28 +0000" MODIFIED_BY="[Empty name]" NAME="Bollaert 1998" TYPE="JOURNAL_ARTICLE">
<AU>Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A</AU>
<TI>Reversal of late septic shock with supraphysiologic doses of hydrocortisone</TI>
<SO>Critical Care Medicine</SO>
<YR>1998</YR>
<VL>26</VL>
<NO>4</NO>
<PG>645-50</PG>
<IDENTIFIERS MODIFIED="2013-11-29 17:01:28 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-29 17:01:28 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="9559600"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bolton-1984" MODIFIED="2014-01-16 00:46:09 +0000" MODIFIED_BY="Greet Hermans" NAME="Bolton 1984" TYPE="JOURNAL_ARTICLE">
<AU>Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ</AU>
<TI>Polyneuropathy in critically ill patients</TI>
<SO>Journal of Neurology, Neurosurgery &amp; Psychiatry</SO>
<YR>1984</YR>
<VL>47</VL>
<NO>11</NO>
<PG>1223-31</PG>
<IDENTIFIERS MODIFIED="2013-11-28 17:21:43 +0000" MODIFIED_BY="Ruth Brassington">
<IDENTIFIER MODIFIED="2013-11-28 17:21:43 +0000" MODIFIED_BY="Ruth Brassington" TYPE="PUBMED" VALUE="6094735"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bolton-1986" MODIFIED="2014-01-16 00:46:27 +0000" MODIFIED_BY="[Empty name]" NAME="Bolton 1986" TYPE="JOURNAL_ARTICLE">
<AU>Bolton CF, Laverty DA, Brown JD, Witt NJ, Hahn AF, Sibbald WJ</AU>
<TI>Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barré syndrome</TI>
<SO>Journal of Neurology, Neurosurgery &amp; Psychiatry</SO>
<YR>1986</YR>
<VL>49</VL>
<NO>5</NO>
<PG>563-73</PG>
<IDENTIFIERS MODIFIED="2013-11-28 17:22:44 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-28 17:22:44 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="3011996"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bolton-2005" MODIFIED="2013-11-29 16:42:44 +0000" MODIFIED_BY="[Empty name]" NAME="Bolton 2005" TYPE="JOURNAL_ARTICLE">
<AU>Bolton CF</AU>
<TI>Neuromuscular manifestations of critical illness</TI>
<SO>Muscle &amp; Nerve</SO>
<YR>2005</YR>
<VL>32</VL>
<NO>2</NO>
<PG>140-63</PG>
<IDENTIFIERS MODIFIED="2013-11-29 16:42:44 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-29 16:42:44 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15825186"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Boyer-2006" MODIFIED="2013-11-29 16:43:03 +0000" MODIFIED_BY="[Empty name]" NAME="Boyer 2006" TYPE="JOURNAL_ARTICLE">
<AU>Boyer A, Chadda K, Salah A, Annane D</AU>
<TI>Glucocorticoid treatment in patients with septic shock: effects on vasopressor use and mortality</TI>
<SO>International Journal of Clinical Pharmacology and Therapeutics</SO>
<YR>2006</YR>
<VL>44</VL>
<NO>7</NO>
<PG>309-18</PG>
<IDENTIFIERS MODIFIED="2013-11-29 16:43:03 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-29 16:43:03 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16961159"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Brealey-2002" MODIFIED="2013-11-28 17:58:57 +0000" MODIFIED_BY="Greet Hermans" NAME="Brealey 2002" TYPE="JOURNAL_ARTICLE">
<AU>Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, et al</AU>
<TI>Association between mitochondrial dysfunction and severity and outcome of septic shock</TI>
<SO>Lancet</SO>
<YR>2002</YR>
<VL>360</VL>
<NO>9328</NO>
<PG>219-23</PG>
<IDENTIFIERS MODIFIED="2013-11-28 17:58:57 +0000" MODIFIED_BY="Ruth Brassington">
<IDENTIFIER MODIFIED="2013-11-28 17:58:57 +0000" MODIFIED_BY="Ruth Brassington" TYPE="PUBMED" VALUE="12133657"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Briegel-1999" MODIFIED="2013-11-29 16:43:42 +0000" MODIFIED_BY="[Empty name]" NAME="Briegel 1999" TYPE="JOURNAL_ARTICLE">
<AU>Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, et al</AU>
<TI>Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study</TI>
<SO>Critical Care Medicine</SO>
<YR>1999</YR>
<VL>27</VL>
<NO>4</NO>
<PG>723-32</PG>
<IDENTIFIERS MODIFIED="2013-11-29 16:43:42 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-29 16:43:42 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="10321661"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Burnham-2005" MODIFIED="2013-12-13 18:38:40 +0000" MODIFIED_BY="Greet Hermans" NAME="Burnham 2005" TYPE="JOURNAL_ARTICLE">
<AU>Burnham EL, Moss M, Ziegler TR</AU>
<TI>Myopathies in critical illness: characterization and nutritional aspects</TI>
<SO>The Journal of Nutrition</SO>
<YR>2005</YR>
<VL>135</VL>
<NO>7</NO>
<PG>1818S-23S</PG>
<IDENTIFIERS MODIFIED="2013-11-28 18:00:03 +0000" MODIFIED_BY="Ruth Brassington">
<IDENTIFIER MODIFIED="2013-11-28 18:00:03 +0000" MODIFIED_BY="Ruth Brassington" TYPE="PUBMED" VALUE=" 15987872"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Chalwa-1999" MODIFIED="2013-11-29 16:44:57 +0000" MODIFIED_BY="Jane Batchelor" NAME="Chalwa 1999" TYPE="JOURNAL_ARTICLE">
<AU>Chalwa K, Kupfer Y, Goldmann I, Tessler S</AU>
<TI>Hydrocortisone reverses refractory shock</TI>
<SO>Critical Care Medicine</SO>
<YR>1999</YR>
<VL>27</VL>
<NO>1S</NO>
<PG>33A</PG>
<IDENTIFIERS MODIFIED="2013-11-29 16:44:57 +0000" MODIFIED_BY="Ruth Brassington"/>
</REFERENCE>
<REFERENCE ID="REF-Coakley-1998" MODIFIED="2013-11-29 16:46:41 +0000" MODIFIED_BY="[Empty name]" NAME="Coakley 1998" TYPE="JOURNAL_ARTICLE">
<AU>Coakley JH, Nagendran K, Yarwood GD, Honavar M, Hinds CJ</AU>
<TI>Patterns of neurophysiological abnormality in prolonged critical illness</TI>
<SO>Intensive Care Medicine</SO>
<YR>1998</YR>
<VL>24</VL>
<NO>8</NO>
<PG>801-7</PG>
<IDENTIFIERS MODIFIED="2013-11-29 16:46:41 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-29 16:46:41 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="9757924"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-De-Jonghe-1998" MODIFIED="2013-11-29 16:47:09 +0000" MODIFIED_BY="[Empty name]" NAME="De Jonghe 1998" TYPE="JOURNAL_ARTICLE">
<AU>De Jonghe B, Cook D, Sharshar T, Lefaucheur JP, Carlet J, Outin H</AU>
<TI>Acquired neuromuscular disorders in critically ill patients: a systematic review. Groupe de Reflexion et d'Etude sur les Neuromyopathies En Reanimation</TI>
<SO>Intensive Care Medicine</SO>
<YR>1998</YR>
<VL>24</VL>
<NO>12</NO>
<PG>1242-50</PG>
<IDENTIFIERS MODIFIED="2013-11-29 16:47:09 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-29 16:47:09 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="9885875"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-De-Jonghe-2002" MODIFIED="2013-11-29 16:47:31 +0000" MODIFIED_BY="[Empty name]" NAME="De Jonghe 2002" TYPE="JOURNAL_ARTICLE">
<AU>De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, et al</AU>
<TI>Paresis acquired in the intensive care unit: a prospective multicenter study</TI>
<SO>JAMA</SO>
<YR>2002</YR>
<VL>288</VL>
<NO>22</NO>
<PG>2859-67</PG>
<IDENTIFIERS MODIFIED="2013-11-29 16:47:31 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-29 16:47:31 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="12472328"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-de-Letter-2001" MODIFIED="2013-11-29 16:47:52 +0000" MODIFIED_BY="[Empty name]" NAME="de Letter 2001" TYPE="JOURNAL_ARTICLE">
<AU>de Letter MA, Schmitz PI, Visser LH, Verheul FA, Schellens RL, Op de Coul DA, et al</AU>
<TI>Risk factors for the development of polyneuropathy and myopathy in critically ill patients</TI>
<SO>Critical Care Medicine</SO>
<YR>2001</YR>
<VL>29</VL>
<NO>12</NO>
<PG>2281-6</PG>
<IDENTIFIERS MODIFIED="2013-11-29 16:47:52 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-29 16:47:52 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="11801825"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Deeks-2011" MODIFIED="2013-12-12 08:26:03 +0000" MODIFIED_BY="Greet Hermans" NAME="Deeks 2011" TYPE="OTHER">
<AU>Deeks JJ, Higgins JPT, Altman DG (editors)</AU>
<TI>Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<YR>2011</YR>
<PB>Higgins JPT, Green S</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deley-2005" MODIFIED="2014-01-16 00:48:16 +0000" MODIFIED_BY="Greet Hermans" NAME="Deley 2005" TYPE="JOURNAL_ARTICLE">
<AU>Deley G, Kervio G, Verges B, Hannequin A, Petitdant MF, Salmi-Belmihoub S, et al</AU>
<TI>Comparison of low-frequency electrical myostimulation and conventional aerobic exercise training in patients with chronic heart failure</TI>
<SO>European Journal of Cardiovascular Prevention &amp; Rehabilitation</SO>
<YR>2005</YR>
<VL>12</VL>
<NO>3</NO>
<PG>226-33</PG>
<IDENTIFIERS MODIFIED="2012-08-13 09:39:51 +0100" MODIFIED_BY="Greet Hermans">
<IDENTIFIER TYPE="PUBMED" VALUE="15942420"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Finfer-2009" MODIFIED="2013-11-29 17:02:28 +0000" MODIFIED_BY="Greet Hermans" NAME="Finfer 2009" TYPE="JOURNAL_ARTICLE">
<AU>NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, et al</AU>
<TI>Intensive versus conventional glucose control in critically ill patients</TI>
<SO>New England Journal of Medicine</SO>
<YR>2009</YR>
<VL>360</VL>
<NO>13</NO>
<PG>1283-97</PG>
<IDENTIFIERS MODIFIED="2013-11-29 17:02:28 +0000" MODIFIED_BY="Ruth Brassington">
<IDENTIFIER MODIFIED="2013-11-29 17:02:28 +0000" MODIFIED_BY="Ruth Brassington" TYPE="PUBMED" VALUE="19318384"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Garnacho_x002d_Montero-2001" MODIFIED="2013-11-29 16:48:49 +0000" MODIFIED_BY="[Empty name]" NAME="Garnacho-Montero 2001" TYPE="JOURNAL_ARTICLE">
<AU>Garnacho-Montero J, Madrazo-Osuna J, Garcia-Garmendia JL, Ortiz-Leyba C, Jimenez-Jimenez FJ, Barrero-Almodovar A, et al</AU>
<TI>Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients</TI>
<SO>Intensive Care Medicine</SO>
<YR>2001</YR>
<VL>27</VL>
<NO>8</NO>
<PG>1288-96</PG>
<IDENTIFIERS MODIFIED="2013-11-29 16:48:49 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-29 16:48:49 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="11511941"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Gore-1991" MODIFIED="2013-11-29 16:50:32 +0000" MODIFIED_BY="[Empty name]" NAME="Gore 1991" TYPE="JOURNAL_ARTICLE">
<AU>Gore DC, Honeycutt D, Jahoor F, Wolfe RR, Herndon DN</AU>
<TI>Effect of exogenous growth hormone on whole-body and isolated-limb protein kinetics in burned patients</TI>
<SO>Archives of Surgery</SO>
<YR>1991</YR>
<VL>126</VL>
<NO>1</NO>
<PG>38-43</PG>
<IDENTIFIERS MODIFIED="2013-11-29 16:50:32 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-29 16:50:32 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="1898697"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hammarqvist-1997" MODIFIED="2013-11-29 16:50:05 +0000" MODIFIED_BY="Jane Batchelor" NAME="Hammarqvist 1997" TYPE="JOURNAL_ARTICLE">
<AU>Hammarqvist F, Luo JL, Cotgeave IA, Andersson K, Wernerman J</AU>
<TI>Skeletal muscle glutathione is depleted in critically ill patients</TI>
<SO>Critical Care Medicine</SO>
<YR>1997</YR>
<VL>25</VL>
<NO>1</NO>
<PG>78-84</PG>
<IDENTIFIERS MODIFIED="2013-11-29 16:50:05 +0000" MODIFIED_BY="Ruth Brassington">
<IDENTIFIER MODIFIED="2013-11-29 16:50:05 +0000" MODIFIED_BY="Ruth Brassington" TYPE="PUBMED" VALUE="8989180"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Herridge-2003" MODIFIED="2014-01-16 00:49:29 +0000" MODIFIED_BY="[Empty name]" NAME="Herridge 2003" TYPE="JOURNAL_ARTICLE">
<AU>Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al Saidi F, et al</AU>
<TI>One-year outcomes in survivors of the acute respiratory distress syndrome</TI>
<SO>New England Journal of Medicine</SO>
<YR>2003</YR>
<VL>348</VL>
<NO>8</NO>
<PG>683-93</PG>
<IDENTIFIERS MODIFIED="2013-11-29 16:50:49 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-29 16:50:49 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="12594312"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Herridge-2011" MODIFIED="2013-06-15 20:48:43 +0100" MODIFIED_BY="Greet Hermans" NAME="Herridge 2011" TYPE="JOURNAL_ARTICLE">
<AU>Herridge MS, Tansey CM, Matté A, Tomlinson G, Diaz-Granados N, Cooper A, et al</AU>
<TI>Functional disability 5 years after acute respiratory distress syndrome</TI>
<SO>New England Journal of Medicine</SO>
<YR>2011</YR>
<VL>364</VL>
<NO>14</NO>
<PG>1293-304</PG>
<IDENTIFIERS MODIFIED="2012-08-13 09:02:23 +0100" MODIFIED_BY="Greet Hermans">
<IDENTIFIER TYPE="PUBMED" VALUE="21470008"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011a" MODIFIED="2013-11-28 17:50:07 +0000" MODIFIED_BY="Ruth Brassington" NAME="Higgins 2011a" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]</TI>
<SO>The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011b" MODIFIED="2013-12-12 08:26:15 +0000" MODIFIED_BY="Greet Hermans" NAME="Higgins 2011b" TYPE="OTHER">
<AU>Higgins JPT, Altman DG, Sterne JAC (editors)</AU>
<TI>Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)</TI>
<SO>The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jeevanandam-1995" MODIFIED="2014-01-16 00:51:49 +0000" MODIFIED_BY="[Empty name]" NAME="Jeevanandam 1995" TYPE="JOURNAL_ARTICLE">
<AU>Jeevanandam M, Ali MR, Holaday NJ, Petersen SR</AU>
<TI>Adjuvant recombinant human growth hormone normalizes plasma amino acids in parenterally fed trauma patients</TI>
<SO>JPEN. Journal of Parenteral and Enteral Nutrition</SO>
<YR>1995</YR>
<VL>19</VL>
<NO>2</NO>
<PG>137-44</PG>
<IDENTIFIERS MODIFIED="2013-11-29 16:59:05 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-29 16:59:05 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="7609279"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kleyweg-1991" MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Greet Hermans" NAME="Kleyweg 1991" TYPE="JOURNAL_ARTICLE">
<AU>Kleyweg RP, van der Meché FG, Schmitz PI</AU>
<TI>Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome</TI>
<SO>Muscle &amp; Nerve</SO>
<YR>1991</YR>
<VL>14</VL>
<NO>11</NO>
<PG>1103-9</PG>
<IDENTIFIERS MODIFIED="2013-12-13 08:07:42 +0000" MODIFIED_BY="Greet Hermans">
<IDENTIFIER TYPE="PUBMED" VALUE="1745285"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Langouche-2005" MODIFIED="2014-01-16 00:54:32 +0000" MODIFIED_BY="[Empty name]" NAME="Langouche 2005" TYPE="JOURNAL_ARTICLE">
<AU>Langouche L, Vanhorebeek I, Vlasselaers D, Vander PS, Wouters PJ, Skogstrand K, et al</AU>
<TI>Intensive insulin therapy protects the endothelium of critically ill patients</TI>
<SO>Journal of Clinical Investigation</SO>
<YR>2005</YR>
<VL>115</VL>
<NO>8</NO>
<PG>2277-86</PG>
<IDENTIFIERS MODIFIED="2013-11-29 16:58:14 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-29 16:58:14 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16075063"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Meduri-1998" MODIFIED="2013-11-29 16:58:38 +0000" MODIFIED_BY="[Empty name]" NAME="Meduri 1998" TYPE="JOURNAL_ARTICLE">
<AU>Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, et al</AU>
<TI>Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial</TI>
<SO>JAMA</SO>
<YR>1998</YR>
<VL>280</VL>
<NO>2</NO>
<PG>159-65</PG>
<IDENTIFIERS MODIFIED="2013-11-29 16:58:38 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-29 16:58:38 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="9669790"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Mendenhall-1993" MODIFIED="2013-11-29 16:57:47 +0000" MODIFIED_BY="[Empty name]" NAME="Mendenhall 1993" TYPE="JOURNAL_ARTICLE">
<AU>Mendenhall CL, Moritz TE, Roselle GA, Morgan TR, Nemchausky BA, Tamburro CH, et al</AU>
<TI>A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study</TI>
<SO>Hepatology</SO>
<YR>1993</YR>
<VL>17</VL>
<NO>4</NO>
<PG>564-76</PG>
<IDENTIFIERS MODIFIED="2013-11-29 16:57:47 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-29 16:57:47 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="8477961"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Michelsen-1982" MODIFIED="2014-01-16 00:55:36 +0000" MODIFIED_BY="[Empty name]" NAME="Michelsen 1982" TYPE="JOURNAL_ARTICLE">
<AU>Michelsen CB, Askanazi J, Kinney JM, Gump FE, Elwyn DH</AU>
<TI>Effect of an anabolic steroid on nitrogen balance and amino acid patterns after total hip replacement</TI>
<SO>Journal of Trauma</SO>
<YR>1982</YR>
<VL>22</VL>
<NO>5</NO>
<PG>410-3</PG>
<IDENTIFIERS MODIFIED="2013-11-29 16:57:20 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-29 16:57:20 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="6804639"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Nanas-2008" MODIFIED="2012-08-28 15:32:26 +0100" MODIFIED_BY="Greet Hermans" NAME="Nanas 2008" TYPE="JOURNAL_ARTICLE">
<AU>Nanas S, Kritikos K, Angelopoulos E, Siafaka A, Tsikriki S, Poriazi M, et al</AU>
<TI>Predisposing factors for critical illness polyneuromyopathy in a multidisciplinary intensive care unit</TI>
<SO>Acta Neurologica Scandinavica</SO>
<YR>2008</YR>
<VL>118</VL>
<NO>3</NO>
<PG>175-81</PG>
<IDENTIFIERS MODIFIED="2012-08-13 09:05:41 +0100" MODIFIED_BY="Greet Hermans">
<IDENTIFIER TYPE="PUBMED" VALUE="18355395"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Nuhr-2004" MODIFIED="2012-08-28 15:32:44 +0100" MODIFIED_BY="Greet Hermans" NAME="Nuhr 2004" TYPE="JOURNAL_ARTICLE">
<AU>Nuhr MJ, Pette D, Berger R, Quittan M, Crevenna R, Huelsman M, et al</AU>
<TI>Beneficial effects of chronic low-frequency stimulation of thigh muscles in patients with advanced chronic heart failure</TI>
<SO>European Heart Journal</SO>
<YR>2004</YR>
<VL>25</VL>
<NO>2</NO>
<PG>136-43</PG>
<IDENTIFIERS MODIFIED="2012-08-13 09:37:45 +0100" MODIFIED_BY="Greet Hermans">
<IDENTIFIER TYPE="PUBMED" VALUE="14720530"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Pandit-2006" MODIFIED="2013-11-29 16:56:55 +0000" MODIFIED_BY="[Empty name]" NAME="Pandit 2006" TYPE="JOURNAL_ARTICLE">
<AU>Pandit L, Agrawal A</AU>
<TI>Neuromuscular disorders in critical illness</TI>
<SO>Clinical Neurology and Neurosurgery</SO>
<YR>2006</YR>
<VL>108</VL>
<NO>7</NO>
<PG>621-7</PG>
<IDENTIFIERS MODIFIED="2013-11-29 16:56:55 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-29 16:56:55 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16730883"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Papazian-2010" MODIFIED="2013-11-29 16:56:21 +0000" MODIFIED_BY="Greet Hermans" NAME="Papazian 2010" TYPE="JOURNAL_ARTICLE">
<AU>Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, et al; ACURASYS Study Investigators</AU>
<TI>Neuromuscular blockers in early acute respiratory distress syndrome</TI>
<SO>New England Journal of Medicine</SO>
<YR>2010</YR>
<VL>363</VL>
<NO>12</NO>
<PG>1107-16</PG>
<IDENTIFIERS MODIFIED="2013-11-29 16:56:21 +0000" MODIFIED_BY="Greet Hermans">
<IDENTIFIER MODIFIED="2013-11-29 16:56:21 +0000" MODIFIED_BY="Ruth Brassington" TYPE="PUBMED" VALUE="20843245"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Pape-1991" MODIFIED="2013-11-29 16:55:11 +0000" MODIFIED_BY="[Empty name]" NAME="Pape 1991" TYPE="JOURNAL_ARTICLE">
<AU>Pape GS, Friedman M, Underwood LE, Clemmons DR</AU>
<TI>The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease</TI>
<SO>Chest</SO>
<YR>1991</YR>
<VL>99</VL>
<NO>6</NO>
<PG>1495-500</PG>
<IDENTIFIERS MODIFIED="2013-11-29 16:55:11 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-29 16:55:11 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE=" 2036835 "/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ponting-1988" MODIFIED="2013-11-29 16:54:14 +0000" MODIFIED_BY="[Empty name]" NAME="Ponting 1988" TYPE="JOURNAL_ARTICLE">
<AU>Ponting GA, Halliday D, Teale JD, Sim AJ</AU>
<TI>Postoperative positive nitrogen balance with intravenous hyponutrition and growth hormone</TI>
<SO>Lancet</SO>
<YR>1988</YR>
<VL>1</VL>
<NO>8583</NO>
<PG>438-40</PG>
<IDENTIFIERS MODIFIED="2013-11-29 16:54:14 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-29 16:54:14 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="2893867"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2012" MODIFIED="2013-12-12 08:26:50 +0000" MODIFIED_BY="Ruth Brassington" NAME="RevMan 2012" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2012</YR>
<EN>5.2</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rowe-2001" MODIFIED="2013-12-12 08:27:03 +0000" MODIFIED_BY="[Empty name]" NAME="Rowe 2001" TYPE="COCHRANE_REVIEW">
<AU>Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW</AU>
<TI>Early emergency department treatment of acute asthma with systemic corticosteroids</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2001</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2013-11-29 16:53:48 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-28 12:34:13 +0000" MODIFIED_BY="Ruth Brassington" TYPE="DOI" VALUE="10.1002/14651858.CD002178"/>
<IDENTIFIER MODIFIED="2013-11-29 16:53:48 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="11279756"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Schols-1995" MODIFIED="2013-11-28 18:23:49 +0000" MODIFIED_BY="[Empty name]" NAME="Schols 1995" TYPE="JOURNAL_ARTICLE">
<AU>Schols AM, Soeters PB, Mostert R, Pluymers RJ, Wouters EF</AU>
<TI>Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>1995</YR>
<VL>152</VL>
<NO>4 Pt 1</NO>
<PG>1268-74</PG>
<IDENTIFIERS MODIFIED="2013-11-28 18:23:49 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-28 18:23:49 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="7551381"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Sharshar-2010" MODIFIED="2012-08-28 15:33:01 +0100" MODIFIED_BY="Greet Hermans" NAME="Sharshar 2010" TYPE="JOURNAL_ARTICLE">
<AU>Sharshar T, Bastuji-Garin S, De Jonghe B, Stevens RD, Polito A, Maxime V, et al</AU>
<TI>Hormonal status and ICU-acquired paresis in critically ill patients</TI>
<SO>Intensive Care Medicine</SO>
<YR>2010</YR>
<VL>36</VL>
<NO>8</NO>
<PG>1318-26</PG>
<IDENTIFIERS MODIFIED="2012-08-13 09:23:32 +0100" MODIFIED_BY="Greet Hermans">
<IDENTIFIER TYPE="PUBMED" VALUE="20333354"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Stevens-2007" MODIFIED="2013-11-28 18:23:29 +0000" MODIFIED_BY="[Empty name]" NAME="Stevens 2007" TYPE="JOURNAL_ARTICLE">
<AU>Stevens RD, Dowdy DW, Michaels RK, Mendez-Tellez PA, Pronovost PJ, Needham DM</AU>
<TI>Neuromuscular dysfunction acquired in critical illness: a systematic review</TI>
<SO>Intensive Care Medicine</SO>
<YR>2007</YR>
<VL>33</VL>
<NO>11</NO>
<PG>1876-91</PG>
<IDENTIFIERS MODIFIED="2013-11-28 18:23:29 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-28 18:23:29 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="17639340"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Tennil_x00e4_-2000" MODIFIED="2013-12-12 08:27:19 +0000" MODIFIED_BY="[Empty name]" NAME="Tennilä 2000" TYPE="JOURNAL_ARTICLE">
<AU>Tennilä A, Salmi T, Pettilä V, Roine RO, Varpula T, Takkunen O</AU>
<TI>Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis</TI>
<SO>Intensive Care Medicine</SO>
<YR>2000</YR>
<VL>26</VL>
<NO>9</NO>
<PG>1360-3</PG>
<IDENTIFIERS MODIFIED="2013-11-29 16:53:12 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-29 16:53:12 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="11089765"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Van-den-Berghe-2001" MODIFIED="2013-12-13 18:32:32 +0000" MODIFIED_BY="[Empty name]" NAME="Van den Berghe 2001" TYPE="JOURNAL_ARTICLE">
<AU>Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al</AU>
<TI>Intensive insulin therapy in the critically ill patients</TI>
<SO>New England Journal of Medicine</SO>
<YR>2001</YR>
<VL>345</VL>
<NO>19</NO>
<PG>1359-67</PG>
<IDENTIFIERS MODIFIED="2013-11-28 18:11:56 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-28 18:11:56 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="11794168"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Van-den-Berghe-2004" MODIFIED="2014-01-16 00:58:00 +0000" MODIFIED_BY="[Empty name]" NAME="Van den Berghe 2004" TYPE="JOURNAL_ARTICLE">
<AU>Van den Berghe G</AU>
<TI>How does blood glucose control with insulin save lives in intensive care?</TI>
<SO>Journal of Clinical Investigation</SO>
<YR>2004</YR>
<VL>114</VL>
<NO>9</NO>
<PG>1187-95</PG>
<IDENTIFIERS MODIFIED="2013-11-28 18:03:53 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-28 18:03:53 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15520847"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Van-den-Berghe-2006a" MODIFIED="2013-12-12 08:27:31 +0000" MODIFIED_BY="[Empty name]" NAME="Van den Berghe 2006a" TYPE="JOURNAL_ARTICLE">
<AU>Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al</AU>
<TI>Intensive insulin therapy in the medical ICU</TI>
<SO>New England Journal of Medicine</SO>
<YR>2006</YR>
<VL>354</VL>
<NO>5</NO>
<PG>449-61</PG>
<IDENTIFIERS MODIFIED="2013-11-28 18:17:27 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-28 18:17:27 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16452557"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Van-den-Berghe-2006b" MODIFIED="2014-01-14 09:11:13 +0000" MODIFIED_BY="[Empty name]" NAME="Van den Berghe 2006b" TYPE="JOURNAL_ARTICLE">
<AU>Van den Berghe G, Wilmer A, Milants I, Wouters PJ, Bouckaert B, Bruyninckx F, et al</AU>
<TI>Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm</TI>
<SO>Diabetes</SO>
<YR>2006</YR>
<VL>55</VL>
<NO>11</NO>
<PG>3151-9</PG>
<IDENTIFIERS MODIFIED="2013-11-28 18:18:56 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-28 18:18:56 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="17065355"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Voerman-1992" MODIFIED="2013-11-28 18:19:16 +0000" MODIFIED_BY="[Empty name]" NAME="Voerman 1992" TYPE="JOURNAL_ARTICLE">
<AU>Voerman HJ, van Schijndel RJ, Groeneveld AB, de Boer H, Nauta JP, van der Veen EA, et al</AU>
<TI>Effects of recombinant human growth hormone in patients with severe sepsis</TI>
<SO>Annals of Surgery</SO>
<YR>1992</YR>
<VL>216</VL>
<NO>6</NO>
<PG>648-55</PG>
<IDENTIFIERS MODIFIED="2013-11-28 18:19:16 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-28 18:19:16 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="1466618"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Voerman-1995" MODIFIED="2013-11-29 16:51:41 +0000" MODIFIED_BY="[Empty name]" NAME="Voerman 1995" TYPE="JOURNAL_ARTICLE">
<AU>Voerman BJ, Strack van Schijndel RJ, Groeneveld AB, de Boer H, Nauta JP, Thijs LG</AU>
<TI>Effects of human growth hormone in critically ill nonseptic patients: results from a prospective, randomized, placebo-controlled trial</TI>
<SO>Critical Care Medicine</SO>
<YR>1995</YR>
<VL>23</VL>
<NO>4</NO>
<PG>665-73</PG>
<IDENTIFIERS MODIFIED="2013-11-29 16:51:41 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-29 16:51:41 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="7712756"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Waldhausen-1997" MODIFIED="2013-12-12 08:27:50 +0000" MODIFIED_BY="Greet Hermans" NAME="Waldhausen 1997" TYPE="OTHER">
<AU>Waldhausen E, Mingers B, Lippers P, Keser G</AU>
<TI>Critical illness polyneuropathy due to parenteral nutrition</TI>
<SO>Intensive Care Medicine</SO>
<YR>1997</YR>
<VL>23</VL>
<NO>8</NO>
<PG>922-3</PG>
<IDENTIFIERS MODIFIED="2013-11-28 18:20:08 +0000" MODIFIED_BY="Ruth Brassington">
<IDENTIFIER MODIFIED="2013-11-28 18:20:08 +0000" MODIFIED_BY="Ruth Brassington" TYPE="PUBMED" VALUE=" 9310817"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Weber_x002d_Carstens-2010" MODIFIED="2013-06-23 14:03:35 +0100" MODIFIED_BY="Greet Hermans" NAME="Weber-Carstens 2010" TYPE="JOURNAL_ARTICLE">
<AU>Weber-Carstens S, Deja M, Koch S, Spranger J, Bubser F, Wernecke KD, et al</AU>
<TI>Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study</TI>
<SO>Critical Care (London, England)</SO>
<YR>2010</YR>
<VL>14</VL>
<NO>3</NO>
<PG>R119</PG>
<IDENTIFIERS MODIFIED="2012-08-13 09:10:09 +0100" MODIFIED_BY="Greet Hermans">
<IDENTIFIER TYPE="PUBMED" VALUE="20565863"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Weitzel-2009" MODIFIED="2013-12-12 08:28:05 +0000" MODIFIED_BY="Greet Hermans" NAME="Weitzel 2009" TYPE="JOURNAL_ARTICLE">
<AU>Weitzel LR, Sandoval PA, Mayles WJ, Wischmeyer PE</AU>
<TI>Performance-enhancing sports supplements: role in critical care</TI>
<SO>Critical Care Medicine</SO>
<YR>2009</YR>
<VL>37</VL>
<NO>10 Suppl</NO>
<PG>S400-9</PG>
<IDENTIFIERS MODIFIED="2013-11-29 17:06:20 +0000" MODIFIED_BY="Ruth Brassington">
<IDENTIFIER MODIFIED="2013-11-29 17:06:20 +0000" MODIFIED_BY="Ruth Brassington" TYPE="PUBMED" VALUE="20046127"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Witt-1991" MODIFIED="2013-11-28 18:21:35 +0000" MODIFIED_BY="[Empty name]" NAME="Witt 1991" TYPE="JOURNAL_ARTICLE">
<AU>Witt NJ, Zochodne DW, Bolton CF, Grand'Maison F, Wells G, Young GB, et al</AU>
<TI>Peripheral nerve function in sepsis and multiple organ failure</TI>
<SO>Chest</SO>
<YR>1991</YR>
<VL>99</VL>
<NO>1</NO>
<PG>176-84</PG>
<IDENTIFIERS MODIFIED="2013-11-28 18:21:35 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-11-28 18:21:35 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE=" 1845860"/>
</IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2014-01-16 01:54:16 +0000" MODIFIED_BY="Greet Hermans">
<REFERENCE ID="REF-Hermans-2007" MODIFIED="2013-12-12 08:28:24 +0000" MODIFIED_BY="Ruth Brassington" NAME="Hermans 2007" TYPE="COCHRANE_PROTOCOL">
<AU>Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G</AU>
<TI>Interventions for preventing critical illness polyneuropathy and critical illness myopathy (Protocol). Cochrane Database of Systematic Reviews</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2013-11-29 17:11:03 +0000" MODIFIED_BY="Ruth Brassington">
<IDENTIFIER MODIFIED="2013-11-29 17:11:03 +0000" MODIFIED_BY="Ruth Brassington" TYPE="DOI" VALUE="10.1002/14651858.CD006832"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hermans-2009" MODIFIED="2014-01-16 01:54:16 +0000" MODIFIED_BY="Greet Hermans" NAME="Hermans 2009" TYPE="COCHRANE_REVIEW">
<AU>Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G</AU>
<TI>Interventions for preventing critical illness polyneuropathy and critical illness myopathy</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2009</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2013-11-28 18:22:45 +0000" MODIFIED_BY="Greet Hermans">
<IDENTIFIER MODIFIED="2013-11-28 18:22:45 +0000" MODIFIED_BY="Ruth Brassington" TYPE="DOI" VALUE="10.1002/14651858.CD006832.pub2"/>
<IDENTIFIER TYPE="PUBMED" VALUE="19160304"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2013-06-15 19:58:32 +0100" MODIFIED_BY="Greet Hermans">
<REFERENCE ID="REF-Berek-1997" MODIFIED="2013-06-15 19:58:32 +0100" MODIFIED_BY="Greet Hermans" NAME="Berek 1997" TYPE="OTHER">
<AU>Berek K, Margreiter J, Willeit J, Berek A, Schmutzhard E, Mutz N</AU>
<TI>Critical illness polyneuropathy--only due to parenteral nutrition?</TI>
<SO>Intensive care medicine</SO>
<YR>1997</YR>
<VL>23</VL>
<NO>8</NO>
<PG>923-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hermans-2009a" MODIFIED="2013-06-15 19:56:40 +0100" MODIFIED_BY="Greet Hermans" NAME="Hermans 2009a" TYPE="JOURNAL_ARTICLE">
<AU>Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G</AU>
<TI>Interventions for preventing critical illness polyneuropathy and critical illness myopathy</TI>
<SO>Cochrane database of systematic reviews (Online)</SO>
<YR>2009</YR>
<NO>1</NO>
<PG>CD006832</PG>
<IDENTIFIERS/>
</REFERENCE>
</PENDING_REFERENCES>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2014-01-17 10:43:53 +0000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2014-01-17 10:42:51 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2014-01-17 09:55:51 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hermans-2007">
<CHAR_METHODS MODIFIED="2013-12-12 08:15:21 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel-group RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-12-12 08:15:21 +0000" MODIFIED_BY="[Empty name]">
<P>420 participants staying in a medical ICU for at least 7 days<BR/>Age (in years): intervention group 61 ± 15; control group 64 ± 16<BR/>Percentage male: intervention group 59%; control group 61%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-01-17 09:55:51 +0000" MODIFIED_BY="[Empty name]">
<P>Intensive insulin therapy (IIT) (insulin infusion titrated to achieve blood glucose levels 80 to 110 mg/dL), vs conventional insulin therapy (CIT) (insulin started if blood glucose &gt; 215 mg/dL, tapered if &lt; 180 mg/dL)<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-12-13 08:11:06 +0000" MODIFIED_BY="[Empty name]">
<P>Incidence of CIP/CIM, based on presence of abundant spontaneous electrical activity on electrophysiological examination and need for prolonged mechanical ventilation (at least 14 days of mechanical ventilation)<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-01-13 23:03:55 +0000" MODIFIED_BY="[Empty name]">
<P>Single centre</P>
<P>Sponsors of the study were not involved in the study design, data collection, analysis or interpretation of the data, or preparation of the manuscript</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-01-17 09:56:00 +0000" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Routsi-2010">
<CHAR_METHODS MODIFIED="2013-12-12 08:15:39 +0000" MODIFIED_BY="Greet Hermans">
<P>Quasi-RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-01-17 09:55:56 +0000" MODIFIED_BY="Greet Hermans">
<P>140 participants with APACHE II &gt; 13, second day in the ICU</P>
<P>Age (in years): intervention group 61 ± 19; control group 58 ± 18</P>
<P>Percentage male: intervention group 68%; control group 68%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-12-12 08:15:39 +0000" MODIFIED_BY="Greet Hermans">
<P>Electrical muscle stimulation (EMS): daily sessions (vastus lateralis, vastus medialis, peroneus longus) of both lower extremities starting from the second day after admission until ICU discharge. The EMS consisted of bilaterally, biphasic symmetric impulses of 45 Hz, 400 &#956;s pulse duration, 12 s on and 6 s off, intensity able to cause visible contractions, duration of session 55 min, including 5 min warm up and 5 min for recovery</P>
<P>Control: no sham stimulation</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-12-12 08:15:42 +0000" MODIFIED_BY="Greet Hermans">
<P>MRC sum-score, weaning duration, ICU stay</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-01-17 09:56:00 +0000" MODIFIED_BY="Greet Hermans">
<P>Single centre study</P>
<P>The research project was co-financed by the European Union (European Social Fund) and the Greek Ministry of Development</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-01-17 09:56:16 +0000" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Schweickert-2009">
<CHAR_METHODS MODIFIED="2013-12-12 08:16:11 +0000" MODIFIED_BY="Greet Hermans">
<P>Parallel-group RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-01-17 09:56:07 +0000" MODIFIED_BY="Greet Hermans">
<P>104 sedated medical ICU patients &#8805;18 years who had been on mechanical ventilation for less than 72 hours, who were expected to continue for at least 24 hours, and who met criteria for baseline functional independence</P>
<P>Exclusion criteria consisted of rapidly-developing neuromuscular disease, cardiopulmonary arrest, irreversible disorders with 6-month mortality estimated at more than 50%, raised intracranial pressure, absent limbs, or enrolment in another trial</P>
<P>Age (median, in years): intervention group 58; control group 54</P>
<P>Percentage male: intervention group 41%; control group 58%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-01-17 09:56:16 +0000" MODIFIED_BY="Greet Hermans">
<P>Intervention: physical and occupational therapy co-ordinated with daily interruption of sedatives consisting of: 1. passive range of motion for all limbs in unco-operative participants (10 repetitions in all cardinal directions); 2. if interaction achieved, active assisted and active range of motion exercises in the supine position; 3. advancement to bed mobility activities including transferring to upright sitting; 4. participation in activities of daily living (ADL) and exercise, encouraging increased independence with functional tasks; and 5. transfer training, pre-gait exercise and walking. Control: daily interruption of sedatives with physical and occupational therapy delivered as ordered</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-12-12 08:16:11 +0000" MODIFIED_BY="Greet Hermans">
<P>Functional outcomes at hospital discharge, duration of delirium, ventilator-free days compared with standard care</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-01-17 09:56:16 +0000" MODIFIED_BY="Greet Hermans">
<P>2-centre trial</P>
<P>Time to first physiotherapy session was 1.5 days in the intervention group and 7.4 days in the control group; rates and timing of physical and occupational therapy in the control group may have been affected and the control group could have been at disadvantage</P>
<P>No funding</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-01-17 10:42:42 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Steinberg-2006">
<CHAR_METHODS MODIFIED="2013-12-12 08:16:28 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel-group RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-01-13 23:04:01 +0000" MODIFIED_BY="[Empty name]">
<P>180 patients with ARDS of at least 7 days' duration and maximal 28 days' duration<BR/>Age (in years): intervention group 49 ± 19; control group 49 ± 17<BR/>Percentage male: intervention group 40%; control group 58%<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-12-12 08:16:28 +0000" MODIFIED_BY="[Empty name]">
<P>Intravenous methylprednisolone sodium succinate diluted in 50 mL of 5% dextrose in water (single dose of 2 mg/kg, followed by 0.5 mg/kg 4 times a days for 14 days, followed by 0.5 mg/kg twice daily for 7 days, then tapering the dose) vs placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-01-17 09:56:20 +0000" MODIFIED_BY="[Empty name]">
<P>Primary end point was mortality at 60 days</P>
<P>Secondary end points were ventilator-free days at 28 days, organ failure-free days at 28 days and markers of inflammation and fibroproliferation at 7 days<BR/>In the first 88 participants the safety board ordered retrospective evaluation of neuromyopathy. The trial evaluated the next 92 participants prospectively</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-01-17 10:42:42 +0000" MODIFIED_BY="[Empty name]">
<P>Multicentre<BR/>An adequate intention-to-treat analysis was performed concerning the primary outcome of the trial Concerning CIP/CIM, however, data were only prospectively available in 92/180 participants. Also, there is inconsistency in the paper concerning this exact number: the paper mentions both 91 and 92 as numbers of participants: 92 once in the text vs 91 in a table</P>
<P>Funding not mentioned</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-01-13 23:04:03 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Van-den-Berghe-2005">
<CHAR_METHODS MODIFIED="2013-12-12 08:16:39 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel-group RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-12-12 08:16:39 +0000" MODIFIED_BY="[Empty name]">
<P>405 patients staying in a surgical ICU for at least 7 days<BR/>Age (in years): intervention group 61 ± 15; control group 61 ± 16<BR/>Percentage male: intervention group 67%; control group 69%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-12-12 08:16:39 +0000" MODIFIED_BY="[Empty name]">
<P>Intensive insulin therapy (IIT) (insulin infusion was titrated to achieve blood glucose levels of 80 to 110 mg/dL) versus conventional insulin therapy (CIT) (insulin was started if blood glucose &gt; 215 mg/dL, tapered if &lt; 180 mg/dL)<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-08-28 15:11:59 +0100" MODIFIED_BY="[Empty name]">
<P>Incidence of CIP/CIM, based on presence of abundant spontaneous electrical activity on electrophysiological examination, and need for prolonged mechanical ventilation (at least 14 days of mechanical ventilation)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-01-13 23:04:03 +0000" MODIFIED_BY="[Empty name]">
<P>Single centre<BR/>The figures reported (<LINK REF="STD-Van-den-Berghe-2005" TYPE="STUDY">Van den Berghe 2005</LINK>) are slightly different from those reported in the original trial (<LINK REF="REF-Van-den-Berghe-2001" TYPE="REFERENCE">Van den Berghe 2001</LINK>) due to a statistical error in the query in the latter report, where only patients staying more than 7 days were considered instead of at least 7 days</P>
<P>Sponsors of the study were not involved in the study design, data collection, analysis or interpretation of the data, or preparation of the manuscript</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>ARDS: adult respiratory distress syndrome; CIP/CIM: critical illness polyneuropathy/critical illness myopathy; COPD: chronic obstructive pulmonary disease; ICU: intensive care unit; MRC: medical research council; RCT: randomised controlled trial; vs: versus</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2013-12-13 18:34:55 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2012-08-28 15:13:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Berard-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-28 15:13:00 +0100" MODIFIED_BY="[Empty name]">
<P>No clinical or electrophysiological data on weakness, outcome is plasma amino acid concentration and nitrogen balance</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-28 15:13:01 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bouletreau-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-28 15:13:01 +0100" MODIFIED_BY="[Empty name]">
<P>No clinical or electrophysiological data on weakness, outcome is nitrogen balance, excretion of creatinine, 3-methyl histidine</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-01-16 09:29:22 +0000" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Brunello-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-01-16 09:29:22 +0000" MODIFIED_BY="Greet Hermans">
<P>No interventional study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-15 15:05:47 +0100" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Burtin-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-15 15:05:47 +0100" MODIFIED_BY="Greet Hermans">
<P>No incidence of CIP or CIM as a primary or secondary outcome</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-15 15:05:47 +0100" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Caruso-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-15 15:05:47 +0100" MODIFIED_BY="Greet Hermans">
<P>No incidence of CIP or CIM as a primary or secondary outcome</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-15 15:05:47 +0100" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Chen--2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-15 15:05:47 +0100" MODIFIED_BY="Greet Hermans">
<P>No incidence of CIP or CIM as a primary or secondary outcome</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-01-16 09:29:43 +0000" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Chiang-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-01-16 09:29:43 +0000" MODIFIED_BY="Greet Hermans">
<P>No ICU patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-28 15:13:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fl_x00e4_ring-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-28 15:13:07 +0100" MODIFIED_BY="[Empty name]">
<P>No ICU patients, no clinical or electrophysiological data on weakness, outcome is muscle glutathione, free amino acids in skeletal muscle and plasma</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-28 15:13:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gamrin-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-28 15:13:08 +0100" MODIFIED_BY="[Empty name]">
<P>No clinical or electrophysiological data on weakness, outcome is muscle protein synthesis and muscle free glutamine</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-01-16 09:31:59 +0000" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Gerovasili-2009a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-01-16 09:31:59 +0000" MODIFIED_BY="Greet Hermans">
<P>No clinical or electrophysiological data on weakness</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-01-16 09:33:32 +0000" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Gerovasili-2009b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-01-16 09:33:32 +0000" MODIFIED_BY="Greet Hermans">
<P>No clinical or electrophysiological data on weakness, only reports on muscle mass measured with ultrasonography</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-01-16 09:34:17 +0000" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Gruther-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-01-16 09:34:17 +0000" MODIFIED_BY="Greet Hermans">
<P>No clinical or electrophysiological data on weakness, only reports on muscle mass measured with ultrasonography</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-12-12 08:16:57 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hsieh-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-12-12 08:16:57 +0000" MODIFIED_BY="[Empty name]">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-01 12:16:46 +0100" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Huang-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-01 12:16:46 +0100" MODIFIED_BY="Greet Hermans">
<P>No clinical or electrophysiological data on weakness</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-15 15:05:47 +0100" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Johnson-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-15 15:05:47 +0100" MODIFIED_BY="Greet Hermans">
<P>No incidence of CIP or CIM as a primary or secondary outcome</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-12-13 18:34:55 +0000" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Karatzanos-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-12-13 18:34:55 +0000" MODIFIED_BY="Greet Hermans">
<P>Subanalysis of data from <LINK REF="STD-Routsi-2010" TYPE="STUDY">Routsi 2010</LINK>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-12-12 08:17:00 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Knox-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-12-12 08:17:00 +0000" MODIFIED_BY="[Empty name]">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-14 09:15:45 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kuhls-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-14 09:15:45 +0100" MODIFIED_BY="[Empty name]">
<P>No clinical nor electrophysiological data on weakness, outcome measure is nitrogen balance.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-15 15:05:47 +0100" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Martin-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-15 15:05:47 +0100" MODIFIED_BY="Greet Hermans">
<P>No incidence of CIP or CIM as a primary or secondary outcome</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-01-16 09:35:25 +0000" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Menadue-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-01-16 09:35:25 +0000" MODIFIED_BY="Greet Hermans">
<P>No ICU patients: ambulatory respiratory medicine ward</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-16 12:30:12 +0100" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Miao-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-16 12:30:12 +0100" MODIFIED_BY="Greet Hermans">
<P>No clinical nor electrophysiological data on weakness</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-28 15:13:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mohr-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-28 15:13:17 +0100" MODIFIED_BY="[Empty name]">
<P>Retrospective analysis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-27 15:09:21 +0100" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Morris-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-27 15:09:21 +0100" MODIFIED_BY="Greet Hermans">
<P>No incidence of CIP or CIM as a primary or secondary outcome</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-27 15:09:25 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nava-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-27 15:09:25 +0100" MODIFIED_BY="[Empty name]">
<P>No incidence of CIP or CIM as a primary or secondary outcome</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-28 15:13:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Paddon_x002d_Jones-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-28 15:13:21 +0100" MODIFIED_BY="[Empty name]">
<P>No ICU patients, healthy volunteers</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-15 15:05:47 +0100" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Pichard-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-15 15:05:47 +0100" MODIFIED_BY="Greet Hermans">
<P>No incidence of CIP or CIM as a primary or secondary outcome</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-28 15:13:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Porta-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-28 15:13:23 +0100" MODIFIED_BY="[Empty name]">
<P>No ICU patients, concerns rehabilitation after extubation in intermediate care unit</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-15 15:05:47 +0100" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Rodriguez-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-15 15:05:47 +0100" MODIFIED_BY="Greet Hermans">
<P>Randomisation of body parts</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-27 15:09:30 +0100" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Routsi-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-27 15:09:30 +0100" MODIFIED_BY="Greet Hermans">
<P>No incidence of CIP or CIM as a primary or secondary outcome</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-01 12:16:49 +0100" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Salisbury-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-01 12:16:49 +0100" MODIFIED_BY="Greet Hermans">
<P>Studies rehabilitation strategies during the ward phase after critical illness</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-28 15:13:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sevette-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-28 15:13:26 +0100" MODIFIED_BY="[Empty name]">
<P>No ICU patients, no clinical or electrophysiological data on weakness</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-15 15:05:47 +0100" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Takala-1999a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-15 15:05:47 +0100" MODIFIED_BY="Greet Hermans">
<P>No incidence of CIP or CIM as a primary or secondary outcome</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-15 15:05:48 +0100" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Takala-1999b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-15 15:05:48 +0100" MODIFIED_BY="Greet Hermans">
<P>No incidence of CIP or CIM as a primary or secondary outcome</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-28 15:13:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tj_x00e4_der-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-28 15:13:27 +0100" MODIFIED_BY="[Empty name]">
<P>No clinical or electrophysiological data on weakness, outcome is plasma glutamine levels, free muscle glutamine, muscle protein synthesis and content</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-01-16 09:52:19 +0000" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Toledo-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-01-16 09:52:19 +0000" MODIFIED_BY="Greet Hermans">
<P>No ICU patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-01-16 09:38:01 +0000" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Vivodtzev-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-01-16 09:38:01 +0000" MODIFIED_BY="Greet Hermans">
<P>No ICU patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-15 15:05:48 +0100" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Watters-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-15 15:05:48 +0100" MODIFIED_BY="Greet Hermans">
<P>No incidence of CIP or CIM as a primary or secondary outcome</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-15 15:05:48 +0100" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Zanotti-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-15 15:05:48 +0100" MODIFIED_BY="Greet Hermans">
<P>No incidence of CIP or CIM as a primary or secondary outcome</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-12-12 08:18:54 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ziegler-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-12-12 08:18:54 +0000" MODIFIED_BY="[Empty name]">
<P>Not an RCT, no clinical or electrophysiological data on weakness</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>CIM: critical illness myopathy; CIP: critical illness polyneuropathy; ICU: intensive care unit; RCT: randomised controlled trial</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2014-01-17 10:43:36 +0000" MODIFIED_BY="Greet Hermans" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2014-01-17 10:42:56 +0000" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Abokhabar-2012">
<CHAR_METHODS MODIFIED="2014-01-13 23:04:06 +0000" MODIFIED_BY="Greet Hermans">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-01-17 10:42:52 +0000" MODIFIED_BY="Greet Hermans">
<P>N = 80 critically ill patients, mechanically ventilated for at least 24 hours</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-01-17 10:42:53 +0000" MODIFIED_BY="Greet Hermans">
<P>Once daily electrical muscle stimulation vs conventional treatment</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-01-17 10:42:55 +0000" MODIFIED_BY="Greet Hermans">
<P>Muscle weakness evaluated using MRC sum-score and duration of mechanical ventilation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-01-17 10:42:56 +0000" MODIFIED_BY="Greet Hermans">
<P>Single centre, abstract</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-01-17 10:43:05 +0000" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Alia-2011">
<CHAR_METHODS MODIFIED="2014-01-13 23:04:11 +0000" MODIFIED_BY="Greet Hermans">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-01-17 10:43:00 +0000" MODIFIED_BY="Greet Hermans">
<P>N = 83 patients with chronic obstructive pulmonary disease exacerbation receiving invasive or non-invasive ventilation</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-01-17 10:43:01 +0000" MODIFIED_BY="Greet Hermans">
<P>Corticosteroids 0.5 mg/kg 4 times daily, tempered over 10 days vs placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-01-17 10:43:03 +0000" MODIFIED_BY="Greet Hermans">
<P>Duration of mechanical ventilation, length of ICU stay, need for intubation, weakness assessed with MRC sum-score</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-01-17 10:43:05 +0000" MODIFIED_BY="Greet Hermans">
<P>Multicentre</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-01-17 10:43:10 +0000" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Brunner-2013">
<CHAR_METHODS MODIFIED="2014-01-13 23:04:30 +0000" MODIFIED_BY="Greet Hermans">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-01-17 10:43:09 +0000" MODIFIED_BY="Greet Hermans">
<P>N = 38 critically ill patients with multiple organ failure, systemic inflammatory response syndrome or sepsis and early signs of critical illness polyneuromyopathy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-01-17 10:43:10 +0000" MODIFIED_BY="Greet Hermans">
<P>IgM-enriched intravenous immunoglobulin vs placebo for 3 days</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-01-13 23:04:32 +0000" MODIFIED_BY="Greet Hermans">
<P>Electrophysiology and muscle biopsy</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-01-13 23:04:32 +0000" MODIFIED_BY="Greet Hermans">
<P>Terminated early due to futility</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-01-17 10:43:21 +0000" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Devost-2011">
<CHAR_METHODS MODIFIED="2014-01-13 23:04:32 +0000" MODIFIED_BY="Greet Hermans">
<P>Randomised body parts</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-01-17 10:43:12 +0000" MODIFIED_BY="Greet Hermans">
<P>Mechanical ventilation for at least 48 hours</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-01-17 10:43:19 +0000" MODIFIED_BY="Greet Hermans">
<P>60 minutes of daily quadriceps electrical stimulation of one leg in a randomised order for 10 days, then of both legs for 10 additional days</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-01-17 10:43:21 +0000" MODIFIED_BY="Greet Hermans">
<P>Non-voluntary (magnetic stimulation of the legs) and voluntary muscle strength (MRC sum-scores and handgrip strength)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-01-13 23:04:34 +0000" MODIFIED_BY="Greet Hermans">
<P>Abstract</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-01-17 10:43:23 +0000" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Files-2013">
<CHAR_METHODS MODIFIED="2014-01-13 23:04:34 +0000" MODIFIED_BY="Greet Hermans">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-01-17 10:43:22 +0000" MODIFIED_BY="Greet Hermans">
<P>N = 100 critically ill patients with acute respiratory failure</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-01-17 10:43:23 +0000" MODIFIED_BY="Greet Hermans">
<P>Early rehabilitation vs usual care</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-01-13 23:04:36 +0000" MODIFIED_BY="Greet Hermans">
<P>Grip strength, duration of mechanical ventilation, ICU stay, hospital stay, death</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-01-13 23:04:36 +0000" MODIFIED_BY="Greet Hermans">
<P>Abstract</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-01-17 10:43:26 +0000" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Gerovasili-2011">
<CHAR_METHODS MODIFIED="2014-01-13 23:04:36 +0000" MODIFIED_BY="Greet Hermans">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-01-17 10:43:24 +0000" MODIFIED_BY="Greet Hermans">
<P>N = 172 critically ill patients with APACHE II &#8805; 13</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-01-17 10:43:24 +0000" MODIFIED_BY="Greet Hermans">
<P>Daily electrical muscle stimulation in upper and lower limbs vs control</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-01-17 10:43:26 +0000" MODIFIED_BY="Greet Hermans">
<P>Strength at awakening based on MRC sum-score handgrip dynamometry</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-01-13 23:05:12 +0000" MODIFIED_BY="Greet Hermans">
<P>Abstract</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-01-17 10:43:31 +0000" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Hermans-2013">
<CHAR_METHODS MODIFIED="2014-01-13 23:05:12 +0000" MODIFIED_BY="Greet Hermans">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-01-17 10:43:29 +0000" MODIFIED_BY="Greet Hermans">
<P>N = 600 awake, co-operative patients from medical and surgical ICU. In ICU for at least 8 days</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-01-17 10:43:31 +0000" MODIFIED_BY="Greet Hermans">
<P>Early (within 48 hours) vs late (not in the first week) supplementation of deficient enteral feeding</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-01-13 23:05:27 +0000" MODIFIED_BY="Greet Hermans">
<P>Incidence of weakness based on MRC sums score, autophagosome formation on muscle biopsy</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-01-13 23:05:28 +0000" MODIFIED_BY="Greet Hermans">
<P>Subanalysis of EPaNIC trial</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-01-17 10:43:34 +0000" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Mikaeili-2012">
<CHAR_METHODS MODIFIED="2014-01-13 23:05:34 +0000" MODIFIED_BY="Greet Hermans">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-01-13 23:05:41 +0000" MODIFIED_BY="Greet Hermans">
<P>N = 40 medical ICU patients</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-01-17 10:43:34 +0000" MODIFIED_BY="Greet Hermans">
<P>Euglycemic control (80 to 140 mg/dL) vs conventional control (180 to 200 mg/dL)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-01-13 23:05:36 +0000" MODIFIED_BY="Greet Hermans">
<P>Duration of mechanical ventilation and the presence of critical illness polyneuropathy</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-01-13 23:05:37 +0000" MODIFIED_BY="Greet Hermans">
<P>None</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2014-01-17 10:43:35 +0000" MODIFIED_BY="Greet Hermans" STUDY_ID="STD-Paternostro_x002d_Sluga-2012">
<CHAR_METHODS MODIFIED="2014-01-13 23:06:31 +0000" MODIFIED_BY="Greet Hermans">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-01-13 23:06:42 +0000" MODIFIED_BY="Greet Hermans">
<P>N = 40 critically ill patients after cardiac or thoracic surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-01-17 10:43:35 +0000" MODIFIED_BY="Greet Hermans">
<P>Daily (2 x 30 minutes) electrical stimulation of the quadriceps femoris, until ICU discharge or up to 14 days vs sham stimulation</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-01-13 23:06:53 +0000" MODIFIED_BY="Greet Hermans">
<P>Nitrogen excretion, muscle strength with MRC sum score</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-01-13 23:06:54 +0000" MODIFIED_BY="Greet Hermans">
<P>Abstract</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<FOOTNOTES>
<P>MRC: Medical Research Council; RCT: randomised controlled trial</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2014-01-17 10:43:53 +0000" MODIFIED_BY="Greet Hermans" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2014-01-17 10:43:44 +0000" MODIFIED_BY="Ruth Brassington" STUDY_ID="STD-Kho-2012">
<CHAR_STUDY_NAME MODIFIED="2014-01-17 10:43:41 +0000" MODIFIED_BY="Ruth Brassington">
<P>Use of neuromuscular electrostimulation (NMES) for treatment or prevention of ICU-associated weakness</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2014-01-14 11:21:17 +0000" MODIFIED_BY="Ruth Brassington">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-01-17 10:43:41 +0000" MODIFIED_BY="Ruth Brassington">
<P>Medical ICU, mechanically ventilated for at least 1 day, expected to stay in ICU for at least an additional 2 days</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-01-17 10:43:42 +0000" MODIFIED_BY="Ruth Brassington">
<P>Electrical stimulation of the quadriceps, tibialis anterior, gastrocnemius muscles for 60 minutes a day vs sham stimulation</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-01-14 11:21:17 +0000" MODIFIED_BY="Ruth Brassington">
<P>Lower extremity muscle strength at hospital discharge</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2014-01-17 10:43:42 +0000" MODIFIED_BY="Ruth Brassington">
<P>June 2008 </P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2014-01-17 10:43:43 +0000" MODIFIED_BY="Ruth Brassington">
<P>Michelle Kho, Johns Hopkins Hospital, michelle.kho@jhmi.edu</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2014-01-17 10:43:44 +0000" MODIFIED_BY="Ruth Brassington">
<P>
<A HREF="http://clinicaltrials.gov/show/NCT00709124">NCT00709124</A>. Protocol</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2014-01-17 10:43:53 +0000" MODIFIED_BY="Ruth Brassington" STUDY_ID="STD-Parry-2012">
<CHAR_STUDY_NAME MODIFIED="2014-01-17 10:43:45 +0000" MODIFIED_BY="Ruth Brassington">
<P>eRiCC trial: Early rehabilitation in critical care</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2014-01-14 11:52:22 +0000" MODIFIED_BY="Ruth Brassington">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-01-17 10:43:45 +0000" MODIFIED_BY="Ruth Brassington">
<P>N = 80, sepsis or severe sepsis, expected duration of mechanical ventilation of &#8805; 48 hours and remaining in the ICU &#8805; 4 days</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-01-17 10:43:49 +0000" MODIFIED_BY="Ruth Brassington">
<P>Control: usual mobilisation for up to 15 minutes, but no longer</P>
<P>Intervention: usual mobilisation and within 72 hours from admission, electrical muscle stimulation assisted supine cycling in one leg, and cycling with sham stimulation on the other leg. The cycling will take place for 1 hour, 5 days a week</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-01-14 11:52:22 +0000" MODIFIED_BY="Ruth Brassington">
<P>Muscle mass, muscle strength, physical function</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2014-01-17 10:43:50 +0000" MODIFIED_BY="Ruth Brassington">
<P>30 May 2012</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2014-01-17 10:43:51 +0000" MODIFIED_BY="Ruth Brassington">
<P>Selina Parry, The University of Melbourne School of Physiotherapy Level 1 200 Berkeley Street Parkville VIC 3010 Australia. selina.parry@austin.org.au</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2014-01-17 10:43:53 +0000" MODIFIED_BY="Ruth Brassington">
<P>ACTRN12612000528853. Single centre, protocol</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES>
<P>ICU: intensive care unit; RCT: randomised controlled trial</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2014-01-17 10:42:49 +0000" MODIFIED_BY="Greet Hermans">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2014-01-16 01:34:16 +0000" MODIFIED_BY="Greet Hermans" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-12-13 08:11:19 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Hermans-2007">
<DESCRIPTION>
<P>Quote: "Treatment assignment was performed with the use of sealed envelopes, stratified according to diagnostic category, and balanced with the use of permuted blocks of 10."</P>
<P>Personal communication: "randomisation sequence was determined by shuffling envelopes"</P>
<P>Comment: probably done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-26 14:43:43 +0000" MODIFIED_BY="Greet Hermans" RESULT="NO" STUDY_ID="STD-Routsi-2010">
<DESCRIPTION>
<P>Quote: "patients with an odd number were assigned to the EMS group and patients with an even number were assigned to the control group"</P>
<P>Comment: non-random component in the sequence generation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-26 14:44:27 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Schweickert-2009">
<DESCRIPTION>
<P>Quote: "computer generated, permuted block randomisation scheme was used"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-16 01:34:16 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Steinberg-2006">
<DESCRIPTION>
<P>Quote from published protocol (<A HREF="http://www.ARDSnet.org">www.ARDSnet.org</A>): "The randomization scheme to be employed will consist of centralized, random permuted blocks."&#8230;"and an assignment will be made by computer-generated randomisations"</P>
<P>Comment: probably done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-26 14:46:26 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Van-den-Berghe-2005">
<DESCRIPTION>
<P>Quote: "Prospective, randomised controlled study&#8230;use of sealed envelopes, with stratification according to the type of critical illness"</P>
<P>Personal communication: "shuffling of envelopes"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2013-12-13 18:20:13 +0000" MODIFIED_BY="Greet Hermans" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-26 14:40:39 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Hermans-2007">
<DESCRIPTION>
<P>Quote: "Treatment assignment was performed with the use of sealed envelopes"</P>
<P>Personal communication: numbered and opaque</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-26 14:43:51 +0000" MODIFIED_BY="Greet Hermans" RESULT="NO" STUDY_ID="STD-Routsi-2010">
<DESCRIPTION>
<P>Quote: "patients with an odd number were assigned to the EMS group and patients with an even number were assigned to the control group"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-26 14:44:33 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Schweickert-2009">
<DESCRIPTION>
<P>Quote: "consecutively numbered, sealed, opaque envelope"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-12-13 18:20:13 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Steinberg-2006">
<DESCRIPTION>
<P>Quote from published protocol (<A HREF="http://www.ARDSnet.org">www.ARDSnet.org</A>): "the data coordinating center will be called and an assignment will be made by computer-generated randomisations"</P>
<P>Comment: probably done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-26 14:46:38 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Van-den-Berghe-2005">
<DESCRIPTION>
<P>Quote: "&#8230;use of sealed envelopes"</P>
<P>Personal communication:</P>
<P>"Opaque and sequentially numbered"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2014-01-17 10:42:49 +0000" MODIFIED_BY="Greet Hermans" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>Neuromuscular analysis</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.02" NO="2">
<NAME>Mortality</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.03" NO="3">
<NAME>Other secondary outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-12-13 17:46:01 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Hermans-2007">
<DESCRIPTION>
<P>Quote: "ENMGs were evaluated by an independent investigator, unaware of treatment allocation"</P>
<P>Comment: Review authors judge that blinding outcome assessor probably sufficient to avoid bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2014-01-17 09:55:53 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Hermans-2007">
<DESCRIPTION>
<P>Personal communication: Mortality was obtained by review of participant charts by a study nurse, unaware of treatment allocation</P>
<P>Comment: Review authors judge that blinding of the outcome assessor was probably sufficient to avoid bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2013-12-12 08:15:27 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Hermans-2007">
<DESCRIPTION>
<P>Quote: "This study could not be blinded for obvious reasons. To minimize the bias, however, clear guidelines were used for sedation, mechanical ventilation, weaning, and patient discharge"</P>
<P>Comment: Review authors judge that the use of strict protocols was probably sufficient to avoid a substantial risk of bias despite unblinding of treating personnel</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-11-26 14:43:54 +0000" MODIFIED_BY="Greet Hermans" RESULT="NO" STUDY_ID="STD-Routsi-2010">
<DESCRIPTION>
<P>Quote: "MRC scale and handgrip investigators&#8212;though independent from each other&#8212;were not blinded to patients&#8217; group of randomization. Furthermore, ICU staff was not blinded due to absence of sham-EMS sessions, and this may have affected cointerventions."</P>
<P>Comment: Unblinding could have introduced bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-12-13 18:16:19 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Routsi-2010">
<DESCRIPTION>
<P>Quote: "The investigators were not blinded as to patients' allocation"</P>
<P>Comment: Review authors judge that unblinding probably did not induce bias for mortality</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2013-11-26 14:41:24 +0000" MODIFIED_BY="Greet Hermans" RESULT="NO" STUDY_ID="STD-Routsi-2010">
<DESCRIPTION>
<P>Quote: "Furthermore, ICU staff was not blinded due to absence of sham-EMS sessions, and this may have affected cointerventions"</P>
<P>Comment: Unblinding could have introduced bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-01-13 23:04:00 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Schweickert-2009">
<DESCRIPTION>
<P>Quote: "the nature of the intervention prevented any blinding from patients and health care providers", "therapists who undertook patient assessments were blinded to treatment assignment"</P>
<P>Comment: Review authors judge that blinding outcome assessors is probably sufficient to avoid substantial risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-11-28 14:56:03 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Schweickert-2009">
<DESCRIPTION>
<P>Comment: Review authors judge that blinding outcome assessors was sufficient to avoid bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2013-11-26 16:33:31 +0000" MODIFIED_BY="Greet Hermans" RESULT="NO" STUDY_ID="STD-Schweickert-2009">
<DESCRIPTION>
<P>Quote: "the nature of the intervention prevented any blinding from patients and health care providers"&#8230; "Decisions about sedation initiation or reinitiation, extubation, and ICU and hospital discharge were not controlled by protocol and might have been affected by knowledge of the intervention"</P>
<P>Comment: Unblinding could have introduced bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-12-13 08:11:33 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Steinberg-2006">
<DESCRIPTION>
<P>Quote: "To receive either methylprednisolone or placebo in a double blind fashion"</P>
<P>Quote from published protocol (<A HREF="http://www.ARDSnet.org">www.ARDSnet.org</A>): "the pharmacy which will dispense either MPSS or placebo based on a predetermined list in the research pharmacy"</P>
<P>Comment: probably done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-12-13 08:11:36 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Steinberg-2006">
<DESCRIPTION>
<P>Quote: "To receive either methylprednisolone or placebo in a double blind fashion"</P>
<P>Quote from published protocol (<A HREF="http://www.ARDSnet.org">www.ARDSnet.org</A>): "the pharmacy which will dispense either MPSS or placebo based on a predetermined list in the research pharmacy"</P>
<P>Comment: probably done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2013-12-13 08:11:36 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Steinberg-2006">
<DESCRIPTION>
<P>Quote: "To receive either methylprednisolone or placebo in a double blind fashion"</P>
<P>Quote from published protocol (<A HREF="http://www.ARDSnet.org">www.ARDSnet.org</A>): "the pharmacy which will dispense either MPSS or placebo based on a predetermined list in the research pharmacy"</P>
<P>Comment: probably done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2014-01-17 10:42:46 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Van-den-Berghe-2005">
<DESCRIPTION>
<P>Quote: "The presence of CIPNP was prospectively assessed electromyographically in all 405 patients still in ICU on day 7 and subsequently on a weekly basis by one electrophysiologist who was unaware of the treatment assignments"</P>
<P>Comment: review authors judge that blinding of the outcome assessor was probably sufficient to avoid bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2014-01-17 10:42:49 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Van-den-Berghe-2005">
<DESCRIPTION>
<P>Personal communication: mortality was obtained by review of participant charts by a study nurse, unaware of treatment allocation</P>
<P>Comment: review authors judge that blinding of the outcome assessor was probably sufficient to avoid bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2014-01-13 23:04:04 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Van-den-Berghe-2005">
<DESCRIPTION>
<P>Quote: "it was not feasible to conduct the study in a strictly blinded fashion because adjustment of the insulin dose requires blood glucose monitoring. To minimize bias, we assigned responsibility for adjustment of the insulin dose to a team of nurses and to a study physician who was not taking part in clinical decisions, with strictly blinded analysis of important outcome measures."&#8230;"To minimize the possibility of bias caused by delays in the transfer of patients to a regular ward because of the unavailability of beds, patients were considered to be ready for discharge when they no longer needed vital-organ support and were receiving at least two thirds of their caloric intake by the normal enteral route"</P>
<P>Comment: Review authors judge that the use of strict protocols and definition of ready for discharge was probably sufficient to avoid substantial risk of bias despite unblinding of treating personnel</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2014-01-17 10:42:44 +0000" MODIFIED_BY="Greet Hermans" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.02" NO="2">
<NAME>Mortality</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.03" NO="3">
<NAME>Other secondary outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>Neuromuscular outcome</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-12-12 08:15:27 +0000" MODIFIED_BY="Greet Hermans" RESULT="NO" STUDY_ID="STD-Hermans-2007">
<DESCRIPTION>
<P>605 and 595 participants were randomised respectively to CIT and IIT. 74 vs 69 died within 7 days, 379 vs 378 were discharged within 7 days, 14 vs 9 were excluded because of pre-existing neuromuscular disease or technical  problems</P>
<P>212 participants in the CIT group and 208 in the IIT group were analysed</P>
<P>Comment: Missing outcome data balanced across intervention groups, with similar reasons for missing data across groups, and similar demographic data and baseline characteristics in treatment groups</P>
<P>Review authors performed imputation for participants with missing data but this involved a substantial amount of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2012-01-16 17:24:41 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Hermans-2007">
<DESCRIPTION>
<P>Figures are reported for the total population randomised</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2012-01-16 17:24:57 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Hermans-2007">
<DESCRIPTION>
<P>Data are reported for the total population randomised</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-01-17 09:56:05 +0000" MODIFIED_BY="Greet Hermans" RESULT="NO" STUDY_ID="STD-Routsi-2010">
<DESCRIPTION>
<P>44/68 missing data in intervention and 44/72 in control group, reasons differ across groups (EMS vs control: 28 vs 22 deaths, 11 vs 22 impaired cognitive state, 3 vs 0 prolonged use of NMBA, 2 vs 0 consent withdrawn, 2 vs 0 no EMS session. Significantly higher APACHE II in remaining participants in the EMS group (mean 16 ± 4) vs the control group (19 ± 5), MD -3.00, 95% CI -5.45 to -0.55</P>
<P>Review authors performed imputation for missing values but this involved a large proportion of participants</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2013-12-12 08:15:58 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Routsi-2010">
<DESCRIPTION>
<P>Quote: "Analysis of patient data was by intention to treat. Patients randomised to the EMS group that did not finally receive any EMS session were not included in the analysis."</P>
<P>Comment: 2 participants did not receive EMS. There was a small amount of missing data. Review authors judged that this was not likely to have introduced bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2013-12-12 08:15:58 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Routsi-2010">
<DESCRIPTION>
<P>Quote: "Analysis of patient data was by intention to treat. Patients randomised to the EMS group that did not finally receive any EMS session were not included in the analysis."</P>
<P>Comment: 2 participants did not receive EMS. There was a small amount of missing data. Review authors judged that this was not likely to have introduced bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-12-12 08:16:18 +0000" MODIFIED_BY="Greet Hermans" RESULT="NO" STUDY_ID="STD-Schweickert-2009">
<DESCRIPTION>
<P>Quote: "Data were analysed by an intention-to-treat approach. Patients who died during the study were assigned scores of 0 for ventilator-free days, strength testing (MRC examination and hand grip), ADL total, walk distance, and Barthel Index score."</P>
<P>Comment: adequate imputation performed but this involved a substantial amount of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2014-01-17 09:56:18 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Schweickert-2009">
<DESCRIPTION>
<P>Quote: "All 104 patients were included in the analysis"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2014-01-17 09:56:19 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Schweickert-2009">
<DESCRIPTION>
<P>Quote: "All 104 patients were included in the analysis"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-01-17 10:42:44 +0000" MODIFIED_BY="Greet Hermans" RESULT="NO" STUDY_ID="STD-Steinberg-2006">
<DESCRIPTION>
<P>Data on neuromuscular outcome missing in the first 88 of a total of 180 participants, obtained by retrospective chart review</P>
<P>Comment: reason for missing data probably not related to outcome. Review authors performed imputation for missing data but this involved a substantial amount of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2012-01-16 19:55:07 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Steinberg-2006">
<DESCRIPTION>
<P>Data are reported on the total population randomised</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2012-01-16 19:55:15 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Steinberg-2006">
<DESCRIPTION>
<P>Data are reported on the total population randomised</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-01-13 23:04:05 +0000" MODIFIED_BY="Greet Hermans" RESULT="NO" STUDY_ID="STD-Van-den-Berghe-2005">
<DESCRIPTION>
<P>224/783 CIT group participants and 181/765 IIT group participants had neuromuscular data available</P>
<P>Comment: review authors judge that the reason for missing data is unlikely to be related to outcome and review authors also performed imputation for participants with missing data but this involved substantial amount of data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2012-01-17 07:59:33 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Van-den-Berghe-2005">
<DESCRIPTION>
<P>Figures are reported for the total population randomised</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.03" MODIFIED="2012-01-17 07:59:35 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Van-den-Berghe-2005">
<DESCRIPTION>
<P>Data are reported for the total population randomised</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2014-01-17 09:56:06 +0000" MODIFIED_BY="Greet Hermans" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-12-12 08:15:34 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Hermans-2007">
<DESCRIPTION>
<P>Study protocol published at <A HREF="http://www.clinicaltrials.gov">www.clinicaltrials.gov</A>
</P>
<P>The paper reports all the prespecified outcome measures</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 09:56:06 +0000" MODIFIED_BY="Greet Hermans" RESULT="NO" STUDY_ID="STD-Routsi-2010">
<DESCRIPTION>
<P>Comment: The study protocol is available at <A HREF="http://www.clinicaltrials.gov">www.clinicaltrials.gov</A>. Secondary outcome measures mentioned: a previous publication on only the first 26 participants reported muscle mass preservation; there has been no report (yet) of muscle properties and structure. No report of formal assessment of severe adverse events</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-12-12 08:16:18 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Schweickert-2009">
<DESCRIPTION>
<P>Comment: The study protocol is available at <A HREF="http://www.clinicaltrials.gov">www.clinicaltrials.gov</A>. The paper reports all the prespecified outcome measures</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-12-13 08:11:36 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Steinberg-2006">
<DESCRIPTION>
<P>Study protocol published at <A HREF="http://www.ARDSnet.org">www.ARDSnet.org</A>
</P>
<P>All the prespecified outcome measures are reported in the paper</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-17 07:59:36 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Van-den-Berghe-2005">
<DESCRIPTION>
<P>The published report includes all expected outcomes and the approved study protocol is available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-09" LEVEL="STUDY" MODIFIED="2014-01-16 00:19:17 +0000" MODIFIED_BY="Greet Hermans" NO="9">
<NAME>Diagnostic criteria for CIP/CIM</NAME>
<DESCRIPTION>
<P>Were formal criteria used to diagnose CIP/CIM?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-16 17:25:25 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Hermans-2007">
<DESCRIPTION>
<P>Predetermined electrophysiological criteria were used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-16 00:19:17 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Routsi-2010">
<DESCRIPTION>
<P>Quote: "Patients with an MRC sum score of less than 48 of 60 were diagnosed with CIPNM"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-12-12 08:16:18 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Schweickert-2009">
<DESCRIPTION>
<P>Comment: MRC sum-score was used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-26 14:46:07 +0000" MODIFIED_BY="Greet Hermans" RESULT="NO" STUDY_ID="STD-Steinberg-2006">
<DESCRIPTION>
<P>Quote: "we reviewed the charts of all 88 previously enrolled patients for evidence of neuromyopathy, as defined by the presence of the terms &#8220;myopathy&#8221;, &#8220;myositis&#8221;, &#8220;neuropathy&#8221;, &#8220;paralysis&#8221; or &#8220;unexplained weakness&#8221; in the medical record. The charts of the final 91 patients who were enrolled were reviewed prospectively."</P>
<P>Comment: no predefined criteria used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-17 07:59:38 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Van-den-Berghe-2005">
<DESCRIPTION>
<P>Predetermined electrophysiological criteria were used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2013-12-13 18:23:41 +0000" MODIFIED_BY="Greet Hermans" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-12-12 08:15:27 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Hermans-2007">
<DESCRIPTION>
<P>The study appears to be free of other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-27 15:08:38 +0100" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Routsi-2010">
<DESCRIPTION>
<P>The study appears to be free of other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-08-28 15:11:15 +0100" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Schweickert-2009">
<DESCRIPTION>
<P>The study appears to be free of other bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-16 19:55:11 +0000" MODIFIED_BY="Greet Hermans" RESULT="YES" STUDY_ID="STD-Steinberg-2006">
<DESCRIPTION>
<P>The study appears to be free of other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-12-13 18:23:41 +0000" MODIFIED_BY="Greet Hermans" RESULT="NO" STUDY_ID="STD-Van-den-Berghe-2005">
<DESCRIPTION>
<P>The study was prematurely stopped due to a formal stopping rule (Lan and Demets)</P>
<P>Comment: prematurely stopped for a data-dependent reason</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2014-01-17 10:43:57 +0000" MODIFIED_BY="Greet Hermans">
<SOF_TABLE ID="SOF-01" MODIFIED="2014-01-17 10:43:56 +0000" MODIFIED_BY="Grade Profiler" NO="1" READONLY="YES">
<TITLE MODIFIED="2013-12-12 08:54:20 +0000" MODIFIED_BY="Grade Profiler">Intensive insulin therapy versus conventional insulin therapy for preventing critical illness polyneuropathy and critical illness myopathy</TITLE>
<TABLE COLS="7" ROWS="14">
<TR>
<TD COLSPAN="7">
<P>
<B>Intensive insulin therapy (IIT) versus conventional insulin therapy (CIT) for preventing critical illness polyneuropathy and critical illness myopathy</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> critically ill patients<BR/>
<B>Settings:</B> medical or surgical ICU<BR/>
<B>Intervention:</B> IIT versus CIT<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>CIT</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>IIT</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Occurrence of CIP/CIM - in total population randomised</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>220 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>154 per 1000</B>
<BR/>(132 to 181)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.7 </B>
<BR/>(0.6 to 0.82)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>2748<BR/>(2 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>1,2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Occurrence of CIP/CIM - in screened population</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>495 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>322 per 1000</B>
<BR/>(272 to 381)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.65 </B>
<BR/>(0.55 to 0.77)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>825<BR/>(2 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Duration of mechanical ventilation - in total population randomised</B>
<BR/>(in days)</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean duration of mechanical ventilation - in total population randomised in the intervention groups was<BR/>
<B>2 days less</B>
<BR/>(2.93 to 1.07 lower)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>2748<BR/>(2 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>
<B>high</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Duration of ICU stay - in total population randomised</B>
<BR/>(in days)</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean duration of ICU stay - in total population randomised in the intervention groups was<BR/>
<B>1.48 days less</B>
<BR/>(2.43 to 0.54 lower)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>2748<BR/>(2 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>
<B>high</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Death - at 30 days after ICU admission, in total population randomised</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>171 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>161 per 1000</B>
<BR/>(137 to 188)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.94 </B>
<BR/>(0.8 to 1.1)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>2748<BR/>(2 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>
<B>high</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Death - at 180 days after ICU admission, in total population randomised</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>231 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>201 per 1000</B>
<BR/>(176 to 231)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.87 </B>
<BR/>(0.76 to 1)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>2748<BR/>(2 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Serious adverse events, - in total population randomised - hypoglycaemia</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>18 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>113 per 1000</B>
<BR/>(75 to 171)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 6.27 </B>
<BR/>(4.15 to 9.49)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>2748<BR/>(2 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>
<B>high</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (eg the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> confidence interval; <B>CIT</B>: conventional insulin therapy; <B>ICU</B>: intensive care unit; <B>IIT</B>: intensive insulin therapy; <B>RR:</B> risk ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> we are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1 </SUP>Imputation of a large amount of data because screening electrophysiological testing was only performed in patients in ICU for one week.<BR/>
<SUP>2 </SUP>Significantly fewer participants treated with IIT in the original surgical ICU study, but not in the medical study, reached the CIP/CIM screening period. The reason was the benefit of IIT in the first seven days, a possible source of bias in the subsequent results. Any bias as such, originated from earlier ICU discharge in the intervention group and is expected to reduce rather than inflate the effect.<BR/>
<SUP>3 </SUP>Substantial heterogeneity present, explained by clinical diversity. As only two studies are available, we could not perform a subanalysis of medical and surgical participants.</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-02" MODIFIED="2014-01-17 10:43:57 +0000" MODIFIED_BY="Grade Profiler" NO="2" READONLY="YES">
<TITLE MODIFIED="2013-12-12 08:22:36 +0000" MODIFIED_BY="Grade Profiler">Corticosteroids versus placebo compared for preventing critical illness polyneuropathy and critical illness myopathy</TITLE>
<TABLE COLS="7" ROWS="14">
<TR>
<TD COLSPAN="7">
<P>
<B>Corticosteroids versus placebo compared to for </B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population: </B>critically ill patients<BR/>
<B>Settings: </B>medical or surgical ICU<BR/>
<B>Intervention:</B> corticosteroids versus placebo<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Placebo</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Corticosteroids</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Occurrence of CIP/CIM - in total population randomised</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>231 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>293 per 1000</B>
<BR/>(178 to 480)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>RR 1.27 </B>
<BR/>(0.77 to 2.08)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>180<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>1,2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Occurrence of CIP/CIM - in screened population</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>229 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>250 per 1000</B>
<BR/>(121 to 518)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>RR 1.09 </B>
<BR/>(0.53 to 2.26)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>92<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Death - death at 180 days in total population randomised</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>319 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>315 per 1000</B>
<BR/>(204 to 484)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>RR 0.99 </B>
<BR/>(0.64 to 1.52)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>180<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>
<B>high</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Serious adverse events (dichotomous data) - shock</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>165 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>68 per 1000</B>
<BR/>(28 to 166)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>RR 0.41 </B>
<BR/>(0.17 to 1.01)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>180<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>
<B>high</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Serious adverse events (dichotomous data) - serious infection</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>330 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>224 per 1000</B>
<BR/>(138 to 366)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>RR 0.68 </B>
<BR/>(0.42 to 1.11)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>180<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>
<B>high</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Serious adverse events (dichotomous data) - suspected or probable pneumonia</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>154 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>68 per 1000</B>
<BR/>(28 to 168)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>RR 0.44 </B>
<BR/>(0.18 to 1.09)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>180<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>
<B>high</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Serious adverse events (continuous data) - blood glucose (mg/dL) on day 7</B>
</P>
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean blood glucose on day 7 in the intervention groups was<BR/>
<B>15 mg/dL higher</B>
<BR/>(3.41 lower to 33.41 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>180<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>
<B>high</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (eg the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> confidence interval; <B>ICU</B>: intensive care unit; <B>RR:</B> risk ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> we are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> Imputation of a substantial amount of data.<BR/>
<SUP>2</SUP> No clear diagnostic criteria for CIP/CIM stated.</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-03" MODIFIED="2014-01-16 01:41:33 +0000" MODIFIED_BY="Grade Profiler" NO="3" READONLY="YES">
<TITLE MODIFIED="2014-01-16 01:41:18 +0000" MODIFIED_BY="Grade Profiler">Early physical therapy versus control for preventing critical illness polyneuropathy and critical illness myopathy</TITLE>
<TABLE COLS="7" ROWS="10">
<TR>
<TD COLSPAN="7">
<P>
<B>Early physical therapy versus control for preventing critical illness polyneuropathy and critical illness myopathy</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> critically ill patients<BR/>
<B>Settings:</B> medical or surgical ICU<BR/>
<B>Intervention:</B> early physical therapy versus control<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Control</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Early physical therapy</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Occurrence of CIP/CIM - in the total population randomised</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>709 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>574 per 1000</B>
<BR/>(425 to 766)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>RR 0.81 </B>
<BR/>(0.6 to 1.08)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>104<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>1,2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Occurrence of CIP/CIM - in screened population</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>634 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>393 per 1000</B>
<BR/>(247 to 609)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>RR 0.62 </B>
<BR/>(0.39 to 0.96)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>82<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Serious adverse events - in total population randomised</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>0 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>0 per 1000</B>
<BR/>(0 to 0)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>RR 3.36 </B>
<BR/>(0.14 to 80.62)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>104<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (eg the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> confidence interval; <B>ICU</B>: intensive care unit; <B>RR:</B> risk ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> we are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1 </SUP>Imputation of a substantial amount of data.<BR/>
<SUP>2 </SUP>Data were obtained from a single, though high quality study, with a limited number of participants.</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-04" MODIFIED="2014-01-16 01:42:22 +0000" MODIFIED_BY="Grade Profiler" NO="4" READONLY="YES">
<TITLE MODIFIED="2014-01-16 01:41:59 +0000" MODIFIED_BY="Grade Profiler">Electrical muscle stimulation versus control for preventing critical illness polyneuropathy and critical illness myopathy</TITLE>
<TABLE COLS="7" ROWS="9">
<TR>
<TD COLSPAN="7">
<P>
<B>Electrical muscle stimulation versus control for preventing critical illness polyneuropathy and critical illness myopathy</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> critically ill patients<BR/>
<B>Settings: </B>medical or surgical ICU<BR/>
<B>Intervention:</B> electrical muscle stimulation versus control<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Control</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Electrical muscle stimulation</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Occurrence of CIP/CIM - in the total population randomised</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>764 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>718 per 1000</B>
<BR/>(596 to 878)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>RR 0.94 </B>
<BR/>(0.78 to 1.15)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>140<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>1,2,3,4,5</SUP>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Occurrence of CIP/CIM - in screened population</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>393 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>126 per 1000</B>
<BR/>(39 to 397)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>RR 0.32 </B>
<BR/>(0.1 to 1.01)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>52<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>1,2,3,5</SUP>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (eg the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> confidence interval; <B>ICU</B>: intensive care unit; <B>RR:</B> risk ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> we are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> Lack of blinding may have introduced bias.<BR/>
<SUP>2</SUP> Non-random component in the sequence generation may have introduced bias.<BR/>
<SUP>3</SUP> Important differences in baseline characteristics and severity of illness between the screened intervention group and the control group, which may have artificially increased the treatment effect.<BR/>
<SUP>4</SUP> Imputation of a substantial amount of data.<BR/>
<SUP>5</SUP> Data are from a single study with relatively small number of participants and events of neuromyopathy.</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2014-01-16 01:42:46 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2014-01-16 01:42:46 +0000" MODIFIED_BY="Greet Hermans" NO="1">
<TITLE MODIFIED="2012-08-13 08:33:07 +0100" MODIFIED_BY="Greet Hermans">MRC sum-score</TITLE>
<TABLE COLS="1" ROWS="14">
<TR>
<TH>
<P>A. Muscle groups</P>
</TH>
</TR>
<TR>
<TD>
<P>Shoulder abduction</P>
</TD>
</TR>
<TR>
<TD>
<P>Elbow flexion</P>
</TD>
</TR>
<TR>
<TD>
<P>Wrist dorsiflexion</P>
</TD>
</TR>
<TR>
<TD>
<P>Hip flexion</P>
</TD>
</TR>
<TR>
<TD>
<P>Knee extension</P>
</TD>
</TR>
<TR>
<TD>
<P>Ankle dorsiflexion</P>
</TD>
</TR>
<TR>
<TH>
<P>B. Score</P>
</TH>
</TR>
<TR>
<TD>
<P>0 No visible/palpable contraction</P>
</TD>
</TR>
<TR>
<TD>
<P>1 Visible contraction, no movement of the limb</P>
</TD>
</TR>
<TR>
<TD>
<P>2 Movement of the limb, but not against gravity</P>
</TD>
</TR>
<TR>
<TD>
<P>3 Movement against gravity</P>
</TD>
</TR>
<TR>
<TD>
<P>4 Movement against gravity and resistance, submaximal</P>
</TD>
</TR>
<TR>
<TD>
<P>5 Normal muscle force</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2013-12-13 12:31:48 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Intensive insulin therapy (IIT) versus conventional insulin therapy (CIT)</NAME>
<DICH_OUTCOME CHI2="14.608166660023887" CI_END="0.7644077786983635" CI_START="0.6056843539712439" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6804335614970148" ESTIMABLE="YES" EVENTS_1="337" EVENTS_2="522" I2="79.46354207328646" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-0.1166749021657075" LOG_CI_START="-0.21775364488006246" LOG_EFFECT_SIZE="-0.16721427352288498" METHOD="MH" MODIFIED="2013-12-13 12:31:48 +0000" MODIFIED_BY="Ruth Brassington" NO="1" P_CHI2="0.0021840531917294292" P_Q="0.5554976892713182" P_Z="8.889343668012894E-11" Q="0.3475602184199735" RANDOM="NO" SCALE="5.55" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="1749" TOTAL_2="1824" WEIGHT="200.0" Z="6.484725571469545">
<NAME>Occurrence of CIP/CIM</NAME>
<GROUP_LABEL_1>Favours IIT</GROUP_LABEL_1>
<GROUP_LABEL_2>CIT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours IIT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CIT</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="9.568381856095215" CI_END="0.8173592272897754" CI_START="0.5984800091307305" DF="1" EFFECT_SIZE="0.6994091490761839" ESTIMABLE="YES" EVENTS_1="210" EVENTS_2="306" I2="89.54891208315455" ID="CMP-001.01.01" LOG_CI_END="-0.08758703019759362" LOG_CI_START="-0.22295035163887475" LOG_EFFECT_SIZE="-0.15526869091823417" MODIFIED="2013-07-15 14:35:00 +0100" MODIFIED_BY="Greet Hermans" NO="1" P_CHI2="0.0019795902520800546" P_Z="6.912699397609891E-6" STUDIES="2" TAU2="0.0" TOTAL_1="1360" TOTAL_2="1388" WEIGHT="100.0" Z="4.496358967645913">
<NAME>In total population randomised</NAME>
<DICH_DATA CI_END="1.0133592143908725" CI_START="0.7007107259042287" EFFECT_SIZE="0.8426575049909466" ESTIMABLE="YES" EVENTS_1="150" EVENTS_2="181" LOG_CI_END="0.005763420853176649" LOG_CI_START="-0.15446123463234462" LOG_EFFECT_SIZE="-0.07434890688958397" MODIFIED="2013-05-07 13:01:47 +0100" MODIFIED_BY="Greet Hermans" ORDER="1" O_E="0.0" SE="0.09411675575703123" STUDY_ID="STD-Hermans-2007" TOTAL_1="595" TOTAL_2="605" VAR="0.008857963714228671" WEIGHT="59.23071069025125"/>
<DICH_DATA CI_END="0.6574022648751762" CI_START="0.3671571014140513" EFFECT_SIZE="0.4912941176470588" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="125" LOG_CI_END="-0.18216880402516286" LOG_CI_START="-0.43514806741501116" LOG_EFFECT_SIZE="-0.308658435720087" MODIFIED="2013-05-07 12:52:17 +0100" MODIFIED_BY="Greet Hermans" ORDER="2" O_E="0.0" SE="0.14860127158274694" STUDY_ID="STD-Van-den-Berghe-2005" TOTAL_1="765" TOTAL_2="783" VAR="0.022082337916009318" WEIGHT="40.76928930974876"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.680720975807193" CI_END="0.7749981994428679" CI_START="0.5487979695860135" DF="1" EFFECT_SIZE="0.6521636591278773" ESTIMABLE="YES" EVENTS_1="127" EVENTS_2="216" I2="78.6357698916768" ID="CMP-001.01.02" LOG_CI_END="-0.11069930649102548" LOG_CI_START="-0.26058750407831194" LOG_EFFECT_SIZE="-0.18564340528466872" MODIFIED="2013-12-12 08:32:27 +0000" MODIFIED_BY="Greet Hermans" NO="2" P_CHI2="0.030503020415264537" P_Z="1.203803504097754E-6" STUDIES="2" TAU2="0.0" TOTAL_1="389" TOTAL_2="436" WEIGHT="100.0" Z="4.855010523606238">
<NAME>In screened population</NAME>
<DICH_DATA CI_END="0.9577761908072451" CI_START="0.621560629030126" EFFECT_SIZE="0.7715672178289" ESTIMABLE="YES" EVENTS_1="81" EVENTS_2="107" LOG_CI_END="-0.018735963210673164" LOG_CI_START="-0.20651650247046693" LOG_EFFECT_SIZE="-0.11262623284057002" MODIFIED="2013-09-27 16:48:09 +0100" MODIFIED_BY="Greet Hermans" ORDER="3" O_E="0.0" SE="0.11030321828986345" STUDY_ID="STD-Hermans-2007" TOTAL_1="208" TOTAL_2="212" VAR="0.012166799965101265" WEIGHT="52.10261817147653"/>
<DICH_DATA CI_END="0.6934722043298192" CI_START="0.39334396928660925" EFFECT_SIZE="0.5222768513355973" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="109" LOG_CI_END="-0.15897094158146988" LOG_CI_START="-0.40522750400667273" LOG_EFFECT_SIZE="-0.2820992227940713" MODIFIED="2013-09-27 16:48:20 +0100" MODIFIED_BY="Greet Hermans" ORDER="4" O_E="0.0" SE="0.14465232375820777" STUDY_ID="STD-Van-den-Berghe-2005" TOTAL_1="181" TOTAL_2="224" VAR="0.020924294768649362" WEIGHT="47.89738182852347"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="4.29833302849374" CI_END="-0.9754246638283534" CI_START="-2.1427686077377723" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.559096635783063" ESTIMABLE="YES" I2="0.0" I2_Q="11.834300770466538" ID="CMP-001.02" MODIFIED="2013-12-12 08:32:52 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7448452865139592" P_Q="0.3336048471142895" P_Z="1.64601959719313E-7" Q="3.4026838398793866" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="3223" TOTAL_2="3288" UNITS="" WEIGHT="400.0" Z="5.235429147503216">
<NAME>Duration of mechanical ventilation</NAME>
<GROUP_LABEL_1>IIT</GROUP_LABEL_1>
<GROUP_LABEL_2>CIT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours IIT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CIT</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-1.0739671227354242" CI_START="-2.926032877264576" DF="1" EFFECT_SIZE="-2.0" ESTIMABLE="YES" I2="0.0" ID="CMP-001.02.01" NO="1" P_CHI2="1.0" P_Z="2.3056039195519308E-5" STUDIES="2" TAU2="0.0" TOTAL_1="1360" TOTAL_2="1388" WEIGHT="100.0" Z="4.233033259746943">
<NAME>In total population randomised</NAME>
<CONT_DATA CI_END="-0.6890110627779136" CI_START="-3.3109889372220866" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="9.0" MEAN_2="11.0" ORDER="5" SD_1="10.0" SD_2="13.0" SE="0.6688841976500588" STUDY_ID="STD-Hermans-2007" TOTAL_1="595" TOTAL_2="605" WEIGHT="49.894739313893304"/>
<CONT_DATA CI_END="-0.691768075682142" CI_START="-3.308231924317858" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="5.0" MEAN_2="7.0" ORDER="6" SD_1="11.0" SD_2="15.0" SE="0.6674775325654065" STUDY_ID="STD-Van-den-Berghe-2005" TOTAL_1="765" TOTAL_2="783" WEIGHT="50.105260686106696"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.7329996394016862" CI_END="-0.5053131769960322" CI_START="-4.598774178978659" DF="1" EFFECT_SIZE="-2.5520436779873457" ESTIMABLE="YES" I2="0.0" ID="CMP-001.02.02" MODIFIED="2013-12-12 08:32:35 +0000" MODIFIED_BY="Ruth Brassington" NO="2" P_CHI2="0.3919126409812076" P_Z="0.014531243308007143" STUDIES="2" TAU2="0.0" TOTAL_1="389" TOTAL_2="436" WEIGHT="100.0" Z="2.4438555507946482">
<NAME>In screened population</NAME>
<CONT_DATA CI_END="0.40545883252968995" CI_START="-4.40545883252969" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="16.0" MEAN_2="18.0" ORDER="7" SD_1="11.0" SD_2="14.0" SE="1.2272974664349152" STUDY_ID="STD-Hermans-2007" TOTAL_1="208" TOTAL_2="212" WEIGHT="72.39781610063271"/>
<CONT_DATA CI_END="-0.10426919870053153" CI_START="-7.895730801299468" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="16.0" MEAN_2="20.0" ORDER="8" SD_1="18.0" SD_2="22.0" SE="1.9876542793788539" STUDY_ID="STD-Van-den-Berghe-2005" TOTAL_1="181" TOTAL_2="224" WEIGHT="27.602183899367287"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.14087104148347762" CI_START="-1.8591289585165223" DF="1" EFFECT_SIZE="-1.0" ESTIMABLE="YES" I2="0.0" ID="CMP-001.02.03" MODIFIED="2013-12-12 08:32:44 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.0225284231539182" STUDIES="2" TAU2="0.0" TOTAL_1="1181" TOTAL_2="1163" WEIGHT="100.0" Z="2.2813385174728236">
<NAME>In ICU survivors, in total population randomised</NAME>
<CONT_DATA CI_END="0.318778460790887" CI_START="-2.3187784607908872" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="8.0" MEAN_2="9.0" ORDER="9" SD_1="9.0" SD_2="11.0" SE="0.6728585173978926" STUDY_ID="STD-Hermans-2007" TOTAL_1="451" TOTAL_2="443" WEIGHT="42.43977036054854"/>
<CONT_DATA CI_END="0.13239279910571877" CI_START="-2.1323927991057188" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="5.0" MEAN_2="6.0" ORDER="10" SD_1="11.0" SD_2="11.0" SE="0.5777620446283139" STUDY_ID="STD-Van-den-Berghe-2005" TOTAL_1="730" TOTAL_2="720" WEIGHT="57.56022963945145"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.16264954921266817" CI_END="0.7907824046273908" CI_START="-3.9806511548987094" DF="1" EFFECT_SIZE="-1.5949343751356593" ESTIMABLE="YES" I2="0.0" ID="CMP-001.02.04" MODIFIED="2013-12-12 08:32:52 +0000" MODIFIED_BY="Ruth Brassington" NO="4" P_CHI2="0.6867289874381616" P_Z="0.19009305827282919" STUDIES="2" TAU2="0.0" TOTAL_1="293" TOTAL_2="301" WEIGHT="100.0" Z="1.3103038715606738">
<NAME>In ICU survivors, in screened population</NAME>
<CONT_DATA CI_END="1.0930315759117328" CI_START="-5.093031575911732" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="15.0" MEAN_2="17.0" ORDER="11" SD_1="11.0" SD_2="14.0" SE="1.5781063327230354" STUDY_ID="STD-Hermans-2007" TOTAL_1="133" TOTAL_2="124" WEIGHT="59.49343751356592"/>
<CONT_DATA CI_END="2.748488566963326" CI_START="-4.748488566963326" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="16.0" MEAN_2="17.0" ORDER="12" SD_1="18.0" SD_2="17.0" SE="1.9125293099929006" STUDY_ID="STD-Van-den-Berghe-2005" TOTAL_1="160" TOTAL_2="177" WEIGHT="40.50656248643407"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="7.622079090748244" CI_END="-0.8768177436574778" CI_START="-2.083680159383272" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.480248951520375" ESTIMABLE="YES" I2="8.161540746845958" I2_Q="42.51482795024262" ID="CMP-001.03" MODIFIED="2013-12-12 08:29:18 +0000" MODIFIED_BY="Ruth Brassington" NO="3" P_CHI2="0.3670943359885651" P_Q="0.15646323485536007" P_Z="1.5252689393116987E-6" Q="5.218737098678757" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="3223" TOTAL_2="3288" UNITS="" WEIGHT="400.0" Z="4.807896236272036">
<NAME>Duration of ICU stay</NAME>
<GROUP_LABEL_1>IIT</GROUP_LABEL_1>
<GROUP_LABEL_2>CIT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours IIT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CIT</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.0834263350386144" CI_END="-0.5436747649030296" CI_START="-2.4257882721947914" DF="1" EFFECT_SIZE="-1.4847315185489105" ESTIMABLE="YES" I2="7.700231417730953" ID="CMP-001.03.01" NO="1" P_CHI2="0.29793276991588646" P_Z="0.0019861877009072944" STUDIES="2" TAU2="0.0" TOTAL_1="1360" TOTAL_2="1388" WEIGHT="100.0" Z="3.0922899089701095">
<NAME>In total population randomised</NAME>
<CONT_DATA CI_END="0.3109889372220864" CI_START="-2.3109889372220866" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="9.0" MEAN_2="10.0" ORDER="13" SD_1="10.0" SD_2="13.0" SE="0.6688841976500588" STUDY_ID="STD-Hermans-2007" TOTAL_1="595" TOTAL_2="605" WEIGHT="51.52684814510895"/>
<CONT_DATA CI_END="-0.6483470829517128" CI_START="-3.351652917048287" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="9.0" ORDER="14" SD_1="12.0" SD_2="15.0" SE="0.6896315073694991" STUDY_ID="STD-Van-den-Berghe-2005" TOTAL_1="765" TOTAL_2="783" WEIGHT="48.47315185489105"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.7150747151767743" CI_END="-1.4761022370070034" CI_START="-5.698802363500699" DF="1" EFFECT_SIZE="-3.587452300253851" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.02" MODIFIED="2013-12-12 08:29:11 +0000" MODIFIED_BY="Ruth Brassington" NO="2" P_CHI2="0.39776474968746633" P_Z="8.677486730638E-4" STUDIES="2" TAU2="0.0" TOTAL_1="389" TOTAL_2="436" WEIGHT="100.0" Z="3.330228097722544">
<NAME>In screened population</NAME>
<CONT_DATA CI_END="-0.48768736628499765" CI_START="-5.512312633715002" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="18.0" MEAN_2="21.0" ORDER="15" SD_1="11.0" SD_2="15.0" SE="1.2818157137232131" STUDY_ID="STD-Hermans-2007" TOTAL_1="208" TOTAL_2="212" WEIGHT="70.62738498730744"/>
<CONT_DATA CI_END="-1.1042691987005315" CI_START="-8.895730801299468" EFFECT_SIZE="-5.0" ESTIMABLE="YES" MEAN_1="19.0" MEAN_2="24.0" ORDER="16" SD_1="18.0" SD_2="22.0" SE="1.9876542793788539" STUDY_ID="STD-Van-den-Berghe-2005" TOTAL_1="181" TOTAL_2="224" WEIGHT="29.372615012692563"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.09842835793793492" CI_START="-1.901571642062065" DF="1" EFFECT_SIZE="-1.0" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.03" NO="3" P_CHI2="1.0" P_Z="0.02970953080042125" STUDIES="2" TAU2="0.0" TOTAL_1="1181" TOTAL_2="1163" WEIGHT="100.0" Z="2.173941474087678">
<NAME>In ICU survivors, in total population randomised</NAME>
<CONT_DATA CI_END="0.318778460790887" CI_START="-2.3187784607908872" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="8.0" ORDER="17" SD_1="9.0" SD_2="11.0" SE="0.6728585173978926" STUDY_ID="STD-Hermans-2007" TOTAL_1="451" TOTAL_2="443" WEIGHT="46.73656558985101"/>
<CONT_DATA CI_END="0.23533759902442042" CI_START="-2.2353375990244206" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="6.0" MEAN_2="7.0" ORDER="18" SD_1="12.0" SD_2="12.0" SE="0.6302858668672515" STUDY_ID="STD-Van-den-Berghe-2005" TOTAL_1="730" TOTAL_2="720" WEIGHT="53.26343441014899"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.6048409418540971" CI_END="0.3046449208818287" CI_START="-4.656882449588915" DF="1" EFFECT_SIZE="-2.1761187643535433" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.04" MODIFIED="2013-12-12 08:29:18 +0000" MODIFIED_BY="Ruth Brassington" NO="4" P_CHI2="0.436737098817952" P_Z="0.08556435249707384" STUDIES="2" TAU2="0.0" TOTAL_1="293" TOTAL_2="301" WEIGHT="100.0" Z="1.7192747659114822">
<NAME>In ICU survivors of screened population</NAME>
<CONT_DATA CI_END="0.23500386731199274" CI_START="-6.235003867311993" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="18.0" MEAN_2="21.0" ORDER="19" SD_1="11.0" SD_2="15.0" SE="1.6505425063058763" STUDY_ID="STD-Hermans-2007" TOTAL_1="133" TOTAL_2="124" WEIGHT="58.80593821767716"/>
<CONT_DATA CI_END="2.8651654413414556" CI_START="-4.865165441341455" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="20.0" MEAN_2="21.0" ORDER="20" SD_1="19.0" SD_2="17.0" SE="1.9720594214125295" STUDY_ID="STD-Van-den-Berghe-2005" TOTAL_1="160" TOTAL_2="177" WEIGHT="41.194061782322834"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="7.6880755499171505" CI_END="0.9542030502271016" CI_START="0.8088783864085332" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="RR" EFFECT_SIZE="0.878540962945837" ESTIMABLE="YES" EVENTS_1="716" EVENTS_2="845" I2="8.949906194984848" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="-0.020359199499287727" LOG_CI_START="-0.09211676897105171" LOG_EFFECT_SIZE="-0.05623798423516972" METHOD="MH" MODIFIED="2013-12-12 08:29:35 +0000" MODIFIED_BY="Ruth Brassington" NO="4" P_CHI2="0.3609008814994631" P_Q="0.4923829891051106" P_Z="0.00212534506891871" Q="2.4067314661610935" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="3498" TOTAL_2="3648" WEIGHT="400.0" Z="3.0721336989385186">
<NAME>Death</NAME>
<GROUP_LABEL_1>Favours IIT</GROUP_LABEL_1>
<GROUP_LABEL_2>CIT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours IIT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CIT</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.0225558394810392" CI_END="1.102632283509628" CI_START="0.8027664707667325" DF="1" EFFECT_SIZE="0.9408274160474318" ESTIMABLE="YES" EVENTS_1="219" EVENTS_2="237" I2="2.2058296095093075" ID="CMP-001.04.01" LOG_CI_END="0.042430703855961115" LOG_CI_START="-0.09541077502994748" LOG_EFFECT_SIZE="-0.02649003558699317" NO="1" P_CHI2="0.31191381986185396" P_Z="0.4512563918142285" STUDIES="2" TAU2="0.0" TOTAL_1="1360" TOTAL_2="1388" WEIGHT="100.0" Z="0.7533220931656537">
<NAME>At 30 days after ICU admission, in total population randomised</NAME>
<DICH_DATA CI_END="1.1679129196591735" CI_START="0.8287603407404314" EFFECT_SIZE="0.9838292073586191" ESTIMABLE="YES" EVENTS_1="179" EVENTS_2="185" LOG_CI_END="0.06741046270672789" LOG_CI_START="-0.08157103970513055" LOG_EFFECT_SIZE="-0.007080288499201312" ORDER="21" O_E="0.0" SE="0.08751247198705635" STUDY_ID="STD-Hermans-2007" TOTAL_1="595" TOTAL_2="605" VAR="0.007658432753285321" WEIGHT="78.11601318650487"/>
<DICH_DATA CI_END="1.174533978409126" CI_START="0.527774452724483" EFFECT_SIZE="0.7873303167420814" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="52" LOG_CI_END="0.06986558511714604" LOG_CI_START="-0.2775516359221681" LOG_EFFECT_SIZE="-0.10384302540251099" ORDER="22" O_E="0.0" SE="0.2040745953814729" STUDY_ID="STD-Van-den-Berghe-2005" TOTAL_1="765" TOTAL_2="783" VAR="0.04164644048011188" WEIGHT="21.883986813495124"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.024363432111904233" CI_END="1.1409415066458497" CI_START="0.7229719400421383" DF="1" EFFECT_SIZE="0.9082228220730584" ESTIMABLE="YES" EVENTS_1="95" EVENTS_2="112" I2="0.0" ID="CMP-001.04.02" LOG_CI_END="0.057263379745025544" LOG_CI_START="-0.1408785581983399" LOG_EFFECT_SIZE="-0.04180758922665715" MODIFIED="2013-12-12 08:29:35 +0000" MODIFIED_BY="Ruth Brassington" NO="2" P_CHI2="0.8759637539013423" P_Z="0.4081817037323735" STUDIES="2" TAU2="0.0" TOTAL_1="389" TOTAL_2="436" WEIGHT="100.0" Z="0.8270976857823399">
<NAME>At 30 days after ICU admission, in screened population</NAME>
<DICH_DATA CI_END="1.1817190175789294" CI_START="0.7140136422395968" EFFECT_SIZE="0.9185660018993352" ESTIMABLE="YES" EVENTS_1="73" EVENTS_2="81" LOG_CI_END="0.07251422475037428" LOG_CI_START="-0.1462934903347822" LOG_EFFECT_SIZE="-0.03688963279220396" ORDER="23" O_E="0.0" SE="0.12852873495667885" STUDY_ID="STD-Hermans-2007" TOTAL_1="208" TOTAL_2="212" VAR="0.0165196357095642" WEIGHT="74.32892595473233"/>
<DICH_DATA CI_END="1.4626648954656811" CI_START="0.527370730736219" EFFECT_SIZE="0.8782748173231153" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="31" LOG_CI_END="0.16514483827830728" LOG_CI_START="-0.27788397737248355" LOG_EFFECT_SIZE="-0.056369569547088154" ORDER="24" O_E="0.0" SE="0.26023731934128075" STUDY_ID="STD-Van-den-Berghe-2005" TOTAL_1="181" TOTAL_2="224" VAR="0.06772346237793574" WEIGHT="25.671074045267677"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.3183383830641104" CI_END="0.9970443553560941" CI_START="0.7633637521333154" DF="1" EFFECT_SIZE="0.8724147638296653" ESTIMABLE="YES" EVENTS_1="275" EVENTS_2="321" I2="69.86443561320552" ID="CMP-001.04.03" LOG_CI_END="-0.0012855208679763911" LOG_CI_START="-0.1172684661084704" LOG_EFFECT_SIZE="-0.0592769934882234" NO="3" P_CHI2="0.06851111149071865" P_Z="0.045133158094877474" STUDIES="2" TAU2="0.0" TOTAL_1="1360" TOTAL_2="1388" WEIGHT="100.0" Z="2.003411313755294">
<NAME>At 180 days after ICU admission, in total population randomised</NAME>
<DICH_DATA CI_END="1.0857078111001977" CI_START="0.8136831133394116" EFFECT_SIZE="0.9399053739142715" ESTIMABLE="YES" EVENTS_1="220" EVENTS_2="238" LOG_CI_END="0.03571296236089155" LOG_CI_START="-0.0895446969816644" LOG_EFFECT_SIZE="-0.02691586731038642" ORDER="25" O_E="0.0" SE="0.07357696913323095" STUDY_ID="STD-Hermans-2007" TOTAL_1="595" TOTAL_2="605" VAR="0.00541357038683242" WEIGHT="74.20704800182311"/>
<DICH_DATA CI_END="0.9395375154613481" CI_START="0.48961613581961505" EFFECT_SIZE="0.6782423812898654" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="83" LOG_CI_END="-0.02708587396413397" LOG_CI_START="-0.3101442779908746" LOG_EFFECT_SIZE="-0.16861507597750425" ORDER="26" O_E="0.0" SE="0.166269907687005" STUDY_ID="STD-Van-den-Berghe-2005" TOTAL_1="765" TOTAL_2="783" VAR="0.02764568220224517" WEIGHT="25.792951998176886"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.3077901349719625" CI_END="0.934809706708903" CI_START="0.6570727562763475" DF="1" EFFECT_SIZE="0.7837333670203808" ESTIMABLE="YES" EVENTS_1="127" EVENTS_2="175" I2="23.5351320323701" ID="CMP-001.04.04" LOG_CI_END="-0.029276786707466387" LOG_CI_START="-0.18238653926836754" LOG_EFFECT_SIZE="-0.10583166298791698" NO="4" P_CHI2="0.2527952800006793" P_Z="0.006738255432426126" STUDIES="2" TAU2="0.0" TOTAL_1="389" TOTAL_2="436" WEIGHT="100.0" Z="2.7095105884622446">
<NAME>At 180 days after ICU admission, in screened population</NAME>
<DICH_DATA CI_END="1.021222155881215" CI_START="0.6941868033091787" EFFECT_SIZE="0.8419732441471572" ESTIMABLE="YES" EVENTS_1="95" EVENTS_2="115" LOG_CI_END="0.009120228451615187" LOG_CI_START="-0.15852364664916327" LOG_EFFECT_SIZE="-0.07470170909877401" ORDER="27" O_E="0.0" SE="0.09847484208476269" STUDY_ID="STD-Hermans-2007" TOTAL_1="208" TOTAL_2="212" VAR="0.009697294523618949" WEIGHT="67.988883274381"/>
<DICH_DATA CI_END="0.9668065344190643" CI_START="0.4506057878507512" EFFECT_SIZE="0.660036832412523" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="60" LOG_CI_END="-0.01466042295972049" LOG_CI_START="-0.34620323423779836" LOG_EFFECT_SIZE="-0.1804318285987594" ORDER="28" O_E="0.0" SE="0.19474988850812705" STUDY_ID="STD-Van-den-Berghe-2005" TOTAL_1="181" TOTAL_2="224" VAR="0.03792751907392791" WEIGHT="32.011116725619"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="11.87164015582005" CI_END="7.766715795280451" CI_START="4.456399295129498" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="RR" EFFECT_SIZE="5.883161292669015" ESTIMABLE="YES" EVENTS_1="314" EVENTS_2="54" I2="7.342204989196286" I2_Q="51.53742533929063" ID="CMP-001.05" LOG_CI_END="0.8902374134589387" LOG_CI_START="0.6489840968654667" LOG_EFFECT_SIZE="0.7696107551622028" METHOD="MH" MODIFIED="2013-12-12 08:29:51 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.3733687832703906" P_Q="0.0667295786700941" P_Z="7.029754859301264E-36" Q="10.317239715399825" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="5247" TOTAL_2="5472" WEIGHT="600.0" Z="12.504776170802753">
<NAME>Serious adverse events</NAME>
<GROUP_LABEL_1>Favours IIT</GROUP_LABEL_1>
<GROUP_LABEL_2>CIT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours IIT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CIT</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.18161796554807552" CI_END="9.486350245395414" CI_START="4.1497696275643605" DF="1" EFFECT_SIZE="6.274246418876103" ESTIMABLE="YES" EVENTS_1="154" EVENTS_2="25" I2="0.0" ID="CMP-001.05.01" LOG_CI_END="0.9770991551919318" LOG_CI_START="0.6180239877350738" LOG_EFFECT_SIZE="0.7975615714635028" MODIFIED="2008-11-04 19:25:26 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6699864639011313" P_Z="3.1266419155349814E-18" STUDIES="2" TAU2="0.0" TOTAL_1="1360" TOTAL_2="1388" WEIGHT="100.0" Z="8.706767257635256">
<NAME>In total population randomised - hypoglycaemia</NAME>
<DICH_DATA CI_END="9.535558240356771" CI_START="3.7005770445564172" EFFECT_SIZE="5.940291906236179" ESTIMABLE="YES" EVENTS_1="111" EVENTS_2="19" LOG_CI_END="0.9793461230359077" LOG_CI_START="0.5682694504795878" LOG_EFFECT_SIZE="0.7738077867577478" ORDER="29" O_E="0.0" SE="0.24146847232192942" STUDY_ID="STD-Hermans-2007" TOTAL_1="595" TOTAL_2="605" VAR="0.05830702312548639" WEIGHT="76.06064636254821"/>
<DICH_DATA CI_END="17.133240063903628" CI_START="3.1404766168978955" EFFECT_SIZE="7.3352941176470585" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="6" LOG_CI_END="1.2338395000824867" LOG_CI_START="0.49699556411805085" LOG_EFFECT_SIZE="0.8654175321002686" ORDER="30" O_E="0.0" SE="0.4328257754218176" STUDY_ID="STD-Van-den-Berghe-2005" TOTAL_1="765" TOTAL_2="783" VAR="0.1873381518694977" WEIGHT="23.93935363745179"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.7674032708926729" CI_END="14.3498050219249" CI_START="2.3689162529029173" DF="1" EFFECT_SIZE="5.830393326562608" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="5" I2="0.0" ID="CMP-001.05.02" LOG_CI_END="1.1568460001308205" LOG_CI_START="0.37454970760118134" LOG_EFFECT_SIZE="0.7656978538660009" MODIFIED="2008-11-04 19:25:40 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.38102161049045247" P_Z="1.2466994377204545E-4" STUDIES="2" TAU2="0.0" TOTAL_1="1360" TOTAL_2="1388" WEIGHT="100.0" Z="3.836756561287465">
<NAME>In total population randomised- at least 2 hypoglycaemic events</NAME>
<DICH_DATA CI_END="12.221480431911862" CI_START="1.7900644365558445" EFFECT_SIZE="4.677310924369748" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="5" LOG_CI_END="1.0871238167467612" LOG_CI_START="0.2528686644642257" LOG_EFFECT_SIZE="0.6699962406054935" ORDER="31" O_E="0.0" SE="0.49004560608036696" STUDY_ID="STD-Hermans-2007" TOTAL_1="595" TOTAL_2="605" VAR="0.2401446960386742" WEIGHT="90.93643077590542"/>
<DICH_DATA CI_END="300.9271146232488" CI_START="1.0060304081536462" EFFECT_SIZE="17.39947780678851" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="0" LOG_CI_END="2.4784613210093456" LOG_CI_START="0.002611107850871322" LOG_EFFECT_SIZE="1.2405362144301084" ORDER="32" O_E="0.0" SE="1.4543266708654996" STUDY_ID="STD-Van-den-Berghe-2005" TOTAL_1="765" TOTAL_2="783" VAR="2.115066065590727" WEIGHT="9.06356922409458"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.204037793270388" CI_END="6.102085248418347" CI_START="0.4198330103182101" DF="1" EFFECT_SIZE="1.600580150777154" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" I2="16.94612863572861" ID="CMP-001.05.03" LOG_CI_END="0.7854782706054813" LOG_CI_START="-0.37692341702703014" LOG_EFFECT_SIZE="0.20427742678922553" MODIFIED="2008-11-04 19:25:54 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.272516210100167" P_Z="0.49090013152707557" STUDIES="2" TAU2="0.0" TOTAL_1="1360" TOTAL_2="1388" WEIGHT="100.0" Z="0.688877870053432">
<NAME>In total population randomised - death within 24 hours of last hypoglycaemic event</NAME>
<DICH_DATA CI_END="13.051094905196885" CI_START="0.4951193361629405" EFFECT_SIZE="2.542016806722689" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="1.1156469477921884" LOG_CI_START="-0.3052901126002745" LOG_EFFECT_SIZE="0.4051784175959569" ORDER="33" O_E="0.0" SE="0.8346654630264205" STUDY_ID="STD-Hermans-2007" TOTAL_1="595" TOTAL_2="605" VAR="0.696666435169109" WEIGHT="57.22396301926597"/>
<DICH_DATA CI_END="8.361794700470844" CI_START="0.01391978656366888" EFFECT_SIZE="0.3411662315056571" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.922299500508443" LOG_CI_START="-1.8563674238440984" LOG_EFFECT_SIZE="-0.4670339616678279" ORDER="34" O_E="0.0" SE="1.6322027059877902" STUDY_ID="STD-Van-den-Berghe-2005" TOTAL_1="765" TOTAL_2="783" VAR="2.6640856734338643" WEIGHT="42.776036980734034"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="9.20648220600523E-9" CI_END="11.716596146328571" CI_START="4.0996474636948355" DF="1" EFFECT_SIZE="6.930650306748467" ESTIMABLE="YES" EVENTS_1="96" EVENTS_2="15" I2="0.0" ID="CMP-001.05.04" LOG_CI_END="1.0688014606942857" LOG_CI_START="0.6127465125356653" LOG_EFFECT_SIZE="0.8407739866149755" MODIFIED="2008-11-04 19:26:26 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.9999234426453413" P_Z="4.9486226801918E-13" STUDIES="2" TAU2="0.0" TOTAL_1="389" TOTAL_2="436" WEIGHT="100.0" Z="7.22670256975421">
<NAME>In screened population - hypoglycaemia</NAME>
<DICH_DATA CI_END="13.087001914069107" CI_START="3.670478727334575" EFFECT_SIZE="6.930769230769231" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="10" LOG_CI_END="1.1168401659313918" LOG_CI_START="0.5647227114130606" LOG_EFFECT_SIZE="0.8407814386722262" ORDER="35" O_E="0.0" SE="0.32431652580954523" STUDY_ID="STD-Hermans-2007" TOTAL_1="208" TOTAL_2="212" VAR="0.10518120891317341" WEIGHT="68.9079754601227"/>
<DICH_DATA CI_END="17.58603436433615" CI_START="2.7311592469059547" EFFECT_SIZE="6.930386740331492" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="5" LOG_CI_END="1.2451679174645778" LOG_CI_START="0.43634702347777954" LOG_EFFECT_SIZE="0.8407574704711787" ORDER="36" O_E="0.0" SE="0.47510539685584185" STUDY_ID="STD-Van-den-Berghe-2005" TOTAL_1="181" TOTAL_2="224" VAR="0.22572513812154696" WEIGHT="31.0920245398773"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.4568005022815665" CI_END="24.02854442439736" CI_START="2.687806364684218" DF="1" EFFECT_SIZE="8.036421755855818" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="3" I2="0.0" ID="CMP-001.05.05" LOG_CI_END="1.3807274633715805" LOG_CI_START="0.4293979780059485" LOG_EFFECT_SIZE="0.9050627206887645" MODIFIED="2008-11-04 19:26:44 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.49912310087067513" P_Z="1.9202235291144318E-4" STUDIES="2" TAU2="0.0" TOTAL_1="389" TOTAL_2="436" WEIGHT="100.0" Z="3.7292869896028495">
<NAME>In screened population - at least 2 hypoglycaemic events</NAME>
<DICH_DATA CI_END="21.486082836890645" CI_START="1.9393334960571975" EFFECT_SIZE="6.455128205128205" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="3" LOG_CI_END="1.3321572457665396" LOG_CI_START="0.2876524986317733" LOG_EFFECT_SIZE="0.8099048721991564" ORDER="37" O_E="0.0" SE="0.613547258848847" STUDY_ID="STD-Hermans-2007" TOTAL_1="208" TOTAL_2="212" VAR="0.37644023884093397" WEIGHT="86.91938067271757"/>
<DICH_DATA CI_END="322.52422330483176" CI_START="1.0662092361204125" EFFECT_SIZE="18.543956043956044" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.5085623380489794" LOG_CI_START="0.02784244031495871" LOG_EFFECT_SIZE="1.268202389181969" ORDER="38" O_E="0.0" SE="1.457187147690503" STUDY_ID="STD-Van-den-Berghe-2005" TOTAL_1="181" TOTAL_2="224" VAR="2.1233943833943836" WEIGHT="13.080619327282433"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.2260254667885691" CI_END="3.962712359032318" CI_START="0.1512108360264941" DF="1" EFFECT_SIZE="0.7740833603313002" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" I2="0.0" ID="CMP-001.05.06" LOG_CI_END="0.5979925493922937" LOG_CI_START="-0.8204170854360876" LOG_EFFECT_SIZE="-0.11121226802189685" MODIFIED="2008-11-04 19:26:09 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.6344866944192116" P_Z="0.7585791934747547" STUDIES="2" TAU2="0.0" TOTAL_1="389" TOTAL_2="436" WEIGHT="100.0" Z="0.307347094393231">
<NAME>In screened population - death within 24 hours of last hypoglycaemic event</NAME>
<DICH_DATA CI_END="7.168209043847933" CI_START="0.14492202370106874" EFFECT_SIZE="1.0192307692307692" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8554106620092351" LOG_CI_START="-0.8388656100772554" LOG_EFFECT_SIZE="0.008272525965989857" ORDER="39" O_E="0.0" SE="0.995226269026412" STUDY_ID="STD-Hermans-2007" TOTAL_1="208" TOTAL_2="212" VAR="0.9904753265602322" WEIGHT="59.6227797106757"/>
<DICH_DATA CI_END="10.055493882613273" CI_START="0.01688792706468655" EFFECT_SIZE="0.41208791208791207" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.0024034061337692" LOG_CI_START="-1.7724236553205188" LOG_EFFECT_SIZE="-0.38501012459337475" ORDER="40" O_E="0.0" SE="1.6299471515137283" STUDY_ID="STD-Van-den-Berghe-2005" TOTAL_1="181" TOTAL_2="224" VAR="2.656727716727717" WEIGHT="40.3772202893243"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Greet Hermans" NO="2">
<NAME>Corticosteroids versus placebo</NAME>
<DICH_OUTCOME CHI2="0.10953706180242935" CI_END="1.8177385439437912" CI_START="0.8015491046497121" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2070653264779903" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="32" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.25953141624112697" LOG_CI_START="-0.09606986666584703" LOG_EFFECT_SIZE="0.08173077478763997" METHOD="MH" MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Greet Hermans" NO="1" P_CHI2="0.7406718395075652" P_Q="0.7406811752737354" P_Z="0.36761525256613203" Q="0.10952888096594612" RANDOM="NO" SCALE="6.2" SORT_BY="EFFECT_SIZE" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="133" TOTAL_2="139" WEIGHT="200.0" Z="0.9009493649899712">
<NAME>Occurrence of CIP/CIM</NAME>
<GROUP_LABEL_1>Favours corticosteroids</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours corticosteroids</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.0773097346186553" CI_START="0.7714532651867501" DF="0" EFFECT_SIZE="1.2659176029962547" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="21" I2="0.0" ID="CMP-002.01.01" LOG_CI_END="0.3175012562880201" LOG_CI_START="-0.11269037846186117" LOG_EFFECT_SIZE="0.1024054389130795" NO="1" P_CHI2="1.0" P_Z="0.35075619370301103" STUDIES="1" TAU2="0.0" TOTAL_1="89" TOTAL_2="91" WEIGHT="100.00000000000001" Z="0.9331235471714752">
<NAME>In total population randomised</NAME>
<DICH_DATA CI_END="2.0773097346186553" CI_START="0.7714532651867501" EFFECT_SIZE="1.2659176029962547" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="21" LOG_CI_END="0.3175012562880201" LOG_CI_START="-0.11269037846186117" LOG_EFFECT_SIZE="0.1024054389130795" ORDER="41" O_E="0.0" SE="0.25269669573501613" STUDY_ID="STD-Steinberg-2006" TOTAL_1="89" TOTAL_2="91" VAR="0.06385562003539531" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.260949496268355" CI_START="0.5263640990620546" DF="0" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="11" I2="0.0" ID="CMP-002.01.02" LOG_CI_END="0.35429086144445937" LOG_CI_START="-0.2787137396656599" LOG_EFFECT_SIZE="0.037788560889399754" MODIFIED="2013-12-12 08:30:01 +0000" MODIFIED_BY="Ruth Brassington" NO="2" P_CHI2="1.0" P_Z="0.8149784050914317" STUDIES="1" TAU2="0.0" TOTAL_1="44" TOTAL_2="48" WEIGHT="100.0" Z="0.23400846768233202">
<NAME>In screened population</NAME>
<DICH_DATA CI_END="2.260949496268355" CI_START="0.5263640990620546" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.35429086144445937" LOG_CI_START="-0.2787137396656599" LOG_EFFECT_SIZE="0.037788560889399754" ORDER="42" O_E="0.0" SE="0.3718300361153947" STUDY_ID="STD-Steinberg-2006" TOTAL_1="44" TOTAL_2="48" VAR="0.13825757575757575" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.51651281713316" CI_START="0.6426533163886496" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9872142580395196" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="29" I2="0.0" I2_Q="100.0" ID="CMP-002.02" LOG_CI_END="0.18084608519510456" LOG_CI_START="-0.19202324695621664" LOG_EFFECT_SIZE="-0.005588580880556051" METHOD="MH" MODIFIED="2013-11-29 18:09:07 +0000" MODIFIED_BY="Greet Hermans" NO="2" P_CHI2="1.0" P_Q="0.0" P_Z="0.9531496077160192" Q="6.272952195081076E-35" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="89" TOTAL_2="91" WEIGHT="100.0" Z="0.058752041565777194">
<NAME>Death</NAME>
<GROUP_LABEL_1>Favours corticosteroids</GROUP_LABEL_1>
<GROUP_LABEL_2>placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours corticosteroids</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.51651281713316" CI_START="0.6426533163886496" DF="0" EFFECT_SIZE="0.9872142580395196" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="29" I2="0.0" ID="CMP-002.02.01" LOG_CI_END="0.18084608519510456" LOG_CI_START="-0.19202324695621664" LOG_EFFECT_SIZE="-0.005588580880556051" NO="1" P_CHI2="1.0" P_Z="0.9531496077160192" STUDIES="1" TAU2="0.0" TOTAL_1="89" TOTAL_2="91" WEIGHT="100.0" Z="0.058752041565777194">
<NAME>Death at 180 days in total population randomised</NAME>
<DICH_DATA CI_END="1.51651281713316" CI_START="0.6426533163886496" EFFECT_SIZE="0.9872142580395196" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="29" LOG_CI_END="0.18084608519510456" LOG_CI_START="-0.19202324695621664" LOG_EFFECT_SIZE="-0.005588580880556051" ORDER="43" O_E="0.0" SE="0.2190252914386478" STUDY_ID="STD-Steinberg-2006" TOTAL_1="89" TOTAL_2="91" VAR="0.0479720782897846" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.392790974323348" CI_END="0.8170289138814517" CI_START="0.37641010913649503" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5545610359931441" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="59" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="-0.08776257392417004" LOG_CI_START="-0.42433872136794487" LOG_EFFECT_SIZE="-0.25605064764605745" METHOD="MH" MODIFIED="2013-12-12 08:30:10 +0000" MODIFIED_BY="Greet Hermans" NO="3" P_CHI2="0.49837853855641767" P_Q="0.5053129470383089" P_Z="0.002862885698734196" Q="1.3651548792338999" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="267" TOTAL_2="273" WEIGHT="300.0" Z="2.982089202790358">
<NAME>Serious adverse events (dichotomous data)</NAME>
<GROUP_LABEL_1>corticosteroids</GROUP_LABEL_1>
<GROUP_LABEL_2>placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours corticosteroids</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0064888182922345" CI_START="0.16619341027437357" DF="0" EFFECT_SIZE="0.40898876404494383" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" I2="0.0" ID="CMP-002.03.01" LOG_CI_END="0.002808954405045162" LOG_CI_START="-0.7793862003967587" LOG_EFFECT_SIZE="-0.38828862299585676" NO="1" P_CHI2="1.0" P_Z="0.05166830715980442" STUDIES="1" TAU2="0.0" TOTAL_1="89" TOTAL_2="91" WEIGHT="100.0" Z="1.9458870641339223">
<NAME>Shock</NAME>
<DICH_DATA CI_END="1.0064888182922345" CI_START="0.16619341027437354" EFFECT_SIZE="0.40898876404494383" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="0.002808954405045162" LOG_CI_START="-0.7793862003967588" LOG_EFFECT_SIZE="-0.38828862299585676" ORDER="44" O_E="0.0" SE="0.45946530585904155" STUDY_ID="STD-Steinberg-2006" TOTAL_1="89" TOTAL_2="91" VAR="0.21110836728814258" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1065678697952728" CI_START="0.41989644457535835" DF="0" EFFECT_SIZE="0.6816479400749064" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="30" I2="0.0" ID="CMP-002.03.02" LOG_CI_END="0.04397805592585041" LOG_CI_START="-0.3768578026848513" LOG_EFFECT_SIZE="-0.16643987337950042" NO="2" P_CHI2="1.0" P_Z="0.1210635512686174" STUDIES="1" TAU2="0.0" TOTAL_1="89" TOTAL_2="91" WEIGHT="100.0" Z="1.5503249104872365">
<NAME>Serious infection</NAME>
<DICH_DATA CI_END="1.106567869795273" CI_START="0.41989644457535835" EFFECT_SIZE="0.6816479400749064" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="30" LOG_CI_END="0.0439780559258505" LOG_CI_START="-0.3768578026848513" LOG_EFFECT_SIZE="-0.16643987337950042" ORDER="45" O_E="0.0" SE="0.2472010665190233" STUDY_ID="STD-Steinberg-2006" TOTAL_1="89" TOTAL_2="91" VAR="0.061108367288142576" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0893276133261778" CI_START="0.1762749856830767" DF="0" EFFECT_SIZE="0.43820224719101125" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="14" I2="0.0" ID="CMP-002.03.03" LOG_CI_END="0.03715851268716629" LOG_CI_START="-0.7538093119239935" LOG_EFFECT_SIZE="-0.3583253996184136" NO="3" P_CHI2="1.0" P_Z="0.07576399224144018" STUDIES="1" TAU2="0.0" TOTAL_1="89" TOTAL_2="91" WEIGHT="100.0" Z="1.7758114961079905">
<NAME>Suspected or probable pneumonia</NAME>
<DICH_DATA CI_END="1.0893276133261778" CI_START="0.1762749856830767" EFFECT_SIZE="0.43820224719101125" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="14" LOG_CI_END="0.03715851268716629" LOG_CI_START="-0.7538093119239935" LOG_EFFECT_SIZE="-0.3583253996184136" ORDER="46" O_E="0.0" SE="0.46461841553047306" STUDY_ID="STD-Steinberg-2006" TOTAL_1="89" TOTAL_2="91" VAR="0.21587027205004733" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="33.41367441519155" CI_START="-3.413674415191551" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="15.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.04" MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Greet Hermans" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.11035263137466025" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="EFFECT_SIZE" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="89" TOTAL_2="91" UNITS="" WEIGHT="100.00000000000001" Z="1.5966101661842045">
<NAME>Serious adverse events (continuous data)</NAME>
<GROUP_LABEL_1>Corticosteroids</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours corticosteroids</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="33.41367441519155" CI_START="-3.413674415191551" DF="0" EFFECT_SIZE="15.0" ESTIMABLE="YES" I2="0.0" ID="CMP-002.04.01" MODIFIED="2013-12-12 08:30:20 +0000" MODIFIED_BY="Ruth Brassington" NO="1" P_CHI2="1.0" P_Z="0.11035263137466025" STUDIES="1" TAU2="0.0" TOTAL_1="89" TOTAL_2="91" WEIGHT="100.00000000000001" Z="1.5966101661842045">
<NAME>Blood glucose (mg/dL) on day 7</NAME>
<CONT_DATA CI_END="33.41367441519155" CI_START="-3.413674415191551" EFFECT_SIZE="15.0" ESTIMABLE="YES" MEAN_1="159.0" MEAN_2="144.0" ORDER="47" SD_1="64.0" SD_2="62.0" SE="9.394904478059935" STUDY_ID="STD-Steinberg-2006" TOTAL_1="89" TOTAL_2="91" WEIGHT="100.00000000000001"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2014-01-16 01:40:56 +0000" MODIFIED_BY="Greet Hermans" NO="3">
<NAME>Early physical therapy versus control</NAME>
<DICH_OUTCOME CHI2="0.9985151042054248" CI_END="0.933191915649374" CI_START="0.5662709126485412" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7269384002451731" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="65" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="-0.030029032205840342" LOG_CI_START="-0.24697574598545952" LOG_EFFECT_SIZE="-0.13850238909564996" METHOD="MH" MODIFIED="2013-12-12 08:32:10 +0000" MODIFIED_BY="Greet Hermans" NO="1" P_CHI2="0.317670327052309" P_Q="0.3246123416209613" P_Z="0.01233031866178944" Q="0.9702728643018779" RANDOM="NO" SCALE="114.84" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="90" TOTAL_2="96" WEIGHT="200.0" Z="2.502547189315656">
<NAME>Occurrence of CIP/CIM</NAME>
<GROUP_LABEL_1>Early phsyical therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours early physical therapy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0831557002388128" CI_START="0.5995552054791808" DF="0" EFFECT_SIZE="0.8058608058608059" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="39" I2="0.0" ID="CMP-003.01.01" LOG_CI_END="0.03469088958400049" LOG_CI_START="-0.2221708220211001" LOG_EFFECT_SIZE="-0.09373996621854978" MODIFIED="2013-12-12 08:31:03 +0000" MODIFIED_BY="Greet Hermans" NO="1" P_CHI2="1.0" P_Z="0.15255878639228285" STUDIES="1" TAU2="0.0" TOTAL_1="49" TOTAL_2="55" WEIGHT="100.0" Z="1.430551533369994">
<NAME>In total population randomised</NAME>
<DICH_DATA CI_END="1.0831557002388128" CI_START="0.5995552054791808" EFFECT_SIZE="0.8058608058608059" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="39" LOG_CI_END="0.03469088958400049" LOG_CI_START="-0.2221708220211001" LOG_EFFECT_SIZE="-0.09373996621854978" MODIFIED="2013-06-22 22:19:16 +0100" MODIFIED_BY="Greet Hermans" ORDER="107" O_E="0.0" SE="0.1508818408828148" STUDY_ID="STD-Schweickert-2009" TOTAL_1="49" TOTAL_2="55" VAR="0.022765329908187047" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.962915255235337" CI_START="0.39328302547197364" DF="0" EFFECT_SIZE="0.6153846153846154" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" I2="0.0" ID="CMP-003.01.02" LOG_CI_END="-0.016411932816438497" LOG_CI_START="-0.4052947978133478" LOG_EFFECT_SIZE="-0.21085336531489315" MODIFIED="2013-12-12 08:32:10 +0000" MODIFIED_BY="Greet Hermans" NO="2" P_CHI2="1.0" P_Z="0.033553601284129736" STUDIES="1" TAU2="0.0" TOTAL_1="41" TOTAL_2="41" WEIGHT="100.0" Z="2.1253957900127185">
<NAME>In screened population</NAME>
<DICH_DATA CI_END="0.962915255235337" CI_START="0.39328302547197364" EFFECT_SIZE="0.6153846153846154" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="26" LOG_CI_END="-0.016411932816438497" LOG_CI_START="-0.4052947978133478" LOG_EFFECT_SIZE="-0.21085336531489315" MODIFIED="2012-03-13 15:07:42 +0000" MODIFIED_BY="Greet Hermans" ORDER="108" O_E="0.0" SE="0.2284317199004123" STUDY_ID="STD-Schweickert-2009" TOTAL_1="41" TOTAL_2="41" VAR="0.05218105065666042" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="80.6201767528727" CI_START="0.14003442382179745" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="3.36" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="1.9064437459717474" LOG_CI_START="-0.8537651911920594" LOG_EFFECT_SIZE="0.526339277389844" METHOD="MH" MODIFIED="2013-12-12 08:30:38 +0000" MODIFIED_BY="Greet Hermans" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.45477145507584005" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="49" TOTAL_2="55" WEIGHT="100.0" Z="0.7474840135782881">
<NAME>Serious adverse events</NAME>
<GROUP_LABEL_1>Early phsyical therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours early physical therapy</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="80.6201767528727" CI_START="0.14003442382179745" DF="0" EFFECT_SIZE="3.36" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-003.02.01" LOG_CI_END="1.9064437459717474" LOG_CI_START="-0.8537651911920594" LOG_EFFECT_SIZE="0.526339277389844" MODIFIED="2013-06-13 12:18:22 +0100" MODIFIED_BY="Greet Hermans" NO="1" P_CHI2="1.0" P_Z="0.45477145507584005" STUDIES="1" TAU2="0.0" TOTAL_1="49" TOTAL_2="55" WEIGHT="100.0" Z="0.7474840135782881">
<NAME>In total population randomised</NAME>
<DICH_DATA CI_END="80.6201767528727" CI_START="0.14003442382179745" EFFECT_SIZE="3.36" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9064437459717474" LOG_CI_START="-0.8537651911920594" LOG_EFFECT_SIZE="0.526339277389844" MODIFIED="2012-01-17 09:20:09 +0000" MODIFIED_BY="Greet Hermans" ORDER="113" O_E="0.0" SE="1.6213603929446172" STUDY_ID="STD-Schweickert-2009" TOTAL_1="49" TOTAL_2="55" VAR="2.6288095238095237" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Greet Hermans" NO="4">
<NAME>Electrical muscle stimulation versus control</NAME>
<DICH_OUTCOME CHI2="3.99204353226938" CI_END="1.0381975858724517" CI_START="0.6852893201030262" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8434842723816109" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="66" I2="74.95017296488437" I2_Q="69.78571706451748" ID="CMP-004.01" LOG_CI_END="0.016280014676242308" LOG_CI_START="-0.16412603639574558" LOG_EFFECT_SIZE="-0.07392301085975163" METHOD="MH" MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Greet Hermans" NO="1" P_CHI2="0.04571566442606978" P_Q="0.06887242741850952" P_Z="0.10822427720684712" Q="3.309692975786752" RANDOM="NO" SCALE="12.52" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="92" TOTAL_2="100" WEIGHT="200.0" Z="1.6062259336973357">
<NAME>Occurrence of CIP/CIM</NAME>
<GROUP_LABEL_1>EMS</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours EMS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.147510691848813" CI_START="0.775456084195591" DF="0" EFFECT_SIZE="0.9433155080213904" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="55" I2="0.0" ID="CMP-004.01.01" LOG_CI_END="0.05975674073592927" LOG_CI_START="-0.1104427922173253" LOG_EFFECT_SIZE="-0.025343025740698025" MODIFIED="2013-06-27 15:12:11 +0100" MODIFIED_BY="Greet Hermans" NO="1" P_CHI2="1.0" P_Z="0.5594325760909609" STUDIES="1" TAU2="0.0" TOTAL_1="68" TOTAL_2="72" WEIGHT="100.0" Z="0.5836845360166995">
<NAME>In the total population randomised</NAME>
<DICH_DATA CI_END="1.147510691848813" CI_START="0.775456084195591" EFFECT_SIZE="0.9433155080213904" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="55" LOG_CI_END="0.05975674073592927" LOG_CI_START="-0.1104427922173253" LOG_EFFECT_SIZE="-0.025343025740698025" MODIFIED="2013-06-24 16:59:22 +0100" MODIFIED_BY="Greet Hermans" ORDER="53" O_E="0.0" SE="0.09997604815801753" STUDY_ID="STD-Routsi-2010" TOTAL_1="68" TOTAL_2="72" VAR="0.00999521020529424" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0092297690709136" CI_START="0.10031379624749655" DF="0" EFFECT_SIZE="0.3181818181818182" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="11" I2="0.0" ID="CMP-004.01.02" LOG_CI_END="0.003990052341525704" LOG_CI_START="-0.9986393339574244" LOG_EFFECT_SIZE="-0.4973246408079494" MODIFIED="2013-12-12 08:31:47 +0000" MODIFIED_BY="Greet Hermans" NO="2" P_CHI2="1.0" P_Z="0.05185153761597172" STUDIES="1" TAU2="0.0" TOTAL_1="24" TOTAL_2="28" WEIGHT="100.0" Z="1.944364284406214">
<NAME>In screened population</NAME>
<DICH_DATA CI_END="1.0092297690709136" CI_START="0.10031379624749655" EFFECT_SIZE="0.3181818181818182" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="11" LOG_CI_END="0.003990052341525704" LOG_CI_START="-0.9986393339574244" LOG_EFFECT_SIZE="-0.4973246408079494" MODIFIED="2013-06-23 14:15:00 +0100" MODIFIED_BY="Greet Hermans" ORDER="51" O_E="0.0" SE="0.5889494646075093" STUDY_ID="STD-Routsi-2010" TOTAL_1="24" TOTAL_2="28" VAR="0.3468614718614718" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2014-01-17 10:44:19 +0000" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2008-11-04 19:00:24 +0000" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Presumed pathophysiological mechanisms and their interactions involved in the development of CIP/CIM. Dark shaded area indicates events taking place in the nerves, light shaded area indicates events taking place in the muscle. (Additional abbreviations: ROS, reactive oxygen species; SR, sarcoplasmic reticulum).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAyAAAAIlCAIAAACiqAs4AACAAElEQVR42uy9h2MUt9Y3nD/kxt2U
FAjpvdd703shoRhIbwRw3fU2N0roEBLSgFBDQnpCgIRmqo3B4LLe3ne22YQO4f1+knZnp2jG3Od7
njy57ztiWGs0GpWjI+k3R0dHF/0fwxnOcIb7N925c+fwe+bM2QWLlpQUFLKrtLAIV1lRsfgresSn
Q0pK4cevNNqwsnKSQmFhaVGRmFp5SSl5sbBQfJ2FlIov5j1F0izYu+SWRijP5ciSHVJaln1EL1lp
JSFi4fOPxExzflwsUxRSzD17yV9ktyx+thgoT2FheXEJrh2tuw2OMpzh/u9zFxkkMJzhDPdfcH+e
P//nn38u+egTwIWrRl153bXXjbx8xKiRo3BdieuK/IUQRLj6yquuGDHy2quvGXnZ5aNGXoHwm268
+dprrsXtpcOG33D9Dddfdz1SuPrKq9mFyKNGXIFk8e41V19D0hlxhZhyNqOsn6SGpPD06qvw7lXX
XHXNiEsvu3LUlXiE9PEIqV13zbWXX3Ip/CNIAbJv4Zd5rhyZ848U079CTDybVy4Ovah/BL1kL16B
AouJ5OlA46MYeErKRqp/UwmFg7v37jfYyXCGMwCW4QxnOMNlJVhwc+YtHFJa9sGHH7cd6ABQ2Llr
D65W+it68LujdffuPfu279wFDwnZvXf7jlbcsqdi/F279yIRhMODmIi2Z+/+bTta8Wjr9p14hBBc
O8X0c368wtLftWcvS5Y9RSDeQlK72NPde7ciOSQiL6dY2lZJmjvlt/m3aEg2nBZS+oqiYK1yPwqA
kpB67WtDOV58aWxpYRFKZHCU4QxnACzDGc5whsu7eQsXlxQUrlm33u3xdR7pOtLVc/hIN7m6uom/
q5td8Hd199JHXbi6e3q7enqPdJPAzsNd+CUh3T2HDh/BbXevEzFZUvB392Rv8egIS5DesgjMg3c6
DnX29DqR7KFOJOxkgYjfcYikSLNwIjUa2JNLJFs2RWqiR/TnasGubB3zcXJPWbIyCkhikpDunoOd
R1BUFMPl9jzzzPOgHiCXwUiGM5wBsAxnOMMZjrgzZ86eOXNmwaIlpYVFK1evO0Lh0cHOwwcPkQso
h/2yC+EdBzuBwA4TxNPZfuAgfhGh7cBBFv/AwU6EAEKRRA7lE2mjMREfiIQEduYTz+aFX0CWgyQ1
8nrnEZLFwU6kc+Ag7roQTrI+3LVvfzsCySNaHvbiwWxSkgTZbaeY/pF8NMl1SPGK5CJVy70rRmMe
FIkQhJbN2ed66qlnhpaW7di5y2AnwxnOAFiGM5zhDJd1f/755/yFi0sKC1ev/bLX6cpjIyl2EXEG
vW3vOHiQSph6nH0MDLV3HEL8Ax0EeRw+0t2GGBSIIASgCgCLybEYPJIBGikGoiGAU4jG0EwbwWQ9
+9sOdFOZFlITPfJ3s3DqkBRCSVLOA6lcfCm0QpHIJUVRnYdlKDOP4Q5nAdbhIwT2dR7u7XM9/cxz
AFjbjSVCwxnOAFiGM5zhDAd39uw5+nt24eIPSwoKV6xc09PbR8RUhzrlF5EeMfHSwZzf2efG747W
3QAWnYe78CKTMAFIAVwBBuFia2p4xe3xiZIt/DL5kJimmBH8LD5wXhuVXLEL0dhqHX7xdH/7AQC7
tpz8TPp6/vZgp/xpttiyfHO3OflWFj+J70r9Hbmk4EcpWalQl15nHwBWaWHRbmOJ0HCGMwCW4Qxn
OMOJ7s8//2QAa9mKlS63Bxgii2wOSy4GdOiqGZFF9Ti3bt/53tSqG2+46bZbb58w8RUmqSLSHSrK
OtLdU2uybNvRum9/+7r1G4BFZs2e2zx9FuCIdM0xn0vOs2vP3rfffQ+Jd3X3tB3oQEbvTJ7yzXc/
rv/624am6fvbO958653W3XtlKXTmS6hMVn0pcqS/nUe6AJUY/hPDmShLlhTFYWRlEGjrSPcBiswA
LV944SVQr3XXHoOXDGc4A2AZznCGM1zezadK7itWrnH2uTgKSbllNUAKoKhDFFU888zzUyurd+3Z
t/m3ra++/uZrr7/V63R1A0C53D29fcAfP/3yK+KtXrv+2ede8PkDGzdt+fGnjUe6urt6mK46UQ9v
7zjU2+eiqvFE3IV3Aa1uu+0OQCgEMkXyb7//EdE+/nQZstjXduD++/+JHJGF2+NFnB5nn9PlBvBC
jngdgAzIDEkdOEgAH0pzGPfOPgahcItHeJFp4rPFQbYo+dvW7Ru+/QFx2juy+lVi3SXKXvm1SHHl
EZk89/xoUM+wg2U4wxkAy3CGM5zhZG7eAgqwVq0BSJKqHzG/qOpOxTaHAJJWrl53z933AtYAsvS5
PNt37poyrXp/+4Gvv/2+zmR54omnEOGL1WsR/s7kKZcNv+TLrzas/fLrL7/6BqBq3foNL4weM2Hi
yx8u/RQ46fdtO958692nn3lu7LgJ337/E6DVffc9AJhFMuruAfRZuHgJ4ixfufq1N94Cnrvzjrv2
7W//+pvvZs9dYG9ofvzxJxcu/hDJ7t3f3tDU8sLol8aNnwi0BCDVdqCjps786KOP19TVIwXArI8+
/hRlQ9YAbcBSQG9szdEfCK5a8+UTTz7t8frZImnbgYNMxUqm5nVIpTrWeVgEWDsNgGU4wxkAy3CG
M5zhFACrtLBIlGAdygtppDvysrsI3R7flGlVwC4+f6CtvYMJh4BLAsEQgismTFqz7qvtO3a9+tob
O3buttgcd991D2BTTa25zmz5/sefH3jgX8Ben36+4uGHH93y+7Y6s7VlxvuIMG/h4tdefwuv3H33
vUBmSLH9wEHgJGCvlWvWLVux6q13JiPavffev2dfW1WN6b777l+7/uvPln1x0403f/fDz/MWLEIg
gWJfrBpfMamn11lvtU+trNnRuntqZfWadeuB8ADdNm35vXn6zJnvz+1zuVnVANpQGIutAfl+/Oky
4D8Au6wSfX4r4pH8zkepwhat+XPPjS4pLNxpLBEaznAGwDKc4QxnOKmbv/ADtkRIJFiH5JvvZJvp
yAY6QBMGsNweLwDGAWpMweP1u9wehH6+fKU/EAS+GTO2YtuO1tVr1wMheby+mrr6WpOlqWXm2+9M
jsbiROfpCLkAZb5YtdZUbwMqGjN2/K7dewF0gJN6+1yHj3Qji389+PDK1etWrf0S8Gvv/vbbb78T
4dW1pncnTw2FI8j0iSeeWrFy9aRXXnvzrXfNFjuuK68Y9dWGbz/5bPn1114PdLX2y6/8gdAvv26+
+sqrn3r62VVr1rV3EOjG5E9ff/PdQw8/etddd48accVjjz0xeUpld08vKdjBQ3k7DhKRlWw34qHD
xhKh4QxnACzDGc5whtMCWFIdLJmRAqkeEhNWAWAt+uCjZ599AR62ua+ru8fR2LJz1x6LzbFw8Yce
nx/o5LU33mrdvfez5V8A0wAJTausaWiaXme2VNWYEAH4iWnNA6o99NAjldW1DU0tr7z6euuuPf/8
54NAZkw1CtDtmWefX7lm3WfLVrz19uQ9+9ruuuuevfvaamrNuJxEEcsHgPXp5yteefWN96ZW1pks
QHIWW8PGTVsCwdDHny57YfRL11x1jdXW4PMHtu/cNXVa9Y033DRu/ERiA6K9o9dJNj+ieMCFSAdw
jSwa5tT51VpookkIEXoaAMtwhjMAluEMZzjDaQEsIsH6YhUBWGqTUVKosW9/OyAFwMT99/9z7vyF
Pc4+wKwlH33y4IMP40WzxQ5Mw/TKKya+jGjLv1gFwNTrdFXXmqpq6r7+5vvrrr3uqw3fAkI99viT
i5d8dNeddyMQmKmyqnbM2PGAUDfecCNgFpMwAUA98shjq9d+uXL12tffeBuQ6Pbb7wAkqq2rn1pZ
jawR7dFHH1+z7itgO6TQduAgoNVUohDW0dg8Y/bc+X0uz9vvvjdh4itI4a13Jh/oOLRg0ZJ7770f
4A8gj9jr6jyM4q5bvwEgr6fXCVTXfoAs/cm02iUyPBGAsuXCLMAylggNZzgDYBnOcIYzHAdgFQJg
rZXtIuxUmjtnFg06qHGC9V9/e+eddwM84br5ppu/+e6HQDBktTd+uPRTl9uDCK+/+TZAzKYtv999
9702R6OjsQWoyB8Izp2/6Jabb7nummvfeXcKcMz8hYtvv+2OBx7418uvvPbq62/+9Muvzz73wpbf
tvX0EktXXT29QF2fL18JAIT4e/e3P/7EUwB5pnprvdXh8fq6untffGnsp8tWoFSjXxx7xx13AsDN
mj3P6/OvXrceWd922x3PPPv8hm+/B3R7/vkXUdSHHn70/TnzSU2pDfrDR7o7syf/OKnt+C62uxAw
i2MQVSHEohIsFNiQYBnOcAbAMpzhDGc4HsASdbCkVgnkSOsAsQTazUyAOvvc23fuWrZiFdDP7r37
EQ6sA89Bemjg/vYOXMAoxGRoe8e27a3AN/vaDuBFhLDjlon1BHqCIbFWunMX2Qm4rw0QZ9eefUT/
KWsg/iBeBADau78N6OpAxyGANpRnf9sB5EV2Ah7sRARkcaS7Bwhp2w6SEbN6yqyV/r5tB1IDDGIm
FbZu37mvrR2FR8ooM7Mjike4JdWip/RQxbJDouErPtzM+ZEpAViFxi5CwxnOAFiGM5zhDKcEWIup
BGtNL5VgMRkVXT0j62WHctKaQ5IzZ1gcQBlmZYqIfChkOXAwa/uApEDlQ8Tb3UtPuXGyt/DDTk1m
RwoekVilohpdvfSUQ6KD1U5fIEjoUCeTn3V197AzCsUSEqNWVGuKJc5AEksNgczcQxY80Vy6qA47
q1dHDjAxpaus+SuKpZjFefHwQQYumUl3cTshrWUv08EyDI0aznAGwDKc4QxnOJmbJwdY9BhjdiZM
d17pO79WeIStoOGXmWlgpy+zU26YQIid3MzOkwEEoXbeyVP2FpES0f2DbFtiO7UCz2CTKFIS4RED
OswEFz3WhgAgJrti+I8ly1b62Kk4QGn72w4wEHaEwa/cOT+kMEQ8dphJquh5O4fFCBQmksIAutGS
HGb4jCwm0tMV2aE9DO0xuNnd0/vscy+UFha17t5rMJLhDGcALMMZznCGyzvZLkJy2F9HT2/f/vYD
gBfMmijAEMNDDMewAwHZ8TLE5EF3D3AJCydW1DsIEmKSJybQAgBilqW6e5wMpjAbVywmW3ZkmAyB
+CVm3NmpO7kTAOHHI8CmLIw72MkgYHevUwwUzyJk77KVSpI1PXOapYzSttGsmRo7PUy6l5VEPPSQ
QT0KqEjIvv3tnURvnyGzIx1MiNUpLhH2GoZGDWc4A2AZznCGM5w2wMpacj/CIBGT3HQR8EQQibgM
x5YCAZUAX4BOGIpidkEBOwiCyQl7iJrUkS6mIIUIO3bu3k9MpDPV8uzBf1msw9YfKaDBK3uoUhfy
ZpIqBo/wFsNn1EhVJ1srZECKJdV2oIMhLXJOTk8vO4WaHSOYk0iRo36Q7J59bUxLHTGJ6XYqIdu2
vVWqvX74SJeoZUVkdfRsaeA54jmYNeJAVg1FgGUsERrOcAbAMpzhDGc4JcCiuwhzSu5H2PY6sn5H
YE0v0Aw9QJCAKoJ12juYsAdg5YMPP54zbwFbKESIy+MFuIEHgOOxx57Y8vs2pMkUzJd89Mknny2n
ZxH2EIMIZL3OCdQCuMNeIacZ9jhF7ah2KsFi6vOIiWsfMBQ9ChHx2dIeS4fpsDPldCTi8weWrVj1
0phxR2hGQFf4ZUpUTA7n9fn73B7cu9zeRR98+P6c+V5/wFRv/fqb71mlkIizz32kq5uWhUjpWLFJ
1vRMa4kEy/n8Cy+WFhYZuwgNZzgDYBnOcIYznAJgMTtYaxkYaqNLhGzTX5+LHPP36ecrvvnuB8AU
PGKYAxcTR02ZVvX6m28TSOL2bN2+c/GSpT9v3AQEs+W3bbfcfOs+un4H8LF3H9kGyBSzcAv4tfyL
Vb9u/g0ZEU2prp6vv/nuo48/ZVkziRHRkWrvwFsbvv3hk8+W7dvfjsIAIW3b0bp85WqyD7G3b+Om
LZ8uWwFgxHTb3R4vIm/49vsPl3765JPPAAwhGkAQckZS8AMPIa8VK9d8uPSTNrrJ8Z13p7z19mQE
EvR2sNPj9aOony9fuWrNuk6inU9EVijP5t+2Lv30c5ScITlmE0u2RGhIsAxnOANgGc5whjOcAmCR
swhXZc8iZLIrJp7Z8vu2Z58bfd99D1xz1dU1tWYAHXtDc5/Ljadvv/vejFlzRlx2+YhLL//hp43f
fPfjLbfc+tBDjwwtLZu3YPGeffvvuec+YJHPl3/x7HMvIE2bo3HBoiXrv/720Ucff2nMuDvvvOu2
W2//7oefgIqmTKu+//5/Pvjgw2PGjicHM/c66eJb35p1Xz3+xFMPP/wokho7rgLFQ46IeeMNN33y
+fIffvrlhutuwNPLhl+y5KOPgeqap8+68YYbkc4dd9z54kvjdu3Z99hjTyBBt8f32bIVCHF5vG++
/S6yRiIARgBqo0aOunTYcJS/YsLLy1as2rVnL16/9977b77plrfemdzV3bNy9bpHHn18fMUk4MWn
n3kOCI/q/ncxfX8mwTIAluEMZwAswxnOcIZTOuAh0ZL7Qcn5g06X+513p7z+5tv+QHDDt9/XmSy/
bv5t9ItjOw51wjNmbEUfjfDu5KkAHY888pjd0RQMhb/a8B0A0Novv37woUeaWmaOfnHM1u073V5f
da159tz5677acOXIUZu2/O7zB18YPcbe0LRi5WrERJy2AwcrJkyqNdVTcwxE9/zz5SvvvPNuYBdk
9Orrby795HOrveGF0S/1OvvaOw7hrUUffBSJxr5YvRaBP/688fbb70TBUIvxFROffPKZPfva7r77
HqTc63R9tozgPGAyPGqjmvsNTS3AXu9NqUQVXG7vk089s3rtl/VW+7jxE1DxvfvagNI++uSzVWu+
BBTbt78dQPD5518ECGOaZ0yI1d2bBVjGEqHhDGcALMMZznCGk7n5CxcTCdbKNT3OPqafzhYBgR6e
fvq55V+s8vkDuAsEQ84+NwDTRx9/ZnM0ORqb05n+aVU1NXX1gFz33HPf3v3tXT29Hq8PmAOgDQBl
+JChwCt0/dBXWVWLQIChp595zkVOEfRXVtdabQ2NzTMQ7b77HrjrrnsApxCfWc8Cilry0SfsGEHE
n/n+nIam6WaLDTmiJNt2tN59972AQYgM+AWQN2v23KeefhaRkd2aL7+Cf/eefUiTLiY6AbBefGns
J58vB4RCHKSPAoQj0arqOpbgI+TInfVvvT15+RerUTiP12+xOWrqzMCdFlsDskAZ3njznaWffEaM
StC9jUQ/jC4RlhYVbd/RajCS4QxnACzDGc5whpMCrA/KiopXrl5L1v6orjrTrwJ6eGH0S9NnzvYH
gs4+1+IlS/fub/t02QqgrjFjxwOy9Lk90yprak313T1OYKPvf/yZnvTc+cAD//ro40/vufveXzf/
9vobb3/86bJINAaw8v6c+avXrn/kkceQERI3ma0Wq2PGrNkTJr1Cdvkd7Pzhp1++2vAtU/ZCjks/
+fzlV14PhSPsHJ7m6bMQv7rWBGwEMHfrrbd9/+MvwVB4X1v7hImvAPY9+ODDyB2wCTV65tnnd7Tu
Bm77fduORDK1cPESwL5Va76cPGUaUsZb67/+ZvOWrdW1ZoC2aCz+5JPPfPr58ppaM7JBfRHhpTHj
Z82et2zFKrPFDkAI3PbKq68DYAH5sQ2Ph6i5eWRUUlC4fccug5EMZzgDYBnOcIYzHHF/Ujd3/qLs
UTn0sOe2nDnQ7l4nsNFtt93xwUcf11vtADTbdrQC+gBL3Xbr7bt27wUKqTNbHnv8yV179gEtAVcB
db3+xluPP/7k1u077733/j179/+8cfM999y3feeu2rp6ZASA9eRTzxzp6vF4fVOmVuEtAKC77rzb
0di89NPP77//n00tM1xuD0oAQPPFqjVXjBgJWDZ3/sKHH35099791TUmYCA8Aj6rqasH/kOCQHtv
vv2u0+UGJKqYMAllBtIC7nH2uR966BGgoi9WrX3u+dFPPf0s3sIj5MXQ2PqvvwVuQ7EPdBx67LEn
1qxbD/x0y823LFi0BOEAiL/8uhnvTquqddPdka++9gZAGHJnpiWIHXkqwSovKd1lGBo1nOEMgGU4
wxnOcFKAxXSwVqxczQyNEuNV1D4nOzrwm+9+BDYy19u2bW8F9PEHgu+8OwWXx+s/2HmYICeTZd36
DXgXqAUxF33wEWDH3v1tM9+fu6/tQE9v38LFHy5bsfLLrzasWvPlb1u3z563gFru7Fv+xeqPP1sG
pAUc1tQyc1pVDdBMd4+Tic/63B7AnSnTqvC6qd66cdMWl8e7cvW6Tz5fzjYednX3Iq/JUyoXL/mI
GXTA7/SZs22ORoBFvIVi7Ny1B3AKIV9/8z1gE6oDLGixNQAzrVqzDmVGBGDH1Wu/XLxk6U+//Orz
B9et/xrQrbF5BjAiyvbdDz9TE6xupP/Rx5/+8NPGrHUuakoeWTz7LDnsGXQw2MlwhjMAluEMZzjD
5R1ZIiwuoUuEnuy5MdS6FLOl2edy9/a5AK26e507WnfPmDXn+muv//HnjV3U3jqADiAXhTvEPBVQ
EUBMOz15EHfEvHvnYXiYbVIG4BBnX1s7W4tE4u0dxEIp3gKaoaZHu5kFBLz14dJPTfW2UDhCVuj6
XMz+u2hutONQJwLxFsom2sHCLQKBh5xUGkcPQnTi9W5iSasP+eIeeZE1Sno+DxLEU2Zbi5owPUQj
9BGRVXcPsfZFcuztyBmOR+5MfMUMvmcPeyZLhIYOluEMZwAswxnOcIaTAazsUTmAIOxwG2afvYMd
a9ORPRAQgGPzb1uff/7FeQsW9dB9fIeJKc6sWXNmm5SdpXOAvgJsQo9j7mbH9rVTAwfZMwQ7DrEX
EcIOe6ZgqJvtXqSHIRIb66vXrp87f6Hb49tHly2ZmVFqgZ0cU8istCPBvfvbs+ckUhOg8O/Z19ad
My7KjpdmK3rMICrDhaLdUVY8BLGTf9gKIDNzKh5iiFqwFJjBembUnlk6JXawCguNswgNZzgDYBnO
cIYzXN4RHawFiwAR2FmEwB772w4wPXdAnw6KRbKQgu6b6+1zAV0R651tB8RDA7OnLzProxSOkLOZ
KdxBCDs3kK77EUCWMyXVzcRFxAroASJKEtXGGY5hh/N09xCclD1tkKC0g0gQ5cQjlh2DaOzk5iyA
o8cgttEDEJETk2yxY3yQmniYYBaiAa5ReRuKQdAhtW7KNO7b6ak4R6gBd2TXdqAjCwGzh14TIAgU
yCRYO3YaZhoMZzgDYBnOcIYznAiwzp+fv/CDoWVl69Z/HQyF3R6vx+ujK2/+7l4n/iAEt7hcbnjc
uHz+IBAJfp106RARcMGDC09pfDcN9NELj7xIzUVXDz1eP5JCON5FIAuhObrpYh9JCrgNjxDB5w84
+9w0X/IuywvRaL5edssWBOFHOOAafYoSBpAgEunKJuVmNQIeYuEuuiuQJYVEnPQxNSdBioo7UnFi
rMEHItCHAbH6rJCsJMho9ItjDR0swxnOAFiGM5zhDJd1586dY555CxcPKx/yymtvNDS11FsduCy2
BlzwmC12cktD6q12+jQbIvewR8RvyXrylyV3iXHE+BabJClbLibNPXc5TGZrY/P0WpMF0ewNzSQw
WzBZvtK8WGqkMDaHpNj5VyySsuXKbJcXWxZNGtlqb8RvndnCCnzHHXcBYBlLhIYz3F/0TfjnefUg
ZgAswxnOcH87d/LkSXIWYWHhkJLS8pJSYIWSwqJS8SoqIiEFheyW+RE5+1uY8+fiiE+JX/Iof+VS
ZjHzaUqe5pOi1/Dyofi9dNgl0nAgwlJpUgW8ksj96pRlcQpV75LaaUTO+YeVleN3xKWXb/ltm8FL
hjPc/5w7f/483fRMfsXAs2fPGgDLcIYz3N9xwGIefyC45fdte/bt375zFzmJuXU3PMRPb9nvzl17
2NMd4tPcI85FwyUpsGuX+FSalHjbunsvcsHVSn/F69FHHwec+ujjz/bsa0MclHPbjlZ1ptsVhcnl
LguXlEFdeLFS+dqp36VPUYxde/aRX1pmUO/Y8eMGRxnOcP/3OQNgGc5whvuvuDNnzzKYdZZK2s+c
OStiLzxiX4rS78X/FTfplddKCgu3UTsIbEXgL1gXuBB4ChKdPn0G/lOnThm8ZDjD/QXurx+ODIBl
OMMZ7r80Wp0/zwAWIAs8Z8+eE0cxUb4l1Xj4nx46mfxf4SZOeqW0sGjX7r1nCeY7/7cioAj1RHIZ
znCG+x/6pGEDguhhzgBYhjOc4f6O7gwgFYUI4jiFwUstHxLHMorHzjMYJB3vFEMeuT0vxjkv3ipS
UDzSKuSkl18FwNrRupvpW4gFVo+2Wb865M9sCeXlPC9/JV9gZV1yPhF3ogwnDamV4Qz3F7qzPLn1
X/BhYwAswxnOcP+/nIhvpFgHntOnz/xl63FyDHRexG1kiVBiB+EvUGv9t9zp06f/11dRDWe4/4c+
C8+cQaf7y7IzAJbhDGe4/4oDeAI4ECEL+xxkcAGPjv7xR6a//9jx4/+7Ok/jxk8YVj5k5649bFRl
4OvvoIYlxVV/5YhvOMP9P/sRePrMmYGjRzP9AydPnvwPA1hNzTMwlr00Zhyu8RUTx4wdT64x48eO
q0A4+6UedlVIw8WQ3DVB4pE8yseX/LIrnyDLhb6ruJWnnw0Xcx+fjykv2ARWcumtJFlpmmIcsbK8
Wshrh2gvvjQWtGK/IN0Lo1+aOOnVCRNfBiVZIiAjLtwizjh5OWUkzd9W5H8pfRREEKsgSSFHzHFa
RKtQNJ+EVmrK5JPiVV/JAyy+nKQTZM0kaQiRvLJCsttc4OjRY0BMeEBPhFRUTMrRcyJjTuqZpOIH
SalE9hgva1k5NaRE4LOBilDyW1lFyEVa+cWxFRMmMZaY9PKrimqqeVtBN2mbjpXkoiajlFUIucZW
KDxZ/9gKRkzxYuHir/iUELZiIiX7pEceefyqUVc++ODDIp3ViWRDxlaIuYi5SwswJhdBnXU2tbH8
0sJz1airLhkylBZjImhLm35CdnTKXdky0FdYaZEjIoNnQJyKCS+PnzBp4qRX6OCGHjqJsRA8YlL5
euVKQq8KMfExY2UUEN+SVlmajjSCeKtIdsxYRfh4yjPjwDwo9suvvk54g/D/xNEvjs1RRvbKWHlS
qoyUBciVrULaoPnfsbLq89pRTEreauNkvCSlkjRlDSKPV9dIzQwKgsuykFdHLKGibNymGTNWrzCK
riROi2xcoj1xopp7xRApW0rrri6Somxqqo7l9CBOvdT04XZbkQeUbMxrNTXrqjuvglW0GkseQVIS
KU3GcnpZbiKYiF58++13lpeUfrpsBZVmnaUS73PkF5+L9IuRunO5XxIoWfXP+fORz2Vv81HOiS/i
uui8NJTGy9uLkNwqU2FJi3mcO/fqa2+WFhaNvHzE5ZdeVlZUPKS07NJhw0dcehk+H4eXDxmmfeHp
8CFDqWeoIjLC2SNZSPlQMVx8V0xK4Ve+LomjTnzQS/m6vGAarwwVY6rjI4RZDwKtMBsNLSsfUlJ6
3bXXMTM511x1DX5BzEuGDkP8EZddrihzNhGRGpIiiSFq+g+XF0Cr/NnmkBSe+TkkzYXkPTzSKSJI
C69TKW7KCuJL44OSINelwy+BB7S9bPgl5cUluEoKCq684kpmA+nySy4Ff5ZSLuXSR11OCQMM5XLX
cEkxhmtzoC6rkF8UnllpGjVyFPyMN8AVaiZXsKKUB4ar+oK0uYcr6C8tOe1f+eZWXOrAfJWzIaDt
UNr3QXzUgrAuNylJdnpPNd8acoExb7juBhTpyitGXTFiJPrXUNriKJ7OKywCfllFWK9EXdBDMaAh
ApgKjy4ZOpzWbqjYxy+wYMM0yCjln/8iTShvg/IoNjgHHgzIjIX+bXoOWoZyefP918rM4wQ5N2aH
UBlPXnheg/AeL8EL5PwLrg67rr/2eoznaA4MO7gFR5UVl/Dbpfy/qY/893WiC+UHrXHj38qi/H+k
4ujF6MLov0PohLt4yVImgP+PkWABKqJv//jzxkx/fwb/+weSqXQ6nUmRi3hEvxhCn0v8NAJCsp7c
bc6fFh+xEKlfEpLNS3qbDczk05fmIomsTERa8uyL3MiZvD9fgAwnqZSqkKDSwNGj+I3FhVQqfez4
8SNdPZgM8PUci8cHBo6CmCAnniZTcGkZNXJ1UdAhR9h8MZRlk9ddWjZZxXlVVlBY0SK5jJTFkAbm
eYBXtpSSVWQ8I+EKJSlY5LiQSCSSCBKExLFjx0G99+fMR49asGgJiIkLNEwS1szgEUia1mh0FW+k
0/Lyq3g7rWLOtFhUGQ1zRZW0WlpsLBSNle7YsWPvz5mHiXzGrDnoX1KmVZQwxWsjddeQ9jgl9eRd
T2wOBRFU7Z5vIJECcUHAHxR+1uy5xRcXoAqnT58WSKCCMvIypOXsmlGQNE9bkRlSvHaRvstuwQyp
VM5DK0v/ZlIcniS3MfQ0ykLxuDAwMID4M9+fA/7Zun0n0sG7eE44B4kQ/lEwg6wnKugjbx2tR/xB
RlIpdSunpTRBsU+ePPnDT7+MvOzy6TPfP3r0DzB6PB5PK9tX0rvzw0haMWaqy5nmjbQp1bCc7wsZ
9Yid5iSYURJNi6WVhU/nx8B0fmRIc3tKmlNI5dyUZ56MIkSzjbT6o7TMO3buWvfl1z5/AFGTySR4
jLAT4UVl++ZHgzz1JDTJ6E15at5LK7t5Ok/AjCzHlLLfpdMqaqc0RvsUZ2xMq5o+rTuWpqUtKJ/c
uZORmk/SavAgaSBK7VQKEyvGpd+3bmfCo/8YgMXKvXPXboYKmVEcQ39zUCdubjp9+gzbRg6eAMoe
VzGRhYu73//P38OEz3+KO3nqFJPfLlj0ASbIWbPn5Wku3/v2d1NsYpqY+CXnKBcU4vc/kaXnzl80
rHzIvAWL/yYKRuKOoQv8ckUTsIrMX7gYrfD7th1Min+GqqWfPYveeu5vqDvFeHvbjtaSQnxUfECb
wxg0/vfd+IpJIy8fgXaRbgQ5a4znf5VjNufgJk56Bd155649Uv3R/0GAlV0vlK0AShYg88uNsuu8
ZIWSeVBuACwwkHTrIypwLnedlf2eOZvzn5PHOasMOSO+Ik1H8UrOiZE58c/K4p/JJa4sCbdg6vLk
Y57LP1LneJZ3m8udeBSwCUM2ANalw4ajQ4oTLfMwv7rW5zi5nJFX+cw5eaa5Wp85p0on/+K5PEkV
VDora0dlA6kaTpmOmqTnZOVUc0u+AGdVhJU+Yh3m5MlTUg6cM29BeUnpgkVLwLLHjx/PrX1nZ0p1
Mc7x+URZGEafcxzS5VmLV4UzXKpKyy+2O6b2suLi+Qs/QI3OqbqSnIHPaGR0lvf0jLxdyK24BU96
poTUJAH5lZlUGMSuDDlCp6BwzryFOTh7Xsc0g8Jwg+qJ1iNNawvnc44hDIaWpAa6tEwwwCNa/vyT
RmZIcWfrbjYe0nTOnTx5krARNbWqSEdV2vPcYmsHnle8Irf1IKud9BHzs7mkdfdeAs3nL2Jjy4kT
JxTFU9qkkBZGbntCXlR17ue1GkVhj0NtniObi4LfVG2tJimXfwZ7el66t1TGw/KM5K0mNxeiIJE8
U355ck8xngPyiodOol3OnM3KIHgsocnwXNslPPsmf6oaWl338/JOxk+H28UUNNHncE6j6zqO3RZl
1pxX8s3Ha1DxqxtAZUhp2a49+/6ab4//TglWeXEJGEjs5AZq/rc2E50iEhfiT2f6MTiOfnGMCoMb
W43+DZKKhGUz/bwFiyXCibNZEcXf7wtS3OMGD9BJWVExoOF/Fv2PHT8O0i764CMMCCD+/7rkVW0t
4gLt3zAWmkfliPjkpWLm039/WTIgIEoLzvngw6XGoPE3cRUTJqFFMD+KBx4YEqy/eFxlfWF8xcSS
wiI0xF9ji+6/DWCNGz8BDLRj524iGMhKP86c+qs2Q/5HowE0PAiVFaucOROPC5dfcin44DgmKiJl
YZ/L2eUJg2L67uSJEyAmHOPDrByIwhRyPsmZM397fshuaTl96tTc+YuGlpWj/CdOnPgL+DC/Nebc
OfE6L5VhyyTZ4j4Yya6ZP/8k3wk0PsUlBSh8XuCt2CUj5pJLR/n9npedS0KksnPJ1hyllF0mjyfA
6DwVPoEB5BHOKSrOxHrokfSDh9wzgLV9Ryu9OyNmRHjszJnz6opIsj4vWxCQ7RPK00T9+jlZ7Qap
u/T1XMwdrbuY+FBafWUJz6naUVkFybanc7yY0oUO5e4q5XaqfDTpkoj0kXy7looUUh4QY8rYJv9I
VkfF9q4/5c0hI7uS8XIJnufQTdlMstQkDMbSnDDx5dLCom3bd5JRnTAhHc/PnJbUWlnHfO+Tdh8p
5bWqqeANGYue426CkzGqOk1F/5U9kpXzvPSpotGl6Utvc1QSiZxfH1Ns4pNS/k/5hjytTpGLyXou
BtKXX3mtrLh4K1nxP8fmCA59ZGPdn6ouxhkM86woHTPPnbvo5PFjJ08cx+8p/J44for6Tx4/zm5P
SgMlIbm3RM+x8eMngIFQbgSexthDEjl24tgfLMKp3MUSZ0/ZlQsU/bKnJ2Uh+ddVb+XfzWaUL+rx
k/IIJ3PvnpJ4TqmJIJY5X3JJ4U/kPXn6KOolKYAyr1xhjvb3g1ynTp44ffIEbuGPx2KYVl96aSwC
2cUiZC95jU5Jm0NO5FOKhlNQNU9YZflPnVDW8ZSMkseVtZblK2EeSdZ8FpJdEvZQMJjYdjLeO3ZK
yYrk9tgfR1kiItHmzJ1ffHHB7DnzEH7s6FFWWhrt+B8D/dIKntIolfTpKWnhpfysrlf2FWmauXQU
DSdhS8YGKB/KP3fewqJ//OP92XNJh1KT7oSSr5QMefw4hyclNZIyuUgueLL+EyL7nTgluWTcKAk8
TV8BwAWKAaXnzl8Iss+ZtwC3uBQvntZILdcXTp7ORTstL4AkgvQ6IX1LeoGS+MWfbBcjNcXdMWnW
0iyArFDac2fPwHOOfiKyimzdtp0E0RTOnDqFofmPo0dZiKpUCsrkSSpmdJpDVTnxZcXjEjyXwgnZ
6ygQyr9t+w6UGSVnbUEqcuLEoMmyFjwtb53TqkzFykorqGADRVNKKCDeyl7MF+mEMuvT8lzUraYg
vsKjrOwJDuOJraNK+YSCxyRVUDScrCSKcFxjx1WgRXbs3AXOYT3i2LE/KINxml7RE7UYgFcYZdlO
8yuooKS0dU6qu7yKOPym0WGw07ySq1M7rZ0pLyNlL1P0QUngiXNUEQLduWLCJKLLtH0n+dg6fYpb
ZXUup+V9QdVSnPGQeS5yBaLuYMyluAJRcjFPNiTr9wciLl+o1x/t8kW6gkKnJ9wXFHrcwXFgoILC
H37a1OeLuUKpI56oKyx0ewJ9/ki3m/x6QvEeb8gdisPvlmXB/JKQYCxfpEAsH1m8xAgBSWnzicRy
l6QWUo/6kj4KykoiK5viFSmtcvRxB2OqjGKc+uai+aKJHl/YGYwfcvn7QnGXL9pxqGfYkGEvvlTh
84U9gVivN3zYFQzE0+5A1KMkmroY6oaTe7hVzqepSllFRreUJoqsZSyUi8ZoEpAQSvKKmBq3lWVt
Kkskf4Gv8C74Chd7yxkUjnijzlCqsy/oDUSmz5xTUlTcOHNBH33dExIQvy8QdgUinrAGfTTy4nML
h680yCJ/Hf0Che/1Bvv8YW8o7vQEPYFInz/WEyCdq9cTbJlB9q81z5jt8od6fFFc/kiq1x30BqMu
f8QVEsA2Mg4MqhpFljXxMHJJCB5BasGI0C+k+uOp7C/z0Csdpxc8Qppc2dt0JtGfFjLJWDIjpOPh
OH2UTMWEtJBknvffn18CXDt7QTqe6E8ifgYvpmKJWCieiqXwK4STyWiapZbNIptRKiMNyeWYvxWL
kX8rLQvMpaMoczZQGkGaIA35I5EagD+WOpo8lggLqMj06bPw6bjpl639QkYIC0eTRzPxTCaWFIKR
AVopTuLSsqkvQV5CbrEVVVa/G08J4TihZzAKCmeEZCISB5374+l0VNi0cXNZUfGsGbMzcSEVFdKk
mWjrkCZAA4HCmXgkkYgkcjnKSxXPNUFc8Sgt+ZVXXNmI6Xxklpogp4mYizojeTUlZOE1oiJTBbfI
mzijICnYWE3/uJzn4/JfJSsqG2gg0R/xhaOBaCqejgZj6CCgc0roZ5vANm78PRUfSMX7o4E42isR
jfvdfrwVC8WS0QRLkDSQoGJvNT8Iqr4QV1Y5o+4p0pYVb9WsKPCoEVdRW4vDFRG0+oW6+aTMoGg+
QUV5efFygwa6ZCYRRV9NR/xhEBNsL0RicdKXwfmJceMmYFDdtHELIidjqWQ0jkBc8CBCIprASIWe
pShwhtvoHP5Uss1FSoDCnzDylw+Too/MB4ecPmcg5gzEPaGEL5KqqJhYBID18yanN9IXSPTSEdwd
CBNoFRacwAqhuHhhatGY1XhzmyIkqAHI1G8pQJgiRIrSFLOjAsZJ5id+XtJSBeWva0ExMTVfENMn
6NMXjPmiSXi6nd7y0vIXXhzv80dD8YwnnGTw9HB3n8cXZumoU3Zz6Sl9moeeUQ5q5LaF0q+auQMx
fjrcVpOCy4CqFgENmCjxS+NL2YlBK5CuxxP0g7tcAVdA6HKHfdGMyxd+f86CoosLWuYsBhl7vSFA
Cqc36AlG+nwhlz/Mb/qAnG04zSp/xONhtxr6y4gc80YS/mjSi+8QdwCRCWzyhQCz4McHDMDWjFlz
SwqLWmbNcwWjnmi6yx10ecO+QMRNyh9DdQjACvBIF9CAfYGYJ8eWYvFkACt/JfMAS+CM45g/MDxh
3MGQBLTUtvdALBTFBI9pg41W778/r7SgcObMOdFAiE7/MQK84undO/fGkV1yoD95NBXP6I2qsvmb
O+mmVZgsrTHcc8bHjGLeor/9cSHiC2Ka/CN9AlgKU+DcOQQpbtm0HYEZDMKBaDqWSIbjAwCTBNxo
zEMK6KYqW4YPrXQjSOYhzNz9yX4QHyEDyUw8TGAWSN0v9KPtNv2ymegdzl10NJn6IzWQjqUZ/TF5
xEMxMuuQpAhEVs6CEpLK/dwmSPPnToHPM0qkJWhg5bguBtKBX2p6SmdHLtpWww5ZCdPiWxkRMuqA
fuQVz/R1u99+671PPlmRBBBPZCLoXVFh7LjxAFi/bdmGW3ycHM2cOHigs6rK9OGSjz1OTxb40gTR
G1mzKlmUy9tcfovzYCIfGSiaQ9E1dEGeMFhhBi+tiqkUwJ33YkY5XMjaBWMRyJugaDXkD+/etT8Z
I58fdMgC2wvjxk3EuLR505Z4OEYCo/GMkIoEwr9t3oo+NZDCuNQ/KMup2yXD/cQiAEshFpJMeG4N
QUjH4d5lK9f1eYLgHG8g0uMOAG+Nm/AyYMH6b37wEVwVd/tCfd7QnraODT9t9kVTmEt6fWFMgZjh
gLdwKSYb1cd3jC8x4sls3CpkpphCtAQMbi3hVlAtUNHCgrKU3YOIiDigYdPmrb9ta/X4w75Q1BfE
2B473O0aPuySF14a7yE0DGICPuL0YFT87sdN+9oOcajBATFcpBJzc4WUMnwWU1UkxsE3AV3CKoVY
2gXmC4FimoIiCdbJo6sg+QXaALrqcvnXf/PjkR53MJL0UOgQjiVmzp5XXlrWNGNOIBT3h2L+YNQf
jrV39nz13U9uf0hbAqcQ7HELHNNrayUby9Lp9YbRC3wUXQFm4Xf1+m/bO3tRQrc/4g2EPb5A8/TZ
JYXFTTPnuIKRHpfP7Q/3uQOd3a5vf9zU5fT2+cLurDgqqidqlRebUiwqReTeQDQQZgArKRNfUY8S
4uRGlmQ0KUSSbJrHZbU0/OufD33wwSe7d+2JBMOpeAIAa0hJ6bx5CzGoCdF4645dn366/Iknnm5s
aBEiZFBLsi919bweV82FsiktrSFvuLChXxJNKVahv5s3bgl4AoBW/fF0KoZhOjlz5uxhZeW/btxy
NH0UcYAgUfKeI84fvv8FQzZHosb9+he0BV3cr/m4fF5UECGeGkgdFSLkaxu1+OWnXwPeICaSBGAW
CBsVNm/6DQBr9uz5iUgUcdBAaSHpc/t++H5jPBwHFEbJafOlVUKClFKkJEFaeYGToEtndTRBKixJ
K8USUpSsgMuCHGZx4bUKbStRgjQRLZAhaBBcrLUyNb7IJxGODSTSG77+fmhJ2QP3/6uxcca6dV9F
Q5Gx48YNLS37+eeNrTt3L1r00csvv15aUPTUU886u/tYmkIYAFlAIyazIsa0JoiUCYfSeqIsze+N
lN7XyKDYSBP6a0STsH1GDRbV/Mb9aNEhhQR1JaKEqzMAqOE4Rsx33plSMf7lj5d+dqDtUDImZBKp
sWPG43sJHQRdO+gLb/r1twULljz80KNAugRaJSgmDkTkg1JaA8Sn9eR8WQmWcj6IcaY96ed7JIGZ
7M13pl467NI5cxfv2r0/EMbHd2RsxcTCgsLvf9zo8wcxb/34y5a3J1eVlZYvXb662xMEwCJihmAM
7wJpATQoMYdyCteWpnAkNLryLfnEKRdKRd0KP1cMoFMeLQDBWd5SZsee/rJxy7AhwwGnVq/b0Nvn
6XN5D3f1Dikf+vxLFS6vHxPtoa7epZ+tePCRJ5546vkep0+1bMcT/PCX22J68CXX+tpLdUoxjFyQ
o1pGlKAQ7rLpYIA1xl+uzYU4/RGAKpYXE2L1+aNgrSnT6oaWD6uus7XubvMAogbD02fNKbq4sKll
VigUcTrdG7dsm1ZTX1pSvvijz/1BHs9IPy10SqIGr9qg083D4lTEG0UtvGGCEWfNW3z55VeYLY5f
t2z3+YLBYHjGrDklRaUt7891ev3+YHjL1p1Tq83lZUOsjTNCkYQvRCqu/WEQ43Wx7BIhW1QlgX62
RJiQgiqph//hKKT7AUFw5dbIoqHY22+/V1ZYjM/0Jx5/+oMlH9tsjWVFxVZr48qVa+69+358NeJC
HCESA+Qigi4m1uKhHL44RNBdE1RKR9IcTKM7NbLf2mrz8NJyc51td+telLA/mX5/9ryy4pIfv/9p
IJlB4Xdsa62rswwrG/rx0mWxrAQrzRPzaK8p6Kz9ac1YqilNiAisRfCx/uW6r68edXVtreWXnzch
JnDhxl9+Bbp9f9acJP1Ab925t6lp5s033jJ79kJ836dYkwVjVIKlsRAjDDbd8md0xfogb8FIDUO1
BUt6vKFmToG3eKS1aszNVOAtSGkuW6vkXgIxGB0PhsE2ixZ9WHIxOZCjtLDorjvvvvWWW0sKCu65
+95RI68opQd1AH4FvAEmu8qvSdF8gYA5FFPTR2t9U0eayxM6cqoW5+UipDIXIkXjgg/1R4iQ4uBa
nVZWCNviKS6vxsNCOjFAV1oTRCiYGHj6qWfREMPLh7744rgVy1eOG0d243322fIPPlh6/33/wiNA
YeDggVR/MkpeEchSe78mhFJ/7FEPT+ZHHl0kH4ulE7b8az7n6fVjdI4e6XY9/PATGExLi0rGjJuw
+ssNzz4/uqig8MuvNsydv/De+/41pGxIcWFxQ8tsfKkDTrFZkCxq0IsD47jIiSuyUi3ZKAGHnpaM
UvTlHlQ5SS2H4AqNlOlowBTVPB0MhD5c+vlll1xWXFB06613NE+f9f2Pv1x+2YjnXxq3Y/f+t96d
csnwy8pKyoYPv3R/++FAMMpd99FYoZMudemI0/IAyM1dFONqenHRrZ6CWky6MujWEXQFYoNoj+Xa
ro9gLFZ+IsdyM5mWN/jCi+NBzKFlQ55+5vmVq9dW15rLSkobm2YuW7HqwYceBWcWFhSZbc1kpVtc
IpQunGkpIwY0UKBCdsiVa6qo1wesExac3hDQ1eFejycY84Xir789pfDiwiGl5c8+N3rNmvUAW0UF
RTVm29LPlj/z3IuXDLsEt+MmvhrEi+4AAUbRtBTmurWwNYfnGcCKEYAVoAArLtXBSqp0sJSyB6Cr
dKKfqJiEYsAZ+OxDgf75wIOY1/GlXnxxYVlRSUlh4aXDLikvLsWINqx8yJUjRx08cCgRjaXopyQV
/yQ5eIIjh09ral9JypZRzOuCvnxIsfCRHR+FUOLFF8bgG3fkZSOeeeb5b7793mJ1YI78+qtv1q5Z
/69/Pgg/nk5+dxpG4awES3ONKS2HLLL5kiMN0pE3qJSQyMJHIs2kHYmoMKHiFUzbw8rKn3t29Gef
rVi7dj3KabM5fvjuh1deeQPAF4+eevJZj8vPdOZo7hmCseIaM5ygPdcKKb4ykKC34qmzhMcBVYLu
+pccQGQUS3WKZVm1rIunZSVvvnRGa/WTpzIovT2KuZnouiUCXv9995LvCvQCwKniiy8GwCotKiK/
YKGCwl9+/jUWDMdCMbkAJjGIDInbBJqKTWk+kB1E54y3Ks1Zm9NsWcXHmFKbLS5Ze1WJKnnFUHZS
FVjP968MQVfksyFGl8KBlvbu3n/VFVeiC6Ativ5RgAGqvLgEwxHQCzuSbsxLFSmqNhr2h8kaejg+
kBqQfq3J1A8Eje4Z5/PqRRcg+ZDNuM5g/GC32x+Ob/lt+xUjRg2nx6VhAiOIqqBw5OUjwEnDhgwF
2MKU4PIEMI53e4JH+nxOqj/kJlq9IadCl0hTiUcBaGJ6qzPqeVGNAwZVZw5qqbNoLfrkf3lzM08A
Jg/0+EOhWGLKtJoizEnFJcWUmPAXFxaNuHwkgAIu3NobZ7i8QaLarFBg4oA53vJWMKZHZIUML6ih
zSZKrXSEeRq7EyQvxjgSU87ScEwtFHRLPPnVsUB+xZAE+iO793Vce80NoOTwIUPBnJcMHY4RDbel
RcWlxSUg5j33/fPAIcLEgUgim9rg0CSmEhQpGlrdvqpvFUm7EJFbIOqlq4RI7bDT6wvFdu0/eO31
N6HFy1BgfL2AHwqLgLYL/3ExGaMLCu974KH2Q11dfV585PjCyT5vWCkjVOFCRRcjVMpWISfBCsiV
3AWZqjtHm5XeJqJJjGWY45n2OpWpxFatXEuO+iosJDCrrLyYfsGXsDnm4kKHoykejjCd04EUWdvK
6Z1oLCdpfdcOol+SHmTi4S5k5AfxTOfB7ptvvDlb7IKCyy+5rIRiF1xMJnHbrbd3dhym6jJR9Zoa
Zx1KU3IzmHK3tpwAZE9RTTh6m+ztct53z/3s6FJMJFePIsduXj780mLKOWiLS4YM2926F9/oTJk6
SeaeRO51Df023bkko7dWm1bujeCo8/MmLY35PqOlRSRoS2gE3aeqkkirI0P2WorzGoyUiWdSESEa
DGeE5KqVa4bTc0XJyYNFxaR1iouHlJJzLZ9/fnSKqipme1NEwEUEMKEYLt5Cue5Ersaa+jJCTd0+
bU0vrtBXrUCprUGYUQt6BZ2m1+7RuiAPLB0JkO+9o+k/AJWEUCziD1mtjUxqiEGV4KpC4sF3IDlj
9OLClV+sYftyiHo7WoGKh5VbMeRKgRnuEidv8LlIEwEoVchF1V3BE070eEO+SLyhZVYxgGFhUXlR
CWGj4pKSiy8eWkZG2PLS8u9+3oTR3Ek1RdjCRC9VdSdqWLKljZiOfpXe5j6uArsa5XDXwtQ6WINv
DdNXvhlUy1gFO5hEkMyy8V6X96mnn2WH+4KS6If0W4cMl8OHDHv5lTfcPqKX7Ymm1Crhbo7qFX89
lAOq1IunAV3666zlDbqEqlYhD2rJrniIQd6gTPVKsZLb5490+YAhYl99+0MpGdEK2DG9YEiAfnQq
4P6igiKqKRjt8QQCsQxvS6PGMqUW6TgbRaMcMbA8hO2u9dG1cvwCaQUigjcYW7rsiyI6FlyCAhcU
4rulhOItVAcw65sffup2eT3hGAFnkZTTK/tQcas1sVTi1bwOlijByiu5J6XoKkNUspLSwVc6z6WI
ihJBV5iqqTZVOkH344wbVwGy4wORQSv2sQ7KV1S8PJDqp6o/Aj4Qk7E01ZbQ02lVfjjqKDLz1zFT
fD0PnVW5eCoRI+Djl59/LSLQhHzjgvL48hlSUsKOTwZq/GbD9ykhSXYqsaUEQRso6Ci7cMQJaW3h
jXJtlKmr4zdKdxFihvj5p18xDhNcjqG4tAzzBxmZi/G5Vlz8j4IvVqzuT6TC/lCKthdejIUEuuVK
IQNIc3TbuUtyWjvdeLpxGZ3JO6490XLlW/pKMFyEp95twCsPX3taq4G02CyW6aeiQUzYA6l0dXWd
KCkpJ1xUioH90qHDtv62NUVkkIR/GOQlq4QiSogl9VC4jtIeZ41VpmGW0RTDpDmLboKush23rVUA
PcNF23w9d7kcUUu9UvlFJItMPhtiKTbI9BMmj6IhfC7vA/f/ix4/Tz6Zhg8ZwvoyfquqTEfTAxi7
0DvY3gIhEk9QmKUtStTePqkSsl6kaaFAY9XGHYj3+qJ0/2DkwJGeW269neAAOoyWYEi6+GI6EhVM
raz2BekUEkkCV7F9cHQPV5TdcrbpKVa1grFBdIdV+iUcRSjVtOfWE7roQiu5iMI9KILR0c2SYKPu
YPSIJ+ANhlev+4pIWQoBqoqKCwrKqDC5+OKL8Q20a/c+fzDS5Qn0KI0d8HarceVnGsuUbvXeApmE
bFAFr5jmWmowNrhFAzVEVmFlvlIRVV3qy6lhiW/1esPdwURvMOqPRJ9+9rmSwgIikCfaPyBmEUVX
hW9PnhaKCrSCRNOcJ3DSVg5TGi6J8ZcX9Subk5mJQrheKpsMAGYFo05/YPxEclpWKfneLSmio/MQ
+vlbMfHlcAyvRI64fH1kSVTAxdHH56pU5kKYBEuSe06CJbfOIMIsyYqJQpk0xcw0xOkaB/3yA3iK
bd68BfM6LoKxCqlAhUrjtmzegTiYS+JhoT95NBHBFNKfSRzjDsoKxZeM7AM9PQhy0to2Jag1Jzg7
pDKJo1Gyzys1cdIr6IMofBH56iVLPEPLCGSZPHlqWkikgGkSKSG3tX6Q7U48MQl/sNYbu5UVYVom
gEqJSDxGRCYpi6UBRQW0ojN6AVuNQhOMHz+pH3MH1XhjmxIoJs5QJff0oKICqeyBL5mIa5pIUOqt
a+0P1VC1yeio6OkKLDNqJTwtKZqKvBnFTggFdNPaTUlvk5H0QPIYOByAKRmN93T13HLzrYBWVHxV
gi9ndIrq6tqMgI4TpfyfYtM5/U2zbxUNKwA8zhe4GlppTX0pnqWMjAJxCoMBCxXQzHC/gi5YHMsX
XccH6wi89Wuq4d6PfkH0HjDgEKiaFMLRL1auYZL10qJCOrESOdatt9ze1dmVphZMMqTvZ4CxiKo7
2RQiX8cUNPcJ8pT8UnIzDeo5LBhzB/lqUh4/BuiYO5Lq8Ud7fKHPV60rLsB3UmkWGfwDAKt05IhR
O3fvxwjuFGUM4oTNkRtxd1ppiJ20dqJpmFmSJ6iym6CCC24diMk1NxDUWZ7TkY1J9usF4t5QwkNt
iT382FMlhcUUE6D5CwBVi4m2UKM3GHf6Ir5ISrU4GOUsSw1q/YujqRbTNKTENz+mUpzXEX1JCK5p
S0JrVVp3T5w7yDEw5qU2QVz+2NLPVxYVkE/5Eqr9gB5FxA+Fxdtb9/qJSJUszAXo8pzeN0ZQtS/y
Aq2p8VcGeZSU8yEA0A8btwwtH5qdIy8mF+bIwosLf9q0tdft94cFXGR7aTDmz28W0V0C5i4RhpgN
rawOFn/mk6s+KCZa/lqYkKypMTPhK0AJAVhFxTU1Jo52sNQSEl+5SmPNSOuRel5U7LHiGlKS64Uc
TeF7liy6rVi+upTWgi0UohUwsg0rG7Jv976BBF5JZ4Ayw3HORnd9HWRBY0FN0JOrZdSq2bmn1NJP
kiqtR109rhtvuBEYiyzUko+0YroyVbRt606Z1QPudoELFvJpVkel7ZRR7hMcVAdIe4V3kK3+gylf
6ywlC7wFMkFjKVPgrY1K+wiVKbKpOhVPhnzBBQuWZLvDP/7BhFhte/bjA+aP9LF+YUBLyyqj3hMg
KHGVepuknvkGHWsLwmA22zT3MaQvyEadzo4NHa7T2XWokNUNYkOLmm8IR59//sWSwpwOHP32mzlz
DtcYHu9WWzItaIxCglQHS9OEklK6EAgn3f6IO5To8UX6ApE+b6CCfnAzcfpQKnb75LMVHn+IKLOH
E/zpkGu4UqG2olYT1reAoLA/xNVQ1sccegBOZ7EsxsE9mnN2TCF+6+oLAGB5wwl/OLFi9XogqiFk
GeIfhJ6FRY889uTBIz2AX55gvNsV9IaEQffhqzGKW9+MajCmZ9tTZ9UsqKyLBp6I/ZtmXXWXhnXU
8ANZaRDZTuGLuHzhd6dUM87MigMLChcv+djtC/W6gy4/WZn1cmSQmhsbNWOqWVTWfXQEflGlSa1A
zBdJuLzBhpaZRBuPLRPTVfgp1fWHe9xeanvCFyJGswAT3UyXUWEILaCHkrOGRoNSQ6OxLMASNMxv
6ugmq77ghWj8UEfnzTfdwlYG8Xvrrbd3HOjQnOQEbbOfWvZyuCIE+VoPZ3kxfkG4AehqgC6l4UP2
vfcqGcAiS/ZUSL9kycck5Vj6aHIgr6OmPTNJi5FRKvZqGfNMKRWAOE2QTuWMXBDrDFlBWhpIubrG
RHUMsmuF+KiYMPGVdEJhVTKtYaxVY7FMR91EUGkfX+DmMkGuOXSBmxL09c11JVuZCzRkIFst1cZk
amthkjgpaoCXWjNJdB7suv/eB8BFRLJ4ccHMmXMzcbKnJCNkMvG0pv1bHVmdcAHiW0Fj+VXQQ2z8
CFriNG1zVhmN1UOlBFrQ/fbgbsXVX7nTDk/Gha2/77j+uuvJggBFKQ8++Ijf49dWN0zrAa+4hgVm
Fc0v4sg/lCIEWXgwkvSFhB5P2EnNYbt9gQ3f/ABYwAYgXA8//KjT6fb4g33EQLmgaSZKPjG7dZbV
NDbKubXUX/h2I3nmHxXrUFpmI9QGt7iAL6gnvnJr6RJR2+IuarHdH4yNq3iZKQ9RYXLRvEUfYjbt
9YT7/DFPMM6XqeiblQpq7AzQ2iuqIqPezH0hBiy4S7RBLQNRutBWT1wk7o8j64bArL5QfMvWncOH
DmdCrKFl5TfccJPT7fPRlUHQnJjczK4wxvha9gGdgw2imptJORI4OUfpSEBxi4b2R9oOHBp5+cgh
dK0H/FBeXLp5+x43NeDupQpbfX667M5tCG2xGQVYuQXKoNRMg6CpFqOYBXVkBgJbOhT6k+mZM2cT
vTF8cZWWVlXVZhJJPZvgXM0e9dY8/c1Q8pQzXCigDxPpbb+QyMQFZgRh7+79lw+/lGF01GXkZSOc
3U6yNSkUH0j0JyPxFFHaSA8yEQrcLf38ySCjlZrudCvRyU3v27PvsmHDyZoUU/25uGDjz5tkxsH5
esTS1bE0x86CvkK67pXRNnSZUWqRpxXrXCpr40rBUkbLwDpnCVhX5UvQV4RXIUKen/E/2wyYojLF
FDUUNyX7pVd45x13uXpdAwI1OEcAlhLQaO3215XJpQexySShYYZruJUroNLSPJNDCs5WX/6W0jR/
b4S0HTkG2PQUAXXt3qm+Yeh5EpMnT2WDavE/Cj5e+lkmwf1mSPMRuUqWllHbaVNxy0VK25LiBzHb
k5W1mpPdBk/U1QMxzF5skzmubqc7EI5VTHqNfnCXlBQWL/1kWSAYASxw+iLeSErxukT7JC7PIpa/
lYZnPXGdbed8eYm2WXNNKYgaUgR5pr0DWR3hbBVy0xW9Ypz6ymody5OUeohqmidMjkDxhN3+8Hqg
VbJKSHrjZZde3rq3rcvpcQOnBgW8Qg1eiClzCRXTpmFMWiqFDpxbCzVqGafQ2ZFwIdBT3/qoks4x
ZY1Eakv5J3uR5vNFUj2ekC8QnVZVV1LAxFdF1bX1viA5gsYNHg4nSJV9QZeCdJxfWUZq07g5BSxF
i6gbXZvng/nfbncIVfD6QxNfeY3uISWbB1FyfK4ATnW5/MxoFlPw90hTyJIlpmp0GfVUS4TMkntC
95SMtJ4ZQIXdbbJEEva6PLfcfCv5WAQ0/PU3eh6FEltkuGte/EMnOB/3Gel8HNfdXSXPMaNQv5Wv
dQJgCXSJJ05NE7HlzqFk/2AB/EI4hlkT6ApXv0BkXRmuIQA9g/LKCSajXpzS1nPnzk+JiIDSUo2T
RCISM5vtbAAZWlo2ceKrmPLRwJrqyQLfIvbgG9HjGsfX6JyXIqS0RXdp/qqlmj5c6kkm/gzXkKm+
mYYL0+u6ED/bGyvuJGAhP//467DScrTIlClVaSGRjMQyRFsr0c8s6WsJCAVtTX++DDitlthluFiH
YzeEv1SXUcsp41ybYfo7fHXtdV0g8QeTFekrbCVjQjwU2fjLZqJxUVg0asQoIF2EqI4MSvOtEOub
wNDu7xfxjHfzVjFys6k/nOijG7W6PUGqYhwBLFi+aj3ZA19UctPNt7UfPIxpDMP34V6vO5TQAzQ8
VKRcSdRUPY7xsJRMPOC+wI2BWnaYONKImI6+l1t9dGNAZR5dhSTIEY2egCec8EXTTm/Y4w+99e5U
UBKTq7VhuscfJoHhJKDqoR4PWT8adK2NY+JS17YF94AXTYFijGOCVVM0dQG6VtxDjTRFMlqJSAMj
brJDMOwD0YLRzb/vGD7sEmCUSy+9/Pcdu73knJxwrw/RCPgAow6+CqlGn5oqgDHNnZX6FJBcff64
H5zg9v34y+YhZUOKCgqvuea6rdtbCerCJ00IIDvupPtwPeQbJqxtlIt/IFLuLMIschXNNPAPD9E3
asCbtJh6Lz4W33uvqqyoePTosZFAmJ2Cx9XxyqhX8fSVdbhbxgY9wi+uayhBUrABTJARgZ7h04+S
79q5p7ykFF+9o0aM3Lt7PybOWEjAvJiKJgcS6X4hqbWEx1WLyfBtvqd5coK0vioM5m+2tz+/VhhN
EDvg0XhH+6Frr76Oqbpv2byVClGO6lu6z3D3dsV1D6QT9OGUrmq5SuDBOUKHYwg0rSdSVRrd5kjC
eKaVuIZheaZD9EWVMp3CrByLAawYNbsApDukpPTbb38kpl/jCQqwiByUZ6Q+raliqKPzrr/VUduy
w+C9T9BXiUurrMumtc5cygwie9Y+KkBL+01n1Vg+sBCzJrFEOBC656570S9MJqsQjnGPZtJUoo9r
bbHU4Bzqv2iQuVCtBs7OL6P2F3yRJCYDT0g47PQ9+viTRRcX1tTb3f4gO8CEHJhDlghjelY3JTOr
+0IAUCCmuYVeafNJW1dax4hDUPdsYwUS1VM2jw4uCqJV9obJ8XC9vghQFNG1CkS27txTVFg0pHzY
7v0dLnIwdrzbi6cJcrJKRHCrFzSDurXWqibfcKsM6GjrpA+23qe1ZzPIO81Qwxy/m6NipXP8djaC
PyL0eIJOP9kTAHoGw8Krr78NtPru1JpgLOnyI06crLeGBFDeGwjneU9tbm3QlVDOkrRs2dqtPp9A
regmf9TnF1A8bzAWjgqvvPEO2fb4XpUvEKasQhYHPfQ4BHJStXItW+cDJt+UBJnJyCvVwUpzzFpq
iWE0Ti7rTx5LxzOAbN9992N5UcmGDd9n2Hyjod+a4YsrBtsZrpi/9a1cChfwpZsbKFPUYkUiSs/o
jSUHkpnqGhNG5MrKuoEUYEomkxhIhIWBvDr8YLvSdACioLeacyECpEQ0kTdNmTXfQOxltLTMQplf
f/0tIN1ULJ2IDeg0n+6iUlpvEoprr2Rxj0lWl+ECWkRD80lbVClwNzdobcbkLD9xbLDpWViVNRMz
/ZrKHYIuUASM69tvfhw/bpIQIVsL++PJo8kMAPpAzoYcPxcdW/k6NsYE3Z0H6pOL9FCjhlXef+PA
6ZTmQq1mK+jZ8shwl9cH19IjhpGJQZmoMHfeopKLC9v2HWA2HTT1JrU0I3UMgqiXpwWpkrt8OiR7
4HOb4WW74qnUyknOe04AQnW7gm6qQtTUMuOSYZds2d7a5wsRe1fhpDsQ6/NGxBc1LzFxSS6SK1cG
vvZ0jHOksY5pBp7UxK3aJOjmHtgnx5rZAmfLrC651JRAVK++vpAvknD6ol2eiDec7Oojx+Pcevtd
r7012UsOJI66w8m+YLLTRQxeOL1Bl6RRpAYLXAF+Li5ZdnLrBv/ugp3mgqnmgUKaRjECGiuzKmTA
ZwytEAIgop4waUGQlKi6e0PzFn1YUlTy06bf8VXQ5Q72BclJ5NT6VNwTCPXJjT6oE2QeGdl5a6nq
FGSBF1IFGtjlQYIJfzjudPtWrv1qyJBhH322wkPEcjF2WDVbCiRHTnlD3kiiT6fwrAzyCFk7WApD
o2FBRxGKM91qWwscSPzRH0/3x1N+t/e1V98I+wIZTDBSXSXeElhGqoTBO4NZc6ebcAEf5YMfwyyB
LOEYEVARa1gpaiYqsfGXzUNLy7f9vgPYJeiLpIWj6RixGUbQVSzOmR0vcIe5MJhRCa6UQqV8zYQl
YjRM26lIfN/ufcNKyr7b8D2qEwvG+hNHtc9w1MY0gobRUe7qyeD71zjVz3CtsccH047X2IOZUTOJ
yrpERvUVkdFadeIv0qU5S5+SyKI+HGNpJsSK4DPG5f1142Z2PrdoBiUTT/KV5YXBtvLFdQU2goZY
MT7YJ4cw6OpY+kL2E2gvpKb1LNQLOgpnqQsGPfzPgEw8k4wkMvHEwfaDb781mSgt4PMp0c+nlU75
uUpj/NzTUkvuHOtTXDxEz/cI9rgDgUjK5Y9hDutyh50BYefO1hqztc8b6PUFnYBWfsyXCY8/zplL
tEd/DYylAAQxl9IsOHdDou6kPoi9It6ylFxOM8iEeiGAMgtY6ZQZEnq8SD9BNNl9IVvjjK++/xng
oMcbdoXTh12hXqr05qJHu+inr7YRJWYqvVWhai3LqNFBTMBrbGFzcw1sBrQlQxqtwAVAXODFAnvc
Pl80AfRwpC/gCsS9weieto4as72nz0d3DgKtJo64w0f6fF5yrHKQgE45xXKYOCpFpXmApVH+PFU1
GkgJhVVVYOGuUNoVQENHPb6gJxB+Z0r1QXJ4NXnkZkd5ktN1BKLLj48cAKwL5b1sNZW7CEWAJfDM
Nekbd+Z+9cYymThRAO8Xku7evlQ0ngzHgEguzAz3YAeZCbofyoOLfNKDncScxsyXiibjYSEZTafi
mWgg1NvVU2+xM7PpmcRAKt6fjqaFUPRoMpWOxjQ/5dXqR5yd5GnOOSRc0wmqGS57eh2xnJT9Cmce
zCIAWMczA/PnLfI6XZlY4o/0iWQkqXfOCXe7nDDINr2M5jYrja1qktkro7aVpXPUXfzCtLzjg64y
pwcxOC6kNM/A0T8sT7pESI/fBhaPUTOw8MTD8RSVnVAjcHGi3heMZNjB6lqKSsJgJxDoWDbhVuTf
2JmYUp3vxDt6SNAAH2o7KerTrvQO+EtpmvLSNKCqWmjmHfUzkCDfRemoEAuE4uEoPpCSYWEgeYxj
X1fvYOnUIDt+VKcOXNTTF9i4cXOdyVzf2FJlbrA5pltszSZyNdXjqm90NEy32lrw2Noww2RtsOCy
N5nr7RZbk8XeXG9trrc04y2zpcnS0GxtaDGbHdb6Rntjc1291eFottqb6q2N9dYGW8N0eMwWh8ls
szla6urtDU0zGxumWywO5Gh1TK8z2RDfbGs0W+kleuhV57Bb7Y7PPv/CHYj2BCJEUIHP+lBSd9FQ
2/4T13YDbzXNh8/9cLzXH9nf3mVrmFlnd9TY7CZrsw0kMtmttqbaOovZ0oC6wANa1ZhBIVQHZbY7
HE0mk8Vhb2qwN9lQtfqGegvxNDSCpCBdow2UxG9Do5V4mqyOBltjS525Aa/DY7Y14AIZrc3TLUiq
3maxolFsdqRvayK0BcEaGi1WO8Id9pbGxhZTvQONYkJQ43SU0G5rstqb68yIiOwcVgeaDBfSb6pz
OBg9McX2+MOgJ7G+EUwOpuPFWz7TsW2hCdFisjNqgjE/MEQ45gxE97d3Wwmd7Tk6N5ksNoulwQoe
sNjBeA5Hi8lqN9scIILd3mKzt9RZG022RqAocKPV6kB1bSBf4wywVh1edYB1GlHxmjrSFhaTrcGO
aGiLBrBlXb2t1mw31Tc2NL+PCMiivqHFRPjZbnM04bexuaXWVG+1NVhtjXgFqe050HXI6e/zBX/Y
uN2M4tkbau3TbVaHxTEdhXGgZW3oRyiwo97ebEGR7Og4dksjeMOGBq23tVgQrXFmndlGehCStZO+
U2e1W5taLKRDocugmRCNdCurfToJtDrQ7hZbI9rOXG9DYcA8FlqFBnsjaeiGFlSvvt7R3PS+yWpD
ye2NLeADi62BvGVvrCfvNpvs02sdjXVW29z5S5x9kV4CjsNffLHGYW1saZhhrXegS9ptjc3om2BU
a2ODrWl644wme3Mj9SCaDX3Z3mhzkEzx1GK2t0yfjewcDS24BYXNdaZGezPoP71puh2doRGvOOz2
JhDUbm9oaGwifAtWBJnsTY1I09KAyGYLYjU0omvUoxegyzTjanS04KKeZuapNNevWbH2pPBHPJBY
MG+hyQJSNTeii2F4QSdpmmFDmR1ohSZSfnszSmVDUo2NTaCthWRM0kEEO6KhCg4HGoswEq5GdEy8
iHCrpYGUFeVB0RqaSE2RBEpOK0IDmxHbYXeQ7giPo5Em3tTQ2AI0RumDHgqCEAa2OzAAIvUW0JMU
tRFcYUW+IIXZbjOZrR/M+0AIp7ZvayX0aWhGIzaAe8n40ExGDweq0EQqYiPkIrfgZ3T55lkguI1m
0dI4HQMIqt+ISlkdM2bMRrHBMUgQJUTdKakb7WS8RbHRTg0oHkYe1rKglR2tASI3zrA7mhqbZzY7
WloappPmrm8ESzRhPEGWjU3Tm8EYLaRT4WnjTDBwc/NMVJM2UDNrNbG9cNU3NIA3Fi78MOSPC9Fk
Gv8iaLz+wVS4BjvojbcLVXPVUlDrx6QU50L+ISTSwtFkPENOyQzHjwrHu7t6QSYbaa8W0ATtjCZG
o6N1m5vQLuAQR3PzdDS6FYNsy0x0SdDEDjZqmmEy2Vqmz0TbWS3gGkJScHdLy3RHQ5PZbMUIbEG6
jdMbCV/NsDUQdsXYMn3GHLuFjDMYr8BmJGtHM3oFruktMx0YUxyNTWCqxkaMcAvmLuwPJPAxIAjJ
ZDyhBCVaJ/1dCB4VLsxkqJYNBY6UUWWaTmUDD/TvFwYyif6jQuKYkMlEBn77bRcmWCvphS0WDMpN
MzHh2sFRlkbMiOh4DaQrNoOMTRjorODnZjtjZsqB4PHpLbMwoIGTcYHyYFl0hxnTZ9nQGTHaoUfa
m212tCeYGFlYmhqamtAWGGHxUgPp0Y1NLQ7SkRtJqzagLez1Zsf06bMwGaH7oBXIeEX805sbpiMX
IBuzHXNGw+IFSxLBWCwWuQgfwUj+nw8/WNdorbaba20mU0N9td1UY6+DZ5qpqsZWN81UWddQX2Wp
qbbVVVmq6xzkaa29tq7BXG0zTTVXmRostY76aZaaKlttrdUMukyz1E611NQ1WGuQpqN+qrm60lKL
y9RkQ+J4q9KK25pKc2Wto+49U2W1w1zbYDYhQXsduWziVUt+7XVVdnPFpIljxk7ocgX7iLZv1OUN
esIptRlSt3rRUKnFfwG2LnMhvqDQF4z1+sNrvvz2lttvn1pfjRqZ7JYam7nGQapf12Cpspmm1dew
eqGClZa6aeYaPK2yovwmFo5fVB+/IMXU+ppauxnpkAhW87T66mpLXZXVXEPIW1frsCIcT2sc9SAd
XqklxK/FI1MD2qiOpF9vmlpfV99sn0bLU2UxTzNXT7NU1thNlhZHlbWqxlE3FWWwg+AkNZZOlY0m
azdXW+sqbabxEye8NLaC0jPhDcWy9OQvgWkYNA/wjJVzdf8DMc3zIrNAVugL5eh82+2sXma7tc4B
OphQBXOTAyGVhGImyiG1teBScltX24AQ3NaZHPU19nrEQYtUmWqQyBRLFTjNZK2HH6R4r7ayvsle
aSbEBPvVkhYElUxoTYRUW2vNTWiUGrTyVEsda6Aqwn4m0jUaLKYm+8233rpuw0+ucNIdDNmaZ46d
UIEyTK03oTDTrHVTaqtrLKYp9dXmRkuNtXaqFSWsZrmgGGjQKhup1zRz5bR6FLge+VZSJiHta0Wz
EsZAlWnZTJWECCgbILelxmGZaqpGJ60kvFFPuxvhFrTjVHRSK9IxTzFPMzmsU2trp1mqUeAppirQ
AZmiG1YSoiF3U7UV9Kl9t3LyHXfe3X6wxxVBRSLjxk0cM3E86d20sqQj2+soS4PsNnDstHpwFPps
jcjnNfbqyvoqE/ityTa5dkptI0pbaSLtYrI0W8B7deA3c7WlueG92vdMjdYa1LG+BrQiJK2vqayv
QaXgQcomm6kWXcMB+tTWWGpr6jGM0KGG9v0q1v1t2evNyqkTJ718PPmH2+m555573q18r9JmNlmR
E1jdUmmuNtPOUodOajPjF0RGo1RZqhirVFtrQCK0EahaS8mOgtU56qeYqsFX6Fm1dkuVtRbFriLD
l7myvhYv1tjqq2kfxzBIQmwgdFU1GcFI46IWhAnBLTZwQjXtbmY6cIHxak3gXksVuiQi12HQsJjw
FM2KAiPf2qb6d6un3X7bHcdSAzNmzHjw4QfNtMXZ6IcCYJitBz1NU6vByRgt7XV1jrr6JsJdIEuN
ubKGdOo6C4pqBVUr6zAEIXdrba2N1BcFRi6IY0LrW6sryahlrUXfAYNZ68k4g3LaazFQgObTSGep
qbTVTjFjwAdfkWEfgw9hUXQ9GxrIVAcCIr4Ng7/pvbopSBNFqhXbiw7d8NCL+DEQVdZVPfPsc50H
DmUS6TTgSyzVH+sfxLIAb0Eqo7MUxbGUxlvR5hubJdGOxoVMDmANxFPJcOabb3645/57wboYt8n4
aSUT4tS6StrWaCOTudE6pXYaaWtwL+2GVYTgdLQnPFBXY62pttCxxVpNeg2ekp6LCRFxSOvX1VPm
wfcdZQkwXr2DDG51djJi11D+xGiAfgROrqZdpsZUi8Z9t+q9++6939PlJuVPZcieDJWYkKMPJ2gc
qqhliE7gLT4KF2Cq4/+j7L2/4tqWc1H/Kdf28Hvj2ueee+xhX/tE76CEtrSTAkEIIZRzjuSchRIS
AiEEIomcc+julXMHMnRaobsJQto69v35Va2WtpAA7f3G6MFomqZ7rZoVvqpZ86uNpptvOsfQfOWv
K69WArgpDwDrv5dXtQUjO7coYveuxGwU6e20W6DwkKuCVZpGlwTCTwTnCZIBw0wB40WTB3ACf03O
ARMGhUy8mnw9KQelDf8LEOU62jjaKRg+POAfYeFMRw1WACl2Oj5BF5F4MxVADpowrCm8B74F/2Ta
bHIWeK0bAHISM9KTw64mGyI+vCEZXkSbzUm5eO3yl3/50jfjfrWy/Dez2kpiGsTgW86AJOm0QyVd
OsP4CH5hXPRa7QbDqzbRoBxBVvZRoscmqyzvsYp+RtIoQaPsIV7UbKxnXNYowjMiGKRD45yayGoU
pdGcykkBjtdoOciLBiNoNPyUghz85PwU56OUEMfrNGfQlErLBs/P2iQ/+fNDXPPcGXDUttRGx8bN
+pfmA6uzXs2rhvdKgp/rYf//QRawMQ2Bqq9Oe415Ldja2b3/QLTdS7sCjNNLcxoF9yUEGDHAwk/B
YMQgy3hBPqLo40VV4FWO8tKMzlE6R6g066PkAM3rBOMlOY2RArQYoBg/JXgoRaMlP826KbhNxeBE
Hws/7QFB8NO8l5Q0VvAzosoqOi9pDK+xYkASDFnQ4SfIluU1TgzIYkDkdRvvp1gvS8yNsH5SMETe
IFkPIQd4+BzWTcrwTh8jeRmHLqA8m9/L01id8Wg+1fAay5tzia3jc1I34TfXPjvpaJNjBNoaOe87
EGX3MhNB1ullOJ9NDNCoLSCEAI9yVlHsNvc43Kxd52SdFTRC0glFJ2SPRfRxhIfkDN4etEtBidYp
RqUnvLIchI8iQGKMxvEBkVMZU3tZu04qOi27acFDTBis6LfIKmm+UxJ0gfHRgs7SXpLXedrL8Lq4
N3L/y7Zet74071cz8wsq65/OwOp7KMmgaI0R/PxEUKG8Nk61CR4bozF2v9UZ4O0BWlBpNASD5HHR
R5WQwHpJ2eAElZVhEd2UKyRPLNo5r0VQCTlIwwfag6ykU9T8CDwHReI9FOVjWIMXVI710jRc0gJJ
a2hNoG8kyMqAT2YdmhPkw6u8qAu8n6M98L1gZTynspzG2lXeZTCUfXhbxHa7a3oKeVmD+/fFVLRX
cirNqBRnsIxGw4P2o4bTPmJ8doTWQZNpWiNBmKDY/ALNG4SgkaClvA/+heI0G6/ZwEuwBkt4rKwu
wGJRC1bKzzGwBDrD+xkBFFjnw8pMz4OuMrIhwKVKIGQPSfms8Dl20HMfzfptrM7AAy4j/AQf5lUN
yWNnL55/FVqanZrdtmMb6bSKQcWpS6JKsbqNAq/lp0BhYHGFBav5hJeDTkElw9/Lg1fRZBZkojKc
l6TdNjkogFaAdgngfzSO8dCMxyponKDT4LvkoAReSw7JQkCQgrygg0NTWB8j6nA76NZg+fBjfeDZ
BCkgCrCUOg8PFvTBbZkAaWusEoT/Yim/TQrw8NUgYXibogmchxqfGyNnyK+3bX2lLWdnZ99Mvek0
F5RVKfScflBFG+e3wSegtod4vC/0nORkgGPcFpcGjtQmBEjea2F1uGwLfLKMlyqIBieBdoHaaAw5
bxE1nvJZKD/N+HlJpRRwMqodvAen21jw8AE0B9GASxXAS8g+Dt7M6WBHJG/QKHk/wwcUyzzNzhK8
B5SZBYnBaooqI/rAw7AflslctZ8XzrnITHi5M+fPzk9Pv115Ex6mGz49t/mRydXNzmS9/nSLaiOW
zrWDTX7NyTjzc/66uPxq8SdzfvkKAKzV4E+Dg6Mnz54Gbed8IBxYFLAmuHGGw8AH/hwWEf4EdoqK
Qfso0CIJF5rBP/l58PYSeHgPOHzwXRbOD+/np0IORUX1hqgHzgFUETwAxEo7mifF+gjFR0HwtcOy
wgeCPwHnDwqmsdQ8gVbvphQdTIYdcYxs3bFddXuXjMXl4Mrbpb/+Asvr0mb86asbkNR/5nTI5yle
fw3Nx9LG23B/XVldCb4C+a8GQv935fUr43Vu/p2bKYlgAmCPPEQB8Mkey8QiJxuEaFh4H5gPB3Lm
QT4G2ClH+6wCaKzPCmhECoJsIeBCnEUD4X1WJShLYNSgxn5W1Fnw/5SHEMCK/ZwISwwB3c+EvT0F
3l6DRSTEAKeERDkowk/JAHfK024CQjPvGbYbEusB9zvOuEkwakG38AEM+rSHBH/CTlBbt2xT530r
i8t/M+leTUrPTs5JRa/nt6FagP/VGfhEuGiAPjafBdyrANausv3iwL3qUhaMKmhnddAM8MIMuFow
JFElON1C+8YgUPXzPaTPYvWN8wZrc48NOftyH+eAEfIGBb8K4I4NEjABo3KMyhB+itBIUmOqe+ra
LF0CXG6ACz94491DMFFafWft93v3LuivZtRVr7bo1wIzXnXjk1ybDY/76MjVJj1AH7+o6W8WkPcr
0NTWuSdyn8OAtRkXfFZatcBdMJqVVa2sZiM9o7xOoo8zmG6uM/1eJoQiBmKzzhI+uEGaVm28YaN8
o+i2MOqPcxqsCgQqsEySVWE5afB0gvkKjzoE7okgPGOcRprYFMMG4RvjDAYiH0Q7kDmgB9qPwmcN
htQ4SiPa6K7n3fWgE0JAYgzF6rUw+I/wUXBtGA9ML8/JuJpUfcc7eU6rr3z6ol835bnZUb4NZwWq
oV/YnNXWDXDcZOiNqr+ZB9SiBUHOP0buBTnzppxBFKR33Lx+CvSQ9AFqAQGSNj8geAb9PmAmiP2A
TUMiOUOwfsTrtEZQPoLw2UjNOj4zdr/yATE/CvEbP0QjaZ2Ez0FY4IP4ynXSnY8bng47RwqfFJlg
DpCcyIKl+SC6MDTgLYMmvTb4FlKlDsbHNXf0e4xXcz4tNSevtr3GFYKPAo9J0DrRSXdVtT+HSA+G
IBns2NxYWkkm42HG50bw6wyC0QkpIADQMfWHwLXWaRFW02sT8AlDIM6gLQsWcLuczsA10Cq8jbF6
wUewfIC1AIg0KLAvmwqKQRMa6hXEY5uPoLUxAOWD0jCrWcuayspbysHj8zrLqKBI45TfCmiG9lql
AEFNjkTs+sY5NQsy9+qLcQcPV7RUyAHwJhAYAK9jqAAIKBo8PAF1pUDsOkVqNsJjG1WGH1aVMjpp
XbAAiGchkdAZy8I4pSE4ozTS5gVcRfYJvaQHro0DAcIroH4FFQVDjkGA/uA3eICABuI5UoOVhexL
JCEOGdyLnvoXPXViQMBrCD+C+BDfPeH75aHzVy68Cr5yz3q3btvKzFhJjWDAuDRybG4QMgrGR1Lq
OK1ZQf60ZhufGUkuSofVB18E1wB4AkCGaREACiHhoVhwcV4L4bcSuMRgemx4CawLI2CA8DabH4wd
LY7yjePKqhwYNdg+q1vMNQVt4RDuQ9Ko0YTHgkLwk+DWbAtEUdkdapYUIQB7SQuYqiHAssLXwb1D
4gQ/QWes08T2iB3L/qX8wrtJ2aliUCTBXcC1GSzcMughCzKEZNXgOT/gXUweutie4qd3QWgj8jBc
G6FSCGdVkvSSoGBwbZRKgDOHJ4TPIgXhainz9q2mEUHAJhsGG2r7GuA2wbIYnxXS5qklR01n9dkb
54qe3HG4Rbgp0EZeJZQgQy9APGNe9DZcSLqW9SD3etYt2xxJY0CClJJGrOC3ih8WizcXizcfnMU9
6DKEMxfOzU1MvwmuIrRaXMZS1q+ZLvcZvu/PRPrNuK82a+R6v0W1FHj1euWtCbBWVozXXZ29Fy5f
BEWFJSY9aDsgT/A8rIpCBt/OonunzAgF6mFD3dCs8CdeFyBQglcnfaBCsDSsI4SmMTI1XN5YLvrR
w6NJggfQMT22gZ/x87Cs9cONrWNthIdKKUobnxnkTNdnhgP08Bx+HeotmKFlZvw/v/rCO+fGpiJ9
8e3iXzemG/3Mwb3PHBrdEIRtOJL511DOrq8XbsRd8mZxeSWE3CivgqH/Xnm9GniVnJaVlptJq6D5
HOmH+Mj38H1FFcUAjyg/qDdFecikohRi3hK2I/BvIP+JJXAdWL8AtQePquBPyFXgQxgze8TlsHks
4BnAgwG2YTUGwHE4nsIaoaUDegYIpMJSUpArQlTlwksArmDB0sf3sP7hyvaqR41lmGQiSgGsPG7x
jGEyr1NW+PBpcntEBIRSBFge308pGbmJmUmQz4EndYRESHo4Q5QDMhgwB6APklRNkHRZ8PLVXXW7
9+2R/KKiT9tDTkEDO3RykB0a8nRw0hGyOwyZcdl2/rBr1DkMmED2Ma6gMigOPGksZ+dJuy7CG1yL
DnjCuBlZlZwBp6RLECY5H3s19UZx2T0OEgWIQMaHBx8Q4RUAKNXt1ftjDgAgmNNf+41Xbp/m1oMb
zDf8pPl63XTkhU1mnqxl2f5w7t0bXDBPn7V29e2LiZY1nkBjM0spOiurnEMTIYGWfJwjKDsXFd5r
62I6Htc/ZhdIGZJULzex6BI8nOijHUFF9PPORVnyM/aAPLnskjERxNyXxXwFAJAAv0KyCwmo5IOo
IwDEVkKSK2C3+xFKQ3BVVF7WBUXHz+G9oEASD0jOaxNVBV6s6a67npEMFyPCN3plyQCkBQk65FgS
gAZRF+HzIbpjVcaU576YGJDnvP7Gr694/Lopz/UlqHX8CJsNcPwVs/A25STzBOfDcu7s2xsT9bOc
RY1RNMgeJEEVZb/s0BVFEyeCCuR/FNx+wO5YnBA0+Ks8qlhOXDzn0MNCEx2aIAcksCvrlOWrbV8T
LgL+F9JNYmEcDM+1ZEf1U+2il33aVrU/7sD4NFnVUm2bG7drdkFXIOOXIPv3URBmQMNNpILlw/3R
kU1tvR5tBe46LbeouvUF50dTxOKEztR01x87d8oVUiaCkuIRyQUy9xGEWEbwAagVOSz/sFJA4v0i
r/NKSIaMCi6SXiAllVN0UVJ5UHXWDw4CUlsZ7loO2WkPBekR/HVqURAwmRanlgRHSCAXKGeIh8RD
0ekpLNfB+8n6ntqo+BjZT9b11tV01Tg1YWLJDlmXaxGkwWClAW2KGXeMbIuIkB0zs0haoUfuP/C8
vcoFF+BjFR1yRA5SagdojgcUjLfrwoQugfYKflb2cS/aaqJiY8ArQRrnMhy8mxdUAdYC/sotwIrI
sl90qOKxCydG5RF44oA1As33MQ9rS0flQcXLTgRk0FUAcwziNhb8CSyEM+Rg56hraTdvZSZJuqho
HFiHgpUefCKbT+AxJA9evXHttb7qn9W2b982Lg8CRBMDlAg6j5VC2RlUeBCgKkwtTfGAAGYtRU9K
2HkLNUM4ArIDjAusFTJXL+0MgS5heZgzS4mSgRUj0+ggIeYBLoBJcn4CALdjESwXLommZsZEwy4b
dgS7qhWN10vbg7IdHKYGN8LwPppZsElYyxRHJy1f79hqtYNGiROGHSKo5FdEwEw+UvJzUyCEAA/Z
AjVJbN+2fVV7lV9070b6bcaPiQS8Ga5kMiRi/NY41sM64Et9vCvoZOfIqq6awyeONfQ3xx6Jl3U7
7xf4OUEMyg7DyZo1b1BdR0hG97JgcxjgdUXRy0sAB1VahqVUucJHhTcyE/kFK+BvEN1sYPJK0vUd
3+7MKMreGxMZeSBG0WXJJ7g00eHnpuETfFzzcJPVZZ3SZHDm5a0VsKANfXV3n921gzANK9z+2mXC
VTOfW3yEottPX7gw5Zh9E/zpzdJPIS2wElra8CzhL7PabspHuuHontVfOPew5pX/WgLY9xYA1lIg
+Dq4/NPSfwHAOnfpgqAxsgnxERD7KLAOSWXtoCQqJ4ArDkiCl8JdHS/lAp+jg/mIjYPtP8ZEgh6y
PkIOKXZNludJSGhHJ4eOnz81FXAJfrApidKsYI9gQeAZJjSH6OXyHhUk5qRwHvbes1LebZP8tN3g
QEl4FTAupILoNMwkmbBOWSO++Uab98OlIhFa4PUvHFz9/GGRDbnENvmc15+fqbD2BOWnPGGrrzdj
qlt69Xb51avFN0uBFQBY//fV6pvQamp6VnJWKocpNEt4SEAgz5qrIw/FcnOSEpyUNcYyMVT4pJBz
k+SshfezEOx4L4Mx1EPJmggSxoch4eZPCDwb41y0Y/3PQ4qgnEHRtajYQyKkf4QHcBIvhyRFlxRV
cBrKZNCpQI7tJuB/ZZXhzMIhM080Djbsj4t1qHTjQEvjwEtuYdwRcPAeMDcZnA/jBUeEBXury7Jj
586FaXdQD/yN1xdMSUtNzLgpmYUTxQCXYeNUBvSJWyCYGfLs9fNxx+OLyu8oXqGypfLHqH1TqlTR
WH3w+KHTV88wc4Iwb+ll+8HUY47EPWt5cf9J6d///d+VVNyjp4gnNY9PXTqbkpfe0NPk9Mj0BH3k
7InDp44+flEu+Yhesiv2yMHDpxKeNVVMaUJiVmJpxUPQ5rBCYzL94SfgROZFZ21MXNysNzjtW1aN
lQWvvqBvxoG5ySHB9bNrfmm6CyCPeT00seBv6xqMjI3l3BCieFYTFVUa5IbuVZbeKbsXdzzhZW/L
5aTr8SeP9NG99CRR1fx8wi93jnYcPHbo4NFD/bY+2mUrenzv0MkjbcOt/UQP/EvC6RPd4x3sHJ3/
uHgyNMHN0d1UX0VTJUSC45dOHzh6KKUwEwBoN9l35sqFA0fiiiruQS7r8tkvJV6JTohJzU+dNJwP
qh8NC4MTulheX0Hah569rEjOTxPmLAN0D1xMTHx0ZctzcUGo7W5Iu5MVdyph2DFqX3RwfgjkzIuO
FyhPX3Dau6Qarxa82ry22VHKzQta62uHH7exbzyCet2+od9YmftZzgcP8h7QVA7kPBmwN/c3P3pR
furquYu3rlW31MWdSDh3/RI1P+7SheS8lANHDt7OTpp9NZv3oPBP//mX+u6a6WVHakHagYSDF25c
knwiFmx3bL+cdBNEWtlUNanL3Ax5LfVG3PHDyXlZdi9b012zHxDDHNnYUSd4ic7xzkOnE+JOxndY
O5yIngWHgSADg6guxsTFvmzrnfMGZz1aem5RXUcjAFybn4PMgfaQdZ1NEbt3X7h58fDJw73j/ZJP
Km+ocPj4PmYg7kR83MnDZQ3lTo12qlxWcc6Bo3GJeWnTwalRYaSwrCT3YWFMwsE2aytgvvlX01eS
r8YciU0pSHOF7P18T+nzJ6evnOwe7XraWB11aH/mnaw7T0uFBVKc464mXj50LD4xNxXU4OKNS//7
d/97iO8fooa6x7rng5OJ2UkxRw6cv3GeXyAhspKaxGgsM01u2/mN4pybdOsLWiA6Ou5553MFEADk
DOFwEgCvxAPsoHwATMXr6TcPJMSCtKeWnLXttXuj9rt07llzZezRgwmnj3bZOu1+Xpijz107G3M4
trKxqq2/+Y9/+VNx6R3XgvjsZfWRs8fyHxWC5ovTjDTNnL5yNio++mFNKaBhi3Po6Nmjh44dSi9K
m/SLKTkptzNui24CLyPwwfzDrgAubEQaPH/h/NvAT95p/7ff7iYdI5B9wuvUBHX/2aOH1WWHTx97
Uv8s805ezOGDT+urpvzi04YqZY5WvPbTV87FJMQ8aaiUAFU3Prt0+3Leg3zFK565eg6Wu6yuzOET
iivuWpRxh4+lJ22FZUWAaTJLcvfFRV26dW0K3OgMdSXp5sETRy7cviB7yKngRGnN46j4A2evnedm
6ObhluqOalCw9rHWl32NgOG27tgqzpLExNi1pGs/HtibeydPUUVywlJRVwGur7a3FnA54yK/3fXt
oi+QnZ93I/2GiBkzIYIf9thcGi3ptBNixix5/vr5qEPRVxOvzBhKTWf1oSMJOXfzfvObf2oZbp0I
utLyM+NOHLpy+5owxzCTtqfNz64kX3tQ9XDCr1y4eSnu2KHyF5XTukhOWkD4Z6+di4yNzirOndB4
CsDcAt050vXlti3sPK+o8vTS9IUbl5ssbYqhPHrxOO74IXiAP7H7ABmLE2775eTrY4qlaaAlKTv9
Zmriy76XEAXXLNNH60UDWvU7zly6PDOx8Hbxr28wxC6vLi1/7qz+Zn3WS58hvvosGdLn6cLDu2OA
q5beIsYyK1ivQ29bWzouXr0EyQlkGi5DmAoqZfXlj2oeHzt/Iv9+4ZOGiv2HotMK0qc0uzzP38q4
BULOLsmR54Uzly/9y7/+a8dIh92Q04qyYxIO3UpNEhdocsoSlxB//MLpw6ePPm+uBujGT9rOXzt3
6MTBp3Xldjd97+nd5Kxk2U2W11bY55ghdjAm4UDssbjW0VYZMFlA5FUOO3lA26fJHRER2rTnNc50
Wnm78nbjc7JLnx/ftCGf6ucphVd/bd1xA+rU1c+c8F1Beou3r5bevFla/u+VVwDE0zKzb6clTgRZ
1mcVDMqhSy19rV98/dWN1Ntg492WdsAhT+qeTGt2ymU7d+Ni3LHDZbVPaTclG1JSfmpkfExyQboz
6AQ4+6Sl8mH1o+jDB7JKcqY0BzwyirOiD8emFmQAohqzj5a+eHzyypk75XchYY6OP5Cck3qv8oHd
LSyszCZmJUGkSCvM9CzNXE25/r9++7uu4ZYBYrRtsHXSzz2urQTYc/rKhRFpwKVivwSjEjanZduO
HXMTc69fvfkbv7aYmoVt0ZyGNU8lwNo1mlVxA9iu8acuncq7lzfhVsAHNfTUvxx8efjE0Z7hlj1R
kYzTWlpdGhV/cEoXLiVee9LwFKLI4bNHHz599Ps//qFtuL2xp/H3f/7jEDdyt/JB/Kkjdjc4svMP
qkrHpXH4dcTRd/LyqfahznFmZPuu7S43nVWcWfCgSNQoeAgqKarUh+caxap0XUdt9IHYea/u1ldU
Y9mjBmf8oV8iXgqtm1UX3IicPbjZ1tic15j2G/NaqK1zcE9UlOTH/gYZclZdauhv+h9//7cdg52F
D+7842/+CZxUzr38UxfPNnU3RcbF2OfFnT/sftFRW9tVd+7Ghfqu+u/377FIlpaBltij4LAGa7sa
9h+MAuX4LnJP82ALpIYHjx1+XFue/zD/RXu9PC1/sfWrLltPwulj15NuTcy7ADnxAb647B4subzA
nrp8unWwJTohtqr9uUvnIw9Edw43V7dVJ+emTC4JR84eaehq6hlq/ctXX0wsyPtjoxNzUzptXWMT
Y/aQIuo8yLP+Y3l6tdB7eYY253fdfGLgZpwLm5PWrv0rylkNoJy7BvdGR8uqGJbzhCHD/Z64dJqZ
ZhJOHjtwOE5ZEKMOxhQ/Lip99vDEuVOzfhdgkbTC9Oaext3ff2uZGHnRU3Py0mmfPhd/LCHvYaHd
o/zud79LLcwknLbde7/rJ3ofVpWCgQlz3NFzJx5Vl9b31ccfO9LH9p04e5JzE/sORL7orq/rro8/
kzAZskN6KmGDIMeprKhz+2OiW7uHfcaKTzPScvKqm6plg2UMSdJ5zmAaepu/3PJ1L9HV2FN/8Fj8
2MT49m928BNEwpnjAGcH2P5j50/KC8Td8uKT50+75h0nL5zJuZvfOdb9v/75t60j7eWNlUfOHHX5
xIKHBTl3cqc89tOXz+Q9zG8dbflyy5YuS8uDykf7DxywuUaKyu789p9/Z9e49PyswpL8ef/M+ZtX
nrc+AwvaujOCnbHdykhKK8hs6ms+dekMPU1l3c2uaH4C72cNiQfYNEl8tWXL1IxvTlvyhpajY+Ke
tlaa7X2MEGAon43VSMFgBAM3JQHMpedmuNXpk5fOpN/JfNnffDDh0Lg0CBCBUmwdQx0JZ45O6MqJ
CyczizKtyljC2eNNfQ17Y/bXttVKs/TWb3b0Et397CCkZINk/5kr59Ly00eEkUOnDtumxjPvZbYN
tghOasfuHZzLBgArJTcFEndeZzgdk1csHP783GCtk2PnL16AUD0z6dkRscPmGGb8WOXlZpjf/fPv
Ch/d6bb1/tNv/vHR8ycD7NC+mCirMLR9VwQ/YTt//XJiTtqIMASX12lr/8Of//S8qXqIHDx18Uzh
o2LQjR+j9vRYuy7eugyJkDBty7mfB8/bhptPXzkPHjkq7mBp1cPCB/nf79/v8M08a64YF/vaRrvg
NkkXlVaUVVx2JyUv7XZW0qRuL35SnJqfDmk0ACx21ppanFpUWqy4xS+//LLN0tY03BwTf8DCj3Yz
XZzBjsljO3ZEvFlczS0ouJl2067DLdPh/TXFwOqpIyg+eH4/qyRrVnPEnzjc1N/YPNx8+NiRu+Ul
f/nyizFxsLG/AdyOOEsX37+TfTfX7pH+/U+/L6+r6BvvOXHhdG5JvuBiv9uzp6Wv8XZ2YkZxjmNe
iI4/mJSTLnsJVichebidkXjp1hXI4C2zo7zOCl7ck7VMjgHEt3vsefcK98dFO/zikDiYnJ0Grt4R
nMwoyTt27kxswuGsu/nWedzO/mS9wg/aR9j94oWrl6cnpt8svV4OLv+0/GpJD37urN8vzQzedHTJ
ZqBtM86CtU3WS8vLwdWgvmQ2ua+sBn9qb+u6dO0K5bEiUvTRE0FlT8y+c9cukBIBidypy2cAiG+J
2No92nm//H5OSf6U23nm0jmIiSVlD//zq69oF1E/UB974vBCyJtw7AhAeWaB3haxo6q9ZkgYjjp0
wDZlPXfpfO693EG+68eovSNc/6Oa0qSsVIeH2f5NxCAxsD82qrq1pq6r/vjFE6KfFfw0dmWpaKHk
pBUA1uKC9tYcr74UnsSw4WCZpc1bqT5qZVvfuLauWLh+a29pE4awxc/yvS1+eoTw3QSFxbdLwder
S0v/tbIKqpKelXsrLVHSaAHbW22AXRq7Gv7u7/5HbXtdbdeLfTGRo8zwt3u/5yeYM5fPl5TfH5cs
P0bv6yC68h8VY6XQ7zp79XxiTsqE7oAEKfdBvsVhhRUUZ7iCB4VHTh+fU6dOXzyXUZQ9zA7/23/8
2zA3Ul7/dF9s5Jh9vK6n4avtX9vnpbz7hTfTb7s8znPXLpShnEQAAIAASURBVGYWZt8rf/DnL75w
zhK30lKTs1KGmJ4fYyIt9vGsktzMkkzJwzgXRfCcVpdl565d7umF169++ptZ70pKZt7NjBTWcFKG
IhhYnBeDGIAVTf5h/55jp09euXHtx8h9hWV3Xw61HEo4XPKw8Out264mXT9+7tR3e/f127rPXLks
eG28QdlDAu2wfrXta26aaehuiDp4AFLbdkvb4VMJvIf545d/Iqasspd1GTKpkZ1Uf/79kovXrv77
H34/Y0zczk4pKnuAu2P4wC18GUPsuwfn4xq7GvdHRmlIZr3k8RkAsOaM1U+plX7VTJLNWq82AAc4
K1APLeihlvaevVGRDo1n/FZBJVgfCcgGENK03/68sSryYJTTK1Z3vog7ktDa2xabcKhtpOPHmL0K
7h7SksFVtdWcvnJGmCWr22u+3/+jSxUVD/tD5J6XfQ2QYZ+6cgYMbPee72cXp7hJa9bd3LTcjP/5
m39sGWmraXmxdcf2+KMJHZZu1mABhPWSvdIC6VQFUJ3vI/dUd9YoOgtxF+TTONSSmJdBL9i6iJ6i
Rw/OXbn4+z/+3jXLR8ZG1rRXOzRB0c0WWo3kvCzKMypaRWrvJbdP96ghlOfGtcDPT9QObSrVj/i0
3nG6bjDw+J2cgyjntu69kftBzrTfwvttik6nF6Q9bXkq+dgbabduZt7mZ4hU5DHIOnnubGx8/NVb
12MOxR4/e4J12E5fPMNpBOenIL/Mzs/5yxf/mVGcLXvELTu2WZwDdpW9mXErNTf9+IVTvUQPP088
bX1y+faVl4MtsfGHO4neU+fP1vUhDnaoLtHPixpuUIoBVgoA8mBxh16j9sfENLX3edWAV/XmFBZW
Nz2TNeytYTSC0SzPWqtPXz5v95ETBn/y8pkWS/PuH37sG++7eOs65EMTfjEtP6uuszb+xJHY+LjL
168cOXkUMFZzbxMYtuIROiwdsUcOTWkTB48eBkW6fPNaTPzB1PzMlwMte6NjFJW6nZWampNLz49b
neNfb99hnRk/cf7M8TMnzl+5FH3oYMGjgh5Lzw+R+xRduJWVklWcm30/v7LlueTjJLgXlQbzJDzY
1kZPjG+LiHA6ZxZA7H4tJvbQs/YqCLQiZFlmM76A+6GMaPb2xiYcjIqOvnb9OgR1gCPNfS0Hj8S3
jXVFfLvr3NVLF65f3Xsgupcc2L57pzCJocgRcDgDAiT6I9IIMT0Wf/qoIyA4NOnQqYSG7sYduyPY
CcruBVUU4SuIaSb/QXFSRup//PEPhINKzk2/lnab9uN+37tH0Hy8/3VEGTh38fyS8XZ2Tt++c4fV
OWRuvbEW5+iObyLYafBuY9t2bmedJDNriztyqM/WtfO73YN075ad28kJWvEykirbJke/2raFddHc
JPP1jq02edzu5m6m30rKTRmXx7fuiphZdEBK2Uf3ywvUk/qqlIL0P3/5Zd69XKs4svvHPRHff3uv
6q5L525mpVxPvw0K5tIcdp98I+P21ZRr4N9yH+alFuTQHv6rbVstMwQxRxY/unc19fa//cu/toy1
1fcD0Eme9CsgZ8Jvtc2S23ZELGsruXnFtzOS7X6JVgWA7CQeXhEYHW7fbp2g7pQ/SMpJ+3Lb1vbx
7oaB5tiE+ObB5r0x0YpXTMlPB/M/f+PiibNnjp4/IbqFP331F2GGhbv74usvAXtdvHnl2z178u7n
Xbh5cVQadbiF/NLi5LwMPMAUICd0MS0nFXJsJ/b7Y8sm57XZAxTcYFN/U1ZRbnTcwUPHjgySQ+Cv
usabyNmhsZkB8DmQcj96XuoMSYxu7uZj++ynqyYFbLKbPHvp7KTLsbq0+GoRANbrt6HXm/c+r352
EvNmVA6rnx9V/otzHt+GlsIVrDcrr96Elt8u/3dnZ++FK5cozYZphkY7gvJ3kT++aK+bVSf3RO+v
7X4B5vztvu/bhtsgB44/fuTCjStRcbF3ygvbBlr3HoicwsMQxMMXZZl387/euiW1IJv0sMfPneR9
6FLAwxeUlwDqJR0UhMhbGalJuWn3nz/OKCyQPCIs1oOqx/tio0C1RA+nYLsO9gDh4RWDBLRhmbRg
l8+MDy510Qh+GEW14SnCTyDR4iZ0ZRsOVt9sUtBn5iT+ItHuhkc7QyvLoTcAsF4vLf11BY+apmfl
3E5PEgzJ4iFsKkH56fru+j1R+yZVhfeS+2JjHlWX7/zh235ycOvObQBnwYRvpN1My0s/deFMTFzs
lWtXDh9NOH7m5Lw6AUnmqH3UocpHzh0XZvm4Y4ej42LPX7146GgCYKy23tY90fsmffbHdWW3c5J4
HyTSPEA0MJ+Yw3GA5C7duhp96MC5a5eaesDi9s+qZHJOZuadnPTi9BsZScK8xe7HbWIRTzNgl60F
8uqICABYK6GVv8FWknQAWEnYTAdqhOfRsLprD3G8m4n4YXefrZ9zWQGsCQv0867aIydO5N0pOH35
rOwTx+0jw8KghR86c/kMuFTFz7aNtXSNt23ftcM5zzV1NeyN3idpXC/VFXv0kDJDg1ODbN7llVvH
WstrK3f98B3kRs+baiAPm3DLqfkZxY9KRAxm3CcPIcAyGlXXXhMdE+tTlyDt9hghnzlXZOMG6g3m
On9mvt4mw+Pe1b0C5ncttXX07Y2OwkqGTsoGuFQRkv690fsdXrm6o3Z/TKTgpavaniWcONbW2wZx
ETJ7yIlndKc4SzX01t+vKj1z5SIoR3XrMzQ/nzTj5UE+1d3V7AQRHXcgsyA7OT91askJiUtaZlr3
aPvuH79/0Vo3bzidbr689unv/uWf+6xdR84e7xhrmVDZIaary9IVGRdd31OnuMk90VFtg+2QpKYX
ZpCyDYJf4cM79V31X23dokzzUXExtd313DwgYInxE2CoH+SpLc2qix4DOTnnfIvrKNpDn2wLujce
0fNpjfAT6lH3pvP73pcM1Q9yxl43lDMl6QBcqJTstIqWKgAxyRlp11JvcX46JTM5ozA//uTRuxV3
nW6Ksg9bpOFRduTkxfOKh7+Zlhx7JK554OWF69fS8jLts/TWHTvG5ZGZgOtq0rXsO7kXrl/qGety
ePjK5meXb19tHWyGTGCQ7jpx7szL/oY9UfsnvQCL+YqWyvGJcWzGgsCjYccxrREAsFrbu+f9gTl1
KTO3uKa5itNtPDa6ibzH9rz9xbFzp2Z1x2xg8vjF051E5w/79nWOdkEuJS1QE4aUmJkEcREASvGT
u8o8BX5hXByp7WwEjDKhS53WtsMnj874nXHH4ht7X4JijIij1CQBwD0yOlpQ2VtZeNKbnLeRDuuO
nRHjk2MnL2Ihk50krYASFoQXHbU/Ru91esSUnLSMgqzC0qJnTc+cfomasjYNv3QERchVAC+OT9m2
7dghueb8SHIbjIo6+Lyjyq5hwwfcpmC2V+MxtACvBLio+JiHVWWOBdkqj47LQ3VtkEUcbuxvOn/j
EjdN05MUgBLCYftqxxbCaXP4xJcDrQNMz5mr5wkXQThGQCBOnygvCCfOna7pqN3147e0bHP6hda+
pvbx1hPnTqXlpHUNd0YejLYKY4nZKYnZyU6vJJh+QFjnDUYcQxcvXHq1uOKZWdixI8LiGuXh9aBo
nbRu2baNniTHZywQz7gJhvSQBw4d7LP0fLfnhyFuKOLbb2gHKSyw3WPddb2A877hpihplvvPLV/a
5FGnR7iBfB8pio8+dCSuqq7qSupVxS8mZ6QArGwd74BYm5iRPGm4FK/UbekGqPGgqjTjTvaN9Fvi
HCN74a6br6Zcv5Z6w+4VCx4Xp+Sly3PslojtjIOITYi7fOtG91D77u+/q+tvbhvtvJlx2xm0Q2Tl
DXbUNRqxc+crYyUnrxgihD3A8gGJxb5DbCURDZ6bJyG1APzUPtB28eblpv6XTUPNh44eaeps3Hcg
ZkZzJmYn5T0sZmeJMafN5hinJqx/2fIVPWUR5ojf//lPndZOdso2xPbTLhv4bZtilee4wrJiLHWr
shxkJT9V31f/Y9TeKX0KVnlKc5ZU3AfTqGl/8d2+H+pbaktKS+KPHa5qeR53/NDJi6eOXzjZTXa7
QnbBD3CcCh9ZED+sF2serH63cBwermTPXDw355p/tfj6zfLyfy+btAIbFDw+GSO4uvHUnc/wmP/6
nut1b/4Je7D+azm0+nrZpOlf/Kmjs+fspfOAZhwhJ+3Fg5x7YiLrOuomvFzkgZgX7c8nfdyPUfta
+tuOnjvZ2N0sz5GjHAiZaOxthIA9q7muJd+AWP6yowFieXJeJjNPHj97alLlHQt0ZkFuadXD7/bu
sSpWuxfAfXJmSc7j2vK0gmx5mt31w/dl1U8gqE/67U5VedbyzDI5ZmY7nKTjoXUI4WC/nmnvX5d/
WgktvVlc/QRTvl4/Ne+9VF9v8IYNZpD/wlDnzUdpbUxxvuF71r5teeXt4pufluB2lnEOVWg1Myvn
VnqS3eBZPNPNCj6uvvfl9/v2TKkOyc3FHDpY/qISkuExdnTbN9sph21Kla+n3Uwvyjl86lhx+X1m
ymZ1jgxyfeAVT126MKgM2nXp+LkT4gQL9ljy5B6Yp8VhGRdHG7obvtu/ZyogP216cj09EZbDqbKn
L50VJ9mYw7F3K+6JswyEj3H7aG1P3Z7oyAm3mJiVCnEkqyT3asotu4flZrhHdeUOXZZwG9BGTVq/
+noL7g4ETSb3MMDC82sabX8PsLAJw5DOXr94I/22OEvfzLzZMtpc19dw8MihEXp46zfbe8meypbK
09fOTOjYFXTveemIfTwyPgakEPHdrkFqqHWgfe+BKN7PNI00Jpw9Nq3LV5NvFpYVWZy2yPjoa2m3
Ir77RpgT24ba/vXf/23CpyTnphY/KVmPrsIPRiMBEEStAQQ+HIeyuK71Z5NJ0usnwW1K5fDR53wI
/O1m87UZ+AFgQbCsaHkKeBYMoLanYU/MftZD1fbUwuJBir/vQORcaHr33u9KXzxuGWn5PvKHgsdF
529dnjAU2ccdOpHQS/RUtVTCv7M+ygWakXLzy+1fD8tDrJvesnPbODnSR3b/z9/8Y00H1odrOqqF
eQmkOi4OPa6rvJWdTE4SZ66fTyvOOXbx7M2s5DFl7De/+23neGdN+/Pc+7l9RN+fv/qCnxMf1z75
jz/+nptio+MPVLVWw1fTbhJW2TzxTta3vwB5+rUwYF30qmsAlvZLhauNxwWum2y4XuabTDRCIKu/
kzMCLGzAQiDLGXRqbvqz9irKz6RkpSflpHI6ezsjMSU/q7Kpev/BSHbGllGclvswj59hD58+DvcY
FX8w604OO0d9u+eH5Jy0GUP5h3/4h8ySrHFlbMd3EaP8cEXD08ScZG6Wjj4cA8+bBhoB8fRQXfBz
IqjsjYmE6NI23r79+4gRZUTEo/vYvcjhSRN6f0x0W8c7gJWRU4QAS7Nx2JnOSgYLsOOLbV+PCsOP
a8uiE2KJaduX27YI8zwEtsrWZ91EF+6mGfLDZ6UxCQfpaVtibkpxxZ3WkY5de38AjeqhO2MSYif8
8r2qh9fTb7FzLGDu4qcljUMAAWMIDznADv2wf0+f0F/4+M7/+//8g6gLuQ8LLidflbxiWlHGy4GX
DQMvv/lxt1NTEjOTk7KT+6i+QycPWxxjBWWFt/OSsCE3iKdsxqesW02ApeqLALCiow8+b3+m4Al/
HqMjACw8FMZLBqcYHKjupcTrwpxwK/t2cUVxy3Dr/gPRkkfYG7u/09rVQ/RcTLoyGXAcv3gqKT/V
6rLs3v9DZWvlqStne6k+m2vs2PmTDlUEsAJKOCgMnL12ITEnBbzVvoORxU/vgAkQim0ANPbLPwNG
zCjOvph4ZSLgFMJBOsitCdthgDV48eJlBFiz7h0RJsAy4HVxfHJ8+84d7DwzOjm2/ZsIdhLpOeKO
xveSfdt3RQBIvXjr8s3M2xan5ceYvcUVJTt/2G1zjk8azuMXTuXczxngBrbuioALllT6SfXj3/7L
b/PLCuyGBNlOdnEeNUft+uHbzOLs27nJacUZE4YLXHlxxd1heQTwokUYK35cEn8yoeBh0YGEg/wk
c/jkkaTcVKdf3L57J+jbF9u+6h7vH6b6//E3/9Qw3NzQ15SUlwzoxK4JvMGMuEYAKS76Q3n5xbcy
bos+gtVB7UUpgOkupzKyyoHa1HbW2ueFnT/sejnY1Dj4MvbIofahlm++/9blV5oGmxPOHBt3jj2s
LbtTWcLN01u+2cHMWMQF8uz1SzezbtPTxLELx1tGWgGgX027ycywUfEHEOSpkhJkRR85tejcfyga
RNEy1J51Nw++hZ2nsu/nQv7mWZy9nHh1X2zkpG53GbJLkwDJ2XVR1njOSzNIioENsh/QcPBnp82+
A1hBDgDWvGsBAdbKynuAtSkA2iD6/so2oM/3IW04Oub97thPi0tvVv5rGcn6kabhTehNR0fPuUsX
GNVqD9jhXng/CYlxbVedU+XBBms6Xzj8HPiK1qGW0urHt7JTwJxv5yRVtVe/HGwGAcK6HDx2KLMo
y704uyd6b3Jeuisk/58//EfjQEPHWFtk3AHZy5+7fjk5P31UGd7yzXaLw1pSeR9wmDDD7Pxu97gw
snvv908aK14ONH21c8uwfQj5XMwDKACwrBOWbRERninPX1fevgrhZMxfGHa0yXChzVrOf7k0tX42
8+e471c3Hme59p3vANbbdzXOIAKs2xnJgo8yq3cM7+Ma+5v/9u//tq4HhPL0x+h9NjuxbVcEuH3Q
z5z7eRbH+NZd20e4gbvPHkYdjrVOUol5yZn3siC8Hjt3AtIYzsuevHyasFsev3hy4EgsO8veyLx9
p6LkZX/T3thopyaMygP7DsYM8oMvOmv+zx/+fdKnPKp5HHc8XpjnkvJSwIW2jrV8t/eHeUjUk2+l
FaaTk9Suvd8PsL13nt6POhKraBKk4uNzw8y0DVzTwrRnJbQGYPFIZkPbDfn9AWkGT1F5+KLykqx7
2Q19dY6A1MV2P6h+CCihdawVXrxf/ZCaJxVdhEBSVHEvp7SgZazdoTmeNlXBf0EweFhTJmnc+MTw
vZqHnNvGLjD3qu9nPcjtsHZOLU1WtlZl3M1+3l5TUnnP6hxvGWttGmlaa6VrnrMIsNo+ACxvAACW
CQi00AYjdTfmGV8/MDi0MRpbV1nx/wywzMAv6YIjIPTyPfefP5T9Yj8/8LDmEUClfrG39MWjMWXk
cV2Z3S9aXeMQHfPLiiDqjCqDFS2VvIdyLkp9/EDG3ayS8jtj8jijUoomDLID4PTtIUgohS6iq+BB
QV1fbVlD5YAwMmIfyn2Ul1Na2GbrtuuCojkfN1RkP8ir6qixByaIaSbjft6z9uriivsW59iwPNA4
WO/U5Wctz9PvZHUSnYVP7gge7mHtoyFpSNR4QccNL84EWD9XsN4BLJCnf3H9Rqr7c6TtGxW3Pmrh
Crk34r9wrwPEbuTlD4KcW9t/rhRSEp5jJV52N/TwvYxON/Y0vuipZXSitvtFXX+j01AAtWTez3rS
VD655FQ08VE9chOwC2LOw7ynbRUvuhpqICyp3L3K0pqOmsx72W2Wds5Nch76aXNlzsPc5+0AOvlu
qvNRbTnrJsrqKgBPjNutd6vu5TzKH5aHXUt2wM2Mh6B9ZDg1XwOwln+uYHHI58TzOjMgwjreuwf/
/iDX4rLCdxWXl4g+3jZpy31UkHEvp4/t5RaIiYBc3fEirSS9rLEcovigNATmA1896hiElTIPn7J3
qx+kFmdgg92Ss5vpBic+Nj/GztJVDc8f1JQ+bXj29bYtxLxNUsU7lXdTitLBs0t+gVtgCsqKOojO
hoHG5+3PJwJKTXdN9sPcu8/ugp3KPjZcwRqbBIC1HStYulnBisYKVhhghc9LggcwiZSwz90ZtONO
x72c8qYnjpDYDU6g5rHs50GYKYVpeY8KRuwjko+n56nS+rLsB7mtY+2uoFzVUV309I51avxpK3yy
YA+J5Y3l464R2SeUNZSn381qG2sDhewmutNLsmq7a8vqy8lJS11ffXXPi3Cat7Yi8nPMDlewVpdW
3GsqWFJQpD3k3fJ7rJsi3FZMOhcYyk+U1T6xTFruPrtPTFsFD/+44QmIAqAzr3L5T4pBIIKH5b3c
wxcPsu7ndBG9sgrok5UXWIDjfUIv46cpp62w7M6Dhkd1HXU1XbXkHHn3OXqwZ61VkBCDfnbbugGI
lNY8kuY5p0++U17yoOrhs+aql8NNdkPMLysW3cwA259ckF7b9eJJw9NOpmtIHKzpqRZVWvRh5Bib
tkbs/GY18CorpwAAloJsFyIfkOQgnjVG1gND6Of6weTL6p/U9zX2sn2jzrHyl5XCAp33qLCy5enM
ykRF87PkwhRQHkj0eQ+TW1rIuQnJS9Fz7L3n99PvZraMtjoMGW4273FRQVkxOK76gQZFFeQgS3ms
pmOR7z1/eDX1Rkpheh/bx/tozk0D+i95erd5qOXRi8fMHCkZAmMerQLFYP146jnMoMEiTwT3MyD+
GGAhZH8PsFbNCtabdwBrafOeqqVNJnyvHVz4uV2t1Q0GFX928PbbcAXLBFhvQu8rWBfPUz6rbNjN
gEiD2gMYcgTYR7VPBsRByc8CJOqluqaWnSVV9zPuZVU0V4L8RVXILc2r6aoGuJ9RkvWo/klV2/Pq
zhpmwVZWX1la9xiUv9Pay3tt3AJbWvsopSil1dIuedlOW0fjQLPDL4DKgWaSU0RRZUl2ad6Yc1RE
zi1GDggIsIw1FayVn1aC4QrWOm6w9ZMWP0PRvllT/K85JbDhDu8vjlP8ZNrM8isAWG+XwwDrfQUr
I0nUkWCSQ2IwekAYLCq78+RlBVjrkDTMuznQZMXHU7PUvecPckvzW0danToLhvn4ZWXavbyKtip7
QJRVpuJlBTFnVQLik5YKYsY2seSED0kvQe9q1+h+vu9uVanoJvh5sqq1DvBZZUtV/PHDlNPq8EuV
Lc/yHuWDvTtCMj1PFD2+U9td0zzcWtX2DBKkNktn9sNs+HbbtA3tC+nfSHLKum37ds+MZym4jAAr
PSMMsOjwFiHYCTJgaQzjA4sSFTzuKDhDEuehwoxegOUlH+1cVJyLDt7PIckCHrPieC/pCIKLtyrg
FDSa8xFKiJc0FhCoEhJovw1ySpNeRZBUnl6gBKT8EpDmy0fjYWkfco2G4ZS4ptQcdrJhgPUpIPAt
urX1xFcbNlet2zTUQhvMGdzg3BwG/p+3riSdDVewkDHV4J0hGU9++hhHEF0hp1L2AC/6aXtQJGct
ckCUkEaB5yFbBVjjRzCO23OIykXnokvw4qlOgL2ukJ33MvAJjEbLuNnK8z5SNhRJk0CM9hAki/BA
xkJRBWEi3yAes9IZ1gNrxAoarQQVxk1JZozEhVi0Q/SCVwQdWTY48IlBkfUjc50UwOY2eiOA9W7L
dcNNwHXTBj8jtE8KV58Uutwb1Q4/bMW2r9kiBDkHWNzIQBIEyq4C8iApzYqn90GjFmzwBga3zAXW
h0yemEwjp5SghEQkl1oAscuCn7QHHAA1BOQGZBgVKcEUEDLotg8yQhGkJ/gF1m8TVVHQ4XMECUvx
yNIpm/xyklnXQQInFXuw2tq7cfafFgZYz7CCZQikF+vYnJdCtgU/i/pgiMguq7OgD+B2lZDDpIcV
OI3C3Z+AxMNfg5KgwrqL8IRcsLwr1iKrKm3u0ImQn+AeJR5gFEjV2kV379rzbV1XfVJ2yqXbV+Gd
jJuGteYAOQUkAaklAD/BZ4KVYfsUEiFqeAwKHhDvJZUzGxzZtRUsEHsYYIEJK8hRyQnvARY8kBxY
4xVdVoJ2ymtjfFZepQRYF2zq4uBL4cF6Gc7LgDkjaQgYNf7J/KmL9pBkEl6AaWDbIgvKbAjgUjiV
V0IKh0QM+DmiysMKwn+Z68iw5oHndd0CGL8RYF28DADLM/seYCHBI3wgOWnYBSREJZywgj5knnMh
Wyx8OygDfjLvZ3gVmRuRFUVHFg983WtCZ2wtFzg/a10Ylf2s5OcFpAYlHbqEkCXA2f0COYv0p6AP
Cq4aj9Sp4J2wsw0kj58AVw4SA91jPKRJTYkMCwKyPNjB4wGsB22kvYQL3488pYybpFR6bMq6Zcu2
18HVjMxcBFhIuMXiFqGBRBgcHjUAbQSHwNnhRpDBEi4b6UNhIUA/BT8t+RkZhGwKE/lUNdRq+BN4
bEkTHIsy8lboHGgCrBRIg/XgmXY8za6DnyeQKAs+RAPwRCtmaUrw4zaxGIA1kiCKOIOKyUqADopH
kmSkKkQUjkQbpAnZ+fACrQHE79aOB40KrKlghbcIl15vzC+6tNHe08cFldfrZzlvSjewOZHpOqbN
NRUs3CIMV7DOXjrPQbDTJcZHAMDi/YC/wZ3asCkqIMHyORZBvWnQah55dkAmSEZqYmIewrlJpQt+
XgG7sxsQCiGXdigBRQrAiki8jq0aWDNG/8NgqQb00wNLwCsmvQ6kAbhBjAylLOchQc0woICiAsBy
mQBryvPX5Z+wgrW4unE31a+Yff76V+6ubrZduLThlOjVj9Hw6ie4ah2jKYo9DLBW4HawgvXqXQUr
QDNIBMiRAID8HEAOycdC4oo0kG4bct+AXfswFQFjsSM1D0svEDLEU11GNiU8JEfh28AEIOp5kT6U
RdUV7AEJEj/KPYxU3progNTaObzj+12VLS8KHhdfTLzk0iWHIcHawaLIhkBDxmLgKU6IPnaNBz8m
qzTEX9lgsbMCYYBJ5WNQFsfYzm92qQvqq6VV7MFCgJWOAMusYEmYw4EhYUbCINWphsAZKZhVRkDW
LxJZwpGTHXswaS/FqhwDLsCPJ4rh9jjURcAQNrMkBuBAlEyuc6vbyhrg9ShORSwF1supSIOLXwHC
wjtnOcyENkiDzC1C6uctQgQEWMF614Pl3ux42ic1krXx/tMpxR/VwNxrsAVWsMytq9b3Faxw4Kfx
oCULVy4jmTUyRyP9qwYgleT8Ns5sEwYxIvRGTAYLgMAI+3hAeuh3eJAb62MIr1U092JEZFVmkAHf
Y5WQ4BEyS/g0AUIaMqcFZXizPcSFqWnhr7QXfiJTLQ8uEqUkUB7UHoBxkOLQHpvJey4wJgkh7gn6
EMnhXzWEeiDP8BahT10MAyyfWcFyryn1uT+VauhzU5/V9ZRjG50h+PRt717xaGsqhdEfKoUAmMw8
G7kDTF3iACFBJoBsvH6S8oIwBRAvbxK+0ZBuQrTA7mlQMJr2c7SXBM8I74GwQSG1N/47gEsMjbB8
SCQmIF85+i+GBogQYkm3zYy4PDKOGrzJigR2aDWPR1H7D8S0tnfNq0Hswcp5D7ACuNcDy42moSJB
OWsSaEF84pFZlANVpyG1DSokrgL274tYSgSwxeAtGCwSxpos6hDU0RH4zU1JWDW3DYuOAJU0mtJI
uKo+svdKyrWHVaXcHGtyUUJSKyD53oINQjvcL24C6mZLvodAVO1DuAaWC8DCtaT8XMHaFrFDNnuw
PO8rWB96sNABhbcIeWQPV1lIElgVrZhVIU2isGhk8IyHwE/G7jSE7LxKhymPGVDggAB+w+RBhgSD
VOAykBCVCuM2BB9I9S7SkFYh9RQWP8zgjRCZ9tmE93XrNXUsLpxrDdsHwwDLPbMQgVuEI3CnIiYP
NueiBLcGklQMDgI/p5EQveDzeXPH0xQIiEgCKCwHkcpfMtEkEiLgUXAC8ArtpZG4HBQAfFSY23aB
QNZyHVAm6gnlJ0QQLx4sBeNFGlIA6wisDcakbUM3Bb9S+CdYcfRmeCV+hvESCPpRSykHdn8zrJ+A
LILW6VE8EfbNsraUlVNwOzPRgXSyEo+sdZQM5q/imW6IJRKuMuokMq75aVYz7VolTJRDQBaB5Q0N
EZ7pYEENJHP1IQHjcXiAToN3Rdp6DSmjEVYifTG8nwbcbG4UgLOC5Jl+hxRN9UMO1ZkxfMVMMHgz
upuEjYyJ/ADMYcKGxPHBjQCxWcEKbxF+1IO19HrTjunP9Kqv3wjbrLKyET3B602LK6vhHiwEWKFX
CLDWVLAgqEH0RVI0JIjmOWx4BxNgGCTr51i0VqxHoGloSDJHYvgzbx/yXoMxcxXINNCgZPDVOubb
pAc+SpQD5vQCUANwCHhWkVPMo6PmJj6qK2/+BF3FQwO6WV3WPmwRbg9vESLAWn4HsDaV26evb0pz
/x6/vt60srhurOGn4+HXLdmm7K8f/wkA1tL7Hqzl1fAW4a2MJJOgmzGps3E4BOANAblLULuQgVnH
LkA8jqNjFgp5GrwCaiyZ9Q7BwFhseleMj+iNYVHgQ0wPBgZCL4BrIkyudsgMSchC2y3dN7PTUgvT
IZtCsAtGpGFqATbF+s3+Coin4JAx7nMmVR4e7GO8VsgVMdVUGcJHEJO2rdu2L0zOrQQXP9oi5N8B
rDATFYR2+G7UHhFtWyDmbSa3OwNRAV2JSoe7H0QcDcEiFaQuCgj2wVfKPHpPyMMgn+PR5lGNRLO9
AwQBqiMgxTPu3/Pg7+C2AVsI73cEhDU9kmub3Os3bsreuHDi/oXBOBtCgQ0wwYctQrPJ/ecKFi6V
zkO0xqivsZTXiosUwCITQB+EOOjH+XBDG9iG4EWaRwjSIDEGb5kj5jEpodHrYWgBR8zjG9BZm9UL
kDM4UPiTea5H5Rkvg6M/MFmUpJBdCtoZZA1lRKx/2E2r5kUzm6Q8Fjlg9ikH3oWTsJuGJwjD8WgP
HwZYaypYIe/aLddPxLJGJu6NeRyCG80l3GBCjlsLbfjmjw4TrOl1gyCBSMhAWiZAORzSsYoYIUwc
KZgoH1wbKo/BIibDqR0YGwDpggc0oQBOfUEor7GMiW4RIkDe6QX5yxxWIJBG2RnCbJtFhncsdAm4
tYH4GIOHeZAwjDxMgPVui/DnHiweZ6QAjmHNFWfM+UWwUgCyOcI7DhiOQNAsInMv1oBFq9eCmW5A
Nqs1tOm+bbTJIB+OasL78gBGKfwXjO68aReAFGUPJy2wkp8Fbw7LihhRN6PdewsyMZzZHIPXz5tb
OeijOayZYQXL3CIMV7BCHiMYFRUb3iJcA7AQ9ENsVpDLFKwPZMuGZwBgrEXhvHsb6DnWbkGeEOOD
vLlVCiBSQsCkY6c50rTiIQAWa5Ah2aTjw4SPQpSPg0fC+s8i0kKrJxYsYcNZG6p/9gkjjsELFy69
WlrT5B72QqghghmfMLaFObQweQsgPALwIZivOBYVwm3B8SP4OtY7eRxMBDHPhuWEIDbXI+MoRFC/
aY9m2Qa/XX+X/+CvXsakM6XhjpyLigLL6qbsWG7EMqHDrGqbCBUP5QmmYQJuw8VFtmha8CGZMIgF
3AKlESPO0W3btr8yVvIK7txIuykbDAAsnInkt5lbpbj7DOk76CHgKiylmMIxgzfk4oR519gyizNb
cFFQwSj3ODhhTgufCkQeebgFjAR+GkES8nGYVMkBRglTqpo01kjQYJ5vcIQEQGOcydcThgsCOi6z
JocDOZC8I6yoEkJYnAP2YbGC73+akAsB1s8VrKXXr02AtbK4+otd5xvtZK1+eibu06Nzq+ta4zfi
EF+PP5ZMgLX8AWC9QYDVe/bSeQiotBpmnQV1RT9jDwKYJpCE3WwvY82UCR2+HyERFkhwbA74cFQ8
6X09D8wEpMqoHFI9wypg6QVHtQC0gijAmUBZNG0ETCaMA8B1U4CP8US/masEMHEKbxG+A1jT73uw
Flc3oLf4BOV8Slex+guDBdeOdNx4n3F13eTB1Q3a4JY2+dKPW/Jfr90ifN/kftsEWJh0uSnIdWkT
KiA/u4E1AtJnNXfbzNUJ8OasKjAWAdIk3CgA8aoAW2mQKulFhUcLMgcQmQelcUsHI6ZhY3AnDRMt
wU/LqiD4FLtuzjEDV4k7GKwZOnGtw5HdTJtJE9XgXgRrmjNoO2daAaPTNhduESIN7NK6U4T291uE
clA2S0o2jBzgXnGPQ6JxphUkqQJvMpaSXiu6b7gIL01CnIB/QeQo44kq3ArhORX9naDxiko7dLtr
UeJ9KA7TyN+FLk4ND/UzXZ5GiRt1SoYrWO8qLu+3tD45RbhhB9XGLUTrCyqbzXs2K1g/9waZW4Tv
Aj8LCbpuhl4A1GbhTTFfBLgpmDeF5Ss/idMJMcLxzqBLAUDmAXwgS+FDNyAlPwUe/F081llz+JEQ
Nk7InERVsAftsoH9lbIhOxYdAk4YZMxwIishu1mcwM0Ic+8JZ7zQHkxAcRKTQYKrBdQL8AtQvxQe
uKab6WYAUyX6/Zar/+Mt1/VNaevY8D/GSWuQllvbaCt2I0KyT9rePzS5q+/kbFYKsckdq+4QITw2
eEUMshCcuAXwMgof3vQ0iwScCR/NGMDzmF5jvGG9NkrFsMF4LSyapbk9igTTPIRAHinRzZ1rrw0A
Fqube7gG7wjiUCazlCKYw8VwTwRkDkJDJB3k3gGs9xWs6qZ3W4TgiLFJAtEJZWYg4FLHkKPfYByY
TrB2UAwfQwGM0EVKwxftQRfvY1kP7vaKAQJRctCOJWhdUHC/j8MmSIyFLLlgdSzK8IpZPABTEpBS
IfCuWQqVJ1yzxOvEyI2iMATKTQjmhg7CCB0zMIA+7ypYH20Rrj9F+L6CZe5fYLcARlZMoF0BEUmN
vSZFlvmZ4UBrVkzNU2MaDgUDP8CG7RpHp8HlCQgr5y0TS04G71dCR2ZiVgzh4JvMn9hKDNaEMwGZ
cCV7fZ+7uUWIPVgerGDttLhGeIRlIkZ6nHBK49aMCdRMFBXmKAaPzIeLSXZdBCTnMESzzichpDMo
s6AFjhgwtwmGNJP6GaMma84fDI9Phfsyq+w+WvQw08suHEEIiwsJgJdWdA53diDV9IY37DgTL4qk
e4xTTbXUCHT9PiukOthZZcoZ/pfVSdu0FW5kSV0MAyxznqPIgM8MgksBMeIouvDsINaEy4KZ0Jvz
70BcBIRnCMAQp0EI5s6dSZeA05MAdkukZ0TAQhd6JLB6zP5x4w+FAGoA3gmuAdTMLMK9Q1c4hc0s
zAumHFD/EXhx6Fg0VEgQnQLByRyEKuhhqMd8nBJ/eM4HPjS5r6zpwfr0FNvG1FabTLn5ZKdpw56e
T0DGRntea+s0b8MVLLzC91uE7wGWEJBMtQTQgzVIGaMVajWHTC40eGZ40G6LiJOm3s25QzkHOQZ9
i4BFRNBwAEzz42BE4M8daGKCU4PlkMw0AMK5JTzzFCc4GQKN2ogFS8oN+QkSprxjF8Ove9/k/mGL
cPnNp1uE60tQq58euvzFmTmf8mB9zH216R7ir+PFWN8vbwIsrGCt6cG6nZHMoU/jcRNDwzSMgNRU
Ix06E+6Qwf53H4Vx0IQToJC4FWYIiibCg1uwyippNghi4grxAgxK8jATSy6EUCBVzJxhZe1mlRFt
RFBpKeTk/FZzewqTW9GsKYKlkwsW3nRTsHbhvMVEbFYEPLg0BBgOGJHVa7O5bNsjdnqm3a+XV9b2
YFFrTxGCu8fqfYDC6ZV+pmms7ULyZQhC/x9l7/3eRpKei+7/ce312uvjPce+18f3nMf27s7sTpJE
UjkzU5miRImUqERSgTmJQZrRaEYzCiQl5ggwJ2R0RiMQzCBiNyKTpFnvvT/eqm6EBtDgzH1YTz/V
1dXVYHV11VtfeL/OiV7CTiBc+B6wSMPv1oUv+0xgOcRcahQ+D4OCaw6lwXBsi7Ot0naTi7hTXjw4
12dgDKhDjTII2P+ZAwYCihag6RIfBJr2CrdBeLyKMD0aYIW8CL0J3NYSGP3ExNKJj64Txf8U8m6L
pg8AkzgEWG7UyGCQG5DRGgCg5Ew0oMGTB1r1UmBzw2Jg/VYtzuTfKdQsKl8Pt6pXwcwLuhpa4ehg
uFwwy8O3a/LT6LoGGky44IpuALsfJ6VeUr0a/FHPol3TPc2vnuoZMEvC2yn41YE86D0V7YEgQw8x
mY6EJpa4AaoOob5G7zYS0ByH1HMGAZwAA8pFKDculGBBiaCHN3IPJA7tLMpxlUCCFYvDvNGNiDok
chIsl19Ih0Fz1r4oDL2phYE4wI9f137T/t2TN9+qltWdU916GKBAwysQIaB00zAYp5vilOUQMIH/
lENOEItIUekkMbHkNd2tKJ7Tz9Lc3hp8JOAWaEQItiNenYmLeMDFiYMSC56PDX54vAbQHkXTUFnb
BAEWpGnQ6aBBjJ5fsDmNFXg78JMm3XB2gEzEDD4PY0BhNEsTHv2L7hfnruWC32OEIVNwA6M0eE1S
ZKK07gGxqs27dQW3oXwkUc26EqpHWZ2RgbAYYdQ0XOpgRC0SymZIDgzxPYDpOStJGopeYBBTygl1
iGBewHnED+N+hFSEQoCVnt0eNnIPiSt4FSEFLc8wFG7jcGxVc6fiLsBGLwdb1WsK0BTofDi5uDjr
Ah8/i9EwniMMosW14wVQGJEvK14OtYJl6dajuz1zfWDAmxhKa1fA9Yn/2QDIwmjoJMbpwowcHory
H/SGjdxDEizOi1AxP8fTNICvSeuAc6sJDBgwwsFKBuU3OBeLGqPsnDbfS+mtmMmnu/mgaFA1MKAc
HsNHaBYBaBsaOYHZk9FxsWMhHOQ2uzhviMYJ5yAb33e931FOAl1UlTVVEDYuwBkDuTrh1pYzFoFo
2AGDoxngfwT2lgDjgv+FgmFqGG5v6dGZfSYaBkrSmTjNqWpJnpyUDABWHedFaICBNWE1mXmqrLmC
swWEiweMs8SFZ0VtUCbNh53mY/twoApDHRinPQdAEPQkAl+B1wCAOwyN5ab4UYHBe6GqhYARbSGy
N7jIt2PtE7pxBEY5hDMP6dIawS7OCQaDDpqFwJDDYBKjW9486ZrqNkKrXIqzLoKqCU7TTfAAi4rM
2BGJYwRgLUAbrJ0wTYOoQbQoP7soX0MMSNrND27XeHxhCVbIBgvyYPE0DRKoIoQGUh4ajHMj5LmF
On1utgf/subrt992z3QRDv2LvjdgxBq8BtqtNXCTrc7FG71BkTC0mYHRJEm9i4svySAd422T9BS9
huYV5atXlZgN9jkJJyuKi3kH5ReUE9qAGrx6yG/MS4ih9wNsNuJFCCVYnIpQKKNKpNeLD/C8m+Ph
tgg82p0lXxSuiUcoEoO8nBdh0AYrKMGqKa18ACdeDzXP6nUuKKnFoLwZpx2IyU0uBPQktDKEQa6g
/h2aWIG9JVQlDSpHzly50DXerQfbGzj1wc2DakV5p+KezkI8qH3UN9cP8BOkFwFvxG3mPjG4EQVf
kM5jwJxyBMYmorhvjeRnADDITT6as/cgOYClgzayUFBCw30IF+qXYHGwedYuavcmJbPrLr/b8ysL
B7BKqx5FJFhQwI7rGcMEPds9208ukzor+Wb4bWZO9hwtP3ryKLKo1NswtVnWN9Ojmp8DUzDqUunX
8QlyZoKaAIvQsGZkWCVRr8oQBn3d1Xr4+FG9kwT/7ZxhlnBiaqMK/HvKebkJLEhWlLLiCrNiUDFE
raG0gyDXUalSOolOGuzQOh6iGS/OxW3Vdu6iItyFkUE8iF50uL1oZ0NrlEYsZOQ+LFj4OfmBYLsm
WAygxQOYtgjtsqp3umccG6fdtGJZdeDIYYlK8uWeL6bISb1DZbZiPTLJND5tYlSYTaF3oCrj9Cgm
MblQfEHRMzMgI2cX3MYXnT8cTz0JHqcwyKQaKQC1egvZLxscJcZoj0a+rjFYUNnC1KBiUO8ES4KM
hGGLJgbkQwYLHGq8dYvQISvs/R6maYihvbCK8lm4ogVOzC+J7pwo/qA46atQFXuKt3VjIMCC5vxu
/bR2rGeil17V6R3Y3UellY+rWgda7zy6C6Y/2oqqDDM9M53Ysgps3DEA/a3ICCJRL8mNDDGCjPTK
+7VWiG9ult76tu07wqUcnOxVL6vA+ifTT/XLBnALirJa9YrS4KIlWumYdlwLeZNJZEUrkQ/KdZNg
ZuQgC1i0CGjkznkRQiP3ME2DmxJaCwlFsGFOKT6hVihymKQmPvvss66xHtquRZaVvVMDKkq14jKo
VuWS6WHFsvzzr76QL8tIG663UxiDklYcc2AmJ64xqwbVfYrlWb1VNzTTO6KRQONKD66yKgg3tK6d
hwG29EGFjvDHhHxH6IgXIWeDFfIifCvtoD16AtpT8+aACOHSLnkMxLyqe7IXoWaNjGnGOJl5Lmdc
M7nnqz2j+IgWwA6bblA5KEGGwaSmsqkoFyXDpqexKfBSZo0zHdNdc8a5Bcb4/bsfj5w8BqaIjrGe
Kf0kAC5ykwrMHgqdcsFD6WxayoYozbIh9RB4KbSTRNeQEdXIsHwQW0dJB8rt4HFeTcYbuQdVhJwN
FqeX0UX3f0TuBSY+iqXnbYZB2WDf7LDeatA7sdTsjA5J5/XbN56+eY4ABGnXjJPT76b68TU1YVfT
Ni2+igyqhzCbjF5TSmcHZ6gpk0svX1QfOHZkjgZfKzEIYSKmd+kGwGgiprRWtdqpVi0qdC5d12yP
Wg/9FQCKmqane6f7NIsaDuGFzGs8cJo2cqJoMK2pF2RJyfu32a3GhuZ7lQ+0cIqHuFBlll+5fnUC
nZSohxAbeCMANaJjxHjPbAdh0UKZh1NLWlVSTDqpla579H2yfiU+YYKGgHDG7pkbmNJNmlkCd+B6
Vj+GTPTPDVJWFOx1wWwzopUOyIbQVdTsok6cOvFjxw/aNTlYsSbQ8f6Zfv0yQbpURhc1R431T/ci
q2raoRhSDmkWZAaGGtWOSFRSygGVgzxpO+2O8feMYGLu0xDzIvwl4g1RCZYoM7hYHD1x7CWKHqIB
1gdo8x5SEXIuQbgdjEN83m+UqOHShi0jOIOXN1R1SbpbB9qPnjwO9xXr+IxuFswnmAWau2gtanKd
6FcOzq3Mgs9kSNY/KJfqlwEIwA4cPfq6/x3l0HZKuhVrcj2DTeOjAzOD+DrUp2MOHbIuAxsA1KQx
OXSYC8HAaJQN9KsGMCjUh1pa3otwfdn2cRMgEoEEK07xuiMqyUss1Uv4XgIJAhMFthL7K2zHawO3
Y8Rj4atCgLUR4cEKTWVc+HBPOO47Gd5xxfC50GCWXtWkZqSX1VXq1gmAdXpmwPQFPhZcvabumx4A
k+rprPQ26Tujw6BjaLC1BhgXBpe0abF1bFA1olpQzNvwUeXIqEYKNmk6Bm419e4g4XlwkHujaaSg
/RyhZzjDKhbVLCr3JUMvwu3AR97IvaGk8mGYpgHaCbnxr19/c/jU0XsVxUmHUvAVyPAEyTCf1vz6
b/6mta8dncdOZqTWPGk4evrEBDKtWtOcOH3y7qOSBzWPCu7euHQ9725ZSe71PINLn3Px7O/+6b/J
dHOFd4uGZoc6RiGjXXlTVW5hHsAElJ3cdyDpdvm9i4WXz1w6txgwX8zPvf3wbsG9wjsVxVAa5EYA
eIRBGcUAlsDrzRdNKR4JhBfPeBlPHBBH9OATMGcKAFZGxAYrZh0NYyzI0erXywyz+w4lVbbUHM84
2THWqbUgR0+cbvy+5e/+9m8e1pdbthZyLpy5W/Xo2q0bNd/UUw763NXcKzevF1eXShSSpIPJDxsq
v0raK5FJiitL//Zv/o/Oye6BmYGab+rAfvHMxQsP66tOZKV99/aHBe9qysGDtx7cu1F699zVS0av
vqql9kJBfnF1eeqZTLPfAPa4saPBG1yE0DheMb4/Y0M0MoJOY0QZ24Xk7N64KIQxJnG+RBIvrp8F
kkI2KMECH1jTq6eXCy+X1jw4eOwwbtVWNtYW3b+df+vGHz79RD6vVtKqc3kXG75tOpF+ekQ7NqaZ
PHzy2M3S20OyYTgIC65cLrx69UYBmPs+37c39UyWyW8svHdrzqD+oacVvJ2SqgdpORmrm0vDc0Mp
hw+Ad3Tw+JEfe1rBirj/2KHq5trTOWkv+34gHND3EHegQhVh0AaLl2BFmwoJ1xgKWqpSJOdiBt6g
Zk11t6b4N7/+de03DRP4yBdJX1a21P75qy+kMokUG75Vek+9ihw4fFhjQTMu5vRO9NOsPuvCmQG5
ZBKZyDx/Nv9uwduR7uKKsrL66tzCayW196ERpBvT2tXgEQYWzgKcMivGeik8PqNoGqAEiwNYr/tb
wW+DllvQ1wxSR4Jqw3LQJ/sfNVYdO3Xs7WgPYUczzp65V3X/N3/764f1ZSsec9aZ7Ac1ZZcLr3z7
+rnRThXcuXGl6NrDuvKeqf4zl89XP637bO+X7UOd4C38w9//pneks+BuUf/swLzbeKnganljOZhD
fuh6RTh0KYcPFj24e+5abk7uBR1rKm+uu/3g3p2y4gvXLpn9Js78SMObLnBG7jdDRu77FeagBIuK
RZMhFRWjxBmssLiouKL4fP7lvBvXjQ41eOMtz1qSklNyLp1fZI3P33x7If9yWWMN+CrN/nkwlk7n
ZF4vuTWilp7KTr1bVno09WTjd03tY52/+fvfFNc80C4q75bdBUD51qO7lwryLl2/DH4qmLtuP7ib
dS4HfNHHTp9Qr8h7Z/uSj+yvflJ/6OQxxbwSKndYzjAOUjAAgAXALg2RPQewNlyb9TWPS6sf8qEV
AcxVmOb2JO29/ejBpWt5+XduL3gXvm394WRmWnHV/azzZ2mXueZZc9Lhg/cfV2deOAeG5aOm+hNp
qW3SdoPHnH4u+35NRca5rG9eP9O7jQWlt3KvXy6pKC2uKJ1f11e31F3IzwVz9cVruWOa8X/+H/8D
IE6jz3S3ovRs3sXS6rLTmekGr6GsqfZM7tmSykfZuefAulD/XUv/VH/9t4/P5p0H81L6+UzCAa2O
MCfYmceuN1EqQk9IghWISLCCwYADCeRMgZ/za0tUU4QRais2ooswhkzo3g9hFeEmZ4PFqwhvFOAs
BtCz3kfP+02Xi65eKricdzP//JWLEGA9rnrx9gcwvfz33/3TtH62fehd2pmMR3XlqTkZBkYP9mnp
Z7OuFxf+0PfyYv7lO4/u5N24VlFf3TXR9Y+//cf8ogLKqk2F9Ev4o/ryS9dy75WVXr9bsOyja79p
PHTiSHlz1Zd790hnR1XzqoMnjtQ9aQAjDYA5CLDcmIIHWEsAYEGd2vvATsL4zfEBnoUANLC1WzAi
UYqswK5sDiJ9vi0iUIxrMOJF6I8YuUMvwtBekeZxFYexaG8sD3k4D8XMPT/87nf/dOHq5a7xvqRD
+ytaak6knQLdjlpR8OJMHsOJtNNgd3E278LbsS7chdV9W/9u5O2Qauho2ombD251TXSDDXxR6e3c
gryb929BQl0GC9kdYkJOPuHqr/fC0OY8wII0DRzA2gEAC+zFy8rr7pXfh3vWoIoQ/jNPvm/un+hd
9ZoPHjs0DDZ/071pWWnYsjr73FmDQ3/93s1HNRV6O930/dMrRdfVNu1nX34xo5tZZs01LfUqs2rN
twJGlXxB1jvWm5GTpbPi4KNtG357Pv9i/+zgPKuvaq5teN5IWvAjJ44Ra2DEKA8cOSTVSP/z0z+8
HehYZZc1RiXNUAhcKuBWKZ4HKyLB2kU/KGZnnUifJSj3iSz80fxM8ax6fNfrPZjOiYxqRr9p/W7N
u/pt2/dljytMTurAkaOT+Hjygf34Kto723km9zzu0GlMSG7BNdphOp6e/qrrrc6Kvep5+e3r7/RW
qvB2UVVjlXR2GOBaHUu1DbQ3PGv8rvPFlcJri07jqGIEwHAFNfOnP/9Zppfhi9ov9+7TrVOns9Nq
nzWvei1avYaAtKI6UWZ8HmBFG7mHVK7xClNxltH4q6LyLRE0FsudEVLFhoHsKc7InScaBUOx6eVT
BTG97F/adyC5c6qjorG2qrm6d3IIIAyDz3T5Zn7j90/nncbqlvo7lSUAJ+1L2Wfxz+ts2sr6csKo
Ihe0f/r0U52drGxpaBvs1nvos7kXBqalp7MzRmWjiy4TQPbP3jyTTA+DvcGC2/imq7W6uR7s0f/j
09+rSJl+hZAbFCSjIxhca1eI8mCBVSSMXMOYJuj75g7aSMJwTy5oMaD3ULPGmeSU/cSqtnOi4+mr
bxZ9ZoA8wIZ4ghrJvZqnXVYnpSQjFiTzfFa3pIv7dtI6pgc7x3oKSu7o3HSffODC9TyThVSaVLkF
lwkbzhtjQYcXB7RDwt1oHNoI4uwQk3vQBivI5J6e3T7cpnNzHBZ2lIYeUphqWd4z0dvyosXIEsVl
xcW19wm7Mv1MltI4e/TYMYOD/rrt2ZmL59a9ywD9g82Y2WMESHeKGDO76Q5J29uh9mWX4WZJUUVj
5ahCmp6TZbRiJ1NTB2cHn7U/q2ysMXjJgdmhM5cuai34J5/+SaZXahchspQvKXOvX2nteb3GmjRm
JWWFmlawwlEendaO8gArSDTKGbkTnA1WPOc7L7SDBuzrqmevni8xuFIvO3zi2AqL5Zw/Nzw7eKuk
uEPaTdkRsNlT6FQmp+l6UcGIdrSyqb7g3m1inZrVzYE9tM29+kNXW8aZTCOjS8/J1q5iynnZzbs3
R9CxoydP6C0EvUYeO3V8Cp28ff/udy+/J6xYWU05wPcVTVUA4pidBtSs0pjl2jW1AepPhQArJMFK
2b/jDjQ+brlXUQq9jKGPC6VcUGSezSGtJDGvulRwbYElj586NYfMLnnnL+VfftH5srK5DgBEs8/U
M9oPtmqYVdva87a6qeqd9B14TUu+xf7p3hNpJ8aREYCflOZpI0vl3cofw6Yyz+eUN1Ytu41ychJ3
Q7ZMsBQhDqT6eYPCpF7yLZ/Lu4RZyZOZ6SWV99e9tllSYbBT92sr+qeGMs5lVjbV2HyrCt0cZUc1
nO2dEVrfEtH7ijCTO0lHJFgCFaG4O5uAa3R3VszALorFbRFZTnQ7O3HIIGzkHgRYIRWh1qGGBnAM
jGtyv+4RZkJ0ZuKzLz/HXXh5Q2XvaJ9ELj2VetrgosH2rFvS7fKv51w6903rt+DbuV16Z4E1ETai
5dunJic+iU1dLszDnWqwUe8d78Us8qQDyVOItKj0Hr2ELdrnb96/LSMnKhqqrxYWmNzk3Qd3a1pq
h5VDf/jTH2kzZrbpcJMiSNOwoNzLAawPm9Dt7n3YKzOwtZvplV8Mb4nzYG3t5qTpTxDCyJ9YSxgQ
oycVGn5tbP0UiJZgVXEqQh5geQk+OmcYZoXHWEh8FZxvMacCYJ3TWand492dYx0tL58uePR3Htwp
rX5ArKMZZ7LnfaaMrMy2kXeX8vNe97eBTWlZXcXA9FDPdN+RU8f0VmJYMbg3eZ9Gr6Ct1J4DeyVq
CQ1JACD1DMd+ILJr5ey08KAEC+x1hQCLM3KHACskwaIhxQCDoZS6qOT22bxz//qv/ydYtHomu8H2
TjMvz8hIt3jms89mZ+Vk5RXm5ebnNjTVa5YV4H1rllQmq0EyNX6xMPdM7rmUg4dIO/FG0nYqI1Xn
JtOzM1/2vcq6kKNaVKHr6ic/fnOvshRMH6mZ6UaXUclZeiJryNCM9OCxw8mH9oO9O2dxT2AOFPxj
QRuszGwhrYAlymZIjEog7PW2y/IvgsaE6sIIwzgvweIXfsGCGuxi/hSxzRkAzl2nqlsazl+5vDcl
qf7rerC0pOw/oCDHk5KTlxyG4dmeQ4cP5RVdvXwtD+z4DU4czIBv+97NM+iCU1fTXHfp+qVPPv2k
4etGqUyanp1BOtA3Pa1PXnxd3VJ7r7IEWZYhi/Lkg/snsaGDhw8qlmbVa7Iv93yJm2VKSp516fxX
+5Oav2/Re1Fa4I8ZswIJecXCxK0RiaAYnVWcHjaaQz/GDTPGnyCeNyvaBo7v57C3ZpgOw+jEZom5
vOu5Zy6f/9f/+a9S1XBVUz3YJg5NDVU31lAWNOt8zsnTJ68XXb9y/errrjc9k31HT52gnTrcjQ9N
SfJvFZzMSvv88y/NPt3D+rL2wbeYVXntxrUOSScYY4YllLTjpVUPyxorpHJpcWUJAEBvh989rK+Y
d+KN3zbvSUkGCFiqGUcsSo5fgwx7EVoAwKrlAZaGIxrFY7VUgg0WxXkC6jkrAdKFq5aVSckpyLzc
7NJXNdXmXD7z+VdfNjxtHseluVdz0UX5ocMHKZs2LTv1XV+r0Y6lZacNzfVLprof1pYbbFjXWGfK
gQP5hflXiwqu3LxKrUPqIz50ILSPgVobNEZTFhZe0gIvQj3vRciFynkrbcedWsKNGDyQl0GxrgSw
nrRQdU+acvLO/efvf1/eVEeuo6lZ2XJ6LiXlIL2CAQCxZ+/e/JvXLt+4Unj3psFOXysqGCUmdHbK
6JgvrSy7mHf5T599VtvyeHh25HjaKe4/yhpRScuaypu/fypbn5bNy7PP5YzTE/v27gWbN2xFnZS8
b2ZhbEY5ArYiB48fefxds9EJOWKgsaYXLC2aoIrQH5Rg8QCLM/widDHiQ77zXRqDD+8dk4KtXdqZ
7CMnTi27kPSsjIHp3nuPHnaO9RoZAnxK+bdunLt6ESyoMnqirL7qXsV9vQ01unQvO368fD13T0rS
mXM5tB3PysnWrGjmDNO3S+6AOTo9K5uE3FE02BN3TnaBXW97dzvCaB7WlbX1/rjMGK/fufll8r47
j0rRZZRjBNRAbyMIsEgjtDqFEizNohwALJ/d2dzYcre8hHBDBhzcgYHOyS+6oXaqVPqxvKIC+Tzs
E3xeiVrkJZUlVc3ldU+qH1TdN7qU7f2vH9Y8JF0zrb2vq1rqGr9rTt5/qKDoZt61K/fuPxgCKPZy
7oLfaGJ0lwou94z3omb0VFbqgaMHn/34zOgmUrPSeoY6jU4CAOX8omtnL51N2Z+iMMxgS0Tm+Uyw
6tR/83jRo3vUUPluqJ1aIjLOZiUdTGl49ljPQGM11KaBLFkiGzk86EUoMHKPAVgJVVGi6/0ukZ4T
MY/v4iIXzecEVYRcqJz3MNjzFg+wrt8sBG8TcyKUE1v0zQ/PSgrv3Dhx+uSfP/sMdSIVj6vA/qdr
vCf77Bl8FfvkT59eunoZzOoXrlx80fND/8wAQGA6B/RBef7mu/NXLmaczTl7/tyixwBWsb7hvvl1
PCklZUQ7kluYr7dq9E6ypOZR11Tvo7rK8roqrQ0Bg7C4+qHeO//4+ZNPP/8s4+KZMc0UpyKEAGsf
5Aq3QxXhLhKsXyLz2wUtBQQG7/EOmImkWbsQlQUSScIEACvM5A4B1kPo1MXhJ94cVhcGWNG22mGY
RTJgA2kA88y7oa5l31p5Q+25q7l//PTT+q8b0CUVAC1GnyEtPf3dRFf2+bPdo320E6msr+kd7e+b
GTyZdmrBSbaNtH/y6afXCq9dKbx69vL5cXQcXYfeixq7CroAC3bRQrDFqQjxMMACCz0EWBsfeSN3
qCLknH0wPavDnFrMoQEzvmRKqlsioaBSMfJ2tBP8IO2SJj0HrPeaq7euVjZUGJzYuFr647sXqrXZ
Pcn75han5QvK0zmZM4YpZBVNy86cW5lrH30HIBTN6DKzs1qH2sEed0Qziq9pKxqrn7V/j66hmWdy
KCuhWtOA/eigWtIz1r/KLI3JJ37/pz+i6xhHCESCTkGjAUGsxEVMZGVlfhFxQEzU4RigYGO8PH3A
YFhFyNkGxUGWYN7ghWRgDxvKqp80LDmXGp8/qWyqMljRlEMHJdr+lIMHtcuazom281cugW33osPQ
OfKOdiEAYLX1vV3wEKdzTtc9aVx0m/MLroPti1QmgfCUJdv6Wx8/a3rd8zon76KRNUo1Y4dOnpDr
Z/YfOjS3oFAsq/YfOqigpt4NtpldBsSkSjqY1D7aCv2kwkPBG0N7EVIRRgBrnARLlL41EWN+tFeg
SH+6otneo0GbLYpoNCjBolmKWNZ8tucLuWqSXqL27U+WyAaqGupqm+u7p3vu1z4Aw+NSYe7z9u/0
6/iYfOT1wKt3I+0ZOekGFn0lfZF8MAlfVE8gY59//hm2Kq96UvOm7w3pUJ7PPTc4M3gs7eS0cgR8
jbnX8561f9s11l1SXYo6NC/7Xlc0VY9qRia144tWfc3ThtQzWRRr0HkprV0elGBBFWEYYPEqQqEp
XgTWcIRM0HULUmpx0f30HmrOPLf/4CGzncy+kN3yrGXJoc+/WVBZVyOjp87lntcsKj/74nPcoj2Z
ebp/tG/epd+TtLcXhljpLK19BBBD91zH1aL8JRdmdGHtg+0mlw63IxwHFcURBJC8Z59wYxcWMIRp
GsKxCCHRaBr4Nt9QDKKyygG0hcxPkK2KSjubWdtcu+w23LpTVNZQTq4pwCSgNk3v358CEMDTtq8z
zmQueEyaVU3117UAFgCkNWucMLBY6tnUJz88sbuXLl69VNVS1T/TdyL9tNGFp2akg53983fP6548
1toUg/JhsG2bM88cOXIEWVYTFm1y8r4xWjI82bvm0uNm9ams0+pFldFvoNwUzhCoU0g0ahXGIozb
RQQzuEPXOvo26+IF3RoqVYweT01bcdPp2Wc7ptqv3rnxRvIWcchz8s6qFxEDQ/7Y+YPcMPmwrhJs
ag0u4n79g/N55y2MsfnF15k5mfNeQ1pmhmZFKzfLbt4tmtLNHDp6DLMC5EQePXlsFB25df9O52CH
2qV6UPuwU9rdP95LL+Fr7Py5KxcePS6DBsucUxIBfRhDKsKgDVbKFutuqGsoriwl3JC5Q++lZWbl
pWt5CIOrTHOXbhSAWffIiZPjynHKSV8uyH/V87qquQYAbnxN0dbf/rC2QrU+0zHS0/RNw4uO52cv
XVh00vSq5uvvW2bRETCHaNY0mB09f+1C31xv6/CbZf8iuYL/ec8X3bPvAKLqHe/BrJrUc+kagwJf
1GafPyOfn3vZ83rRRhnX6M/2fjEk76v75vGLd991Dr1bss+bLQbwVUJLYTekzqJcVLzehN/iixu5
B3YSB7nb3o01NN4Y62eNh3YRvQhEOx8jsQg3w0buAGBB7kaws3JibZL25MP7CTM+o5z+4qsvcQaD
EqyJ3r7Z/rSsDNpB7juYMjo9Mm+nXve39sn72qTtjxoqAPR8Ofzq2q3reoe+e2oo9/oVrU2dmp3V
PdavXVGlHD40SU1cvnkNX1UABHyp6No0Nf2ovrK0/D7CqO5Xld6vuT+MDo4qh8EoetH1Iic3J6gi
NCvCEqwNPhZhBJtu74jQJYgwNewkDgstAnPjKRsC23G0WAmM6EU8PeM0iWEvQp5oNETTwBHe4hEz
LN4GK5p8OEySB9dfFjd6qeOpx4em+89cPtP8vGWNNV27WVBWX07biYzsLNKFnTl/rnOy+0Jebvvg
O9qJFt27DQBW91TvybSTZgc+qBwAwBdf0CyxppaXTzQraiOkU9aBWZGyY8KoEsLZhrfBAlhFREXI
0TTwAAs3eaB/NeFCci6eu3D1ctnjqv/4w++7JvvaJ7pTczIxO3n4+LFv373Al8gDRw4X3LsJkMGE
fFK9rN6Xkkyu46vswrHUkzdKi8prKw4cPkSsomPKsc+//GKGnMk6kyOZGe4a7k4+fKC0+gHYL9JO
HbjxdFYagF/KZSVYRaSoFCx7oNmi+3dulxWDiRWHLui4waNLHIswmpY9Xl0Yw+TkiouTE2W/5d09
FiEvweIti6kYRyfe5oCFjNXvRjtTjhyse9aYcS6rvKmCWNMcOHpsipg+cvxkeXOD2W1Ozcw6f+3K
1aIb1U9rSCd2Miu9tb/D6NaXN1UfOHa0vKU+6UAy+D7n6Nk//umTVmlr31Q/6DSjU5dz6dzN0tsH
Txxu639HriKg28EUjy5rvtj7FbqmvXLz2oWC/LvlZeD1gZ0lpA/xRI2/8CSIJVIRisKjRDpWEfrQ
aKlVrIgrgfF7WBXrEqhiuX42u6iL1y7fKr5V21IHJVjK4bK6KrD+TWpnjpw6PopPqAyaU1CX8eh0
ZoZUOd4zOZCalQ5Qptys+Cpp791HJbceFv/5s8+RNXXTi2+yc8+r1hRXblyTqCfeSnsOHj+cf6cg
41y2mTF0DLWDdXHereuSdFY2V08Ro5/t+6KisfZo6okfun9ArSrShep9evCUiIqQA1jgjfM2WFQU
k3VwjedobGAIBM4bEVJF6BhCuaz4fO9XBgdV1VR1+NiRum8awE+taaqbJscvXctH16l9KfsxO13Z
0pB86ODDx1X/+9//fUA2NDABMGWFgdEteOdvlty7CLbLhdcrmqtIKxaky/LoDJD2HZLVRQtyIqbf
dDQPljMowcrqGO2APiVuGE0B45h4ABQrBz/vxPHaZ02Hjx6FUdKsWOa5s9gaknLwQGVjpcmmv5h7
6Uph/sX83K9ffL3oMuQV5E8aZ/Ss/mF9ReaFM/XPmvfuT658Uj+GTn3y6Scdw+055872jnbbAssX
ci+VVpecSDvV2vsOtRPg31cvatRLGoChZ+ZnwOd//e7NwtJblwoumyDtNUq4tIRLY/QFaRoEKsIg
TUOUrE7wIsB/Ma2fPZGeDr6sgvv3Dhw7tryhT83OHJYNPKqtzsk9v8jovnv9XcbZnKLSO7n5l/UM
BSbDW2WlNGvqnOj5458/qX36OOPC2YyzGTpWdyLt9IPG8hnDdP6taxRL3XlQnH3xTMaFLLASGJy6
ywV5/SN96nUlAKO9k13NP7aAAQb67WjqyXF0giOMiJJgRYzcU/Zvsr7amgbwjYNdLrYOGRTHdRP5
twtolsYXFHk3CowutL2n49DxI3lF+Vnnz86z83cr798pK6G9+tcD7WWPqxEGedXfXlr3YCGwCJbw
i/l5Z3PPt3z31MDQhffvZF84e+v+3dLK+y7f8vWiaxfzLt4ve3DxyhUDa7iUl3vh8iVyTXfuSu6d
ByWPaqsOHz8+a5Ln37uZnXvmbtn9nMsX5j2G0rqKd9KuwuIbF65evPPo3pnLZxEYKAJD+bgR4fEv
FCoIiEYjACvA8WAFEmAdoWOguPBjO5ESamcX2+1dYr9wV4NG7sJgzxzAAm8T/EekA1WBbc/eL249
uHO3rOQ///h7+YqsqqWmc6J7WCsFU/QYOdYp6dyTsu9m6a2sC9lGlm6XvHtY88js1ivMsoPHDpU1
VBWU3D2be8Hooy/kXb71oFi7pN6TDBZNTe03jdkXsy9dv3K9+KbJiT+oListe4DZieLy+wDrT1Gz
XyXvq6yvuVwIUHUbryIEACskweIAFgSsEVy187MBiPxi7oGJZFExKErcD1FMORsvVhQjlA9Sm0aY
3IU0DZyKkBe989ZXERssXGj6HB5+tIM2ug0ARUhkI/XfNqccOtjw/Mn+w+AzLMMsSNqZTMShyTyf
0zbaXv91494DSQ8eP9x3IHlENdY10X0i/SRlhzPGvfLS83kX829dv3I7f96jJxwIpF5yQ0dOkSD0
Xl6wEgJYbixs5A4lWKt2FtpgVdwPMrmHeLCwFeTV4Otxclyuk82a5rQW9ZhqDGexKXK2Y7YHs+Gz
etk3nd8rzCqjxzS9PDs8N4BYNTRLapaU3/f8MEvOwADUS3IzYxyaGhqnJsaVo2qzAuy2Z/GZH3te
gWEHRi1iUY5pR1CLEndoJtBxzKYBH+3rwda3Ix1GJ/Ql1tph4B3cohbSNEQAFlRp+SIMTCLyqli5
SwJra1+ieC9xKsIgP5PQf1C4mPG8HQDz9s8NvBl8g6xqR4kxiiWlqgn56pzcoP5+sJVgMYON/rb3
ded456LfgLnIQeUIuohQDHTtHpZJJNpJmUk2To2TNmRMJu2Y7iQs6KRuCndjhhW0TdI2ikoMTi1h
00wqJKRDpbdrR1STyLp6nqU7p8DmqZNewzWQt3o+mu0iMjjEAWs8TUOcylWU/MKaEId544WCokZy
QcZ8V0SCxXtrUgyKrGOtvS8niSkZNTdjnJij5TLDrJHRtUveDqES2k1LtWPfdv8wrZejLCS2GFEM
GxkYm4JY0YJtn9osH1OMqpflhIVuH+mZXpiUyiSEXUc66BGNtHX4Hb1GEU5MoZ9WGmWUFSGWkGl6
SrmqlJvnvut4PomNLwZMmB2B9LBO5JTQBouXYAW9COPihAhmAT48EefBBxVwuB0dVA6jDsTM6oZm
B/rlg6pF7QQ6pl1XTmqmVHZkbG4cHPF1omeif1AtHdfOKNYQMMVP6OQqmxoShVuo1qE3XRM9tAN6
q4ESjKNEp50w7AmU+3qjZQkh+keO3UoAsDgm9/T07NbhtxQLeVk5Og8UCsNZ1OTU9c70vhl9q6Zm
R9Fx1KkcQ0ZxVi0jpwHoxx2YfoV4M9TaO9trclE6LzmJT6ktMuhex5Jdk539s72KBcU4PgYWlVHl
mEQ5OK6ZUJjAu6NUetWLru+n1JN6O6W1aftnBk1+E+YghuQSxIFpV9COkXcv+1+iFi0Xfwb0HiSF
B5gmSoIVDPaM63gS4+gQW3wPEOAzcZEqWtkueSMzKyfJGdwhlypG5Uuz+DL248AbuXlm1WvoHOsC
Q0gHp1cazGwTxCzqIDEn+J8n3g51alfwYeUQ6SZVBu2PQ2/Aa5rCxlBWa2INA7OD3aPdy955MDZm
iEl0SUu6ELVBMaUbB3PpqHrk1cBruVEGQyM7USo4RfASLI5zmFcRJqdse7ca6ppKqx+RHASnIaO9
dkw7ZgKwfl0xRU3RbvW8iwT93yp5jZvVlBMZJ0Zn9VM4i6iW5DO6SS2j0S4pZIZJOBKs+MvB1/2K
XiPH3WXyGHpm+n/s/ZG0IHobZvYae6d6nr/7jrJRKIuRy+SrgXblmla7hv3Q92ZcNw0+pbmluXnf
Ut9M3499rbiVUi3PjRMzyCpUlnVMdL0efEPYOEZNyLmFEzY0xpkmDLbCEqw1syVKRcjTS4qaB8Wl
nYTG1MHjjiizpSibQ0Bcwxhicg+FygkBLJ7ml4KxhijlgvJ594s5/ZxEOSxfk4O3rJiXYS5kaGaw
H+kzOMhx7Vj7UDu+pNGxpGpBoaJlFJg3XMgcNv2853v1GjqOjKKMDFtGW6VtGqtsSD5C2lQLbmOH
tKN7tBdf1eqdGrDCzhDTAFiodfJZfFLnQjXzytbeN92T3Xo7HgFYySmckXtIRRgfCyie9WpXwd7O
LqJEf2yIGxEMJwq/Agkwcfw7jXgRboQlWCWV0V6EwcRrCfE4cSk337I6woVINcPqFegV2zPe/Xa8
Q7OoHUNHwa5mVDuKuDSj2jHFinzFbe6b6e+a653VzZDrqHxRNoaOYQ6AolCwuHRMdL6RtBIOyJCi
5zh+wRgwhp3bYqYaHmC58LCRe1BFGPIiDMYihKRWbpqjaSAgJTz4chgNWKsQu0JtU8y7KMSl1jm0
Biin0XKEaSQN2WJQjFXpwcaLxTQ2BeWBXCzzPj3Nws+PD8WqcioQRgOt85wKvYeGdqksR4ro1Bq8
lMEHuc5RC8RS4J8xefXzrI7zhyI5jkdIICRQaUV4myKhcoQ8AnGruIhaSogMxEnJIwSY4ViEEdsg
AU0DJehlSHINeSmhksXs1+vskPUVRpVyU/MsjjGzCwzkziEZxbxDg7LoohehnRqVDbruGyAXAEo4
ZUaHnKMv4/jxPaTZCokTSRukK0ScGoOdJpyk3KoGu2GlEwMLm9qu1Ll1RgYjXPJ5H8dDbcOWYGw1
GeZQxvv1hFWEMTQNYSb3ddHQQ4KeieNu9YmrCGM6U8gRL+J1GMWYH/QiZClIMuTCFn1wzAD0SbBq
6IXuJcxuYoEltI45GuAAL6QhoZ0YCkmJcI09yHZNchyPaocWg3JjFExPegaM4bkFBsddqHpdYfCi
uIsEuFZll5NuGEcSZ7Qk5HiDsa4A4DC7aaMd0Tk0Jh/J8SsahTxYkGi0H/JgER5KKLgKi7IgTQAT
pMCG9I8crxIkboHusZjWpSFdMD4DygC8C6P+IYx60Usp7VNLrA5zyUmXyuSB/7LRoYVfHKOBGkDw
fbk1YPuxAEmqoNugZl2Js9BIEYZeYGD8ODG2XoEXYRSTezAWYetgO+2hIZUltOgEkzj4rpEFFlrY
qBnS5MBRN61xKSiGkDlkENK5wABGaBtkoYRozI2rOXp6cMrxdhIUx1yP2zGO6hayVyNOGXgRaqdM
45DhMPQHZnCAiQkzesCzNDBKAWSXwXmGTxjYCxK3QkpxHf82GRiDKDHAiuHPC2YMXkjvpF9DDPBd
ENwGSWYEezZWy80wBsSpnvfiYAygMOikFnMpTF4Y2o+zY1Oa3ajJBePNgY9asa4yMCbaY6A8mMlL
aBxyjEFxq3bBYwCPkFtn4RTqRjXgrUE4CCOl6N162k7Oe006loIEsND5AHRX0MgdSrBCACvg2X7c
0Hy/ugyMTB2MYwhegRb0vwFuoAGkxsDkqXFqMDfkdqdZA/h5YOY0+uDw1ntwIwOei87D+IlgpoW8
XzqvHrGq9S7wH0HnUNSpwN0o5Ox1YSScTiHrLBha4HWYXRQY5ypu2gHPxVgNjMPj1oDhCm7X2REY
AtUDCZMJBxfXy6MD7cNQku4gvyiMgxln/SbwIsTDTO5RNA2xNj3bIhKpwK7iq0Bi4ypxq6MY8veI
bOZDSEUo5MG6frMAUhN7dFy4SQJydsMQBTTvtaq3QtZi+I+vY1oG8rfNew16D0U4tBqnEtKmwO8a
zNIyGpKKgcUOM7swrX18wQkWY7BMKM2MAUw1iF1pAjP/OiRSwli1xkngrFLpVOldtNFnVDvUpIsA
V7kIWgivIhTaYIVVhAlZQBNBK3Evwl31s6JhcPyJZY0BsRCTsTwafIXNkJH7RtjIHdI0hMZYmKYh
GMkg2goqPOORHp3KroJ0324Md4E5k9K4EMwJAAmY3BAwN0KqC8hHiFI28JnrYFAZOwJpvcHId2KY
GywB4LPF5j168NZgWCqOXBROSjBkIRGnIsQFKkJICCykaYASLCuz8bCq+k5ZCc7SCCSsIwgrJMqD
oa/cQfp5kGCGK+ED05IsoffRXB6sbTBcCYyY5g1yRQTjbIAVhQu4Bu/iWtDxLQRbDqfwJf5BwfLw
Q2m+3Ib2jPYcPXnS6/Fb7YyV8S7aGLv/vQh3JeNbj+diiLnERBOUx4AzAe+AzRFYc/nBgjogHU/N
yqQgkxhYWgCYFSY0+jRRQuMqowYWJsggyvL5UMaNGWAFgAnAVVgC8j/30EiJAbJXo3yJIVLOt4Px
u+ceadfptAyGCdicG27vzqqdWfNtRgmi4q3WmDioJBp5MJ6dgfGJsbpHyi0u9yrrsTAeAF9SszIW
YJw+tc6tDQ2/yFCkI+MkcuTLIeki3P1zGRhBDw+XRw/CyGiMGeG0YBzG3wuOJzPS+kcmbE7GarNW
1Ne39rfpITiArmEE3DnQwUw4D8PjwFMuwJygAl8eOgavemgoHGUoGLMZJBiyV0c6CRiaN3RLqB0d
4Ylqn/BEHh0q15Fx5SRHr4otqPclpdCGJYs7YGGYtMycN8OtkDgXmhhCInuSDWozIS6EIZggPzif
+FPuSEUVRsojJSRkSIoqDOa90U3FtBN9Kiyc003eunN70+NdWlwDs5jcOKlxQkrlRM4c8dzioiYU
YlO2UO4rIL/xRgsFPXFiwrj4iULFsQkObE5XwOImj1bHqjCzYt++JJ/dX1vfXFL+wOjQ4QDLOghu
NqZi+yS+37xRXQSDZLAEFz5IvAMpwcuK6nyvSDUq+qXzdSixliOvNeZFe9QGK5J/49qC2bjt928F
Nt4Htj/6d2IEJzuJIFEsc9V2gqB4CakcRBWOOwIBD5//CVb4acP3fjuwsen2vve/Hx6WFN4qpLjo
4HzS8RknRkGeVUrvhvRIYLPB57lMME8GK/AxfCEDPozJzQV5hPHUWYILJ88fSf5eYRKWhNvhE29t
rVpS70tOZi3MB//m9sbmli8Q1znbUbZW4mq77V0M3ndi+lwUdcXbVCV6fburff1bf9kIbPm3twIQ
YO34tryMv6q2rqS8BOzT+ARDejAUCcm9aQp6l9M6bgvHJzpI+0nTHmEhrQudcshYz2XgkS8nYUj1
UH1PsM2olj2RU+HVYMueYDnccjBaAMhIRoew1NyCZm9KysrC4ofNjV85XJvl1TUlVfdhEEpI5ayj
nZDWD/I68PRZwQzYssBTGFUQ8oZjOhYlwI4ZEq1yp5yoCZKCenHcqSH5MExgdefvFbQQOY0cYYaL
e4gbhM/l6/sIPtM12n06M4OFvmbQVGjVzq45PTExg8XEJ4mMh+I8CsWkX4xne8XhXnO4+welpzPS
5xkou9L7jOF1i4xO/MoXk0jhqTtmIQzdIlxoQ0tjTGs4y6/HkRReSsOruGDl1oWXZOGz+DqIE+2S
dqZlZLqYDTuz4YBd6jE72IR+APFs+DFkrbE4LFYuaI0nxBLUt7F+i8dvYbyDkonjqak6B79QUdGD
JJT3RY8fHxGp4BPU9AUHEgVZ74VXhQ0S0eOcv4rHXgo1dTItdWB01uXeYtyBqsYnrQNvdYyWAIDb
ozV6EaMHMQQzWpDnS7ikNQgqwDx3ymeER70H1XsQGoYpVVGMRu9F+cRXCDcSeUTkKaGrXiTySzxI
pA73OCiZ86BKw0zygYN608qKC/S8OyMz5+XgKygx9cKIzlAF6dLy0Wp5RnuC5Zhg+HgdodNgJngp
eMpFawkSxnDRRYlgIX+7O0iRHz5GGuRaELYfrhx+CsjI6JmbRbfAcsjYPPuS9qmMU7jbyLlWCUBk
6EOLfHrBYU9Hgd3oj44U/WzDX2L0101GPig6ApQFX3eiu6CjMYOgMMoQjJNBsGrVvHz/oUNbns3a
hobi8mK9E2ym+WikhMGNRXdCsLuELyXUjTjfmXyfcwyrweiuXDTGSH+GK0cKhe8l9Aoip3GvQPgS
yeiXGG4hXAeMJZOTLrxdtLyw/D6ws+EBS+hWgPVux4fKEbPsiYJf0XqlHZFYLmJ6wEThdKIR20/+
jZ3AT2CBBwDrg3/j48ZHqXQUACze3IcPRRpMniB1MBe5HOcDX/KJi7SN0p5gNAU+YBqXguGnSCgW
xblXz0m4uRhc4Xb4WJxBgbc7aModdRXst2GUHhxdRiAoX2c++qDsJ+D2JSam+mUulgGxCI9RXFkJ
xF2BBCZZ/l3hbxxB/08Bv9/t3/B/2ApAJ4OAe7OiuuZRzSMw9XF+YzA4gZ7PcCU0jDGDgB14ONEw
ljwCj3zejXD7c4S/BI6ES633IhSrIWEAQA0/uwbre4KVuRYEt3OZUHl0YTDPJ0gWT1i1ALERblK5
qAFftH3V+tet9wBgbZVX1ZRWlOg521iDG7KQk9D/luASGTqSfPxUgkFoboiEw1hCTSIXjI/zliJ4
XEVyGsZQeHAiPM748RRqPHiJF/3xV0NPDKZQZRL0S9tw++nMzDWry8FsrDN+i8ttYzyCmDY+MVoB
n0iA5zguhnj6gLCsy+b0r7v9NsYrkU6cSks12wkDQ5gYmuJ259wGnQhv00lP+JRPkZJInahbgkfh
LXziIssGEzdbEeF7Yf1I5fAtUT8j5odFPZpLWgZpH2pPzcx0suC/21i3sXbGu8r4E3Kyx6NPRlTZ
moB4bBefRC65PJurLu+i1dU3NAbeMmZBcDeOOLhYnl5+eJCCscGPK5L2Rg2YYJgX4XzkDc5QMaNL
0CZBC8ZhzGiPfigsScvO6huedri2bU7fw+qGV33tercWBnBgYaB7PbcxBXkYzYaLzMqXhPP64NXI
MZjhL8FvEEb9AwmHoXxxPgNDmLHBCqHGQ22GTsM/INQmHvUzWP6X8IurRmOeS9q/37xsW4U8WJ6M
jJw2aZvBzT2Fs28AXzFU3LuJ2O/XG9VFfC+FFp5gL+m4yI98n4c/4dA3HmkkfK8+MksQgp6PmjTC
b0dhUuRfK9hy+Vxr7JEjR9BFGeYi9B4s0rgnZuIioqcy4cRC6uOfLhgYkcpRv0H42yLDSfhTBR1F
CCpwgVnduBqaB5CYA66mOFQoIEn7D/odnqrampLKYh1Uc2soFqFsajMXSihmHhb+7HCfxzw3NPjJ
+P+djgx+4Ush4/sh+vuK/fSiuiVRJ3sJFIwo13z+zZsrC9af/H8BGGsnsAlAzM8HYBFd2gNiykR/
gsiDIvTicQxboUvvvf4NzzYPsN77AluenYGBoaK7t4LQKmhhjYfCIfABxXF+bhFiIJJ7ZSFoxX1N
3PoIw7l4uWjNXAnf4eAT45ZLXHgMgTZhngg/CFvTkE5Mu6ABAMtrcW27Axse/8fNj1Fx/eKtoPy7
Eq/vwncl4iSY4BXs7ifoTyDTCrXw0e/b8G5sbfwU8MJQOdve7YdlFaVlpTAWUxBuwpA1tDDxJcIj
H76Jy/Cx6oMBVTmGZxhmnovGy9fn4j1TkQrh+sF7BY8IXg1mdKFLwmqYC8FtkOMGZ1A1tJBLdizb
f/J9+JXVvlFeXVtcfo+wqTCX0gjhIYHCuFekMAFcBhLJBTjkbIMoLjwWH7AZ5sHmjPLqCZbGGQps
43BoPcOLT8C6HmwhfORLYhon3HGPc0dOAUjsGO06kZ7hdG9ZHBtrTr/d7bMzbjFTIV+Erp1JRBwg
wARxJkdCfge7y7/O+hYttmHpODS+dsBwXRSc02H4P3gUZmLy8QlGPorK0IL6NNjQCCpEKkcqBMuD
SVjI3R7/A0JtYrQ76jeAPfRbybsTqafXGc+ay+9ybzgBZnVvxmFNMSQab68WS+4QTXMVo3uNkXXx
eZtnxQF+ibdfMpZ59gwNI7iB7R0VGhtE7BDaZUSFSjAXhkGLk3BNQjiiIuPNHTvqwi0TXJjC8A8A
6WRaav/wlN25tWply+qa3vS/I5wKyq1FWQokzK2LP0ZO3cHC+BQu10GdO9jGEJxMm5NCQz2RLq4+
THwm0kKwRCdM4fr8JagBZDXaBdkf//Tp/JIFAKw1uyv1dEabpG2e0dEOGJQa4CoDS8yD59oxsJ0I
J70LD2YYHKRIOTTWCZZAMhgXrnNAkziQ+Lu4+Md4uKYhnGciDXIZXDQfbhykCd3Mjdt3fvK/XzNb
k5KSkMU5DABQVh3SjGMhTTpuiNKe43x5SPMuPOLhW4RJ0FRs/eAlDy52b0yzuPDRMMPiGgs0mtQ7
dSYvTTpRjUm7Z2/yNrNV09BcXHkfsWuh4bkHKrsXvDq+z4W9LZrCHQV6nrIjfILd7sLDryCSXMFM
+IUKX4fwpQjfbMyzQuMBDw+MYP3ogaF0qPWM4Wph4ZJp9YPv4/vABx/r2fQFhIv3jrhj4LYILVYg
QWjneKOfcMsxxkbiiGHrp8DGpndn07/jZdgP/s2PgZ8GByX5hdf5bQl/DG9juB1RRIUHM25ePwi/
HcqJ8nsbMpThboFKfxKgaoaEJrxgfmNIuI6EbozRD4bKqRjVIQx75yYUC8qv9ux1rTnf+7YCHv8O
1Gz+HEVCNHIV9vlObEybBOygu0ihRMGWmKhsJ7AtQjALecg2tvzvt2HkH/97UOjdrqisfVRVhrOk
IFHhPMctTPGJM4kLZjiHYp2wJFjNHczD6OkeHR2qSXGzq7BysIVQO8HC6DaFN/KnKIuQLqjEQ51K
bE39xZdf2JZt7z3vf7XseP+ouu5RXRlA05DRx6k2eGFoNkIg9YVBQliUz0CZPydTQZ1aXgqNwziU
KOKErt28LgB1Iji4USDcDt8ePsanmHLQprAcsyrfjXQfPHbcxm5amW0Lu2ljvet2pzAGzq5h8gTx
WxjfzwTOE+IJu8cCrelZyfhUalY6ACioS43D0L90yAqN5pmmaRjiXscFuo/JBC8J88G7vPzyKbAK
8gSPXDxRMlyZC+/KhZEONc4V0rs8YpcSkDR2bfdYd2pmps3tXbazLnfAAfrHvS3Czx4tprLuQoUV
o1IUpR+LcR4M3eVwbVnYDdDVPQPDR04eMzKozq0mbSp+7MExJhge4XzwkmCokJ6IagmUg1Eavho/
zCIDmwke4wcq/4hw/bSsjN7BEavDu2ZzVjc9fdPfbnZjpENDeVBopg0ttdFIPlQSdeqJruBGYArd
qPdiev7oRSlWiztVOlYLToV1IrcIHhEsD18N14/kQQbgHjhrY0vaL/buMS2tL9lZq8uTlZHzcuCl
3gPdSvTBiBOEwQe3d7qQ+iMcnoKOY1UOW56GapJhMsAYbsCgH1BI90GHRNqCpsi4piIUOOA4PS8D
q/WGd9O27t6XtE85P4WwBOXW0Nw0F0Sl3tAU6QkWhufKULXIDMtXCxsv85NvKNFRU62wNeEs7NEJ
HxpBxt6o9vmM2QdePSRPMXpo0MNauwpZ0h44fHjDGaitb35YVw6mbGiWC4WXkZ6nI15UcX0e1ACQ
UdVCXEHhuCJRFcR6PppeSOi0RdJx8Uli31HMmxVwQiqtM/NuCiCVtYXlHc/Wh433UIK1IaatSyRZ
CezqTuiPZsUUszraiYNT0SyaXMbt9bu3trmfBw2bvB+k0vFbd29z6lpuUw0zeDAT4r0M9W04wRIS
hjyHQixeEEWCSQnMIZCgn1cL4jA4ugsVEJSTuqj3JdKNutAr0zo0cqtMsaz4at9e66plxwdlge/D
ACsRR0MiEtcERvFhOd+OiDfidsLgOUJNbuAXBIEWqHR/2tza8n/Y2viw7ff/BRS4ArV1TQ/KH+qg
Jg7RsTBRjJbPBAu5ctodKom5JKij4+ZA6EPmAhMFeI8IZldBTzJBBZ2wHeG9bPAptFuQCaXwKYAE
hAMqAHUeTLuk/GLPV9Y16/bGzq9WXR9Ky6vulZUaGD3N6OYZysySyLpGsP/Dhfs8PRg9Tq0BrH/g
yKJ6FwJWQZiBruNyyqoyuBCwOuqdWnCkHZqYHWH05i9qxxn9oPAGNJifd9Ht/R2n0rMc7Ma6a8Ns
cS5ZHC7Wn2gJt8YzY4n7x/kSG2xxCz+7ue72W1yerr6hE2mnDSyJsQjiQEg3Cp2GWITgXIcIN8Il
YYkw8VcRUlCTFKkTOZJuLQESWGIZDUgEhLxciTvuidxDyci9wgwafCj0GEKEFWgH2TXceTo9Hayv
62zAyQGsFUcCtWC8/2ACB4JfhlzjQBjoZ+fGqhP8AFYyNnUyPXWB1S36yHlHjF0/Hi2ZiBo54US7
EJpBhIIHPYNGD+bYYRbTpiFO8hG+dPTkCcnotN3pttjtNc1PSiofdY93veprbx9oa+9vhSmSCZ0O
hI79ghRTLZRe97e2Dr0F6c1AW9vQ23ZJx1tJx+u4apFGBkKNxDwu0YMGu99Kup63/ZB84JDeDAEW
2KhkZ555OfwaBqRygRGCowyCgS2TAzIOgJ0S9JULHflMOB9Tzh9BCwSk1MLja4YTHt2asKbwFmHi
60xR01evX3+/ue2w+/YlJ6HLctytN7A42BOChHFHlOEy8IiAI18SvMqfhqoJ68BMqDCmTjhhbLjl
6JpxeYwNtRx+CneJcMgRpwLuBBwI6tRgrFq9rPjT53/eZjera2pKyksWoeUsBhZgsE7jDrVob4j2
GH/kOh8mXPAKUBcq7OeY9xLpcyb0chks/mqie+MrCH/kvA812/D8gmuWpeWPmzsBD5RdAZgVFcUl
ESFTTLAX8agsiRlE4yPuBaLZOAVr/0/+wDbUD77f8gXe+7Y23TtjY9NXC64HByqDChK3Hwv2c6TD
w4n/BFD4KcF+AJCIrwY+KHAjCXk6cP77wlyo4EYs9Na4DHyVGB7K46GrBhbGJ541zCXtT3Gu2za9
GxxL6k8ioQMTyOp2i/AoGmYnkXengCNjJxEBrD+B12Ec5PoQgBKszcD2ls/31y2Ad3eaW56dvXC+
XfKuffgdNx+2tw4KUn9bK5gq+TTQFjq2wWM4ha+COXDo7eu+N21c5lXva5DpHuv+sevHSM1gfUGz
gtsjrfXHNc4dX/W/eTvwtkva+XrwTcuPT5P277csr3m9vl9Zmc3Kmoav9u7JKyq8cuvm9dtFIF27
XZRfVBBJtwqu3Srkj3k38mHmdiHIXy26nnv9yo3iW1eLCm7cu3Wz5Da4BEryCvNh/aKCqzev8zdG
tVYE2+ErBFuOflZ8ff6Wk+npmWcurK4zDu+2hfGv2FgHE4iShYiSWMb7tTEJSLCEcXVCYMvObi05
PKt299DQRFbOGcSkwdYwrUmjWZCrF+SaBYXaDDPwaIanfIlGpEShXgjVjLm6EFWTr4CuqNAVpXZJ
oVkEpzKQNEtyeBpujW9nQR76JfJwU+GjRvhEQQWQoa26H16/OHsO9Kdz1eWzubwud2DdvSnSacwv
JQtNCKpcsbIuazzVvs1j8wAsGxiSTv3nH/6YW3j1yo1rhXduceOhUHRIiA4bMDK5+nCAFdy5CQfq
7cKCuzfzw0MuVDnqNCYjHKLRg/D3f/xkcGTW5vTaXa6RSXl5bX3l44bKhpaK2oaKmnp45DM1DZF8
bUNUiinhT+EtXKprLKtteFBVW1HfWN3YUvW4GSSQj202URI0XilWobS8+lF9bWV9XX3j1zbnlsW9
uWJ1nD936cyl8yWVD4orH5RUP7xbXnqv8v7d8vvwlEswUxU+gvL7JZFL3ClXDk5hfA9QUgETKCyt
fgSO9ypKS0L3BlsLN8sdi8OFoTqRlrnC8OPg27x246P/w8K8JSk5eQYZQ5ZIwqQNfiOL8sj3IsjH
pN0vCTN8zfj6/79O1YJTfEGphp+hVm3UaBc12jWVVDZ06PDhHd9mU1PTgUMHymvKSioeFFc8AMf7
1Q+FXRHqqEjnw56pClYIVQuXPLgH3mNFKSjk3wJ/S2nVQz6VwPSgJPpdCJPwvRQLXnRUtfinRxeW
Vj+4d784NS193jC/swGX2C3/9gde4rK7PisQF9MmTr4iDr9+RkG2FccOBTMffH4AsDa8WwG370Ng
52PgL0ND41/u+SoyLQgmh6tF3KTEZ7j81dARzFogc/32Db4+WA0L790C62BR6R0wHYGJ6HIhXEDz
uXkJpHALUS1zTV0tEnli4S3YyMX8y5999oV10Qr7c2PLy/hEwlqLUIYmFCCJ909CpLX98yhNJP5g
dLdHv7hNj29746dNmPf+1yYYIR8mJ2Q1dXW1j5vrHjfXNjTV1DfW1DfVNDSBkhr+FOS5xJfXRGUa
o8sbK2vqq2of1ze2VFTDzJNvvmv++luQgndxrUVSfajl4HMbgw0KKgRv4a82NNU11tfV1dfXN1TW
19Y8fvzkybcbbrCN2P7VisW5tLg8PDzcMyzt6BseHJro6h7qHRrpHRwHqWdgjE/hfN/A+LB0Ghz7
Byf6B0F+ZkgyXXiz+Le/+S2YsscnZvv6Jf0DUol0Ehx7+4bhvQPjXBoLpkGYj7Q8MC6oMx4qFCau
XDLU0dOnUmN2u3vJ6gQrsZUN2Nltcfbw+Bg4Cdd+b7SZUUyhb40JrDJ+i9Mvn0N+99t/PHT0yOdf
fbk3OXlv8n4+7Us5EM6EU8yl+JrwyJcnpfCFe0BGkP/3//j9Hz759LMvv9qbnJK0/yDX7P49+4LP
3Rf9RK5E8NzkXX8Gd/xy354//PEPV/KvOxjfkt3t8PjXHeyqyx/LsJDIT/BnOzahijBC7iDU2Nqd
nkU7A6De4pJjUDrdMTDQNSzp7JHwYyA8Avlh2RsZJOO9wkugvH+sb3Cib3C8q1fa9q7/dXvv264h
WC1SZ5w/Dd4+GDkNtx9urVd4C1dtQDK6uOqxuwJ2J8t6369anDaH2+b4YIX+AX54jE7W0NEKNgNc
nfCRLwxX4G93sgEn64eJ8dPGpTkFQujmXWxArM2ANXJjbOPrgmYj97r8LteGw+NZs62zLr/NsWle
Z2ys+93brmqA3WoeV5RVgymtEsC0uqbaqvqaytra6vra6oboJFJSU8UX1tfVwJKaqjpwbGxobm58
2tjQwt0C64Sq8XXqIynYQmyF8DGc7pc/HOwZ/Inddtv8+/YlfbXvqy/2gi/jQFLK/mAC3wtIMMOn
FJHEVwtW3h91b7iF5P2CdlKiGo+k6LsidfZHXQ1mYNq7b9/Bw0fAFwp+dcqBg599+TmAifu+2sfY
vVo1WlZWUV/f+Kisqqa2sbyiriquo4SnMf0v6MBwNfgWGuqamh4/iWoh6g0KO5lrIXRVUDlcJ9I+
fyn8M2J+YbikrKbmUUX18+c/Mg5fwLe5Df48gZ/876PYBER9/QLxGGv7Z9iwErWzi+NhmCYgsLHp
2wl4Nrf9G1uejW3PB7crMDQqnZBMiqZJaThNwWOoZHx4YnZsdnx4HOQnJBOz47MzozPFt0v+4W9+
XXynBJzOjs9I+yVjw6MgMzUS1cgU31TwdAq2KZmMKZmSTAwPSaRSqVau+av3Y4D1bW+/34R+A9vi
FmmJmMBiCau2xc3SA2Jm7GLvZWd3TaI/htgsNszOh8D2zuZ/bW3sbPm8OwBssZvvNz9uBDwfvBsf
vZs/+bd+8gmOfMa3+TF86t/6yJWE8x8FeXD8i3/7L4Ht/wrs/HXzw/+z9ZN6Vv3i2Y8W81q4teAt
MG3Ft/PRJ/4bwnf9lz/w/3q2/+r7uOXf8bi8f934y0fPzqYv8Ks4B7EoWUWcvMdrYwIWh4dffaFr
vcPtYDx1jU//4e9+MzIxY3GCSwGbywdWCLvLu+p0x7afiMSS8SVctmNILBO0lshiXdzUXZzVSUTz
ZXF6rawfpCWry7C4RpmWSNOSbn4FJjNM1PxybF6QQAkFjzDxdXThvKAObV6lTPBecARXlajuf/3P
f/vn3/13gjbqF1YJ0wo5Dyos6WFroceFf4PgQSKXIhUivxlkCMOCbn55fsUG/i+u9+D/aIMqV594
PEehkI8R4V+Ii0EkxLsJ8NluZPG+hCBY5O37BCpdL+dhugGG39fPvvuXf/6X9s5eq8svhvZiFMRx
EjtxEloRui+B7FMcblpFQzmJhG+Cvx98QRZm0854m1qe/vY3f1/f9LXVFYgxfdtttCek1eBiPrIh
Hjheve70gAcxYEVJtKP9eSVC1ES86fX53YEt/8ct39ba8qpWo7Wt27Z8CefcaIejOHtkMeUOKNny
bXpcHvu6w7Kyvrq0tra0ZlleB3k+rQnyoJw/jTmuLVu4YzDDFVpAZeuadR3mrTaLCxxB43aL1eNi
HFYnfASsDBN8KFd/LdS+Jap9i/DpwgQK11es66tWy4oV5kMZ8XXxZ13uY61kQM8ENn0bW/7tTciZ
+dHP+ryMG0OxtRUbKHc73dv+zU0v1NP5WC/oxvjH7RZwJlHolXjllNBfT0RMsi22wMfKV3bil/xA
nCX7LoSiotFgEsQ0FDe0Fw0p7d9KaIQUauf95nvQtzsbYImFPfzkyfPf/t1vnjz5esu/wWtId/zb
70G1wK4SoF/wOHE5X2BbxHRdlGN9l/5JFMQwVvG6vSPK4LAbf+l2At/GX0KEtiXOzSGKHQWNvA/s
gG4HHf5hA/zgzebmr//h1383OyPb5dfuJPoSAwnGs9gv/5WYTCIhRSenMuMAFuvn5+gwwPr7X//d
6OQsD7Ds3EYcuv1HAaxYiGONJkSItVUXNVSP/mHW3VfBXyJ3EaEeiKIm56i2IJSE/6zTu+pwgxIb
5L8OgGQXHLnMBn8aUw4TC1NMTWFl/iqfNy5Z/vf//b/+7V//zby0Cp61BvCBe9PhDjDeTXt0s+En
xh8FzwrY4gph77FBUMVnwD9r4f7ZXQ2qfOLeALEqP1+cnbtvPRGffpRkSwTTJ6gsKn302RmPxeVb
dfqtTnfL02f/7bf/2Paux+LwiROkifKfxfy/4rb8vt22BPGjKwqYxsd5jFziAdYaZCbzNbV8Debl
+qankEcjcbdHw9wEjG6hjI3x2XhaEx5gAZjiCgEsEfXBtohsIN4yRjD/vt/cAkv7h62/BjybLS3f
/F///C8NDc070HY1blXbPSJsAqvnDU/EAQ2sXuCUW8PgkhZJG++jTjfff4i6uhNzNVwIqu1sbO2A
KZhjGwf/CHjKonlxblZmXbOD9ZLfhYOaQb2Gb/Nn2oz5JXE/LJzErZFiSBr9CaBAFDzaggAL0iOB
nwRg7uaIdOx3v/3HZ89+8DJe/q6Axw9+ecDtF1ultsSVcaIh6hI59gcSmDn7Rak+txOujrEr8XYs
FPMnoGgKJB5j4rAjMawJ7BbvJf7VgEHCjxBImMkDLP8WD7BaWr4G6DYEsHbAYv/evxmjJ92JgZW7
h7UOiMGjCACNNjkX5wvdTqA9/P8oe+93Sapye3z+EOfESTB5QMXw8D7tbgAAgABJREFUuZ+PVwUE
swIKTCSqeM1eUEG9KOCEM8MAKgYuIipKGHKYhKhcvUqYmRM7VFV3VXV31e7uqjP4fH//7lBhh/fd
1T5PnX6qu6srdZ3eq9a73rUshcUqUAjabRDo50LrNjC/C03gFeP/AkC+tbInEsBK6bcwc+AwBVjH
j50EwH0M2dhqXqmgGT0EMVeg3kXab3fxA10ALC55rksA6+nnj/IPEjeIfQaw6DjXbWKO6haCChjb
oJt15YPWkBzMmtwYnBxDb8RJHcZjiXmXI8uGfFx+ZG+Ug9L9Sl6HwjUK2uj5pGeSrrbBl3x9trZl
4yYBsFpdpv5uBISB19JYNTINqJwRtl6wTflxsa3XxKbFyn3J5h5pCHCwhkGr+q1pySsc4cID7DYg
TON36FvxUitueuG+A4fof9Evf/XbuqdQTY6k2HMsbl6GZZdj4jMYoJvKM+i+BaDronZIoU/GYNH9
5wALYLDQM4AZjhTJBPnNTMlgCYAVI6El2G00CMVIcjZJOX1ydhCn+/n5P3To3mXh00Ms2SbGuIso
lwWcKt4a8gEso7UKFicup2yx/N18JhlKKx8qRz2g+CNh6bnsQLp+98CBQ6smJl8+8acojOjm6GOG
h/hKhtJ+Ytsd5vPlR/Jj1NYAuxDFeICuruZmd+ccCKbDKIk7FDcnr/zxz/RbuPPOA4JTiTv0KPqC
WakwRzArO6BsGVOdEzT2DsBGoEMSinUQJ3eCuTElI9CxePYOwTlX8wJmOrMkY7CYZJtdrhRg0Uvo
4EEZYCU88dBUoyf2sGo4D8cc8rE7pWp//AQOyVHbM1O5LAjiG6sbGZ5lpErrCIShCQ7d8IygDGDF
AmD1D+y/OwNYo/yXxVYz1dhWmF5RMToGeiNeBrDy8abR6nh+h5UIxyYEwMoYrCDOGCywPGcafpoj
MThamAMYxhwEEQTdIhh44QotsWSd4Y9ePixFGYkluB/O5Ln55BiP5Vt8SaGbER8sSnJOkLNH/MU3
5+vnbdl63tbz5pYaXodQgEUnh9WPooJwUqbA2Iq8G0H2urzP2tfhWMJwApNxAVK0AdAQgGbuVR6k
eLnWhsnyeb8TC4DSbHGANT7xwEO/pQAFqH2bunvwatTqpBAh6pg2YMbF6YC0nHGAjMGSANaUwmBZ
7xMC6wkvbhjKDgO5REhstQlS9RsqfYp06fjNOq7pGE9v2VdPTt1zz0/iDkFWpf9OGSqZBP6ZUw2+
BXQop/zGt2AUpKd8Eq/zaVl65MsM4zCiO9/1I84DJYcP/5j+Fh996aRAMP1eXwyfYjTN1yNmkmWx
EuVFZZeWy/2UFquM2IsNigK42xakGiFdkrI2vWX6SAHiieN/pN/CoUM/Zvxfr8/hF8VejL4SPWh2
ggctAFmEPpXYBavsxIYImgCu60akIIKHQI4N8+EkiMEpnBiD0n5FiXAgSoT8DEsMFoO8GYMVCwbL
WlDTKrZYoDVowRoPqw2xEO/11IwdhF3HEiB4h6jCLGOBVINxVZcTwBIRW5UzhUisZX7aRYlQMFjT
BcDCfvrMFMV4hOxLletaYacQzKFX1mCJEqEnNFisRMgBVtjXS4S+vXvfEnQDBzADpEgQoUYAgRGW
hwMvcwdEGo+bgZIs1CUvr0DDJ2p3HmGhfg2hZuOgjddYozfnG5s3bNy0YdPpuSW62ILbWWwxtqnd
iQGmxJYLpIjKFTyRY68M7QmoZ+8GCJDAHIzHwlzdzbwdi328r1fWHEuZL4gEQGmGA9fv7p9htykM
YDHrfwiLKAoqxIrWrsECCqAgaIsclCFWtGjtvETINFgHhAbrEAeIPesarLhNmmdfenZoeYkwyBks
yy2mcoObILUJ8Ws4iIIoCpgMaP9+9rMwM3N4EA1tP09msxLByQztN9ocYAiwcIqloZnlgJiVHTk6
ORuFcb9HDh68hwKUYxnAYoQTHThZfY2wGVjHYzqPS1iQTryKl80M+CN606+rkbDCXLFpRpxEIcWJ
FLotR0Hv+NET0+xbuJcDL4bn6EEJPk+jAyvG4Bgf2MzyE8Ftu3GWKwV5AquyKsWIH4KzHRUcVQKH
6FmCaAwHqVKDJQGsgwcPJxxR5QBrsDwipI6N/jvpHiMFpFeJTammGVbFSCE1BqqNAASvzHvGkJAZ
m1hZjgQDkchwBIiflAwW+3hfaLBKBouMdocAMovEZue2QkcJyhgGlDAyDRb/dXZ5YUvSYAmAxUXu
jMGKcoBlKFcCKKZGFWk5RQAOFjkMcAagj2g0KhiC1MeNdk8AEfoiq6Z5Yc3rZJWmQr2UUVNRTk3F
5dOgmIkKKFPO5MjGCTJoxR5zBmvblm3ztabH4nhZ4DR9t1VsVN0BR+LSHG0ZZbtRsUyNByzWeX1Q
VCcFYsbCs20J0BpKkFwYHJhxjDBZng3VoUnScl0vchlpGjeCvtPuMIDFGaxmO3aUPCUUM6n7DLnP
g1VO0J4e5sPseDTKGawMYE2JEqFkRwIoJuEukEhrIxCHlt8q9MQ1ybMK1BLhyK6PwK0bAx8DwhRd
/6QA5cCBw6snpw8durcEWFhXF/Z7inWPkxKp9Hv9fg4dSnYqo5GS8vXiqURf6YwXmx/0gh6FJkw3
Rhh+Er/FR186SQFKvqG0HN7k1aq0WcmKSfsj1yXLYqVdh4RrrlPj3Tjs8g2dTfpn424/7kQnT/xx
auXY4cM/FTssuCte5SwAYpVYOIaC6hBXT0y+I5snpebIbVNBJXCEMxlWoUPoMsOrgSlYk7Ko3XXO
Ji8R4iJ3zmDlJUIyXLb8x2HwBa6aJbZSLKkip3G1PtBoEkNMJLHeQaGdCmBxLRnlOzW6ULEvJQOd
y3GSlwgNgFVRNU7QXyp7BJBeIgRveQ3qxZUAlixynxqbECL3ZtZFSMoSoW9vD+xVsybqU8eiawG5
FmzAw+TbMoOVg4+iyuaUDJZFVYMegqP2nfEzyVYr1PQCYL0xX9947vpN6zeeWaD4h5UIG2GfAax8
u45a7nQwTZvmjKBg6FiWlAmRmYGqcasFaRRXsYtVChYghUXAzCyyBRoGqFO859MrMK75xGl1RInt
l79iAMvcH0zgJYMwB21cjQDoKTdJgDIyEx0apFRRIqRgel8BsDiDBRZSgT30DcrWlzWUsWJClmmw
SIIpYYnx22cVeC4P6CMd4P+/5cFbMzOHufTkHi5pQhim6r4hRSAiuB9TcK3ipETHTxqiKhYoa3bZ
K2II7HcHKVmmuJCiN/pbvHpyKisRFmqqeEiRyoBV3JRKn7IDRU2wwGH5nuQvlkVDO02SmnQdwtbk
GixWH0yZbebg+NETdCzZu/dQHEZi6xyYChyZoqo4i4gKc/SOq7rbULCSwA1lZAirmwEnp6QCPWgj
ZYyPnZrjAObVGeN7SIaFBosxWBxgraIAS4jcGa5aXiZpBrBMoTfAMA1RClBDhxXsb4KQYVU4DISn
MOeE7UBVSyN2wdj4sATYtBIEVB5mBrCIymDJXYRY8Ro09EIK9BpGpAuvgPJhLCEnEsCSuwj3SzYN
nMHyFYAFyVDAfnhYOh1humYHM5iwmDVU6WlMhoMpwT3WPCjepU8p6nICrOVNG0QjKyUTFaBKrFPI
59+Yq52/9TymwVqsex2y1Oo1QiIYLKi6VIlTgaJeARx1aZoJF9Sz6oANp7roJ4JPJs5cQoADceuw
1hDbncjt9Jsh02CxLryJyf9+6HeNduSAvgxgsS/HrBpwNDEZcCrQlVudKaR5AbBEFyEXuZclQthq
BOyyRJoMVAZLBViYUzZa91ElrvlvHOn2hhEFH6wRjwKsqZVjMzN3DyNMoz2alF7uIuwJgDUUxbV+
l2RyqAypJCp3laYAvkkAsJVjI9LpDWNBwqUUYNFNMJg4PvHSC8fFbysRYDQeCryyXKIlFckBSqwk
AzSqHF7XuROoWz6uPFc5n8S7IPu9Qb835CTc8MUXjlKASMf4omjV74lOzIQg2ju9oipHysRWbW+s
Sm3slAbccZYAnaRAn2CCV50Q8g+VTyVoB6sJU8AhVgY6KoMlYNbBg/caXYTcpiFGyqmmBM0MctYD
bSqL73iXqOWfndgcLopyZIpU5yFsh4jGLD2MuGQTNvswuVUiASzBYO2/e7oAWHArZVJB7sa2m89i
+RXw6GWUM4oQOjcgzXbE6lYcFnBapXfHvoOsRPjiMa4oiijACjr9VhgvtcKmNEoh5j2GIgeEO0E0
OvDCCTPIKoIf2pLri8Y6imia7d5i03eDfr0VsSQZPjlBOfFXOtnEyqAUrIR0Ek/ZTDt7XV6mmS+g
zbshhTsB+2ArdIOuF0ZvzC6ev3Xrpg0bz8zN07U53cGi47t+120H2WfNrUgz/K0w31C2vPSUTXSj
btCjj14nanVjNhNG/LhIze3Sb7nmdhxWIe2UtAfGUVn6GILqtkFHcRw1GhFgshMIkxZ4iF6NDT+u
+3233RVdhLnI3WylBJ3YItQ1DUTwCHXqWM4VKvhTfLAygDUx+aOiRGgX29k7OXyDwVJ9sETTOH8U
UzaP6E9R06DlgfjZfSuJmcidjSsH7xlGfdi9Bs6LTRKpNzsFGrDxvqQYJ+3REVdZXvAKQiXDnvaH
M7yL8PixPzKlFH2XMUOiGJqOILxVJNspJui2NcYDImu0QMYGb/718ZrIMGYD/DHOYM3M3FtQfUPu
LgE4/diLaARBNkTwef2Um1BEFHeSpBdQnE06frexuNRqNluO26w13IbTWKw3lupew3UbDa/ZdBtN
NpM/0lfY1GiKV8Qy+dPsLf56k382f7cpnmZLglP2qYa6NmklLafle236tNVsNGtLgdeie+vWHS/b
Vr6H+ablqXidPjr1httsOnQ9jlNbWPRbrbjX+9He/VPj4/sPHCJRRF9xGk2/1fYcp1mrFx+Ud5U/
OnSi563t0j1pth2nvrgYtNqutmRTf1o+Fks2y0e30XSNbRUHmD+WZ15+qmwuOwnNtue7Ddeps71l
j026u26zXqcgftCjlwXDmhH3BxnG9GJbthSR0T6GWInlQWuRIL+evyX7YCXMB+uw4YNl4FrwFwNr
8SFGO4Iqco+sNgpSiYGJ3Htuh9S5ZsjlAKvwweKjS+y0exxgRUtegNxz2xrBNPSjvY4re3rWwhNS
Z8zXL3wKKHBsdQb1Fp3p04mCDK8zcNk8fRRTX0z0FfGil72oLVAuKZ568FsDRvh1+qz1ks1na35j
vrF105Ytm7fOLtRr7ciNzs473XZv2C5XJW9X3lCxq/IuDbx8KhbjbpzMEYAbgjNb/AZz44zrXrfd
Hba6A/ot0/PQ6pJ6qyMqiU1LH9worW1oQa1X0RYaGGp0BJ0IBqgpAJbfLWwasi48swsVAuiOzUbB
Kt3DuNUgsjYKKOen8MHy/N6+A7nRqKbBwnRdWI1Y+hd2S3FeVjbNAJYAVXEOsDjOWLa108OqBQaw
2E/YPxOSHjx4mEtP7imLepCXzEgmhGihwZImmyDaeagNLd8xCWAlAmAxm4bxHGDxAUMBWLHpT52M
WnQDRUWmNN7ktDBlDNvzYcqb0pe5zQQrER47KQEs9u0McoC1LEqTFZU1BLMSTXt3dhhllJgg8Lrt
8Mtf+trGc9dv27zl/G3nbdu89byt296+7fx3nv+OTeduoC9updOmLXSGvkWnrXxmK389fzGb35pP
Yslt+ZLbpHe3SZ/axte8tVxsa7E2vsWt0sfFW1vP37ptwznn0pl3vv0d5289b8O6c7Zu3Hye9EF1
W1vVNZc7//bzzqeP69edQw/8PLqec8593/veT88//UdYu2r1uy54z5qpVXT99IRsWr9h25Zt8trk
g73g7e/csnHz5vUb6UnbumnzO86nu/UObc+lndki7aS5Y9rCW7XdlqbyFG2VvgJzsWL+3LXr2PdL
v9tNW959wbvpkvTA3/n2d/70J7+Igg5j8nIvlX5vkPvhYX0q1RyYbnAaI9Vz46LNRe6DHGDlRqN2
7g0txyfWRhNZg2U20wWA2Lx4ajBYrO/pjr0HeRfhMT6uxDzYjgMszmBpDfAOKPAyZS4gO4UZPqHd
asaxAG1i2cyiGzBCrttfaPr0GF0/qjkBo0PaFIuwtJyGT/KJAg465rF5OsMf6RDOHrN5NhUz/C39
3XIZJxzQd+ljI1uMvDHvbN28dc2qNXNLLt1uze8vtejOk1ozNNdvvFLuT75CfZ4tIw6Hqb+zPWSv
tNl31+QlYMePWh2Grgy/csWaHPSRcmwycN1MyzG+fdNcwOAylQY9rcRGr8C6T9x21kVIAVYJUKrS
FZ0gsun6RzOMcFCNl7Vayp+2JZuGsoswIEgLoWEFByA5kMGKRHNGYTRagqoMWkkMFoH17KanM3cA
EshDAKy7V01MzswcHhbdaphhkmm2ZKgZUlSxUdmKldhsuFX4KPClAFjCteHAgYOrxicowBrmjqaF
3GokKa69wQrmjbQW98R2RCrQOTsQ+FgCWEczgFUMSBmDRYwqHnp3rrekQe1+zHxr0OsP41zdFfd3
7NhDN33elm2b1m+kWIGOxBvPWU/R1eYNm3JolYGhDBIVL+bAS7woT+LdbH6T/vFimWJJeV7a6NZt
Jdhir4hdorhnemycPqXg5r3veu+GdeeWO6bucL6hrdrW6cHSY6SPdLrgHResX3sOXRV9Zc3k9Nrp
1RRf0mXe86730BNCXxRPZVxY7C39IIV356xeu/HcDRRgTa0co/iMrqo4J9mmNxXHVZ6rbdKZ2bpJ
PvCt+Q7nOEk9jcCp1o9XP8MUWlHETNewZcMmelDnrllLYRY9h7t2XkMvAHqZlX62cZprMVWjf9iS
Y4jGTcaIBahVrl4yWCQpjEY5wAIRXmKtjSIpjVCT4wqrPwIwHrj0xpcBrH5dACzeWM5KhCtNgFWW
CHEhuTUmBc4VwY0eTEWXhZZTx6qa13XDPkVXS27g+d2GG4S9wULNnV1ozC7U+aM6LTbmFpujT+by
xSsLNYc+zi85xVv/eGN2C70heNd7/vb31+nrZxacM/O12fn6mblF+zort0ufFq/Qo5ij0yI7nOzp
YuP0XK3W9GcXm67fzdRmWRBeBDM0fmRWeB2LcQZgzRqhNGSlKNDYh5zBIjKDxUqEAd6RgJU1K649
q+moxUNBukkwy6ByVM4+CWAZpwjsye2h0Fa2aSh9sDjACiK/QwpQlQoeK0dalcU4rVyV9gf8p/Mt
OrpTgJUzWH1YdAwDtaqIGLOxH2v2xiLttOZ2ApYIxWIMYE2XACvhACsVtTa0w5+Yep1E8/rS3ZhA
+yVV3J3CmutE/gpEiZA3qaWiRHj82Ek64B08eG/e5pYOon7JYBGkq8DuhWYohGLWiJryFoS+2NVB
RL797e+tGp888sRTcbfXanpO3Wk7La/htZy213DlyZUe+YwjP/XUd4un2uRBM57xVFtP/qJHj+XO
O/dNvm3lU08+3Qs7dLFOu6t/vJl/pGnuDC/q0cOkP6Buq7nUoDMterxN743X3nzhuZdOvXE6aAW+
59MXm/wtNz9Sc8foPK9a+ml/+PhjT06PTVC0GrbaypJN+Tw42Mk0jtTRzpiHnChPPbfgmfeadCdD
ejj0y6XHHne6b77+5rpVa666csdyP7vYRFMF78lN5aaNVNP5VZqwYOk6BBFOaVE5BLFpsKRiW81L
K1KkiBC562UXPYVXK2FwBouVCFlIH1+SAyypROjHTOQuABZcIowqyCeZxoAHjAi0gnSq7a3xShYd
lVu9utdttDp0vLn9zv2XfXb7+vWbOIu7devmbfmMmNg8f0W8nj0VU/5W9ik2nz/N3ipXxfJw6Ezx
SN89b+t556xZNz02NjU29q53vmvzxs3nnff2jes3btlEl9iyVdmNrcW2si0WuyT2qnwrm4qjoKtl
0wb2SLdbTOesW79m9dprb/hCsxXSwdgLKZLuNXxMOm2yUEDAEZASY8G7uhQd4MMkdKK/2wpKBivT
YP1K1mD1YNoM5Gvt/qhAWkCVGRhaGS9X3laNRjMNlk8cG3eFxPtAAFHNIowKHyydvsorhmhVjoD+
jRxg9bkGizNYZYkQzPG1eJlWNLIhnDyp9K5UFFGqwCsxS4QcYDE//RNSiVBU1lKkkytVEQ/slok1
LoF3xtUWYnqJ0ARYrETILSFKBitWxzmQsqqMwyvF9WcFPyGcn+jISq+qW265bXLl2InjLw8j0m2H
Kd9WL+iRbrxM+mcJBfR9Pg2QyVymf7ZfvNKHPl58pHzkH9Ge9rV3405Md29m5vDa6VVHXzpGd5g5
ovXklffVGXPrbJ5+MGXRy4M47PKO1AHFGRRrsqf0ddY/EfGV98XTs9Jn8x1jM5yMTHt+Z9CLj77E
nMx27tiT8KMrFlMPZwDtXrH+4lPF2SjfkuaVk3lWTH19nfK26LXE7Et6fe5v0qGH1nZb61at3rXr
WgoNozDi5rfM3pbecfHekaTSIQLC+gmcXAne7Jl2tWpUTpFFePzoSdiZllRFDGHqKzLUGPcVqFEh
kpRiAixFg+X3hMhdYbCwVEGwB17dAccM9FWqHpFj79sC+v97oGUAM5oKmRRJcHJX77xmYmzi3e/+
P1s2b9nCi9Bb8imb37SZT3ymfCrm1Xe1qfi49CmKcjZt2MRWzg3cN23c9I7z3/7e97x30/oNFAOd
t+18+u7GDRu2UYC0eYuMhzbLWyx2clOBmdQZZYubik3zg9q6bes2Ol1wwbtXT6/+0tf+M+jQk9Zj
Eq6wv9iyOXdUBQT1cPN9mw+ZU7lmCKiJEmGtzRis/QfYZamWCCNYFGUx6rQYgI3QY+FUdPzp7g9t
qYtQdEHetS/vIvSjisOHjeMV7MsZrDKTIAdYpFRfxTLGQlAOQd2SOMBKBcDKRO6iRIhIK1JQuEqG
AMcDYxHdUyc1y2dmbxpB293FgecMFmvKEwDr+FEhcs8ZrLxfDG6SR2gew7wnqUjhIMjYY2b55e9y
gDVgJUImcmfVEEWDpQIslcEy67AJXCKEvnouryk9IPoMZvVvueXWqZVjJ0+8QhHGMOqfHZ7N8hz7
acmV8utNzNNHjg6H+fxA4N389ewxv0SzJYsPZushQoVWSgmzT2Uzw7RYefk0Owo27q4cP3b0JMNA
vMuyWFvxkeV8bcWapdUOOVBjQFb0ljLXMRFeyU87S2HKUiz7AuJnR0HK8yBWSGEo/44GFGCdOM6c
zPbsua7fi4ojlT4iHXVcrqE4V9K5HUhnTD4/A+AVopyr8l3pCxK/D5ltPWvjZddby2ltWHfO9qt3
9btxwVHxM5BKdi04A4Q5ToFWsWSEWiGBjEb3S2HPZGT1oaURBKG1ViD9WShFJACWlwGsvES4l5cI
X8xKhE5bKhH6EDMBZ7dZuAFTHRwhzkCW5kHEHEgALKZDohir77Q6Tc+/4rPbL3jXe//6t7/PLdbp
NLtQm+UzfD57FK/MincXsvls4Xx5sVj+qL1Yk5eX1szWNr/U4POsind6rkafnppbOD2/UK5wodyx
cgfEu/yVfN+UF2cXy/3hxUG+D3RbS435pSadnn3+xUs+8vGvfvNb7aBbc9qLLisRsmg/1GYCVoI7
tuBIxIgc8POMRnJ7D0pH0DbvIqzJDFbRRYjwRlq7g2PpfDRQlAMqF7FDRsINZWvTttFFmJcIq1zi
MIcLFdgxBku2UmsXGqwBqHOH8IpamVKVTFmJsNBgcQZLdKePFOqMBYPY8QdiRgr7UFsJ/3zcYk5F
ItqPdRHKDFZuW5WaxuKW0D3YFl8XXaX4Z1MwJ85oYn9rkAGsNO8iZD5YzCzj3mI9igaLIKMXwdoG
EzCPud/j5mG8eEpPEc/kHnzjG7esmZymeKXbDoRhATORjwbDLIlvAMB6MlRezKFMOaPwrIPyI0Rp
zpBvEoBN6GTtcBgNu37n0MF7V09O0TPW4TtMsuYPbbXq5mTxovlKvsW3Bstn+8xcdNgjJIxy9DPQ
jzqfGXILEnq6SKd37KUT0yvHr73mBgr79KOQQKp6KgbADDHOkrmYfCyxOh8P9Z8ICiiDiHFCFAh2
47cGdKbv1pob1lKAtTvlSJrnIrDeW14fTC2++UgOqV4uTO2KK6Azl69cNxotwp41niyR7yhSuy9g
PKwwuSid3C2GOlqJIWewRBchD8grbRr4wgXAinINVg/Q5dipDmNwcsC+QlviTVTRZqUOdbV2vNSm
M6Qdxq2gu+vaGyfGxhuNRt3v133mrM1n+vkMe4WZLYUDOhayKZvvZ0/5u8V8/tgXS2oL89WyGfFi
ja18sNiOa/StIHGCpOkP6Ss1P66HsbSqYlvZDkgz/fypsul8h9m+0eNlh+zR74gduzg6Oj373AsT
K8d37rk+6MbtTtzqJTxqeoDahgHFQaQhFKcP0RAbQJkXmXag8gozBivXYE1qUTmjgye4zIcnLuvm
6eipgAndQAJYYT+LymEM0GSWRWjz6bWys+oJFCVCJ8jDnuUSodZCSHKfHt3Kz6aNyBmsAmBNliXC
GDEsAFrkEpvbk6VJO7bKNWCTG+U3URy1sGngXlbDmZmsi1DSYCVAibDKKBx1JyKQzRVBCp2xtTYa
S12EnMESNg3TOYM1zNRRAz7gqU4TqLeQ1bihZLCW4w6TdjEKh5M3FA1885vfosPYyydeEYQQ3TqP
GEoHUcIhLMUcFZNlGfktcG3ai8U8tGTK8sjJ8NCh++gO//HlPw16jH0h3YFYGFwPOImBPLP5iNh8
ElFQxSFvVBSqlt8a/vOtwVuW/WfQpCfuVYZ/euVV+g3u2XPdcj+B94Ggx2U5e9iBgJ+Sz4P8SI+X
HkgcdCnG+ie9+jq9bjtcO71qx/bdg4jQ/5S4CJUiKQWsqSWZAPLVs8XDWwJ5DIClOrkPlLBnW7F+
CNiWVljsqmHPTmDxAQLkSjmD1efRLnEGsPZmIne+TKyXCNEYO9Su3dFgmYTP8ES2Hi7Aso7umSSF
tELihnRsjvxuvP3qXetWrX5zoYZLizT3SIBucapc3Q3XygghQvB8oVKHFAHuprYUINiy/8jzR+mV
t3v3dZ7faYTE6zDbWKZzB0xNowpzdowKNXNyfNTqHcPldS9stDteGLvcnZXiBpba1KVXXXfJ61Ck
SL/NvfuLsGeeeN0hNWY5QRqskN3jrhx9RwFGoJEEfI05YLUuwC8DSyFSOsZ2yM423f9MgyWHPYN9
BqN67aoi90KDVTBYBLphNcNZzWFeHWuFslX4YB08eDjrIlRCbXE/wLginMS04bbnyqVgqKKdwcoO
XNdgZQBLsmlY1ngs4Pc9SbH8Xc2vUuuoAqKEEgQp6idNBVipYtMgdRGeHeQAC40ESWAfLOQEctd4
Ef6T+aamZHDLLbdO80IMZ61SsVcpa5UHq594yi8I6DFhMqlKm4ZIR+EgcPDgvXzcfXkY9Xno5DLc
/lmJhuE0ggSOT4ZWztEJ+z+iYPTEsROrxicowIKjA00DFLAvBM0YTWyOrBZTlWyj/F+bK/AooKf7
7DXdc9as3cm7CAtML0qEPIMcj9mJqxzb7R6zlrxC2cldaLD2S07umHIAO/xR/inyA1yBDLSImFfY
52QarG4pclcBVumDVQAsQIgTITClp49SMF/SQ3XQYGuYX9Ew7wQCYEUUYLU7EQNYq9eUAEszHDdj
EJHkE00l7Vga1kzBGTZMgpJwk02xVJGCyEEAxBPPvcTq/buv94JuPYwpwKLfJm8kxOiZCMnk1j3W
0UqcH1WYYEGI2Ql6IrS41WHlM69DL8suBVvtLgMoi6242eruO3D36qnpXzz4cM0NG9y8XuxD4eyV
mVCAwvNK5zbNSR80ksAq47AXfNYFKTRYkk3D3TrAMgEoklJges27nHWWVYleEJU2DfFQqxWi1D3i
PJmXCN9SfLDErzDgPgVHTMANa5WRiNYUXsBeHBqKhLLkbFEi7Ksi98ymIQUqpJZuO+x0ETjAGBrL
EytGLPckMxqNEw1gsS5CPtot84C8ZRlg2dEtQbgB9fDp2DmMsu80N6Yf3HzzrWIY4+RfusylMBnA
wniLUb5fEOWTairCQnKoAOvkMO5zsLhckVVHoH8QYnV3s43W5UqGMRHNIoNoSAHWNAdYALyz5D/G
SLh1bDTVWhhizJSufJ03CGcAizGXOcDaQy8AIUdjkrsSYCWGuwFcCjQq1yO41eOAVQZYokQ4nTNY
KRgcZM/lBKAtvPMrYMNDpRVfGSPdMNNg1TWAJUqE3MkdAFiWUQoSTjlmf/4ImTZ6QF5F+UnNjCsY
LB63sn377nWrVp9aqIMLV/phVumOe6hlEdYQgIzHUPIgFLcXwKGNpldTwWC1coDlKgALgIYop6h+
TY5FeAebYEX2kqIjcBVfM9vPMF5yfS/sup0B78KLDhy8hx7Lz//7144fe/Sb9UJu1t9ttDvt3sDx
M4gG2BwoYZF205CoUhTlwEAZ1sjnGiyJwRIid+x6xkAVYhdXMljZu0YXYawIMuCcCjw2Ry8RFj5Y
MeLeblUzpGbR0Iq0UlDxamlQMiRNehdhv2SwSqPRXKk90tBuTw+UgBoceIJ5ScM1RCZy54eQMVhC
5D4tO7nzPMeyixANv8OMW03dMfezoAArFsHVxdoyBovhFQ6wRG8jL9PY+LAUNH7Eeggq45WIPTK5
AFjLHGCxEqFoexQMlkwapdXcCdQxagz5Kew3psCjQRSLGxV6Vo8XAMtMBdBhytDWZkFw6qgy3x0L
fIz7WYsD17BnAGv1Gu6DNSgZrH4OsLAGWAvCNpWg1SGY+r+G4uQu2zSYiREVlloJ8OuEE+0rYItF
nCxhTu6yBktlsPhKSgarxkTuOAoxb/Gt9qGOVREPmEromi1IDxQUXevEC/gwzAHWju271wqABYpa
bMbcPWu0YoS2VVryWwJY0e+AvJrdTNzmV8meMoDFGKzrCgbLZftGAMVbgPtbgkayeIIhHhCJtC5y
3FP3QpElQB8Xmm0nYFU/ocGad7pOu1uWCHmyNeOHukQEPgpHWREEhMinkBZUS+kwqAr/DtTUbWM9
jhH2LEqEpUgfdYZT8nksZWiJweLeZkqJcKALeInV0VgbojJH76Eqclc1WPYfcfvACbVDA0UlPMbH
HDBSo49PnAe5i3BmRgJYFMHITu6wKj8BRbuppYoEE1oJGlCDq/VLgJUZjfYhgCVE7knWCGk2JGLD
Bg5xuJN7ViLMP5h1EXJCqARYJYMFGJkmtu5LTGFjEQhaiDft6FSAlXAGK1WiXYZVbF+iNCsgcmy1
4I6ShUNeIkwFg3X8pMRgWWAEcL+RwpYfCZoAbS+ja5cKyRksdqIyBsttOAJgcbsKlcEiywmUEF/R
FELA7Q5H4rzzUy2J3NldRxH2nGLJ5YB3aPKvIDylRAiJOUwSQkRtQDYNmdHoixnAcv1egNg0OEFU
EZ0mjfeOvX/ewg+hw0wEoIRswFYZLFmDVSX8h+k0yIBeJQ96QD1Uk3NZjAlsTQO6LYUTIN6eeusZ
A1hMUKkArF6mwUJVdJALBlDwtYTqmJU1XCCfHRHnn1gOd8jsJNiuchTV8kUXXrtD9tL/ovGJX/3m
90tOyMuI9NLtLjk+XZLO0w/SCT5pFh7R4AUda+6yYxO9mcL5CDIazUuE+n9B5FR6zRuvu9wcuMwi
pKdF1mBpTUlW8z0w7IIikuWcwZqZYQyW5IOFpOlBBZQUz/xCIQsZWrw64eHQGIbFsZ8lmdEoj8o5
SGHiCZDBksb1VHYQBesOOnpIkF3Sx4wUpI6QcaXQYPH9p2NelkWYGY1yf9QSYNka5i3eFsC4UgKs
Iruaa7CmJAaLC7DoNCxLhHD3KBwHlJoplqMEhIOaPJNHzEuE0xmDlQMsyPE1GZHtQFIp4XZR9b+M
lQjZXr01jJITxzmDtfs66D8oSWTfWptJLF6OxyjSkcxZuLUVO1EcYDENFgVYQoM1KHaVM6apSB9P
Ku401BxSYvjrIt0kKSh1N6NyuG5MLhHa7u70n6kETTEH1XWlBgsWFANIq7Bp4AwWkxi3wyjrIgSj
ciCLSNzO25YoAkYTVjA0puoLgwhhrsFixtZxViJcrAOCGxzW2Ic3J7C6dpnZJkBgyyibjhRvT5Bv
w1vbmAZLACy/ozBY9rBnq925A1psYObs0LVn1umW3IDCI6Zq7/aFtGiu5tJH1w8b7Wiu2fGCeP8M
68V98Ne/YyXCDll0/JobUHhBHznvxS5jBxDp4xE6GJq3x+nYbLf0QnmbMXDCB6sUuSs+Xr7Rt2hB
vUYjYRmVk7vzM4DVIUr7utQuXnHHbN6gqzYN3AfL6CI0wVBsjSOsyrcBtLrEqvLRyZKScpCicoSG
nXcRTqgASwt7JkPQBVHzlEqxfj0LtrDESCPyam7ToETllGHPXB1VZhESiYQDTlQCKHUIKveRAVa+
fL8sEcbcmoFjrGUFYIEsBdaDmYzK55nfNbEGgQs9O5E0WJnI/WwVl5ZUdOxXoy6Y0BUteBRg6Ros
DEOUZJU1mE/r+YXVbHhDrnGJDjnASgsNVr/QYHEGK84uOX7TlaaFpo0MbQp644Sj7C/8Hw1F5cgM
lpxFKBf1LBy5XipNRmr+IKXRaGQNo5VvmiWRO/+x5gDr0FRuNMoBVpSHPYeKz6HKnUAgIILMuyMr
KdWDC0kVTew6atEYrB0UYK1eUwIscPi3cWYRWuzD+uxA2IS1qlnKuPZThEUh5R8UGqw9cheh0GDZ
sVSAnHYMvqh8pIO5mOJTgZAK5PSnv70xW/O8gGmwFrzIaXcPHLyH4v5fPPiwG8Re0Gt4YdDrLzbb
L53480Ldpa+4fhewYgfPbWCI1u10V0V4AHpJt7USoRz2HKikIOQDbIusFkkMgsGSuwhlDVas6dwH
Nic9SKWL2DT0K5yiCOScSfBeM7PQQyBaixilN5TWSkqbBpIDLO6DxcKeGcB6Jesi5B4E3Nonxbwe
TLSXgkQIWCsheHYhWKQwGCwhcpcZLMXJnXuBLgNdhLBxq83wQhpvVA0WymBxao2hQJhTNDTCKcim
mN+yUcFJCWClkYLjYibSP0vflQAWyUTuBC+r2flRS/EIoV3l0V1osFKuwSoAVgp60pKhDQ+NTO8B
SJTAZm/q1ctz3PsFg8VLhKKLsARYqfDBKkquKVbPxezdydCaSJgYbjKJBoVLo9Ei7JkXr43vN1F+
i2LkXxvS2wESPTJcYdFcOwHQ3yfCnlmvuwKwsrDnQuTuA12EsITFQZmDCs9um+eQOlo7mHWWUh4q
AZafAyxWIqyEJpDLgIMIkG0aHXAYHpmxc4JoJEcMkNWTPnXk+YzBagXdEmAFxFR3OZhnrDVrD6kM
9iqQmYG6hCkD+768gPUPhvGtt//ofR+4+OA9P/nbm/MUoNDd3rv/4OTYGAVYjh83W+Hrpxd+cNfM
e//t3792822dOKEIxgssVUuIeQUdTAKoGIpaclQcbF4i7CsAi4vcgX2wXT9GO6pp0yA0WKKL0HRf
5DO2TECTp2EEz7CIymElwiIqB3OtBJvzK8xFk8rcHnR4i4dmJULGLpIPVuHkfpB3Eb4yKGwaMif3
tLrDKMbjPuJhhY27pZkrRtVFpZM7Fx3LYc+mk7veRUgqTH3QfeZYZBhrDFNfdBEym4ZYdBGmAmCV
GiyMxrOUruIRpFdoORW1nxBklQBYpQYrE2UjvXVaeQ41XQOV5onh1qHwRryLkNk0lCXCQoNl2F2a
wLHa0GRUeTgQO6NO4h5suRS5Cw3WrmtyeVZWIuQmDsval5ViYQaxtSRNcGEowm7KUTmFk7tSIiRV
OrB4aGt3RaxAVuCjMhjZK0fl6D5Yz75YMlhSidBSV0LqMuYuBQjhgdVNdBsF3IOxpNNkgMV8sLjI
vQaSDY4l/MeER6buSjMB12KqA6Q0VsFmRUVx0AFOQs/W9CcN2ELkvlsGWBx9KhwkuLfgOQ+0UKMI
MsiAZeBg3lFxaKIlsNUhdKrTef7WlTuvnRgbP++8t9/4uc8fP37sh3fcOT059eOf/fKFYy9/4Qs3
bd20ZXJs4tNXXFVzWktO2O6lNbeLnl57ERCsGOrtt+A5iWwFcTWLcP+MocHCSN/KPB+lizAXuUs2
DalmKp1LslBNBgIs5KicgzLAUm7+ED8CS+BMbEl7BX2AksqWQ3DMyNX93KaBa/ZnMgarymgUve22
dO9jNRG8mGVvGcvDnvMSYVqUCA8evK/IIiy7CCUGq6I4QoY2cTERNg2SBotkXYRTRomw8MFKzYA5
jM2Kse593Mcf1B4R5DsqS4SlyF3QckoZEa3BJdayV1KdFgxqsFhmgFoiJEi7omlzBVrpjmA+nqL6
Rdh+bAjaNKxeu0v2wSptGs6ibsOY20WlaTtwPwBcPGXYszAaPSD5YMWAzAvWtJGq2quxPytAWYlj
Wkzlg0EGsMKii7BXarBeLH2wpKicnhFLEqE+AnCYYGStbanODkazOpxqZ9AAQoPlqTYNnMGyQT3M
nUEn/wK0acAJIgSfmZYBPZv4BtC/49yYuel8i0KDtVvSYDlyiRDrJaymzSLUizwwG+sAfKZVmZnF
aBhxhTubX3IDuqsn//L3889/BwUlk2Njm9ZvmBofp5flls1bJ8YmVk9M0uO69CMfe+3UrBN06WVc
8zqNdgxzQlil0lQNqsSS1qjh6KZfEWBFprYISF2ETIM1lWmw+ka3YKT3BODsoGOWCP0CYHUzDRaB
gjLiKkWqLlxIGINVarAOl12E2C2+MTTaOgERm2ag2dsiu9F/QxWoVDBYGcDiJULhg1WWCE0Gy4YG
MFCClplSi1TZIuqXAZbsg1VosPJRbVh2Eaa2eGm9dAtVJ8tdzRmsskbDfLByKXFuNMq7CFmJkICu
8YqkJsX8Oc2QxBGRK97Gn3cR3ktvL08cK2wazlYQilWttTAqtbjj5hdAJnLXfLCQnKIRCuiIxSh2
v4GZlWsNKGoXoQij9HiJcFdeIkyyEmFa2jTEVlQ0gpoNNhORVWgGCC59sLg6cKYQucNld9zA1mxD
wdT3sVYiRDGE8tQsEfIuwjLsWXJyN0TuFd6SlqECNMpCWDHA8bKHVk9KH6y+rsEqAJYB0Rw7kgDU
YxGaBWQxoAdJL+SbcgLYhdypkHnpu33k+ZemM4DVNZzce7CfEyhus7ptWby7YDt7A6sJNksYLtBv
bdFp172w1SH3//yByZVja1etnly5ctXExOqp6Ymx8WmOrihYeezJp9sdtj+LbkjvE9q9Ze3i1EFP
pSZMxVXqFyQhoVEb/UqRu9RFeAjoIoTd4NCcgGL3eFRO3kUYSBqseAik5cRWx2cCyLrTzMn9n4rR
aBH2bPkxJUObTLVqAmoNBI0PS0EJl6rByrMIZR+sgUhVU7IIpR/3FOznAqiXBE9dTFLkVhjSSAFN
bRS7yD5YktHofUAWIYgR7Zb6ilGk3kWo8lJ9zQdLaLD46bVZQqQa0tJwXpVjQqonylnqdFLqHMdS
ehdhxmChNh/V1yqxtm7gAkfJyZ3ZNKyamIRE7gnE2yUA0WWTHiawna/FiUq55LISIYfXstHoNeIt
QZqeLWwaYLFaYo9k0O8BKq1YbCL30geLidwJzi7HozF/aANKUvhg4UUHw5VbAKyii1DOIny2tGmg
AIsIBsuB01oiBF1FDqx6hmzcA+Qm3pKTo6mylBbFMipH2DQoPlgY8rPUPS1t+XqVEFd0BZERG2w1
jMBIOxQg6jNCg7Vb9cEqS4QW6ZhdpmYeCJCXh5xMSPLP43GYb1m9lblhLTYZxvI8/+rtuyiWOnft
uqmxMXo/unpymj6lSOuyK64Ke3HdaS1x3qveogArsTYB4M4IQDBRVOGr7gNo2FFPguyDJds0ZD5Y
JjC1+Z/BHh9uafymZhGaSc+aTYPFpVMxbBwUGiwR9jwji9yRBihbIodxB5naowZjK21AKm6OdaNR
Uji5v1KGPctKWLs9D6g5k0YIxNMBNHRIIK8H3YbgbA6w0jyLUPHB4vuvaLBs/umQQgjhb4ST+1BZ
Jndyz0qEGYOVA6whirnBRi1DfJNaslxGGSm1Hs/MpqEwGu0npQYLpAyr0BWamZ0gTqTKtSSc3I0S
YVLdUmo1N0kxtwWCOkjZ7TnyEuGy4eSuAKyyRCg17Rpfa2KrZhJ77GCCVg8zA+Hi2hOdK4cNDVaC
Ol1VbgiIi85+qVYYXAKiXC7CYg0frNLJ/QWtRKiK3KtbzwAdumOKqSsD18xIFlCVLI3ffMjJS4R+
psEqo3KwvDwf20PFWdSx462KLCA9aMUJYCd6qHES/E6xvBrJaFTPIuyVDBYgIOuhtVcs2q/SsROs
zanL0G9KYCxOX/keF2PReT+MXzr28uTYBKOsxsY3nLN+9eQUm5+Y+u3vH3f9jhty/VaHeN3hohM4
VeGJlf63cMwOhNuwgGr5q2lJDFYe9iwBLP2/APIXBc55eSm6hUO9YLD8ruubXYSlWQOsecJ5Ds2m
oXRytxg9EFv4awrGjGCaJIMMS2EhcAJ/MD/2XOSedxEWDFZh00CQljS91FVVN4RHMl0CjypjjDFA
lAiFpaeRRajZNHCjUZBCMOzN4MAfJWpmWffBYiL37+gAq7BpAA8Za3qARDBowgkKvBKLuLtgsKYk
BktE5aSjhPuCfq0x0o5gj3LiH2ddhLkG6zjLIpwsRO4pliJFABq44DhT09GA2BovYKcug+XiNg2S
k3s/c3LfKTu5Cw1WnEflWIJoLEySTYFeaQAmqFOlizAvESI3RRjaI9ZoS6MFZ0WViWVkVMdiocHK
S4RMlmswWKYGC1LNw2LhSEcGmJrHkLyYaT8opADGbynsWQZYeKqJvYAFEFqIIbsxRuoJhiPGD9uc
4kd2lDiSa7CYyL2jidwhhIp1yQWVYnasyAh1fRqQtNHqsEkIAfOVs6/PCSk0ue17P5hk6OpcAbPo
/d/X/vPbfodVx2qtTj2IFhy/1UuWnACxq8W/Pks4EoCfoO/X0EXJC/Cw535d6yLUzr/JQWIaMgOT
qTYNuQarKBEagTnw/bpxT1wMDGoWoWQ0ipmtE6SPCSyKWagUglTiYmTANpkz8UOshT331RKh3EUI
a40R03bJj9Rm+YP65ie4+5fChZwdlEajBcAqGCwx2jGA1ce7CAmijyE2ByNWIowTVeTel2wa+hqD
BXl+JlX9bonJ2KXYiYVzIZHCruzkvnJMLRGaNWirutmM7s7/QVLTXwrMoxRdhLmTO+8iPKn4YNn7
Jwhic2XvKARCrBP0rCrbHRQidw6wUglg9XPwmoncM9sLYjVhj5E+Vi2XMB6ipv+QiLC0aSBZiVAA
LItawDw5OKZHftYygIX5QUMsQlEiLMY2Myon12DFS14AJCWPZH0EDecB3jAFiLsjbGwGLYLKLEK6
811mNJp1EWJ9iKB43xTugLQW2oOGYSNEbQN6WwRRNWuoJRsqDFYhci+d3BWjUbuBgqWfAKapLMaw
NjST24RyOorjhnZvwF7vDOiVeWp2YevW8wS6WjU5tX7dOa+8+vdWyNOdw7hBsUWHzDfbzL4BtR+r
Oi5/NFd9mPtU2zKk1wsndwlgHXJUo1e0q0C6VBy1t1TxD/PVLkKQwYqzjsIKuwTTeSgbO9+iN6wz
jIGTbBrMnny0WSyBiRPICV3TIaUV5Y8ELk2WmWUag4VkEXIqCA2mtXAqNi8GbPBO8K9ABxOZ0Wgm
ck8UBitXHJclQtj4AGi7w+GLFPYcJ+oXVzJYSWHTwJ3cM5G7gXpTzOKyKhoZbtdHwEEK8TdIFuFZ
mwebtfsS8mNLrLhBOSdC5J7ZNDAGSzi5Y6clgfsokWssxf6tMI0dwaIFEgGw9CzCNWu5TYMRldNf
rgjtBuGRpQOUIDFTupFHzmCRjMGakZ3cwV8PYvVeAfcfSmJYAcibLLRH3kXodfp1wWAVNg2KyL3H
NFhBbtNgKQDZzcHBHn6L/RUmPbFbCSgi96gexEZUTqXTqbXsFUS2mELENMEBgmJsuc4Aw2GJbjTe
LWJ8yhKhlkWIaPwdixoMBMF2c05U36Z/6Y12R4AqipmE2p0HP3ed+K25pt/qxDfe9KXJsQnWUbhy
7Nvfuc1td5x2ly681OpQDF3jKi46IWqwnhNECHkZ2S8kkAx2YOQNfDtyVA4vEU4oDBYsyccZQWNn
SgarCHvm/60FolIAFk59ow0+mQbrnxRgCZE702DFAzxsB+9mIojtDamyigDHG30Ih820FJG7xGCd
yETuieKDRdCxIbUzbRXm4yB1p0IHhGYAugilEqEQtuthz6ClmaXOFQNkpJRFWHxQ8cEa8l0qNViW
DBa70nkk7DWEXQxQYVwZlcMA1rHCB+sskhKTVNjhmpW42Goka+DvzKYh7yLMRO6gBghm0SD7Tdud
DJIQgJUjNQar8MGSuwg1BitWGSx4hxPTsCMFX4+Ho1pnxVIXoYjKyZ3csy5CEEqC/48WszHELHAF
0IKE/vobXYRB1kV4p+gifPFYU2awgryL0DTCBu+2TSG2hawCq1Fg/LAdGxVIrrRpiLMSodRFaImd
ceCTFsmCfWcUIRrmgwAbu0OVoCCqwjER3K8n7V5p06D6YDVarDrc8ONG2F9wO4tuSK8BKcJFx1ut
zoD1DXT79VbYYCnLAzqWt3oUKMTZ5GczDUYjxQ5Dt336KCZ9PmDbymakBeTFxFOvM1hwArrdZ188
OfY2Jr1613v+bX6hJi/m8D0v1yytTUzZtor155tmj35c8zrirZrXbQRk3gnpiWoy1TwrWeaXE5OI
1VodhO1jEnumYuz0l1rdGv1Uh66BnuTMyb3WJm67m/lg7cu7CJFbIMe02gLBXClyl+r1WdgzAVsI
l3FtE9phrjq5G1E5FZURvRBAqqz/cLNv6EY8qagC5GegiMpZzn2wjmc+WMPMB4tApAscFpvYypQg
G0Fw9y9LaFpu01AYjapdhIUGKwdYxdAFSXYAPEeQtJDsLcloNO8vk53cmQI6d3Ivo3JiqNYcV9Uo
bZXiBCgWY4SlysCVNg2cwcr8Mw2yNoWkSNYaFtT7hjCaxUkojEZ1HyxiRBkSw0SKWOtuFkKXDKtL
deqqhAYrzyJM8izCNYoPliJyRxpmY6t/BLE2Hcemf4TeriuXCFPOYNEvOusitKr4Ua9RABoC/q4r
LObmesBt6eQuGY0Kkfs+YTR6XJQInbYU9uzjbWJmqjGGM3RrhggZYHBHeDvfoIrcFQZLLcw5Vgmz
g9VxQFU+rKyKDPtQ7RuJ0PRrW5ohYvFgADiZwSqc3JsCYHEYtOR1KCRyO31mJeWGmNdG3evQBTxu
5MF6Tin48Cksa1Pg5XX6bAr75QwHLqxg187tUsVTPlN6qPIXHRbwAiwjHkX2M0V1QY/svu5zE2MT
37z51jDsFh+hM/l6YnkNyoy6fnkH3DASqdIipUcoESl8NFtZ65wh0y7O4jaj3VumGGuu7rldsuD6
HJzR+5aBELnXfAawshLhvkPCyb36tqE6vyh3cudiSsd0cpfDnnWbBtRWSgYZigaLhz1nDBbmXQ6+
biMDoAzgCq+BZHT3nZzJQ0qEstFoP7F6hyZwYxcZ4YYbTFizD4pSiTBjsEQWYSwBrLxEWGYRAokf
ENtBqoa6vEQ4VN7KNFiMwRI2DUzilihO7rAWLYGvMYJJ0BJUblXyH0OsraHQkIkS4XRhNFoyWLgs
3WLjCVqW23MVpTNQGI2KEqHi5G5WtQCXc7NpAGi/TQ07DFtONnSAw+JElQBLaLD2yEajZwuRe2w9
b+Z/NMHDG4hqnme9EzM1WEoXIYGYdZvtHF5jVV9f4VhEJJDhU5FFWJQIOcDiWYSSTUMJsEariKGC
EouaypK7ArsV4PRPXiIsARbXYClROWD9C7acMBKswUi+IEKDTbCKZ4A4YaL6a+uQDHleyF2EpU1D
SOg3vuSFwj/d5caegqSBO9f8XqPVbXX6TV65c5meutv0KeTq0dWKyc1n5MkVUzv08kdgmXboSvPZ
K3yi8343ZhjFa/ud6Ne/e3T8bWOPPfF04IfFysEVSjsQajugvNsOnVZI10+vefpINyHm3XZHIC1X
BPxZTGhLPqnP4VpcbwVO0K17Yb1F1zDgDFa/7vddvwRYJYMFN1LY3bmUG5JMg+XnWYSZTYMU9hwb
Inf4vh+mFpaFD1acabCyLkKLI7yKnFKsPz+2+jNhjXt601m15Y84cNmmAXZyJ1BUju7klKAN3rbk
HyUWOtU7+Q3vKzUHLWOwiixCOey5BFhwiRDoD1B60BIg1hoCWHki4aAsEXIGS+yVGvacVMblwmOY
tfMUbS3ESRoj7JmUJcIYKYxahHFYw79WCMPtcEsNVqyK3FGImWA5mDYsG1f5XFTZ58pdhGUWYcFg
6Rqss3iVU73YAMP6BJpJbCbvEr2dA6wBj8oxNFjWXEvcSywBRO7qtKLKM111AAoKDZawaSiMRnMN
FlsmdjWbhiCyyXEw26ogwt1EeygTYwnpg03DCxpMCXsundwDQ6jkR/Y+AIARDKBWL0tjgd0aqpLA
gMRbjsT2ObiK64nnmNHoHg1gBYyqoRiLxf/5XadFoVIkzA4w6Ew/0u4NeVZguNBs+13yzIsnHnvq
uUePPMunZ/5w5JlHpemxJ5+l06P59Bg0sQ9KM3z+OW3hJ5558fePP/XE088/8dRzv/3DkUs//PGH
fvPIY088+Vi+2kelDYlVaW89Jr1ebvdIsf7n6fofe5Lt8+NPP/fwI48++sRTx07+iR5jDrDYSahz
Cwn6PwJpCiPu4xUtOeHRl//isfMZ0PPT6g5rFJXyEmHdV0qEGYM1ogrQavcqReXkGqwgApzctRIh
GcFHMXPEHhYDQylyjwdokgnyC55iYw/qr4jXsGwW8Im9RCh3EZYlQqICLDKsMM4meLNkbA3Ssan+
jXn+lGmwSMlgJbGswcqIN8VoVBFZJ6OkIYH1VtFFmOg2DbeKSF1h02CUCBNUsk0wAza42Q03K1dz
o3EilgIsKez5ZeHcpgAs7AsliLUVkpSMU2IKkuZGo4noIjwuM1hVPh0VjKAtuAl0eEL6RvND5gAr
EQViIypnUFSlSwaL4LnUUqdeCuZfgfsG5UkADKhiNMp8sKYzo9GkKvw0Sa1eccD+SNTpCkwPrkEQ
yRoxLo1GS5uGzMm9KBH6IZEYrB7eq6X4jjomtWNHUQDNYxekw0kmgsHyAoon8ixC1cldpdPsoYo9
i8IdSIPBnQhsKSiY88UonqtWprAIe5ZLhKwy2OrQJedrTjuI5hYbf39jdtEN6hgxyQEWxeJLjs8S
A4Po9Hz9//y/91/60U9ecdVOYLp65+VX7rj8KjrtZI9XStNV7K0r+KM8oy1wef76ZZ/dfvmVO+nj
Z67adfXOa664cseO3dd/6vLPqh/ZUW7uSmle3rr8lvTZq/dc/6nPXP2Zq3Z++oqrLr9y+2V0/sod
G9ZvfHOhkQuwIif36FJE9FoBscXuUm77rztm7v5xpxs33Bb9V6Lnuc1F7hqDVWrdzFI4YOHbsxjM
lmHPgfDBkroICxKr5LEGKEsPmkOqGiwBsDIfLKyUZglzhQ2ZoAqLpXM+RuPnwGDp/NjzEqHQYFGA
dfSPpdEot49a1tAJTGAkQAmD/Cu+lJjPFjJMvqUYjeoM1lBjsPoJai4f4+2QEH4FswhLo9HIMBqN
oYQTi6sQloJCoAQ6o8qTQsuobiOqBqvIIjRrZGiS5hBWvsfA9YCSXvlU2DQAWYQx0pCrqcIrNfWV
idrqdYv0S6phz1mJMBO5p3n85XJ/GYjKIVXz9uRvM9CJQEZ0YucLkXvfELlrZVbAajWxm6qkWqyT
5CGyQpYoIbG7SjHCDSUNVlg6uU8VXYQBYjSK4R5dlg4JsTE3SLOXDcZbKhwJTEP5PItQAKyuAFhr
FCd3THWOdgYgQTdo9xwmDov0zoAKB3k4RVg/RSBJFkRHpCxCGWA53cFis+22wpbf23/w3ieefoFe
A4teiJhIRUxR1OlT0OB3+3Wn/fqp+Y9+/NOn55ZaQddjrEmXz3RafKaYvHwqnrbUeVaqy2bYpLyV
LdlzW52gS+hjw223gy4r50nLyCsXeyKvUF2VNONne1tz2y6vD9LVdqJ+2I3ePDX3kY9+6rUzS1xH
VSrcGXunidwlNtftDN0geuLp5ydWjj925JlWO6y5wZLXaRcMlg9psOwG7kj1HM4iFGRbGZUjxTyT
Uu0OCXhtjEsJsGIpKkcGaoarDZT5ilc0LP5+plbalFMQMB+6XEYqEaaFk/sq7uQ+1HywRBchoKpO
EkiGbEkHSu2Bj/KJAuJfEi3suRC5ixIhyyJcOVYCrCIqJz8Em9bYLEghWTFZVI5SJ9XCnkubBsXJ
3eIKBhQl9WsglWKaoKTnxObqLg+HUlQOZ7BIYY4FtRDilrZgjTWGvNwIXinOw54Lm4ZpYdOAyOoB
N13LFUUq9OPpiLGAJAdYsRSVowIsxck9TuFsR9QJNrHFeGPfLCLrLDVYUtizYLCAnhJixB1qSr64
ijRVSoRBlcuU3OatZRH6WdhzDrAgo1EwDSaIbE3+QVVpzBJWoycE93AZk0wXES+IgSzCoEy+s8Un
w57dIFrqVXBdutAKD6gJInuui60ma5RuxT4fef7odGE0WgCsgDgd4nBgMXPovi2bt/3pf/7OKk1h
5CBNnW5n4HWHFDR4QeS1O7Pz9fe9/8K5OQrSeo1Wj6nIKRZps0468eiyHj3i8ckVU1BOnngaZsuI
d+UXiyVbQb/Z6rWZdp44frTkBgwXMuf3fHk2xa60kuL1Ys3a1uWtCORU90K33aHHRRHn3ELj3z9w
0d9PLRSKNF4Y7WQaNdBqhP7XRGnTC+rN1gUXvOcd77jg4d896rQ7rK4qlQgVBgtMYarUTRrXjBvq
lfesizBWTbAkkbultmL+sudZhG8JBotrsKSw57ja6KFSU4+NSSYgSE3LIoKNeTKDNeCWOakclSOM
RtNSgwXcs47UDwXltABaE/MW3ISDUFMn0EXIGSyWRZjXawqAlZFwMbZXQzxRUd+HgsEqSIu8RFgw
WEkR9lwCLLSKmsDdoLrnEAIER+mhiw0n99wHiwGsWMoiBPP7YDLDcBOFrdKHmG19cR60sGfFpoFg
CQH4FTJajGNFCyH8PwgxWCwqRxG5lz5YBMkIqkwBAkuEMWSBAVXx1LBn3kUoO7lbopksfYVxVeZ3
PFyBeH9Hup1SOQzHpdFoGLu5TcMUc3I/LjRYahchHl0H2A6ZUhIjvDmwupKimCyys2iSTQNnsHgX
Yc5gAXYSjukmirm3W0zJdafvCG6NrLRaCCI979kilrd2MjKR+8qx3XqJsL9I8USXfP3m70yOTfyf
f3tfw20vum03GiBfVq/W6nIvhm4YDb1298xc7aKLL52bX9K9EoLMHKGwb2hwjC5MHMr5/BXl9UB9
K3vK1rbkdmpez+smFOTxtseoXDgwPqi+CK88326D7nOPrZaCrXZ30HTDU2eWLrz4wxRgMXIoLwvW
Wh0n12Ppujf+WPNCCrDCsPfF//jKxMrxibHxW277wUKzXZQIPcFgMR8sVYMFwHfr/5f6j5ZpsHzV
yb3DRe5AiRCUvEBlu/zF5cFQYrDUEmGMW2iCml8wQ4bYYytwsU6FnY8CsNQswoOrTKNRIvlgAVtM
TIrF5ngJ8kOov2KCWk6QUuQu2zRMyz5YJI/KKZzc7QMVUatOaBdeCbBKBktosI4qJcJUj8pJdCYG
OuqR+gZQJ/pqHF/4YJUMVmE0agPHo8W52Lxk4Wa0ootQROUoIvcYsWi3hL2M0kwQo3V/sJhe9IoK
F7GcwZKNRnORexH2nDGCCQywIHwMc3Kj3NuoC2QMFlG6CHObBlWGBbGVaHBQRRKlnEUIJ+yquigl
i1ApERY2DayHv60xWIavlV6FhPKJ7TbZqIocNmuoHJNKJ3cOsDiDJUXl+JEtTg5OuUF8wC34xi54
twf2ofnNkVZYdICyY7ljz714bGJsYseeG5qe3wojhzk2dd0gDoPwW9/57qrJaXpd3nDjTQ2nzTpJ
A4rAIq8be93IFTPZU9Zq6vix3yV+GLX93uzswgc+ePHpU7M5guk12p02U9CzEp7T8ingaDDeiyxx
hy3utsBEQkutbp3ilXavGcaLXsfpDugrToc0eYHS6fbZW/RqZMswRMgQf7dPJ48DCOGn4PBaGF1n
ixtGeDy10BF28L1hM6QHQpETc3hfcAOn03eYfwThvZAdoVtv8GKfHyU1utsMMtIzxngmpzt87c25
iy669LUzC6xHMozo1KRgNKSbZk+doOv49ASyx3IKugsssYceb3zfzx4YXzm+aoqd2C9+8Uvz9TY9
oiWu0PrR/sMUzt6592C7RzSLXdVINkLuTwAmtbRpCHMNllwilKuERMki1GyfUjjOjAOsPIuQMVhZ
2PMAbwTDk0zsKbZkCHs1YW6B1ffihtEoyboIMwarpwIsZexJdO+rCmYLD8wGUgitEm+VUOQAayiK
cbIGS9g0SFE5qRKVY0mpsxdBygPJuwhJUkTl3Hzzd6ZzDVaSAazcyb0iHzCxWEKgkiDQSV8dI1Mw
aEVmsIQqvwBYsSSygRRUqZkXaU+NJHhKkvRiWSKUuwjJsMLmALVETxC9YIKW5Ow+rvmpk20aSif3
wqYhj78suwhjxBPB3pKCpUyaiByAmInURZj5YB3YX2QRJqjGkQACvhS84cSNcFfgdIvRiRYYRqOh
8MGKiizC3Mld2DQwDZaMSNRbeWuYmr1jrsKAtIcYgtsKkU5QMlhKFyGmvsIBn2MR12NmXZgJqtpK
6ZjWptXi+nL0Bc68IaU/8vRzE2PjO/fcEHTjWqPl+azcdmrB/cIXv7z+nPWTPHnmJ/c/QL90BjsC
JmBv+RF7DGKPzbBX6Ezdp2CFYSaBZl4/Pf+Rj3/6NGew6q0ss4VeIU0vPHryT04rcJh1VshF8cyW
vcH92T0OAoQ3BH1xyQ0oAqNP6QxdwyJdmD8VnuyME/K7FNzQNdO3/vr67Kv/OEVXSFEU/fh8wxN7
suT6Ylt0+XZvsNBsLVKwyEzhh8Is1OFb9LhNPP0sh1bRE88eZRttd1lVtN11WxQXDpY8Csv6FGBd
+uGPvTZbZ2wct1etUVDY7mW0WZARdQ73LG3mRql1wR6F0R///Ndz2Yll6dRrpqY/u3033XO2A+1w
/wEKsMb3H7qv3g5xJV+khTHA4eiF9iszGu2VDFbAndw1jwai2jRU3G5KDFB/KBmN5k7uclRODIXP
V5h3J3DomMVl1B7vg498UhehaBUcSmHPuQ+W3XoH4QCsJQ+0rQzRkCEDpAywJA2WlkWoabAg54Uk
hcpMKV6dzDkMqYuQa7CmNQ2WXCLEPNYJYuKg9wMmeOMYZBFekauzXPhg6QCroncvUTAccAcyhO34
ddcGZb7MIoylLkKLO5q9jG7Vn+E+bYkeZAT8+/B/7f6yHpWz8xqKY4qP0+uNu2QtwzIvgkPq2Got
EdtSjBR/uzLsOeUJ7oenNJsGAjVe4HyVTnohXQUrcAEHHDtTMFh1YTQqZRFmYc+5yN0LIpZFiDmw
w6kjWJCfLRvYFnVXidKkEiGX48T1IM5LhGtOLdYVOysAZlmMpiLEiCvC2xsjSwXQhiyRIq+jMZGm
kamRrk0B1qrpVVft2OO4bS7u7j3w0CPveve/rZ6apoM9fRx/29hfXv3fls+onflmu9GOm22KttnU
5JN4heJUOi22uxRJNPzOa7ML/37hJf84NUevmUWHMUlzdc/v9l8/vfChSz92eqHO4BHDSQwezdc9
ES9Yb4X06qo7rcx6KuguNVz67XCzqzjo9RteGPQGdddvd+J2hzDZO1+STrfdfufNt35f6NYXGy6F
fQt1z2NGXD0K7Nr03oCF53TcNtPFN7yATnQ94i26NrpRirPpZ12/s1B37rv/gbrbpkCwGfTodn0O
x+ed0OkOT88tXXjRJW/MO044cDtD+thgFb2+eComr5sU82LyO3GTnuF22On0PvmpK+i5PWftOhGe
uG7tOTd/53u+Hx48dA99uv/u+xY9H5e3Y/b9kIVv0UVYXA9tS9jzcDmGnaYhX5+8cSYTuWdGo1IW
YYJrp+DYZqARzFLxwUqZZIjaEJjQTcsi1DVYOYNl2jSAWIrgJAFq6QQ5f2KZfdCZFF2E3G5K+GD1
jxddhDmdkIU9EySLEN4rWJUi0XjLmcg9LgJz+mUXYZxpsIQPVsZgEcy+KKniY+wej0mFFTgBuC5h
03Do0H1FOnWeAIO4yNrt+MHSG8HDiIzRfRDFwu6EabA0BsuW95xYJIap4SaQ4kZcsMzLmDeNRl0e
lcMZrAHs5E6GI90UYaX8SvMzM1KwCHtm/9qpYjSKGaSBzT16f0ySgDa20u6taAaG7kejr9Tx2w2Y
u08JsLiTu9BgZTYNZRdhLEflQLUtzfIK7xYMIH9zOEOmp7u9+1GF8FyKynEFwMqd3HOAZQkhBvJ6
YVBlPsVcJxDrzqom/Crz1cAQpEPSt+dfPD45NnH1jt1h2K013G/ddvuq6dXjK3lq8sQkxQGf+OTl
UURqDOiQdm/QoHiiU07NfGbJCx2GkChg6lIoNV9rvvff/n1uqVFv9Zjiyu9RLEvh0en5+gcuvOTb
3719x54bfvPoU67fe/iRJ+jrzVZ45Lmjf3v9zO8ee+rnD/7mmus/f+f+uzvxgCKe2+/cf9WOa755
y20Nx19qeL/5w9M3f/v7h+69/9W/n95z3ee/98O9M/f8lG7oO9/7wV0H73v0yDMnXnnV8zuv/M9r
D/7mD2E0/OGPDl6967o79h1m7Y1ucMe+u3dd87kf/GimS9I///Uf9z/w8P5DP77xpq889vTz//md
733ui195+S9/o7jqF7/6LUVdR0/+6fovfOnqndc88tgzLu+UbATR66dmP/CBi//69zdPz9XOzNVm
F+qnZpdOzy7Rx7nF5pn5Op9qs9kMm6ePC4uNhYXa3PxSo+F8+Ws3n7OGoqsJBmHHGZVFZ668cvt1
19147tp1dx04VPdD4PKW/2uQfysjvlPOIowzgKV0EQ7yKQdYoKKFoBaLXOSeyDYNHGD1R0oNG8EI
FJVoYOlsoLUEWPYSYc/i2AUDJHURcpuGIipHra+Bd+SA6WWCujDEo7WsW4wG8l/5IoswlbIIp2Un
d6L6YMUWPszaAmk4oRddhAWDJds0ZGHPBYOFxZ6YcTSjBPxBmUspaBeJuakxLCX7YJHCu0G3AMBs
yWLEAR8zR8UMR2Il7HmgO7kncKqxJcbATEGwlAVJFV2nq7vKLEJhNCpKhKyLkAyK+4EMYJHl1GxW
GDE8Ci0EJzbTWlL42+Uid82mIR5WeqRJF2QCNP2A36CURdiz9BwpY3BWImQid1fzwdpblggbfqQC
rAjtaIOT9SwOUiAXZVqJ9qyoDonjlTVYWhahJsYP9KKMNQNRY5IiWAsPKtmDCM9C7qGJOhafJAkR
wo5cQfTcC0cnxsavue5zLx49+dGPfWpynI36UxOTDF29beWa6dXfuvV79abHEMNi49R8/dR8rZje
nF9iMwtsWqy5c/P12bnFpaUGnf7y6t8+9onL3nzzdK3VdTv9JTegUzuMT83VNm/eduDu+x598tkP
XHRJ3W3feNOXn3r+mOt3bvjCl0/NLX3mqp2XXXHV3GJj+65rH/z17/7w2JM3fO6L9Avaf/eP984c
pjjv3e/9vw8/8vgLR09+7BOffuKp5488++L4yomXTrxCcdgd+w//7IGH/uuOve2g+41vfZcir4ce
efzK7btPL9TpVn7z+8d/+dBvb/rS13rx4PNf/MrhH//speN/nJyYeuHYyzOHf7J+/abnjp6872cP
UtC2UHcuvPjSN88s0J2h63/+pRPv+/cL55dcJyBL7e58zbnggnfTf9eN6zesW732nLXr2OOatWum
V61bs5ZOa1eXE31LvLhqatU5a89ZPbVq44ZNPJGagap1q9esnZpeMzk1yTHWaj5zx96Zut8B2jKC
CAswwLPbC5uGnixyz0qEss49z37WxyqccCoBFlv4LSmLUHJyB6gaPLPP9JSK8VGBWA2lwH4uCO5I
DJYe9jwsuwhTLuxN0RY2PQ0NafjSvJFguylYE6NVx4qqWWY0ytVOQ3YIktForIrc2SGAve6J1Vc9
AWk2wMk9ZiJ3pUTISKzcyZ1Y044xoymLdVZlT1ysmUCqdCmvBgoGq8giNHybkuo6r81eJMFtz/T1
MAYrzyI8LroId18HEIogu0nwrk8rNVhh0KBxYFJUTtlFKJUIRRdhonURwskz1lQDe/8j9t+k3qdJ
DBYHWEKDJWwaVOcq9HIioPYrsaPSFWiah2GbJKwKXB5L54YFwIoKkTvgg+UFutgWi8NDS3iR4cmO
R/ihftZw3LKDOLn7mpO7eQjQGmCSzMdTUzT5vw7CEF9QuC0fizLU+T/HTiX6vWefe3HV5PTq6dVT
E1OrJqemOMASgz29IunTdWvWrV61du2adWv5DP1fQqZ1qyenz117DkUP9JECiy2bNi8uLFH8veR1
RKHKC3r/eHP2fe+/qO60T80ufOjDH296/p37Dn3z2997/uiJnXtuaAXdqxmueqTpth978tkbPv+l
u/bffT193Hfw6//57W/cctvCUvODF11KYdaTzzz/iU9f4QddiqU++snLKcD6wY8OfP+He8/ML+26
5obT87WPffLyv712is4/8tiTbit488w8vW537Lmewrj9h+79wpe+/vWbb33y2RfpSlrt8PEjz1z2
2e2e3znyzAufuWpXw/UvvPjDdA+ffPYlunvfuvX7/+99759bbC55YTMkb5yZf8c73vXpy67YtXvP
1dt30mn7jp07du4SM+yVHbv467vYjJjo/M5rP7t999U79mzfec0HPnAhPcNrV62eWjk2tXLlqgkO
aumpXrVmauX4D+7aP++0dYQN4GMoktLQY+lO7oLByroIh+ZkM4YmwKClZBHKGqy4OsZYkXrYjcXR
xrfEzGhLsQZsne0vjUZLkXtfsWlICoAlC5hARoHghRXAbsBAY3DyWoKnGmcfKTRYWVROLHcRZk7u
zGi0aITERheCAwVoYKYAhUKBXPicidwzDdbRE7IPVmY0CtpWxUOQ3qgOmqyOHEjstuZ5VE4BsKQS
ITGiV2IM+dmzgRNraU9BQkKDpYc9x3hVd8TTgmFEMoRr07HKCBpyLhlgcQYrBZzcS6NROdsxqaix
xkYPqYUCh1CjjML5hZf7YGkaLIyRiqtSJok1tZBAGizcEzz7vc5E7h0AYGkarMxo1Mxvge62HaDv
Sa+7OWb5EosHgSTeUFWurLPIWYRZiXD1GtXJHeB7DGIJEkuB/Bmodq9ME9INReGqomPmPeNQT/tG
nnn2BTq6n7vunM0bN6+ZXjW5coyipakxOvCPcwZr1fve/8Grd15z9e7rPnv17iu3U0ixO5t25PM7
2HTV9t07dl27a88N9PWrrt71yU9fccEF755bWHSC2OsOvaw9gonfL/zQh2cXavOLdYq0KB564/T8
xz91xee++NXb79zfcNuXfebqX//uUcdrU2B0401f2jtz+N6fPbBYd/7+xulX6d/swvs+QPFZ6/Gn
nvvM1bs6Ud/12lfu2PPci8fv2Dtz2/d/6LX8L3/95v/4yjeu/9x/+GH3iit3UKBWb7pvnJqlcGrn
NTfce/8v6UbfnF3439dPP8FXQlHdY08+t333dY7bevTI0zt2X19reh/9xKdfOHryk5d9lm7/sSee
uvCiS948Nc+tVoNTc4sXfejDuYdqx/NZKiI3OO36Yc+T3FOziS3TbbTCRitgH2kFX/jiV+h5pv/w
DMLSUz0+sXb12s/f9KVvfvOWibeN3bXv7nY01It9ptG/7bIs/19ym4ZelkXYzrMIVelV2UWIWCRg
9RdZg5U7uUtdhKCLT2XYXGwosUYxPUJj6bDmuDwqh0gid1IwWK8MCqPRDKmkgCgHbIq0S92x3i57
MjRST8xKhES3aWA+WGYWYeGVOoozmRW4CJsGdQ1K2LPu5G4g3dSeQWmLTrIqulDHKQVeC3JFlAgF
g5X7YOFDLNa4GlclfFsSoPOLfCA7uR+XRO5kBN8422Iw2yoToimY2YC6UQzgLMJdmcjdMBpNkOsf
bFZNbPmJYHMDooiSRO7CpuFwZtOA4VTwhocM4YYbkGDmS65A0ut6mAO7ZNPQk2waDmUMVhGVo4U9
+/pdtVNhK9obreSB2FD5eKFTE5sX6C3se3IWIRe5Q2HPBpRBi5I2T0jH0iypgVqwCdHukqUXj3QU
CG09+3aef/HYxMrx66678eWXX7nyyu2rJpgkaNXk5NTKsVUTk3Ts/9p/fqsdhCxNOej2unEz7Dey
idCJPmWvBIQijJbfWaLYxw/p+XxzbvGSj3z89dOz3B+LiMRov0NOzdUuvPjSU7OLc4uNiy/5KMU6
Tcf73E1fnZ6cpoCGbuLyK7fvvOb62cU6RTwP//7x3z/x1PZd19LFfvrLXx3+yc8XefGOfpximk98
+jOPPPbUkaefH185fvT4y3fuPXjbf93huq3DP/751OT0vT/9ZaPp3f/LX125fffsfO2r37jlrv2H
fvngw9d9/j8ofvrO935w7/0PPP380at3XeO0gkePPPupy69stQMKwj5z1c75hRpd+UO/eeTiSz4y
u7D40MO/O2/b20+dYWCxEUb0oOg+vDbnNDtDNoWDuk8awYBOzXDY6CSNTvHIZpp8Yh5jXZb0HPbi
Sz/8sanx8dW8DstF7uu+/d3/CsOuKFgcuPuni00fS/t2VFbSsRuhCYCl4rOMwSIadyUIrYEtoRlq
nOYAizNY3AeLGY0CTu6Jck8cW5yvEziCBi0qJagwApQba0kgRI3KAbIIE8UHCwpjxpv5kZ2JjbDe
uIpjIOhwkgOsVAZYzKYhF7kvy12EmM0Pwd0mEcF4SsoSYX4IStizpMHiIncykqN9avGfBBk+Asmh
SBXsiIc5wGI2DSe0LMLRo6MxRRGCs1M4oahgsHKjUSXseWi7bbCJ+m0GHxVOwgQpLLIytFoizBis
EmCVJcKYLrCsNaKm4GUfa8oEW8xRaokhks7DcpFFKGwaCh+seARsZ0kLJZDQTS8R6gAisuASxQeL
/0y38i7CAmC5PjcaDQoGSxUh+Tg+0BROvu4pADNASlQiol4CNek+InIvugilEmFV2B8UjAPHIPb+
hXUGkc1FzPzKALkYUDDFW/p7jz/7/NrVa666akcr7Nb8zg9/NPP28945OTbByRVWKPzYxz8Zdjpu
m+W61MMBlmvk0C+duXSyTXid+I0zix+86JLTZ+bFGC/8rtq94Rvz9S99/ZYzNW9uyfnqN2+dq7lu
u/OTXzx04Yc+4nf7TquzY9d1//HVm7/89Zt/+osH/U6v1mztO3jvVTuvufnW7we9/txS86Yvf32h
TvFV9LvHnrzpK9+4/Qd3XvShS4+d/DPFUvc/8GuK8/729zc2bdz8yv/8gyL+Zquz/+6f7Nhzw96D
99XdwPW7t981s+vaz3/vB3u7JH3h+J++870ftjvkhWOvfPu7P6A7cPxPf/vWbf+12Gh/+eu3zNe9
vQfvvXLndffc/9+33Hr7X1+b9Trs8OeXGh/8wEWvzS65zOw+zrVNeCcsf3GpHfvxMj3AV//nf6cn
p9atXkMxFj3Dn7jsM7974rlGMHT96K69B6bHJ+/cd5CfSdxlFMqUxJxQ3NL4Q/hgFV2EAyUtpywR
4hpSAhgClQxWnDNYBxEnd2sqbWrJQraQB2REnSz6Wyx3EfLSBjMaLUuE9Ae66CI01qA7Y8VINApc
pUpgAydS7VItrzArEeZhzxqDNczYkf5yf1kfnGK8coq1SinMpQqwuF+22kWo2TSgTuspVuhRqlTJ
CD4XhjeV0U4vJRBIDNaxl5PCyd1uZDWCmsqKDpMUau/nbvgYg4V8U/L/YJWUykbxEgugAfthcwYr
zkqEBYOlR+VoGqx/KbNhlAQIrJnA1GDlYc+KkzugmxwxMigBEsdjrUSIda4ZZgfcyb3ndfoNXmUo
Re4ryy5C2QdLvtUGUwWd6jY9oNsc95cqSRoHdToA8E2hwaIAS4nKkRruAGH4qOJivAILyd3Q0g8Y
GYnZkIJRQvDayuWf4/e7e/ZcX/f8pXbYjQd/fOUvH//kZVNcgk0fJ9628ujxkxRVU3jBSBpEecYB
lvh+GVn15uzSBy++9MyZeeF1zroLmYVVx+v2FxyfPjJL0i67Zp4/9sqHPvzxBx56ZLHutcP48s9u
/8ORZyiAKoILF+uuG3QpCKawquH6YTSg80tN76odu2fu+/lPf/7gZ6/eRb8312eJhK+fnrv2hi98
+7bbKWzipgwdhid6g4YXeEGv7rT9DkslpxtqeiFdZol5qcfsLTdo5U5d9BW6b7Vmmy7ZYL4kcd2h
4KzXaLMDf+PU3CWXfOS1Mxxg8YNtQtbt2vdCARa7V3H9n/7sAS50m6Aw69bv3t5o+RTrU4BVd8N9
M4fXTK+6a//dzLUVUy6CGkc/wtxr9S5CZmMRlQyWqnBfjqFbdoIExcRDSYP1T4XByhQtI4RgYE34
Fu1IJbEPAh0C63YVo1HOYM3MHFo1PpkzWGqJ0OQnLFaQqHdiAvg/mW3htkJVud1C5M67CBOhwZpa
OZZ1EfKMaqVEaG+PtxXIVNW5KBGqMcAFg5VwgJVmaTmg0Sje9Ulwd48YhTWYoahRa05UJ3fmgyXC
noeak7tptRBDLRoEd0VCGnJBdzEFYBVZhKPYRBHcliLGmjxGaCxAqC+Ris1dxJSonMIHSzUaXbb6
uiWjVjnhvoEEvQbYf4TURZiXCI9zBiutEqobTg0IK2niUebkDjTr4S14zEeHlFE5MoNV2DQUDFZZ
IuwBHJLFadOPMIXWSBoUMFJGkrCAZRQlKkfrIvSRVBy0J6CH+ryrJR7HAvu0jVZUA800wGg0aZ3+
FT/1wjF65V177Y2O35lz2jWn5bfDxVrzmzd/h2Lo1VNM//7jn/682QpcCrIZwIpAvwzHj9kQzlXV
bhgVACvL8mO5yN1FNxC1wrm6x61EO/N176FHnvjxLx+mwL3OHUTvf+DXr/7vGxQT1Nxg0fEFP0Tf
Yo6gfKbdGyzx9bw+W/vhvkM/OnD4f18/02x3xItH//jqXQfumVts0MVqHl1DmxmNBj06zyzd2dq6
LscZC42Wx3dVmJp6PHCQ7W0QLTl+i4Enhk4a9KqmB99hFg/0YOj+nJpdvPTSj1KA5RUAC0bbyhXi
dYb0H8QPe9ffeNPa1Wsnxyd//LMHGi7FcN1FJ1j0onanP3Po3ukJxmDV3NDmcOtHcO0YajNUnNzL
sGeiVgbzGYK4ZhOsrS/JughlkTuPykkhI+kUSVqtpiigjmhbE1zFD2hij8opughLgGXPSI4RXgpr
zgctpEcW3MhDPvPBgpzc5bBnyck9qbBgHbFpvzAaVQbpTIN1XNNgySVCkIkEWxNgd8oROvgsJ1xO
B8c0WGYhjwyr8nmq+htMi3nDrWoQkWUNYBUlQruHuH33SFXyIAj3Y7RkxgGWrMEqfLCuSUqAleYa
rGW02hjbezCTioQfU/KovotmEYLWaP+KR1dqkY3mNg1WWkgdg7MSYahG5exVughdi01DpY8AEsYM
UDUB0jZlp5GwUBE1Kod1EQqROxaYCBpq+xFqOorsj5FviPdRmm7sIDgGvBugIiniufrk80fpP/Ou
Xdd6YdSgaMPvtLzAaYUNp7VvhiW3TIyNU0wQdFiOMrcmhz29RH2wwXeYnlVeIrz09Jl5CkEE9BFI
i74732zzMiKhOMbrMOzV6vbFW27Izdy54xpdwOMJOc1Ov8nnxaeY/7vrU4QkDN897u1EoVi7f3aB
5e1EfpTQ/Rcfb3WytGYGofgrIo+ZTq0uW2GN7Rs7BL4zRaKOKHSyhRfp7nVIm2FxuhsD+o9wZr52
4YUfUhgs30IDZ2959D6k1V2qO5s2bR1/2/jPHvh1EA8b7dALOvVWtxFS+EXuuGsfvW/Ze+BuN2Ob
wPKxpms0UzJVo+CCwcqBYJlFSHSF+zKAhHBpjrhTzJ3c6XBbGo0Ku2cC53xZ5CypHG4PlMwSPB4u
qWD1tZWXP8SwTYNuNBpLWYRkCBvk2J2Q7I1mWB8l5lVBVA0WN0QoSoRTcolQMFhs8E6ARkhii6ZJ
bfXiLItQItUUH6yiizDLIkSynLFEmooKDpbPSKpGaMkHKxU+WCvHKMBKSgYLq1dC2nnoaWrNvsTE
bUMBsPoGwDJbbv+FGwmrzQEBz3MCgl1phwdAF6EAWEXYs1wihG3hRuO2LWGmsf0fXzMaHZQMFjHa
JG1epkm1C2u5qiQ3GrVRQTqmMaNysi7CnMFq+HRUjgyAhSQuW+zd1cKHY+/jA3XosC0W5pIgM1iR
4eSOR/4ZflQOBubyodqBSSazGxFlmwwSDjw/Uo+k2TmI+Mgfee4leuWxsGcKoQIWdBOEUbvDqmat
oPvTXzw4NTn17vf+38W6W2+FLsU6iFEqY7BY7GBPJN4wBusiXiLkOTZFLjKFU3WKeDiUETvm0kuo
FS40236cMHt3Hl9T44sttbqLXkinJRaME3g8WFDwYQwzsZDBWCTbUBjkdAd1n4UYet0+u1Z5tE6D
s1Z8Ex1BkgmJmMcjd+hTFrNDAR/bf5bHLECb4K7oxz2Wh8gCeWpu2Gh1uaKfYsd5ViKcXfI6/VKD
BYFXxRbEo+cz/u3vn1h/7sYTr7zaDvkmvE4Y9Zs+/cdhxvT7Dtw9NT5x594ZgVZhiA9IJyPAVDZH
8HoWYTv3wTIV7gSzaRja7K1FiTAWIvfDrEQ4cw8Q9hzjdRMsjhdLCCEj6FIJVsvTSzkCaMJZhErY
c7IsAyz8Jjg1caSdqCNWrY/dW1IqEWYid8mmIRXJu0pUTjJqUIm9hTCP+x0q8iYGsKZLY3Th0SAZ
jcIpPRbrgWFF3E0Vw4GmQEphz4AP1igiP3DctcfUYBIuyaYhNZ3c0e45uEQFu0uMYjEKum0B53kg
wp4zgEVEFyFzcmclQqJ3EaZaTBZWqcSUiPFoBijGUeRZhAPh5J4xWEdPwvEJNuFdAtvsGTArzboI
TYxiteXUuwiFBkvywWrwLsJAsWmIYEcDs7fcjwBQhbUcKgblVfk5ajguFIvLAVYnt2nYvnvtqtWn
FuqoYTpgk414tdtynSNEr4MRTrD7q4wUHUyCAzidAqb5zx97+dy16+jhMwf2kLQoTGm2efIxwy5O
O7z/gYcmJ6b//Nd/UMjFLgYEiMsAy80B1ukz86LMV+MarIxDEh/hGIgFC1IsxXBPr9Xti88K7JVl
DrJU5mjBDUSmXhFEKIpfgnaiH6TLzFGc1OlTTOZyDmwpL0eKwmJGSnG0sdBoiRzobFVZrCHbc5Hx
TNfJCohsgU6Nf5yRnUHcCFhK9Oun5y/+0Id5iZABrLJEiLc1OPz8tILollu//4sHf+P5nWabgrlO
Ixy4LIOI7v+w3R3snzlMAdZd+w6yurytqQIolzsQIV0CLM0Hq0t0g4Z83pp6Bvwoy2HPB0XYMy8R
Gn12CPgY3VTaTKMjUKc0saZ/qLfsKbfBlLIIExlgCan+2cJoFDTyRjUloM1pAmuelHA6q7TIOEsZ
wCqc3GUfLM1o1EwUqWx8k8OFTCf3AmCZWYSRpMFijQIV4nSoJT6pNCUCrzGgQxMO8S19sISTOypy
j7HNWcKaqrkuLcdQROWkudGoXiIENWfxcKRAKsgGPcUCnaxGU6KVAWGw9gjspQKs5YovHbSDQfNq
gP9fQISgdRH2sy7CacnJHehWHiFufARHlQQyGvUjwJIgxxNCg5V1EWZuRplNQxb2zEuEgWw0GkQA
HkI9n6BaIYC6wIIalsccwdF+yraUsOcdHGApTu5owkwE0EsY42V4VTiBpU0ycuz84oiwuPJd6aCO
PPPi1MqxXbuupU9nvQ4FWBQHLLqh21vm/Q1d+nXffd/9D//+cY9zSxhiFiJ3DrBKkTsFWALlMFKK
241muqWcixINhi7Dc715imm63JyM91U0Wj2O6Sl+GnrdId0l+shrlMxYq97uMf/SzqDNioYUIXUb
FAP1knqb7UbdZXQXXVu93aWrZTiDG7nVGOlFxFMWAEUhGkVsfkbQ0uUZbuuQRZddxsL4rR6wZQK6
5la3xgOtzyzUP3TJR1kXYciOJWOG/n/K3sO7bSNrH86f8TvnWzfJdsqWbHb3fbckm02yqXbaxmlO
3HuTLJc47lYj1XuXe+w4TjbNseNe0qtjx1WFYidBNIJVkm21794ZkATIAaT3HBwcEEQZzNyZeeaW
57KXEJrG8iGd/bc//9rj8rqRLivQ0eNxBkIOD4A/dHKHVUpZBXr/lOlNhHbD8AjTsIY0HqykiTAt
F2GGJ5Z5KE1G4oskD5bq5K7yYGmZ3E04/Zip0ESWo4NgGg9o6HNq6lSb6YMlalLlaJM9J2kaGLFp
imGaOXZsoMLwIBFG1xgZQDc1FyHVFSWJRrP0yZ5pFGEoSUZv5PfNTEFowDdLU+XomNzTTYRKeqoc
oyg2ITi6w42J/xCbM10xsnsmoyDTmdxNABbb9UcZNWvyWKPnaBQhNlA0yCvnzp4DCZw/f7FpIAiL
JU40IHMXzZM8KmkMnyE2kVgiipACrLQowgTRqJIGsERW6mhGdIhiiGbE4Jh42vQ4SeXBSkYRVtYl
ndwNQLPCVqKPRROviyJkkggwrFFJeKTmItQALD5pImSlyjENr8sET94MA0c6hOLZDuzmOX8yQEZa
9FzKyd2T5MEiuQjTbHbGVBFsBnyPsc+714Sr3YiVdCyJsQ148z2m7vmJM58dPzOZ+GBB4153cW5e
cQDg8Es3nQEHpwAmcHo4qJUvvvkeJmZAM+mKN20gJwVYgKJ8wiXUYE27SmgaaHhE0tsd90Rp5A4E
Qbq6idIINUkEBDgAE7jhRYi00FLmRrUZbj4JmuxmjxdvQZs1WtZUtlgP7/RJWGa710Fws5sgtmRY
BgI7Yjek2ilaBtV9nqjWbva48ZgYIqnKh3rl44YoCj3QuwjAgp+Xr3U8+dS0dA0WS4OoXRJ0uALd
HgCFHhIgySEnhQc/yhtAAotOl+DyChVVtdkTEWABmGPEQGSAY7ZZWa88TqTKSXYxCrBYRKNCgmg0
jX4wTZOhn9JSTO6EpmHyhEmqBovpZiSMZgMSg0a2PLZ/khgchRRnNHKHpA9WMopQmypHz+SujMLi
KBqkLRON4YVgzD5q6Peme2mSyT3Jg3Xm9LkEkzttIE0uQiM7kWjAnyTqA9+0wZiSxgcrEUWYIhoV
tD5Ysi5VjmDMgG+CXUZNksPMamKcjC/J5J5QuRENFklQaJCMz4RVX2FgOFaooImLdzKKkAIsnQ/W
qEz3YtCM3T6tR4vGcXmsk6H0TAl6mgaaKmcK9cHKYHJPq08xgwxWNND1mhh5TehjNAOOnqaBJHse
N17Hg2XYB1kMdmx7NEO7fxc7U7LR4jhB06BlcteZCNUoQj6VKieN2DNNPcOKXrSnmcyM7VxsZ6Y0
LZceQBAHauLo4/Y7yMTZTdUYXBCnTIfPBROwyz9rzsK7p9zdcbPLyQVJ7jxfD1FdkATGnIuT07kb
mKbAseYZDBi65xs58nvMuS3YjtXavwAiAADycDKiYbJ3IcQUjlMn9/mLAUv1+ARfQO6xe3vwYjSN
oY6HuIHTaDu7cW5pG9FL9RAgBVP4letdTz717Nff/nz12k3crt5IbeTMlavXr1y9ceXK9atpe7LR
n/Q4ef6q/vhq4l91016gOZk6k7wr8WRtqVLv1b/l8uWr1693XLveAfuLFy/b7a4vvvru6WeQpoGK
B9WEUQ+zDF43HWKmspdwCMPEQXZ0EYNe4+ly+dz+QHkl5lCvqK51eLy+QMjtD3bZvQDjAInS3qe+
wtDXkKEB1ZkIiQ+WwxPQ0TRondxFw1Wa4BdocBB1+hbJT6LAQF2F4IchNV5Tix4tdbVNiRDusBQI
huWo4JfgpxSQCTmh2bI+lG56GwXThEaN5E9LqKdZ9EsBCT5K5vgQL6OziBTmvQL8VVXdAF9x8sRZ
cg1Oe4KPp88hOq3gWEPbWFSrZiouJpA112GIiShCvQZLZyKkPliqk7sy2ipcGVV/Q/eij4/KkWBA
CvFSFKRClEQft3XLjmSsFkxvwQAWrBcwqp8zyOU85qyIgiHRRlomk0ztC3y74OfhgPPAPkQy/ISg
zMEAX1vTAMvLMyfPhAUxKiuyX0B55kXex4Ocg8QS/R/KcAYmUMyom5joSgMiEUuRdiENRKk0RHiL
xEeCQvj8uS8ADSxYsIQQYYQCXuh+Ci02FAl6E4Awg0WFMgoZqVFkiXnqIa3GNNSH8QGk/NB9oK7c
dtfv7r1v3pwFEUkCMYAtyAsAqYMBAaqUzaTPJOwQxvBFmb50pPC8NwCST50O1eAbqMxASr1aq0Yz
fMF7eejp8C/vF6kwwHFIiqan3RRYrWxIwaUkIexdRgFudgOjA/XBcvpTUYRuH19SUUuTPSd4sAIM
J3d2KByftrhnMPp4jG1/BnTzOvp4PUojWhMfVZO4iBqDznCdbsIM5OHcfhHmm1lzF2ZNmNTZabMB
nPLL6KHFSUTVgQasDruHiWbsBuyOhkzraZgpk1bURC3HTgqUDtTsBnehusWLVEwdPZ5OuxfAFjkj
Hj2GJsL5C5agqtIvAcCyOTxQOdQh3eUXKbUBdQlHEJamC0yiB08A/oVb3AHZw4nXO+2P/vvJJ56c
/sRTZHsa9tPINv1xevD0dHV7Km2bpj+eljp+Ou2M5ifjOZoXqbdM0z3/6ekZJ6fpnp8o3pPPPPvY
40898+wLT097/t9PPP3M9Bce/fcTVzp6VBsi7RfkIOlRntmCNFMNCFWn3YPRi06fB6C/B3Vs3W5f
t4dzuH2l5dWTJ2VV1DTYXN5uh6+jx+v0ISy+0YN+bJSsleFx6OVNdMaOBLRKCEbCRKhqsOS0rM8G
jDWqKw/d6BkAKDh+iejOHJJ7YZyqJQCrsqpO5IgLjqTSPcMm+HH+CGpXtGbZeY2JGzL1VWxfsbHQ
nAJgQuWK5OdhAqNTF3xmRWXt1Kzsc2e/gilW5DC2Cw5k6lVmFOXHTDYiGKX9Udis2WMhZc2YO4kG
S04BLF4+m0bTkMbkbu5oJZoEbOoQUlgMx4KRiIighKjQQKLkjW9vuTsr+8TxU0FygegT0PYqyhFB
NHR2EU1J2w388ELmrJiCll9KZQ0AzAQH0Mogh+FgLAoTsC9QXVU3ZeKkL859IXh8gjeApZWCHMxw
vgB9AiwkQDZS9A1MCgNzi6EeHcqI5hGdyAEphQgJDxbRCUV4n3D61FmAyAsXLlFfLSIgoP0IAAEq
DnklvTbE0RTD5gn+jBzbM85AeXBxRWI+iHI3aO+2wwwyZ/a8CCqzUQxAGFAwOCHMNAhmLH5CmQoz
kRVDyuoO0EOTT5MJOwy1idO+DOdhmJI4saYGV02nTp5VYA3FyQRUYTJNgcCslK8YMwOEaBT4zEB+
dxnhFaOcgHomdwzISkYRqgBLq8GiJkJvGtGofk3v5cfEwGnAy5WRg48RXah9tY3wJzlVD2sBvZsJ
zOpCLkeBOly7vdzseYsmZ02+caPTG4BpDy0pN7qdNBKNBqxlqpTsxjkH7aMQkDL5RXkzBZWXRQZm
pvNLSymthvJRZ3P0Onf6qULl81M4HAO+tHkD3chYIXnQL01wEYck5C9weJzUW5y4mRtZOW1uFUY4
fDxlWr/R6bh8teMSbNdwf/laJ93jwTXyUz1WD5J/XbrakbxSe1figtRB2l+Gt5AyJB+eLIB6hl6Q
uqYzcQ29veNah+3qze5frty4dPUm7H+GU92ODoKTHAkNFkoa6SBGiwE0tnKSi9ouSfxjN1Qs8eW3
+yVHIAi3A8CaNH5iWXU9QK4uN+8IKHYueLPHS62r+ATi72XP1FNmaqAT1yT1jglfsWSy56QGS5v1
Wc7wE1d/wiAFG4xcFGmFCMcgjG4AsEQOhjCAUFJlZc3kCROrqupgDoDLYGijaIzObbDeNeA/VEaL
rmchEtGUrtqA5ocWXluAuBKOwoyAugqcycSABGPxpHETzpy+AGXGkquE9WS9zoIaZkog0Zwh09j5
3YSHSX9vRGaYCJMAS2UJT0URhkw5PI0mM0YoHPWzgblWDgB0VgRfIChIb7+9hfJ2KiIxHAckouiC
uZY3nL8zmSCYrLBGHJWieUwZal5hiwQjtAZoJaDmkodqUX2wLpz7UvBxMOlGgvEgL4pE3SVyILgy
UWEi6DHM4jyqSVc/GUOXCcGShCiAKcl+kqYBepDIQakU0oLj589fBIiKXE+hTAiXNFRJYy4bY9FQ
GkXJMQNKNBsdB6gmm1SR6Ha4Hvj9/fPnLURoBRdAN4dRgiB+yS+xjJJ6o3PKfJlO9BUywawpwBdK
8acQ/IqDEkGxwYQGFyB+ZSWaCL+48FWQx0EJapLciK8QyecYEY2GtNEtaSpMHQhL0DTY03ye9P46
9gxP8yQPVjeZP7QmQnRyJzQNxAdLTACszOBBPo3/iaHFMWKfMsobw+T8ZMUM0ky3MOt3Obx0Rvz+
0rX3P/2cOlb3uJEu3OH2zpw1L3tSdkdXj8fPkzM+l0/4+sdLX3x/kcARn2GYnj5VnHGmwkxfeKb1
08Rnn8nywDQ1MiCai5PtxKebACzRFQgiK4HDe+T4KcDKc+Yttvn4Dg/X4/J7fLw9ECSADGtP5UQg
XlP2zMCClKZQdXtCaoMeN9KyUy514pLlSFB6OtHPnf5UD5A0gf7U7OnFjsSZxEndX07909RHaX/q
7ko9P3mZus/c1At4gpz8KCR+QJxwkscDgOlIxMVTDneqwYKDLlJR6fkxtWsYn0r6BQALPfqhtpFN
Xuqw+3qgrjyB0ora7IlZ5dUNAIOgCbrhekK4SkjwfQ7ofS6OTRfH9lDkGUSjhAfLowNYukDC9AAl
zeoQzsDEQI1NAW8goRqBuUEKCpg4paoamdwrK2th6qIjHQ5hkhpYhMNfYtU+ltz1IWYoFmOuNUim
ZphRTh8eHxBgIzZQZEKKyKG6uiYY3E6fOg/oCj5N8PHURBhW6RNH0VKEMk2BwtjIfsaIsfQXqxos
DdHo2ZQPFqVpQIAVQR8shcEhziZ8YkbJ6Zz6r1+5efXydWhQOSAAOoE9AKxt2wuzJkw8d/YL0c/R
81C8jms3L/7wMyNp7lgyCQoGtFiCAf2BQYplaDgY0P0ejnP7JE5A1isesI5EfbDOA8BCrQwqXOFf
kAG4EmBEgs8prDNti6wYUnEMIXgJQKDTZpF65n0B6Eck2DMuBeSTJ05PzcpevHgZ5wmIuCxROA+X
7JXJu9hW8kwOp1FZPY3oy0UGJYoa8IFl5kIYuyB3d3TdM3nqgnmLJD8Pw4gEaxI+GJUjEQmWLhHT
tygmhstRghuSxGCSQldBoUQAI8FMWGmRYBSaD8QSyllX2wRrP6jYpAaRKrdUTlQz/05FZ0gVjdOQ
p3ywDJe8gUyFk85ESBAYTZWThRqss9REmHByT6XKsTP9c5m0T2bQxCzgbjTPpyTUwCm/ywnoKkBi
74WbPZ5Fy3KeefbF2qb2i79e93LIrz1z1twpk6feuHHT4/Xf6Oj66NNjq9ZsGP+bCR8cOYGUmA6/
GQWDoZqK6bZvyIPKZqkwyZDDcOrnGWeoCY+wT1Fn8+vdToq0YPv46PGJBGD1+DGTMbpgu3w24rsG
GOsmkoLiJA0TvDNBXpVsXy1Yp3t4uIvDy5CcM6Dm1UmQiAr2xEbOqLiHOvbZU0oyeka9xu7TXebQ
XKZ9SOrhiSc4WFvimlQxHD5mMXQPVylSibKqC92n0GU+8b0B+i91sTJK9U2BTvJKB8Ggp89/7Q3I
gJnspN4cbj/6YGEuwlokmnd4rnX1IPsXJ53/9udOu6/b6Xfp6Rvs5ope0vTcLwYAAACAAElEQVQp
gJU0ERKahlDCJpjSY2mIRjP1B7hmJQOTqgQSg4CxRJyNEEjJAVwO1tY2EB6s+mReZL/bHxRkwc8j
MkOnFmkUJnHzcH1xDMyK5o4+muMgXcgKghJANUzAw8EZ0c9XVtXdPXnKlxe+FvwBxI7IkCRzHh9s
IdHEf2WsRiu2hyzTcz/dhMewjSYBFomCTCV7rk4ke1ZzEaZrsEwTAI8hWN3WZX/h+ZfmzV344X8/
BXkK8oLMC2+9tXFq1uQzZ84j6YAkX7l8tbCw5JGHHz17+gKbLjwtfZCBxSrEzoakMKnt07Ag7xOp
pc/n8q9YntPWttthc4RlkEyAgCLyT46b8OWFrxAgEle8b776viDfsnnzDqo0QlsnNc+ZE39kQnwh
w/0uAVBwcUJNe6Q3EWwH/4qkW6Gz19kz57LGjZ89e76ccgFEfTC9GE5ybj/DAd8oObcBobwBfYnC
NrgnLva6fC67GyqQxF1KvJ/jvP6p2ZPnz18MJ3myFMF1VzDmcwdcdq8xM3CQncvBhLae1d+T9LkE
OaE6Kpm9gKwARZLAR6qoqCZI+guR4GZaSKxPH6+PAGB515mbCPUX3GUY5G8wNySd3BNRhAFX0smd
0jR4ND5Y6OSelrw5kK6p8vBspgYWgLBnpJSxM73CDfMik7j0BAMTddaGg3Nf/3DP3fdOzpp8//1/
ys1bf/LMuXkLFt8z9Z6zZ8+XlVc99/x/AHNMGDehpKoBXbhgYuMVu2EGGwM/MCO3NhMcaRQIaZSH
x5wNNc0Xjfj9nPnyu19v9iBgQm8q9LIClJw9YeKceYtuONyAjwFrulxIsH7y/DdIcKA6samUCoRC
3TBK1EE8fpJ0ndQE2U1j8dxcd2qPaE97ry1DY2djSoXGRc+mv9dG/k0dJ/5Kbtq7bBma1NRlifPJ
n9T5Keld7tD8TH4RhWX0J9tzjgDcm0QpmLT3bdpW+OKM1z858nlnj9Pm9Hi8HEAT6FY19c1XO21u
H2d3efYceO+lV99Y89bmmzaPg7jQsXMbGGeOSjm5q+CY5CKkNA1Cuod7mJ2KGEcfwB/U70omIMne
Zf/4o8/cDl9IkshaEMe4qioYFsZVV9dKARHewXsDsIi0ddpPHD/jcXqpWSEDLRlTiRrxGJmExDNT
8RisTSVOhOnq+LETzm47IRFVYOoS/YGaWuQkPH3yjIiGLYAmuCDuutH5/uEP3XZXyPCZiqHrPdPz
XczQ1bFiu8yi6hJO7hoTIUx7UsoHizq4SHoTIZP2gun3JhpnOCF8FqdPnXvg9/cDFHjuuRcLCoq7
O7s3bto66Tfjjx498dlnx2bMeOV39943dVJWfX2LqvnTq0MYikwjoCkaJ88RRs1jAwBFBLmNBEOn
Tp3/8x//dHf25PXr3z5/7kuA/vX1zbAkOHniFKCEQ4c+mD9vEXzOo//6d8f1bmpapV5HMm+WdZvt
JC4apnqklik0VIEE+nhYhHCwVvH7CRAMws/zZ89Pnjhx7twFtK9R2zrUYXdHDxpW0FQtj+5KJRim
+AwZwVkxQ4WcwTPy/bc/Ll60bP/+d7s7usMylEolGn1j5mxFlKLBMGzw19697y5csPSH7y+a1obC
zhnKNLKLGfzy5CdVpVNLH7XpQ0V5nT7oyLAuEnxcwAsVK8Lab8qkrDOnz0mcwHn8FF1xHg5qG724
BLN08iHTcNS0n3cZZgjOQCr2TB8sLU0DAVhaHywYuFk0DUz0wLN/Gs4cGWGGHibbFlt5QGm7kYOe
BORTbVZL6y5MCYfp9ibfO/WeKZOyf3vPvYDEYWyaNH7CxHETctdu6HGRpDFOzskFGfZHz2hsC+ZZ
5Mwy8ASYyYXsGb78dhNOCj2WdXn8voDYsnPvjFffWPf2FsBVDmIePUFijubOX2z3+J1+/sefLhUW
lbwyc/a2wpJr3U6nT4AaI1YzsZPYWI0iH20uf0ePi0RrIt0UZQrFaE0kIOUT2aAFO+NAoMTlyePE
9ULqMq+gfQJNKa19To/uFkH7ZGLXFjR/qY9KJqhObbpnCvQtlJu0h5g+AV8SUx0mK0w2TXeSYEIb
5ZeBd12c7CQRA1R95eKQTmJF7nqQwMf+/eSqvPX//fjT7dsL4Ofmrdv3v/f+uvVvw/nsSdn/mfHa
zW4nXAxAv8tlQpPGRvkpHyxvMhchrzq5p5RYqbQ5RooECSOGZO1wv2vXOw/+/aG8vLUHD75/83oP
nKmtBYA4rq62AY4d3fYD7xzKy1v/z4f+1djQSuLvZN7HMYZRIy5T0Thmxyhez5CGlAEgguiwL5WX
Vj7/7Asrlue+//4nXqcnJAUrKmtgLD535kJEDnXd7Gpr2/P221tnvPTquwcPR5WIGUGOyGL8Ek1d
uY2i/Q28TzLpErRO7kkTYTJVDvVBkbU0DeYOYYJxfiS9mgSqTgwI7x3+MGvcBHgdLNL+8LvfP3D/
H++eMvW+qffAWApn4PzcufNlXhQ56f+Qn9icR1408zfK9NJTY1dREaVEQyCiDVOzsrFs48bPmjX3
P/+ZAcczZ7752KP/htLC9vf//du33/wINQY1SWMPie1YUTKZOVmUASxHeJ308r4AQQOqeyJgrGNH
T86ePb+0tOLnHy9HQ33w7+lTp7MnTFixIodz+6WAAFV9+L0P1+S9lZe37ua1jjDa3CVjRalB/IQ2
X7uoh4ZGTpAiwzcuFopUVtYCjP7Xw4/m5q5tb99z6eLl+6bePWvWHFtnV3v77pycvL/+z99gPm1o
aE72lzQ/SLbOLC39VKY3Xjqbq4pW1X3isp4ux7ZthUVFJV9/+S00eiQIF0hV1XX3TJ5y9gwALFw1
SaRK167dcOb0eR7d7xRjd7oMPGpiIyZRhMZZaXVQRr2GEI0mchEmTYSEaPRoIoowweQuqESjTGKe
TL5yBqUniwTByxuTixpZ0FLX0Ky9lNmoh0TG0YmQc3tyc9fBoAAdDMbTSePGwwarmcmTsqCbPfjg
w5d+veb24mzk9EndLhOvl0yoxNuNklunebkxUVqmMZRN/m7o3s58msfLub1+gFkbt+zImpQ1cfzE
p6c9V9/cfuDQ+9kTJ858Y3bzrn0vz5x9z5Sp8PkzXp15E0GA1EFMhDRXIHUeYgFN8nxBodM5Oieh
fxvfDZM6J+uBVAIG6RFPGghLQSUVG6XwU48GAGkBUxr86tGjtwzglQRVQk/6w3l9YXgKE5OZEKmX
upo8kWCvpBJLpVFI97pTm4xy3Cc56G/aXNBfvr945U9//BMCegLrYZwCabz3nnsnwIw1fsLkCRMf
e/TxK1duuNz+bruX5CmSRjdJ6z2xUrkIE1eqPFhJUCVqXN1FA5QgqE7rkWAkqIZWyVElWl6OvBJT
Jmb9+Y9/2rHDsmHDxnunToURdvv2wt/dc9+UiZPuzpq8bWsBzAfokeMPhCXFjMfIxCfJhP/GnCQ6
jTU7I4wuKis5K1f/7u57ocIfefjR/ILivDXrs9FVv37HjmL4LpiPYTLevq0Q8FYwk6ZBMAhpFIOm
DkOpYoRMJkjTgHkjHiw0EY4bn040SgGWpIyByNQ0MXDSwCrKsiABBNmyZUf2+IkUndDVadYE9efv
7/vdxZ8uhkSVNp0RdiAGWewVikE7KmbsaCKby0PmFRIvJqM7nZ/jPN433pilFhUG/EmTssaPn5I1
CRYGdHXd1rorJMoSJ2CEaTCC0JAyO5jkeDG1GWWaC6Et4MmoQXH7iVZYbmxszyLdf+brsz54/5PP
j30+NStrzpz5P/940Wopm/b0s9Cgf3ngT19e+AZWKcQ2J48JdAqjxb0yFZbMzEKJ60U/RjOsWJEL
RYIyQ+944Pf3w7x575S77yVzB0ymgLnXrdsQCYZ4n5/pNq5k5s8Z3dWS5Vupch2j9xXa9zk0tkaV
2CeffA5FmjopG9ZFBw+85/f4amsbMfzizLlffrpUWGh96B//hPIvXLiUZlOlNLMs7ZQyuulc1PGD
3MUejtMSGOtIqoQMDVaKBytB08DrfbACZjleGPCCnRnansnGrk3ExshumxmrqIcm+g+/+Ov1f0BF
T5gIA8Sk34yDnjYJOhuCrQm79h/s9nA3nf4uMss6PYKOsosVbsmg5vIaK7QY//L2sXvNjyVRTxqF
GCAeV8Dm4jp73I8/NW0SGRMnT5x47933TMnKggO6qsueOOmBB/7yxXc/MdCblzdOB2mQ4IiZrscQ
Q4/2Lib7v1kaynQMyiC2ZeMVNm42ClxgtrUBKX96VVismOCZDlXYIpMmTcJZaiIM93DwzuH/dnv8
ne5Aj1/ucaGHrkH8h+Eb053c1VQ5aCIMJeMH9U7ubD9ZzWxHfbB4H9/TZf/Xw4/Q6QrkB5A69CD4
hCkElMCI9tyzz3ucblg1Eg0WOsIbJd3T8xkqhnl1jHUeoUwSVNY6Pg1PhMWIrcP27PQXsPuPGwfL
XPgQGAHwc8jSC77iycef6u7oCov6nHrMpDfCaFl+0/3H9cl/zDms0zIOiTofrFSy5wyaBsrkruNK
ZU1UhtYikZEFMozYFPBc8NqVGw/946FsgleyJ8IeB1KUh3ETKsprZGTJUkJI06CMkmnOiHlIyy1u
6qqVrpWh1UsUeBj9qvJOKT98/wtMvVkTCBQYPz4bDrKyCMzKnjVrril/gS6uLTTGXIrpVae7hvKe
SJz4nxdn0H50d/bk3//2t1Ce++6+BwYBGJlpV9q9a38IrvSLEQzPFDOhQKZh2kj+jRMjKmaJC8Vg
IqhCunLpyh9++3soIe34d0+eAoAGDlBDMWHiI/96rPNGp+jzh0XJ1KdeMa9txSSZuhg0c9gSgtXV
tVBpUHUA+x78+0NPPvE0FO/ZZ5+/OxuG2fH3TJn6wB8euP7rjRAf5N3+uBIxUqKHxkjKryEaTc06
7Hg9/RxGAZbTr0v2THmwVKLRFMBSmdztmROYdxS+acM5zGucBXmUBHC8ceI2NXzd6eVadu5NrLfG
0xkOWuXlV2d29ThtHr/NJ3Z70AfL7jYkF7WzqtGQU94wTjBgqIvS6f/4/6OPf+oamyvg8kvdTgBY
nr0HD8MUTmbBcRNhiEF0hbL427vvgWatrG1y+EzMu7rms7PzGhlbUUd3ITLOjW2EKZnxE14DFgOP
Kfu5EQGskYAxiTPS1Ehenq3QJU/r6HIgB1tCAQDohMIUOJ63YPGNrp4Oh7cbc/tIdjfn5YIGdGgB
I25enZO76oOVlipH1uUiZFs3lCT9FbWeqPYOb+DggcOTfjOe6H3H0yUKjLawR33AuAlnz5wj6ndJ
5f4m1M+j5hUJZSZpFtiO6oYZakdNJ5c8yYdgxvroo08JtIJeMI4qcekephCYMI4fP6VgLUk03nCU
6ZNVsBArgHFsIV2KaW441QcrpOPBOk9MhFqAJYcTwV8ZeFQxTjmiKGzvcjrRKrD5PYGwHC4uLssm
qzWoQNgAIsDPma/PctiIyxovqsCUXXWKUb48U17yDJugge95SFVyUG4kNHMHvHxdXQtCmclTCMya
RNEMAMT3Dn84ioVai3GNeL2NwvEMcmLKSBwgffzREQB89029B4oEIJWAPzomAAScuHnzdmTwIqEM
UO3BFMAy8lJn5QgyT6ucxsuQEUUYSkStCl5/SAwePPAedHycNCeoqxFa4CkTsw4f/i+qLQVR118E
JlIfSyp3he0UZZpF2+/xrFyZkxxXaQnJkmkSKreysvftO4g0IgBYJSWc5gppFgdgoHhO/HuXWZZA
1kZNhIkowkSyZxJFqE2V46U+WNpchDpNgLFnupHKx8jXe/TwOp6VVDH9vRjv5uXdXm76sy8A1JhC
0BWZISbs2XfQ5eNu2t0dLn+XR3D5ZWeS38jQtMrKlmOmfOLZmh4mgmTyrzISAWXk0tHAFBcn2ggl
PWYd9nBr39oE33vv1KnZML7QxRxR+b7w4owr1ztSdAOaj7KPvXXME3IzPYcYRKmZ6YBYmMZjHBnA
zvwdGIP2y5Rh3yQ6IdM4yAzz1FwMcOfEmQtTJ0/NnjhpEhlMs8jCCxDwkaPHHW5vl8vn4ORuwrzv
9okmSReYSxEkGk0xnSZyEfpFbf5BfbJnlvONfiyWKLlfYuqiCVJAigAdqho4Iksrlq+SBTGALqUS
4ThAcj92SKA5hXQa5aBRlmU2PamS4bGrU2JF5WgYyejFDRs20SUW0cRMTDaE1VoeVcIhVPLJERPu
U0bZFPYaPRN4mWTtzTAs6i0sJNlzpomQSTQqBlO5CNNzKQZHzQKUBvuIXRJBMzyz40bnv/75CDGx
jaeA4J7sKcc/PwUvFfw8IcGSGFmZmYmQmbGWrFtCJgQEmseSiH0VZZIoUZzyAfnNmPEqql7UMqP0
Ll68TJEyRcvARSnTyV00NeyaBY2i3jHIi+Xl1Qkd9ngKsAAKwMHv7v3tTz9cRL94DiC+TKGtGfo0
STItjCHJuimdJhkuJLRRSvKyZSupUw12GVKZUyZlr1ieEwmGMDpElBWSzZPRQZgRl2LQME9Omkmd
1blC6cpg8Yfvfvz7X/8OFQgblBPBH3ZwVAeuXbsB/dgCYlhEGjyJONsZJppkkuYbRNvcZZhrz4A6
PJOmIaXBOqk3EWqd3I2oqry8kd0nQ3lmTEnAdJln4zPebqAysXkCN7qdHn+gpLx64viJ2SDQxMbx
4kuvOl3ebruLEmV1Ov2ASGwujsWwZWAASjMjGlnNWFmDepj8ZCwjVMYUzhs63ZMboQVvdLsAYEGD
2uzur7/76S9//h/ah2FwUddw4yceev9jmIBptmNm3ut0vSPrwO7Vs8wzEuoxmVr5jDyYvCEA8mTY
8pjqKKaJ2WuQfYgNudiAj03rr3ls5tcxxZjQ5QsbNm/PmqAureiSa+HiFSCcNzptTsKmgbmu/VKP
izPT4LLQuSZVDnE4c6cxuQfTrIT6uV9hznDUqCEjhYEsB8RLP19+6MF/Eisn1WPhQPbH399/8edL
lOaAUtRgmI8cMYAOpsFQTL9doyTKbD5oY9oqqhLgxfNnL1BDLZ0t6Kr3kYcfddqdEi7EJYaGT/g/
JD1MKyqbi1w04CA1hJ6JZM8EYLFpGiQl3cmdTXZqnAGGFcQXQSuhTCkM4KX19c1oIUL9K85kzz33
IiXGRCopKGRQMbMT6WbNMaTTERmUaZlJllQib06U1WDAEOVMov++884hbG40GMF+Mox+X37xjcyL
Zpy35gnFjX0KtfVGe02m5glOOmyOxx97PBsFbwKFqnQo2Lo1PwTIysMBGsAERBxm9THK5xhirEYM
8A2DkcEkd0KCdwozS4YwWkWQv7zw1aTfjLt36t10HsGpZNz4Dz74SPTzPpcHulWImYl5DDButHSl
ijFQUxKLQB4qrZIkH8tKqK+oDuWvf/nrLzg0yQE3h+sraHMk7jew+DM17oap6LUaLL1GxM6mnuIJ
wOK1uQhdRIPFSvacIBo185jRc7t7eCPiK7bhw8hjxmsS3MfM+gyAQ8IAMbf/p0tXH3n0CcAWqEIY
N37X3nddnkC33ePhg50OH4mJ4yhNOdOHxm5u5RzVByuT795ET2bkxm5kW9QUyU62Lifn8MvXu5xu
H1deVTdRdfYcR/1+Fi5a5vYRtUcyqXNGRmd2RsU0IlkGvSrTJ49neOl5DZovUyXJ1OGlZ/UOMNJj
G/jkmeiBMh2eeozWA2YUG3xmZdr9cpfT99V3P05OqFFhjofts+NnHB6uG1Niy5gOkqYlcPoNlxnM
aFyPlgdLUKG2N5HsWdAlyVFpGpi6AULQQDaVzF1JBLFjnhke2c+hzJNJD6ID2YYNm8MyZljDiZZw
K1OSUjPPhtFjxxQ2AWa65yzL3zyTDYEOxH4+ipT0gugPrFnzVhaJdKFWj0njJrS27lJE9NCHexGH
JVV3gvFLmYkFM+LAQ6OySzCDIjNmdI0PFslKpM1FqCGvT9I0hIwmOdMJL8Moo1DNmRTAvL9+t89h
cz7++JOqI86kSXV1TchByuO/MidE5dBoibqNdTyjJs9hx9Ur2s8nKwGJ8lrRsPwbV288+PcHkyak
LVt2QNWhukswNrqJJi44ilH23zSrK41dTXSilLQEBUQth9/74O7sydT1nvajP9z3+x+++4nQjYZU
gBUQQ4JklpRJNI1jTTcTM5ilTNY5gK4obBJ8nMjxM2a8SnEqRTArVuQKHE9iQZSoHA4x0RU71RWL
b8XYrzHdUz7DCx7ANICSG9c6ME4le/LUxNAKHXzTpq0hZLbjSDZoqE9JlzPRKD93mlnQICT2Lia6
SptRtKZDYiJMACwM6QokAVYqF6EeYNnHEiXHCMQz8Ko2VGXxLAJShp8y0xO528V1E32Ayy+07NqH
SqyJWQsWLPJwaBCkefpoBJaRi5XdKBOc15i8ngFTeHPfKWPfMlNfrgzdjw0GQR8PYBEAlosLArK8
0Wl7ccZrdHwBEZySPeXMha+dSNYgwjVsCJWGMDI1Z14jsMsKhDTCIpkGuHReUwOGDiaQ8ppTGxgH
5Y0as+llAjKDTOrpjo/qQbcbTXhejl+6IodqTWBef3vjNpRPp98FjeWXkR/fLzgSaQky9YVsDZ/a
f/mUk7uGaFSbHkdzIJvlryUGF6qWSP4FS0CY4J09jmnPPEtjiKD8D//zXx3XO6legaaBC5IkPCoJ
9ag5ngU2mDBYdhupEJR0pyiWp1cIZl/CNiRxws1rNx979HG6zIX9Y48+4XV5eK8/yCN7IUwtYUbS
DLP1N5tWXmRNY2OKPWS8iEE0mpYqR5uLUAoxcKpgmvCHmWgZlXkEl5OMyDTIbu++gzQQ+z//edlh
cxA9DSBXtBNFCc1YOrI0cvhjGWVCZsRmBkha4+SOMbAE5VP6UFIPUkVFDR367p0y9cfvf0KmWcHE
o04ZU+jl2PAr9bvXRYMGYxicK0ozZ9IgR6xJWPPv3LmXaB/hKwCyRHjUY8mqydVcXWpia2YzSymZ
OuPMbwRQohBKT0UEPMp/fuzEpN+QmIaJE6dMyv7iwlfIxuIlnF4+PiKGTUNAlDHR3Zln+TQgfCHp
25VIMFJaWgUFo4rVqVlZ9/8OAOuPmBlaCseCMRDOMOZvUEx0ZiGjFNqsSJS70n2EmUYczbxCCBpI
FCEZo0my54QGK0E0mtJgIdGoOXMpr0+TnEFw5eUNXWe8plF1Y0iwo80wjWl0kRebt3n8l653Pvrv
JyeNn/jhfz9Etm6HHzAlqrj80s0eN7WNps2gZg5J+nm0x8jsZeLPbowJ7Ey+VjbIC+jbMdDt9NnR
bR/wk9Rp97l9XFVto2pEHz9x3YbNHk7oRDJMsdsr2o2SAhlWu7F2hxWIZzd1IbezE8LwaWGAdpO8
lmyNqYk/lq727EZUrkZtZEST62Wp7jTHIIckPVHgs2PHMfKAIN3vfriI6xa/BKLo9ImAsboJ/xZl
izCR/8w83LoowpQGS9IRuItaE+EoiWNVNvbE2Cf6UBkWkWSLpQRWh9QPo7KyhiamJblU0UxDaQBp
zplRtBEmSqzMJIni2LgW08gtdQAxKGN6NdnnwlmhsrKWjMX4IWVl1SEJJzOaOY4oD+SMHLRM5+IM
ZZU4ZquTMJp2RMyM6kJDZyiZKoeYCGs0uQg1NA0hNr2QIce6oa1E5nj0r5dCvB9aNsy5/TCgPPH4
U/DqxsZWzEVD8mcj5iNuQyb5qg1p0EVjCgwT5nH9RjNI0iQEJLGg6lceEuWO6x1/uv8Bqr4Kqe8K
GziEKWxlhlkSGCVTE2xoK8Q2ikBd+d2+5uY2Aq1QfTV92rNwhtKl8j4pLIbDiTg+w7SbafDdzH9I
MTQXimnOl9qo1TDAJorURTTDyQsXLqWr9GXLVolcgLoEIBUFQjHTHm3EYGdiWDSXH42gJtJjB22d
tgf//hBVsE2eNGnjxq3ERYzwx3LoVYkuZYY0DUGGts9U+35XukHHCJokxmgN0WggRdOQMBGykz2P
EudlavDyjEaj5TWw43iNWNQZSgj4t8vhgzms28N3uf1dDve2AsvDDz/qcdptHqHbTaiS3Ejz5iJJ
UVL8RmzYl6aj4kfBr14jDZBxFCGT7yATixjbUgFgIUmmX+r2ALKUbC7UZHz9/c/ZNM52ytSzX3zt
hBZ0eLs9gs0nsdJpM8x2RhDHzkzLrW8Ie3r2yQwWscy8fkbe6F5j4lkjWtdRAyMyWM0yGTrSMmob
0p14DDNTkb4j2p1ur9f7+ptzJo6fuHzVapvD1eML2jxI09rR4/Xyis3l70pzjDPMwqmDswmiUT6R
iDrhg5VO0JDkwWLTeAp+1XpCMs4msxMGYQyNwGzl43767nuqh3/w7w92d3SInEzCBhXBJ9KkeDIx
02R4rQaNSMwZqgsjcge9piGUxkZoFARE7o3DAOvlyFgc9bu5y79c/u099wLA+v19v7165YYiSgLm
XCM5gtBbK2zozpLulK2Mmrt6FA9lcQzUD8RUpzURJqMItRosXaocYzoGPUHGKM7vAKlxWsKWDYXk
KLRsUJDXrd94/+//0NPdA7OszMOj4KWhqBwhScSNTYRmPENsEu00+1qI4ZKcopOlKQRS4BJzYopE
gSRt2rQtmyRPxIQqAF/kaBrWDGldxEzyHoosZGDI7Z7iudUkbkJdIBSjp7v7r//7VxpmUVNTRxWB
WJliNCyivRVaHKDt6LGWbI8iVuyIqS047a4wQcxq7j9e4n3+w4f/S32wTp48ExREaPqwFIYNOktI
UBhBKkZZxk0SVJvwRxj4OAaFCKabRLeEYGVVHXEMzbp78uRffvqFrjRE9EMNKZimM6jSiGQYqUPM
YcR0hXCXwRyvm8i1k1My2XNaLkKa7JkNsDKAhd3E/UWr79FOuk7R4ZNtXn+n2+70wRNsHR7pmo8n
NjtKjqBSJNi99KT+wEsuS13MuCyZKc/pF4+eulBcVp1IZmfwNPWBvMObLEZAcw05n9oC6hO0V2o3
fXm6fb5urBAvVKaDHNi8fLffp7sy467UW/QlsaeXEPaidushm90r5a3dMGHchJdfe9Pjh/f67V6O
prix0wA07UvTDjK35Bs1n9/j9tvclNzVT/LncHZ0DBK9fhHJM73STbvP7pMR+Tl9Lr9gpA1ihEGY
5V4cA41FRr5qpjax0yP3eN0er9/u4twBscMpOHyxbuRfpVWR5CZN1G1aFXkSteExEEgSzdrj8jk8
3P5DH0JbtO87BMepBvXor09va/W428U7fVwXIDO36PAGCZ52O2AJYfcQelgQML4budB80FW9XjEq
SehGI0UVPhKVeyU/kjyRk2G6UYePcMLzA1CUwksR4oqkBCQMZcJjgB0RRYiQ4+DaNW/BOLtp45YQ
DFtSlKguwjLZ09AnvJeXQ5hiWaTjL32RxMFoFQgKPqL1inudXFjukzlfHOZFjERzRcR4WAhEg33o
bB7kFZmDOQbeSPU35MlhAvXCyAiAb4/hJsZgjif/UlMgTFDwaj4WhFk/nChAJMQLURE+LaQEorw7
UFVRmTX+N6XWshAubZHCHvZhmCrgMhmWvHw82BeFV4tSkAtFkZTIA7dD1UVluD4ABwrPBwOBiCTB
XvRLxH4HNQalkiQuACgWaiaIdSijzZGPwQVRmQ+LQgiKxksiydtIp4owUfupWJY11lNfqJDK5I4u
Pmc0qXJSNA2yhgdL1KfLJfuoIIQCMYUTwgIUW4mJobgYi3DumAw/ednPhwANQNk4GapU5qMyCIwI
yCkc4hXY4FjySR+893GZtULwcBF4BQdVGobLwiAhnBKBsnESCgYc+EU8hkrwiwrM1gE8CRvy0fPk
RmwXkB9/RAI8EZb88JliWBAkvxgVYAtGoJ5hjuejgIAViZN4bEoqaZIf30vEVSR1rqQ2IrFkowfB
77/5fvoz0502u+TnQWCCfFS9TFQS14ToMZW3IKYxjsNG5BYgphDkA1AAkFJASHKAiyowqXMRiUt/
r5j8KcPnBDklGIBrBEquFhJAnnkocAggKS9VVVYBxP/H3/7htrnDpCqgbOS9kTAxCsN7k/00rcMq
ImbfC0m9QT4m+oPE54wLiTxKO++jt6PM4LLKp+/p6l77k/aR5MmQQKzk0B3wjELXZnJAeG76C3Nm
z4eTok8gqEUhVya7pO7Jqg4Mk1D1IXYUYpiBMSBEhJjoBTEQAa2HRWgLwMQgAzA6cfEgr6nA5Iat
Ew1CP4IuJlGfeoRK0E+D8PAoru4wz2Pw+pVrsOrLHj9h+/Z8GK9g0BMJnRjgfhBIuDfE87Ra6AZt
TbcIiSAhhY8IXqj2KIxUJO4Y9hxR4PVKgRjvxWFQ9oOoRO8aA/eBznuJOrk7kybCZBShnsldlyqH
Ge/mHZOrUHLC83IwSUhXu13Exyvi8vhtrkiHOwzlcfpgCiGbD4/xZ/IAzwupaxLn6U96JT1/0+ai
U10PAY40iw6CLf31qVs0m7YAqX3i1dprnLqC6R/r1b3C7o3dtGGCZJvLBxscwE+7J6b7TPou9SGp
RMUklU1yr6+ZZG3oqyhZgHPnv5qcPbWxdbfby9mc3mQ6Z4emkGlF1ZXEZ1AtiS+l0z+UDWNR8ScU
WAJs5/GLhPxC7PFKALC6XWjBBFjAYI7NVHoZspmPjdbVQOvJctLnO72KOyC4vJzd5e90uLpcvIuL
eXxeJ612n6CpIgm2ZJ07knWlb/1kzdCTLm/A6eFgcWJzeG90OVblbbhy0wYAKyVLqXoWdHLoS3um
7PBxsBQBdNXjlns8fqcPOq/k8Qlukvqw0x2wYeNy0FUDAUXwkUzGOC0BQhBoGjukaeaDeJIP0oNg
6kAmIYGJvSAHvACJYBUegpW3DwYFj/+br77LGjfh5MnzMOVR15zk7XJAop5Y9F6yRxNSwMvTCwQv
4Bv00Q7ycUAhMo6VAcHrD3hFWBYrARi/OJyq+VhI7BVg5uVEkdAawZ7HbyG5TQCLBCTC6QyvIx8l
YCbBgIeDkRG2IA8oJJzceK8oB2KCT+SxGDGAbQDvvvn65z/d/8Cvv9xQhBC5JYzgxw/Ph7mE1BJH
PUskmY+QkwJ8iASAKhCBvwB8wKOCMFtw8C88MAJVBC/C8vBqfYpYGJEs92UZPg1u57wyD3UaS/i6
qTaLSKbmSe84r06WBjQNFD8FcZkeTveq0WvXACgEhSjyFKC6rhdmuLAQA7gTlmViJw1iIQNQm1Bs
KYj3YgCphF7hErGigkjJHofbZbeHJEkOBMjFmB8Jr+RFzJyNegJJuyEUQNWRRPfaLYh17ue9XpQT
DiuZVFeYtDtUiCygb1wc/vV7PH5PCApDhQrqmQgeCqqEDtcakdMcEEkDaK9cJCoN3hsgd1EJlDTX
JDeJ3iv4Rc4TSFwDzRQn9jsQFcBYPAJBPgbiGtTdm9qgrkCWiCDJJFkeSFGIaLDgu2TODY8N3bx2
47f33Lsm7y3OI0DBQLpAZlR7Kx6ItOemuiftoeQngABcDAgkzhdTLyAMCgmxgAcbi1SgQDJb4wHv
Jc/hSX/XHgjqAfZi8vbkmICFId5+NF8yhxZMac/udw4d+oj0FylVGOx6krZsyfP4BMz7GeI9ftTM
ySBFzpgMWNwnBcI+lx0qGYRZ4IKCP6wQ/jm17TJqVUZdKWYkxGrETi2T3sQr0A7Q48SgH/p+QCgu
Lr13yt0Xf75IxgcyDmANwAdiqkpFHd9o00vqi9AhVSY5WOHJcH2IrANRTwzChtg6AKAfRwBYHEYB
Z8mi6HXfZZwqmGe4nqhRhJSmId1EeIz6YHmTPliCLhchkxebySHEMj/Z3T6bx98NUICLt+88WFBY
uD3fsqPIsq2gdHth6fbEHn/icRlu6gE5k9hSF9DjxEGBpXx7gXXztsL8orJNWwvyi8rzi8s3byvS
3aXd9M/flnlZsgyZ58l+m6YwyZIkrykoLN6eX7jn4Ac4WfrFPQc+gJ94MnlZ8hMKEp9fmKqKbQUl
sG2HrVDz4YVpH1JCr9TcW2KxVjxw/wPrN2zZtsNSZK3cUVS2ZXux+i3JT9ZUXebHqp/D/KuAFCzf
uqOwbOsO3NMLNm4p3HvwMKptvCKgK8BYDr9McJg5gXvAgOaDNw0yNUVaTCutRkRvOgEOcl02l9MN
5/0On3zk+PmC4oLthVDb1u2FVtzTmseK1VRF4nibtvZ0NYM/84tKt24vLrRWFhSVFVrKly5fvT3f
WlhcnhLjVEOUpreIXvK35RdvK7CCJENVb82HZ5Zv2lq0e/97PSQRJ6IrZB7hbnTaaxvaiopKi+CN
hdb8/KKCAovFUgY/yVZaWFhK/sWDxDFcWVJcXFZYYIWfVmsF/MzPt1iKy+C4oAD+gpNlZWXV//vn
/9m8eUdxcTlcDHv4izwHLrbCHp4GZ+gBPNNiqbAUl8NfcFwCjyousxQV7dhWWF5qLbGW37xqCwtx
mOwFTmyobaoohRcXF+QXFhVYrOS9yZIUFFgt+LpSstG/SgqLsFTkXSUlJVUWK34CFqbAWlhk3b69
oKgIvtq6Y4eluLi4qKiQPrCoyLpp0+Zpz0wn3wUXwANL6FZSUgGfDB+1Y0exxVJOnwavtlor6efQ
SiMfiD/hr0QlWIuLyorxTAmpUihwCa00LB45LoSWIM8/fPgjgIxUZUX4xhASpQBWRox6wkSoMAAW
NW9pNFg0p3VGcBmeEQVeEiJffvnDp59+dvTo8U8/OXr0s8+PHvn8syMnj3xy4uMPPz/y8Ymjn53+
7MjxI5+eOPLpySNHTn0MZ46egYNjR89+8smJT8jPkyfOw/HHHx8/duzsp5+epNvnx/AC+Pezz07D
ZR9/BM/H83ASbocDOE9/wgFsH334OQgGVHhBATRNKchJYSHUfNn2bUUffHTs628vFhVD/Rdaikq3
bd1RVVWF9ZlfTC7GRoGKhZpMtkhSpBPyXEYOrPk7iqH+ofmKClFsyJUl2uu1G2kyKxSJtJqV9BfS
1jugFxSVl9dc/uVGa0ur1QLlKLSibJRpC6ApA7Z7oheQHgHyX1gCEmW1YFeCjwVx/dv//m3unPkV
FXVFhbRzUeGELlOe+LSy5BclOynsS6BUOwpg5vj+24s/fHepsKDYUlRcgnVCJBa+1AIPgY6MgkdO
pn1smfaTaQmpxBKBL0uILj6tGK+xQJ1s2ZK/dWsB6RoWcr4scWPi4Zpj2gRWUtRiqH/S64sL8w8d
+CAW7Guoay224GMt1nLSlGUl0Mdx9NCWraxIP0ZBi0DrFODohBWYv8MCtURvgVLBE1auXP33v/69
vLyqsLA4P7/YasE+C39BxeI4ZinXtFeZVmBgDwMUFY98HBDKYcNmAmGAi/Ot+TBeWwqLCy1fnPsm
LMbvYvN5MhbxWh6sjCjCJJM7AVhpTO6jeKMbTW96Rxy3n+9ye22+QI8zsGzZyi2blpSVrrFaV1os
q2GzWvPoRo/1Z/IY/1rSzuQVF+fio4pzS0vXWKxwcnVhwaqKivXJJ2j39MCS8ZDMNxqVwej65OeU
l6zavHnZoqXLbW6p2y3BwaZNS8tLVxm9hXwUFptuFnqsf5f+Frgml+6TB1ZrbmHBiubGzZUV6/IL
VpaQywqLcizW9K+m5SRbXnJL+8DE9ckrk02zuqQEK7ykBFowD/YbNy5asjzH5vQ40WgYsHlEJxJ0
8bZMHjUG4ap5eoAxWAbNoyj0arObziCGVboCTlx+cFDUopKKac8+CVVnseSQLVe7ZUjCam0r0/pJ
qzRotRLSiEXFOZWV64uLc2Aj59mVrJEcdY9nStYUFa0sKsopLV1Pmi8H6nzZsjdnzV1oJx6EnW6+
E+2z3OUr1x997Int25aVleSVWnOtlpVlpTlWyyooQ4llNZwpLcF9Wdq+ZHV5aV6JJaeMHCT31uKc
8lK4cZWlaAX8rK99u6JsLXwRXF9Gt1LoZasqK9ZWlK2Bi+lL4d/iwpX4E56JZcixWuiL4DmrSkty
Hv3XQ0c/PSoHABzE7Z22fz/y2LYtS2oq11qKckBKK8rWwWgADymx5KqvKFpZXLi81LoKK9OSi6+w
5sBzoMB4DfTxopVQYNjIX7kVZVC9Ky1FyyvL1xUVriiz5tBvKSMX1NVsLC3BJ5NHQTmXW4tXlVpX
l5EaKC9bW1aSA8+H45rKNQU7VliK4efKEsvKyjL45FVQkhLLCjhTXgKPzbEWw1+5leXrodhW6AV4
nAcH5aWk8CVYLaXWFVA/Sxa/Nn/+YliOE0SlEIAVSjI5MYPmKJN7IlWODmAlLYAy1WBpiUYzPUjk
3iAfXbJo+fPPPTNn9iuzZ72yYMFrsJ89++X581+DM3PnvD7rzZfnzHppzqwZ8+bOxDNzX50397XX
X3+BXPP6m2++NGvWy2+88RJs8NecOa/OnvXynDmvvPHGf2bNmjF79ivz5r325pszYIOTsM2d8yo8
BDb4F/6CDa5P3PLStq3LiFzlEJkEYcupLF+7fOnM5Stzqmvrp097vLpqPUhdRVluqWU5VHhZSa6l
eCWKsWUV3AgigXeVrSXCjBuVRnpQikMl3LumFGU+F9oCDogA51BRx1s0N+JxCTQZdhNsTSt0lhwi
+WtAnq2W3MceffjQux9Oe/qpHTvggtVVKCGJN2qfltjDQ6DA5aVrYYO3E2nMIbKB5SkuhDF5Y33t
W3BgxZ4F8rMKroe/sBOBTJasoZ1U3TTHIKIV5bmLF7/e1tLaUNf47PTHQMxALLG34rvyiOjCM6Fs
a5PdIVE5mgei8OfQXk87PvYFvCyPXowdgdRzcdHKyvI1cEB6Yl55WR50dlL/qUclX5GoTKj/3PKS
NWVW2GMxVix7Y+mSFV4H/8i/Htm2fQX0PtIBc0ldwbev1bZIshHpvsSyprJ8NYgH+Ryo2HXk4jzS
sjk4HBXnVFeua6zfSMq8ihQsr7gQHp5Hvg6G31zm8+EMPLYgf7kqaVaULlL4HAv237wyK1YgfPJz
0x4vsVYGuehdzCB5O8OLRZ1pUiZCyoOVoGlIMLnzmihCFsDy8mwyawZbks6BxsUFbzqcnR6vw+1b
szbH0dk4Em+9pdSM9DWN9DWTrUnd+pt1e7qp/zZrLtachAvijeqV8SY87msaijQMRxt0V/Y3M16R
9nb1fLPu1ZlF0hWgSVO85BPq7Z3Nq9es6fFGerzR1Wvy7F1wY0Pqyem3N6e+pb9Zf15/Rj1uVLf+
xEZ/RupGehtG6IdH4UzLSKxppLdFU/Jm4xpuTv+QzM/sTRQJDvpb6PMFZ/nSlbkeju92+mzEaGgn
Tn5OQu46Vtjk5UcxDnqZAbMG7vmMgAzig+UKgoS7kbeC73R6bG6h2Fq6o2DtSG/9SF9DYmvUHOhb
R1tjOvFI/ATZu9UyGKkfCtfDzztKHV4QSbS7ToCbGIKUbOh4M2lcqOedeNxbMxJp/OZswSuvz/b4
hS6nvwfpHni723f9Zte/H39S8dVgW8AtvXUjsdohEAP42d+e+JZGk204WjcSx2uGI3UDISI/cEuc
VEi0YTgCz2yFn3gZnIF/Sf8aCNfDZ0IXgz0RjMY7oVpybz1U5mC8bSjeNhhrHIrtisk758x+6diR
Y4IfgEXU3tn97LSnejrhma1D8fbB+O7b4SaU0r7mxKMa8F3wqFgdfTIWL14/FKHPJ0IYbx3pbRsI
wXHrUASqvXUwjPs7SvVIrB4uHoDCQKeAr+jHDxyEV8R3DoZa8GmwxdrgJ34XlhZ6SsUgPBxe11uN
lRbDt8CnDcNBL5V5+tJGvKCvBip5GGsYfpJqiddiG0XJE6A11ec0nz+x9bXX3ggTnRPFQKozlhA0
yleoarDQUSYFsLIxVU6T6gCeSdPAimEUAz0RUVyxdOF3X1SO9O4aju+/E60biO4Z6dt5J1Q5FCmH
4g2FoVZrRvrrR2LtwzBWxOnWNBghTdybbBHs7NDcyaoYwBvx3+FYI/2X3NJETuIxDry9TckzcM1t
pVGV57420rjQTM3nPt+2ZOnSqsryUsuakf595BbSg3pbB0I1Q3hZ7UgfyjPcOwR9KtJkMGQ1p3or
fggZneBntC7VPbUdGW+Hpm8iEltPpZp8actgrOl2dM+c2S8fPvT+q6+85HMduB3ZPRhJG7S140Ar
yiR0TxQM6C9N2PqxMvLMOrXwvXV9UgVeE8f5Dr6LSDLZ49ANHaFFHcnVLpnqsLeV5oFY49EjZc1N
9VUVVaWlq29FWodALKPV6jX4sc3qvZEq/XP0W1w/DvTSk420x+FxjHb5OqwT2gH7GwfCZDDBXt+g
3pL+CnJvb8tgtP5WqGIoitPNZ58ULVo4z+3wvfj80z47GRPw7TVYIVBRdD7SzenJoa+BDH01A+Ea
LEa8aihCX6FO6yhR8HYsG7Q1DLMV5O2t5N7aoXDZSG8V9sfUnKj76uFIgzq+UdGio1xv01C8YShW
MxhtHMLPbC8qhAVegRQI3GXEnWhPD5vSAayEBkt1cld9sDQaLG8SYLF5JhmOL0z6opSTu1vqcrt7
/ILDLebkrhBc0LQgf7WqfMTJBvWe3Gee0e01lyUPoCXCjepxjAzZODe0qFvaM5kP1F6m3XqNy5P2
zOTPSKXfXp+7OtftVzxcCA7gJ5xMf2Yv83Ut7LcblUpX/sbBYD2OMr1kfoWhIdRIZqOMStCeSfsi
o++FLdaMm/pv60isZSTa7O8qzV33ltvn73Z5kXoAXdCIj5eO4NQ49tCcDCzhqmXXsIGw7dSmHK0q
T5UHI0ldXgnwX7fH7/Ap27bvKClZT3op6b3qPuPD0xuuRVfz2r+gfmA2QsTQSsSyScW4SUljCkza
6yKNZHJqG4ntJGIMAKvl7LEdr70xx+XlbMh/hkgRlivXbtyY/uzzQVfNSKh5ONQ4HGogz2mFnyPh
VnWmjCe3xsQB6S+0MOFGTeHb4EXYrFh46EFNw8EGnAB6G9TKIeI0DMgGnh9rxQ3eFW0mMtaceF39
MBkNhwFz4MDX+sYbLx799KQi94XlaE9Hz7PTnwn64Y0wD9WRmbtS7bC9KE5DMBlHycPxFQ1YPER4
bXgm3ETqs1FFkzCA9FePxKvJ8N0+ILfhlBCsw0/o3TUShWvqhkKVOIbCaBslQzb0iAjFQLU4RsfJ
GQRJu/EVkbohZQ/BxHXqrAN/RQgA7SVbqGYEMJyKI7FOBuU60iN2Yv2E60inaCSQq+3s0R3z5i7E
JI8+ngKjkGoiVNLtg4lAv6QPlkrTIBAn93HjVZqGTIDFTN6MPlhir9y7aP68zl+hCSpxaRcrDtjr
L3/XgBAnUoK4Cqb2GJljQq1EXIn49bWoB9CaMFnGW9T27SVbpDGxympJbfHmQaU+9ZNehq3ZnDoT
JSu9PtKI8EZEG23njhUsXbqyuqKm3LoW0V5/xcit3R2Xq769UILrCkDMdDqkk32ciITR6AdN0N82
Em5QURq0ggJ/7dJ1T+2oG2lQL4u33RKxTlDMABfGSkF058979Z39770848WAuwUbOlbBHoGxuqjw
gxSVk6LuJlJqJdiuHhFPnNQz9kfEBHdkqI12dfmEckWWCrFWTcdMIV2iNYB95anjZY11TVUVteWl
q4ei9QS+N+Js0tvQG9gDGxHUKrKi0Nzem1gV0J8glhGy9o5pLkPRbRlSyKABNQBr5v4W0otbsKPh
1zWqmBUbukUzkjSlComgpxVlvq+SYpdzp8vmzZ3rdQnPPPVUiNuN/RQEAAAlVEt/Ha7ZmDMdqZZB
GBCgOcjaCQ/6SU8PEYlKVjjsVdFqwtoDaYEC9INQVQ7Cmja2W1+fTbqxPdZ0R6wflOGBrYNyAxFU
BG1D2FgN5CtaK8rXWi3lEh+6azTok+5vbvcKNn2yZ/TBqqjRAiwtD5bdyzNYmph5+hgXpArj8YU7
nQ6bX+pxR9etW+vprr8t1eBo3teOldhLDuj+/7rRu6CW1aGzFR8LzYOTxGh3mR//n25MO9nf7u6u
zV2d5/ZwLrc/N3c1/By5tTP9ssz9WN8Lj9pFtuTBLpSzCK4RsdMCuoJBPwwS3E6uST6qTbMfQ92m
l60Nu0o8eR6evJOzVa5YvabH6XL4Ak5Ogonf5uFBzLpd/nSCWaa52VBxlaGU1WukDKJZM72+UoJ6
rcuJHK1EfdXj411cb35BYal1DXbmXjIOxslcjnoj+nVjlkB6AFIHEkirCM5QWIDz09jkLfkTIAL2
i904ZMO4BtNh354vTlhfeX2WBz3fRZtH7HBw0HmvXr3y5NNPh7x1OJ307Rnp3RsPgAzsRWQWpc3U
luhimgMY5aOt+I34mfilt8RGcvzuSO9+fA7+RaSov30IetOtdtyoUPXtHlCgkHtvia23JRgB4V27
h0JEJuHD+4n4wTSAI3UdmQaq35j53Geffi7x6KRsu2l/dto0vx0G7nKs88hOshhtJut4gDht+Pb+
fXeU3SP97+DYB70mtmswtHek/yD5qx0XuzCGYi/DNS7shyItA+EDDTXLAo69n3yw4fTRok8/KDm4
dxPUBo4G4XdHbr2DUKy/4cIpq8+2aygCYKtyILSL6Kv2j/Tvv/5zs+1KY1xoL9z2RjTQgB8bJ0AT
Pqe3dTjSrH5X3ztQhiGY+/sRC45EoMbeGQy9c1umfQoGH2zEIURae8+fsM58/U0B0RUyCYmEfwsA
VtLnXRv3R3FSKlVOggcLAFZ20gdLl4swjYpaR48k8TF4wvIlizou19yWy+EzByJ17+63LJz/alx8
b6S37nawBtoRPzBcS8YHUvhwU2ICIz9xhttFpKhdFZ4oASX9BHXRoQCbrJn+BDlBUaFjC96blOc2
FKcYqZwYQaIoz3vPfV6yeMmKivLK0uJVI/EKmJ5vhT5akzdn9uz/3Anuw9aH69V5kdR/NCHD2o3K
c2wXkZNmlKVbrUMKnDkwFPuAcT3d+sn6M7pbcrZc+sY60rsPb4eTvTX9wYYF82ce3H94xksvenrq
ELVQaKjtRMkNi7cX6yeG9Wm7utN2hQBKkLr+1gFUYMNd+/vkfSPxA0F346/fl2H/iu7Ez6EYFNXM
uwzLicOR9eSxgqaGxrqaplLrClwYRKpJkzUMRZobqtfAhvKJqrid6dWSPO5NPC3WknzyoNI0EIR6
QL0mjnVQ2/071V5Mp5Vbu/FDetv75WY8DreyK6GPzkdEcRhvH4xUnzlpnTtnjqOHe276c5yr7bZS
QXpiOy6Z4Ht797BGJNwPKDjmxHlo/fduB/f/+GVJr1CPi6VeMr9HyfgMYyM0Vi8ZXeO77dereEfT
YLiN4KR229VGf8/76njel9gnt/62wWAzNkH/eyHfLmz3GK3kdoLkdgHqvR2stRblWIvLxYB4lykP
OCMFhy4XoQqweNVEmJaLUGMiZE5vpgmS0/kSPb6Qze3q4cSOnuCatWvdtgYyQu0m30w2bS1QcJp2
sl+/70/7K2G3ogsm1bLWortGe5d63JI62a+/JvN1/ay3p51JnW/x2Krz8tb6/ZLPJ65Zsw5+Ei0o
/brMUmnLrDEn9WvrRPtGOky0q1vieAg7fPMAXXz0tqgDZX8bq5KNP7bP4Ov6SDljVLmS0Ir1tfLO
ytXrNzjcbqcvgDS21ETo4lQNVhpB6GjpnO3muXTSEh2a5Bhg5QOwAwT0I42Cze3v9nDdrnBBYaG1
OJeITXJRTipNHTgM2p1Zk/2tQ7BG7E/UElpG6nC4R1st6xbapv2smqem2DiZ29BYVgUT1flT1tdR
g+XvdsHnyzYM3uSvXPn1qaefEdyVw2iS2xMT21obF4R5slDGUYaMXPHEINvbRo1rsB+AYbS3rV8B
gWmLSw0eW/mtUNPZ49vOn9gyFN9zByALmT5vBetBqIZjTeqY1dt+J9zKu2r6lbbzJzeeO7ERDmAE
HMKBuG0A8X3rMIhHdNdIfB+isRha5ebMfvn4sbMBTgqJwc7rdhh2RU87mgxgXozuD/tq7gAiiTcP
x1siPKyA93httcc/3XD9l/JhtLC0dF8rP3V007WL5QMRmIpaonz5mc+t1y/V34nsG4rtDvpazp+0
dP56cNmSl29cbvX2NAYc+6oq1luKlsGcFxOrz54o/PJ0dVSoux3a9ebM6R+9Vw0fKPurzx2v/PLs
5ri8fzj+rrV4SVNdzkj/+z9+3RBHTdjBby8UnDm+JSrAGw/2B/f0yrsv/VDyw5fWkf4Dw/Gdw70t
gzhX7esLHqgomf/rT8W3UdPWfDuMgjSItsW9AOZmz56nKq4IMJKRaohnJGlO4CQEWAkfrGQuwux0
mgbkwQqlASy92VEU+4QAt3zpwks/1CDy7n+/+3rj/b+9L2vcb94/VBxXmgbjrXEJWqcNzXn9BGTD
5AoYCKfY9uFY660gTle/fl8oOhGBDUZa1UGGihBc1k8wE1xMlhN3Qs09162cvQLALv5LRY5e379z
KE4MYSghLUOo4Kwaju08f7J0yfLcsvIaS1HuSLxxILq7KH81ZqkfN6GpbuHtEKwWdt0JNwyj+aaB
jOqtqiKtl7iCaA/69gxgzTfcCVWDvN0Ot4ru9qL8WanrkxeT64didQMAFvv3OW7WHflww3AM3tUy
gDY7XJHOnTvz0Dvvv/bqy7ynAa38gIfSHpI4HkY7zN7BWPtgrHogsruqPKfMunQguqc/2DqEmpWW
26H2kH/34oVPBH173V1NH7//1nB8P1kMw3PguxrvRBrVLsneDgHmO3HM0tTQVl/daC1aRYAmyOS+
22EcE6zFeSWWNdBA5Oc+XU/XbINU06wZBG6FmkNc3c1fi28rCKfggiF1ZMAx5w42986gt7bnRinn
qLryYwFeQ9eNcc0woh1V+pqGQ/CWAyPRpvOnSufNneP1SE8/84zbUXsnWjrSvxux9S0QxZ23o3t0
NampT+jOt5TmdWv+8+35kpFbHx4+uPG2gidTM2MsYZXqp8Kw+5sLO1ydIKK7hnvb+pRd1eXLi1Gc
mnQSkjgeiNSTgXH/d19Y1q6ePhAl4Bi1XHsQaakFayq15FmKS4NS8K606cTOZBLXzF46olHCxKPL
RZigafDqogj5HiYPeHpEIW/C4u30wknJ5hOcXmH16rV+ey1ZGtKF4L6BYC12xVt7iZG1fCR+CE0D
6EiEaHdAaieKAVgNk2UKwM/IQbQv4HJ5F1ny/nckVon7aA3u+6n2tR1R8609ZOnZNBLeRYyG1djS
cVgE1ONbIgR69xKMEj2Ad8XaiGtCO65N4aXwRugP8JDIAaJxbUDxgiV7tJo0SYPq6YJK7L14pr9B
nRr7mwOO+jV5eT0+Cba8vNUBO/Ev6U8injb1mPwcUmBJ/c5ItOr6pd2ypwHtJn10nQfPbBoOk5UE
1swe/FJYAcDEgx2VChB8y7vEel37/ZelUX7XnVDNSLQCV/m39hFLShtBbGTNjc+sVpee8UK4azBU
R5fpxCC9bxiXR+/cjraHhEMj8bJB1BvvQqUu0SsQGNemsSagepazVa3OW+PxB7o9Yo8/aHP53T5E
V50ugalStZv4rRtkRkrn3mRmS2Qzs+veZfPxPW7R7UfJB2m0ucR8jCFaTez9UIGVcQkddIZRfQKD
4EHah2Gph4IaIYqT0E5c86FswOp/Jw5q+Fc9gRS7iVYAmwyVTyBvIA/RQ8Mh6MPVw5HdxImhZqQf
Bved6JDRSyH+vpHoOwSOtKquAzg0N+BE1dt6G00nzSNBfOb5EwUz35htJ9T8Do/PA+X3Kb9cuT5t
2jOKrx2Hnv6d/XL9wb25fWINWfa1o8Dg9EPcYnCMaxvGngLFaL8dpFr6+sFY/Tdn6+bOem4o3vzd
+bqvz1jQsyHajsLTSwyFfe0D0XcHo5UDsT2DsVq/o3nT20uH47UXThd+faaQGAVacYGLhgCiCYBF
dqwZhtFhVOmVjfSVv/bqSyeOnw1yEdkvOrq9zzz9dMBVT+S5fUDZXV2x9P1DRbfDTaJ751trl3z3
Zc2Lz02zFq+aPu2pry80i96qefPeqK/d8MpLL5z83ArT7fx5r2/ZtHLBvNc//bA0HiwtsW7aumn5
lk2L/3DfvT57Y0vjpv27ipvrtxTl47RdWJC3ZdPCZYtfW7d23YmjZb+7Z+qKpbN51655c2Zu37pi
2eJXW1vyFW/TY48+tHD+a96O9vnzXw/ze8tK31q6eO7WzavKy9YMxpq+u9Dw+qsv11WteeaZRxrq
82HOGwxC3cIccGg4/s6sN187e6osLrfDdDsULiFdGyaS5gsnC2fNmotB4KKa5oWY9kIhKZKRqS0V
RUjoiJBEKpkqR5eLMKXB0tA9ZCAtwgUqL1uy5JcfynH2ld6rqcidNO7/AXx5dvpjEV8bDgL9UOAG
tM+ClMarcDXf2zoooVWrvWlDW+PGEbmppHD1r9+VjvSWk0F1DzWgwOjRp1SBOPWBiMYrvjnf0N66
EcTg8IFNJ49uRz0TDDIg/2gd20k8XWCEab8VAsxRNRSrIMqencMhkOfSZctWVFfWWwpXwiKkT2r5
8WvL6tXzc1cvuvljoeBszd++fsGCGY11626Ha2780vbfw8Wb3164Lm+Rv6dpIGr59cemt9YuzVm1
4PKPlSPhug8/KD90YNuyJXNbmzcPRNoP7Nr20IN/++HLuuFYXUvjusWL5jTUbL0VbumV92zfvHrJ
4jll1o19wWZ3d8vJo0UxoWrz5twVy2ZVVkBz71my+I39+w/PmPGK5GofVtpJr2zAARAni7ZeueXQ
u9VvrV34zt6tErd/25alixfM+ehw1WDUWl662lqUB7Xa3rJlxfLXc1bOcXW2fvhecdZv/r/DB3dw
jj1nT9df/L7tyk+1wzBE9xWfOloheFuPHakAYduyOSfg/mAo3jKEs9hegpbIyNxXd/pza31je2V1
Q1lJLnEtgpOIY2A8KbGiszwOEbBE6dt9G2fSZoIhKtB0jrZsAm0RkzWjxGLr7CQ6m+YLpwpmzXwB
JgU05eMH7iUTHzHZY9/cfe5kBfQs+7X68pJVwwRhD+F6icKpetRSx/ZQR89eqfWO0oBeXOheVnn2
VOW8eQtdLvHJJx+PBFrhPM4jcOOt3cORqj55d1N90aL5r+7YtjzC749JbR99UHtg3/a5s1/45kLt
lR/K/vzA77ZsXBIK7PngsOV2sPr6ry2rVi1YnTvno/fzB+M79+7Mv/xjU59iufhd7acflV79qdHT
bYkKbZs3rNi+LWf2my/XVuXdDpd++t/SVatmr1294ObltjvRqs8/Ld67a/vSJa81NxXcju17e8Pi
v/7lLz9/U4Wr4jBZEmDF7iSeXo0lltWWolJFkO7K0FfxxsngAlqAlfTBcqURjabRNGQwCWUCKbsJ
zWnipNPLw4K72wcHQm7uGgRYfW0JP1wCHrHjtRMhqKeuqdQHZTC4G6erSDlVaA+HaxF4wWI39A7a
XHubesUtRIVbdUdpHo7lDwNOop6DIAr4qFaCRZoQvaE9GxfKd8JoLIB5jpgAmhBRYQHQjQCaH24f
DBJkhsCrldxVi/NftAHNw72NuJiDiwH8YjdowWm1v0VVmKMZvg1v6WvmHQ1r8lbbfAArpbzVq+Gn
CrCSGCuJtODgVttAePdguG532+afvikGCDUY2kOxEVkg4rpwOGYljpNtRGHeSqZk6EvV6EB6i/af
VugJV3+uHQy3ox0niDBoIAJLqwpSRcTV4Bb2ouEwHOzH7oHGexg1Ku4oxHkwhsvEW8HaXe0b2ls2
3YLVW+9OnDuhM0eoUq1NbTgKjrHwO7meqty8PABVALDsCYDl4qQut5AulkZMaRms8Vo9VkYWSG0O
GZ3B2q4RPDvT+OjjbW4BARYIpBcBVkFRicWaN9JXAVV64XRteclanB3RNQE63naUHzTsEm3/rfaB
IMhh+UC4dhCWfSB+ULcKcajsI5YsmIdQUEFEmwbCRLr6GgbQB6gNNYvxw73QIjF0Fo5L70C9XfnZ
YrtGgxKI+zaMidTYHa8eCMGE1ziMS+QaHCij2AvOnyoCgOUgEgUAy+3ju70AsG5Mm/a04mu5g2IA
I2z7h++VwTry9Od1B/asX7Tg5dbmjQisb+2pqXx7ycI3Nm+cFw7gOvLT/25fvODNnJXzYJwq3L7q
f/50/5WfG6/81Hr9Yt2546U3LwHKr7ol15/9vKJPamyoXQePyt++8pZycM/ODY/+66Gfvi299kv7
j1+BSOz65PDWZYteyd+6gutB1HjuRO3hAwVLFj/X2rQFFh5D4eo5s189cuSYEuDCvNx90wEAi3OR
qR3t17t//LqiID9nKFZ36MD2t9bNvvRTw7492/vDrVs3L6uv2/Lz9zWzZr4o+dqVwB7ZX3/4YOHa
NQuGYiW/fNc4a+YrP3/ftOGtxQOx6mBg98svPe/srK6rWV9btbalcUNF6brBeEtb07bB2LuOzop/
P/JwSNg5d84LX5wtFf2tFeVrAA/9/N3uJUtegcaqKN/4zr7i26HG55974psLZa+98lxMggls17y5
L7k6ar88U7J960qQ+dMnq2e+/hJ0VXTaCJWVFOa89urT//uXPz/x+D9X574e5g6g8MA6GFfGbedP
WGfNmicThnSKjQAYBQUFAZZBFmESRajSNCQ1WJgqpyYFsFJM7saJcWTMZaQsW7oMARYOmPvC3r3H
jzS+9tqLt5R3+ySYuZvfe6ewYPvyr88Ro1W8/tdfWgvy8/bvLhZd9atXz1m0cNbt8B5XxwHB3XTj
YvVQtKVfah0ItfZcg4bbd+iA1VKw6PxZGMZ311dvXLbkTZjaedehoA9XfedOVMGTvzxbPRxt7A/W
ODr2nTxiqa/J7by2XzX39OF8dvZ4weIlK8pKqirK8ojbcku/0lZeur64eD2M59s2ragoXytx+6Y/
88T1y/VHPiz48x//cO1izWcfVVsK1430v/fSC9O/PFt45nj5zNeeBzFbMH/mqzOeldyty5a88cF7
xd+ea3n5lWcDzqbD7xYtXzwrxrct+/8Zew+uuLbsWtg/xG7363bo957tZz8/t7vdt2/qqxyQhIhF
zjlHkUPlnDNFlpCEpKsIIkhIQgHlHMiZonIuoAq+vfapgiLo+hvjjjsQFMWpc/bea6655porOfzn
i7UadTXCT6sWZkdLFUL59weoGRnRMkFtZnoi2nEKWfnMF2ZKclhzS3to6GnjHFC26xaBxyQAjgSK
p5KFCfaJoJ+GByWf3krLS9IRcrIsyqMiTr96ymIxCqXCos9vRLmZSevOLh77jFJWcW+Q/fv/+38e
3ePc6+MlxIe9eMKqqUxHyZtN23ymLGVogB0ScnR2gt2iqczJCnfqm3EKJIZczpeBY4AlVLARwKJk
YyQk95hxUHNxGupzGPQidBZ5oRwpeDXSRK7PEnKzLAtSj1n+8bnq+TCLx8wcf6uA88Ta1KGpbqxN
6T5bh9bn0G1yeNipjjaKRFg1P0FbtVDMi1IBt4RJL9ZBXY91p7e+OD9u1dj66U0rCjRjb2R0Sq6I
V2iYlWBaXbiBQqGlGX2Rlx3/6bUYJ5atqwbl4G1ONClycmLq6LEjy9MieKVLDow45OfCqxerEmJP
OQ3tmWkxKnkpOhVPBh25P8jvuyUsyIvTTgoOHTgoFZWa5hVHD/20ahAXFSRdv0wbfcdPiA136AXX
L1OOHDww9k7x43d/ejpMF/Nr7vXTK8rSuezi+fGm//sv/1smJWtnNEcOfr8809nRxszOjPLY5PEx
4WJB0cxY68F9Pw7fZ7c01f3w7Z+nPstwXt2MAZYYmEXgSkXAYNUjgKX/q/9mLO7O6LWEhz0vBnYR
QomQGTCLcEvk7hv2PLarJfArZg2bMuRd0+sQwIJvLo8igDWzlJubP4cOYh+DBaSUFwqoOOd2Y2Bk
4wBJAF05qlWQCKAnhOARbx1K1+J1UPMJgKwCVCQCZsutwP1KTXYdh0HNfPuMOf6e39lS8vGVgEYp
WLervVY+NIk4COFqR+8N+ewXEdA8kJBxsOJStu5Q3x9gzHxGL5O3a8otC5ivsrLXQVSL+w5cgnUU
59DpYIXngTuYgAP3GFswicXDeRu6/naiJWpxXBAIsBYncD+OD1HJt5NYcoCPkB+wnw4r9HOS0Xfy
a5fYZ1uLNcqS4bsSmTgPnQsWbdPrZ9zbt/htzZWtqsrlaYXXRv78WtGsqhJz8+/1o0RTdH9QtTQt
nR+TXe2u18hz371QDw0of75Yr5TmD/RK2pvLRdyy0Tcal4F3f4CllBQ3Kyss2i6nQfRsmNV3g6wQ
FXZ31ZgWRUmJYTHRJ03oJiD4C0ITAk7x/VfuJ2nhISrmgcHK8zFYcwCwZuYWp3YyWEt76rHG94Rc
v+Avuns+4I4p1Nth1o40Y3R2cZRgsGaxUee0rrYBGCyvmXF/gL/vpx9+99vfdnVU+sg/qwjnN2jh
yaGDCZqwxE6D2IPTwTWTFCpcLo3XoiEeIpQYIHKcdRvFHht5HWFTK9G0gvJmFHqlHmDX+eYFFZ2a
h3731rXaW1doXrSeAX61Yfq2CXQGQIkD/7RC8KZohcOflvdcJYdHAMDaZLA2AZZlQQQ6G7NUOyUJ
PnHEMK9KiIuQiQtmRmU/fvftu+eskWF5cUGCy3w+NTlGrWgwL0gzUmM+vpb1XOdwmYUSQcWRw4eX
poUMaj6Pk3/1EpvHKVuxsh/fl1WWZz0aqs/PifPY1JnpsSp59YO7zFMnTyxN89jMag6r9MNr/qmg
Q9Nj50SC8tKiZLuelZwU2ays+vyuOSoyRDcBpc/o6NArl68ZFhYtywhgjR45fGR+EkvU0Yd1SbwW
dVF+/PwELy2J1HerfnGyjc+rEAvLgoOPMumFa9ZGpbw6Mz26tCTj02sVNHJTCtwWhmFBFXo6qLOt
9syZPJeFuWLvSEqIGv+sYjNKUcAQ8s4waOh3Gd1dnMa6tPrarJ9++ItVy0yMj+rrYa47mjXqegYt
u6w4OTk5Ct1kDru8Sd1gXeKTSGGdrWVJCdFWHXnVwouNDn18X/TwLp3NzHcbuX23yHExp+FQAq2P
+uk96dCA+NDB/eiCH9+Xblg7cf1CvQq0h3SghxIdFWdY0m0qrrC9gsm0c0SPIUCDZSRsGraGPe9l
NLopcjftNUEZvsB/NDUl5fUzFjBGNpHHLOnvpUeEH4ElalNz6CUlhQm3rrMO7ts39oGD1klE+Olm
TYWIl9lYm02KDAsOPqabFcZEnbh/R9RQl/L+hWjdLmprrutorlFJs4qL4u/08g8f/uHTa3ltdXZI
8Em7Vsnn1Z7rqLzbL4uJOnX7BjUuJvT2TbphgXs6+Nilc7UsRg65vnTFrPLL+/hDffXp6TlUCgsB
LK+V5YXqnozSmFNfn4OOUwT0lcrKri7ad3/+M8INF7oazpxJX7UJLEuq9JSoC+foCXGRbqtixdpM
ijz1eFCRnBR24XzdqlWCPlRKYoRlsTknLwHtvihSSH8Pw2Xh99/iZKTF3OmvT4g7xaDl9lxHEUfR
c42dkhTx6B4rJvoUjVp4dwDBmk50/a2tZ4ODTxpmRLhOAtww7sBAmb9weYoTFXnSbWo3LYoPHvxJ
Lim93I3wGamjtVIsrKOSMzdcLd0XBOc6ymuqMwW8Qruh9eiRg5bl5r5bdVGkU167JC46bGFcceU8
mdyYr5RVxceFdV9AyK/2RNB3K6YOXxctMEZqLE7ibTFYBMDCmhCvEfQwDHopjVq8ahSgZzrzmZOZ
Fnd3gFtRnl1ZXuC1n//TH/4gEVUI+TUnjx/02MUdrY0lRbEjD0ToAl4/l448FP39r/9WIW8UicrR
3bMaO1MS48TCM51tDXk5iV5Ha38vp6Yyd/iuKDUpYmFSTAo/3t5K4zJLhJySdUvThoOGdsGTu41D
t0UhIcdbNA0oD9lwtq4amX23KPFxMTOTU4cOHdDN4A5E0Jkp1qAZQr44fqm5qeHnK/ToqDAhr1S/
IC8uSrZpGxYmuCVFUNYPDw8e6mfadNIjh/d9eMEqL81bBTpfwmKW9Nwgu0zU9taGf/7d7zra691m
NnqHC+caUUa0NKV0WcR1NekMWrHTILh8kXulu76mMiM6KthhYGdmxr14wkYRNi4mcniI+fCeODE+
HLgSO8vXELYdYDXWU43L+r/aIyztiDd7MViTBIPld3LfKhFu98H6vNlFuJeAfXy32n3XdzZ5iAn4
qQ4zWH6A5SQAlhIXL6TOZfWKvhWIRKfMstDqMgsWJxTXLtPfv+St2WUrZvHkJ/b1S8xnDyW4QCZw
6hT9N8RvRlhQsHOI3aaW4bvop6LQkKDhO2SE1YwLF+7c5saQgj02nmVJMtjDvHub5TaqXUZxSPDx
m1e5Kya6xyq7P8ge6GE59M0rFmV2ZuyV89xVE2t5GkEQmtss+PCS03eTZl5C0Y7lMfFXTF1PH1Q/
uUfxwvJiQdMEKH8lXrPkQkf1i4e46cYmIDpOlyaECFeNzi1vMVg+DZa/Mhig9VkzI7jGd5n4KAo+
fsAVCYpJEcf0s5qUpMjQkONTX1pjokM6WpitmoZ//M3fvngi7+qoRzHDaZDHRh1Hn/rxkHT/T9+t
WVXoZU8fiUT8wsa6rPEP0u7zlOPHfhz9IONxShByn/ok5jDK8rPjx9/xThzfZ1q8dK6dnpOdvOFs
Tk0OV0grxz/Ijh058O6FMD8vJSMt2q6TYFpRDfQVTj4CABYuEQLAAgYLSoTAYOkIgEWUCIHB+m9H
K+6etjSz9FXl++6Wi8Dm2b2nNW/fC7hEODOvJRgsBLCAwSLnot2lkpanpsacOHFUxMsxzooc+nMN
9RmF+clNyornDwH9v33eilLMnKzoN887nAbOtSvsi12MM2WRHGYeuoGrlqar3VSUk6Gs1DB/1qFn
D/YKpYJKcl0ayolrqzJSE48LBQVuU1uzsuybP/5+5B7/9TPZy0eCdTvKGgtSkkMkvMoNV5fXzO67
Se9obkxLOdasbgTVuR13ytg4Q32NCGBBiZBgsGZ9DNahwwf1U9CWhVCgblqAEJVpSZSdmfrsCXfN
xouKCEXn3Zr9/M+XuWxW5oH9fxYJyx/eY3NY6Oinem0ct1nce5MeF0uyG6kMaiGLUeQyqwryk1Zt
YnTwtbfUrDsvXunmcVnF3/35GxE/z65X5udmoFCH0lmZuFYkKENHvNtCnpuQHTm0f3leWlaWoZ2Q
uMzC0uLs2Y/Q6xQdHXLl8k3rst2iXR77OH786NHZcVw/tchxv7SUwyxLSiTl56R47MrYqJC2lka7
QVhSlC7glL15wX/5VOm10tqaa7LSY7q7mEWF6ejEHBlmR5OOvxjh5+dGucw887LmRNChsY9qLrNY
LCySist53IpXI4yTQX/ZWLk28YH73TffmJdVsdGnh4f4589Vo1x5zSp//ECZmBDusfFR1t7WXG/X
c48dO/TwLhwjK2aU1F0kRQShpOtBP4fNKNuwM3tv8WNjTqFDeVUnBxLdKfFY+VkZkfcG6rEDAh+y
NbeS2Cz9N+ugRLi07CefjAElwr1nFAaOygGApd1isExbRqM6y6bR6FdmeBvBR16XmpL6+hlm63HT
++2btfFxEasgFm6cH1c8eSjr7xP++U9/ePJQdKWrkdyQ5TZzVwzsdbMMrY3GhqINKwqTpx/ek/b1
0skNOU4jIzWF9OaFYH5S/eiBsv8m7dtv/jQ8xB6+S2Oz8j2WIiolu7ONmpUZ13uTbzew0KqLiwm3
LncW5qduWATaKXV+dorPJgNiLRfF49S0LAadA5UvO9djhgZ+SkM2m1WG4lx6KqmqMnX4gSA05MST
B8yzHdWN5NI1a4PHIs/OiL50oQGdjTZdw6pNEkUKfdjPyMqMvX6NumJh3O4RZGfEWxelhUWpG3ZG
XExEzw3Omg2d5BSEF9dsUrvh7MgDVkxUSIum4v6gIC4meM2qdBllj+43hgQfVcsKc3PSNZrOkydP
GGZxe52DwAeEO4BIPy1IiietmKSGec4P33778B53YUYy+l6tX+ikkXOE3OKhflZebuLtW3S5pEwq
rrDolIcP/WhYlA8NCtD57DCw6OR8iagsLyt65IFQKq7Mz092GNSGubPvXzatmrtwEOFizxeiA4zX
FwiwINWXQzJmlm/Y6Q3gM5e3ZiJv2Fo3bC2vn0mH71NrqtJjSKeNS7Kjh/bPjzcuzzIPH9w/P8Uy
L50deSgcGiAjOHXvDv3RA35E6Ml1u8CpFyYlhktFpei4W4VuR14U6fSTYf6Du/zqqszHD0QpyaTh
IR6DfmbFQrPrRJZF7NiCEMnKeXJ9NinixB/+8/cnjh/MyQg1zCIAzRropUVHkmYm5o4cOawnABaE
aTmwaCYpnZKXlhYyOMAsL8tkMYr1C+g8QQuDvzTBys1JQNlsbGzoQC/VsqwIPnX89WN6WUkmWr1r
5gYuu3DgNmPFQhcJSv/uV7/uuSVas1KFgjPnOupRODPMt7ktTAYtn8MsudPHDQk+dKGrSq2oQEB8
1SbPykh+McLz2hpQ1vfwLnVokBkeegztWbeRiblAha9ESAAsCmawlvV/9d/PD9mpN9du88Ha7CLc
HPY8u5cP1t702C/4GO1ozicYrE0NFgJYPJ9i2qWCCohb1t5cLuQUorWlneImxgX3Xq88feogk16w
/y9/vjcgtC/zSREnqQ0luVlxPddqN5xNCfHhdbVFoaePXLmIbhCbSi5KSTqJYsP//O3fjzwUP7hL
ZtPzHt1HqXP4urM7JvpkfV1RchJJJqEMDTJ+86u/rqlKQ+lLdUVWTnZUTnZsTlbS6HvFN3/6j9Tk
KLdJ3tiQa5hT3fiZR4o4UlGRm5RE2nC2X+1uQDBZyC0MObV/sEeBe234uL0cIapmLiP/KroSqGPy
16BDR4xLhHkEwMrf1GBtw1WyLaTlbkWB1mNrKi5Me/xAiFYSpSHPaxeRGwtplMI1m4BGLUB5uYBX
UFOV6zazFiZ5h/b/ZFxUT3zsHL4rFwuz/vyn/zIsChISIh/eBxlK73Wey8gbuEmhU/PcZlrPDUpZ
cdKqlT94m56WEqmS1QSfPKqQFTNomT9+/0f9gqSsOG1xqtNtEeRkp3x+J+KwztCphSsmzPy5lWsG
iU+R42PdNiXhmwDLVyLcYrAWdMBg7el56x+9t9fA6d0s6dIvQbHdLYe7xzoF8LgBDNb2EqFL6DJJ
Bm7zCvMTPNjjp6O1nkbOsC0xE2JCOPRyh1EdHnp8eIj77BH35PHjxiVFUmJkXk6Mfu5yXMzJV8/4
n96p0BJFSa1GWZ+ZFrVmk0dHnSQ35hjmWqsrM6mNhRbthUMHf3g9Ih++Kzx96rh+RsqklfKYeSiL
SE+NsOvOo4jS2VLtsYrQYScTVo5/bEPRfWlS4bN7sLIHbjUQAIsoEYIGCwGsV+8OHzlkmGZjgCVC
0PDooYNLMzx0oDx5xLIbeShjG+xnc9m5yYnhD+5J0GkuFFS/fCxgMoqc6PnalK+eMG9eY5BIp1et
bDqtqKG+0G2hV5SnXeyixMeHaGfFTFpeRjrp4T3JmbJCDrNIN8ctKkxesclYjHwhr0IsKqPTis3a
uvlJ6Ynjh7WzkuLi1KUJrtPIys9NXvzCQJgjOurUlcs/G2FinXbs4+iRQ4cwwBIBaW3nrJq4n15L
//l3/3Cxi7ZhY/LYlSdPHFRIK04HnxDyCj69VkaEHRVwiqIiT9y40rBhkybFh1RXFCQmhl6+QPVY
O9Cuz8tJKCtN+7d/+afFSSWPWSDmFwm5RWxGkXGhKez0ITYju6Yq48fvv7Eua8pKs4oLE/tuMo4f
3cdlleVkRqYkR6xZeG2a+uSk0+Nv+SeCDpoWlVRyPvpReXEih1HgtcpuXaagU3vdKh1EOVtUCDQe
op0OkkQowVu1bW6DCgtTcMXBqlyFTiUhel7RRIlQi/Xpy5sAy7xzcO/W0GW/yB13ERoJgPU3v4IS
oZ/B8pUIA+fk7Jqqa1iAcUOZ6VkvR7g+/aVT2n+LjLJ5dL6hK2SQy9BdFUvqDuz/8fEwq0NTz2GU
rlhlXqPMvihvqM9k0itWDQz04HpvsXQL6oS4sMfDwsjwoBWLmkEri4sJU0gq9v20/9WI4v4gi0Ev
XTGyOOzK9rba5KTQuwM8l7mx92Z1ajJpcUpWXpq+YWucG+UU5CavmjlrJg7O0ER3emhJyekMGgdU
RA4iL1WS63OYjJINl/ov33/7YqT11TPx//q7f3j2gH/9SuWf//TN5Cf5z5e4dHIBSrODjh18cEfQ
c50XGnwcncNRUSHoz2mnm7IyEi90VjuWBRkZCehEPddenZ4cZ1s+n5wYfflCvZBXLObXeOwtdHIR
SlNfPpYnJJDYtEIhB/3RrtLSjMvnazLSkprUHeHhYdopPlhOALehXDFyCI2HfkYUERq0Zga9RFlx
lkJWvTyryMuOevGYIRKUCHklLepGPq/a6+wqLUli0cucRiFae9Ofm4bvUKMiAc2PvRfv+/G7jNQ4
r0368qks+OShL29VF8+SSwvD0aJy6Qkbrc36Bh8BLKEooEToUqyaoady1dRKIZfW1KAEr2XDqnnz
lI+AUUNdVk11Xnp6rHGeffDAT7ZlweKM/PixY8uz5PaW+ujI02JBRWIi6dlj8UBvPSkiFEFbq5aV
lBghE1VkpEWtg3KLRooMuo+g8xC1oT5naICXkhx2p5/F45S69Cj4qpcmFBuWVo8RW2c5JOiBpqTE
vH4ucxmw2M7IH+ylx8fFLszoDx48MD/KxQCryW30uaIkxZ8Q8GvMy01HD+8T8sqtWnpJYZrXyl0c
UxUhTOwQJcTH/Hyx0aptPXTggGWBX16acv0y88ub9viY0yvGts5WOiki+PF90Y/f/2l2VCzkV925
TauvzWRQS8c/Sv/zP/5VrahqUhZnpCVuuK+wGAWx0egzkpMT4149YaB0KDoi/PEQbfguPSoixGm4
gmlCTUCJMFCDhRmszfR9fMeA59m9ugjBAZIQuWMnd4LB2uWD5QNYk7O7+wG/OvZkDzPSrSDqF7kv
bRO5O3FjpJ2JPt7bZ8LwkCMIxzy6x6iryX9wRyYV1Xgd6oLcGDG/9sWI4Ptv/+P1c6l2usNpULc3
1Rfnp9r1tOePq2IiT318hTKD01Zdi8fReuzowaePhHf70Ztk3B+koCi4OMPlMPOcxvbH99nZmaEO
kzAuNqL/JmfFImDRikffS9++kO778U9OU3tZcUr/LSpCM7mZSfMTqriYoDfP+G5TR2FuwtWLjEvn
GcWFyeuO5p5rNAGvdA0hfQsI5HuvUvJySAcO/BAfjyIuaeJDE66dSfwMFojcEdICgOVjsGQ+HsgZ
UCV0tONDR1VakoaiuJBfio74NQuDSsljM/NdFhalIUMsPCOTlFMa890W9tykLCI8ZPQdMyc7Al22
gF+4f99PJi0nPvbU42E+CjB9t9gobNy6Skc7fNXM7r3ZiF5mN3AHexvS00kSYWVKcsy9QUHfLd7P
l1gee1NpccLchMRu5CP4Nfqey6Tnc1hFKKvwmHD/AUjZmqCSuyly95ncEACLs6NEOA3NestbGqyv
ov+92gC3cVRbWqvx/9bcYZfh7TZdF/E11mDNbAKsaZ1f5C5ct1F6b9BKi9O8NtqqWVZamDI3oUQY
98bPdLWi5tVT3v6f/tJ1lnz+bE1kRNCrp5KU5OiBXq7H0ZyfG/f0kUgiLEKp0rXLLI2qNjoqSL+g
SE2Ou3Wds2Llv34u6OsRP+jnomB2t59iXpAWFSWjA4VCTuOyi7Mh4+e5zZze67QYUojHJiwoSF2e
lHttoqKC+MUJvlsvwNos6Z1eDgCs2eVNDRYWub8/fPiQeU4IONgsQW9+aP8PxgVZZnrs6+eSVUs9
KTxsZFidnxfLohfPTkgRCmQzS70WaUZa7KO71N4bnKozaXdvs44d/dG2rKJTy5j0EoeRefUS5Y+/
/3eUaaDnm5x4GmGshUlZfEwwk56NcvfUpAjjgpxGLuRzS8Y+8knhJ16MSNGaQUfhqo2LkoSFUZHT
pMjPiTXPClYNnLi48O7uy+YlrUWrH/3w5eD+fYvT2HbS3oSzFKDxHg8x9DPcFQNUVNHX927ztZO8
5w+p6MSf+Sy5fonx5a16xQyI0LzE6r9Oe/2EsuHgoGhkW5b1Xud+eCl494LuNsomPrAXxliTH7nT
n1Uem2BhvLXvZp12WvzhhdCmY+tmOm5coliXpJ9eaW5drUAw9xWCIA6Kw9D6aIilnWC/eaZ0anko
0xvq4w/00FaMTV4r06Hljr9tRNdpmOW/eqKGDgCwIyK8Nwn1bis0DdhwOcmNG+uckr7rlCiST+S+
B8Da1UK4JXLHswi3GKy/+RVRIjTsKXLfocTyD41GP01LyxwZZuFOBeChB3qZuEQlNc8Lfvzuv94+
Vy5Mthw9dOjhPfa758zQ0KDJLy3PHwrIdWnV1dmVlRkoiYqLie7v4XgdncVFCQf+8v3ZdsqqSfrT
D9+iLG5pUrp/35+fPRLc62PU12WiD06n5nSfq1JIy8uKU1HCUFGazedmaWc4+fkZGxb+/LgcZS++
fn5sxdx3oyE1HSE5LpOaj72RpGhZMsG/O9ttqLp1lZwYFySXFKMF+fYJt+tsQ1wcqbYysa4yVT+D
dgf35Yg8Nyu+IDf+9QiY8qQkk4oKEyrLkzrbGqH1z8Zg0PIVolK0xmSCM3HRQUJ2OfpEy9PKyrKU
zNQIBigvO54NUxGG1k63lpfEZ6bFctnZLqM0MSGspeXcqVNBxjkw7PWaxWBm6xSDG4K7yTQnQAjP
a0ZHonJxUlhalJKeQjp/tg59IpSVdbWSV01NKBBUliU0qxovXaB4rWI2o4ZFzXn5mE+n5HrtEq9d
Xnkmrb252m3ie62a7q66+Njw6jOpuhm1TxwMgk45Jsz8DJZwG8Bas7bYlnihp/ZB0+Wv/prLQJ9F
wWelVZSlrlg7lLKK2KhTdp346KF92imZabHlyKEDunmUXSTfHxR6rF252akINr16qvr3f/uX8U8X
nz6WhgQfevNSTIoMfvZYNPZBkRAbPj8pHuxjg0LgniIxIWL8oziGFLQwLn31RFpzJsm9fA70PND1
hW6Risko/PKe6CuEBsmhPm40KWZ6fPHo0SPGeTEALLAvkYE9r0s09rYtKyO+viZFIYWKs3lRIuKW
e60Sy6xGJi5Ev362g1GQEzz1SVhVkbZqFLx5JijMj09JjOi5SrVpmwtyYl8+4Zm1nM72Mh4z92Jn
/csnDNtyR2kB+vjJFeXply/UoRSoqjwtPydCzDtDqc/12ig8VuH4B7iflLr8T6+4dp08PTlEJSuF
yOvE7XQYRm8XufsYrF0T377eVxXQRbhd5P4LDNauDvm9ZzwH/OnxXfUaP4MVUCKEOI0Ne5xCpx5k
2hmpEQO3xSJ+8fCQ+NM7RVpqTG5O0vFjRzis4jUb78VjaXFR+r6/fDfQw0NQGiU9K1bF/CTvZNCJ
gR5GVkaC2yxcs7JCTx97cIf95IG8pipv5AEPpZsrFnFVZX5c9KmCvJScnES7HvDvYC9aGUyBoCGG
dKIgJ/HI4f3mJUllRdadXgpKSUuLsl89pgcd2z/1SeSxMagN2QJu8dXLTDqlwGNj377RwKAV4Z47
qE6aZoW6uSYaJedsG3lxSrFqIChlgsHKHcMaLD+DJdmSXgWq3aHPUbRuQfhaWFqc8nRYyGWV0Mj5
HlM9m1FWU5W9amUyaLlSYb1SWvf7f//X0Q/yi+eoCEG+fyn87pv/tC53X7pA++Pv/2BYVMfHhj4Z
VqjlNQO32Bs24WAPi88pXbMw+28hdJi/bmcP9rKSEsK/vJWeDDo4M9oy0Murr85AF1aQEzc3hgIe
OzkhZuozTywsKytJcOqFPhsIB2GStOlc4GewCJE7ocHaZLCmA7sI93Kg/SWqdbd/1dIeLNfsV+xG
98grtiOzAJH72JyfwUIAC/p4RXdu8xE4QF94TUoEsKYgQqPUuUEqKh95QDsRdHRuskm/gEKywqFv
i40N6b3Z4DCw0JYevsuWiPKzs5JNi+yZMeGHl4pVCyc6KvT+AAsh8syMBDo19+kDSvCpEw/vMEwL
ivS0WLT8qI1FPG5lVnpUzw0WesT9t2rjYkI9Vm5hfvriGN+hp+XnJiyMY89S3GmB0P9mF+H4NAGw
TM9fvzt0+KBuGtsouJROnaRdU+Mxy652Ny5NytFBc76zdOI927HcJBUVdrSUP7nH6L9Zv+HkTHwQ
KURnlJJyy6J8xajobC3tudow8gAdjghJUFaMMjH/zPRn9IgRaGtRKyubVbUPBsUDPex1m+LSubqe
q+THQ5QHg6x1m+jzSwGPWdzVRsPGRZLrlxluvWzN1oIgo3UO7XRRZMTpq1d7LQhAaM1jH0cPHti3
NIP7JUEMLia6XL0W3IcIHt/4cLA2QdujqwVT97jv1a3C7R0XN+ytoPoHY0DZOlg3CT0m7M9iVUFK
YBHjfknxmqEZkJCtw1e1d6ndBrovsUHAzt4MEcLcihCk1wRv5dKh/LVlxYLehL1mxHZcYFrd7LNB
sfDAHR567kRrZhbAWSML6wSwD6qLmNOAXs/HbchguDrQQ42KigUN1qbIHSARAbCMO+c9a302DSai
ROgbqfuLGqxAG63tVNYyjO42pqdlvHrKxlEQxTZZXw8jJjpsxQh2xz9frMtKD1NIatnMvKHbZK9N
eu1ncn5eUlF+on6G//JFU0pK2KsndAY19/UIDe2O1yPs5LgQy6Js3Uq99XNtUnxkk7ycxch/MNho
mO1KjD/19D7l2mVy3006enAyUVlOZgyPXbjh7rQsKFG6uI6g/1KbkJ8HvYoo/8QOooM9tLT0dAad
y6IXYrM39OB4wwPsu300Igtdt4vhydpbNqzs9uYqOq0UTE9ArsAG4xIHm+hixvZLvKjIoIFesMLB
4lrwjPXY1djBi42LthpQ29jE61YOtD25mHjognrNKMKzCpgbjjZYSI6zCNDHxwW3tnaFhARrp3gY
PWMfSwKnOpqw49RVLCOTeqHVne2FtSp167ngbm8Rr+gJS6q2dUvjhl3lNeNfd+KrguWnWrdiUwyX
ZM2MQRt0dqvBQdTG98KwAQ3RhYqlSzIAWDcBYAWUCHH7p032bFj8m7/96+PHDtiX4QKM85LKMylV
Z3IunKWw6FnW+Y4zJUkuvdyxLC4piNuwCp/cZ2elxXCZ+c3KspH75C+vBNWVuQ11mZnp8SMPuS6r
8v0LAUoXs9JjXz5GcZn75ilHo6h494yBnQKFt68xc7MSivLix95J0H2D5wUmc63rNsISCOfhcGHU
wV5mYnzy9OQiqBdmJF7oBMKuCtDpzF4xd+D5ATLfrXPQ8RYDp18vYS8M7c9d6LGC9MqmBN8NgwZ3
6Atw01Ur7nttxn8L3UMOtCg5cCKBk0zw/YceOAWcGGDK2uRGgcyN+6nBcq8d/aE18NNp33Cdxe35
VL8GS0kwWFAiDOgi3GEItDj+VS3w4jaj0a1ZhAHDnjdH5cwuYQbrq0WZ8V+gEHbJkydnYUSdn8EK
AFiwmNR4h9CvXWZGR4VUlKVZdXy0xFvU1atWQVlxPJdTOfWJ9/wRZ8XS8GqEhxbNuU56TjZpzSZ6
9ohKijzx/qUsKiLErhOuGHkR4ace3qUM36HV1+QM36GnpMTcHWgoKkhFx+WHF8zc7AS3VRoTHfr4
Hu/x/fKgo4edxubxD6Lvv/3WomuurEjqu0FFaBe9fvoTCpBhb0Z4bpMgPz/150vk82drGbRCh5F9
6zqDx6kG41domsCY16HkcXP7e/loZcAABBwwFicEeQTAml0GgDXhLxEG6tydfpgFlmBQ/EbI5t0L
3oUOyrl2mtda36apvnCO4TJxz3XUXD5Pl4srYmMjqqvSyI0F+gXVmpUpk9SkpZDOtVNqqlJxNSd/
9K20+1zN8wfo9OEjiHm+g7pu4zx71CCTVK7Z1CjjZNFyV61NVy7SEmKDa6qzFsZBYi/mFZog1fiZ
y6qY/sx+8+J8Quyp4Ts1oDaDZcrz6dwDuwh9GiwF0UU4M7fTpmFLg7Wnt8IOzfuOMTh7KKsCQfzS
V8ca7v4vYBfgEqG/izDQpgE6KsS3b1BKi5JdBrRj+W1NDRxWll0rT0oIYzNK12yCUyeDblwlv3rG
TU8lmRcpsTFhd/tQrBIW5ac+fcD8+EoUFhK8MC67cp5cXJjqsUkjw4Pv9dNXLHwQagyJZz+Lvv3m
26E+qmleUJCfvGqkMegVAt6ZKxerkxIj9fNN6SmR7S31XhunMC91aVLmtfML89IXJ5WrBoLj5A/0
+gHWZolwDkqE6BQzzOIwA0ZcfDx1hINbaPk4aBFmxxLwlXBhMw67BrqswbQGD5qwtMDAGeg0bPH5
d7u4HpMC1ynYIIu04VZZO90DQASd+/UgcXVjlxCIYQzcii+GKAXaRHRu8lCQ89g10A2A0JKDHRMV
gQCWbm7esGAZ+zh+6OD+hUkeXImtBSMnDbQLoEhmbdkwCXBPCToWeQDrCas8oPH5OOTwN2y0DbMa
Gk2cNHymKzYsXfBiEERiZwoEp2zYgBvcNPg+Y0yiuo1CMvyIDZ0o6Ffg3ZRgge3GURNMrpuxz7jK
g80MV0w0/MGbcWRFZ/qFDbcct3yiT30O7wgJ9N+AGwVWWFoU2AVGg6cA8Xuu10KJcHHZNydny6bB
/LURN/5hzyb/sGddX6BNw3IAwCIc4ZcNOzEWgdsWAZ+lJKe8ecYETxlokZb39dBjokleu3JFTwNw
YGnGg0HacM8Qy2uV+xaJnepFKHOlC7y87cSt44NSFgKbaM0gxL5W0Iq0Ym/H7yzyINjkFLiNLYCf
wMSctQo9QALcWI3vM/qOWYH+tBfc1QlXbhlKApNTUpgMHp2Sh6MvurEUj6XFg14DGFqILbkl8PTN
vNcjzMF+Ovaw5eCW7fMIMmKDTWx9YtOcP9sw+RE9TSp4tkEjMP5bYEwj8mCLfxzCm30CJjAWh4Wx
Dse1xguIGZqy1wBgCUmkkxfO/3wiKEg/LdkwYgyHsDhaJGBnitYqBeCRRQBLyMaC7Qa0RwesKxTO
LHgpgj2KfN1KhwVpkXjM2HkBVjgfFg/UbVhwG82wzADhQVIhwy1fCqIFHuNIYtGCyH1HiRA/OKht
FRWlNGsoaG9iK/wWDOaUq2jdErmK/Szej0JAEhCt2NCn5eKumbj++XIKMOsBJ3R8vKNl7CYa5/nr
8AGZYKJkrt9wX/SCXw8f323pipH47JhiAGyE7men14IOEypsWIdmsIeTEBc7Mzl59OiR5Wli+JXQ
a8NmN1Zs0w/d2XLA2e5WMImwYZcEQK7g14VytjUjQqjMFWjebMH6LWKqVZtvcJaVsFSQgsGNRYmf
bMuGjYEOJZxxNUOLN7rnLumqToQxvQo/bjy7wgpdcatGgccmg1XqJOYLERoslZ/B2gRYe7VKbXNi
3B6HNkflgA/WLg0WiFRmNkuEAV2Ee4Wrvesy2yuDm4FtEn6k2wWw8BO1d2CHVpplSXPi2E9V5cko
VAi4ebHRp+XiuqBj+yTCypnRtlMn9snEdeXFKVe7a9bMbelppymNVTGkU5fP16IHRm4oTEk6zWVX
/9Pvfv3ySdPwHSG5Ie3xPUFaGmn8gyAs5IRYWFlVkZyeQkIvzsuJpVOLlmc1x4/uZzOLamvSf/zu
jx7r2ca6nMK8BIdOWVoca9WKr3bz4uPCKA2FyYlRHhu/rbmRy8xGT+v2DSqfnQ6ydDfRSYs2Egzb
ArsEwjcWPKnFi+OCzRIhdBFiDZbHAiYOXrAekcKOdSo8MEAKH99o08JQAt46TDRrwuGBmOqFkBba
1S1OHQvlJVRKIdYr4NEEVrxJII4qYYsSMw3Q27o1MEbNLvDpbSHJpkJCD95OLNDhEkk8OqocOMS6
W1dRkoHODgegRmx5IvSYlLBLbbjQbuP4Uk8HVrhbsYklpFmta1bx3NhmFyGI3L8QNg3zy5+mtXtb
gO7FM+2t4dvRXfELzu9fsxvdgcbmlkanAGBBgjGvG5vRE12EODdSfH4r7L3eCLvdyZkbl9bWZldV
ZJ8pzxbyClZtSgTuM1KiczLj3zwF+V1DdRr+Qi7m5b4dgY7CS+frUhJPV5RnaqcAZ5DrE948FXvt
TdcvNcREBcskFXQytOS4TGo6NaNVzbnY1XiurXLD3SHgFCQnRor5Z7zosHCfE3Fz9TPASIm4OYbZ
ZmwoDwij7zolYpsGC+FF4wvcRaib4vqcRTcnluwA8QGma5gxxee4FQ9LQSvZ1UpYLG44OzfsFBwR
5etoAbjxwWcReCGQYOtkwHAyrJ1SbJg1eBoJPunAmboJ5+U4l/VZVOOCskMUHX36+s+9Ou2yUWcc
/zR1+OBB7bTQZ89mJTwDpRC/4QyVOXXyuYmmVbRTwCoMV0zMbXhMhwC3VnHxIS6GNYnipQO70KEg
Bx5FHHAmg0iJtkYT2I/BodmCI0ErvA+Yw3UCBjLjXNaOT1sgaOkwn8d+Hl+/APuVY0YQRUE43xUu
PXYJduBwbsfO9UZsH+PC72DBqgCw88BEGpjPwRd3esmBGiwfwFoOAFhb1T1jAMDyidx3AawAJ3dc
HDQFitwD6oMIb9mgG3E5LTXjxQgPb17lulny+kktmxbv1jdjFCjAgAZT1FbVNnPdAGZ9nbg/Vjkx
Acl30wiXdp+JqBhSTeC2mwOIefmWxfGWc7o/iqN4CbUL6WAvOS0ti05j06n5+Eok2OJcsmUcv43s
3+0gKN+SW7h2Xvne33HtflvZtjcBa1wB2q2tbZ0hwad0E4DMvNDog1aF2GOW+gbj2IlZWMoNswK8
EvEYxDUT02e+inCnowXPepLBinWIXVpsCYatKLA5Pg+DG9hNbh1hTMXGovUmLO8jLNcxBwPsA+f2
jXqhSMbiCGiN2QQ+wHcSQIZ2gm2ZEWM4hcWaxJBNdGEWPBQBMI0MBoyiVY1WqRU7NQLoFHvRnnIQ
aFWJ7fXZGyYVfASo8eGOezsKAeiCVaC1soqwP5YIuCIo67diFy4BYBr40x1YRuy3orVz+3sZ8bFx
M5PzRw4fWpgSQ3ZkVeL7rPA9Dge2JAUOWw5jFVx4aaGfwjBHDUaocMc8plY87gW7BTmIds6mNTNB
OGlg3SIYbYA1CeHYjmv3BFkI2m45AXM33J0QzhBAhC+wETwxAcVOrE886YQAWA7llk3DpgZrbE/H
oL0i1vhmiXCO8MHyAyzs5O7zwZoJGJUTOIvwF6bq7ilG3s5VTG7rIiyY3xS523BiinIglHm7m8ff
y0zzuDfV2fzxlWTyk2hpqmlpSrJiFhvnNM8fMt6/EK6DZ7TAOC9/PSKYH5diWCNYtbS/e87+8kaK
3sG2rLAtS2ZGuXa9dG4MZDRj78Svn7L1cyrjgsauYxoX1G+es712uXGh7ekw0zjftDiuXDOLHLqm
d8+UxjmefrbFpUcpl2zig+TF43rTAoIRHMti8/IMxBW7VmFewEsEHOE2I5Z/CoFv3/psGraXCPGJ
bMMGEICQ8KQOO3HiCIEUtZ/HY3oZGzYFeP87MUENZ7caQI9Ndb+fMdTPwA5hShjHAai8CdhatwbG
2RLlPJsIxFKESb1V5jtDnRjXu9Vg5WUV+9J6uB6lB6U+7jZYnRAYBCsGEVwPts9Ar8QhX4OTKpkP
4Pt9e7GXJoQZ7SR/h8id8MEiANb4breFrzt9fEXMtws5fWWpj+8UvC8FTjP0lwhB5D42szA2vzyO
AFY9BUTuNsa6XeyCmTCt4LJmEQ71NZaXpT95oMxIC+m5SvfYpS5DPaZVsBkbZEuYdwFMwAdBnhUP
vEMprLMNPQKoUzg1a2aZ18pcszDXHYAYUErtMnI37FSHjoeAF+hJYeXgvByeIAotrHXi5HISpqMY
wYO9CAsdQ/f66/fwwcIidx3UMvD04s35BE6ZTzC3Z7BBxyisLpnHgLv5bGownXfgg4nQ1Lvw91H8
QLkgnPJ4vdmJ/whMj07ANq+10a1XW5dEQLODWasUkmOiB8IXgNEfJQBWj16rQ+F//PPU4QMHtDMi
X9wlABYkwShpRiFKKhGVHD+6z6XHXJQTRQIJJMcu4hyUQT6GkAE6B2FKo9pH+8Nm5EFAcQcAAIAA
SURBVGE9MthzA5WFe5Ox/Wkz9uxBkAKlrY3YsQz4PBinCGe3eOpDy8xHqc+L1S5ZMcjePUM5j+bd
M75pjv/6KVcPl6rygOaGoNaUkL1AAiOBvQPjeohRaEoCN/gAlgMAVhTYNIAPlsHvg2UEcZV5ByQK
1GCZ/CL3nTYNW07ugbMIjTvUV75So05v0upSktMAYIGPmhybJ0kBXblb1y1y/4hfgt1UbYMpzkAs
riAmkOCxRQilMTFR14Fbp3nEqAyYXgDzDRV7uc9swhf//XHh+4PVqIM9jRhgcei0fAjeUL7xA6zA
9CDwegIbg3b0Ce2uDOzwGtwD/Ml2aTYABiUkhLe2nQ0+EaSfkPqiOySTctzzTpgstvkKx3YpzmYJ
uCnBlpViwP04hOGzV7MKnnkir7UFA3oxnkgjglHW6NRFZ4UTuz+CAw4+ZmHXY2s99FaAM9Cf5t6+
XscXSDhcEZOWh2+UAjO+fGw3SuAVuQcPOcDG2jgwwWmgxpU4CT7AsWLYrF4zYGAHIUa5bhL5IBGU
12XgdA3PEQ+BsGHzZIhoKJdQ4RRCQVwhsIYo33OocJhQb/jcrQhkQywYAFhxMbEAsA4dDABYcj/A
AhMTsBJ0cv2nlnzVpMYwneVBV2jCjDtQxRqMEBTrZpxAotMA6HZcOwKak4fLfGI8V1Tja/O0YlBr
x9AC4SoLeFiCaTNCbGAPjpUJxJRu4j8IZyq/0SgWuTv8JcKtLsJfqNltxz0BDNa2EuFvNm0aZvYY
lbO3Ems20Ith6Svi5U2j0S2A5TcaJboIFZAkoQcAXo540qSTv2rkeCySNZMERnM7JT4lHTHC1oU5
SThP0WHBx4tMBLgVzkcp5NZ4mhKgLmJLAw+Ex0CiIwbMtOSgkcL316UD1hEBF68JO/EDQOFgjxas
MQTrbZSZSV06Jp7HJCKyUi8x7pQY1wUPTBqwaQP2rQ9g5WEfrOW8vE2bBvmGSQqHOy7qY18QGTb/
RP8UgarDJV8zSfwucwjRN3tA6sGEReNug+2NsnDChdWlWDXwMOuggtc78Fxhl9RrpsGFEWsIujzY
OIo3+ybmwuaU4w9LfGQ1nvGO8RaKcFDPFmARiWzVwCGGHoIrKRwlAlh8Vg7mkInjVYF5bOnyFD8H
M1ifp7cDrMAuwp3es/8/Kst7mY7u1RgbMDF6zyW6S4M1s4CQHzBYPoAFJUKhTwaBaxAo3XfoFOfa
G2jknNs3mGvmdhzdVdidVYbnASgx+mnF5DaR0WLyxoa/tgr9wUlOGKmjw8JjkuL8WAzcOCx7LClA
z8Umxk7xfFxc0GxYzmJ3fs2qHr+JWbaqIyaXKwdu1gd0Ec5PQ8XTJ3LHAEsRALCke0SdwOAHNS8O
yJhc+HAhps/az4LVHJEfI7jvVKxbRJD+utvWbNiY3oxXmrsF3IygAMFYs6vYjBIeq9BtxE21VmI4
K9fPYBHHtyg66vT1Kxhg6RDAmvYBLN9UQYLBwvfTyfnwXP3H3/+/3/zNryrPpKJvrhgJw7wmlx7t
PpHbwMLzFqV+rxACiUJNAV2Yx4xydBrOTTl4kDxY86+BhbTAY2V7bK0YUgjhlMA17hUTd9UipjVm
M2m5LsiDUTzjLU9zxIJ89GSjIo8+vCvgsbI+vOSfb2/sPkfB3IMIa3Wx9MqKs3YXb90s8QMIsQ9A
4LMCAYjtNg27jEZ3iai2nNx9DFbAqJwdw56XA2wadpUa7QajWatLSkx5/oQLV2jC6R+6QncT+viQ
RDmlAOVdxLxFRcDBJd+GY2wyH+C2YZhllTq1OCXGYQ8btmmA1/Gh9r3Ypt0Ay7XF8KWmZgKDRdtk
sBREL+HWm+wkw2S7/inbxUjJd/YSbSPnvo6u8HxAtORiY0KbW85FhIVZ5qCMvg5muW1otWClBFc7
KWBSs2GxAdZB2SwH3cM1i+D9C/b0J4Rj6Gj9r5phBCcMTbLw8X1WQ+B3Y1hmI0KS6MUjJo+dAoeD
DWetlja8eTkYGeBcHfBNE8xOvtUoEstZbCG1MdtfAW/GXBTelXa/d6sDh1RAG+iqBL4Kow03x7nw
qGaCYIbhg0JMXPF9nLe7A89OlflcrGGSaSseoioAesmJYZa1ETcDNuOdJYPTzC31pd924V4AK247
wAoYg+tWAOKBvcP25e1OVUNNwgu0ViGBwUkUADgBlE0gZrVBdqRvQucnpT7r+UOOz0HThSV6Dolt
WQLeAg55s/JMs6LaVxxzKbZWArTAi3xyT6fAY2at+9IDXAF3qPxdhD4Ga7uT+1ey9q9ELC0BsL5s
6yL0zSLcpsEKFLnPLO0yat/9/aW9dMqLgV2Em07uWyVCVxd8PBtmCG0w1RWssWH8OzG7EQvWYAiA
BKePeIwJjJwExhtn0kJsBKoEpOXCkgg7Rj+wjGQelPuC0ESKEy//yCeE/Qm3KocS8I3LP64IbjGu
iGGEC3VxF56Y626CSi2MvRThSAkPCYQIoP/Ag3jt0p3KKhfWYG0BLH8XISS46lU9BuNwGcSAJDkm
kGR4Y3CJcW8bhPLRhTW24HiJPz7Ky1GCAiIYFtAeVrXvcISlw8X0CaQgsLWILl+i2I+HQK8ZZHi9
4vQFPr4Gl/wkuGjN2gCSlpgIgSeuoF0N1U+h18zGpBd6QHwMN3Etxqpe0cvxZ8entkM1+9Hng/XZ
L3LfsmnYw15hD3Q1/jWp1tc40d0pxJ7DnncnHn6RO/56eQtgmbHXPzj+d2LNCmAOr6OZaMYGNAm5
kWTdrMD1KTV8gXCqReUxyYn5SO5lEFkDqe4bACUEEQMEJ7RWlZh0EQE7jSlJr0nou3uEuMeFhw86
uP4xxpgUAWGTxM9CKdb04js3Gwij0dHtGiw/wFLuLBFuMliBcYj4AgziFUTUBKhnE755ysvOiLzX
U4s3EYvHyJeIKvC+k5pmZZVnsrSTuKhnlXmssnWHCjCN+dzijKK2OrOuNs8w3+o04GPU3OQ1yLcY
LLfCXyLswSVCw9inqcMHdpUIYYKyGuH1JtmZA/t//Ld/+dcYUpB2UuxcFr59obnUxZQIsvQzwnU7
x7LQLOHn0huzPr8BSdbSlOz+IJfPSZ761PTlrbC7i6qQnlmcOt/ZVi3k5RpmQXXx6Y2S2lggF5e4
DK0IeyGk1dVRV1edev8Ob90uZNByi4sy2ppqW9Tla9ZOu44z8+W8x8KOjT452MeZnbg4N67IzY6p
q8k2L4o+vlK6zRAdnw7z7EtSsJ9FaBsOaBmepiD2zT7yA6w9bBqW/T5Yy7vGCG4yWJsAa9MHa4vB
MuqX9BYfg7VL3u7/AqErAFgJKc8ec7HaDA5MECPbhf6LxMUs4jSwindV9zbxh/9HIEsXEePC1swg
nDfNt4t5Od2dRRgZy91Gnh9S72KPiFmo7gCGz+UrEaamZjFoHFwiFG0DWF8r5O2gpnbAQefu73/l
enZjNd83IeIkJ0Vpms+GhoRqJ0A9tmY761jqWBynunSAXRYnwb4HpjzB7CwlrhheQGuAw8i7fplO
lAtN89LFcb5Tp4KZV4BjxEsT1S4dcNKLEzybVum18RYmxF/eSNYsjBWjyqUX6qbhoayaqOg11kXh
zCeU4XfhjIvXc61eCABLRAM/Cz+agQQDGJ2n96U4i4DY4dQz4AUIu0Cjq8JHQALFjh66eHkKPTvJ
mkntG7+Nm+ZWTcIWZbXHBB1OIIeC4jvKromZqqJ1G338veBCB3VxUni+vRZYdpRX4xkVgL1sOEi5
VT422geweH09mMGamMMAC8cyq8JfIpT7En5QSaJ0/dzChNKh74iJPjXQy9iw0+xa6fyo0KZFwVe0
ZmGto/NnvnZpAgEvjcvAjosJ6b+JdhzPtiSdHRWbFwEwzY3Ljx3ZtzStmvikmhvTuM0sj1mmm5bN
fZY4dWqvrRFzVJqFUZSwnccdMJgjdBFoktBLBIjcf8EHa3yHueIumLVr2PPi9GYX4c5hz0ufJud2
Vlj2EiPvDnu7OS0AWP5ROVtGo5DQYIBlwbHEIfeaRLiK3ITFlUowy3YRwR5yGuxXi6d8g5YIhrfj
dabwmvBasYp9lRE3UR0j8JYK30rC/xNTCICH1JBkg1KkHffAY32JuxWoAiDJiNE3MMQQ8948bPWu
wWgGJ9xWv9zbSjjtEjhjey7l98Ea2+Hk7saKKMCCLevQNtKINaHo0WpGX0nbms6AUgpeA41ReC6Q
etUgIA7EVQOe0uNWA7HnOLvhugCZqF3kMYnWjNyutpKxNyi8NePsBFcJLQCGQJxoI6bgiYEvhWUk
nXwruXS+fsPGXTH44CAuoIhG7vGXpyX2BZVGWWSehTmG6K+vEfcZavatK0a6r7IAMhdsN2cX66el
ufn504TR6FdF7ou73Gh3DV/awx10TyJqV8PsbkA2sxtd+YxGR8FodGmM0GBN+wGWjb1qYKFzTcIv
8BrwbEeXfA3kcVz8HzoiBdALA7UhYpFghs+CRQ8ugdfEx9IENSweIKjlgLSgBwqfhrCB+WAYsyyG
ifQuTAkAwFJgIbBgw312xXgOH4VE5wQhyGMTQA3LWtHCkw/e9GmwsJP7/PScj8E65NNgBQCsTQZr
x3/+qOMyUJZnOq53179+QkXL22WURkUehyl7llaCAao8k/6Pv/0fd25Dbw5CNkeO7FuepnjN0tE3
6isXaic+IrDO+PySkZsTc/TooYMH9xXmR315y/VucjkEgxVYIrwCAAthgrG9NVhyTM22eGyy27d4
CfEkr122ZlYN9ZF/99v/oVJUiQWl6alhK6bWjLSYFg1toEdeXZnmdbSLBIVpyZGXLjR2ddD/8Pt/
vdotLC9N/OmHb8520M6UpdbX5ejmlLHRoUP9bLWCwmaUotODyywoL0u+fYt/cP9fZsaEImHVH/7j
3zrbGqsr0liMYt28uiA31mOXhYcF3Rng5eXEne2oIUUcy82JNSyoT53Y9/Y5zzCnPH7kh9nPfLh4
SPxad5YIIW0DAAE2DUvbbBoMUPsz7y7qBXYRBojc9f23t3cR7igRagOG5AQouhC6Mml1GelZUCKE
/jWlXx/Dw2Q/rgzacX+cXbY337nZL+xSYP9nFEc75sbanPrOdbt0xSRUSKprKrKmPgJygtk7DhFU
l/YouuHvuHeUUP0Aa28NlnLvVmvnDppql6HgbsHWjpUfmGw4t+cexP/Bq10SHxehae4MOX1aPw13
704/LzcrgsfOqqvO7j5HNy10pCRFjX+SowVjX1a79E1nStMQ3CdFnmyozUAp650eWmlRclVlEp7p
1H3lYl11VVaTojwlKZHHKWHR0zMzSG+fK8Y/dLQ200ffSgtyk9pb6hNiT3df4Gw4m7u7OKWFcQ11
aWJ+Eaim7IK+m2QeX8rmigFgObH3KfR8yFctrS2qun/6x78bfafAQgJw5J4bk9kWRUCHg4O/dPIT
37TIWndItVOa8pIkaMOycdE1z34ROvQofrUiwHfs8E8LEy3aaQ6eJ4HeSunSKebHpJZFlEex+m82
xMeeNsxJf77EXoNaW7NhVmGab0XrAYUkLILk7WCwMMACBuswwWABwFL6pHsQoHEzpgWFXVmzura0
kMRlZ//XH/7j8X0mgp7o1rHpBcUFSe9eICwoKCvJpFNyqyuSqA25G66OuNjQvh76mlXeWJvCJGeX
FsYO32H8fKnun3/3P7sv1F27zLsAU03ZCpQSlsWWFcX83I3OYQ2DVshi5JPrM8CNaAz3zUB7BMER
iH2Ty7f5YAWWCGeXvta7txWKNh3VvyZy/5tAgBWgwdoxZHB3eNvD2nEPwc0eIncfwFJhakSI5RRo
6VDmxwXtLbRVAwbguN0AKGh304oet344ZRC0cK8BWnkeEwsHIay02MT10BsiwhtGCOolM8cDTRNS
f0IvBNGADbd2OwhswdRPiT++UmMxAcwlXDEKntxlrZn4n181uXTCZw9Ypjk+2jlWwMtyL4xD5vsI
xi0jq4ATClO14INFjMrBXYS+WYR2Ou6JkJrn1ZYFFI/5C+M84xx62Fy7Vv5smAeMtLVpeUpuXuzA
gnQEodhL42Dn77HS5sc5xnmNl5BY2sQunXR5CqGuNq+V9fqp1DTLhvKoQQTTCRwI+wvmRuXoJPVY
GLhVtQma2M2qdatmqJcWGx2ES/Wi+XHZ4qQSm9cx4mNODvayV0y8Zw/ZTh0M3tJOCswLIAgD0QB2
Z9DNiszz+N46cFLr5Mx/kWwNe94UuftmEe5QoC/t4fSxw2TkF3xrdw0R31U63FaY3rlcAxgslGBs
abAQwAIsJZwdlZQUJmPeuB2ScpB8thKNSBhJq3xCSxjChUE5QV3YRD6ZNshgYUo0xhlSmF9G6Cit
4lUDDV5sbUEPArcO4ZzJjdvc7IpXT/gN1fHoBdDpTbSUO5ucywJcmpGDwAv4s6a+62Q/wNKBTcOs
z6YBi9wDSoS+KuFeNRF/ELJozyYlRNIppZHhB/tuCO8NMP/+17/OyohfA8MUtcuE4EsulVJ27PD3
hrmW5Rn2wf3fO/TtnS2NJ4N+4DCLSRFBkx+h+uB1NJMb8igN2et2GB8EvYcWPPUyUOTu02D1bpUI
CYBFlAitRLGgBa3YNRM6/dk9N2rDQg6jL9AvDvTQw0NPrFjU646uhNgIubTq1IljUnGpWlF+7Mj3
z5/wBNwy7MQrH7zNP33q+IaD03+zPj422AOTiKjJiaSnj4XhocFqZRWfU3L00Pc2LXtpqun5I+HA
bdYf//M/nz5ii/g19bV5a1bGzKjs5In9r5/JSksyvHZRRPjJp48FiQmhw/fYYmF5R2u9TUevPJPJ
ZuRevsgozEuCvMUGNHkAwBIHlMBkg4TIfU8fLG1A99/WlJttPlg+m4bbA7/ZJnI36rd8sIzb7eC3
9Fg2vVG/sJielvnyKR8KpmZ8YLpwZ6jTP0XUpcCQSO7/517ACLospcB7uVsaalOSE8OjSEc/vZZN
f6YfPvh9dOSp0Te4gdRFWCLJdlJHW7ST//4EMlg9jQEAa5PBkuKuDvlXCn+7mLZteGvHa2Tb4NRO
edZ2fOb7yCgHlsXFhrW0nTt9Otg4z3fp+CnJp1+P8N3GJiatmMcptho0SYlR02OKQwd/si2JDbPi
I4d/dBo0Min5ajfNqedfOlf35T2U+08FHXw6LOOxCtOSolYtAholv7QwYcXS2tiQL+DmPBji1tWm
P3vEO3p4/4pFMdDDjCEdNi/KszOiRt+JnIYL5cUpH57SNiyCwV4qlyfh8qUIavg6nCBVll88V08M
8A4LPQh2U1YFuaE0Ljo8Libi+UOGy9CelhKfkRIXE3UKoQohv+h//cPf3+2jWpbbcnLi0lLCw04f
nfwksmol+3/aFx8bnhR3jEEtRofP7Bg9Mz0qMS64IDfRob/08I4kPjp8bkIgFZWvmOndXQ3x0Udj
SEEdrdVE4relwXL4Re49fg3W4YPzmwBrUxXqJrhz2fsXgpDgI5alCyvWs9/88Q9PHgrbW2qZtBL0
4sHbQjo51alv/qd//IfhO3QU1/Jz4i+eI6M7//SR9EJXNZdVtGFrGRoQnSmN1c1fOLDve+Mig0XP
53PPTLxnVZYmbLhal6ZEJUXxLqMyIS60TVOBTsjT4OKEyztgAEHUaiWYW1VslQgJH6z6TZH7no3r
u/AWEZAQwBrdywcrUOS+rYtwz/kke7oQ7a3W8ovc/Uaj6M1zCQ0WVoKDqAgEWNI1vQy314kE/MLf
/vpvh26T1yw4ktlpUDuDDiM5rtnxoK/SJVq3qrzQkcfFiS8u/EEtD48XhIlvihUf9aLB32GA1gqm
wUtcesaGjQVsOa6CYe8N9mBvbVwsOseFRAuGdVFUWxFjXZJnZ8V/eiUQcErevyT332IrpYUAvVFK
h33noM/WItmOq+Q+TmtzVM7s8miA0ei6Q3W2g1tdkVFfnZGcEF1XU1xSlBwWcnL8k+jVCB/tAa9d
3VifHRl2OCUx8tWIYOydoqo8Jys9ZqiPdvMqOTkhIjLsxPmzZJeJ8fmNLPjET8kJoeSGYq9Nw2EV
vnnGU8qqqityy4qT5ic6M9JOJCWEZ6aR3MZz59orus/VO/Tcc+1VN66QHw1xSBGn1u1iIb8sNTk0
IuyYgF91b5D1m7/+m6zMxKUZTUNtzira872ihLjgGNJJDqto1cy7dL4S5WpFBdERoYfH3iGYqFnR
o9sl1I4JEcCa3hyVMx3AYO1Vp97bpO0rEqsd0Oorrlrbp4zP7DBjC/gVv9EoAbDGpvV1RBchAuVW
6fyEKj8vccPOx5+rST+nnv3CW7WoPAjlWMV2rUA7wXYZ0EOUoVtnWlAtjKstS4p1h9Jjw5mAjeW1
StbMkKsZ5/jaqaYVY4tjGTsmOKRrFrVpQe00SABkO0RLUwiqwlZfsfAWJtivRwAhee1ym05unIfO
Qa9duGJWLUzITAsaj6111SK/e7uWMBrdzmBtB1g+Bku2h9Q3IMVvaSpubyGvmNtGHvDLilK8DiUp
4kTPTSCScUVeU16a9XCIx6TlVlakOg0qdFAaFjrbNWceDJS6zfK8vMR7/aB9XLfKulrrOzRlG04B
zMMGXlaI+9UlWwUjZ2AXoWF7F6HUr8FqxxsKnc5NQwOcKFLQihmBUS6CQWGhh616wZpdhqK7QloZ
RTp1b5Bxt596p4/vMPBZjAJyY+6KlX3rGiM+LnzDUnW3jxcVcQLF+zt9lLS0mDt9jNzc5Id3+Xdv
k4fvCh3LfGp9WUZaDI+Xf+TI/tcjFCG/gtJQ6LFWG+dlR4/8+OkVr7QkBV1/TDRp8DYnLTX22WMR
l1Xaqqn32ugvn8niY0MT48OvXaLgxjqZT9RIlMBcku0aLDJosBb9JcIdo3J2jyMMFLkHDnsmjEa3
RuX4AdYOhXvAvGcEsJZm5pKTUkGD5fSXj4nuPLufcbf73StsuyrIm/8E8htYzNs3BLFRx7y2q+g+
pyRFeuzSmsrsC53cdQcxvk2GnQiUO5XpgSXCTQbLhRksB9wfH8DaIXJ3Kr8iXd+rH9C5u1Ao+0qZ
cpfmfcc7QM0IFCAJceHNrR0ngo7rZqGhOzLi5OyYCEHwZmUll11g1CoSE6K/fBQgBGZe5BvmOEcO
/8W6zOZxSq//jBYJ++2ztpzMhLyc2H/7l39+80wllxQhaGXVs5m0QmpjITolKOQCEb9keIhbW5N5
7w4rOipsxYJACSc2NsS0KAkJDi4pSsrPi8/OjH37hLphQkuXLhDK2VwxpSELKzUJObL0yQPWjaui
QwcPXLrAtutVKG0uLY526NlXu8l8Vua1bmpddfK6Q9NQn8dmFCEslZUR43F0dZ0trjwTv+HuLivJ
4HOKV8yaf/3n/917A22xswlxIQ/vCuSS8gtnGz32zprKNKW87N4dfkpS7IdX4pzsOC1Ck4d+mB9X
Tn0GotelxZ3mmzI7J+ZE/SXC2c0uQpe/i9Cl9HcRildMinv97IiwU2hxuo3MuBjS4/sShawmIgx9
/PjC/HQuK183Izx+9Mjy3MU1m5hcX8Ll5GRnRY88pCvllfFxpIKcsJysGLGg2DAvOXXymEUnZdHy
ULAeuc/jMkvRZXhtPHQbjQvSmKjQoT6e14r2Y+idPi7IG4jBr7AXhFAXInrtiVmEWwBL91fje44I
3LPlCn9/j1mEs9jJfdsswgAN1p4Dd7/WUbhHSPO9GLoIN32wcgIYLCCimqC5Giho1ZMH8u9/+Oa3
v/5NXPTJpUkleLFYuZZF8ZP7ivMdJc3q8oVxwYpJatc2Xeoiq2QVr0DCqbEuSV8/Fbeoy768EYy9
5T4cEstEBS8f8W9cpsjEJW+eIgTW/PKJpFld3X220r6M/pbGvtz8c3ejVJTXfa7RblDeG+SdOnmi
+wK5RVU6/QW9Z+fHVyhQdaSnRr96Sp763GpdltXXFeZlR2unFQh3b7jPeq3CNyNM6xIPC72Jw2jT
bgd8nBcnfBqsAJsGicNI5XJKTwb95HWeV8rrkhNPo3B1rrMBrelnjwQpyeF3+8VxsSEr1ta7fQI+
pwDFv/0/fWPVnv/yVngy6ODs5OWpL9zTp47MTTSnJp+80k3bcF1EoGfsAycpMfTRfVVSUphCWo6g
D7k+p64md8N9QSTIu3WDgaIIuT4L5eVok7PoBc+GubExkTaDuLE+165vevlUFkU6qV9ojgg90n2h
UTfPP3bk0Pykqrwk5f0rBIUvZ6XHamfEPG5pfGzIxkpPeUk6g5bp0/E45IvjTKzBWvy82wdrTyOP
r7KeSzsJp72bNpa+IpBf2tsjPuDdCB8sELnvYLBs6DmKp0aFRYVJ63aED1oR4slMj8jPSy0rjjfM
qw0LSrTtkxJii/ITZsb4M18u5OWEZWXFxsWcnBvXtDWVXz5PXbFIrUvCqorYmS8dtZWJ+bkZGWmk
N0/pbkNzRVm6UFAeTTqBIMuGs+XqZWpsVEhVZUZBfuznN5Kx90KxoPz9q7by0jgB7wwp4uS1yxVO
o/TyBVpi/ElKY0FhXuzyrOz+QOMeo3Jeb+8i9NUH/Rqs3SEE/5PPLbh2pWHV0jA/Li7ISVgxS+Jj
wvt7KT5TU4e4tDj95vXqFZsiOzO+9zrlRNChhWnW2LuzDHJBXXXOH/7z3wdvUzF1J14HQpe1Ttho
WQkvg2Ys7ZcTglafyN2nwTL6uwgJBkvqY7BA3dgIPlI26a2rrLjYCGyCxeu/zf39v/+/V0+5Iw8F
0aSTX96J0Pn7+AFPNyeTCausy2qU79KppWvW+oEeKikiDIHjOz2iGFLYmk3Vc52WlBDx6Z0gITZy
eVo4+lbepKiyLkqOHPh+ZFi2MKPat++Hl0/+P8res7uNJMsW7V/xPr3uO696rpl7x67bPW3Lq+S9
p6coUZTovZGlh/fe0cqrqlpVJVGik0R5qeRLjhSNaOFdwpIgyBcnIuFBzcxaubASQCIAZEZG7Dhn
n735aGmxd/e2uQ/ic90NBYf3zYzJK8vyFilBBgzKrXl52Q/vSOSS4yIw8hL4HLzDh3LXr1099qY1
CP0EByM9MlqGwBuWIZDRKcL0qBRhtA5WnDqoMcaLMCZFGMXBigiNmqNShHFIC0uYkirC/MOFYQ4W
Di+R6jNcvEwY7qQ6mJSOxnP1VHQXcjUv+3SM5jIWoyjgEs19kK5b8xVlFogEtdd+5KI5DArAAZoI
cc2mMp7O5QtFsICpI4+WsQCAlYSDpQiR3JOR0BOBlDdpMaAqOfl9JXUGb1Qiwqfel7WnvbML4SfT
FEIP3fv3o5tUGnTxhdwKkaDGppfm5qYNv25cv26NbVb6YUT+1edfURaVgFc72Mf0mKWbNnzT19No
nuvYtPGbu7eFQkE5s7XS62CzmRXMlmqfrQ7tiHg1929L6k8W3x7ipadu9zvZg72c7Ky9Hpv80MEM
y6wg6Ja/fCL2m4DGfuVSo0is4gvkbEYJrvmVQXkdJV1wNk9PyNet+cwwpVtyqxhN+a3NJX5H25Kn
e9kl95oVl76t79Ad2b17O7rfKZO0vCTH7+jwWNsvfcvvaq/csmmDWFQXoNSrvvzUMCn0O5nMlhIh
v7qyPO+XJwqvrWmwV3zyeO6D27zsjF3Dv8jLS/ffuSEE72SbOAhI9DuoKYFwmiYmReiOJblPymMi
WPhU++ziBZfqwR323l1bFt0yt4W5edPax3dZGuVRjbIGdTPzjGb0rchhkH/6l38ffi0IulqP1B36
7gK6o7PuDCk7O07o1PULlNpj7Hp2X2yeZq9d86XfqeSxq9Ba6M0TTWtL9YKDZzPwaqoKbHOifVkp
twZlCw5+Zsbu3h7GIuQfsBYSwA8sqUUiWJ4IyT1k9jxlWDmAROOqsYQU4cSs+X2UTAMjGmBFyzRE
W+UkQqiEeNVYUnvdkNBoiIMVpeTuwRwpkmmCinflglP64K4kLzc94FAuOSVQd+0V37oh/dd//F+/
PBb3/cRM3Yv6Ytfx4xVKeeXcB0lW+s6XjyW3byjQourdcxiFv1n1KQIlA1fZf/nz7x/dbrn6U0tm
+s6f73PSUncYpjRnutilRQeX3Gy1sqq1uZAyn8OdRv7iseK3v/7NjX5G72VWVuaO6WE2As6OWUlx
8f6Rl4K8g1lD/UwRr7IgP9s4qUJQxjTNnxxVbNm0zjknBH0Eb1SWkN7oCFZEpgFzsHw2AYdRzWYU
eyyNHdqTAm5twNnYd4UhkdQ8uCc7fDiTzylisyoWqFaIi1DqKz+wMzN3+xyivquMrKzdPnurx87N
yU65cLZ15471s+PigEsedCt8NmFWxp57N5m5OWkDV7lLbk5qysahAYnPykfvLlA6JqMML554rNZS
9KX3bvP2ZaXOO0QXzjNzD6QdzN29cwfq6Oq0lB33b0kdesXmjWtfPVHVVufOUyyfg8Xn1twbYgi5
R9jMKsrMYraWc0B8WYgT9mLTB25JuIpwlk4RhpTcV9BwT2rltJLtYKKRc5KyxBUqDeOCuLTZsyGm
irC1FDi8bubMSDeCMpDIo3gSQUljY6XHop54J1p0SavKc7XqpmWq5fvzTfduyO7dYt8ZQphGe7Qu
98ypY6+fC3bv2rhA8c+dYVRXZH17jo+GQsqsGbjaVFd9wGlSrfrqy1fPBJYZ9drVX8+OiirK8q3T
6H5mFhRk3BjgPrjDOZSXfeemdP261X6ncOCaODtzz8RbaWbGnoBD7Jjl7di2ZeI1D3XCFExyH4nS
wYqqItSE1DeiARYEKkISHiosKwCvd3XUtGk5fgf/8X1wSVr0dGdl7uy9cgzHX7nL3o7qitzBq2Kv
VfnoLuvf/vn/oLlkbESQnbn73m3Ut7vyctOu97VgFIW7PZ4dFwjhzIe9vWiApaYBVlimIbGKkCKI
sCvobMSVGW3XrwpT9myAYJhLdH1Qsmb1ahajvP7Ewfe/CObtrW+eiEuLskqKsu4Psecdnd+ea+hu
r5u3654/5KFFxbJbgpZSLfX7UMtPHigYDYXL/q6eH8Aeqq6mcPS1OOjRXb7UmH8oo7OtntVS/vie
qPcnVuOJ/PoTJSeO5jj0WuuUVimtXnJf4rQWvH4ikgiKnz1Qjb1WFB3eMTvWuUBxz59hI6iNBy4Z
1tzS4Ki2MkrnKcQxuhajg2WP08EyRStg2aIjWPZYkntEaJT2IoyRabBHtxCKh9ktHgSwDuXmPf+Z
j2stcaEZLZqfHLUARPYoYyLxkM3pXHSyENyUi4+cOJ6PplU0223ZvDZAtYt41Wi0RODYZxGF9PEl
dEjPTToh1IBj3RlM2PDSelG4h0DO/Xov49DhIhajhcMoWTTLMLVDAm5IbmXE7dQTteNVxL8eehFY
3iRO5sYYziXHcqPKyEc8sU3RTl8J70LaVJuVtbfr1LmdO3dihQ5e/1VOyt5tXG7d1199JpNUUSZF
zr4981ZdUUF2Xl5O/cncr774s9f8U7u2prTkgGGqq7govf54GULkX37++we3VFJRLYtRDACouZDZ
fGjZe5HDqJVLyh7dETYcz797E91WO5fd4pt9nIy09cv+n6TCkvSUnQ31VSePH8QUTH7flRaxRM0X
ypitRaQ8Cwv8QuBwekK6ZvXXxintklOqEBU3NhQEKM6HUalKXltYkM3jVNr0CMaVcNlFVr26ovQQ
+kjB4bTWlsol79m6msNc1lGnSf3ZX3/3/g1vwaU4drRIpShAjw/vyj02/nfnJcePZT6+r8zZlzb8
SlNcmP74gSw9dUfAJQu6JQhQTg4rg5SArhBMxsGKTxF6Q2U3FGZa+ztbGg+ikefo0dL/7zf/z+MH
7aYP4o3rVh8/UlRwOPPuLa7NoPzsr58WF2U3NxaVFucsOFU52Zv6e9C3a1L3bj554nDu/l3fXzix
7Plx3do/nulCE1MVi1GI/uPxozm11aUIqsrF+QHqdFbGhuu9CBRKM9O3DPbwQZ6UlKaR+n24bTXR
VjmxMg0rMM2TaguRFOFEXIqQAKykVYTJszYrpHVip8wo+XjAVaDkPhtt9kwq2HVYsZfYlSsClPzR
PXleXia+XWU43qjo7eGVFu/DCkziQ3npt65z1q5ew2JWtWuP7Ny+UaOsvj/UymWDAfv0hLaiPHfZ
3Tk7qq6uLkTnbu4DGJUgYJuSskelqOQwKz/9y/916MWWuc6hQe6dm+yM1O2P74uGBo7s3b0FzaMB
d1tm+q5vzzaj46k5UWnp/ve/wILm8T3pmc4mHrcy4BK2tpT0XhF9e55VU5kL+maE3k5C7pHFkIzo
YL0PkdwxBwtShE0nS5rq8xddok5dQ2tT+aJL2H+ZI5PU3bstQAujzraGutrCgINjnekS84t7f2Kn
pmxbckvvDXH27tkGsQFvJ9pBCBL9zqkR7bK/+3R7w90bnNz9aXeu8w4dTB8aYC845OiMnT/D9VlZ
zx+yznfXC3hVrNaqoLuzob5YwKt59lCUlbnn6aPW3P17jJPtb18qsjNS/U601t862MPxWHhrV381
8kpZVZHrs+mWPF2tzZUvH7MEvDpGa9miS4BmspbGQsx2h3KE2RFuSAfLHJZpoAFWnIHSVBIeelIy
34q9K77YwpC85CJ5mSEouYcAlj5WB4uz5FKOj6irKg5gKRClfkx2OC9l/erPGuvLfZb2rIztvT/y
5p2NfkhDNzv06pPHCgsOpf75D7+79B3LT51KT9nx5L6iMD/77k2pWtWamZ5aVZlTUpStkDYbpnjr
1n5jnkHLMunmTRtePubVVh1e8ugW7GwB78ije5LB3obDedm3rwvS03YHXez+HlZRYfbNPgFYsXrU
aKo4eCB77BfFg1usKJJ7tBfh2hDACucHwyJG2FqEEEtBw0ZKihwpU9v+fXtZLYV7dm346W9Mj1WY
mbFlaKAde86Ill26o9XZ/ZdbF91yj1XV0lTyD//jt+iWQSNdWek+mbjqqy//NHiNDQKDwCTTLBHV
El8o6+RSRFKEpIowHMEyEYC1NqSDhatG/EpQwXG3Yg6s7sY1Vmlx6oINJuxrPdyszK14cGgHzU+P
JOBUg4ojhSvSvRK6FAgyDhJS0w7v+rRkIl8CjpQ4CNoKskUo/xQAf9HNCjg1Cw4xViFpn7fhlau3
Cz31WFioBSCAenGdrEfmMcMCd8EuDjq1i065eVJXVZHT30OoCDxa/BoXPdBCoxGApSRVhGCVEw+w
nOFQUxxFnSi5E6scnCI0D/RFZBqIWmmcVU5E8cEUoWTZLW4EsPIIwPJigOXFACtOsyMUBMJXMBQW
IhfRQyBXF7ooQSfbMt25c8eaM53c0qJ0sfAI6mY8VsHVH5uJOhGaQUGO0ttGQ7SIeI065LWFdQRo
gKXFVDAAWHl5BTyOkMuqArlOWvURFyG51fTmwVt4x7PCi5QSM0a0WDtDi4V1NPhRHWkq0qAmphF3
1I5P7rdIcnMztG1d27Ztc8xIlynR5R+Yt260vX6h4bCP6FR1Aad8+KVu3nZ8wSro7xO8fyN88wy4
KJZped/lFsus0GHUDfTw5sY0o68U1lnF+FvJh3eioIs7OawaeYXwrvr9K/nYG57TIB9/I3caVC8e
SYMUj9Irnz/konb89vbb1/mD15hoPYZvZ0F/TwsouYMOVgmCYlhnRIUV6dSGKdWmjWtt+jZ0lfUj
mpx9u76/yKw/XsBsLaurLSgrOfD4fvvG9auE/Fq3Wbt/X+rEu7ajtfvLy3L6ekSrvvqDVFzts7f/
5U+/P3Es/9wpxqYN37gtujs3wfP+5gBn9871j+5K79+WZGXsePVMgVY1i27twdy9PHaJSnY8LXWz
29SJmantsSR3YRTAWjdLpwgJQzTMriMgXhZ0nr57Q/ziZ/Wrpwr9pDTo5M2Ndvdfrn/9pGPBqTBM
ShBEu31TensQnbdLaB58+pBHmbp9NpHhA1o4Nb95qvTZ0Q/oGH0lf3pfNDPaNfpaik61dVZ3e1Dy
6LbMa4Ucy4ufhZSxc97Oe/FATc12gmwYaBnKaLlHQk4gJHe3NCw0ajfFeRGuqHAdVUU4E/IixJIN
4yGS+ydhL0Kag2VKEBpNnnNMIGYlVzaK5mCBDlZYaJTUxhOBKIQ/3Monj5T5hzMXnUQVXb1gl13v
F9bW5AWhflJSVLj/Rl/Tlk3ffHeecfe6pPcnhWlKeb2XJeDWLnvZU+/lZSU56OLNjMnKyg6i46dH
WUX5Oc1N+QX5qXeHRDcHxfdvoUFZ16Y9tn/fTmAg5WU9e6S9e5OTlZEyT53y2kQHc9POdDXt2rXN
Y+Tm5u5+/Vxx+FD6ozu8U21NQkGd08QYGmBVV+aVlBy4ANI4UQQsjzIqzizX0yR3E+hg0QBLtujQ
sJqL+ezigFPa3XaMz6mYt4n6LjOU8rpH9zX7s/fYZs/v2Lr2XPcRRlMFo7ng4S3xvsxdAWf7sv9i
YX6GmFciFVYXFWQsutoU0rqczPUIae3c9vXwS03u/r2P7wkP7Eu9PchFC82Bq/ztW9ZevybIP7z7
0oUTP3zHyUzbcu0ya9VXf1Yrjj++xz+Qk/L2mTo7Y8eD2+LW5vwd2zbPOxSHDu4V807YZhSb1q92
m9EitUbIKz/T3bw/G01yOmZLZWtzgcfC5bCKOYxCWCOitbtDaRqXFicArA9zUQArJO4/Fhf+TERF
ScJRho+tHFYMiSVgr2m6inAUC40CBwvuhVCK0C2ctzbMfFCUlx3wWKGsenIETZ8XPNZzB/bt+vYc
t6oiDwGRZTfz/i2xTnX8aG1uZ3vDsvfbxgY4P34Hr1N7dN++PXkHd6JlgFperlMeWXbzfTb566ea
mTHV+jWrjTMy85x6/drV42+VlWWZbguUL9TXl9wckDy+jy5H2r0hflbGrkWKM9jLPLA/7ZfHkvS0
7QsO3pKbn5aybfQlb2hQkEI4WNFCoy+wTMOkMF7JnQ7XEza9EqvLyoFi5RRBdaqbP/2+7eqPDa+f
QoYoSLW8esx16M/hjwCkePdUap2Wo2UAQiT2ufa7Q9IFpwwBzf6e1mf3hTOjuql3HKKFhqVPlKBn
gYVXoBgClKDlkfnVE6oiNERxsKYwB8sfFhpt91sYWIwHze6nzZPniPro0wdiHrvQZWJhxHYWpkYn
XnFCMYpy3ioL2Ym04xlaja15w0qMMqzpTKQdVcCjpxDE7ADNXrcOF9OpaY8OKBTF2nKQqRTRNnBu
7F4C6ASL8HmFy5SY1Zp78ljugv3ckosNCulOLMfqkdIpsBgOljIiNBoCWE4CsEyOKFwVD7AcJmsY
YNmMsV6EYQ5WWMk9gYZlJ22a3Q4CsB7x6AgWrTu4ghZUuEYnehzz4sQf1PPzAw7e8AsVl1l5vrtl
AWTh5Peut46/FuJ/rcZScDLQvSQupa6Q+KQLRzTBsiIUwfJhBSMcwbrRy8w9WMBiMBkthQEr0bAl
MdF2gK1k4R29Q/ap0CtU7Ftu3LhHSvQLsBalNP7guI/ENUJJAnZuwME/sD+lvePU3j17LJPKgEWp
VlRmZ+5Uyo8WHN4zN6aFwnb3qWWKF7Sq0TjsseDvgi4kxrpxOEwIAgqhunXwaQHDKGyhIQcpBIj9
4xJs2s1QRrvWeGUBoghDxInQ8TDGCvqutAhFSg5XDAALVHOJagbIrBun1Ku+/ose/U47a9ndOfxC
wWwuPtXWEnR1UEatUnpULa290cccvAoGHpcusM+frpm3n5ZLSr49Xf/glnCgp9FvU5ztav3hW7aY
X/LmaSe6fxdd6ovnWC0NWTf6xfN27egb4eVLTZYZ2Q/fNi9QAvvc6XbtUYmwhjKexQovmlABWXjM
gQgWKLmPzyB4NBdDctfQCz9QHJQt2DhY2ldBztiSGys+Ys70srvNZ2E79Ir1az/TT/AX7FhYFXSC
sPgi6GKK5m1aHHkVYV9ghdcsDp1DLj5LCqyJKsHOKAq/VUzrDoLmEdbJ82HFAHA0ksRZ5TBbSyFF
aLT8aix+UlkhfBVllYMjWOZooVFIEf46NkU4YwrpYCVV0E5SZh8toj0WP31GK7nHcbDa6NoNiNDC
Xff8ofzA/t14uUNEKSS3rou//vKv0++7r/eIs7N2Lzg6iwpSxYIq22w3q6V48p3s1qCIy6lapjgz
45qK8v3olBnGZaUIabkU+glp4eGMm/2yzRu/mRnTXu/lycWVaAQsK87tvyazzrZlpq8fus59+kj5
vz75zcO7rVd+ZKWnbZ14q0UToc+iKijIHHujQ7Pd43vi86dPHjtaEHC3m6Y569d8uQl1nQlBzJAU
RlcwHIdI7hhglZWW0lWEHunLn8VP76ObTTj2SvLqCcyyc6Pidy+4M2PKWwNCn43zYVh3pqP60kV0
q3dOjfCH+jgBNDu6ZcYPyksXj57tbjBPgYmHz6Lr/YHRoal4+wzoL7f6pDPvBXcHedMjWGibkj25
p2hTld25AfB83t5++fv6nh+O3b8lf/OUb/rAvjWABs22m/2Mrra65w/aHtwG/6mRl6dOt9c751SD
14RooKEMqu/P13e3HRl5KfDZmG+eyV/8jEAw9+XP8hcP8WIU3HU0c+9FhOROUoQIYGEdrASZhuSe
Syt4DyQ1yfmI73gcQyu5nkgEYBGZhiihUd33504c2J/+zTerjh3JN0+q/3a+rqo0XS45WZif8voF
f+xNe07Wbg6j5uD+lMd3ZWJBeUVZ9umO5n2ZOzvaTgYohmW286vPP+9ua1mwiwzjZ/LzMlqby6rK
9/3tYrPPLFm79kvKpDJOSrdsXu0ydqkVrVXl2UJuxZpvPn36oO32DU5BXuqtAYTyt8zbRbf62VmZ
25Zcp6SSE031uWg59Zc//35uTDE0yEuJ6GDNYh2scBWhIBLBIjQseiDDwqFeOWHv4sC4FOs7Y+cT
0AwUoh+Mn6K5gQtmunYc0QHysiLokvltBHwocUk2D6YKilCklZjfGhJVIurPXsxp8EgiHCxCck8P
kdxN1tEwwApzsHxECVAE2isO4l1zCqeWIMe0YD2DjgnYsAcUxYX2HUpwyfDR0jshnU81NmFEfw1X
t8BvFmAhYjFBV0HinAMCLgos8IuVNaAgV4Qj6GqYOMEeToyFZNuwZq82FIBpB7oC6u1g13hu2a1d
AAXUNixTp6AjWL54q5yoKkJbtEwDTXIPRZ6iPZspC3Cw7LFCo59EpQgdALDMcTINdtJIVEALUoQG
06GDh17QESxdJIL1EaFzErWKJjmBuTXIagdsPGIXAxIPoKCtw97bJDGHnYsIoTbUA7GyQyicSSwu
vATLysIACyJYh4uZTAaztRD/NmISgAEW/OD/yubS0I9QboIdA0HMr+2/3A7geGV29h6trjs1ZY9p
jL9MSeftnWjo++HbI/oJeSgtLoeuSJQafWoQCvYogzYsxQxCLTr6MJc0aFXTOp/ONqh/d5KSCA3I
BOB0Kng0oTvU3xGwasm5CoABH5Y/8JLvEg5eY8rkWi5fymotxoCezDLyoENu16saG/ItoPfGxRJ6
KlhgeHhgfuARQk/2Yq8zuBBsgifgfvdrlhzY/dOhJeqS6Dr6LcTARwCI06PENtsqvJKRBR0K7Bio
WnBin2mPFBZUbj66v8DzjfhohUnuSQBWSMk9opSGU7RuYoABFWMBmywU80YXkYMxq8xv0T2+J8Oe
Thos7A6ezdgqW4p7tYaWtwS1NhpYw63t0eK1H9zji/aQY4SPyDNJFx180ID1EgEdYhIlTagiDEew
ppOReeO8b6Pq1XEEK0FolL2C2XMygPWxirDpFfWxiNkzAKwpQ0SmAbqpNoj1x0kBfJCSP73PLy1O
wTenDq63S3r7umTb1nVH6zJPHMl9+1wcoOSU4dSR2oOHcnee6z6OTsfPt5svnm1E+MA0pVTIqtE9
ZpuWKqRV6KrYZuQt9ZVoaXXpYn12+pYTR/IRCkGX4cFtxb7MXTxWpUZe8+gu9+1z6cnjxQ3HC/IP
bX36sG3eKq2uzLVPKWXSo6OvpDx22S9PeGNvxfuytw31cxYc7KN1+SWFeX4HJ6YYJyZRSHsRYg6W
KWKVg7AzaHUqsRC2CgMULo4ugGjqolMODGs0F7qwZq6TWNyoUA/GEhIiLON7Cvun8rGhBEwASy6I
82GVcCke+7QBor2O1gROHpZIBRuBACgNKrA/gxx6MJBIxH47OOku2DlomsEcGlxs7yDqwNgJjsgT
QGEm3w8uyN2LThZYsXq6sFwbfJFhXBjNwXofx8GaMiTJ633EdSAEthILBsemExKC8cgs9rOJW1KZ
BuBgCWbHdJ99+qff/ua/NZw8jCaPgL390ZCo54eTkyOnFijZvEOlH5f29xyffi92W/jLLvndm+In
d/nmSZVhQotNQxWvn4r0Y3IwwPFI5kZFPZfq3j3jLDpVi5T06QOhbY7jd8qePpAvUKLbg/LH97Uj
L0X1x4se35c6jR3vnqscs9rhl+ogJaXmup79LPKb2r/7VvBgiP3uZdeBnNTJN7qbgy17Ixys2VAE
K4GD5YuOYGEgAmX28MqCjcSZQGdrEVtnLhF6ll8XqrHHRiUuFXiWuzCA9rcB8IIKr84gcYZx4fSZ
C1tbUrhXY2owdqzT0AqWHrIqVSV4EYYjWNEcLGXQoaTD2DDMSWGah1lBgQsp2nGglKhaS5ahyFGH
owjYswimBAmOVInosJOrDU9OeJaidD6jFldxgtbGklMKzE7iVuYSkukc/hScLnQf6XC8QY3V/PFp
9GA6ERqgPEQ+AJ06PqRZ0Q0LlO1uULJGmMOpSabkriQcLBLBIgGnSBVhtENOFBkruoowhuQukIbV
SmmAFc9tj20KpwgRwHr+My8CsLzyWI31KCp69DiG63XgEoAPDAKmWDEIgRUgswuIW1TQQdKgRL5E
jRAtLj4VYatKjKJc0iWik+cR46AmjmARlxJ/iIN1jXHwUAGL1cpoKVxyK+jxzYtNvr0iOmLhwcEe
+lEUed0b2ujDRPN23iLozogWHPwgJQhS2GQaUsaxjYQ/RV6hD6BfXHIhBKnev2/vqVMXtm/bYkLz
FOoeHkwUBjdrPijgg8CmFAxwXEQZGFSgwVQDjbEWAURYoVd0Yn6LGOu44p4G7uCnlkn0FPUQ0PgI
lXnBjaChv4UiTnkKyHR7sMmxS9jfw5DKtXyBDMyevUQOA38cbhm1y3AOXwU+YCa3fBEWDwLsmagM
We7gCk1QRhQR5ZeQZygCQ0LQGYHpBsd7XDjk5sEYGlYmiqATDw5+suKSgA4zAnZONpodwHkFYpZY
5TumijCKgxWn5B6OYIG4CZFxIeEVFTb5OYVdm05hHUExHk+wqXw4QoYaBzv5TuxJoMQGOEqsO4+V
dFyqUB3rKTw04eUE/Ph2Wj+C0tJudT58cmA80YZMyTSRFKE3uZK7fmUZochaP0Ryj3Cw0DBN62BF
pQinCcCamE6W+FupeN7wEeddHMGKVBFCitBHZHM1tDaGC+NZr2LB3vHqCTbBcGigc/jUg73c6qp9
ADh8XUuUasklWKTUeFhEK8uuJUcXtm/rXnagoUQecEIBBRgUgN2mDFvFaRagcl67BFerG48CzKAb
m3u7eQFKtgiEO+WSG5scuVVLHt2iTRCE+0ESoM5jUVM5lnvQYDdv3ftf5Bs3rBoaRHCeESNzR/gu
tCMhVBESs+coDhYOBXuJkKmMdu/ySNDsgu0UwMkHLOHQVAHzBzBmFsCDtoMORfjUhOEI4vVkvQ6L
CQnMhTCgi1GDAStOl9BGLuoQ87Qdp4pg6ERTgteEy8v9bYsOrMyOOhbCTDAaarCAEzYlhV4rBZUy
Mji6u0LGL6hBAivlGGChparYOCEkSu4jUxGS+4dEgBUVxBqLk7NaQaBhLFk3XkEBSz+WJCoWn63G
VYSmMMCizZ4RwEIYwsU93d34f//lXwwTHBjiwetasuTiBkAiTxMAyo5wwS7E93YnnE9/FwiJubnY
oB54KoBffRIwkcQmerCQdYWCSW4NLWMIUEbY2phfUnyA1Vp6pCYNJNy8tLcDDCvo6mMXcHRdqiqy
mc1lR2oPH607hC7cYC87JTW2ihAiWLFWObQRoSJUs6PD45cIxxja4DdDHAgPPSRx5sc/zI8dmv0q
uOh+UtIvwAN0FwbTErg1XGoYgn2ojynoWZm4r4AWPJ6PabOUcCQgXqaBkNxpJfdoDhYdf1ITBxv8
IlajJh6FLsxFhViXFiPCkN4SOLm202fYrcZyTaCEEnAoF+HOklumtXJRzffnGshU59S3eU2gQ3bu
VOPkCPbldEoCNnxzedCFRoOGIrRGImYPipjiFaJlAAt6PNw7VT6znE5F+fDPIylCb8jM2ENb5QAH
KyTCDtV/hORuijV7DmGj6BRhSGg0ooMV40WI04X2FbwIEcByEJL7I2zAQNwGaauQBEUoX1hcRhka
imnp0aBTi0cGFY7ToJtCG7RhlUjQspJiaTfcZ8ClDi0zuDgsIYfRjK5mlUG8BMPNEAcLAywfSREy
8g4XCviCkuKcq1fYNwcEQ/3C/qvsnh9bB662Dl6Dx4FreLsa2uL2Q+/2XW29dqX59nXu3Zu8wV7m
1cvN/Vdbe6+0RH2qJcnHr+LXo14cvMYa6OFu27Kxo+vC9u3bKT1c0CCsN8BUw2dpp8EQ8PmwaxaF
FyTuLuMH9dSIDC87ldh3S0QciymDFlA4cWugQLgYTiO2YgSzP4pNA1NYGHAgQUabtoHoICAYaFx8
7adWoUiJI1hFOOGrwucf0tx+K/bXgislwnc3mrzwDeLpgNkT8Bn2/4C1CmHjqLEPihICXWD9xEVN
gecEAb5gIgJJCTxMyekBBNwMlQGLiqj9QQcgxQSuTljMuPGIEUtyj3gRgkyDPF5olGTwoXEtXrMR
e0c0yKhBvTnMhXfhQANFW/0EbDimQIKUXgQABCHZS5Kal4R+hhxEtl1KemQLuYdBXBBwFeYtgLqb
lgAsvJCQhCJYtEwDcLCITMN/wAVOQEJ0BGsGc7BoJXcDgyP8JBzBmo71IkxqtZtkGluhECwxghUt
NOqRBwhhAhbfGhyTF+O/2oFRfxu+RSVoEdbVfhQStMAqBe8ajEn5gDwQnPLq6AnJJfJZubhLQVcO
uvh4KBSFYBwXmxDJQKQHBB45sIaAiyfC1sid+HrzaJ1cB9aLt+G1srsNgoouAaHp+S18jaxYpzmG
e54iUi1MPHMi0SxZ2CpnNBpgwehGjy84Q0GWgNjknJjPgE0KN4jmZugWYGuFTdEVtJQl2I/jjuJr
IzCL9nV2ijDDBi9r/Njzx4mTKYCTeLQvIeQNhfS+h4RVQdYZvKJ9CrqPupRBexsE1SDygbWA3SLs
GoSz5kRExytfArQhWXbSQd25USEhuQ9PmcZmY70IV+w8iaoNKyQTV6pDTNB4S8Y7TGAKhnSwwkru
DU0MAFheDuqKxinZt+cYWDkdwSM2nEmIV/Nx3JvwjXCuzSNadIrJreu3SDBnVgQQBA270MHayYA1
b0YXrgsE3tDA6tIu2TvI3LwE/qOd94bEg1eanHpwy4bB0SUm/FBsSiiFjmQTuM26gcuNd68zKTO4
GfZdiSW5h4VGN8QBLEUEYLmJvosQ/Ik9XU59B+bNtOExCMfGARqq5i0K7EopC+EzUJiDxAdtc4mp
8X4ytHVhUCUmWqlOfdf7X4Q4I0NCUDK6kNAdBbBokns0wArLNISqCD3YjtAppkumKexsT8lgGPXy
8XdhXgXFp12h4GcT93QVNhjBk72zfeq9wmPuCDjlC05VUf7uxpMlIy/VaCm16BJIRRU9PzYuuniZ
aVt+/F5k12vmHe3Ettk6K9OPa9xmrduCej4HWoZBRovzTdglAkYMfOdCT1DTkuUULpGjJLQOVkwE
Sx7yIqTNnkkiD7sHRoRGE/WrIEVoiopgGS39YYAVUnK3xlQRJvjtmEIpQqOJBliRCJYsiZxBHMAC
UgstyA4VPF6oqAU/SnBQkUJsxoMjfND5xUtoEQJjoNz4AXWAi8tuPojiwioOpKH9qP9DhOO0y6BL
XkV4jXHoUMF3Fy+Xl1VVVZVVlJVXlldXV1ZVV1VVVtRUVdSQx6qK2tAj2QlvteFj0Afrao7u2rnn
k1//Ju/g4ci75fQHww3iV2qqIjvwVuiLaurQQ0lRbc3RgRv3t23bYpnkoGFw0SX12zhz47KTx7LR
QgsWVDjZFKTY2E5Yy2RUMppLWC1571+hCZuLw3hYddOjPNtdiyXupLTKK2goglIomHDAGriDHord
OD4KPUdD28vCOC8BfpJbeqOPCzpYfCmbUUz7b7qxRTGuFcA5Ewjw+K1qSt8FCTtKBDAOHNkli3Y2
vr+If5eUeM7ipxLwnwBRFe0SxCawm5xPumiVYEyGJ0e4o3E8zEkzxtCSMmgjHskEJgpxXFObyMGK
MXv2RUWw6OmyDUc6ccTaRYYCCc7uSZagLBEPhmg5R0loGQUK+9Shu4+SYxsf4oEhIYwCkKV0k5FE
DmbzZIXpCYXkIbGDl20eCb2k9KhJIcUSWUvQJcCyKB2s0nAEK2k1uyHGsiZepiFKaDRk9kyU3EeJ
kvukfhoDrOGkJPeEPOBYvBi3IbGcMExyJwBrNlJFCFHrJbtqkSyL3RjPkhPh6oCZydMadOuCnivz
ELLqwPy1LqxkKCapYoyoWpdQh3PgqgQ3WmFDanYB0s8dMED7Sdi/bRHoBW3LCOCDeaQWr0JwPbmT
g3PkGpIcAcgFmENLUxGJ2LEfi+eCwA9eOqBZB6ZJWQzDPSb2Lg9b5UTpYMlCcrcCvCDWYYiDdxDA
d2PvHdd5bEotpb0FPSo8HysDZvR7OuEbwTWvE8IP4PCDbzaEMmkFGmz/CUaKfOx324ZbwPo0DnyP
QaRaBfZ5/g5sMIw1bd0wxy851EuOTuymrsTzrg7/Qux77SHROxxodQFdAMgEcFdgZxiP1jAmDQOs
aLPn4Unj2HSc7GdieWBSe5w4z6VkFYIruG0mq0CMjWB9MCbhYDnPLlKcRRd2v0HnxwlDwAIskjoh
TAUZq26cs+5eJgYAbpI8wjRV9AqF65UozENy4cW6Uxh0NOMAagdGDKS4GkewfOqAnYNOLAjcoWtE
4ZELrRbcp6AP0/hGg6toOwm2XqBEHn3DUD+DThGGhUbpCNba5F6EXpyzg/gTdl/2nOr54aSYnwOh
NWzajZMCmIKKDiCQ0a+GJBoQmzgw16K+R2FnX7qyTA4hVQ9z0dFAuAt9l9lifh6O7CphHeLFNglE
gSUcKfHQZs/EKidURRgSGqVJ7vguwBwLWGpTCjos5Ov0m8S4rFoMHZXSBsFPuiMAzkLcgL0RraGD
9nYcWNKxWwoPHkjNTN/19png3k3J//7vf5+dtXP8rWrJLR55o1216ov8wxlBT/eB/WmZmXv2ZW8r
Ls5Ct4BjTldckHooL7uifJ9tFl0UCUQCCEcNyw8u0C57EvrSEDkDOr4FS+2gQxZvlRNl9kwDLFMs
ByvMRo+RYrc6IwDLFu1FmARghUnuSSW1QlWESThY8YpQUTIN4XQhKHrIpoaZUkF5iMyH+UzQW/hL
Dky+RuMP5ILF6O8X5e8YGuCD8wH4ccmx5rPuTGfJy0dC+8xZVvN+OkUYS3K/3stITUm16O2GGYPN
ZHBavJY5yjhntRrNMUnPyImyRcoCjNboNKtFD2FCFkvw93/3SX/fTbRvnDWisxcT2AvVE9hjagti
DqCMLuu00WbyvHwztmbNatsMmpvbB/taWC3lXW1N1VWFixCu016/1tTaVHD9GniX3Rs68ac//K63
Rzz6Tmie6Qg669+9ULNaq860H0cwa+KNyGdBCwDBy59VzJbis1016CML1jOvHrMf3eZJhRXDL9CM
dnrBee5M59Hmk7lDfU0L9o5nd7G2tk/85kmLR88dvMaWSDUCoRwAlptwCqU4KSEjddx4cS67d/1Y
w7F8Yjq0aIdMZcCO3aPpXBhOskO/VUBG3k0sd/AxCEwDyaQdB255eCmFBd4ghi3CWVEsA+4gNXfY
RdeJZhkRzLOWUMGyH09tWGh0oJcTriIMpQjDESzS8cg9osbACANxJ17j+dppzU947MbpI+yHAd5i
WLzNpaLXM24S8Mae6ySdCnbXUlw0oArgWHvoJsXDqR9hXxXtMuwJWZjjkQer2ETJNISqCEMpwuRF
WMkL3eO9CKf0MTpYOEUYzcEam07uzpvcWm7lKBeJYL2ndbDK6SpCjzzW8FyZnH3pTabAG6doB2ec
g4sF0PDHh6gsxj1oygxQHdjYHM0BEo+VvQQogY+XF5CSW7JhNOOCpOySHecjvHI6oot6nger6dPT
lTKJ82icC33EYkI6Ny4uKikZm7W8n7YcKijUT0hICgOPwrLQo4xe94c3cgB9WPTB8si78cfL6I/4
og6LfuqNO0YW1SZe2WCHS0xnUdAMsMRvJB/04FgXJOklxNYQtDBG2flFJdNzhpEJ/cikEVyYpudG
JqbGE6pKx1airicIp0XDo7GkBs8r0eSTZ7QjVYS00Cj6MdE6WMT4FuyxcdzUJ1lwtBumvzVOtlmm
+dYZLQbfPBw6lSCQMTkqd+oVdJbE04rOns8isU6L7GhEhnikmLgQBnF4I+jkJtGPjuvGcXZpntCK
EAR4daQW73ovK5bkbqDNnjess07xQxGjsIc8AJeAi//8cQebWdbVfnzRc3rgGuNobUFne5NSfgQU
d11iyqCQCCtZzJK3L1hoOJsaUb55Kj7TWX/udHOQapt3ikZfiQevcFmtxVPDSqdetmCXXDjd3NxQ
8OaZLkBx+q6I+KxCtKo5281htBy6OYCDW2RAjPYiJCR3Q6LZczTASqY77431XQnffR7CogBr0UU7
+uXS/mvctJTtqKnL3zcdPJjptAh2bNt8Eep8xUB5dAkbG0ovnKpHd3p6+g6FrBZ9fOvW9Q/vNEnF
jc2N5QGXTCwsOXEsDxMPtEnGmUQZ8ZirGZZpUIYjWDd645Tco3SwTLFFf8ZEJfdkVYRhDla0Albi
ht6Ki2B5QlWEHkGAUjiMinfPZb0/NXpMAr+dO0+dGX+reXKX57e168d5P30vmBsVLbllly407ti2
xec4HfR0vHrC/el7xvR78RJaCbjEtjlNXw/rNfQBNMAyM9L29F4+4rUiBNwSsHP9VrX+g27nzs1/
u8j1WVWWKdWCDZ0T4YuHor6fmC6DGMLkFG/wakNaWobNZEbwCIFOiwEBUAr9OwBYpliOWljrKw6V
hkn9GLMKhTJ0rgYHbhBpDFxMYEt6fpIYQeIGrcZpl8GBYNbI8Og3q76xzMqNk+p92Qg+SkqKMtLT
di65GDf6+Jnpu28NijNSt/de4V+7wv5fv/17qaSYzSwY7Bfa9G3bt6z//iKzsCBTLj1af6Ly1iDP
adSlp+25NSiqrcllMWvsRtUff/c7HrtIIirdtWNbAGG4ay15B1L6rjB2btvww7eNO7ZsGnujscxx
169bZZ3UXbvSKJUphCIxo6kQoyIpNnvBK2GSWIDojmrwakt5afazh+qhQQHUGVCsgF16f4h9/4Yk
CIEJsc8mmRvl3x5kOU2dbovs6SPVg1sSt1E4NCB4eFvgs6EVJs+p56NV07sXink7e97a4bXorDMy
9DdnRhFqkQRcitkxTc8PLP1Eu9favuhGHYn90/etLx6LcLAT54g94hu9rJzsA5MThrXffOaYO7/k
EgcgcanGS3ouLFm9pBRGQu94pZFXojcvnpjIWzDvYG9plxg7m5HUKp5V4TG8iQlzJtJ4eD/uqUca
OQYMvgQBe1PAyVxwtzU15rc2n7TqHb9KAmg+ouU4TUjusUruJIIVnSKkqwhDXoRThuRMlwRmcZzf
XPSRyZTcQ2XDidZR3mSlLoluCdFHutpw3BVdXcm8XbUEsX150CldcLajQfbK9zULVk3QzqbMHRMj
kCa/d5M78UZIU3HBbEcDeRkMJoBtAyRBIeBfBwYWbnGS35bEzj3qh1GymVFJQVHR2IwJbaXlFbOj
ErqUJrJpY5/GvYg9rZMfg0t/k7eg/Y/aD7+F3/XgpoAJqMXLFLyfpMFQU57Qp+h0O4IXOsOosKis
/MP0HJr7x2YsIx9mJ+aM49N6dK2TSzOsJJ+WKJObHFHFoa54fd04mlesknsoRRgHsDziJUriIxxw
cFkWPX0g/OMf/gkNcGtWffX1l5/x2FU4VS99+kCcnbZz1defb1y/hsesWnK3LzjEzx7KUvfu/Pqr
L7ZvW/O3CyIcrOJDNs2Ly9moczHgIKmVR1xcwa2mmUleCU2nA4DFTIlTcp+hzZ6jAFZ4g6Xq7Lh6
0/pV58/UF+WntWuPP7kv/usf/3jp4tHiwpxvz9ahy7ovY7tS0ahUNG3bsgZ9SsCrXLf6yx+/a9y/
L/VsN5pxtetWf9HddlzIK924fhUC1iJBVXVl3s0ByY5tG4wTosGrHI3i+E+XuCl7tw0N8A8f3Pvy
Z2xqHpcijONgRUjuCjpF6Itdq3iT+ZlEna6AU0wHvVxqkjtoasjlchoCjkbTpGrN6q9tRlXugcz+
nlZYO0HEkcXl1PX+xFp0cPdl77nRL1508LIy9wwNthQVZO3fn1FTmZeXm11deRiYhZQ8Qft+BceV
6AUebZWjpDlYJIKVlkW8CG2JQqNxHKxogGW02YGDBaLtkRShidbBogFWnNlzshRhJIIV5mC5dGOv
Fbt3bK4oPXCs7lBLQ+my92xZaVZxQTqXVfjysWbvrvWs1pLtW9fOjJ3nMEs/+fX/23+t/u0LccHh
LKn46IF9aVPvZUFXZ+7+tJPHD6WlIgjFRL0oZe/eezcFpcUZD29JvVZ1/cnCo0ey//SH3xcXZsyM
ttefOBR0i7+/0IgQydGa3NycvUHqlM8sGeplZmZkI4CF/iY6J6Y5MwJYOD5nS5L6NFpX+rOYjgan
VCCQ/ZYGWCZcEOCIPdgWIx6WEAaDM2wyecx2l8kxMjy2ceMGh0mrVVT+7TvOkkcx/FJQXJC95GIf
yk3jsCqHfxHwOEVlJSk2g3btmlXzzjaJqGbouqCz7djRunyvlWue5L16IqirOXh/SKBRFh06mP78
sajnx+btW74ZfiXYCOV13aZp+cZ1qyxzquPHCt+9EC5SqrfPVLYZVV1Vnlp5dOiGoKwkx2fWDfY2
SaRyLk/EainBa1opSVWHAJYGS0Ko7w3x//F//k8Oq3zLxlUy6fEldzezpbTwUBr6wa1oCUGdPtPR
XFaU03Aip6utKTtjp1R8ZO/uTZlpuzmssnWrv1ZKG5fne/IOpB2r3Z+ye3PPD+jKtpWVZB6ryT1S
k7c/a/eyu23sDTdt73YBtywjdcvEO92j201bN61RyI7l7tv0EsopeJibJRroac7Zt39myrxxw+ru
ruYf/lbfd43d18PtvdyC3ur7idF3pbn3SnPflZZevEPvX455Bb9Ibz0/Nl6+dPLa5cbeK009Pzbc
ucG6e4N1s781+uPQ5uXopy2x77aEG4zshI7vvyLo6+EMXGX2X2NfuyIqKszishnWWeOvkrjkJq9s
j0kRhmQaDGPJdbBizZ4/Xif48Wky9NVxKcIQwFIkcb9KnH6SGn/Gv6LBIBREMgwTWuuMGjLlboVK
fqS0+ODMey2hc3HYVVzWEQSwRPzyK5eaKKPCqZcv2Jk4Znh6+r3AqQeXw1DNZ1vQhqnHTsl/YMuQ
xFJXOTUiKyouRedzeHympLRkapi/TLInfnUSJWW/OvJ69L4vekdNmwTHfZB+VIc+qE74oCqhwdCR
HuWCQwY1tyRjTRcAq2K+NLzvD/Hc8R+keQM+7dwor7C0bPzDNEg0TRrfjk9/0JsmZgyTCMFMr+hs
kxDNSlYDOxVrhZlUoCGRyDW9QgQXC42+B6FRY4zQKBm2YIWkhHQPcH3kfVdaWYwqtGLTT/Jts23b
Nq//+S739VPFts2r71xnGidZc+Nt6IDcA2mmufYN675+8eSMz9nx9rl468Yvn9wR4To1UqpNKhuS
OXskncK94QhWyCGLUBy8ALD2RjhYs9EkdxpgeZT0haZvLgWXXc1sLXebW90m9syYZqCHy2SUolV4
z2UOl1WGDnt8T/PzPYlGU/fnP/7bvB0cLY8fLQ66Jc1NJQJujcMgR5MKuhH0k6rtWzePvm1fu/qb
1ubSNm3d9q0bdeoTj+7wFJLCvp7mLz79k0pRO/xLJ4KqkPokwWlPolUOriJcE19FmMx2V7Xi5sVu
VD6cdXLgg91albyqrqYInep3L6S7dmx2mjQpe7be6GNi9xX5EsViMWpu9sIKOD1t29XL7GUPLz11
x8PbouLCdIXsqN/R9uYZr/8KCxfByJJfoMThKBLGVkZZ5SSkCI1xAMuZBDHgOA0RGo3mYIWqCGUx
Vjkhknu0PU5Ma4TkfvBQSAcrlCL0Cl8+Uq5fu8Y6h3omv7ri0NOfVTk5ey5d5PrtyvKynDPdzW4z
47vz7Mryg3dv8jIzd85T4srybJXi+C9PxPUnDp/qqDzdUX/sSMG8g/v2BW/n1g1u2+mc7J1Dg82d
uhYxv9Y2J9u0cbVd37Uva++NAZFtTnek7qDbot29cyPCdqiLXu/lWGagTu1WPzc1Jd00ZyDRJgSw
0MnBKl8JzP1YvfuErJ+VuA+hsxSKYJnCYa2kx8frh9FJQ5th1ug2O+yz+pGRD+vWr/FYNCJO6WCv
NOCSImRZXpKLTmZG6h4Bv+bBHe7dIdXLnzWGD5xN69d5zDKpsOHekFDIK2e0Vs47EVqSmKfa62oP
/3xPrpCW5eVmPbonvTUoevZQrZ/oWL92vXVObpnhrV/7tXFKVVtTMD2uc5rYToPEY9Y8uCPLTN/Z
0lT87fnWZbdy4Gq9RCLncMWs5lI8kZHclmqJVAX624mOa++PzSVFOfOU8PKPbLRAevFEvHvHuiV3
24JTs2vnBnTz8rlVF842o1nyRh+/pgrd17LLlxgnjuX6HKLBa5y83N1a1Yn6E6U+u+DdC9n2rWs8
ZmVF2cF3z1H7QnSb2GbbK8oPHK0revVMdeJYXkX5vr4e/jdf/XVoUG6du+QxX1x2a2DG9Ahu9DIy
0rJsZhePJ+HyxEwWg83hMxhcDpvNYXO4bAGTwWMyuOSRBY88Ft7CT6N3mPBBIZfNJwfwOMLsrJxP
fv2b6qo6FpMPG4MHhktM+pFsoRa4ZGOFvoIV9V3ht/hsLruVyWGw2Awmn81vaWINXLtOmdy/+hjK
SXDOieZgxUSw2IKIDtZ0jJJ7Mp0tQ3JZo6SU5NA8NzEVJrljodGxMAcrwQMrSQYw0SA9YaICAocM
YSNWa3FO1ras9K39V0Wz75s+//T369d9Mz0K2RyfVbJ71+avvviLfZoplx5NTdlVXLh/z87NLgMs
shtPluTuT8/O3Pr4bhcUo3oxzQgITJi0+5FflXR16xZPj0qKS8rGPhin5sxlFaXGCVwZHm3REPFq
kCd/Pfxu0oNXamqlRuI+5aE9JWhLMh+GAi4ZTYdcqVlah4LAEXoSnRtmF5aAF+HYlGlsxoJ61+g0
gu9zCGDFZ+vi3J3/A2i+sqBotGRDjIhDsox5rNAo4WARodGYFCHAIAUuWkanRXv9KruxodRrP2s3
tr98rPz0z797/VyoVdVq1ewFigvpQo/Qrlft3rn1wT3mgf2ZaDR8fL/FbgKqU5imA0lnpw4XvMRF
YlTxPmhx/WoFgBVfRUhkGmJShOF7BC4rs7WCyagIOJUes9Y+Ix/oOclsKQu6WNd6ZAJeLRqUy0vy
qioOMhm1aNJFUyyXU8lmlfsdTDazkMcut8yoqyr2eW2C2QnVurVfvXnBXbf2y+8utPZeZtwY0Bgm
ZX1XZDxWtdehmhpTNZw89Jc//v7qj/U4CK+IWOXEyjTEpgjlIS9CZZIT4k2AntG3oRtXervIU41x
snv3zm8u/41TUbyHz6lGGDErY9vNfj7cvMDqlSkV9Yym/GV/Z3bWtqEBHjpdaSlb7t/k/3xHu2fX
hp4fxXXV+7+H+UyLNZ+UHwN5cbyFuBRhCGBBijAt1osQIFGU2bMpVm40pOTuwDpYoOQeS3IPVRGa
I0Kj4TxjHGKLB1haWnfQx3/1lH34cJbHLqdMDbXVub1XTx7Myxjs4y+7Wal7tg1c4y9QIrSaPwTC
bMz0tJQFSlxSktvcVMHnlAq41WNvujisitbmwgWK7zBoV6/6wmXSHcjJuN7Hs8wIy0tz2nTHjtQU
+BzCrPQ9A72tcx80ddWHrDOizRu/MU3J/Db2PMhLQjbq0R3hls3bpj9M4t8cTp7aIIIVAj1E3yti
B2RKipboYBUBWAiS0hGssBxG0jCYKQF7wUesLpObMprevXm/efMmt0ly4yoD3doIdn9/4diBnJ0+
u5jRXNxwosBlPXf5h/pTHXVBV/vXn38ecEjEgrp7N3n3hiT7svagpw+GlIWH95YUZj55KBsaFGek
7VjyaMffdjKbSyzTbRs3rJobb6dMbQhguUxakaD2uwst6MZRKerUsjqPTZSduW3jhnX6CdSpRD2X
joklCvTvmE0lmO4dcj0ipDpiWuzTDfYwKysOu6zc+7fEOTmpd66fSE/dvuAQLrq1qanb79ySyKVH
0IVedMt/vNgsFVYHKdHAVTmbWbzgZPVe4RTm5wj5VYzWsoBLZZpSrV/zlU0vRhB8eky9SDWUFe+z
zkgO56WXlmRJhSdl4pPfX+D47KofvqvPydqzZtWnT+8pIXkHQ5/gZl9TakqKxWg26O1Tk5PGuTn9
rNVioNArc9N68xxlNqBuDBvsGB30DtnwU4vBEXnFYDfMoH5PGWZNpjkLguAMJu+T3/zdwMBQ3Ecs
UR8xk1fIW0aHOfwY+i5z9M6cwTgzZzeY7UarZc5omJxCX2k3TP0qWupzRSp6FNAZmzbSXoSRKkKw
yvkkyouQlmkgJPfk859hhW9ZUStrAg6IjWDRMg0rLOUTkynRVK3EBCJUlTMm3soqy/cv+86MvZaX
lWQuezsa6kvrT5b7bOoluxShh4aGiiN1BctuPp9Tx2zNX/aJGk7suzfEvzHAz0ZrNWfXQK86O3PT
EtWNefG4NopSh9RQk2UrojMa0X/BJZh6L6qorBmbNI9Pzhw6nDc7IcI8Yvl/Cg/9l46Jw2crwbWk
LxJcRUlpxh+pv6CkkeOjWwuL7NFVh7TW0ewwu7i88sP03LvxuZEPAHTeT82OT8+NfpiLl2SLcwpP
XoIaD8ISqij0K7IMpwwrqsNHVxGGOFh0FSEouQvAgwJbHQeh2lx1a0D2u3/7580b1/zuX/7p0z//
+VRnLVoaclllPT8yPDb+suPMMugDSdP2buu/1rjs0SmkJ9D8lLJ7p0RYAVEcu5DOGYFvjCRJ4tuX
NMscOswdEu4jHCy8QyJYIQ5WjFVODAeLblyB53jurh3rlz3tQ4Oq/MPpP/2NIRefdJmO/nipSaM8
8WDo5Ia1X8zbtI8fcP70+z8u2DRcdjmjpWLe0cpiFLMZ5ZRRUVl+IOiWmab4O7ZuNk4pcrJTgNjk
VshEJx7dbUZIRa08ppYfud7PW6I0NTV5Yn5dqGpJHfEiTI/yIqQjWCtwsLzRmzIGzUQjLRcm1RLh
b68USrh9He+eK5gt+afbjy25/7bo4lw4fezDOyWtQ+iSz4538ln5pgnFpW8bxt9Ilp3ai+dbxn8B
ObrrvSxmS+6VS62Lzk6sFi1OIFkmhKhjKGJKWqQnluROlNwJB8sWZfZsI6mrBC9CO45gAcmdThEm
kNxN0REsmr8Vk/MKwTXai5AIjYJMUciL0KV48Qis3G160bKbWVt9aPSdLicnrb+HHXAJK0v265T1
y+5WlbTmWN3Bh7elaanb5l3q+uMF928JfDbe8EvWL09Ef7vYWFaYg9YAD29zd2xdi4bZ9JSdA1cZ
i27x0SN5X3/52bkzJ3z25qzMPTf7OZaZ9urKg0H3qa2b17x8jHqyvOlk2XfnT/itYuu0Yv26DWMj
o3Y6x0fH9hDKIaAq3sQ6KVqiERidIvwkOkUYrTdmWiHJGItQrWYLAliOOfPIu3fr16+3zqCRsLuq
PD07a1dRfk5Zafayr8tjPlWUn55/KLUwf599VkXp5Xt2rlt2d0gFpfeus9BkwW7JzzuQtT9n6+tn
iubGwqF+7qJDwmwpyM7YlpO58fkDNqUX7d21wTqldhmUe3Zu9Jj4+glJTvbOQwfTysuyHXOKoIvR
1d6YlrKT1Lb3/HBSKlWKhHJmc+kySY77FHTdLhSSEzkY7cCVlqNHDjtN9f1Xm/NyM8feynZu2+Qx
i10myY7tG0bfSoWCqt4r4kWKNXCFw26tmbcxey6xRYI6v634Zj8770Dad+eOlRRno67y/JFs+9b1
QbeupjpvcqQj6FZVV+UifFxbfUApqfVZGa+ecgd7Wa+eisbeKNG7HbpjIm4+VEK4dV4z+0YfMy01
04rWUwaj1YhgjtU4iy6Tw2k2WvSzTrPDYUJQxoQe47a4F1EfpveNJqfZQpnNTpMJbXwe/7e/+W/X
BwbsoY+gR3Rw+PiEdvAx0Q3GHmNF3c/ssphcNpOHsnidJhdlRhv1qwT1qfgJZix2WqKtcmYiQqPR
KcIYknvIKmfFwEBidiYZ4X1sOpIiDMk0lM/QOliKWIa7MokNe3wCURU/J0VeZ9+4JuAwjyy6JAsU
FyFutGrnc+saGwqxeqdywS5pbipnsyqXXQwep6avRzTv0Am5NQ/vqBXSmuystPb2aqmksroykzJI
cI2rGsvaipPTLxKTGjH/AvU8QVFRyYdp09jUXFFJ2f17EsvMWdOU3Dgpg20Kb5PJN3QY3mT08VMf
/chUwg5uwQgfT954eH92XOKxaK2zitkxMXpqnVHox6XGSWl8+6F2LNNKE+xIzVMyywz8SMu0+s0z
/oG8w1OzhvFp85tRiHqOQTQLA6yPUK+SxqtWknSfTpAe/UjyeiX75xDJfRKbPcfoYLnFtHYGBgTL
TjQ78urry72WzlePeXm52eNvu1zmeo2iXio5tmBnIzS/aD9uGNfs3b3jyg9sqbB0kUJzudA611NU
cKBDVwdiyiDx0rnkaMPuLgmd2btCUIT2g8MAghg4+CIAi7bKQZ1qMhzBehVJEcZgOAKgOy6erhey
y/ns6rE37W+eic60n1z2tD15ID1/pmHZpxHxjvHYJefP1h87Wug2SC6ebenWHV9yqy6cbjrTWe8x
aRSSWjR5WGfVR2oynUbx2NuzLQ2HOIxDndqmgFP34qH4u3O1Iy+ljJZiAbtSLChxzimWHR00wPJE
62BdixcajehgKVbUFvclcBzpSjes7+UlZediKJVyieiSFDeufocItHAJBDLwIOMUL7mFy87Ty5Qq
CN5zUiwf2oZDOzK/VTpvlwddPFzvKcNqZFGgyqtK9jTufg9FsLwhmQYPzcGKThE6aaFRR1RaKsoq
x2QNAyywyolTcqcbsUXJNNgi2a5Y7jb2IsQk9595MWbPLsX7V6Kvv/yC3VrLbCo8192w6FYfzku7
PShZpIT68faK8qzmxvy6moPWac3UiCpl77Yfvjs2PaIsKchqbSpobig1TiB0K2Qzq44fOVhVnvPw
DjrhrMLDGfduSpephjOnOP/6f/5JPykOOMQtTeVVFenPH4pOnihYcnHu35LUVOxHX8psLaIM3UGn
1DolWrd2/ft3I1AaabRZDFaEKc1zplAVoS2JvlcC+yok4urEESwpjmDdsBnN1ugUocmahBqfrIrQ
YrQ6DVbKaB9+9xr1UvMk6mkdLtMpy6TabdS4jcqAHeTCPRbFh3cckFujutCNT+mhMGjBrgLzFtA6
UZuntE49RJVcBoXbrAo41V6bZm5c6LeiRXuX1yT2W3VYRKrDZTyDBh90QMAumxyWBZ3n5+1K+6yu
sjxXLjlGqNyDV1ulUhzBagarHCiZR53fKaddil3YdYCS3b3OOHG0FN0aQ33CwwfTl1yqjnbGkdp9
NZUFZzqb/PY2paRqqJ+97GEO9DAV4iNo586gQCquRW0OXlUWF2Qsu7WMltL644fLilIf3JYFXW3H
6/JNk5plz5mjtYfMU2LbbHt1xeFjRw431he9/0X+853G8pJ9XHb1ker9739RYmUfZZAS3exrzc7K
mpuepUw2l8WKHp1Gh9Nkp8wmhGKcJjMF+w7K5IAd2Bzw1IyPIW/Bu3Yn3vCOzTJrdKJrNGcyz+gl
Ivk//Pf/MdA7iFugD460SZ7ifWdUa9HNhg6gH+emZtHdhFaAFr3ZarDZDQ7jtMVp8vzqP2UbErVF
vAjpFGFEpiFMck8we15BvzQWeI0l+kBHHQYAK6yDVVxGAyyPPCbllxip8qqS5A6SpeSwHBTv7nUu
i1nltws81taykn1oMcHj1LY0FaIhAPRtPUIWo7q1pQIYr6zy/ivMeTtDwC66f0vUpq0rzD/gtum8
jgt3hohrmyRga6MVShyyFSJVquSlRrDClukn5GXl5VNzxncTc4cKS79e9ddvVn2O5sL169eu37Bu
HXpcv3Yd3l+P9+mn5BV8QHgLH4n310XvkAbJ03VxDUa1HPNd+FPk6do1q//477/70x/+fdvWLV9+
8fmG9Ws3bKAbjG4q6pesQwesW7savbhpIxqC1mzcuOGLzz8rKi17Mzw6PmMZ/mAY+TA7Nj33/sP0
5Jzlo3HNqHLX6ZUpVlHaH2MrJRM/zsGK/hS2yiERLMLBCulgqUCS242laNwgmdF7uV7AL190tgbs
zRpFQ1b6nmUX//0r8Wd/+f2Z7ibjdPvEu9NpezczWsr8Vu1f//jvQn6Ryygeec3fsPaLzvZG4oq1
jMltoF+QnNOTnMGNb42oCJYvJoKFOVgkRUh7EUZI7oSDRUMBRSgYCTVHQYq7YMfWmQheuCSLLmyP
A6TA9mW3YAFU0xQwZIOGKgeLFoJ4B7b0ItATxKCX7OdwUS2aSzpoMy83EZuVLHvPBuydmE/dAjoj
EYAVkyIEmYZkSu4J66VkBSXRJxCkR+W4jlVFV1H5JOj3+20MXHCENVG93GWqdZkoEtlFQRcHREwo
0QII8EiX7AJ8ErCeIQJk8xex9ls3yP9SSYtv4nhXcXlDZSSCFcvBsoS9CLFMQ5QXoS2RfB3FwbIl
V3IPW+WYMMCKaicmlGV2E5J7SAcrZPbsann+SFRUkOmzdlumQGd8yS5yGDqgPMiFpTecsqlhKQ7b
Qx2AU9/tmEOoQj5v65gekfktRFpPFHQq50ZFLj3ICAWdDGpO4rdA8FvAr66p3B9wogUtf9HZOTfe
5rfKPaZ2XLKjdBuEU28lUPkPHkRCy5Ro/bqNI2+HcWkkNrfGf9lmtMQmT0NGQB8JRNERLOknv/4N
AlhEGiMGYBnj44VJk4YIYLkQGjBY3g+PbVi/zjItnTfidD8taILOkph40YCCo0eI1eqxoRCIGmhA
exYU4VnLXl0QVEtEWC8KnTeilqnBGmNS4Ay4NKAX4OVA8R1YF4DEFEj/gP2UlN2SW1O132tR4+ij
4sY1tlQsRwCL0VwE9i/E6dylpIcIbKyJjvSa291GhP+Yzlmp39IRcDQt+09Zp9pNH8RYHojnNaNJ
TYSp8W0BuzrgkPtMKr9Fg8t+dQQmogZnhiUISqKfPW9nglAf1P0hNNnts3CDTnnArpx6I0ZNEaN3
1EMmXnHtc20LTt2iXQCDp1fWe5mRsifNCqjI7jA6HEYn2ozTNtMsWj9QdqPdZjCTzY4ud+wO2SdP
w49OCO5CfNdltaNHIV+MLvTN6zcdRrIgseDHyBb+YHRT0V8R/aXQvtnqsTtdVpt+egbdsBAnRohf
b/9V8mBSXN1WfATLQFcRhknu7HiS+3TEKkefQJ1JFhiIc5eL+zEg02AIA6zi4qgUoS9ZxsSbKNai
TAJuorMqrlNoRHCZ1NlZe74928phFNWfrPRZmK0tJWxm5RKaZvxQTo8WXnkH09AgIhFU9F4BGQ9G
c+n9IY5tTrtn987ujvKWJoTNCxeBIC/BkvxSPOt0xI+qycfcqAnSqZp+Ly+vKBuf+vBmfOb1iP7p
i6evX00+eTH85MW70CPsPH05jJ/SO+gxvJHXQ8dHtqcvot+N+WD4I3HNxr74jjSCdh4+efO//+Ef
/+mf//X2gxev3o4/ef7uxavRZy/Ju+Sz76Ibf/Zy5MVrdMA7tL14NfL4+duXr8eevnj/Zvjt+OT0
29GZiTn7e8Dx+veo80AEKzaWGZf1S27kbBhLahw+lRCXShKvSjDYic1rY5I7iWDFAixQWyEi+xhY
+GS3BhhSyXGYDFwIBMj2Z+06212/5JK+eS7dtR2B0c9Wff01j1seoNTzDvmbZ9L01D2rvvri80//
KBbWoUVk0MnHBcYa8G1wiWN69Upko+h9TyiCFZZp8EaqCEdmzGOTYaHRUBWhXxNfRQizPgYQqCdT
OI3u0kCFPJRDtkHxrEcZtJ7CkuhisBbxYYE0BxvkSxw6LEsow6QKHVZU78Ra8BrM1ZMDuxyk/EEj
FyxrvBhQeog5jyLOizAzI6KDRaoIDZOSZCR3VUIMWxmfjqcBVgd2GpDieuG2kBw82GIE7BqsDCTD
mnAYPEEmEcvgUQhNSsDjAX6kzG+XYFk7METz2zg4gsXHkEvxMYp9ol4MIbn7tTERLG+UkrsxjoMV
HcGyRUeeCMCyhzlYhiiSeygMFuFgJcauwhsGWDQHi1QReohMA//tc3V5yQG4XqDf1o71VrAsC5yW
NqIkjIvUEIDogAIgEFnlLRJLJddRXEF8Dqu9ozXJKWxyjCmwTuXFUyfTUrZNvVfgsyqDmKJTCwYA
AErQWW0GO0h/9yIEbyRo1WqdFKP12vCbdyBJD2AIzgw+XZa407IigyqidhFJEWIOFolgOaJOsjUm
2kcLZMQpbNnMRgNltFMG0/vhqbVr1tqnW7EIHJqnhEG03vZ0Y9lhLZZiOoeFrwVYwwkvbOw6IpgJ
4nnolnFia0WqDYdaedgNHbMF/LqARQsFdxTG5SAE3Y2VzbXLlDZg7Qw5l4sX7LhC1qXuv8IWCcRC
IQJYheiEL7lCvlIerLoHOts4WAveEuqIVKkbC4GiVyg2LbYH9lYqwFiudjAd8WILczqKjI2xXcRY
EyupwtKIj2vzQZp40dYN3RsBSiKMh9OUWBhciP7+kvcMDpEycQhZOdTP3bsn1YIuKCwG0NXU281G
h8XmtHlsZsowo7dBxNEBmxlvJkf4qZXeceK3nOSpcc6CEI9Jb4GnZjuPJ/ntb/6ur+9G+GCrKdQO
adkcaTCqcWf40WqKeh1teqtl1gwRMgP6nehuNVpNsP0qSUVVXL1VrP4Q5mBBHOt9lBdhWAcLH5YY
wYoXYhhLjFd9TEreELLKMYd0sEJCo3BX67DQWcj/C5bXupB5SKiiDVe30U5JtL8mYWRLscuYGPdp
NRZnah9708ljF8vFRY5ZMIC8P9QKRFcvkZrtMIypuaziXx6LXz5Qjr0ES6kHQ5yRZ6irnR79hcdo
KjrbVQ++cuC23QkqncQrAAwQyFdrcQ22itbIJiqxLqyWRuw5wWKCqHcqpkZFRSUl4zOW8elZdDJH
PoA6xsdkzac+IqGZ/Dyv6Li3kqxGQoXp87fv//Wf/uXf/vlff3n7fhhUPIwIAY/PmBN/29hKsaiE
dN5YYr7vY8T2ZN7Piech+cpB/59yxozuh7PWDzOmd2PTo7OG4Wn9yAdHY1Mzi1EWdGHJYLeccM4C
lNxvl/pskgDAC0WAkjkNQodeOA/LVuW8Xaqf4DgMQvIu2VwmkXGS69QLiFsI7o0YoGC1lSBa6Lvk
sLkVi/gRP41+pN8lO6AH65IsudEPkC25pUHo57rBq00paVkjYx9QpxqdMo98MIxPzb569cvqNWus
00Ja1AOURVVLFNEm1tDOHt7QY3jzhTZv+JEYUJAOLMCKaEqyLXna49uhWw4/jWof78xjr18QfYZF
vCIjffu3317RI+gQFhqNJrn78Ld4T8+bxWAm7WkHdz/gBaIpTUnpFfM22aLjFAQG3KfwTUeQGb79
0XAB+ICE2U5DRM2JKUcwXEiX7Ketk92Akj1nlt18bLzYBSOGB8cU3R0hZR3dskMZdEvs+o55hC/h
RkboswNHYloWrZJFtH5zqt2mTo+5A/R+Id4JwQyMTtBMxl0Gl7oO2OBktsMcSekGelqwkrs5JoIV
ZhpFR1NCOIBOEZrsIascc8gqR2LRG9G4bDOBioHDbH3/dmT4zbDTTJlnzeZZowMILgiWIYgGy3Gw
5TGaDuw/+MtjIWB9t5LW+4ayAIZ7lgh9odNyFhs8sGiXQLBzQWtLyG6DWj0WYcGaoh0QpwS5/NNw
gFc1b8Ia33ASTmEXVNCzdc1qXWjUBaZpl98KmvhQLUT9/5y9B3cbV5ot6p/x7rrjbHdPz3S4b9Zb
E3p6poPbVrBlWTkxiCKVc86ZOSCDAINIypItR2UrUFmWZcuyLTlIokiCJHIFoAqRpMSAd86pXHVO
QXPXqoVVKFRCqrNrf/vbGwFWwdctAcNn4aeNPMzYQOPkSZNQiTAFJhhlDcY2ioXzOg8FUcnOkat7
OJsGwW/M2AHAaF1e1d2I0VQyxvCxVG93aMKEv/t7aiGKgn8rSY0qTh7VDPq/y5OwfMirdAsJnUPp
RjGNI6PbibBEvVw1QXhXd+ZUZaPbY7W4KsqXj0IjTRSmnmk0nJVqzxnCcmET9baicaN0zkKrkxgc
4hVXRvJcSFTL56zfIcx8Q+Ng+3jKduVCxcLiwhidxHRgGBEzTl2n84cD/wik3AI/b7Ay29BgB3+K
S51XsDEG2uK7pgSPrxera+tajvM5or11EJtjI2YRSgCLUvtgyV2EspO7JoswSGmIB5w1EdbGXWKw
tFmEPqlEKGQGDXuR7sElTmmHeAsuehCgy9kQijGCaKYFohxYI2iDfH5a8IVyIzdRcCfaOp75EEU1
CT6QdpR3UTuaqEYXTXBh/QDejaW8KBQTpXZnHU/iVnSNPjqaPCqgJRhEA4kHO/K99SBnIzRewrDb
enSeyNN5EF1PBwWbWhQCj/L+wM8u2GtftUYAWJGBEAUAFmyvw5J8WEYwQOGTkoNYhwJK7+mv5420
HI80YQGWL8T0qh3Y88bd6EIDg7i+P5J3GhGfGSiuIDklmhhoqG/y6BmgAmEGwKy+CPNz74AvmCwv
L6+uWKNyP5eYiWyTmHmHJhQaL4dtNaH7vybxxkAIpxNMLtIoyRUaKx9Cfh8dKEamTZKfy7BGJmma
VeJ01UvQ2V9KnhlEcW9DHZe+qJg2c+5AMNIfYh75wn0QLEbv3fvhzbfeivUj6kU+51SjdH/iVdL0
Br3qRBTJksOr1dc3it792TYxTAlCmUN6iZhmK21jrxhpAJMokPe9YzztWVg888yJCxQUuko+WBqj
Uc8YX52No4j7rPNpogHCU94zDu9z7Js3FN2+Vonuc1qlN1KrJDSkWp/yyLdQ+HaGj4zzR1DFsCmX
rL7/9cHN64pgUSaJctAB1Eh5UMXWgWBB7dNEPbqzhy564xnbssVzr3fWQev8JMydhbbdafdT7pDD
tnUs2dzq3XrIswUmdcB7LccTzoru3BpRXkKN8GGOp6pRIBUEqTcuSQBLziLE2jSohnnFaJTWlAjt
tkbh0o/IHmh9/vWtOxPemnTpwtUEw/F0LDoQEsolCGZx0VAkAUuEy3/5QQg5Fli3FvgjgQaVTcPx
ulGYSfAhpFuGUbIF0lOPJlDwbQblmYKfLsxdQT8AKC2yodhBG+JvBJvvphEe8YiCHigjYF83/Hck
0b8ABpuiMTuL7AZh+EQrykBzobDIZhFgMQBRpVDRMxaHKDylGZXVjYR6bRYn2TQkhRLhq0iDJQAs
qZlAS4Yx2pFVnoRxnU7yDMNEE49+6Zvy9mQ2hP5Q2cOa/6bG0bcJvzyNEtuEG4+0YHzTol95qEnz
39ftTdQaHh7h7Z3n69xOl7XBaalbPwpN2DuIlxH1Ek3VxXCdEaY0Yl6HhLsyjzjOZtGdFQoKg+m0
MBVXzm4n7Gf4qJhHAqO0Gq911hbMnx+jUkYrVwN0NtxmGKlKhlMAFlwz1lAvAyyO2MfAGLCU0QhN
kxbAGQ1sn8O7XuHlwJQCsBQNFqVxckddhBoGy2yMJGCCIKZMo3JyhyVChcEaQlhbNGryoqx7F7yt
5AVby7YxTvozJ71iuGMSOQcm0RCSQP1EAssF8/gcSGfgHE3Y4MVOiKUEV/mUU9ADjiVQNKYYTNsq
pi+DuwQBzyGoPsZbYS15CKUvDTrRrTAaKuAlvg3VmMH9btMYj9LIhxphUorQ1pFGDedpMR8qKDJY
cQFggaFdAVhBytQBX9Nn58OKk9SwBvt1G7EXjmW8/6j7D7/9w//7uz8AgNUtAiwKMVgUwfyMIlmd
Eak4EuQKEjr+TDph87TK4l9Sf4D9IVgf7B6gugbox3CHsX3791VVrkW5V41i0E3GK14fwUCSaRIX
CgZg8gryBC49SY+IbISGNajbc4uILeEe55DtctprmDzSo0f1VJ5apE7PVnR0aBB/9YvyguLS/kD4
YW/g8QDVH4n3ByL3f/pp8tvv8P4GeP4ZKSpHAGdZN8akQ+fToZ9vyGWcY+icn8TdfMjxlPOIii4T
BxDjDmEkhQ2eQBLKMgoLpp85fi5BZ6DIXYzKURuNwjhnNmJn/U03LtXxVKO/p/Hc8Wo2DHWT0b72
VBTc9ljvfWO7cKIiQ4E/nTMZPfzovueX78F/7XDfw+YLZ/ZHfB+OJKDkhY82Xjpb8eMdcPTWWMhL
9bcNct4E1fj1TWssABNCbl+zfn3TiWDQIS5yBEXFt6SjH2fjrsKCWVcuwIIa4285d2rfrRs142lv
sNvy5z/9m/+hjQ07+ZDnaaI1GXXcuFT9zXVwiTg6lj40zFq4UOu1CxX9jzvGMgLUg0HyVy5USlE5
4s1xUo7KYfD24opNgxpgPf9CXZ2dQ0VDKkQzETZOQXpm6ZKVr734Ulvb+8j6PEaHKTpECV2KAMzR
wVDZosX3v7WM8A0K3QghEfidt3Xdc4xAfrEO8XANCGK2wkJe5iiseWVbhuKurvvVQicB9LHMoDiR
rBB3XQ8jVsBIn3VyQecPtw8+hakpnjF4IW3I0g70C2xBl2gBRjjRACzEQjejWipAz1424J6EZbCY
FIZeMlYGVeOi5IPlkm0aRO8GGqe+Ug20yiPaGxuheZYCH2DPo8DkCW9y4ZaRuCuXQMxftklMehlU
zYgLm5UZZTkKdUkh3J8UOB5pw6x2J8ISZf/q/bSOJuvPnalobvS6bI3VlcuRdqVZ2TzbpD/0oPZV
NW89KI2V8gkACJVE/0EBPGWQOEGMjANQuHk03ijGcYLHpFfzOSjvonkkga5XKLb5Kd9wDVrIFjBB
2adNKsjSum+QU5lxGH32OQzAEhksh/BFG/pJtcZpuHsYzLHI7RTP6VQmPlIVRnqqAVhBWsgiNCsR
kmpVeXxN9a8KJULZB0sOe4ZhjWkUUAPgDsyYbEeAWkiraISJlRAsoyIgDA1EeoKMFwWSIygG+WeU
H5lth/WIbIuonxhuQUGkR9CaMEAQ3lRlO9AvqQ2y4jIGT6HBTyh5pBrHODfSvrjhze7gkfFkE1TA
wAK5G55byo7qEc3iTeqQEOfnFTWkgpoh6xKC6kSAFUQMVlACWEY6Sk/MUMamAV/QnEwyNJDiTc8p
A4cUhQBLYrC6YXEQmnRABovgPmXQQhE8O0zaTk16MnRkFWmfZDcQTIeH9mTAz94fARgr3h/hHwdg
sM/OPbtrazdLweySblR9GRKK1/K8cBUTxArqW0ZhtSFEGKQFs0qEZjIeJGOSL4XyhYk8n20SGdOE
QzwW/Nk3Xzm7b/qs+QPgjfijveFYXzgGwNbPD7omTZ7ChRpGky6EFeA0jrKPxlNoXMyguwi0XHoq
LTTMD9HHULqzczxz2OvY9quX/pfLumkc/HEwG6JH/T7F6UkCJSwh0DkUb19Y/N65M6di4QHFpkGr
wWIDp9+e/Pd9e1bu2712xvR3t25esm3TkvXrlubS7WtWlHx/23Xx7MEpb7+xa9uqspKZT7kj5+JV
7gAAgABJREFUO7Yu27516d6dZT9/7126eFZN5aYZ703qf+gaSTWVlcxau6q4pHjG+dMNX990bN5Q
dv+Oe97s2fv2LP3utrfq4NrShbNXLisu37eWCx/euL50NNUc9zsL5r3LU+5FJbNuXK4LPa6d8OZf
nLaNs2ZO+ep6U6NzI4A4N69UN3v2Nbq2P0k41qyctXP78pVLF5z8tDbL1q5ZWbBpfen+PSvfe/fN
8EA7rIJlPcNc1eWLqi5CQxahvtSlY7AkHyyhRNjQ4GKjMQCeYlQcabM4gLSOHTsOXgLntmzpitu3
vk7GeCYswC+ejtAJmllcuvTHu1b4g8w2Cfgb5bG6jh3Za6ldgzh7y1jyCIxUStSO8Gh8hRYVbUPx
mrDPuWXjMqkY1AaJrsG2saQNKjqgpwkUrYMf2M/fdtRUbkCER9sYVHwLgW42RCJCpc5IsnEo9n42
dgTuJIsumNAtyT2aaOTDTqlEmIYMlmDQgBgsjOuVCgbpbeslJ3cxKueSrkSo9XzH9AQoOwRbxWga
zHT9/Pitv/85RaEad6ZecmZWG0Hr/KLVBs6SjE+YF5IrM16NY/OQigQaxu1KOErGOZ6uu3S+wetq
ttc7qitXjaWtyAsXKw1sJhhKq89ZZxytah/JeJXO34yQgqyipYU3MmwwvhZ2K6CrVN1owg7g+JdX
LItKStJsBuM6ZsA9vLp9QfcVS8tFgEULACsGARbsZriqr/Hp/lZMXCPCw1ip4X4Pqv08pzK4Iml7
o1puCUbFqRmsARyDFdQ4uZMlMkFKWyEijqyC0agm7FkoEQ65xbtYmJjdhLCw4H8N09ohKoLpj7AP
djjWAdV8KZQcAolocAcm9Cy0w+9YiHXMeMd4l9gqlRHqx/YnMQ8fOgpTbHnEMUCBhQX1SXnHkoKQ
S4D2iCTLtqapjlEYe2wdogXU5YSseNY2kjiKLklNKXAPDS8fLthCkkXygsHDI1yLNEi3wlDMrDeo
0WBBgNUvOptHyTIj7EeNg0dBCuN4rtddUab2+nD+x66eP/z29yoGC0BhAWBF86q7zHzVdUIxDY1E
CLLExznjQm9IZg0kZZhqSTesj0f94VjPAPvAF+zqD1fXN+w/sEkVgOVQzbvEWKu0cywlRFzhArNU
C2GDT1ZMEOp70HD7+l5/t30k2a5a06Xd0KUkZ2VUK0AOzCFahECBecNowvnV1X1zFyz0h+lef+QX
X+hhX8gXjP5w/5d/+7c/AihQWDCzqHBWURGcCgtnFaMZcUmhaioiLEELFxbPmjljUumi2QULZvzl
z//9m9d/9be//lVZTb1ykXZXRZq9LSyeU1w0c8GCGQvmTysqnPn7f/6nc+euJuI80mAJXYRONYMV
D9X9+b//tedBfSLSCgY2X1fLU95VsOC9NH24rHT26eMVc2dNCfbASs21i+VP4lZwep1fVI1nm9as
WvDpR9Xj2ZZPP9yzc3tZW8ve7VtLARTwd3vvfVPz1fXK0oVzvrlpmzHj3aGE56ub9YXzpz5JdGQY
MAbYAz2WefPeG050cP7GSRP/lqAcRYUzvrpmjQcsN6/Bti+HfZ/DumUo+enbkyYMxprra7dZ6jc9
uGfZumn5eKYlHm5etqTgSaKlqGDm2RM1w8ljs2e9ff1SBdIStI6lPFcvNhQWLFSMRtVdhAw+rUWx
aUBdhJxkNNrQ4ETUlDAlYjQP8FYkSE+dOvWVF1/8x9de/83rv96ydefPPz5goyxaM85FqZXLV//4
nTWXRtHyQpdo1hPs8a5ePj+X+nAoVtPauGNp6bxtW5bGgs4k/dHO7aVLyqY3uXYDMBTpc29Yv3CI
cx99v7qjZf/yJbOPf7x9iGuJB4/u3rl4WdnMuqpl4xl7yNf0+cfVA48bjhyuafFsX7Nq7oMfYFgh
vO8dahxN1oymGx0Nm631K0agcKIeQDRUo7CAR9bvmjRRLBHyjMxgxYR5nSxGXzTUZS+ygtGoUCK8
qkTl4Hgv3gDdZCYjRmcAPI3TKd/D7qlTJkX6wOByDN5jZ6VQPDHSzvAoZtvJkwPpVSyQ1UNXFVhQ
1oTrqTYZNOxHmhnLQGngqRMVjU67taGhpnoVUnqpNjSemHH/6mlQM0FMjDqFR3ibIGiGBXc44xqG
JwyvRaNJ+3gavh14DcwazhlNTxG5BTYBJzyS9p46caCkeD4bHDAa6OMlWQTfV70GixZKhJDBelVm
sDTlY1Oxl5HrMuq9tDPP4UwajWyWQYOlKRFSUhbhZTQISUajchchtjqj11oZPBq0o6Bg09ATosH4
LYY9oy5CWNzNCAnErtGkAyr4Mu4s60Cx2LUAKo2l2gHkam9e8s31mvFUBzQV5CEOG03UgL8rLBtn
m8fTNoj0k4LQ1YbunxrR0GUb5Wv6fqnev3uhEOeMVJzIJBMWMtrRHXYDuhZ4IQ0OsZfbYVnfULNq
LFUHb+XhnQc4pYoM4zz+cdVosvnO9eqtG+eh6IkPUccZGAlsaG/w7QyxkN+C/IEscg/GfAEkcu8X
RO4GwBp8hspX0EA+BSm8ohzv+6phhnwqfdX9R91Qg6UpEYJfBYODU+QSnvkbURF1hPZAXMCloYzo
M8FhxtVIevxQvHvA34/U7j3BaJef2ldR8y//8ofCwhkFhTMKC2cWFMxAkzgzf/70QoQYFiyYXlA4
E2IXNA/XLAQAYvr8BdMXFMwASAKsDBYWFswCQGfB/BlLlhS9+fc/v/z8/5o48e/FhXOlHcKtCoSj
gM3FY81YoDqi8CrYc1HRTHBWJQvnoZemgUP/5S9/Kl601OeHvZkP+4I9AC/2QzesC53XT5w4f/p0
J5hOnbwIp1MXT5+GE5iB00np8aRhCXzaKc9/8cWFkyfOnDxx+tKl69u27X75+Rc2bd7R2Smto9sJ
aTp58cTx0ydPnDxz5typU+dOnzpz4sSZAZ+foSiNyH1IMRoN99mnTJnABF18sOPvb/yVCbU94Z3F
xfNiwaYlSwo/OVY9d9Y7QZ97KO4ah03pnoL507685niadBXMm3nxi6rhZHXnF5VLlyx0WLdb6jcn
6MbhZO1Iyn3lYt3yJQtuXnUsXDg3Ez9wFdrzzBjiHE9T5bnhj/3drkUlc56m3Gyg9s03/pJgOsBq
Ny9bw70di8vmLy0DOHWey773CWd5Z/KbY6mmyoqVtoadt67b7JYdT1P1PO0tWjA9Fu5YVLLg6oXq
4WRjceHM82f3w7Z2KMR0XL9UKwIsYZCQjEYxIcTS/TQEWHRcVyJ8Fdk08CwfDURiUTYGk/t4aNhD
x+vrG155/nmwAgBY4PH3//S77dt337/3YxzACJpevmTFd1/XI8ID1XQyYLJfPue01G4G4+X9O9bN
65dEej+2WbbZLZtqqjbUVa9+mjw7473J9761Rv2eHVtWJJlDv//nf6yp2NLz4MiM6RN8j5oP7F1c
Wb4l9/TKhrULv//Gcvu6beWywtvXnb/9x9fv36kDn/+q5SWwtzTdNJ50ZejGW9c8a9csWbdu8ZdX
PcxAE5T3QaEqVFOkKY8AsDhBg0UjDRYV49QAC6+70ot1BIBlM3Fyx2t09CMrGw2DbZOxTF/XwH/+
+x+LCqbPmzO1aMF74CYB/bvRozwVKI9FaBKWg5l5c6eCO5yCBdNKS+YWF89eurQQ/NLmz3tPvQl8
1O1QtRNhKi6aM2/uu5MmvuFxt3gbW//P7/65sGB6cfEsZfMC3InJ+ykQTwxz/uh6Jb8KThJcbRbM
e2/p4gUF4PpWMHP5siJwrKICeI8EVy6Yga5Imp3L733+3KnwtmohfLpg/nsTJ/x10cKydGxQr4XC
JSAZcgg4jfLdUCLkmZhSIlRTUzrbWJPuUSMCw/zAOMRgBXFNWAZLKlmDrAdYgajGaFSjwaI0PlhB
rWtRgCx8wTW4EZzckf0xdO5pfAIl562JaEuSPnqtsybc1xwPOzrP7Rp47AH3qWzQGQ+3jmU8/V2e
C2cr/D2to+mWFO2M9jdfv1zxJNnq7z508Wz5g++tqA3KPci2fH2j9srFGnAvm2FcUd8x2I7EHLr3
TW3fIyhNffCD++yJvUkYkuNORdshSMpaBmMd4A6v4sCa6vL145mmnl9azp068MsPjrFM28/fuZYu
WZBmHNlYu7/7Q7S3E+dOH7z/LcDvreNZdzzsioXaLpwpD/R4RwWA1WNTNFhBlQZL1VunBRxkRZEJ
SYMpyZGrbIYvTtJgqUXuMoOFKzuaKM11nRBBkmM7UVOlRn5mYnacwIuYnKN9+4/9sd5AcCAIhiru
gW+gO8B+/5Pv088///T4RWU6cfGT4xc/+fzCJ8cvgEe0pBPMg+Wfnez87EQnWPLx5+c/Ri/Jq32C
Fp441Xn85MXPj58/ffbKxs07X37hpU1bdp05e0Vc7TjaszyjLJQePxdfArtCj2DJ+WOffvHx52eP
n7oM5i9fvx2Mso/6gt0hujdE/9LdFwgxUVg8giocjmFRdC4YXag4QDMMA/vVKTAkM3CKMsJ8XHiK
ZqRJXA5tHimOjfJ0hKtvsL3y4otWmz0ajqrWZ5VNouKu4sr+5ZfgjSbMu4im6XAiEcvEIjEmFBM1
WPqwZy/jt7399kQu4uCDrnenTIz6YUrVwuJ5TKC6uGh+53lLUcGsH75tfZpylu9fc+bzA0sXz798
vmY849i2eWl76/bxjKu1aefB/Ws///jgimVF4F/c/XPL2lXzvzhVvWJZ6e3rdYUFc9Kx6gf3vNOn
TnmSODrMe5cvnnPny9qysvlDXLv/seNvf/kzG3m/pGTOt7ccXufmluYd4KJ07IMKR8PmNFM38a2/
jfCehlqA3jb89L11+5ZlQ/HK6IB9FThWxl24YPrV8xVP086C+bOvXqzKpR2jXNM4b790pkbOIozL
ACtf2LPEYMklQihy3759z43rX169fO1y55VLnVc6L4LHy9ev3XQ3en//29+BFV576WXwZb364ktg
+sPvfr93b/m9735YvWotBFhZGyrhQQ3WMFftsu06f8YynnbarVs6WvePpSqSlCPJNNJ+z00YoFv3
p3//t9s3GmKRwzu3r4r4rQB6Pv6lBry78gMraqvWZLlPbl71XLtsKy2Z9/WXtjtf2lauKL513bWw
qGCQt3aeP1hSPA8caIityQ25H9wFn8nU//rPf//Lf//ngnlvnz91EAo2klDSOhzzxvw2qMGCPlgY
BovXiY7VvWAGeKQOe0bEBquUCI2SatUoqxmM4QlEov5+JkQl2dSl81cvnPvizKkLZ093ngWPpy6i
6cLZkxfEp8LMSfklaYVTF8+cvPDF6c4LX1xx2jy/ee312TPnnD5x7vyZy9o1pUneofJUnAf7OQXu
nU6de/jzo+5HA6dOXjh9Arx6DiyXthIPh93ccG6akwQTOEmwzqnjX3xx+uK5M53nz17+5NjxP/zT
b2dOmwkWnvz8i3OnL4HlZ06eP33i/Bn5/Uq7FY978sKlc5dOfnb2zKnzYIWTJ86ePnnq66++ZyK8
eVA3jynkcVirMxXA4uUuQvDXMCOoCLsydi/y6jYI7Q3Pc6b1JsxordVgUUoWoQiwBB8sSh327NPu
xGfiDkCWM6vDnjU+WJnmXEIQ53aM8B+tXzNr04aFNVXbZk5/d9/eNfv3rn9v6htJ5pTHve7OV56f
f7CUlc4sP7C5pHj6T98ddjs2bN5U0lC7+Vqna+WKApt174qls+/etI7yR6rKyzZtKN2+be2Bfase
/9SyY1tphv20pOi9fXvXfvJh5anPDy5bXGSp31G26J1w38drVxYwQXBb3L5n+5JYxFlbs9Fu3fXo
R/vM6W+5nftnz3zrWqf32NGDf/rjf3z/Tc2dr5zr1xYk6LaVy+dWV65Zubz4w/d3j2U+2rWjoKp8
fXXl9jmz3qL9sL0cAax1SIMllwgZQpMgLs+RJFE3iZs0NzrX671UJcLf/59fugwMFtHnzFiD02Kp
PMwWSZWlz83UuIHoMnYCmNZCn2GfRqD2OJDs9Yd6+vzBaLw3FPm5J+iPZILQHysMpu5gqCcY6Q5G
4GMgAk2zxPkwmB6jSV4BTdEeZR4+7YcNDdH+QGggFKmqt7788quVdQ19/oGeUFS7oTSB5aGoMi/N
9IapnmAI2qKGwHlS3YGBR/39vaGkP0h3+QJdfcHeCNMdgL+oQIiNROLQKBl6JSeTiPwAUxJOsST0
Mk4IrybgCsJjEkwJaYm4AnopxWbjURqMMuBOEfEBLzQ0WJmwsJ+kuBNas4lmP9LyFAOz8FLQUCAV
6Q9kYkwiEhqMwdKVz9hFOOzlgi1zZs/ko14+3A5uoCN+59NY08rlJXzEu3rl4q9u1t24XLVxQ1lr
0669e9akKe+aVWXXL9UP89ZH9z07ty7rOLR53ZrFfV2eJ4mGfXtWWmo3VRzYeOGsBUCo1SuK795u
XrakeDTjHE40epzb9u9e5rDuctu3DXHN5RUb3a6d9oZt7737dizqWLWy5IdvPLcuV69bU3b8WOWe
3avdti25TGNpScmNizWNri0u+/rx9LFtW0qa3XvK9206d7r+aaJ22ZLCL69UAZC3bGnZravIc2i4
NZcoB5sUylE5jNbJnYljC17gE9OI3FGJEIAGiJxegOBJxFLPv/jS/37+V6+8+vLz8KV/fP1XLz//
AngKvq9XX3wRPILV/un1X7/y/Au9DxqR6UyTYNMwmq6vr9kO7lGfJG0O26YW75aRtOUp3/jtbXdl
xbo9u1Y3una/9cabN6/sj4VtmzYujoU8kye+FfF7s1xVbc2WRtf2psYtO3eUetzbShct+OGO9ea1
uiVl825crSpcMOtpqqbzogN8ffC2Gdo+wVbKp8l2sOfK8nWj2c/GM9bRZL3ULd7M9rsmTZyo7yKE
/FxaXznSZxFymkFR8hTVhD0zOCd3kkeAAnDBKJ4BExuKJmKDTDTAMNlIhGFpOMVoVpgxTtAEHE3C
U3DTEwmFYgxz4eKll/7hhYULSzmWjQSDLIV2Qkl7oxh5K3EGvEQpLzERmo2mYlBUF4gzTDI+CO5Y
ODosH069ufpklD1rD6E7VSZKsdDziQVTyB8Apz3QP/CrV1+fN68gDpZFqXAwBDdhNO9OPoQ8k47F
2DAPLhR0OBmjMzE6muTSTCSQ36DBpM2QJtg04BmsON47zWDny+scaxmChAsrcjdkt+l5ETnsWcVg
UYKTuxyV0xfAitx1rIOZnaPRJkAqEVJ9Aa0PVsaBIv9cyPvAWzB/zsnP9o+la4qLFpw+XvkkVVew
YPbtmzWNzh3XL1vWr1ly/NPq0VT1/W8rBrqad21fc/rz3UN8lde148QnDUPx6kf37eCa+P1t67y5
M2EbFO+5dmnfN7fqN2xYHgW3yJPeCvfbOMo99d13+36pfxK3fHujsv+hpWzR/OhA85Oka9PGJbGo
s7Z6beXBFcG+lhtXXKOZtvXryqwN22IR+6YNS8Yyns7zNcuWLmxp2rVrR9lo2up76JoxbUqa8W7e
UNbXZc/Ga5cvK/j+NnSaAABrzbr1fUGuLxjxR2I9fgoTv42tFT6721PAXPqNszjXuiSoS4QCg9Wn
02CRkBDpuCQGDheyhC3n+UjuFapflC+I9eWiMIGGpH8HpoJJNPfyGenAAC77HLWM9AYB9IEV9nqL
7ZUXX6qut/kCDFa5SKx+YsvHwv8X/Wd7UZAoXOiP9AepYIRF5kkqU2PB15jR2SxhhMO6y1AiJtzP
gdGOt1rtYPC2WJyoasNhRdk4gl3bIqTvG4pLGixVVM6wdzzVmKHtqBPFm6bsT1Fn7iDjUJYPesFM
LNAwHIdhtynKJixEmkg71VeXpgTVQRPYhAtZ4kEL2DNYR9gcPIqiXbB+1Ab2M45aiYdiDjA/yDqy
jB0cOss4nsC2mKZ40MoMNIxBgbZrLOUBBwU7BPNgBXDQp5wLHJEZqIc7GWwCJwzlTUnXCC94CCFX
jqzryvmKQmjTwMgqogQr2TQYmtpkBounRQZLKBFCDdbzLyxevMzh8DQ0OOvr7Tary2Zz19XZ3O7m
HTv3AbAF0NUrAggD2OuFF19+4YV3353W7G2dN2fBg3uQCxwVbmJhm1jL6eN1Te4Do2knvDCuWxIc
eL/90N7VqxbOeG/y9Ssuxn/4L//1r19db6SDbdu3rmTDR//w23922LYMPG6dPnXCj985ihbMunHZ
wYQOzZvz7q0b1m+/gk0G39yomjdnWi7bCu5158+dCG3xYVuG8DnYb12tvnV1f2748JjQ+jDoFBog
+JBj0qRJyMldBlhxfIkQOx7rSoS0GJWjAlgJA6tB9lti4nhFtjHqUceRMFhwwIKjA2AkEJClpWUA
O3J0gsDfkGtYmD8ap1H945ghjOmXofVSOLqYSoR+luD3lmD5/l7fb17/1cLiUkSKCzcG6HdL85rP
Ex+5zRmWc3gcw5C/U8YwqQEWo/hgKSJ3zLvm9IfTWWGZhX8rmOw5vejE2Ccf1Iw3AoPVDwFWVMki
rBU0WErYM4bBMm/dwuma1aMU7CKUAZbMYGUbR+POXPp90Z9z6FBxwbzOL2rG0pb582Zc6ax/mrIU
FMy881VtW8uem1fry0pnX++se5Koyw22jGeObtm48uqFmid8VV315vOnDo6ny2PB9l07l9++1gA2
H+bto6mKseyRH76tX72yhIs63p44gQ44IgO2dya/mQofha7Ng23jqY6iwtmhvlaYdbqxJEEftTZs
tdavCXS3LC2dt2LZ/HfenuxybE0yzRvXlSXZ+ssXa9asLqurWVtdsT7L2bhQ2xt//VMyatm8sZQa
aBrma5YvAzd2DhXAgiVCfzjW66eJnyGWFMRyWkYgYoxMDhoik6X9+wwFvvuP1CJ3WvHBepbeQKMw
K0g4BywcVMvIVO/Oh982SigdkmAWQSyornTj/ylkFwxj6Kfh7YDbFV+Q6QlCgFXXYHtVAFhBBh/i
iXFEI2NZocSPdJPwlASAFQAAKyoCLMh8KNBKiIzQm8FgLiucdqASEu7SCGA5wPlbrQLA0jRtcWZj
AJauly6+ggZrohz2rIrKSXsEPy3U2gKRkABfZCAFVhhJuDWRjhkxxBAlkCg5EGDDcTHuxivPIF1U
o8DliDNZaaF49CYZhEGjV9nqDD0iJ26l2wtgqTF5zxmhpRTtNutBztrQvx4ALDEqh9GEPWtKhNrh
XAFYNKd2cq+rtcaiNLh3ZyO0MAMemTDV0tr+q1de+/Wrr0Fy60VIbk2dOv3YsU+oCJuKxVcsW/Xd
1xZRg4W6vUY4y73bFSuXzR5JteSyjg+PHCwteWffnnVpuuNqp6usZJq1ftOBfau/vlGZYrxe50Ym
5Pr73/5WVb5m84ZFN67YxjOWsyerFxZNs9WtcTt3fXW9vOvHxvrqTfe+aW2o3ZrLOn+47aivXj6e
aofeECgeB4lij0LBK1Sswo6N0YRDMLVJhO2T1D5YcokQGo1yRO0OZgzmMABLLXKnTeTVHM79AWek
ZNDdYxXZEsiIIVd6/pICsACaSZiJwIwZi0YTTl3PHf72hiMbaRr14DHRphUCLPhqf2+fCLCg5EBK
IJBL2xiKCAe5cBAK0wSKBbg4wZy2i5C1SAwWjy3t4f5ZGPurfHJ4HgIskpMQtkwjMVj9YbZbnUVo
BrBI6Mp0xDXMC1E5PahJTQ2woOARACzokQhDLQoXzPjySkMu45o/b9rVC9Zctm3B/Bl3btlc9q03
r9TVVG6w1e/IDX7w2Uf7GmpW7Nm58vKFutHUoU+PHfC6146mmi6erbfWr+v60TXtvbcifd7BmHfj
+gWffnRwzaqyZNQz8c2/ZhjvSLpj3py3v7xSlRv8aP/uRR8e3l62aJ6/u40JeUpLZiVpl6VuY0P1
tvVrC2DW5tCR7VtL6qo3pJm2jesXgyvy5fM1pSVzzp22rFlVlMsevnXdXVoyOzfUumXjcv/j5vGM
e+niImjPgwDW6nXrJIDFagAWiWIkfcj50IBPp+gydhTijBLAS3KJ8OcuHcAyGMGTAi6DZJ2WiUMV
NvcG47MaJSIqvdzQNJdQT+lRBLPcqOHTpggL9fsUPigIsEJsTzAG7ijqLbZXX3q5ut6OSq6UD4vz
zIlAA0ksAqyADLBg+0ggzCA4FdPwWALAwvHkmDs2WesQg9dTCWDZwYBtsThQPFxc7+lHUjkw5Ltn
ZLapACzFpsGjtIurZwbFjnEIkrKKXaoGgamTHMV+eAlsZTxit7ycYSW8JDuvCpAOgapx0ZrVo7yK
oNV42qO4zg5JXfdZVWhPVvZoFfwkvSg+CCYwXhGd3Bl5bNMYjeJKYKhEKBuNcrJNg8PhAYiKjdLI
xp0DM4LurWBBIXRqeOHFX73yKoBWR49+FKdZOhyNg91SzNKyZT/csSCj0WbYXg1RYFsu275j2+Lj
Hx1AJszNyIKhYyzRMcja0BtszQ0fGk3aBQQZD9qmvPMG3W8bir8PEOQwJ8RsNCJn9nawAmzHhv5Y
9vGkd4SvzQ29PxRDNphZoU/c+ZRrQJ47ntEkTOZGhr0ikuaCVl0XoV7kzsQ1lvcGzwVlHdEHSykR
akTuDK4JEcNwYOEUZ0Q5xpHYYFYJAFYyrmGwEMDC3eqQUQKOD6bjZEbNzA1BY1gvrS/laksAi+X7
eny/+dWviyUGywCwyJ8MxtNVo6LjSWmSDOEtq7Vxqi5CJHK3v6orEeavBcfNuhcJ3PxzRMRDUOQA
gNUzYAh7rhVLhLIPlmzT4NOlnRi9mow9Xzi0pzYaRSJ3Oey5BXqKQpdbd4ZuXLdq/o3O8vGUa9Xy
uV9erh+Mt6xeWfjTXXuze9OdL6vT9KmN6xetXVmwZuU8LtxRsX/51QsVuUxdmnatW7Ns1coFi4pn
+B8fGs14PvvEsmzJ/KKCuR99cLDv4ZFtm5fwkZaiBe/Fgu5h3vvjHe+ihbNWLC2sPLh+PPOZ07Z3
7px3a6s3L19WPMwfs1u2N7v33rzqnTblrf27121Yt9TWsBFcRpcvmX+4bcd3X7WvXTUrlz12YM/K
xaVTly5+9+6t1mHevXv78njw0Ejas2Htwp+/a4AAq1dmsKIAYPWIAAtvZuEjluEoPZIwYhFzWzIS
AyQ6uat9sAhROUHKzI8qQPmIXu1RjO+/3uwKp6wi2635SELDAKlOTSqdE5SLQYLFvKHUiL3xEEuE
QRb84CUGy45KhFhj+iipZVLXX+nTAKyoArD8EoNFxxV0pcAs8p0lY8RYgmFjTARYNI7B0l1Msfs0
75Fm40rYs5rBSovIRsRMMqGVlsx4ZDN6hGkEckuBOFlVZGFWDafEFcZSjQrMgvHbbhX55EE8lluV
tC3ZcAuW1opvpEeJKcx6ZaAggTwBgUHTVLS+66poNMrqw571pRblk1SMRqUSoQCwbDY3JK5oFqCr
WJShQhEw33nxClJlvfCnP/5na2sH2AMdpiEso+LREMXT7IqlK3+4Yx1LWpBJN7JkA6ed8maYjvOn
dg7HvMgkGdwNuqHT/SDMC4dVzmx9Ll0nmBuNJZvbW3YOMk7kgO9CDdceKOoaev8pD4MuoFUNuHpL
X+JoAkZfDMXsyGFEsIZ2o89f8G0W0BVyrRxqToStgg8WpwAsqUSI+a1yxCxClU2DhsFSO+Yzpn8E
DUgilLSM8M5MUcTCwDsjwFJnIBoBB9bSyYjtdH12NM4eXYcbsJhSYLAYIWgI/t54WCJUMVgS/tMA
LMNnyONvvTi8dJ3BOccS36l040dzCGDFZKNRCLA6r5gDX2JSp5EpxKNb7jliTYFwHUdhz3ofLFmD
JYQ947IIo/pGQpOIHswgpETl9AVko1GvktmUQj5AQ0186EPYZjLkBpeAoRi4T7IlqY9GeOd4um04
3oCI+la63/6U78hl3SOJQ2OpwyMJyH4NcfZgT12W/RjMP0nsB5fLBOVig9CQejjuSlOtqFvwKDJZ
duVSh9LR+uhAy1j62GjqwJOkM9rfmKSd2VhzLlOfZZsGWXjFZAKNXMQKToOPukeTBwfZ9mTEPcJ7
uZAVOUF8wPqbskwzzNtK1w3F2qAPctY6yB5CTtxqDVZUYrDI6iITs3LjZBJEo0YqeYt6KoD1S5cx
Kse0P9REpU7in3TbYvowKJ9Ok0QysseIrsg5hiYdGPpEHUPADh5WUoR8RvhvkkuE9Rb7Ky++VCMC
LIJ+zrTgqBZp+cQSIeWTDO3gS7IGi9ZzVyLAMrYxY4K3VNdKsUSYQgALabAEgEXqkNcSA7yJyFQG
WHIXoSByF/IP5AKfLs0968GkLIvFQa/MP8nqK2W1jEe/iUBTZVWp0nLgj3orgcGSwZn6VXn5oMSr
yehKLHQigDWI7F2yrmuyk7uU0yyK3DWlq7jOaDQhGY0KInehRFhfb49HGSYcTcZ4yF1FaZ6Jb968
AwwzW7Zs6+56DJAxE6HAKBj2AxyWSMSTCSYmACxEJglhGOC6WovKBU5od5QVHAQdMMZ7yA1TNAaR
hVtSAEPIYxn6sR3JZQ4jx+bmUa4cReK0I3tn9xNwTYYO/q2jPHKKhiGSdnSBFZKhkRt4Evk/D0Kb
NxRY5EURHTCwkgtaZJsGwVwUMVisArBoEkuqhwtyVM4rqqgcJYtQI42P4ykWJh9kMSFIjMAFVyJU
NFg6wgmbsWhGRHF5VtC2BRDCYZQSoZC0DQGWUCIUGayYBF61pW1j+ZLBKa7yIhsC3aXr6xQ1WCLA
QhosJmZRRO64Y2HJPEYLpmlC/4S2mPhcnsHGUIWRRe7dOIAlidxhXpvKaBQzdPlI4Tn4shElGI12
qwGWwGAJia0wFBNZuoObP3ArOYjs1LPOEZgU1j7Kg9spz1OuHsVgoSBxZEsN5a6iXza4wQLXiI7R
JPjn29CuPACKgesC9F8Q0jEHnaM8DFZT/uRgfSi6tA/Da0crsoPrGE/Y4DlkUJRpFplGItUqvDMb
bhlihFqGdzyJLqOpVrQHDyTbwR0bVG5CH9uxJCwRBhUGKzKgKxGaWA8EDaO7kSw035ygQ/fh6Jkf
H0klQlGDRekZLB0CyFNQe2b3LKNPm9HGHV961sm2CF4VeMBESIGU88uNIi2dx1tA/SrGIUXSYMXA
HQUsEepE7obodKPxLLbOq0RdiQxWVK3BgiVCRq++EsAWubkGP0hABouRAJbF/hoUuTtgPJxuSDNu
qFynzGStqhKhS+3krhFLKRGKYglvTEgxUl4yJCqi1cZTnlFJsCXuTeCushJ6k/2ph1QxbYNNMi81
JibKS7hNqA+mJbAlvJT1KOeQ9qiYNqlEOIjCjCHAqiqUsgg5dalFbTSqsSnn1E7u6ixCALDAgJeM
J8B3gVTz8a4HjydOmHzgQCUsCNIMFQyD/TORGB9LJmIpPpbgaWbZ4uX3vrWKWYRCiXOwATpnpo/m
Us1POXjxHGJh6gDET2lonjzCt0iJBU6YjQ0vrchfMFOJgm5aYMJg2opMcQEya0ePgqYKmeIOS9XV
4dZRrgl+FAClCeorsdrrEU3AM83MAARY3bJNAxzLYxqbBqO7tzFYUByVNVE5QnlLiSQih83pDUuN
Mm1c9rApNSIsNAIslcidEEGNqX4yplyase6Pk20RC3AC06aUCBWAtVACWPoMTSZOcsogqspoHFnO
EERXDP4igzhdicFCJcJXZAaLhE0ZnFoO95nwxg+QUYxG82aSaLroJQ2WyGD1iUajkpO7kcFSjTG+
ZzFnIrAFQlQOKhFCo1ExKmcQ5QOmIB6CSAv+sR0I0LSggBGU5SQkBqZbxMsWDFRuFXl4+L91jSag
eTqKjfPCzRPuJ0wTMnx3i9bqg4eexptgrGkWZUUPtkGtQMaBWHEkBIF7OATbGNPoUpKEd3sjvO0J
Zx/jW0aTNug4OgQ9TlGgoQdqLLIfIKhng1byMEri/bGUEADXNMIJYZ9CiXCdTwJYhhIhwcAME71H
piexO8Go5ikS6EEid01UjiaLUCcVMoHRxrKmgZPzBSmz3j2TkpyhV0OHSHx5TbMwZ6vQaT6D0B7r
0eojxiZSKoAFoI8MsOwKwDJiQXPfDeOdDNqDpMGKCndHkMEKRLVdhBqMpR2ccLdu2qdSiVDsInzt
xZcRg8Xiu2xo3KhAGyQj6ksqq7JpMAIsOZpawDdyQEfGoyex1DPyVrKUalArzJLlVgLjhYCRtKag
1vIqK2soNDgD64kaqkwbkZSV9yBsLpUIs3KJ0BiVk+Cxsh4pKodXG42iEqHd7o4EQsizlBXUV71d
PZ9+cjzF8myYhp4CTDwV41OxRCzCgEf4JVI0AFhQg5Wxifknw+C6Wo1y8dqG49BY/PTne84erxnP
HkGxNm4+eKy2Yn2a7oC2zMNN6I20oXJnq1AqHecPgWtdlmqsKV/ORw5dvdj0lPMGu5qbG3fChPth
oVGxFX0gjUKqNEqPBZ/JkeGYF16oxc4DeMnlw67J6ixCRiVyNxFN40CS2sld1mBxTIKMYPDAiDeW
0ug4XleUp5AHAVYsykGA9fwLAsASRe6MCeFkQFfPlGSMLwKSQKG2oheTkKjcRdindBFK9iIagGWU
shk/E2wTAEPQGOg9ODCASSdyFwDWJQSwsJFHxOsPNnkQW6ulFSd3Kn8bv6LhwJYInyUqh2xoZE6f
SFE5eh8seJ0Cf+PDKIMdBXpDa3UL0gq0I0oZJZBnUBAhvCU6DC8QQ0gSC5akvGi5DRLd0IRdyNO1
ouTBD+HyQUHCiRLg4Z1rKzRtH2ocSxxBuMoBM9LhldeZS1bDpC2+EQk8myCwy7hFwn/wMMxDTaFA
eMiWv59LtqF8eIeQwwN3NQy2+gAcDgXLN0L2G9LjqES4Xq3BwqEEo+KbVAokgGYjRvEFKbN0SC2O
AQDr/2izCPsD2rDnAIVTNREAFpFdozAR1PpHozY/nz2E9iUfRlafL1pH1/GKRWAYJo/oTzYgAiyx
i/AVuYswQFT6+wwyLB8Zewk2DT5jF6HMWqlhFvMMLX46zz0BYNEIYFkEkbtUImSIPtpmPV+6Sxgb
7zUCrGGvXHfTy6pUcnKF4kp7lHqfLIQS6CW1DGtQW+ATX1JJ4GVEJRT+ZGoqo+ooHPSOCIKtrFfJ
mJMV9DKzpRa5D7cZAZaswZLCnjkswE3GJIClZbDq6mzIvhW1ENKxNJ8E3zrYc4JNCXRXKpZCGzJg
Ssd5juXBzIplq+7ftcHoQKFEKLyvlAfdW9aOZZwV+1dZGrbzjD3u/2AsVTOedty9ZR3h4P0nG3An
IjZ4AQTXukErvL0EF+ps6xi4/0zafr7rjvick976WzxkS9P2h/fA/stHEpYncSflQ8kW4AILr7qu
sUQDgGv9D52nPtk4mmgSgsDR59nKB3FRObQkcsfqjjHmCJyqRKgTuSfMqB1DlZAnG13i7b8x2EgG
aiKDJXx9YomQSWq03sbOXF2rownZZtazEjdT6zNGrRgn2zTwrJrBMmgHmQRnYgzBEEKXmbyQizNl
vESAhRgssUSo2DSYhO1g8SvW/oohnslz+U2JtMsVBksSdoglwhdwGqz+IBkT6GkAQ9OZjvQC40Gg
N8D2+LhNmzf0PWqDkCXRorkXfPYpq03GxeaTY7eS5sfARTODIgsBLBsGT+1jGcfTFFIhwCh4FCYF
4+e8kKNKt5P2o5q0h844+h/ZN2/a1NvP+6lID/yoQ4Eoa/BPooj9cQTPpF6S/1OQwpWJyUIikcHq
lgEWUYMVxPp1YVymfJqMJkr7q3gWQg6HFI0e8f+jSWcGgQ+W1vtj+cyiqc2YJ0mDJZUIURdhX5Al
ZvgYuweCJkoy8P9FGqyApMESARajMcGilRl8L5KmcVoby8WKPlgAByAG6yWli5AkI2UIbU341eju
X3qnvDMx0tMExdRZN6SH1dqpIWOMbt5JFUArFhY9Yym3+FcdbhF5poy23jeoksNrjthMPo1m1atN
6uhf1GzYjOTeSMAAd95x/eIBBLBg2QsMVGyEAR8LzArEc4GcEpUDBjPJaFQYoS0Wl4SAObA3NODF
iRFsiLzhqfiyxYvvfWtBmXGCRspVVbH229uuwYS9qnLzgx9tbvvW//7TH1evKFhcWvjwfhNPuSoO
rkqwjZ9+VF0wb8b27SvWrlnS9VP9g7s1n39YPZpp/O52/fFPKsf55traXR90bHr5+X9w2VeFej0u
5/4U07h164r66k2zZ0yuq902CounTZA8S8Hs8M4LtqLC6aOZjqc8Kg0nAbxuZfud2KgcXueDhVHn
GJIKVU7uGqNRxjSBDpMNjFUL4cikPHVGVi4RvqrWYDFxQgyi0eiBwzkzEYzozK07aa32XLOaJHI3
lAghRoSBmKobAwMjqLmAaMlyVa8iZ0pGcsTmGNXbFzVYig+WQwFYjPF/RDZlMGMKDbSl6ORuElmD
6yKUnNyjgtGoEWCJWYRyidA8AA7TOIaxXOoLx7r9AwMRdiDArFy9OOAD9zF1uSGraIEz3CS1nKgn
4RKmmhlWPZLWUWakeXmrYd3lsgMiPN6eG2qAzFmmjYt8OBQTUBdKfR9Cdcas3K/klY7epJqRDjGs
PgFYPfT32NesWeUPpgai0cd+aMDtG4iSo5dNFVRBfLIkvgCnwQdk4yW0ldqmQQ2wtIfLR60FTGzS
qHxafjX0wUnag9Qz/cJNqo2kfj3SwoBpejpe2iVuhRgsFjFYqIsQAKw6mwCwcLYRatEVRTaJVd8g
UVofrKgIsGgVdwV17qInVp7+ZAMk0pcIX3rZatUyWHl7cPDJYvLgke3+pX/CW2/S/UcgyQG7W5oR
o4yY6WGPRFH/X03DXkhXDwnZpuhxCOGttFuUe2ZRiT+LXs02ik91xx32/g8OJ88PukXtURb15UFV
w6HOs7uLCksArmIiTDKelIwwElSI0iNR6UPDiNxRiRACLNH1EdJaCfgdcagdgYAMAMCiJYAF1aWC
1sJVsGD61c7apyl7UeGMb25VO+1b58yZPjb4ya1rtYsWzo6FvVPffeu7r5tmzpgS9LlC/Yf/5Q+/
//aW9dYVW13lxjTrvHyh0mbZNJoAq02+f8cxccLEUG97148NK1cWJynvH//9/3vwnbv3UduEN/+c
oBGQTTpHE03NrvXr1i78r//897qqsjs3KsaSCFJnmriAbbLOB4uVonLyUjKMpgRm9MFSSoRG3oIx
Tb4jGefSBN009pYD2TRojUbjGg2WiUzKlOAhVMSe7f4Hc1CtBkvXRSjbNMhGo5igwLxCe9PVDJ2G
GFcOnZO72miUWAmN5+kVYEi5h5of23P/UzLAKHL3ywBL8MEKYjVY+TJ0TdJahBJhiO2PRPrDVL8/
vGrtksddLeMZN7RmQXJ1eD0SHuGMENbtVib9U8OM/DSrWl+9lW4Pg+7xTP0wh7RfaUsuVQUukV9d
s7/64v9ztH31IA0ulK0jsAkZSeMTFpQhrd25+ijGw8GnrY9+cq1dt2YgxHX7g90BtifABKLJZ4kz
kh2tfGSKxSyYyMjQGEVd0kJMiVAtcifpx3FVaR+2IEj6ZZq4tRF06Bjfc0MLHtEaHuPpRenDFk3U
ZsRKpf6LkDVYktEoBFiiBovER5IwH8afAgKsPvFDIDi5a5VYRCEtQdeCugglmwahRGjFlQhxAhQe
I3owIDA24nvc/fbkN3oeNEGSOOsYTzfC5hX1n0j4T2Vdmj+17o+vXkfzN3dBPJFxopKW0LlmRx3K
bhgGD/GcG6oCMkJ/jOpPrZ501xDdH9x4BYCPqEVOQFpppBzINN+8tGfe3AI2CuMgUR9WPBqMCjME
aoRLxRSAJRqNdioMljDagYWwGxG1d2HUwQyZwRp0zZ8380qnezjlLJg//c5tl8uxs6py05NUQ7Cv
ZuqUd3741j5/7sxPP7KUlBQ9Se5Lx+oLCwvufGW9c9NeV73+SbL23Jn9LtuOwZjr3SmTf/nBPm3a
1Fi45Yc7+5YtK+Sj7invTGT9zmS08d23JwR73eMJWA14yjXeueloqN895Z1JZ4+XB7s8sCAAFRfO
ZNgyWcgiZNNSF6GSRYgv6JAa6JiEPipHZ9OAdfSm8UmFumqXQTDHmTFG4pAfE2waMCJ3nVkoI5Je
PNYbkzG1ccKQWxzRXwpHy8XFEmFSC7B+XVy8iNcZjapDyp8FydEkro6sb8PemAk3fmoGi4k11Esa
LMZoucdhYif02RIcJoUa976e82EdevQFI2UcgtdlYxZhne3l5yWjUT3AIvdq4dUt+MCT/hAYGELd
/eCGm1+8bNnmbSuqKtbU1WyqrlovTpXr4KSekZdXra9BkzAjv1ojP5XWkR/VS3T7EdY/WL62rmZz
Xe3myorVFQdX1NZs2rJ5zasvvDhv7rv1NdvqqjfX12yqrV4PTrKyfDWYqdGdp+YM5eXqs1q5ZVtp
2dKlAwCsBIOPAxS0AfOzpsSPGsiSk4zxmAlrWR4183OSSoTaLkKtk3vQiF1w7qDYwGk9M0eZ6smw
MnajJWk+bZkJ0UUqUAbInJYRU+rfiL4VQN1FKPhgKTYN2GJlkCKWiY1ssRKVIzJYPqRuVDRYOiUW
E8/bNqUbw5QuQqTBEn2w6JhpxxPm2srr7ZvF5XGW7e7qefPNN/buWVVVsaK2em3FgdU1VeC/s1Y1
CX8xNF8Bp5rKdfKkXk18WqHaqmJNVfnqGrBJ1brKg6vqatZb6zc2unaCl+prNlShXYGV4Z+0cl1l
+RphK91u5ROoUT1KLwlPVWcoLa+uWAcuaLVV6yvLVwkXtxXLC0pKloT9YSTfTqAuP0YBWLjRXWSw
5LBnSswiVAAWw8XUJUKSMxObhABriZ7BKi6aeeFs3WimffbMqffvWq0N67ZvWZqN14C7wflzp4V8
7nmzZ549sb2oYMZoxjWW8U6aNOHL6xU3LlXZLFtHMt6zJ6vsFgCwGqdOfRsArMmTJiSptgf3qteu
WcyG3BPeemM41hILNL75tz/HQ0iKmnGMgRvUbPP5M7VLFk8bhQLWNqS1h+1EMb9F1mAJ1gyCyF1j
00Brx06snkYRubsFYgO1ZXBityZDbvrDwFOO13g4mXqsY202RUwWw5UIk1qyBAOqCBQLwXwOG0dj
dhPFGZIYWDHJ0cBg8YzWpkETUo6Baxq3VRMaGyPfJFjIqtaRRe4plud1AIuAkHgiFufwRD5uJ8+Z
te9hnaC1XYQCg1WlFrkrAIsSfLAMkhqcZQBJbqwsCfUMBPtC8f5gsunQh3v2Hdy7b9+Bg+V791ft
3V8pTvuEmSpxZp9qieZpJWYTeR15fWWqMm61Z1/Vnv1Vu/ZV7DtYu+dAzc7d5avXbgYoc87cgvKK
BvB09164IVht34GaPXsNZ6LZpzi/B+5WXLhv3569+/e0tH/UF2Qf+we6+vzgA+8PxzEgGDPW6oww
KLxlqHmgHnZzHRmpdnLXabBMo7sNOXqUHg/hqsYkYwJMySxIEVThmh8YBnfqNPLkDGyfNgwnv5l+
IL+Lr0GDZUcaLKFEiI+jJpTacV+xDLCkLkK4T4HBEmwaVO4Mqi7CZzAC1YTmxmDhiVZlEWqicvJJ
XLViL16dgYhWjrHZcCDmsHuqK6vK9++r2F9xcF9lxcGa8oNVBw9Ulh+Aj/IEFsLpgP4lcWX0qm7J
fvjXq4AL0ZKKiur58wvBCLd+3aaa6vqDB6oO7K8Aq1UcrAYzYDIeVNyh+nAHNEfBnsCBA+UH4buo
AY/791fs21deWVm/Z8/BYx9+JuAqNsryUlGPidB4A0YY9iwCLF7uIkQaLKvVJdIJjKTBMqZ/aMbd
BEepS4RIS5p17dqxfMe20o+P7v/n11+7f8fe4t31r//yu2sXLbt2rnI7tvORw9OnTmEC3vVri6rL
V7/fvu/Xr75y92tL789NM6ZNuHGlbsni6XbrzlymY9Kkv/Z3Nb3z9oRvbjT8cte2auWiJN32zttv
xAccaco17d1JsRCSqWXA0avBcROU5/6dulzWisqyQsXWnYh4Jk9S2TRIPliCZcMzNWcozCumi1Cj
wcKokQiDPRHKcMRMPYwpv9HJXWawOFObKA6/BJOZyJm5RZiADM0ehAbhBIoN4Hh1FqHMYKm6Xw0Z
fxzGc5/GlXGJKaim1vDShtoSoTrsmSDqognfMkOuISowkTMCLArDHuGjNrQlQtRYXoUYLD3AClJQ
5C6bHBqzeLU1Gl+QkI4itpdHegZCfWDnA9E+Pw2mgQDT4wshTQnYZ1QQl8iPfeJ8VJqUhcJy9fra
p1Hdaqqn6nUiAPP5QqHuAP3Qx/qC/LlLl194/h8qai2+QLg/BOMafUEaQKK+YKy7XzmQ4UxE3bHq
VOE6/QPJx72hvlCqN8A87Ov3wcpRdCDCKvCU2LymJ/98WPtWo1kU1sPTxJRczCLsNpYI1SJ3kq7c
R3Rsfza7BKPtU0DjqOnLY69FiMQOUiSDAzPzNsJH5NP+tn3GCqYBAwldhN2aLkIYleNTA8e8jmKE
+qlPD7Ciisid1quvwAwvWgXGMQHyhu4/HqfBEgEWVMJyvInBFcnI0XBxjwF8AK+SPB0Ix8M0UnMn
o0GOoRj9FJUnmo7S4hL0KD5FE5yXloPHOMuz4Ch0nIrQMYalI1R9A7x77Oy8ytIsWCESioA14XwU
rBDT7Up+KsxgD6RbR5jiDMNSbDQcp8Is2C1L0ywFHlMxqagHoBWAWahDUyjC4h0BIMBiNCXCS0iD
BQGWNGTGKDah3gN2wBAYLIPIPU17Lp870PWj8+H99sGYs/+h9cF3rV/ftH19wzYUh6K0u185h/mW
Qbb59jX73a8cs+fMuX65Lpfq+PFO643L+/q72sO9R8aSTd9/6xlLeH++1/HNjX3paGPXz4ef8u67
3zSOQT8t2/dfu57yTaN8ey7tgpXTbPMw54Vhz0kr7OyGSrWWsUQjH27RabCQl4HKpoF+tpwAnJO7
BLC4Z0tN4fRSetqMUNFTs4w+/llgsLQ2DaqoHJxpOPc/0hLp/9EcvstEqy6S35rqvywZjaoZrF/9
euHCUrHBEJtAkNdpgsYFajEkETqHqYdqr1camwa10SiOhsQkReY1xKcNNvQYm4Zg/oBeVCKEMEsW
uQthz6+8oInKAQAL3BkrTu6YsSFfLUaLw/pDUehTEIh29/X1hYIDYaYPHCJC9wSjPUGqJ0ShmSic
keeFl9BMr3phiJKeql5FS3oN28pLeoWt4FO4pLsv5I/Eu/rCPYhd6O73f37q+D/++vUam/OX7t6H
vv6+MBzJHveHBJ5PPDdl54ZDoJ33SqfxuB9gFBZMv/SGemCoNqQMH/b41B+dTzefV6VkzPsjrkyZ
G5n6lBKhOotQYrCCTG8eZymjhwKFjz40b2v9nxilEpJwoqZOWuburJRJidCHcXwlcGCqQ/tRVI7s
5C4wWMimwbQiiWHLKG3UtC6LMGpm0yD3EuLNFDiduaX6EiNnEaIuQsdrcokQe9uKlbfrBFjaEkYi
lmEjAFfFknQyQYFbUnARZ6kwjQYkcBQWKT9YVKmEM8KEGpqUp+pJtxx26omFDzAxPMPYbPbXX37l
wvnORAycFRunGTZCoQEYuknJm8uH0O1Q/5RVVtOeIR2D9lTg0DxaQqNDQEogGowiXRH8WMBAFaME
Iwx8zp3igyXaNLBKFyFj6CKE5RJOL0MRloAhU8dgZZGXcsYBFf2ZltGEG9oxDHlzyQ4UfW0b5cHy
2lymaTyJzJOhYVjbgvlTbl6uGk8AYNQ0kqgeSzUi0wr3EO/IZW3jGfd40pIbsg8nXLlB+2jGnUs0
jqcEExxHLnkYWgxmOsYzLbnh98ehm6Arl2pD2YUw9TkebJR8sNKCD5bYRcimdYwIj2V9NAkEeid3
sYswr9AbH4NjaCHEEEhkewLJaDSmKRHGUInQVHbNPHPSi0mgHk2Y198IcajoLIncNVE5itGoCLDg
L1br5M5oxZcMQQ1m4pFh4tRvkK4rDBajF7mTScpn95Qnmq49RzJRxHWbiwCrR+uDhYxGrUYGq19k
sMg1C0wZCy/AAssBlBkIJ6DUPRR87Ot91BfqDsUeDQR9IdYXiqGJ7RNnxKnPMOMLsspTOM+q1mdV
O2F1m0grsPLTfr/fH2L6ArHeANvbH/SHIhc7b77y/IsV9Q4fGNsCDOSuwGrheH+Y7RmIqs6E1Z1k
n3q5tP/uwEBfJPSoP9AbiveE+G5/rDcUGwjn68LDZzznFVlTPkJTG+EQyu9B1GD97g96kbsJ70XK
n8b/JLAYgsLHDxD1T9hcGrzXuS9oMKky5fBMLLLydDLiJP8GkbtoNGrEnT6df29+C/5or5HBko1G
FeJK5TXKEA0VSYJTCWApDJZVHZWDvSkkjA3YjN5YNJFkY7FQJMmkk3Q6DgOMI3GGzbAp7ZREkzyf
SjNJMMnL0by4UJ4Hjwk6Q/kpnkqkWLB/LkGx9bWWV55/4eblW4PcYIpOpOkEF46BR7BykuLB3uQ9
6A4nv6Qc2nBQ+bhJgLEoPslkUkwmHo2lWT4FBq2oWMgDHymUuqMWwhgV03YDaMZCtZO7KHIXS4Ru
TuqZjxlKhLwR0aIS4dLFZRKD1YRKhE5onQBtugDeqshxzbnhD0b5+txgPWz0Gf4UepKB+STqjkw6
coOOH+46E5GOHDS1aUWtAwB+NaAezCYIlYQQnuFW6JU1fBTBprYc34wccGqQ/7s3l3KMwzwM1Jqd
tiAbUtRnkLVwQdskfRZhTDQaZUxLYAZbcMG7VV0ilGktfOWIfgbbBfK4i6dGNKJ1kcG6LAEsTjEa
5XijUTtD9v3CB0vnM6MyD7FR5lk5ixBxVLzig8XITu6iBouTfbCwIjCGrME3aAR5rD8WQ/T3En2w
lBKhCLB4re/MM8jmnuFjJGqwcOFuOhGu3EWIRO60zgdLNho1iNwxJIHPrGHNeBqaQddH4Cp8mBhg
jJbIhy+KUT5DFIl6rFUPVAA7giEwADGW4NEVBW8ffAiVdTakU4YiYvARgQ8K9gSgkpkvSOUpnAXJ
SYJ52wJMmKog/u0Y3inOeN3ELd1QInyMyp0qDRZF7lg0OGQGcK2O5PxvH/5zwKXoYHeIw5FyIc8X
pMx6LXEg1ZfHV530pvQfr18pEUo2DYqTu2lDJQZxYt6jArCC6rBnRiNypw1dhNioHIPgQNFgMWnR
aFSKyiE0W3HkiA8OL08htfOQWtPxwXBEt0CBwAM3uzyNinFM3IJg7uVL12NI+AzF5oI+TKCRdEY+
JAn/s1i2ai/0vLGoypAVNrgsQqVE+PwL6i7CmNSTKL0FnAyFTSo2DYMKgzUKcybqc9mGXPZobrD9
SXwP6nx05LId0Ld9sG2cbxHSL3JDR+GaMDewFXk4IxOKtBPSXXBJOwqKrhJDDNNHcsPvwzyMDHS+
QEamyDsw+z6yzGiDgTnpxvGMcyTlGYV+GVawnO2TjEZZISpHLBFyggbL1HLd4N+WlEuEQlSOYjSq
6wbAQwTj/8IsGEr3C9eWt4TvXWawrmjCnhmCXMlo4YtxwyJZm8bxdlAk5xRtpI/KB4uTAVZx8SLp
JVyGJkP2lCdZueadjCnRtCYqR+PkXm/XlwgZ07wdBuN2xpP+krTRpgFbHDEAEW1UTlRl02B7RQJY
PQFK8sGiFJsGbG85pqkqio80yWv0QIirwwhizMRA5gJkzVPw1sAbBG+zD54/9GyUAJYV6ZTVAAuh
UtzHS9RH40ZTo5TKh+dyKLPQbmJENGUghwhBgVrHczWDhUTuKoBl7qWOtdoy80/HabZMKKvgs3hr
UcTzzFtJzNPYSIjdJL1Nacav1WABgGXsIsxXadX/KtSeHVIXofJvEkuEOpsGRg57jhMv0zijasmm
QQh7dkANluDkTkwz5PKlz+azaWbIDfmYvDbOTLYCu42ECikPARaSwjRoAFZcBFi0iS7NVCVDk/v5
aaJeh8MmFOEkySKDpYrKUXcRciLAkmwadOOx+hNDJcKlOh8sONM2GPsgl6rOpd7PZY6gzMT2XOrw
WGIXJKKgUaoNAjKYwN0+lhDMw+rHEjYUiWFBoWFWFJthEZMwBt/PpVqFjI2xpCeXactlDsOIi6Gm
EbB5Fpn1IyP4Eb4lwx5KUUefJDxwb8nGBHRyn9jT9VjqIuQQCjFosLQaamx0sSC3km0aFHsnEy8G
o96cieNMGQghOYxp0x+sICe0PlhKVA4xEx3Lt+FPg8OVL82xo97tCfmIKj5YiMHSO7lzepE7Lv2a
BLMYgpCACIDi+A5ERsoiFEuEoshdiMoxdHHmsb/nMeo00hJZg6WlfHx4vbPWyV1dIqyFDNbZC5eF
EiHGaJTk/aOrTOUDQ4TKF9kaymjCiU/mofAiJNJ4FoDYcSAoACz4lrUMlgywxJ4AkS0giIF8pGyW
vNYJpnVAH84jymfs3dPlQJM60TCKeDjJAOuXLkMXoQEy5jFSJ7Q6+ki8o4l1rclPBWsoFSREH5Ji
yM01+HjpmPEHhjlVdReh4INVg0TuJHtYsl1FFNP7Kdk0+AS/FR2DxWi7CBmDBgvjB6NnUCSbBsRg
WR2i0SgdI2pZmPyuhrwuCIzGLWQI952kTi5Cv5XwrhGDJWj24w0NVgVg0aJdgli5M6AiA2QhF2sM
Nt+8MeeEJnQVEARYog8WIxuNckIWoRZgqTVYHJ7tY+JxtQ+WArBc1zqrVq8sGAewCWb+tI4n7Uhr
hazCMt7xlDuXaR6OO3KZmtGUFVoqZJozlB1KtdKtACc9iR/KZT4eTbaOQ6+vlvG0F6IoKFq3DnL2
8YxrNGkdTcDQ6HG427pctgqWJsHmGevVCweaGzc3OlffvWVDFmVeps8uhD3DEqFGg5V61ogbxSBX
8cFCGiyWo7Vhz3qOxBQfm2iiMTyWvm1NcnJPqn2wUMUtibeHYEzxHINLSzT5jeHLoByeahXklTKD
JTi5Qx8sUeQeN4rcTfooadNmAmwhj1Sq06K3BCMzWLzGByvPgTjMHSChusrj4refw5ddgjhRjmhU
yGh8sASRe50AsAhO7lhPIKzWB0taPJuaBzMM60LZgs/QUIY9JZxdJ2KwaB3AekVhsOBqSolQZrBM
XCJJBtxk7RQ+pZiU94dpM9SLr336z5MiKaXkJXkAlqERjxSEbKiXUXmwC0FjpMZJPixNRYzuyRfH
STwNsxquL5+Jrk/7vQxowp4FDZaKwSJ8CMS8agPk0ts0BKJ9sg+WNoVQaCo0MVXHlqhEDRadko1G
NRosoqcoZ2a1ZeKIjSv35Jf6StdNXdQPbwRYTNxisb2mLhGyCaWVz7zqR9Lr4EdogpuihmYwbw5Q
dREabBp0RqOKBgurwkFDJh5gXXIvmD+Nj3zAh725rHuQcQUeu3OD9ru37NcuVj6654b5FkMtj+67
Lp2teHSvHsmtnA9/sF4/X3/7qg1pquqivtZLX1TevVX9hGsbTdeEfE1dP9k7z+3ufdDi72q48kVF
172jYOfDcdf3tz2dZ+q77rsADrt5pcHasI0eaFy1bG4y2pzLuLiAG9NFiPPBymO2qfXBQhosVtRg
0eqAHY5svI5VL3H46pv5j1zyl5JtGqAGq2wxx6oAFhZL5bV0x2NBXbKh7I0izvCqGeOZi0ajKif3
vh6fzGCJUTk6HyzSf98Ym0Pj/xR6VzMTN1QaG/ZMsGkwN9xnngGJGqzXnjOO6HpfIu2Yp9FgwYu1
2EWI02BRaid3Q7YgbqQhWTVilNGUoUufXHczGeGM4hUsPWYQuAglQvA2wZuFb1koET4PGSyxRAi7
ASL9YVYoEfqwRl948yQdm/IsOTOU2fCvLyBSRDqEVLMjk2Q/dkEn93/RarBEJ3dZz2TQNvkwuYdE
xs5n8m0aa8Fm9uv53A2wrK1OXJ9H6m5SPTSStZRRJ6cLe1ZnEeZJnSIgNt2aCGBFxagcISNBrcFS
O7nT2rBnhhAAoh1+pCzCtEbkLqoxuHzuROT2cpMhiiFElBhb6GlC+p7qyi68dxFgobdjaQAA62UA
sAQ3L3yJkCH0NP1fTCY1WazHj3ZDtchd3UUIRe4iwFL5YKm7EbUfssBgaUqEyAfr6gXH8iXz21u2
bN5Umss2um1b62s2Hv9439pVJfe+sSwtm93XBZ0a5sya8vX1mqVl87+8Yu395f2Z06Z891XD9q2F
pz47wEedM6dNPHui7sCeZQ7rzrGMu7RkdnXFxtPHD/z3n/7j4IHVX5yqe/ONv/Q/anba1i8tm/Xd
7cap77wZ6m693llvq98OwNyWDaXHjhzIpR2szz5ZLXJHEkBN2LOJYZL2Z6ZmsDRO7gzORwojM3+G
79Gk2qX9ectZhFDkrg57FoxGjbk9JuIhOq6XbT3jidHxPHc+itGoukSodBGKRqO6kHKM5sw8mdGM
NMK4thKQtCEqx6Fxcjev5uPlbqaIVpp5Du++qBP9qMZIkcEKSQBLsmmAXYQXNDYN2hIhpe9ZwxYB
sZ6Z2OEKJ5Hx4UdHimhkqkUSRLoLJz8Cb60/KAGsoAiwBAZLLBEqDJahRGjSkkbAkYTuuah5Z5wv
SBH713D+Dj4TTEMQipGNRikzgscc8pphXEIHgxae+kge8SbfL7Z4R4Zivjy9hCT/T0IxWvp+B5BN
Q7do06BisIIa54U8b0S7gk8HsITvXTEaVWmwdGbu5NtcEtCRNViCTYOiwSJQXzyJmKFJ1T0Ofz0l
apkJGAivrI9rGCytBksBWFKJEONeweDKNyQWjX5meoO0W4O2WtFgiQBL3UUoarA0AAsLFBglKue+
WuQ+6Lp03rawcKb/sWfCm38bjjt3bF5x/9umox273n37jR/vHB1PHx3LHCormXbq87rRdP1nH+3b
vKHkp7v2//rjv926Zs+wH+aynza5d+7auXIsVdfzc+PM6e/w0fqNG8se/dQ2knQULJh16WzNWKqi
aP6MG50V331t/fG7lmG+fcrbb357y33zcn1DzbpcxnXy0+rlSwsA2osHHJOIDBanpjp0uhleW5mV
GCxO5YPFxiXvBh5b/sMyiAyuLszEiWIjM19Q0cldBbAgg8UbO9rMAg3JSi9SiRMH5YnITBuVo+4i
lEXuegaL0Qg3eZwqkTeJIDRK3ExUbqqXJAYrJjJY9fZX1U7uOikCTp2JD6U2+fTELkJdccFYJNKO
akYN1oDOaDRA92md3PHJhibElUkmiYkey4SvCpJcl57FVAlbzaR0DJZKg4VKhKKfBU7kTsr+M7Av
PnWOL2lbw8frM6apmBe/sMQMsQqm/9xgiVDdRWgwGiWwiRSezDP5AQQpszRD3e8qQBHVV8RfDqX3
izeyQepuUzJvRGhrjZoSqyqj0aDKpkHFYPlMQqnN+wpVH4umRAhntDYNtMoHSwOw8t1uKkyApMGi
eYuQRWhxKE7uWCJddQgeZzaIFzaZuymqJduMqQ5GOxYKH4IMsBIqDZYAExWAJaMT+lncCOP5Ik3I
LVEm1R+DJlcuEUoaLFYJe1aiclhViZCAUwUn9yX6EuHFcw0lJfOGeGfpormHmrbu3bWCi9Tmsh8f
/6R67qz35sx695d7rYvLpl271Diccl88V1NUMH0kZfn+zrGCeTOmTH6j84uK2qr1dbVbRlIVbKBj
0ltvxkOOLZuWBHpaRzOO+XOm3bxiG8t4F8wruH7FevtG08Ki2evWlvzxP/71x29tX8NAw7WZuPv6
pbqS4tngrLiAEwuwRD2WMceaIdoXGaJyRB8sjBcrY+gEZAy/Z3PrgTyG4HG1k7vsgyVqsIw9HFhB
ki5Fh8ExZ+aBCuaFRWWKiS0R6i5CwckdybP0WYR03Kzl1vyvwZjy2XjlO6eJytEyWFIXIYcXcTKk
CwWHsWkl3C89R+A/iPfcAoMFvZ2kLEK10ajeB0sAWNjEN1M85DN6iOOGfB+xXGKMfzGNFskvz9Ir
nyQGS7Rp8EldhFWCyB0NYKhEKAEsIuXwLOOixuHTF6SeSRtkxDQk7TwpXA9bddXCMshgaW0a+mDO
HYPztcIIj3TtFD6jPyf+/KOmPyqKKGUjf9G+IC690VDKNAKvXsyaBEAf1CYW4L5E2cldo8EKMoRf
Jtaxwsy1q09xulcZjQpROYb6YIKJm+mfcGOG5OQOS4QWlQaLN7ZZkZz9sDG9Ji1XJHdsc+kYgSsS
3rhW5G7TAyw5W5fkG0Rszn8GbS/zDD2VDJGKAwAL64MlGI3GjU7uOGWu7IOlOLlnRCf3S+criotn
p+L1F8/bfv+bf3I6dicoi8e97ua12pGUffmyoo62A42ubfv3rhrkqutqNzntezrPHeho2z2Wqmj2
7l6zatGXV2sLFsweTzuunK9ZunjhYLxy47pSaqBlOGEtLJx15ULVWLpmYfHMzz4+OOWdv3x5o2Ek
8+HEt966c3Pv9U6rrX7L07S3rWULwGRDsRo+1IS6CLt5qUSIsghZMez5GWGNHJUjGI0+/4LKyT1B
7Jagn62wxZiEzJAHcslo1BCVgwmf1qR2mpwDY+4HZpqvTDbwNHQRIg2WEpWjc3JPGiwPOGyFGncb
ZgIHubxlepVNAy8zWKIGK69QgSF0M5go3xljVA6x7qDjG2gEsEQfrD6ZwSJlEQaw4Cmv7ZYeDPWF
ma7+kABZwF1490DYH6bB2OAbCAXAjD88EISxtQOBSHevv88f9gXRFJAeA2EUbqN5FJaL6wgLA8om
8lNxRnwUVwCHAycDPgofrLNQ/iB16ouLr778Kvgo+vyRgSAFTqbHH/ZHY119QRSGo+xHmtEeQj4r
ebn+DCPy0z5hJ9ol8s6l/cAlXf3RR33hngDV1Q9Wg19cHxaYkjwFzDs3tUajxCxC3NfqM9JsJu2B
gWdw5QgacxgpTKdqgCKKq/JzfqaHVjma5u+XJAB9ycldErkjBkvxwQqae3BQ5t0AqERIaTRYfglg
6X2wBDP3WL4igv6WUYnKgTYN9tdeVHUR4tUMhIw2Om84iVFWYoqimHwwSNBgGQCWxgdLZLA4rIs9
Hjti36Mi7yWXn0jsC6lxTDEahTYTCcjAwbEEjCKvGgAW8iWKJzRO7pr3AjVYtDYqJ9MCZm5ecixf
Og+ArUy85c2//+Wzj6ufJitvXnEsWjhv+bKCTRtKY5HmJNW6enXRymWFa1eVDcWc4V7LquVgvrS0
ZObDe+6xdEt1+YrSRTNWLC/5/hvLaKpx767FUV9rLuNatnjB1Qt1uaH3Vy+f8+U1T0vTjhnvTaiq
WD1vzttfXbPe/dLlaFiVG/5008aSsyd259IOLuQUABYnMVgagKUROXEmvYS8lOus6iJUObmT/NWY
+DNlEmMNM7WAgMdQSqwOYHFCFqGp0gjHVHGknxOPA+u8Ia3BNGVZZrC0IneZwVIbjdL6EiE+Wdk8
LIuktWLIFVJGWyJkVD5YkgaL11mW5APBBF4TcxrPEQNSCNHLGg1WEOo51ABLo8EKiiJ3X35rUIqQ
/qY2SGQAOEDALgwgCzg6AFi9A+GBCAsWPgYgBgztYWYgwoDxAyzshqMU0xNixQnOM91oSbeynFFe
lV9SbyVuKK2MdiKs3BuEddJuADfDsZ4ABJpnL15+8fkXKxucPgitoOEQmB4HqId9oZ4QrTuQ6jQ0
h9Oem3i4bv0bUZ2MeqH8qJr8FN8fif/c7UeG8pHeAEBdkMYwVUFRROG2gevSG40abRpMpFcGBO8j
0oe4cl6QMhPwGR06SI2NxvYOrGGEiVGZiuX1EXIANcgvSDRTQC61SonwFcnJXV+sx1OhxrZZ/WoI
YKl4L1mDpU0hBI9onCaUBpg4yQoIIJKExGAhgKVycifdrDMmZQsuvxKWwZXhGJIS34QW4vQaLNRF
qLJpiIlGo3oNFlaW8WwwkUTR0QT3VAYrClEWQqNRqYtQz2AZS4SGRkhlmGFxXYSDMNAmGXGNZ/5/
0t7DPW4qex/P//HdxDWFwPa+wO6yhYUt7FI3xd1pBNiQEAgL+6FDmh3HqZBAaEtNc2IncXogLHUp
gSQuY03TaFRmRhrb6c2/c++VNCrnXnmfnx8982hkjXR1Ve6rc97zvs8PnNj02xt+3ncMANMTI2f+
PWysS8dWXhnecunUmovD7adyr8ixFafzGy4UNo0MLz6b36TFVxeza0fOvAArXDn1amZg/bDx+llz
1ciplcXshpEzay8Xl5zRXj9rrb40vNJIrbk8/MqFwZe15EtD+ktnCq+eK6y8PLhq5PSGTz9Y1VB3
23nzFQBkeUdo1FVyL+YKNFw6ZApEIDGN8rBMQ8HVwQpeqyaSLgwifo7zZoB3aGA8J7vlJEXIlNwR
mQZeADjsMCMQWeVJ0Bm4lIPlRaveVKZTReiJYJWU3FlX0GeCx4sQ9VRGJBJCkbkwJdQQxb/d33qt
ciix0iM0inLOBKQIkWm3yfEiFAsH+L0IQ1Y5iBeh7AFYIgWEMFUZH/zsIBbsNJZUCNKC9+9kRkop
gF3601o/KetT+gk1SoGpJ5HpTeps6klo7JNMzoz3v/YK2PrIas4ncV/O5vtg5MsW+tI6YL7Obgaw
ViWyeo+UOikl+1LKQAbalo3Jmt0A/8bRT+/XwJLA5F0Y/gmbEplcUsnDZ19CYeGrvoScUvMSz+BZ
IFgaLsqzhUZ9AIukCG3OmYgqjkXRNIGEgZDUr4XqSYOwSUKuqFFd8HiBLSYxFRGg4uh9hCJYWkBo
dMlyR8ldXHOQFtbGOrtzOFh2mE1yqwiNAmKVI7A15anw2VWEzCpnFWKVo/ONxnQ+LVfHxHh0Ea2V
awkn1HNnKJM+i1kSzU4RHkQ5WGFhbkGhlsF5WAcoHYYwqygGDd4qQp5MA2aVEz41BV+KsERyvzwI
SGvtwPGV/1xU/+Zrj18afGnk7NpL+U0jp9oAe42ce/l8YcUlYoazhqhYEQOc1y4VVxClq7OrR86+
dGXoRbK1UwDUNpB1zq4bGd44cvZlWOFCfvXl4gtkF8RvZz39CWx8/UUi+L7+yuA6sp0z6954+eHP
/7NhZPiFy1arlWr1pgjpQO4CLM41wFXKtSNYVT6SexFRxA2AIU9i2sLIOlZYH8TgJb69LfTLNPiF
RoXUQ45xMoYSglpugpoM3V9BaXhI7pjZs01yd7RtizmX5M4XFharkPBuDVTWJGzmzVKEhpMibHUj
WL4fWjwznECmMqDkzjeTGIMY13CIxrZQoc8qR2MRLF8VYUCmQQ6Xv2lR1HUtZFZDYkKAD3qkNIwQ
yWwOAE2/lE4p8Gaf7U9mYCEAL8nOgNBhXjZKUyY045kSmdKndwWyJOMsyThf3R+mlaSc7YvLvZI8
kMgkUplde/aXjyt/eklLWtFSCsmcJtJKIgM9pkrprL3xDNaGTLAxwa8ZfyNDy0tbzgQ3Am2LwRRP
k+iIna80Eko+BFlGwXPH8mJMpoEvNIrZIfOMgGQtwtpP5maQRTWDYQpUWMw2sDBUP8st7RRrRiCJ
zohDo0ruOV+KcPlKn0yDALCKKjQ9Zs++855FAJaHjxUcOfSQ/mfgldGTIlyxor2KWeVoefxFM5Qi
sQRFWIjMqcmvsytYAeyCv24GcygOvgwCrAAHC1fT5gt2c2lnOkJURwWHLFQiKEQFK6UIvVY5XqFR
w5ZpsEpuP2hgksTwQmbPa4j1cnE1sbU58y7xBzxDoRLRF904Ulx9yVpNRUHXwpoXCitGhjbADy8X
1xPFdqLw/gLxzCFbe5GsNrSKfJ7ecNlcR8wHz24kvjqw5MymkTPw3zVXiHv0WoLMhtcSz5xzL10w
4b8vXzBXjQy+DJsqKmtuvpkIjVpuBCvvUXIPq+D6rofAdVsCWMwqx0Fd5qhyVWFnQD3KAsEQV2yU
OFhVXpmGSM9mA405cbKW4cpcg6+whdagMKHRHDN7JpEqRnInAMsIVxEOcuUVIoGXISZvcd1RXSV3
D8CyzZ73M4AVrqQR0M4QxXnM+Mv54RhkbBByTVgEq2SVwwCWt4owQHIXCDbyeLsIPUUDaMXYVwCh
+pNKbzwNA8Px3vi+g+9t7ejauWvvjq69O3bt7dqzH+Y7d+/r2r13F/10p110CZn2ONPufe4Stj6b
IfPuEntTewMbhCW7uw907d6/e+/hA4c+OHDgSHv72olV4x/91xNdXd3shzs69+zu3r97z37AXvZ2
3P26O/K00Flir1P66pnc5u3y/8S3cc9hdu092Nl9oD+eIng0S6JZAMJ64wpi9YiQvjVJbJ6Y9kWw
+p0IlquDhZb7SXguD7cbj64k5aWVcU/DoEArGveSUN9GOUoAQmSJ48V2mkDoIeVXcmcpwhLAElP1
BU3ymz3bSu6yX6ZBD6iMMg6WUP0v4AnotcoJ6GAJ6FDYG7bFe+yK9DaFCcFgbMnEBG9CHCwXYO3z
Kbnb6CQswGiMLmRi8Gvp/XEOS1xsFQK4g3l24vwyDcyL0Cnp8lUR4spM/giWp4pw5MxKAqoAJwEe
OrXuUnEltbVZQxygh9cQYxzr5ZGhTRfy60fOvUpsB0+9RHHVWqr8vpo4D1obqfHzWmJZeBbQ1fqR
QQBqL1wmAu7MhXAThVnriKEhoDfmbAjYa3gdNS4EWLZkZHgjwC9LecEVGqWVg4zkni+R3APmdCHJ
0BKyp3Qrt4qw5EUYJlCjtQg8E2JBjhtB3qZHSCJURWhzsPh1HqO09tMF3D6uOALK/7OtcrwpQsMs
CY2iOlij0gTGQtoG9rIhVqLyvTiZfqFRj5I77xSjTxK+uRCiLkEAFmKorOJClHJAaFR1ZRqeW05S
hMQqh6YIiTa0V2g0PQoiM6/Qz/OTZDYvEeYT4VrBfk/0SffMW1g+tgwGoYpx5eOrquGzsqwCpopx
ZVUVlWQqZ1NFab7C+fSuUOFZHlitvKISfk6m0hL4JLsor6yGxePKYL5ybNm3J18NdwI05vvf/T70
RnU5aUl1ZRWsBg3z7cW7wfJK35bLsXaGV6uorGQrh1fzLakoG1s+efI1b2/piKeIrsRASjspyQCA
/EoQpVMg8QoRUGF9kiKM2RwsnlVOmFSOynOg8Drt0URAYISGy0qFVUzFqmOor1+EfZMWoWeG1LEi
Pk5SSD8iFbLKsSNYOLuLxzzjxgXtFCEjuaepTIOsOQArj0SwIgUw/TGbIgqwtJzQf60wCu8OE1Me
j/oqrgPHxHWcfmAyDabf7NkfwfISmAx+pVg444DSacPkGJzVa3KdUuiapSpCN0VII1hMaNR0ARYN
2FgC87Wcv4qQCI0yDtYLBEsBkDq1auT0upHhtotmC8VSNDRFwNaGkdMkl5fPvHmmsMHMvnLyi7YR
YpuzmvzkzPNU6n0d/bpiZGg1zQ9upJaFay5YK+FfxASaQDG6LwBtsMGhFy4OtZyHHZ1+jqCx0wC5
APa1mfJ6CrD6zFAEy8JAtoWGM22TcqeK0AewBkV2eAIGtCEoJDRFQkolOGhHsPb7IljF0bK/Eck3
zB+dx2pCIkY4YisBLN1NEUpeL0JMyV2IosTKonoI3xgC1FjCuF4ld8rBWhWsIjSiAHS4ssTgq9aV
rHJCKgD4+OF8pfR2hINFSO7dgSpCzItQJPCocmWQCHMoE0vTyFlSIbtOq+msMa2uuaqy6slnly5e
tmJZ6yoYihYvb2Of3mlJy0r7s8Xzr9HMu0tCKyxtbYfpueUrn1vevnzl2pa21Q8uegQ6oa5hxpJl
rc8tbbVXWLaitIXAdkJbXsKZL7XK+WTH4juiltIPvb9tW7X2Zz+79ue/uP7rk30AsPpI7ErviWcR
DM1nskvcwImX5N7f7wAsEsGSR60KgegjqAIhA8FFgmililXXUdIVz4gw0k5RUIcoCwoFfPWMKZ9M
QzutIlxpW+WkMQupsK6HMNMap1IadjkwU3JPe4VGg1R3H9EEzXoYAQ6WLdNQEhoNW+XwmKT66F4i
/Y/OUB6EL7sssjkrBJTcSYrNiWDBy1KwitAouBEscQWZJfBLMXj67GHtSj6J3hfoEso0hK1yXIwY
zjb6qgiJ8R+rIrxsvkAIUqfah4wWEl469zIhUQ2uHTm15oK5buTsqyNnXz+Ve/zC4Jo5s+744L1l
n3zQVlfzx5Gzb9gGz4M0UXhmFc05tl4wl18Zhq8vXhxae6awbuTMW8Td+XQ77O5MDuBU68jQ2gtW
GwmVAbw7/TYJXxFB+degSReLK7TEJlcHywoIjYrFWvVgyMELsEoyDWGzZ7TsIJQq4qpnRXtlumcT
gAsxe95fkmmA01e0uHpUoyyn8BfNYdceQs/nKxeUOFi0qMLxIqQpQhdgMZkG4p5ejGBcjQKzWgIm
qFHgcTRLAItVEZZShIXRvoYh1lUYOdIPwsaMro7Mm9+xU4T9ThUhMXte3uatIoynNcwqR40Qn+S6
xZGvhDxECwlhCE9l8ydjyZRi1DTMmDhx8rETffFUhhCe0tl4Sh5IpNNZncr86MQl0Ds5SyTiXaOz
acD/6f0a/G/au1CJpemUVAbS2WRG7dyzr3xc+XPLV0jQEkXrlZJSOhNX1Bj96m2Au3e6QYNtdsCz
F3vyrF9qfNpd6G7KKDUs7dksXSGVSk2vbZgwfmJPLN4flxNKri+ZTWStoORYwFtGxuo6MWWBEsDq
9ZPcI2E0HjfVuAFUnrAZT8UUs68OKvinhVaVQimvKNaXGqkuJmGyt14vQjuChQCsqDbwesnLwco4
Zs/wruKTafDFsURmqL4aeHvG9iJ0dbAckrslFi7HPfs479PBF26TX5lYQC0vLNzB0AwLjdpWOeUV
B7gk96iMBi8Xo/MkpKMCdTrn4U5nSBUhBVhWWKbBAVi+KkKD0+acB2B5U4TnnicU9XNv7dqx5N03
l86ZOXVd+yLCpjr9ws5tz82dUzOjadrxL1/44tOXr5ow/vm1D3/2n9U33fjbZ5969O5ZNQMnns/0
tX90eNnI6XW9x15+f/9zI6df/c/BZ9470HIqv+WxR+pmzZzWtvwfI+de37n5uW8+axkZ3tT/1Yud
WxcMfLPuvntr5s6uf/OVJy8Prh45t+HKEIC8VkN+0QZYOdfs2U4RhvQ7THFO1kkRlgCWu1AkYMbL
wYWCo4gcfERJaYnkXkm9CH0RrFHKdYrRCU/GiZeSw8NLQascX4rQUQYp5hyZBq72myCHborelwy+
4QFOcifRwZJVjs6Pexn8l6Joh9ZSBEsblcxmqVZLt1OEaU+KkJHcKQeLaBak/VWEvIK1YLBB5OjC
3rwJ/zfFHEX0dCY7vbZx0vgJ3/T0D5BaQtowqo/Ql8ryXPwksZg7ZsYsYSlLouQua9TsWbOtcrpt
odGkX2iUSjYYoyCfqRzQyV/B35+4EEYmV1PXBFf8lyd6Y5ncQMpIyjoFfBqqxCGhaTvP2QlEhmwd
LI5MgyTQiRVoXPFCVvLo1bB4zD9Miwt1+5Y5UaLRqE7IGi6OOgprIJfkblcRes2eUcNEVLjBK+jv
9adiMg0BgOXlYBlBjMUltmNhAA8HqyQ0apPccT1A0wpToziMUa7QKG4gzZGk4jJLOBGsHDV7DkSw
7MJ+vkw8auJmRJHG+DYsFu7dgYwlNsAKW+UwkjsBDY5MgxEc9b09VsgNGqo5e+bszz8hNPbLxY0j
Q5sIcWp43aXixtP5p+vq7pw+/Y6B3hfvnlPzzluLM4kNN9/0q3jfCx++/+JDC+9L9D/2+9/+/t+v
/+u/H7dWjS37z/st7W2L5s+f2fvN84semn1heM1zT9/30MKmkdPPNzfW7t/19NLnZi1fvGjkzAvN
DdO/+WzTW68/9tCDTafyjz/z9Pw1qxY9uGDGqraFQ8Ybm55/iOg+EFGuf48MrjRTa9wqwgJVOWcc
LF8EyxCT/xzOk6vkPnYcVXJ3ZBrCNHm0+IDHtQpHHwU8J18JW555EZII1thxJQ6WztcLEBRPhLiG
EektXuI7xIn0Co2WqghLQqMFv9BoEa9GFFcQG6PjZvH8bbwRLMMXwfKYPZtYfWIhCs6aSP7Uv9qY
AMVYEoxkiA6WU0Xoj2AhVYQBlSBMoBw3cXMHDPbyTfYL8zpsXM6o02oaJo2f+M3JPiLWwMhhKTXB
AJZY5IknsY0hLVQP07XKidOsKLPKoV6EK7lehBzKjhTJXA71jITKK6Ai7wRgNQLA+or0Uj5GAJaW
yOoI+xu15fH0jIT4E5eqCF2Se0K2Se6SLFTPj5S5Sgu15kWiWSpicRNVDhlJt/Iro4bsntIcl0AR
KAzXKtpehE4VYXvJKicsFyejFDSe46F9XFTz1gOwmEyDV8k96EXIfzXExhUSwSrJNBCh0RUuB0tM
09YDRV5m9Lssz8iCF9ASwx1XpsHwRbBEMg3iYngjSjhRIFKvC6rMwkQf0y80ylKEJZkGN4JFAZYn
RchXfNCzal7T750756tPW0aGSZKOkqvaRoaYINbq6VNu79rWcnG49dDe1ppptwE22rfn+dWt9y+Y
V3v3rNpLw8vrau749OjKj99fMn3qnZeGV+/btbK54c6LQ8/fO3faR++1LLi/ua11wacfvXDnbX8x
lHX9x9e//NLjK1oWXvvzn3x8tNVUVt1/f1Oib9Udt9+STb6xY+tjd95x+733NB49TPKJF6wVJMl4
pkVP2FY5xPtSK3ojWKZAuDL8hlDiYFGz5/2ukvtgUKcUrc7DgqZ4Li9YxigAPXAUgSpCRwdLdMFw
KErBXDP2PoO47oRgR6gzMQ4WSxF6dLB8QqMm7kZghDw9dWyh4I7D4+J+JXcbYHl0sFAaIiq2YqAW
XibXflsPmj1rPlHQkHOOI9NgR7D6A2bPlOROUEWamKV4IliaiAQTTuiEcxx2kxjAysWI95+WIhEs
1Y5gnewbyBh9aZq7TLMIFt8CL8wN4olDhuc9YJQCLD3NIlgkZ2dHsKArUqgXIR4p1Hh6RSLjoJC+
gMSnK8UyhguwBpQ8jWBpcUXDHVdkLdqI2s8Kt0nuHiV32yoHha1oyg+z5MMQVdjAGAMZgqK/NC+n
JlCQQizPRSFPEbrSuLZUngbYVjnpEAdL4GnILST0i9q7Mg1yIIKllVKEAcMcAxNZxjWfnAhQ3kty
93GwIiQYODk+S1hPxH3L5NApLG7VvfsgLlBHWERo1AewaChIaDUtdEVE6+ENYUhMIBqpB5XcrVAE
C+FgGU6KMJAWsbl0p03VIinCT1oIG/30mpFBwFirSCnfqVdHzq6rnX7nvt1t5wcX79vduvCB2f85
smzKXX9687V/7uta+ciiOeetlrrpd/3n0KqP32+bNbPugvX04f3tBIedXv3wosZ75ja0LH9o2+Yn
5sye+sTj954y35wzq/6x/5tz9MjauXc37N3zdDG3eNmSRQ8+cPecWbXnhp4/P/SyqW3s2vnkTTde
+8GRtZdPbTxntV8aBBz2sltFWKDgw/YiDESwDI5wmrcEjBa42SlCpuTuVhHiQMrEg7sGKiPCc182
eS8JlhG0yqF4pcjlsHNNCQtWZPv1SEY5z4THdGQa/F6Etg5WDrfKQbRMTS6T3RBG3QLIj7MmaYBd
RZi3ZRpcq5xI7yCBPSJH2dhCvAhRkiw2xLpWOS7A8qYIkQgWysnl2vKoPMEIpm5FXu5TqhvBIgBr
wkQKsPQ+miL0AywNVVzkcqURshE39tabkJMyi2ARTAlLugBgjSVmzw7A0mw9i6TjRYj7NPuggyQI
vAmCIsgKGhrBIgAr7YlgBZBEGhHSlAKe2X546noRHu8tyTSUrHJwXVkevgzLnGpIdSFfipYvlovt
nWtorXK1cHEghRny8JsqyZzTXdLB8guNAsCSDe6WZU7kLI2HSB0OlubTwSIAK18iuRseqxydU69k
FBA+k+HxItRDQqMil1zTQvU2Daz6ySNh4E3QWF6KFS/uFaBhhZ6tfg6W6REafa/gKrnbKUILGyBN
Eb9EFyrjGzhStAQ5nVByx2/2TDlYdhVhSKaBAiwrpFzgVCMOFrX8rBlNX3+2nASuhtdfMTeMnFp/
ZbjlbPH5S8Orp0+7pbn5Ljn52owZt2/f+njXzpa7Z9eMnNn80sZ/NdTfeX741enT7ti7++kjh9qm
/P0vpwpLu3cvnjblb+eH1u/rbh1fPu7joys/eq9t8vjKQ91LR05v/O2vrvvw8Aumsu7Pf/zDwb3r
zg+t6djyZOX/G/vvV586XVh//z+m7dvz1LDx2j/unXrsszU0fLXq8uDyQeWFm/0Ay5VpEF0D/s53
OFJeJfdDJS9CnaOgJpDBFEArIwSmubULfoBFOFiO0Gg47ivwskS13Q1cSB03DOVftxYDWF4vQofk
7so0sEtu0KuDhaMoE6sKxDyVsQichdcVlh4LNKbrmj17OFhogErn5+Lxakcuw28MZzxQeQODnSLE
AFZXt0ty91nl4OkwAQBCXvFVR0TUYBysVEa3U4QT3BQhRX7eFCHX5VDoOuIrdNdCCMM+BBdgAZqM
0eGKmT0/55o9eyNYYsCBE59VnhO2yNo5NPx7I1gxO4KlJ7Ia3uE80XaZq5B5rCcW5mCVdLDCAgq+
wNJo/PVC7stYayUOpxsLTIqLORDjJkn+X5wKo+2lw1Hb0k5TNskdU3IPRzplLPDJvZdVj5K7J0XI
qgh1X+DKLSoUZeIwNgmNYJmuF2FJB8sYRX01r2SJJxUhCB2FIaAuVAj0Co3aKUKLqU74AJYvgmVx
CcIBt0GxJQjqt+PpKEtsDOfvAVdo1PLLNJSERnNmMEWI5k+14qBmzZ4x46tP2wj1ipQQvj5y7qWR
U6tHhtadNV9pavj7Pxf9o2XZgrdef3LkzCtWdtOzT81Z+uy8N155esvbSy4MbuzYumz96vu//nzt
C2sfvXL6pb5v1sHMxaGX8/Krzz71gJFab6ZfXPzUgqK8YeR0a+e25x59qP751QtXtT7U8/mqc4UW
6cS6q6qq+o8tvnJq+X8/XPfkYwuefXLe9s1PEJWHoQ0jQxtHTm8yEhuY0ChJEVKfPh8HK6zfxhdP
8utguV6ExRL0j4pzWAhBR1g8KIgK66iSu0NyR1lchpC3JAju4nUAZlCnHtVJN+wUYVDJHQBWg8eL
0Kki9HGwcLcrEwk68lR8kUpD7vVcDJLcHSX3iGpEThcJotF+DDoGe3HXwikbdwBjOlgJjw5WqqSD
xUjuml1FCAArIYfe1HHf36ABMEaEtzlYaZuD5ZDcHYDlRLASit7rcLAkNK7ALf5CR2LcF5kArIwN
sGjVnsY4WIttDhYjuaulFCGHISQSLudqV2oiilhghUyulpLcWYowljISLILFL0CThGWDgZHbriL8
9vdws+fAdrDhX8IdacLCpBySGc80MK1x3AaFMVoRG10TVoREKSbw09/edDmzyilVEZZXLPWaPWOh
Nb8yhYZDW2f7wRQh4WCxFGHez77Kl2QaBIKfISc1EsEyXIC1qrq8wo5gGVEGzGKSltinmWujZiLK
omH1BM/jmx07FsE6wo7C1cEqeqsIdTHpVYgaw2xoI9r6gzeWeM2eC7rpSxE6kQlilcOgQ8iLsDQg
GadycmH2jJlffNw2cnrl5aG281brpeLTI2daR4ptI0PPz2q6a+/OJVTCahWpKwTQc6odlo+cahmx
VpF1zqy7XFhFFK3gv6fbSZJxeA1VXmgbOfsCFWtoHTmzdoQIh8K0YuTcpivF1pFT60fOrLIy7Q8v
nPH0E/eODLdfGVp6pbiSqI8SZYc1ZElx1cg5InOaT7X+8Y9/HOgjVYTeFKHpFRqNzLS6Su68CBZH
5SHalhtDJMHEFk9GBFFy90SwBFrnkXdKkFJpioo/0DRcAGCFrXIYBysg02BYwZQrWh7IdVyOkGzF
SAul3/plGvIls2eBNSqPmibA2SGi2BiukE/YIYQ9oGmSzgZYsg9gkSpCNEUoLP6SgmXzuN2HQ3LP
OSR3XfZwsBjJPZZUSQRLYVWEHD0nfEcaEtZCPX2dAQwAVkIuASwPyb0tWQJYpIrQ4WCpEfYvXOsV
jg1LpGQr+5WTIiRVhARg6V4OloSWHYgwX/C/LgfLY5Xjpgg5rZUF6U6xhbMa1vKQZC2iojBCBIsv
0xXkM4XqIdCoUhqD8rLGteP0x/O8OlhOipAALAlFpagSPZrq9QmNesoMKcAKktxRmYYI5pMbCci7
VYRtK9pLKUKx1gAqb+OT6BQUigtFgAJC88EQmi9BRrka7MAdDpZTReiLYPF83IK0XL8ge5ify1Wb
xNQlQq4+qAUvI7kzDpZrlVPFqgidHvDINHABRzGvFrLZBxYs+OBI65VTG66cfvnC4MYrp1ZdMteP
DBGLwHdefzZ+fMXIqSUEPxF61ouXh9oBKp3JLbFlFJj/4Ol1VBR03eXiGqKndeZ5otV+uuXS8MqL
gytHTi8/a740cv7dC4NrLw69cml46SnAZKfXf/PFsjXti4raK0P5tgvDmy4MP3+u+OKloeUMq10Z
WjFydtP5wTXZxOI/AcCiKULTNnjOwSGzikJE6QOV2TQKgRQh8yI0vSlCkevfqJWoBIgHCXAGzZ6Z
DpZINkUsixWgZJUEQSLVPpG0nSdtbacICzRiygDWZCrTYNkkdz8Hi5uGMyOkEIRCEkFRBt97FG2w
q+TuBVj7DyGKLXhGFa2yNEXr0BlvBAst0Q8OdZ4IVpYBLEEVYZ8HYEliESwuBb6Ew/wASyvJNFCS
O41gaUymwY1gRY+sAqEjYSNZFaHsj2C5JPc4Jav1+0juKo9qhmipB6lRIUo+T6JJDoBI1QewMhjJ
PS1k8AiEZ70yDb4qQkdoVJTl5Khucsr3uCJPQar7qKJcXGdMGYtRYYwuScZAHu/lxG86FDDtCTQp
iQiNtvt0sELnSIpIm6pBL0KZXmbeKsKwVY63ipDnAIM9KIt5GtrxcLCITIMv1TgKohJPsghnlfoT
BPj7uokXJIYe6y4HiwIUJvpspwjzAQ4WTmQ2Uf3PCCL8aMGi6FdszLMjWC7AcnSwCAcrYPaMWkyW
ukg1tWLt9PqZM6YsuL/xoYX3PnD/PQ8suHvB/HvmzZt5/4IZjzy6YOFDc++5b8bChfcuXNg8f8Hs
BQvuvu++mQsX3rNw4dz58+fMnFk3c2Y9LJw/H/41m87cs2D+vQsfgP/OWvjAvTA/776GRQ/eO2/e
rAcXzpo//x8LF8x5cOG98++f+fDDc594fN78eXc/8MDs++fft2DBzIcevHvBvNkPL4KfzIDGPAi7
uH/OvHlz/vTHPw30xbwAK6cadjSLaxaJyh35hEaDVjkChQVDzIM2+fQsk8OgsoVGgyR31ypHILyE
fbW4+rRmiB9mch0ROHelN4LFdLAYyd3HwUJI7jitDZdWwUUoeLJ8eN2x5bPKyTEOlk1y5/oY8gto
xDK2IZJ7iNOd1ni6UH6z55IOlh3BoinCkpI7SRFqCAsnrQWJPoG3cxmxh6Njg+HqYHlkGvpjMuNg
qQ4Hi1/YhdGMJIHKNqcMnlURujpYpQgWqyKkViQOwNJ8AIsXzECp5SF6tSRrIu/IUPfGXJL7CbuK
0E4R8vTZ0dBLUFSptOuSF2FvSaaBRLCwM4jHcvDk4yjMm5EIaLjGUJj7LmGs0DEKEDZ28UgCBxs5
7N7DNdjxWuW00AgQAVj0+uFb5YRkVtIaz6qo5EXo1cFyI1gBv2dcyo/POTACXoQekjvvyY5b1kRJ
WEX4l5n/g1Oh/9NHctdtmYbqgFWOR2iU4+JsRqie6gGfQROvPxeYtCAowXSFRqHxOAfL8ESwggEM
X7UjjIs5NffFZ1/995Mveo73Hf/6ZN/J2Ilvek5803cSpuP97idbcvxYz8lvYseP9X79ZQ/Mx/ul
qVOnT6ys+vjDL/tOJk8el44fix3/OvbNV/1k/usYfJLpG850PDjTczzuW87mj0tyMq0rWjFvlqac
85nzz9OZwbwFE1tCZpyfAFAoaAZcq9BXhw8dgXnA1kXoTP9mA79lW7O3E9qm+1uy0MhZusHgr6kZ
Q/nCECwnuzDd7ZR+mDPhwtMV1VCUw4cYwJpVJBysfPBAPPsNbMHXHk9jfB2S9x1UaT7v/2HOxDeS
J9GgIXMQZvKaPliAO8JISfGJVdWNDc1wCHDLsCipoeg6PGTyQzyOQcS7FmpvIKhaCNmM0leOktnz
Ch/AMoPOpzg2NfFYu8FXizA8KUKJV2fuf4MnfG1SRZjzeREusyNYzCrHUXL3WOXgL/caot/jy3F4
xlF7bGAcLI1GsBjA8kawXKHRMNuGo+vN55VLXLcWWwcrIWM6WMtYilDzcrBcWxKUXC+FBahwR0iN
YyYTqndLuxKaWkw2vACLpQhtDhaqPYaCXZlXIuBRcicRLN3lYEl8XX5J7CcjIMahwZs0X5RB4N88
Gh0KgXyaiCEntN9JCzhtZAm9eGgEK+2aPXsiWOEUZCTL3o+kESV32UNy14NxLMTNXkA9MfwpwraS
kjvOTo02HePLShkBJXSTb+thmpGFeM5j0SW5e61ySjINLIJF1Q08MugI9dXiqdXzwgMGXvtt4foC
3CSUN0XoAiymg2WxKkLD9Ms0mCgEZNpFWkYrEKZ/EeadaYg30fjEIE3PFWH0nTJl+neuvkbqS9KF
xbwK/TmYU6ENxVzWhK/OZNqfmlWa1NA8W40uKXgW6kqOCtaTKa8VqBqTyaIppUkPfkXWMSw9o7e1
rZ1QWXXowHtKMoNsQfdsirMjaIMzwREVCowJR09HTtEZ1dpU7SoEmGHqBmRT/g2qsganKZfVuvfs
g2GlsXGmkdULcIDooXmb5zlYe4P+ZiNr6qXldmN8uzCDe9RLWyaHlh+ChpHizZwF/Sb1S9dcNbm+
vtlQVLYQ0BW96kx6gjAeIVqKa/DVVUZZ1+lZ2a+DlWNehPtdDhZmBi8IP1uRflzOCmOQATXN19eh
XoSeCJZW0sEa63gRpv0Aa5Q0YVww0wN3PEKjjg6WS3KnSu6sitCVaeDlfURiVCoi580JMjEld5uD
5QCsCn8Ei1UR2krugaAU1ylIC4PCgMSlT/lTjtAKt6sIx5c4WAlXpiHNq+XkqSogQ7g/RaiHqgiF
ptE8hB0weJYx0lJa45Y3OhuXMCNkiefOlNbw6xOve9X4Yu4ajuoQXfuguCt7XQmQ3D1WOdEUK6GA
qmYLjXpjXSm/2bPulxvVQyqgaMGRN+Uhkmkw/2c/V5H6OU/yNIrPofNkl80wwKJVhFQHa59Dcs9Z
HqFRofkryqMXaFkZHoVrAR1EDwlaevrE9iL0AyyX5F4CWC5G5LgiGlnDokdKfU4AN+Rhyqk5mjUr
WjDlBmGeftpTTs3rGULEBtADUKy5eTbsd6BPYmef6eCzedgO35p3lGQmlwbHkoOE5J5T4ZAHLecr
mbSi/enOULTnWUgnDdpMWs6U3N9/72NyaMYQW2hvqjQVSxsMLimyvVO3afgcdpsH8xRfWmSzmTxA
Q+Lto1NIqtlt8DYYVqCApnD44PvQjYBXoEmanCu137OyiRzjoH1owcZ7Ghxep9QS7IdaMbgR0v4i
6XYCfAu6YgDSUtLZSdXja2oaAB2y00pDjCRFmFPzeE0lTz9dcFXoKFOTQ9hCrHLafVY5hj+ijOKq
kigMx2ISS2WOcZnOkkhjyWsW65FpkH1mz65MA0JylzV+mEqNzsiQ5gWU3H0kdyY06rPK4aqEc7EX
kihETO48AIsKjTKZhgGnipDKNNjDWMxNEQZlGrRoNSaEpCVkf4e7kZ1Tt4rQlyLUECFNLHsloQL3
PoAV8wEsWaMRrJywhRiUjK6sDKEuniQBr67Qe51zJN25/C0EyWnca8xDseJIPITo+bKHg+WmCG2r
nJWSbOB3B+oXKZB5Y3l2u1uEKULdb5UjVEn2zgAiKSm50xTnihWrTFumwRRRVgWRLYNDBEFZNRGU
/BBjl2P27BEa9XCwSjINBUSmIcIFBadXC6TtuWwbfiUmSREaJS9CxsFyAJYt35VHzZ79Z7lIoRVb
gUkZOVPRxlUljEWmvF3HYBlZwE8EjU2bVvudq69JSom8BuNuLk+Tbuwzl9XJdeKdjLxluPNs8i0p
uv/KsWvMnclbnn/5fp5z1nH/y7Zp+JfYPyHhvaVLV8C76K6ubpr/Iq7e7o6K7u6MUJPcDRLWUZ7S
knK+Mru1AACAAElEQVTOTJ5OOV1RYR1D0UrHS1J+uaLna+mIjPxgvmgAQDFye7v3Tawa31DfrJPf
Wr6jMJyuMPw9gHWab2V/XxWd/4ZOime5d3fOCkWqmw9YnJkn5lWYyZ/4+vg1V13d1DgT/qums47+
cJGiK4vz/oDq6HLESAW6wch7iL27UorQKHkRejhYQspmhLOCyEVxTJDzJHNEvQMAi1nlZHwk9y4n
glXiYLkpQoGcUpgx49cWl7wRLFrDOGCnCLMuB8sRGtXiLgdL5BAXRbqKNqHTPFY5GiO5w+EzgGVX
ERJRe9XlYEkyx2A4EtciEIennoBsP+YjuediAaHRkHtdFCoNhme8XoT9AR0sjrcjEgqKZINx6w8Q
vr8kckZShXUVKp7JRXwVsZpT3rWNJxZx2QUHYDGSOwVYTAcrzVeTT2ujunLSWkkHy+ZgabbQaNbw
JQc9MxgTtoC9yZmlCJYr08AAFtPB0gtRtFbTCu8L0YaITvMFRUd5dh8GwgV2UKbFdLC8HKySTIMd
wTI5+QWMUobagES6lPB9iiy07kkvmT0HvQjb1rrICdDPoLeK0MAr/GFEJxV5dCpZozhLCjSmRT9z
NLil03Vono7ALGP58pWTJ0yqrW1sbp7tTk1Ns9hnY+NMd4KvbEkTnfcutJc3zQytb69ZX99YX9fQ
0NDU2Njc1DSjqbEZZhrqGxvpEjKRmSa6QhOZbyDzbLL/a8/PvPvue//8p79AX02ZMnXGDHsXDe4K
DeGfu1tubnDWgTY0QzPo5Mw0w0xdbf3dc+bC+tBa2Lj9k/pG75bd9tDtwN5nNDQ03n777ZXjxv3i
Zz+fOXN2fV0jPShfe0oHGDyiZrZyo/cQGkv94P7K2xV0heZG//F6tmnvxd1dTU1dc/OsWbPuhuOC
zocjbW6eAQ3+5XW/0hQVbhZ6kdjGjiWSO1oTYBRE1/wo6ZicN7eSF2GulCIsASw9RDYIST9YAYdT
vRBtyeXlYPFpub6xgaUIHZkGjxfhWA8HiwAswyc0Kv//yEMFOFhOBMtbRRhzlNxLVYQRqp5qtAtv
UNnSx4BxAZYvRTjWMXv2pAhtknsgAzh6QaY0BqFCg73EYfRTgNUEvcRShJjZs4brlPLs//yXhzdF
2DcagBUsnRsFowjPparRHci7jP2JYD7ZTpXEruQ8Z0kx/w/h4JeWMB2skpI7A1iyEWKsi0ysBYfm
iWA57y1pp4owTHI3BFovYVRk2kKj5ElUkmlY4VVyF3gLGhH5IFEyTg/bmZm4JGk4yOTHQK5Vjmv2
7HKw8l6ZBpfA5FFksEJhKpdvawkUmPxQyeK7Avse8Zz3aW+KMBjBcjbiExrlkPRZ+IqEcJwgFskS
khShvdC7gq3obXhyiHBBZXOzZ99TOXZcdVkFdCC0oTSNHQefVd4l6H/pjL3EWej9FcyPr6ysKi+v
Li+3P2FHZWVVMLlL6EL3v1Xuf8lM6Wt1eQXdxbhquibMsDaXVqaf1f7Panuz9u5ghjZsXGWZ55NO
E6uq4XPyxIlkHWc5aTxrQKlJ9gw0ZnxF5YSqqqpydyOwxwrf+t5dlw7W11R2+J7+KfMdhX8L3jZU
ezfr3Z2vQ8onVY+n3VheRZvHOhAa/4ufXXvi65ODhUGKv3P0OinqioGXcyKvFqaFAhcDxTQmTi3w
pJI9AMtyI1hUyT2g1mFyhPTQhwnGDPPr2I3Bxc1REq4tVGjrYPU7EaxURgVUUSK50wiW7KQIJSS+
EkwR4rETP0MoLDTqpAgnftNDqggRgOXl3IT5xSHOkxTpxOeJqKEAy6ODpTk6WKQawFNFyJEGFcia
84TaefEYf4aRASzHKicXS+okgqVokalGKcyXwkr2PBGsftcqx5ZpkNECUk6ASlCvx2fCiTyXeKqe
YcI75posyULnKJ7tD06QGh1B3lVyl/0crEAEK0LiJBgJDiDvktmz7JVpMEoELO9MmLIdpv74paJL
ESzDVnInMg1aPuR4g7NWMecWJD5v8Wz7UJd7lCsWpGqZzptuwWf2bBAdrCpvBMvLwRKLb2HGHSWH
H39ZPg7FDD5HjfPW7qYIqdmzGYhglbwIA4cQQqW0/oscaYGuQMdICqdsXOUHWGQ1g/n3Gdl8Xids
G9jFB+9/eGDfITbth2nvQfYJXw/uP3yATmTG+crmybSfLHEntkLpK5vIaocPHTwCK9vTPtg+mQ46
X0v/8qxTWk7mnd0deG//Xmgk+Rd87u3ev38f7OUI++r77T5nyT7f1thC2jy2wcPuJ0y33nrH1ZMm
r1+/ERp86OB78LkPesP94T5na047jxw62r1n/769Bw7sP3jwwCH2K9Yed9rvO5ZDpSaFjtptsDMT
+gytv9+z3N4Rnex/2bs7uG/vob3dBw8deO/QgSMwwXJo8949+947fBQw92BhSFf0vGoA8s5rHuFW
bhDLRN49whbL4hg2FtkNktxtodFDAdlhKyBip3PESwMrh+90Z/mY8DNaQjNrJTCkMw6WTXKn79wE
YI31pQgBYCXCVjmyhrqvSHw9Bckz4JVShCktpXitcvpJFSET6CIAS7OFRjmAiaM7peL+x2ncVcYH
sJgOVneY5K4mHA6WhPCNBERplZsBFJwsLKFGSO61jSWAxUjuisYReRLS8LEokcvBOl6SadBLZs/i
fBzmbI3lZBG5Ab52F1L2KHFEDaLYbBqmNaphWWYNJc9FmB1hJ9QluSNehNHJTY1fw4iYPbNuKZHc
XXTlsSMU0AtQklA4ReiTaUC1NPUICzArpMMuFCIycQdAV3IwbH5i+KsIOV6EhKZNU4QuQ9ziWWfw
xBpQ4VPOuy83Yhd8rPu8VuwIFlVyZ0Kj3AgWo1jxdSaZYhYDUsUSBwtBVxYToMrquaxh5QdzaoEy
slVCq9eMPMke5goaWQG+Uu5zjip55uiMwT5JIkkzPF+9y3Peee9XUx8kdYV60alVNI0sE+R0COx0
3vuVrUwneznMG1n4OkR56HnKMBvKZa28NmQ6K7u7cDY4yJmKns2WdtTcPLv8W+P27n2vYAwaqkU/
TTN/yrtZ3zxllNNwIJxEU01rjFruaUOpVf69D3r361m5dLCmZ1/+gwqu7F3N9PWb/WmQXiIlolom
nyP0O1IlCmcE0FUmkWKXDQAsCsFNQsOK1O7ChfewF49ITTLPnRVIEdoyDb4qwkJQi1gX+E5yCqtD
TNAxERLeofE1niY45kRc6UlkJSXfn8j0D6Ra29ePr6jauWsvqc/PWpKcjyc1MpBnOAkdjKIroTlK
519JrdibVPvkXAx2SilNSVmtrZ8xecKkLwFhpbV+2KliAoDoT2YHMhruzivS9da4PjZhrhJxcNP6
B9IJGsaLKbmeeHrXnv2VY8uWt7bH4ulkNhcDJKrke0l+UI+n+YbWYRNlHmtHFsUw+pJKMpsnSC6j
n5Rk0gmkBEHPKNqU6fVXTZp8vGcgAbhwIJXMFuC/dGU9Ae1MKTABECQlC5xquHDMxj1rXpmGPhog
8Si5B9VlJRmFI1qodFQbVbBK5nhFy3xeF5IPFepsYbIIEs91IELq0/evvkQGTgF5P1Hz/clML1wz
GaLuBgArrugDcjaRyiynpS7LWttTCi3OVfIxaqR9ciBFYpN2HhxHVKiWh+SQ3CXm2u5EsBCrHK8O
FqYyYCiEc6OzAmyYpTOUwwRDcs7U4NGbb1+5unLsuPa2NaaqGYpBqNC6NVgYZivbSEUfXZAmUtcR
Z+Lz3Ug4itKWpg/lCMDSZINm2QrLiU3FuEP7j8LCfDaXzwLuLJpaDp7Ug6yQEE3YRUSbTKyEEOP/
ioWtaWzJm4EtasapAsEHRWM4rxK++YH9hwnAal1NC6nMIQBXWTg0gCbsE/MG0UfnIixQIPOzhoPx
zgivyciyBn59AOq6jYqH6ULroQB/DkfMJpJa1eAKgYvfLKjk+oELxtII3m1saKIw/RCsYOmwPD9k
mEOUAwe3A7mbjIKR1RnLjVRZ6vwSS0PIPfKaVxq8FJug3zgmNmitCWaWEErYmRYu48lNhYt0ScLI
xp/mpsUWzI+ykFdzbkK/ANd8rpiDp5CWh7PTTstFDx04kicFGQVW4cikSWA1PaNxXJxNXAuQ7/M9
JkLLMRTsiVO3HHjWDygEQ/TEZSmlPLt0BfEi3LP/hCTH5Fw8U0grhSRR2lRCbh6jYCBhSCIGqK4/
FVfNE1JGUnIEYKXVKdPq4RW/byARy+ROJNRk1uqPZxPpLCAG3JtFFupEYOhKQpWZZK0vochqLp4m
LKsTiUxPQu7cTQRLlrS0J2VoQLYvlQWg05cktZbxsCYTT1wqWLrPpSgFRLwAVx3vT7AlMGaz1CQJ
niXlabWNV1119bHjfVIKcFUurVnwr1hSidM6R+gryaG49cXlKLJ5ENk4Vjk+knsIYGkRoZcQpUkS
I2MBW9xbNhHWvxBotOL5PpXrio3eOBHceV+5LuAkGkzKJjKk+nIgkYGJnhQV3hAkArBWja+sWrJs
RSKdSWRyUlrvT2Shhwk4VgjMimd0USIVC7zZHCw/wEJ0sBy8xRsILVJ9rTNtJPYIg6cSjBDkBREe
Ybl8QdVXta+bUFHVvnIN4C0rP6grOVpJ5DwKVVvuUmzmFUiu+UL6nuCNFSiiRvRRC6iWYFDJXdOh
tTmCOE0trcIxtreTZ/GBvYcLVL5oCJ7PChlBLT1vaTlvGMlCdSgEhYS43JfJ5ZaJyHCOkr5uDOXJ
y7qpWUVjsKDnDx08Ai9+bSvWFFQY7OFE53U5SxBwrkDOC9eLusAV6ArH3v5HeQXM+cf0FT2gyV+D
46gt8BzkVaHymdGWeE2hGx38FjA3XBtwCoZycKlYFIsXcoo+Y8ZMOAv7ug/kMtpQfojIwKrGoF7I
OnV2NLuq2xoWHNtyoVe0UFYXZRF5wsOWl0ypY9hFLGcf1qb3Blb10bmLhk+lESGAF7QWpQFmJjJC
6IA0BOvKNJwyT8PbBUkRavm2Fauqy8r37z3AdLwGC6esnKmmswUtZ9DHGldtC0XwKKbXAwBLVJXm
KSOXtf54Bt6/v4mlAOj0p7O9ifTi1lWVZeU7d+/rT6snE9mkkk9QCjzAC3wkQ8xohbzmNMApgu36
kwoDT0kFBvLs1LqmyZMmf37sxEBGj8GbfX8iSVgsWj+MVbw0UJqjciTIOmHhEII1AZ0kMolsrjel
xNLZHV3dcAs929LeG09Dz5yIA+rK0KSPkXIGs4AmE5Iu5NXT8QSlnBN0UkpDk0hAMZmBQbRHSqcy
ekoxAGDVNs6cMH7isRO9RCRM1k7Ekiy9C0O7ZOtfaAnFAHQVj6qJC6uSHuuNfRcTGuWG38Ji/dwc
pVgZgR9lDKzPESkNX2kSjsIjBEQETZJkjVspScFoz0AKThkBWKTfVDb1JRWJUhiXLl85oap6yfKV
cRmewzkAyJIThYIfwimLk7ijJonrA/yHHHcyg36rHMODrvJesBWUe3GenraEYNZg1G/2ysj0C7SM
llcNeE6tWLF6QkVlW9vavKrDaqqsAqiiwpWWklIizEx4/HeuiZuJxB54cqP8cbqgGawQL69ohNNt
FFpaVlaNKzt04D1YgT2C2bM7MZAshB++XqBgFETv6AEtKz0IHy0sCWvxlbFYKAtwrQnN001LKxiU
U8xShK2tRAdLSWZouIuoAxAVAD2Ph2140o6Gny3n5d5xXUSCORcLSW7y4Isp9MYOJWTFoU1/nMZC
g4hCUYAIixumQ5az8lkdICzgpyFKd6PvG2ZTY3N1ecXhQ+/DasOF4TxNylu6wWKQVOnA7kP3noqy
peKLBRiYWroevN5wOXId8xGKDJsJvGX8rCmL5/qHm+TwA6hBVruT4gcIRUPjDKeyxxQ8kWA5vAHC
Vxo+L8Cjqaqs/NCBIwBqnTS3xd4SaSjRECFpA6sURt8PjRLJfRR8YTpO9Eup/ng6qRixpNITTwGY
gLftZ8irdvW2nbv7kpmkmic5snQ2pea/6kuINHvC0MfvzeKNIX30yRebt3fBMAPjgUREPgHcpGub
Zl09+ZqvT/YNyNmBlNIfSxiGue/g0c49B0LFX1qEEiNPTIgToiABqlgynlJOxhJSNidljY6u7glV
459tWdWfVuKKntJMQDAkIJHIpDI6giSEPHdcD5MTx2ID54mB1Eeff/1ux+4+KZ1IK4lUJp1Rkyl5
Wl1TVWX1V9+c7JeSMVJ2QAbX7sMfdu49fLw/QWoC4jJxyE7IcMqC8ujpCCEJwsHypgh9Zs8RPkVI
oAXXl9ckvE9ULtFbXK/KAYsisbQ0oroePikcKVFVwjKVAI/gPkrQ6csT/a+/vRWuqDRJ3bJQcbZl
xaqKsvLFy9vg8k5l1LSiphTtRH/ira2d5NojUEkPScPz1UDsCJbbmQxgZX0kd6/WqDdFGBzPTPa2
7bKkpb74ls0dqUSW6jsXKNsmv3Llmsqx4+BZpmeyBGOpJA8CF9nuXftV8iBDyu6C6MoYtW0f5+GO
axAExQNLzXj0kcdaW1b2HO8p6HnCH9L0FW2rAeYCTIETAIcAT+cTX5948olnH3/s6QLqkobreBW4
bK0we9drxCt4Y/ZjOyr8baxuX3v4wJGiYWowxmuGrqiHDr0HY8nKttVKMk2JTcTbZNvWHW0r1qiU
JoV3OC+1xAsQCvxM/Ok2rtMIr98Mrm3AaJNoo8k98cpa0ainwdEihxGdZAYLJA+o5eB2HczZkL2p
aQbA3PeOHNUVjXoP54mwu0HeOtwuIkxwNSeyPRBUrkVq2xoFpPN1zLEYCwoGI8S4naiJo7RR2uCE
76ZAXC1yfTojJ+Si81wCaDXQFz986GgOXu7S5CnEqHttbasB7+7e1U0siejTCbb2zbGTXZ3duPqu
iOAlqoYew6F+c6ktX3zTe8+8Be3rNh7vBUhDEhlSWnlmeVv5uLJdew8MpDKELyIlvzp2/JHHn21d
+yJfIV3INwq1R0oq9c2zf/Sjny5taf/082OyAkvSU2saxldVA75KKtqxEz2v/futG2+8+fc3/vGj
/x4Tpm/8zH1ZMB5rvIzVu517P/jsKzmrA9TrS6RhCOw+eIRUEbau6ounJTkLKFBKytBJb7y7/UR/
QlhHJiRcY+X9ofZoJwfSMOJmcoN3Tau/9vobVq/bePTDT1LpTEbOTJ1eN2nS5J6+GLT282Mn2tY8
/5db7/zpz6//6IvjMMAzdHWSRkQorUeT0M4JlmTan8cCQqO0itATweJ0NQ52I+rsJG5mUAtmogP+
gLIWHQYTQ2o5qoiPZz3El4ropxnbOA1fwczSFWuuuuqax5587sCRD+G9pV9KLKPycgCwEhk1nky/
98HHD/7zsYryqieeXUY4c4R4lw1mllFJlIAXYcgqh3Kw/AQsB2nhSlSEd5Vnb4c5+vIN08qV666e
OPnZZ5d/9J/PcqoOCIw4u40tW9m+1soRnaSvv/rmX/96suJb45Yvb4f1lZSS1y2RqjuCk3jeGpxB
MVyWaPC1Euiv9u4+AC2sLqt4+OF/dXXuKRYsgIlEMmffgSGz+NZbm+fO/Qd8vfmmP/WeiHGyM+ao
KGUcEcVgaZLORxX+w6fcHWPDC5uqy8r/9tfbXnzxlXhMMlT14AGSIly+vG2wYB3/+sTatRtuvunP
35n87YMH3rdTtHyrWn7GjSN+Hc7nouwlNBXILVAIhQO5vD0zWv6Rn93j8p0DNWVijJIb7D3Zv27d
xr6TscG8ZWQ1XcnmstqMGTMrxo6DEZ2O8aRa4rQ1dPTI0Tf//U4mKbt7hLuGytwH2XgWFvLEEUAg
gBq0XeKHinFbKlPEe0MUSfC0shUmYBlifwUsZGvwLA2C5zRPIlUacyOAd7n77pv/y+t//cLzL8Ej
yMqTQpyWlja4i98/8r5pwJpqx/bOf/7z/37xs2s7O/dSVn4+ArjjZEQzLOUwBlco4BjPkYSCom3u
6PrOd38woXrC/Q8sWtbafrK3b2kryWXs7t7/wcefPrN4aVPzrPGVVdNqG49LckTIAdPylmQEQ8B+
Dx396Fc3/A6Q3I9++JPmGXNa2lbdcusd37n6GmjD3H/Mv+76XxPZkvKKja/8m9TuRSqI4gQgjUNe
DlLm3+nY9d3v/qB55t1Ll688fPSjZCa7q/sAYcy0rsoo6ome/vUbNt3/wMPXXvfrZSvWkMhQOBAV
NAnWopx8ELUC9+dxJRdLqsmssf/IBz/92bUV48p/9KOfzJx194q29j//5W/f++73n1m8bO699//m
t38oH1c+YfzEt7Z2wm8TGb0/qdj5QS+hJ8ic4zopOTpYRKbBjmB5ARYfSHHNIv0YVwoLqOLGfxrm
PyM0W0RkGjgiGumIq1cKXzx8oSw2D7gWftUbJ/nBnoFUXCa2bwQ/jSuvqqi+/a5pzy1pmXf/A5Oq
x8+cPffpJcunTa/73vd+AOcO1slohB3fn8wSKiTHD0rimH5iKULNw8HKe6xy8kW+mTxVPLLY+zd8
Wjlz0Bx+5JHHiTRRecXUqTUtLSvnL3hwYlX13Ln3LV3aMmXK9EnVEyrHjnv00Sdy9H3R1C0rP4jp
zfDrgwz+azqP1CwYQkLkbjZI/Pvfb0+oqIKHyfiKqttuu+OWW26F+RnNM//y51vGV1TCIUyorNqy
uYMNhFzrHs7IF1C1wOIopghdBVjMfoDFygOXLm2tKiu/asJEeDbOmzf/wYf+Sb1WmhYsWHj1xElw
UBMrq9et3UhEQVUjJL5l4na8vIAQRg8PhjzDPm7h7C0iaWuK6rM4+UfONs2ICtNw1WpEuooTKCIp
ZlJJ98QTz37/O9974IFFGzZs6u/tM7LZhobG6vKKgweP5PT80fc/fu655X+95dbf/+4Phw++Z99Q
NC3FPvksHxzHWyUZNk68TcTuL3ANCcTODTydKjQgzes9gTaeIXIn5LodUGcnWt9qsscUfP3mq+O3
334XPJq+/53vNzXNWrv2+UWLHoHH1P/93xNPPfXMXXdOYSpobW1rBguEKkqLNzkAmuuLhb88jEF4
30gxeWno6k/JA8n0a29urqQ6bNUVlT/+0Y9//evfwkvSLX+9/dvXfKeCqcONLTtw+CijXePaBEhN
vijkcCKektIK4TmVVcD2K8aWXT3pKqZBd9X4iRVUdw66qW3l6qSc/TqWwgkxYQIQrrSJ5sU0f35H
X7Vu48Tq8ROqxk+aOPnue+c9+fRiaMY9997/xJPPXH/tL+F0Tho/8fa/T0sphBHPk/aWeElD2R8/
Q6v9PdtJqmavlOmTUnD4b76ztXxsGSDRinFUTA+unrKyqyZMgiUwXT356pa21YTkTtFVr5RmEZS+
BMkeYpKwGleG3o1g+ThYmiQbEaKpYetiP9iVZI6xcfjKxE+ZQNtC45Lr0xx9/LCYPr/sIAAWJZzj
BVA4n8jmCLSl3Q4YK5nRTvYnbrrpj5X0NMF9RDUVx00cP76M3lOAvaZMq03L2YEEWRnwdCJbCJ8s
7ApXkQgWO7RUNpH2KLl7mVgUb/FycJZDjCUpD8LVVeCJlkkqN954UyWVUqwYN44cQlnZxOrq8m+N
ZcqQ06fXmbm8Kis0IVJg+UQ/yVoQdceoPALdUVHdE0e60Chosj6Yt5566llXG5OAKnofsZnq8srH
Hn+qYOSJPL1Nho0iagTkFSKtgbhfEbASiBzQgGJ+9uy5TM2SSlOWw1O6qrwcTgeThZw5824LWp6z
gmXzOs/q0eRx2y2E5cNTpTdFSBQNIwUEQbiw2+So0ZqiukUjKsXMj6gJzqOhGEzw6b775gMQhwvm
Jz/88aOP/t+tt90OPb/wwYcBr5OzQK+rrq5ueK9imSzvXgjzXZwXDscyBbYzRhR1HYnYCcjmCMCy
BIrBvFoHLqjiYUQzqh9M18mK9ar7dILp/ff+8+3JV8MtcM1Vk6kaLRFHnVBVXe3c5nPv+YezQefF
L9xpxihOhL9nxuCVU3xOkqQaA0k5lZLnzLmHqNNSjV24jSfQpw9ME0mjy5Yva5HTGRi/hYiNK7Mp
hbzh4lquN56UkulFDz9aQXfK3pWrHLVfuF5vueWviUSiZyARI/wnbMwWFOSnuSVp2HZgZFIyGRXg
MBw7jTpUsacwIEumQVxdVgHI47PPv+qTkgNoRC2tRZTUyVFSXp7/9khyIpNLZ3PxVEZR9fvnL6wi
DSOgs+JbY6upwDHAwfGV1XfcNTWVTFG3RCbTlYUxPk5lUSUu8Z8rSeCJYJWU3EscLFR/XOaAbBFk
UYNCtUJ1Ltxd0Vt0yTeDwqJrUSIm6E/S2kDY4tNT9dlD6hLgxKVgnbRWSCtGv5R+9eVXxpPn8jiq
5jx2YlVV+be+VUlO5TiYOrt2J1NyLJ5MERKk2hvPREmrBCOOfqscbxUhR6aBI+aZV41sSgGQoZHw
lUU5QDkto7722usT7PYTOezqCvgcO76ygr0L7d27P6/qmqwMFoZMY5CxsHmjiCVIXRkFnr6AFVmF
JyIFE0MPU8/39/T++le/JlrbFZUVNC5ewaS3Kyp/99sb41JCSWVympHnWXxEOqyFi70FFUk8jrNh
i1p5vbQLZDI+/fhjMpCUs1NQCa+jLLoPD4FJ4yd8+snneT2vAxRj1iWBQnpusIHDetE5jDeUeC6u
shRQqXgCFgZH9J9P1LN4UE/gfOe/FEOs7dLJKuaHjCzhUf330y++PfkaOiKwN6UyeiKYpHsZPJDX
rHmBKoTZygIEZtF4sG3th1Ue8F04+Tx9z2VpCcV7ObszEXNAI5QCFvDnDH73GhxVXkFdocCv02CR
dYMUD1KGe56Gr9hR51R9Zfs6uPhttFBZVeFBDj/90U8+/+wLIsxGGO6eYmc/2sYrG0Q00MIYiZ/F
kPza5c4bMNFwH0iqH3zyxY9+/DMax4IXI4K0JlJgDs+ju6bUHDve1xeXibo6GijisaPwUi+bERxL
q/0J5fNjJ6/75Q3QQeMrmDA/cxWoqiir6Ni1ry9OCt09KUKNLwuuRY2dmgjuZIwTseRHn33x7Wu+
W+2Ay/GVlWQ4Ic81EoTY+PIbpD2AORRDZNsyOjc9KRDX8fdYPKUBwOpLaf0ZvTch/+eT/177i+sc
twfyOXniVQRvVVZ3dR8YSCk8sr/EFQ8L4lTJq4Plt8qhESwNw6waomjP54wjnjaYvBY/kacFq/k8
eEjCYoGIfChiBc1VM5EiQRvCwfcB2aRqNM+cw3wnygEZV1ZOIBcVXE7l9Y2zk7KaonFH4raeVPrT
Ef7lHIDlOXw7gpVD6udxxcuAIHvw6V/MmzNn3l3l8RgBaFJFI/DTp9erAK3yFnHSpca3sDJGqPKz
TEbjR2bwxQ4MTqCF4xc7mCsMF0gJ0lIqPeP6k8B9TexKxo57952tOSVnaqZrCB1B4MVf2RFWuyi+
Ii7X966sGRYR8Cw891xL1Thy48OgUjF2rGu30traPpQfomITBnxytBMR0pWF42CT76XNoytF6iCI
hMow5ruJBA+MqPQWTxMcEzgQ1EgGbhy4KqB7c3BDaYXFi5ez6AO8KbFQIqCrCnoh/eHGm7PJTEG1
RJAOdQLlqvKGFCvCdHVDKDaByproHGsacWmhwVcvM3jljSL75wAJL1j/Ec74h54Yg/mCms5MmTKd
hj/ITU1CD+S+KIPbZNWqdUzA1iBqWEU9Y+ApZlEIvICYVXiERnH2rl/KXGVAhz7cCTf22aWtJHhD
8AS5gMaXV8DNfM3ka3bvPZgkEREiRsoTaJCEaRopxJdi3tL95NVR39LRVc4sn0gHjWUx8PsfWNRP
hAZIZVavlB5dJb8mEmVI81NyabWHptjiaeXV19+qKquAt3bnxd1+kM1/8BEJRq8MKbeESSR9GVHI
hpGHQggM3qgHUtpJ6PBsXlJ0KZ1Zs34DC4RW2u5XZROrJzzz3DJosyRnOXk0TaxBFQIQGpFpoCnC
470MYGlOBEvDRSVkTlxH1vjHi2ofqNGuQWhsMhS7klDamcwxVkproy+5ReJ/gvCYw5H64qtvbiaJ
Qhp7GEcBSln5Ndd858jRj5NpNZaQaWJRIQALUw8RufoQFyNmlVM6y4SDpRjY0IUVVxvRLvc9J/pu
/P1NJC1FncsmkEGl7NuTr/74w0+tXIFNTImbzogCOSKBSj2shF7gmVqIFLD8T9KcoprU8iXWK/31
lluvoq+81GRtLMw/+OA/tYzKVKGZLFbpcY9HSkwOZ9/kBhL0EPDC4xNoR5lFI1ckvF39y8+//sXP
rh1PI+vVFWQsgQdUTU2Dklag8bbZombiwqd4EorPp+GGT8z/yaKbm8Xz63FYyHhvcsdC1I07Us9W
QBoLSlT4Vi4aRSpFa8HlkUnKDQ0zKEwfa1M1qCkhDJSvvvrGIDlZg1hBQEFktCcuqkW1YVGR1cik
Hs+HVCS1EITRVsCcAHVh1/lhSD1USMGRmwrePsHLzyyoRPp4376DALAmT5hk39TUj7K+rjGnkcR6
gfhBDWqArvTiKAWKuf70hjdFyBmcMP41ATqJbK4vSZQqP/3i2HXX/3oCibaNpbyoceMrqx548J/p
jBpPZVPZApFMxF07NClsDiioKyyN7qR46mTfwHXX/RqeGleNH1/5rW/BTsvHlnXu3guYj+6RpF2i
XIRDLoRisk4oDEMgpmIkM+pAPP3rG35LH8FlNGdKQXFF1dEPP02SwYxaPqOZPqH8Aa+akud/LKuF
WDLbk8zGANwo+kAq8+Wx49de+0t2XiZVT7hqwkTope79h+KpzEBa4dUthoJkWsjgyNdmFsH6gUem
oVRFGAjb+MOiQRlSrkQCmrAW2tGEkSi/qyWR5/foah6Dm9JENlBRtYo9UlpRjWefW8LupvJx4ybQ
nML9DzwsZw0pQXR9XRJV3I7URrqne0nudiiUXfOSo+TOFb/xjawmd7B3yNcEf+TMpUuWM+dX8uJB
AdZDDz06WBgk+USqUGpQHQdm2CLUKzLDr9T8ym1M6znssWNgJT96KYJF9M3pY/2Vl19nnrvMdhee
ckcOEUoylUQv6rJWNApI8sUQCGRzck8hvTGLm1yLEBoAdDWUp9zefLGlZSVcOXAKWDQRjuWVV16H
LRsZHRCApRN5azSVY6GjssGXJTNCg65Y8NooCKSkkE7jxmz4HLtI1X5MSsDiXeQejGXxKF+OlyVc
HjnFIBruObN7z77yb42104I0agIDfE1NnZLOULX3PDJao2EkvPMF18koolZegRKB3ED43cDAkRCu
Fx94gOij4BqKbBtMUYCN/35oESsnNafqt916JzsLcFNXkyRY2bp1G+BNT5OzuqIRtwkN1i9GCMQY
mOwFFmIcw9Hp4WqBwgCQUHJJ1STJr1R22YpVleOogTnN8cMQfuDI0X4p2QcjgWz0SZkIDCHao2/l
GHEXUVit3IleqX3tC+TlHtAMCc+UNzTNiiczxKMwW6BDiF/OWxDhCAtg4lrzwbG/L67A7ojJTFpp
bV9b7ri+U7P08rqG5kRK6ZUyKeJLo0jCDCxX0j09CqFw5+wQsXjiw5jrowaIxBcnqy9tbWdREHqO
ymfMmpuUlf6EHFeMAY7GuiQyokGUqBwO1ncds2fNC7DCNXpBqTMkbSqytQ7Q7X36WBzZWETcQcar
CyWUMRaVr+T50uACH3KUD3RK7ZNSx44d/+EPf8yKEuD0XTVh0uGjH8PyWDxNFcsykqzbby9ie/JQ
UC3EwWI6WDmeYQhqd2rxJJ6pC56aykj9Azf86gb7laOsDCD45599lSUqnXlmYKdTGc+STIBYUFTH
3F5FulD8JJ1REKeQhgtWQTXyxDjPUNLZW/92O6XEkbv7zjv+rsoKHEXRKLIIFpGt573j8rjeUSQw
v9xoiKYdfjvXAxEU4gQCP4F2Sv3x3//uD6zx8Ir1q+t/FevpN7IG1XkvWBoFWFEa2aPSIUNMY1BE
aEbXBBhYRpJzHUaQ1kcpDcDjYBkc1j8G6VwldBKX0k2T2uMoKcUy8nPvvpdmzO0iA5i2b9th6sRq
qWhYfOA4ipwgqvqGamVFeXdaKPrRw97GZnRETaBRYvCDakZUtQFOEESlsMwwJWAwB28URi6rv/nG
OzZPmk6//+2NfSf7s6kMI8MRG8rcoKEWcGk3YZTaCghq4BGsgChoOjg6JtUcfUDriWwBwFZPv/TX
W2+381DjyuqbZiYzai8MA5lcz0A67uNghfhPSLjIV7DmG8MyWl9SiaVJ+okEsfqlv/z1VoB0MH3v
u98/cPgojBNJJd9P/GGy8YyKe/rKfH89zrgr8WS6AM3IVDgqpfTE4jf/+a+UiUWiDhMnTNp/6P2B
JLE3IUpFqSwMityIyGiSXKiweyB7m6IWRhmSvSUa+olMWjFO9MV/f+NNNJZQPnH8xAOH3k9lSMFa
LGixgsKIkHNfqOAUdkQBFhUa9Zg9A84L8LrQa4kXhZJQd3AvcQornRMZ6aD67HwNDqGkvgjsSqjm
Z+goeCWZ8C94fyBRpbRy/8JF1TC0l5UDxlq8bAUt+ST8QjizCUrAokIP+qiIaF6unlemwU4RugBL
YDZiIrI36JOUGINog7nCE088TfkNhE+6bHmb/fQBaEVMwWyd5aJbhWcItXnQZzpX5oBPe9KFroXs
uGAiz9kiPGcLer5z5x4nRVi2q2sPvAEXyPBpFjTiGlvUC3ymiCmCfYbQkoUXwglnEsMASyfS4Xkq
4w4rvPrKGzaNbFzZyy+/XiT5WYIOjYzBTI1G7wZjiXW9/cO8xcuZokIMYR4YRz1LhFzRyJ849MXT
bRLn4AxRTm0oX7SoWfgg9WmGC+ajDz+B1wwaASXUkUWLHrVyVGGcyaBEgE4zQtBLAO79d4EVlv8I
oHnuTW3ionECrhhmQx4mY1m4NRMao+ISGRF9Fkynt0jocTCfVzPqzFlz4Y6YWD0eTseLL742mC8y
ST94HOWJmBzcPggx0eKZ0wdY8P7LYwy3nB71aYHHsWr00Yc7AKxeKQNP55dff6uCBbEqKrv2HiCi
6iRAog+kiOcVV24qgtgeDC/BfnupU14/RTaw3w0vvQr7hff7+Q8sShPWEcF8bAxOZnXUyBndkYQT
WRCDZ+8PM6oppYhBTS/gOUV76dU3y8fS2oRx5TNnz4X29ErQRfl+xr5KZzlhKpT7z89MpTXccY+G
IpJZYpxCzHAG0hKpRSAOwa1t7VUkiFX+4KJHMgoR4iej+ChChhGWz87MMeZFyGQaMh6rHERVHM27
adwKQRRCyaKCRCygFVTfQIO1khymTPEzgKjyiMyTvMdlGiRZQ+NPCaUA8BReUQ4f/WjypMnwCPjB
D3789Ym+fspBdELIhsRTBvZyxWQtrHzhi2DRK5OQ3BVDKN5tcnUTQj5uQ/lTg0axoOqff/rf6jIy
rv/8p78Y6Bsgon/UGgxmWCk1TIXwKzKvKh6VHtW5zjMW8n7PsS72jwHUyM/MMa4rteC9446/w1vc
XXdOJRVGim5Ry+eiQcZR2yxZkNgyOCVXqACjUQja5nC1griF4oWsUVANon9hWBpA54RMhDPGlf3m
ht9pGZX2f56S9NmQU+CaHAvG1Ai3QQTLWmFDa0OsZyEkmBscAlYofhAtvW3w88ti1z8ORhwuWEUC
0y3Cc9eJVc6QOThtWi0jwn77qqs//+xLWwxTNTxm4SZHpE2Qkedk6HiuSoYIl/MTYWFMHyVMpRe4
FYJoCMoQSoSg0eugfofJp4I5PyT1H3nG+9y39wBL/f/tb7frSo5WfRbgvoDnUiEgRRaBYlEzLtOv
g4W96Uoyz0AX8E1Gyqj9ae1knCTsevrjJ/sGbvjNjYAtGptnD6Tk4wPJmJLrTShJOReLK6ggUHBY
4lUy+kaI7MmB5AAMD4CiAD3E018d7/nJT38Bb/kdnXv6WcwsniE2zEnixzcqTYRwqxBzGNxOJ60U
pGQ2ltJiGaM3mYkl0n+77Q6SjCuv3LFrbxK6K61BJ8D2e+KpuMyBUCHSDFbVz00/edvZR0n3CQo0
Wa4Q2gbn6Isvvrzu+l8D+Nt34HBKziboEOsTgEUCS4KUZZAwfqy3ZPbch0awPFhHEkjY4/KhGPMJ
TQXKguQdP28YogYOiN14MLl2XoxTZFOIImkHYPUksv2kElZrap5dWVYO7w9SmpxcEsEl0Vkyw5B0
z0AqQi3CufVcbFeyyqEAS3KERjkyQiZXrJxjMVvUBy3dLJKYfGHmjNnw7v7AgkX0uQaviSY8xWhw
iMSHYPihPvbRiScrLKUdJoUEFatNjGIiTHXRTQG6MjIG0egiKvMWvPJu2vQaAJSXN72ey+oEtWSM
ojFIU4QAwXJWSOQJidPoKEg1cWXqUPAgCmz5DhPQFa1tZBpXREp0eUsbjCXt7WvhNJsG6XlAh9S1
ujho5E2BLZ1Al5XrsiJUqxeIbhgc9GNgKA0xmuRDH1RvQo/KKhpREJDTaZZuULccgFbs8oYXicKr
r7xBa4HHzZ49F44ik1TI1aXlBnP8BLchctoOYh2BmIU47SsSZTBxwSpuJCkqvx/O64W3JuYn6OiL
XzhmZoa5m4PwdkddnOFZlE1nbv3bHVVl5S+/8hqJMmZJxLegmzR2RTgM2bSCGrByNdW4WqnmGJxj
jocfNCcYo8ZkrZ8EKnISqV9TFy9fWTmu/J3N22AkGFB0GGhjmVw8pScDKcKQrQfquCdhjoSxVCau
6L2p7ADsFAAWMfhTn1vWNrW2UdFyUkohgzpJIOqJrG7LEMiYuaGALR4hd6R5s1RSXEll8jHZgH6I
yWpczr646VV40737vgUZlQTYTsTSAHGYJGlfPIXb44wqsMdRwPJ/UhvsbCyp9MUzCSXXB4N0Otcv
59Op1KOPP9U0Y04mk43Fk0S6HdBYWg/CqVFx45ButGUavvO9oExDuGAimAJWhd4ynCQXllYOgzkp
7LHj/6GEyd5K+HY4yluojc//lPbFygwlOdebMuAVpT+R3rV7H0D2zds7iRdTRu91jHH6EpkBYmqk
Stz8IDcqGZc1v5K77UUoqiEKSyXx4xZW1rRgaFE0SzMO7T9UObasq7PbUNQ8UbiG4dwyCJgjYw+8
NfoAlmh4MEVeGTpH6UpEBDF5leQUGhZp22gjVeOzT/77t7/dlojFDUWnDR7KwVtvRidUJ02P4GoY
fJXOyDo7g681Fao/cCM3lGtCtHys3DAA2VxW++jDT6679vpjXxyjKdpBK0faX1DzQ3mraORF9j76
KLTLo1KZFpprFkuE89JSnFpRC/W8E6soiXXJPaO1haufcz1nLD1HjQgLtEJwMJsmnpsAbW+99bbq
8opXXgGYngPsRUrVVCOf1fBCXaTy1ETjc5Y/KWZhpHVu4R6SxTODM7zgX+gVK5JubwmAIBrHFXiS
GsIIGeYJAZCXCPvliqRkOpN9++0tv/j5telkEs4FuaMBWql5PaOTPsxZo1UM0fllHC7J/WQiCwPz
rn2Ht2zbsWXrdpi27uh8Z2vH5m2dm7ft9E7v0s8tHV3bduyC+e2de+Dr9p274evTzy274Te/29qx
s3PXnrff3bJlW8e2jp1sor/tZD93J7Jw6/bN23Z89uU3fXH5RCy5Zceujh27tm3rcFYI7h2GGbL3
7V3vbt359paObTt2v7t1x/MvvrK0pR1asnXHLlgIbXtnSwc0yd6FvRH47HSXbNuxs2Nn19ZtHXCk
m7ds37Jt5669Bz7575e7ug+8vbnDWW3n1o4uZ6ehltAWbt2+A3ps+45OONh3t2zr2t392htvV1dW
PfnMEmgMbBTas7VjFzQSGgxbe9fTh5tL/WC38F3Pv9jXbR2dW7bv3N7V3dMvffjpF5vpV9ip51x0
erbZGThN7i52dnW3ta99dvHyDjhTcO46uraQxnf6zoWwPWx+67btH3/yWTJNgyhKLpYiWuTJrGGT
3KlMQ78r0yAbiFgXBwxFSCF4eHtBnbBgxZxvU5KscUlakQoLXJkDIuj62dc9cGF0dO7avGVrxw7o
og56Xjo3016Fc/325u1wU2yhX9k1Cd0IVyzrXlgCa7L/wrUKK7N5+C/9Ldx/u9h1tWX7jqnTa996
Z4tz3oNnmZyarTvITQH73bGL/aujcw9cybDQ2WDHVnrDsosQNvXu5i2bN29974OPYikFXg9SiqGq
hVQ8uXPnns7OPV2du3fu2LUVLpHOXXD1dHR07dy5ewdc0jt3w3937eq253fu3r69E9aEFWC+Y3tn
V+ceWNLVtZv+aif8HKYpU6bBvmBmB2wHVoafwNY6unbv2gsrs43vZD/v6t5Bv7KFXZ1dO3bs6NzZ
tXv3XiUlG4qWz+YIr4VDqKLE7bxl5GHN3bu6Yero2LF7F2neDjbt2EUmz0wHnWfHAofG1oRGkpbQ
dWAh6YotHUuWtHTv2Q8HuMNpMDR+z579HfbWutyt7XA+4ZC7oAN3dLJt0t7rhk7mpR4A5H760Wew
C3h07tixE/qQdXUnbR5sYTvt4Q7adTt3snO0g/W5e45o90IDOmGCU0A3sufNN9+ZN28+/KrD6d7O
zt1wjPDDTnouoP3spJCtwRODbgrWgY2QE7eDnNNPPv4vUTTleUcawcgi4r0T4G4LdNdEsQEeC8pE
6P9GwEaGr6FvmIMkeGnldZJXzSRl0l3bd+yES7DDObn003s5sc6EHiMXBr1gOlhn0pmuLnLxwH9h
+b69Bx959LGy/zd269YOei/sZPcXucDpqdwFp2Pbzk7n0tpFr0C2O3Lx2FsmFwOcUBgld3TALzt3
79oDax7/ugfeB7gsNIPv0hiKyoiiWTqnz9FsqdjWBpWT0M1h85SuaPBKc+LrE9Az3d17d5Az4Ny2
Tv+7XeF+hf5njyDWb74z5fzWvZ3Jw2f33tdee/P++x84sP8wu/7ZNjs86++ku2CPLHZnsdtnGwAG
9uyC3e3ay9ZhVwL5Cg/PnZ0AC+Dm/eg/n+TV3JiYbHz8xTfX/fKGu6bWNDTOmDa9blptw7S6xunh
qbaxpq5xWk09zE+ZXlfb0Dx1et3fp9U2zph915Tp0+sammfOue2OKfWNM2vrm2Ad2A5ZXtvg2UJD
Dd0Om/nB93/0zNIVKTW/ecfuq6/+Nmy51lmNrV/j2fvUmnqYYMs19U2wd/isa5gBM9CGpplzYMZu
EjSvtuHvU2vdHbHt2F9hO3CAsE5NfQ38q6b+71Nrrr3ul+1rnr/+VzfUN82E9WEFdoBTaVe4B461
p84+0pr6O+6aCs2AT/gVdAgsmTKtFtpTU9dE1qn1/TY8+bYPO6X98/fpdd++5jvdB46sf/HVH//k
Z3B+7J5xWhXsJbera0unDFoDfQUHUlvfPI32IennhubSb70nKHjGG9yN//73f5i3YGEsniJs65TW
E89INMHkAqxSBIuILeWwDKPKsWrmwRqhUyFX7SlSj1T1Wj9FqckHsrdaSjWfXNz645/8nJ7imum1
pD/hLLNehcumjvYt9Dm7YtmNACeCdX4NvYDhqrOvVfpfspBeRbAduAjhyiGXX009uZBqGxqaZ9F/
+S4h94KBn8DG4SdwJ5Im0R+yf02l1zC7I2AFWAg7JfudVnPTTX+sbZhxciAZVwvxlAoAa8+eAz/+
4Y9r6xrorVFfQ+6ROrgfGxrJ+vA5bVpNXX3jFNhBfWMd7L2mDloGE9z59XCwsO/6Jpjgt9Om1dY3
NMEKcJCzZs+F9enCGlgI07TptbBxWAduD/g5mZ9eOxXuJWhzDdkvLCfztfWwENrzw+99f2fHLhqb
IeQnXj6FhJSIanP+4/988vOf/rypeSZsdtp0sll7qm+ErcEM+4TtQ2PYTmEteE7BksamGTXO4UMz
yERXngEngq4AX0mbadtYm9kKpZl6e3fkkKeTY6Qbr4Plv7z+V4Cxglx4Vx6iMNjUOPMPN94MPQM/
hPWhM+GH0BLYkd23pH/sppIlDU2088nuWJ/X0p2S9pOmNrJ52NTMWXNoV5NmwDrQJHhOQRe5nQAH
fscdd9EtNNjHSM5L3VS4bGrqb775Tw0NM7SMNlgY5qqIBZO25qikRINKmKGvPlKLyS3lE3uq4DKt
Pg/KQlbPZ/Vifgi+wqgJVx1c89DV0BveM+teQtB17LSyMwV9Sy4kGINqG1j/w1kjVxG5oerIr+ob
b7vtzuYZs+sbmuvqm2ConU7HO3ZRsWuJ7pFsk11+7HYgu2NXEd0FOTuNzWTNmjq4GX/3m98vWdLK
mi2KBQrSbYi8Oyb04IfFFmoeytV34Kj7eplhWoHE9og3V27psla4heFIyVOCdl2de+fSu5j1GHme
0AcO6yvW8845anBvTDaxjoU7Aq7tKfTih2ueLKxrrA2tDD8ntx7dMtz78HCDldlNwW4o2G9j4wx2
xmGe3u9kpzX05oJm//HmPzU2zDANa4wk618e7/3TX/6WTMkjV66MjIxcvjJy5sKlS5evXLp8+eLl
yzBz8dJld4L/Xh4ZOXv+vDNzgcyQ342cO3/+zJkzMHP+woUR549uh0ywKfj5pcvOdkZGnnhm8eNP
L0nK2X+/vQUeYsOnz4zQ1ez1Lzm7ps1gv2X7unDx0vkLF2GfMMF2zl+8ePbc+ct0/twF0h5Yzn7u
bsrdCFuNHObFS/A5fOo0jGNLlrct+ue/rKEh9l/4Oe0Asi9vY+yjYC28dMk+QDpz4cLF4eHTFy5e
JO25QNtDfw7z5y5chJlSH16+fMlpjLvEPVh3F3CMsKn5Cx/e073/6WeXPv70YtgIdLv3dHh/4u0x
t5Nh+dmz51gL4fPyZXboIxfh75K3nz1n2WmMr/cuXd7WufvBhx9N0RLR/hRgFz2uGLSKMObINJR0
sGi6NpD54qm5YtqzaY1rXhSQ1EdTwKORBQnzAsUZW7fII6099tTiJ55dAqfYvcjhLLPzderMWXb5
wRKYLrMLid5T7rXEvsL6F9gpodcGW8i2eYHePvCfc+fOsa+XLzvn1HN22EmHX8E1z7bAbgd26Z5j
N6aza9YqWOvCZbKwa89egGXJrC5l8/3xjCzr8BYIT5kzp8+O0GsbLmR2tbA2nj171r142B98vUju
u3PuLUDWvHLFbbzTMxfc9d375coV+/Y5febMFfrMcf+u0D/369kzZ+Fxtmf3PlJ1qNEwFcf0g2pT
mUoq8+nH/5016274of34gS6if7DZy54/9qRy28Z2etG5qQN/589fcHvDPRZ33vvH2u+50UgvQZee
P3dh3rwFXV17eLLdBS0/fVodvPhednrs3LnzFy+U2hN44Jw+bbcfbnDWeHKReJp3/vx5thF3Ho7i
kucA4dyxMxt4Yl+kD8YRz1no3nugqWkWUWFV89wKL7Ers2CM59KhClzii9h/l+8qaPFY4TQ1TFXN
ikZWB4AFY+cZcgldYmczcPGwHoZPuPPO0z/vtWR346VLMBy4pwxujsHBYdgSnBE4d/ad77ns3ZPO
zhc7m+7W2FdY7dy5C+7658+d37Bh05LFrXaqnQeqxDy/SHkUgcCbNzTIrdjl0MWC3E2TxaetHFHA
f/qZxRdp710u9fwV9yx4uuscu1zh2nY7qnS+nJvxMru7YVVnsD5vP6bcbV5xT7Tv/nXuF/dOcR4I
591rgJ3fixdKJxQui+7u/dOn15MUYVLJHzve98c/3fL/MfcW3nEcWR/o949sHM5ilpJsdjf7bZhs
x05itmRbtsyyzIyyRZaZmR07MVtmZmYSSzOakYZBLM2MNHq/qttdU9Mw1r7vnPdW6jOnp6ehuurW
vb8LdW9NINjS3NIWDjEiCEWiYMWtIfpkbLk1tuFgayTUGmnhX0MtLY342gzWDFHCGTkGHjuMx4Gz
43J+CZ0s3ao1Z+GSWXPmV9qq9x08CmWdvXlTY/z5yuPoKz7DoWZ6biTc0tzcgJNxJNTSRE3FfiTS
Ik5WP0P0K23qPIiGm0OEsaBP5OYtHT06DXfG5eFQUzjc3NzUgEfEmi01RmlJcwjvi4Hir6wIMbRJ
PBSX0yVoHjsi2qPu051Fw6SnhPjG2jZx8rTzFy4DYOXkLWGtxpRTL1FPC0mXxPUbHWGjz8ipmZMB
Zm8rbdL4hsW1UjOkxvDjZy5cHjF6DABWud1ZUc3C3XhmMru22LPdJa0iNI9JsiXIBPayksz6RB52
kzLhCRb3aZJuGJY8NywlZLHPBNpdtIyxOSAMRuRcvEm0AeIBFbHeiyNCttPS3IhNHjuczEkaBNPM
O7yN3TDKSTQUbmxopCPymIpRZs/is4AeBErDV0FRtLU0ozHNNFPwtb6pKRIOX7pyvfv3PSvsjmJW
KsfldPrzj56AotYueATf4fwIpBJRaSZC1CsTUhNmSiT2VSAAEhXggCo3ZL8+ePiwrq4G1CjuAKWM
7o/Gi6fgE9ywqbERUwyqKgRegBWfDvpi6SR0QUgMfrGY9GtXbgwdOgIdiMmIjpUapt3wIuBdEX4O
Zis2OigaFuYHOdNgX/EZ5uegkxPcVvQDsXKlQ6LRSZOmsRcxizNz+3r17Hvl6nXGRgRsZaNAnVzP
n96MQRSNbGysF48Tc5wEjJA3Au/S24m7of/FEDBmzvfpHWkHBAB0SMLm/IVLP/7Y280KEgfjlhoY
pvjymGc0MMngEDSrqKPJiWUYBZjA+uI2XaCnb0OdLxhgidnqfE4vmwt9+4PZUm+/dItGI8RR6bO+
vkbhpfL0Z8MaFpCL5D26F9OHbgJSDIdbXvosJsgxWgSI26Lbtu+an5FtUs8xYFz2wHB1rQYDecxL
IRmBMIMsDwmy6hs5DX1OX32g3s+9/PPnZwNj4T05cm3t4BZJONmbmxsVauekDpYV6UBvt3LWGndE
5XV8EKQ7cIapQO226MWLV6AveZ3u/7FWuZ+9AMDq6nQ4oIa3kw4UbU/wGtREBjL4AxT+y6EVkA8D
AZFwO3EHlUHot3BLCKBhbkYWANb+g0d7900CvGsP6zs0IvcLwzUqF8Cryi8f4uiK+k7TKdpHhxQx
FkZ3RKMpg4fmLlw8fsJETuVNNFuIiyUaM2aRgEwErGxFy/E6XC5CNQ9Rhwg5JEujjm+kyE6aMu3s
2QvZuYtz85Ywxhn+j28lGqOhm//0PifPXkgfP9Fqd5RYq8qrvBXVPovDK7sIeQwWpWlQLVhmNX/M
TFm2jlqeEn6a1Kg2Xc1q5KO0m5aMrLQ5MhbkZi9cHGJ6UBO0FQw6NAox3CTn5FnNFN1ws4ApgrAF
JasnM1ZLlNkaaSVyYvMoimkRTswF5AEF46A2gGWLT6JtEvxAHhCZffsPZOniWF2pKluV9/ixkwMG
pHDbVUTYmQQwoms1DZbfiJ7CGUJMrjc3t0jWESauBgwcdObcOSHF1fnYTJ/UbFWq8fuEwmjVkcPH
vE6P0HENBS2HX25w5+tXb4wYMbo1HBGNN9wIslB3UWOoPVx1VPrz6rVrFktFi8qaBY/uyCQi8wN1
JmOULS1Tps44fCjfOCMXO+hLShp44eIVQHYOQIX9o7WZy2D5cQuysu8/eECtFS+iyviY/KZRqK9v
oPsIWa5nCGI0QYQCqJG0ABmcO39p4MDBQW+sLLHh6kKDGGr3y1ZuJhbDiYphGyYOSJQ43rCqnZQn
ye+yVfNE3pgLp/r3T05MP+guIlTG8KMRzewWpBJSIZowipDpsYX3LScPLnTU4SDxynXaCH3S7Bbj
1apSBX4C29mydUdmZl6tv9a0yrXRkjrDJcNB0zKOAfOazQlqEgQMotGNS2jzCH1unyYX4fwF2bm5
iyKRRFOYpkNDQ52spL1cqiogOKJhQYk3PEW+P7EI0QwVJMRszRiX4ydOJScPqvEG/qfC7nrw+Pmn
n31ZZbO3R9mEjXA/F5McxluoDXfk+1C/wy2N0Vb2lcEjxRECcBCKtDQzYxiDWewSzR3ao2zmZ+Ys
BMAqr7D+cuDwwJTUdi5zjB8aZc+ifVWqxZ2AJsVOCDeZ3aSdKxOsOwj/MYNQ69Dho7Kyc9PTx9J7
4bMZPIvvyBfq7tNGb9rS2MhwD9sPY8Si6HG0MKr0j9qqkFl71J9CmoOczbVPmDwdQwV0lZm7mDs7
4rvR7G7SPkYHL4It1Nwg91LHtpC41fHT58dNnFxSbuW1tH1FlupiC6uxKGVyj0/TkKDsjHE2CsOk
nWZ5RF36pKMGoVcmizHLE+A8gxisOOhWVFIxOyNrQc4i5kUDhUSZd5BrLWzo8RUzgk2HpvoWACbW
/7Fhwk+tnDhD7KeQoGp8ZSQXZTuclphTibQd7oRoiTLbsPEY8Vux+2AHhEdP12z4lRNzqLmxjhtB
24Da+yenFJVXlld7K+xuhytw+NARcATuGYwy2RxqaWN277CM/xyO6jv37i5dvuLkqdPPnj9btmIl
Phsb68vLy4gNPX32FNdeuXo9K2fhzl17GhoacJOy8orsnLyf9uzFOf2Tks9duICd23fuZOcsPHX6
tMB/whKg7kc5FmxJTR1+7OgJn3ARmmSj5pX1IP4BsG4CYJEBOLEFgni03W5zOqvpCNkeSHMDo+jZ
s9e58+fJFIF3J25urbTa7LZg0J+YKUN54yYQ5oZra422NIcnT5lxYP9Bs1Bur8ON/j977kIbt8FH
mFETIxWVWXlpWanP78U+cOrZ8+exT6AcvMLn85SUltTWBrnTBMgqVF9fb6+qDvFm4LPaUYX2N6lG
L7fHhTeiHmhsrMN+VXWVxgLXxpzF7IRz5y/265vkd3l8lJhUG7ceME3rlaA+tJwNMsGyRKNMAUGz
CjCaRYVmFX6M1nv6HR5W5cZb6652Hc8/OXDQ4MQAS0hrAaFUc0PMM1BTE2Am6uYGDGKopaWuvv7O
vfuq5sAGKMKQd2N9fe30mbMwdmbYnczG6g6L+sCIs/1wePuO3VlZCx02h2nqXU0WiQ4tyO2Ak9dg
XWHCOjkvydQaoPqePJ26Z/78nLxFSwVeSWyykvtKWMENT1Ys+i2NbGtuZLZ/c0NMzMSu3pPs2cLm
Io17M2ePIR7U0dhQXxuNtJw9dxGaId7lf0ptzicvijt36ebx+pThjLbXNTbJUQXCN0lcL8z/NJET
IiyD3JY4ovhQ4+8jXKoQHRlZufMyc6z26n2Hjvbpl8xPDmsc3nq3ays5tNuimtAEES1BGrPkO4/y
hyrtB9OIRnmnkE0vHBk8dETuoqXjJkwCb2pubqbnMQ+6al03jLFoU9tD7yts8qIZ4vWFPcDQl08x
IlHpT/Xxt0LYTZo6I//4qZyFAFiLwpFW4QLQNEkXZRLzK8fsluofjy1ojz+zTde8qGboj506N37S
1HKLzVLlLrW5S6w8dWqlQ8mD9a5hHizjckPlpnWvnYmQUIeSiZhExBsuYLSZ5NwyLuesfFrtjrkL
chbk5IGQhAGmLT5kB0NPXp4m7rZvaQlpnPriK51GpFJXVy+TNJl/WtRILxErIBMhjS9wjLAbqSaT
iBwCRTcM1tSyZ+GJkdCZ0+f69h9YVllVVu0psVRXO/35+cf79ksW92F24FCI83E2qbGPTwD91KEj
jp049c03nbNzF23aur1Xrz4VFuv4iZNxmtPlHj5i1K07977++tur128uWrL8/oNHTU1Nk6fOOHn6
7KTJ05atWJ0yOPXajVu4ZObsebfv3Js+c/Yv+w+htYKBiJ6BBAK+wz/41NHDxwCwWHFlAbD0K9d4
anWf033tyvVhw0ZidrOglUgLn/JRfYwF9fyqNety8xYvXrpi9doNDQ2NP+3ddyT/BI4vXLRk5eq1
n376GV65sLhk1pyMlWvWnTh1Fq8wPzN71Zr1QJCQlyJ+S565agxHK4t5Yl2nsKNJU6YdO3ZCVxtR
taB4/cnJKWfOnG+N+VtjzA3MecrUGRs3b5s8Zfqz5wXDho8cOmzk6rXrhw4bgWY/ePQY/bl1+64R
I9Nw5vOCwtFjxq7bsHnqtJnbduzCwK1dvzFjQRbeceLkqWjP6bPn0f7FQMqr1oDj4Y22bNuZPnbC
0WMnldFnmIz7ojhWOH/hEgEskygf4wxApnmtPCaZsRIX3jFNY5GwDLbHb+xb1BnG6rwswayripVI
AqAH1akxfDGZJY8ymaCIBgKB4PMXhSByvz9AExlKxfWbt7Fvs1flHz9ZabNjH+eMThtbU1uLbgVI
P3XmXGlZOY7jCKgOA4G7udwe3AcTkuhTjWeJCl7PaEkywGzZuiMnZ1HQq6t97kmUF8MgKEqTtzNR
QSGT3A2ehLlRdBmJNUirzldXw3KIBDERFoDBZubIPEEj5gQYaGhslKeJkSBTeKYQfDKPbWszFKdR
gS4IA8jxmoZxpXSkvqFB+BCPnzg9cOBgj8P5P+VV7kfPCr/8ujOGFrAuEm4Ot7WH2trN/jSxliLU
C9BdxNWKWPJIm+mNgHKyFy2dNW9Bha3qUP7JPv0HMB9ja6jd/C8iBf3JEW30kxybluAv1BZhIcKt
pBCwAOQBKamAL+njJkZao9RsFjMcVaLdTRsDTYJ5iVop0DjEzX637z6gOSP+iFu1/+d/AKANzS0T
p844cfpsDrdgNeNpbeH/9D70RmgkvRTavO/gkS3bd/2n9zl94XL6+Im2apZIqcQK6ONhLkK7mgeL
W7BUF6E7VovQLHNsAm+d3TCHfgdqWSbIZGZW9dkwwj0uabv2qgpb9ax5mfNzFkFFbQnzaKpoa3Oo
haZ9RIqxqKp2QMKBaRYUFheXlGpmqYSxlFilhYuW3rv/kK3SUIeMKJDGLsHQQFg+fPSkSY3B3LZz
9/GTpwVEI/Krratbunwl5jjznXELVt9+A2wsyJ1bsJz+Y8dOJiUPEoGfADd6MQ9QlbNwEb4OHDTk
wqUr9fUN3bv/8Ojx0ynTZuJX3Dx16PCnz1589dU3mdm5xSVleMdLV65NmDgFsyTAyq36AAhu3r67
ccu2ESNHb966A5hjSOowTZiqUNhYVGk02j9pQP7RE34eg1XnqzVLrMyLkzCAdf3qTeAPCtXnMVim
f0+fv+jatRvQntPpwosASLlc7qTkgRkLsvFQ9N6gwannLlyyWG2AnhTLvGbdBghLTOqRo8fgfRPP
YK43h4V6g5cFitUkehYmH7/b06dPv3PnL5LXksdURQQPOXQkH5gJL4T2XLt+E5225+f9+Cl5QAoA
641bd9DP+DpvfiagLY589113fD15+tyglFR0e+8+/TBYwZoanG+xViYPGITzHU5Xr959z5y7gLu5
PV6cBogcT6KKCnEG1NI3iYXB+WqCBikPArpkaQkzkyVIsG6WdNQwo6xcHS9BoRuT4CFNyihftZvl
r2Ip0HxHjxxPShrImHw4Ef3QvPB4vaAi6OczZs0dOnwkhm3KtBn4umTZCigbPXv1yczK7dd/QFlZ
OSD722+8efnKdZAcBiIzeyGI7f7DR42NTcOGj/J6fdNmzJ45a+6ceQu6dPkO4yUoR172QYPC4ymZ
IN++8ycArIDba57cP2AKNxMX6DRPrGqck8woIE+fhtcUiqkuQne1MzMzNzs7j9YQmMq1trZAMAgG
C1BbXmEBeE0s/cGZoVPcufdAxKfLTNgIn4ho1La8xcvu3n8QVg03u/f8DCWT2taiutFrauugp3k8
brJpXbl6vVevvpjUBLAKvvqmC+YYDy0Kc51PeTb4PjEU4ryNTU0QG2DW4tngMgDgIrSe4DYoD6dh
AsctS5EMXUSfgDVzMrItlY79h473Sx7ErfqtRLUOp9MfCCrr3SIR3K3a4RQEh4eCTQhTAfrX6/MJ
iseL2KuqSY/HEY/HCwZKSwDY3aNt+NXlcLbxkHyIt5TU4dDmxk+YxGnXuN8VGMfDEt1uD9pDnRMK
hwXCw/606bOgf5CegdcHpCXNHk8k+SekLHWpxrYUP8IMTU6aOuP4qbPZ3IJFSx8TwyBrpS0YrJFF
FFQoIHe2aLCtzR8IoEmgs+zcPKEZ4wTSAwQ1t8ZbWegrGHH6+EmsDpLdZanyWG0uVhHP5jJONEpB
7vokC6Iuod1lkGzTbpRu1O5KUD6o3Lgutcu4JmDi/A6mHsO4OxRU2EG02Tl53EYSrm9qZPHorcxu
j85HX2E6gDxAGiCPu/ceoOswPwEmqDNBxuCkQlUAjwC3xTCBHiDnMG8BRJpblIWfGBfMvmBNbYRc
d5jGNbUAAY18vPAIkCIGFGz6/MXLRE4YfUB8on9cgpY4+TTEnE0dOgLfSOeBIO/Tb0CF3Vle7S2z
OpwOJlSgtbepQZN4NWXRLj+fyCk3j1EOB1iDAbDQjG7dfwC2A9kTwUNy462hwW/asv2HH3qu37gZ
sh/yhtR0ENvgIUNxZM26jTNmzQGzA1yAEFKwlDDCKXiOh5tE25P6DziWf9Lv8vB1XjWmlfLcQQhI
qL83rnEXYSwGy4zhtl69dvPvH/5jytQZ02bMGpM+7sGjJ2S7eqPTq8ReBqUwHAn2MnzEaJqqly5f
G502FlgHL15WbkkbM67rd90PHj6qTOd4uz7X/mI4dfKU6UcOHzOvVuvt33/A2XMXJcdQbJnSpq3b
c/kyF/rr1z/5wsUrGAiCSnj6kmUr0Zhvvul8++59dCkAIk47e/4iEC3w/YhRaURRkyZPw9dPP/18
/MTJU6fPHDt+4ouCop/27vvyy6/xUsDKMlPiS1dZ+8+eu4C2BTy+RDWePf6XZfI0zgBpmjc8cQlh
T8L6kp6EFjWjpY68SDNzEQJg5fO5kJh+FGdOJOLz+T/84MMXhUWgfHTvqTPnoGYcOHQUv6KH167f
xIZvy3bAL0AxAAJciE+MF/p53YZNpIN17twVzDl93IQnT59jsg8fMerh4yfCti2jBGU+ciMWRMS2
7buARRLl/tVnuHX7E9e8ChqVwErkf3x5LF2i5Fv0laoL8CSfvgULcnJyF7XFGyYAZSyVNjBB8Aqr
zU4Wvrv3H/I5uxRaJdEtY7A+n5iJQBFgy7RgFlwLDNbr8wtdFAwW9wQTFk/BWOAObOE2H1+3xwMu
B3wMPkBRlT6//3lBIfgqedJwc+CNCPfC908a6HQ5KALv3PlLyckpLMi9QgVYGH4ZYOEPiGzFqrXQ
58akjwdAw01BJRDPs2bPKyop9fkDOGHRkuWLly4HoRD4OHrs5PWbt/fuOzB77nxskCvh2KrjFplZ
M4CVwwCW1QaAdYwBLG5XB2lOmjIdXQYOcOXaDZzHnjhnHjjCjl178Er7DhwGb5g3Pws0ipsD70OA
gYkfPnocJ2/YtBW/4lrCEL/sPzh56gyoDpABUFjx6K07d6Nhc+ZmgDQbG5igGjR4KJSJcQxgGQBb
YSQje8D+g0dmzp6LPsHT6XEbNm/Fzuat21esWtOjZ280LBCsgfzIylm495cDl69ex/kzZ8+bMGkK
IU60gZT1tvgV6TqIHjEAWFFTgAVBi1fOysmbPnMOJjmOYOwgydBUPBoEB86Lblm2YjWY6fKVa3AC
+pP3ZCbaSSSormKNWd2E+yYGsGxOqwqwSu0upRZhXAyWy8CCpS8ibpTq3QQw6esmmYVwuUwBmVlG
eLuuVqBZIgl+W7wyiDYreyHGr6mpnoVaRFpBgStXr8vMzgUVrVm3AcONrgZywtQor7BiYg8bMQpT
/ed9B0HbM2bO2bZjN7r0ytUbk6ZMAzHhQgzQoJTUtPRxs+dkTJw0FTAL8xzMd0FWLqYbNAqgZOAA
kBm4cM7CRRisn/cdwPDh0X97/wOglsKiYgAgnIAhvnbjFjAW7oY7jxqdjlmAxwGHMb7AR5MBrL7J
FRhNjJSVqTP5CsBqi63waJUXkrM/Fnyatxg7vfv0u3j5Kkju22+7AGeMHDWmoKgYVIRHgMgXZOaA
x23cvBUiH/BudFo6MArmC3oDKj7oEBuTK3X1c+ct2PPzfsKLsjjhE6SVEhwkJQ04dvQEAaxYolF9
8LI7EORLkK5fvQH51KYodYksfw8fP+3e/Qfwa1D7iVNnQOdoPHAGUCAaRhwZTS0uLRs2fBTZKsBD
7z98jKEBWgVvRT8fP3kaPRCX5kBFz9ymHg+wjhw3KjijrCI0BFj098v+Q9NmzMbERLcDmA4bPhLz
kcYULdy5ew+YJF90PPX6jVtoFQGsM+cu4l3QTrwI3hEdjmYXl5T26dMf744pjyGDvHnw6DGeBb46
YeIUoS4SwCJBfubsBYwCN5MEXiJQEy/1T5yM28gKEjTMwG5ebTCoMZ8YpnQywmdUupsqfHNlY1Bi
+hFyATTTpct3pNJAGoKeR4xMA9uH/jNgYArGC/0M8QywDs1q3PhJOA2DgkkBjgExt33XT4BWuANU
I0wKh8OJ80eNHgOkJeMqjaqvLF1qbdu6bacCsDQLLeNpLGhcCtAk575pgn6j1aAdyI7REXrA1FYB
lhcACxpsLFogHF66YhW4B4gcUATCa868+RMnT8O8g9YBzoP+HDpspN8f2PXTzxD0AAM7dv2EC8EV
IfsgATMWZEHagvhHjh4zLyMTegUUTgwZpiQkJiAEYBZQF6T2xs3bwGAxLnj6rj0/gz9j/4P33set
CgqL8hYv3bJtJ6QqdBhMKzDq3IWLoX0dPnoMl6MN1WogIwBW7979oJMQwCr8WrJgtakJHdBuQBy0
LCl50NXrNwEdFvLQM0ju6TNnB2tqRo5K437H9pmz5j5/UYgdvAOAzo89ekG6gJv/+GNPEAqZbeQk
TFxmkwUry1JZTRasKGfueIfvf+hB4BR8HK1at3EzvhYVl+DNuVV8EDoFO9AyQdwg4ucvCmo5/gNN
Q7qARm32qq+++rq4pAxcycPeqx3XQl2usFR2/a4b+KO1wvLdd92Li0vBXocMHZHDVhFOippYDgV9
NzQ0po+d8Ox5AXamz5iNV6uvrwePg6bSp29/sDDs4CnoGXxFk3DJnp/3FRaVYAcvhZ9olZbaA4lM
lDGAdfJsVgcsWOCPQ1KHoWEYsr79kgBnx46b+OjJUzwRWuzdew+SB6SAF+OeECFLlq2AtMBpaCTI
F/z38dNnSoSWiu65KTXmij599sIY1YIlAyzZgqVdRWgQ7eQyzqSgD07XgiRXmVnVGsPq3ca5THV1
MG0JSx8aOSVLbK6583Mwr/gq1GaWbqQtCu5JAg8EDwgOosKRXw4c+v77HzGTgS227/wJSOuHH3ti
vqDPsfP02QtMH8hCXAU1F9SLuYPTMECgqJu372JOrd+4hWP6wwDNNTW1gO+4m9vt+fHHXmDcEJO4
G5712aef33/46PzFy2AlIC1wop/27rtz9z7BuH0HDqExUA/IE0QWLAjy3n2Ty+2O8mpvOQdYZMGi
iUmxuhGVD9B6NNADhAfuDBrD6z96/LSxsQmzAJMOShHeBUpk3qKlOBMNBtOBgkGGXjQVIgegk12Y
txi8CTf8ae8vQC1zMzJ56Ge7HGemGrzJgsUBFlmw3D5w4aBBqkMqURIIuLxBj//61ZvDO2DBIhUC
mtXAlCHgZug6KK9g3xg+HMf8BXICooVERMcS5wEfA7cBGwSL7/79j+CwIqWFHCEqLME8+kOE7bdP
mTqDASxDfw17HQCsgeQi1K47a2oK1tTi0YDm4MkvCoqGpA7HNGdOzJQhkOUAUgDT0HI//+yLm7fu
gHhwMofRl2gHFAhugMH64ouv8JqAa+AJQN64CsOKt4bUmTR52qo160VcICWFofaDWpKSBgZE4cLE
oVGJy+AY1gR0m5f4fWlScrM6lcaZCAJmNZJrvayUSoB7qfKlGKxE0Rd8oSWUn08/+YyIYfyEyZeu
XBPwF+Jg/aYt3IK1DdM5EAxCYGPCQuWGNo7j4LonT58DtMK4QJSA2MjeDAK+9+ChkDtiR4TBKDHv
ra0MYGXlGVeXSlBT0gyYeowWY7pN7qaxDnqM0s8a2i+Ncu0KgIWJoFiw2mKdD4Xh6rWbmIB9+yYB
YKDbgUl27/kFrBJcBeJsx649AEzgqw2NjejPnr36ABWkDh0ObQRTErAJkCBlcCrEMRngObfMwrjg
VuCQwFhgy2CweAQGtFv3HzCOvXv3BYurr2/4FAz2wSNuK5mHOQ0YvXP33nv3HxKDRXvQvJZQCPev
qrbT5D1//hIz+rq9LNHow6fcghUPsDCWI0alQQwAUBPAGp02FrcA6IOiAxbjdLmhr5NpZ8u2HYB1
ABxg4mjZP/7+DyBHMJS0MWOfPHsuR8RLkRYMYM3OyOIWrJiLEBhuQVYO2fo6d/nO7fGAX4N9g1MM
HzmahQoWFEJDBYZbvXYDvm7dvvPLL78GWgQfZ6FCZ8+PSktHM775pvOzFwUgaOJ96JTbd+4BZ7z/
3gez5swbO3Z8WtrYp0+f410Hpw4HYmMWrFYDFyEZHsPcNotBwnOBkaEppo8dj1eDdMFQvf5KJ/yE
kQNHvnT5Grgh+CD0Eo4LS8HFMPH++Id3ARkh/Lp1+x4AXGCsBACLBcZ22IK1aMmyrl27TZ46A23D
BrKbMGkq+hDNxrzFhIfsp9kL5QC9AXLEaNK1Q4YOBwZHDwB0Hj12QriAZb8h7jBGsmBZyEXIAdYf
f//uX3iaBpHJPWbBMi5laJRJIeY6jM8dKhUq1lYVNEjQEF9Lx+YyDnhPkB/LLOZd3V6U2+fMz164
aAlfJhZqaG4KR1qZxvmM0RLQ/xlmhIByMgxiDEgI8xOT5ef9B6ED9VNWcrSlDBl65uwFMGIW+Kim
FuzXP/nipauAF+AamMwQe0DkOBk9D3KiACbMf9AV+MiR/BO00Akn4ELIVNx/2YpVzSyWawnmP45D
2YLK1qtXXzpzEJv/Dh5n2H6OAyxyEcoAS2/BEpmcCG2JFRKRWB6HWLQ+TRwea9/60oBIkQVAE3+q
xvVzgMUsWAO1Fix9aTNyEbp9BLDw1h2xYNEfOBsFMGGkgHfJXe5yu6GceL0+DES5xfqisIjsu5g1
+cdPAiujJ2tqazUu/ijPsyq6RWPBUgCWxyypphcAy9CCRfyzrq4elEA+EXA2ipcCy6VQistXrgNk
g0gg6UEhAGHgMD4/2wFjxws+ePQYJ0+dNpMuxH3AuKjbfX7/BZxx4xYxZylkWAAs1YJlHK3cAbDl
ManlZ7rMMKCtTJc4NsigvKNJHWht/UqlMbU812iAuwjZXBiY0hGAjj8QyT//+RE4/PzMbKjfYWaK
HoLuxPAVFpdAXkDTgCoLNRt8tX/SwLPnLxYVlwDBA9yDXdy6fRe6U5eu3TAus+dmWKyVICrwEwxc
i6riyvA9zoIVUQGWxwTZ6EPiDPKRmqwB1Jd7Nx2FhGky9PWRPAYrDRnAcgeC3gABrGzJRcg6JC39
8ZNnZF4h8Ap19ODhoz169Gpqbl68dMW+A4fBA9HzZH+FaDt24hRUCKJ26rR+/QfQtWCYAEyAX2eZ
PtOOiYDh9vsD0FsAf6GF9urVBzck+UiOeMwOsIKly1dRzOv2nbsJe0Bv6dy5Kwv6bG8Hm3W5HLRc
8cLFy337JoNrGcRgkemTAjkxJ0PhMJ4EvRP32sqDo8FlHj56EggEx46fSGmmgcTxjLkZC6CCF5WU
QtJT1lQ0S4QEqZE9UZH/Iyt3seoijAEs9CwAPs4pLavAc2/cvI2OQDc9e16Ax6Gvwd3wUNDuxx9/
ig5q4eubjuQfR/PQqi+//AqgECDs66+/BbgBUwO3B8ueM3c+mAgYU2ceP4huu3Hjts/rZ+g4eVDi
GCwILeKkPp8fYg+KCJs8RcW07AvqLwAldT2QzfmLV7w+H0YaHQBQjN7H+OGJkLXYKSgsPn32ArqF
GHGi+HeyYE2bCYCVlftyC9ba9ZvQP8SOITPQz2gM6VUUWQx4XlJaTo2EyK+02YcNH9XIjYsgIFDP
g4ePj504TfY2ORSDLArMRThhcpndKbsIAbCeFMUnGtVasFxm4VPxnjjzstMGudp1+wbxVYYlCI1q
IZusFjRL9IBXnj0vEwoWy8rbCupvBUEPHToC8x/yCdgIZEbZawGwwFhBPEtXrILmBI7Zo0dvEpY4
fu36TdASCJU7mrdAYANFUSgVbgK0BJb98z7m2gPkHTOWUR1AGy4HQwc7hpinmHSQN5j19Zu3ISEB
38lcsefn/Tt37wHXwMlgQ4NSUtG21GEjmBoQ5yJ0llV5ymMuwkExgNWqZIeXjZr6kFs5KylZuWIL
X5QVrGGhf5Mlm+5GeKU1HqXJC29jMVhJuhgsI/6uAizfjY5ZsNrUYgwhJSMRNScuSTotn9QrG2E1
VZi6XLpVv9LZGGAdPmaa1YlbsGSARXeTG6npf80yI1nqE2si1OtyuSHml69cnbEgm5RS1mbldVvV
tO9hNeA17p6SBcsoBisB3Hl5ldyEXkWPSUr3Di1qC5gEX+vq68W5CIOUyV0BWC9zEYpFu0CxYPJn
z1+6dv0WUQiEpsPpoiEDBz515pwwdpaUll3jzBmq79FjJ1lMJP+DegZGwUAV1y7ATEhu6ssbqAAr
rHURGsZUecwTXpjlztCEYZkFrmmzZMmJ3RODMF0pHrdfAViSi1ATgwUocv8hc2QzU9b1m1AMgA12
7NrTt19yY2MjxNnuPb8AIUDGUSRPnz79IfKAHNCl+Lp+0xYMwZChw6H9RrgFCyIYDHbfgUP49eDh
/HETJoHB4jhGAVK7W/cfjp88nTwghdj199//ePXaDfDYvMXLMFOgxwJ+AQtB94P2cuDQ0SE8TTra
RkHumF5s4W2/AV6Hm5fKeVaot2Axw0YqWxMEgAV5cPHy1QqLFS8wc9bcEaPS7t1/aK20T546Q7i6
Jkya8uWXX9Oy1QWZOUAYU6bNmJ+Zg/dv4yk7ZfrgsfdKkDsBrL5Jg2h9BDrrt+/8JjsnDygepAkw
h9desWotbpXG19EsyMpF1+TmLYbUQZNGp41dvGzF+ImToa9DnHTv/kPOwsULFy39/PMvoTFs3Lxt
3PiJ+Pq///r3de6OyYCeMW7ClCnT0MiWpuYI5cHKyRs33tRFKP6g3a5asx5wBG3AJRgJoDogQswr
CDM0AAOAmz9/UYihpcgSfOW+ns2ff/YF+pBkTENDo1BMO+Ii7EiQO6TCkNRhGAXgp207GA6eMHEK
LXSCQl9eYTnKKu/2x1v//cO/g9tiVmdm56Lfpk2ftWjJcmLNInxESD4y3YHtgjRlC5bV7lZisGJp
GkqYBYtnco/VItSXZ9bXaTZIzaDLUGpYSdAs+F0HnsoN72ZPtFNud2mTYPFfi6zVM+bMZyEvbPE0
C3Kvb2xKTx//kAcIY04CJKFvh40YtXvPz1CwMMobt2wDBgIzBQACCAazgPKKk3/a+wvYxLyMzLkZ
mTQ/L1y8gvOhaWEyF5eU4SoMDbQ3skMMHDQE8x+ct+t33Wtqa0F4mKHzF2S/0elVcB+QN8gPj8bn
3l/2g4N06fLdmnUbAePQGPAdXA5FRQ5yl12Emhgslg6KL48Nq8s4+KIeJTiPkBABESJj4VcSiVrC
aqJLOYad2B+BFdlCIy8XYkAtrMZgEcAiC5Y7zoKlWc0U9ChB7izRaAcsWGqGi9hMFGUxmCFKgXpR
0q9YWnkqAhbLD9kuAJkZxzBwESYAWG5WKkfvIhS4jR4nCrOIcEn8rrSft0oMhFyzCLwIKjvU4BaW
TTys4cYCYtLLxqBbqwhy5wDL7TMJWA6Y1rbTrCs0z54Q1Ji1ElfdSWAYe/kiuIAhFmExWHEAK6WD
FlBgKSZZvT6l2lIkrr5NRJoverAuBkuJyo2LUdaSa5siasmmFYlzERpmrtIvtzRbCmCWW8G4dqFR
/ncJzwUNssPH3TNodFwJcmcXxgW5U3+OHDXmMQ9Kg1ZJLgIADKAcSDRM4a07dvXq3dfr84MlQgKC
3UFA46q9+1hU6IxZc2bNmUeXUJQOEAVQWmlZOdh1bt4S5ql7/sLt8aYMHkqrv7t1+97vDwA2QKTO
z8x+54037z98BGS8eOkKFoqambP/4BEAOIANwBU8EWwcDHl0WnqlrZIyx54+fW5AckpQjcESFqyI
sGChHYVFJcEahqMfPXkKMAFwDQ34xKkzpeUVxJsgtglxY/ghD0gdp6o94O/AE2KRnSZPjwhyny3F
YMVchJk5gPC4IbHmkrLyYydOoXnoEWINuPPZ8xfr6xvQSDQJ0AGPI6aA3jl99rzb7cF4QLe4c+8B
Ti4tq4D2Bg2jnVdRxLXXr90QRU6GDBsJgTfexEWoMq9WWpBZ39Bw9/4DwFt/IIgeuHDpCjnUfD7/
jZu3MdlwczydAVP1fJxcabOXlVcADgpGpky5BBiLpZNQXIQdsWDxhVp1womAZpeVWzBqeJeComI+
uO33HjwCMgb+s3CNCj2G9l+6co1Oa443VGhyjJGLsNzuVFYRcoBFqwj/+HsW5C5lcpcAVgLXm3kw
lqZmszb6Kh6caRcMGoItw8ZoEkbYXNobGq06pCB3toowikFsaQq1gIYguzC92/kOBRU9evLM6XRh
3hLNX7x01eP1gp9euXYDc1vxO4cjUHZB2zU8QxVQlJezaVxFd4N2cehIfmFxCSWjevDwMaF8jKOY
CLfv3IP6i+kNaidFuQIzyuEkTRrU6A8EWBKHpmZ8ZVko4wFWWbWnvBIAS9HaRQwWX0UY5bl440wa
eoqVBXYkEtFQTmNTk2YBlN4kFrtV3JopEeQe7yLUVJyNWbAoyF1dRfgygCWMTNIa4Vb9Em6araLY
opSlrFmzRFp8jZUkYwArbBCDpfFnKW9kbMGSF51o1pRJNuaILJiFBU4oS/LLajBxbDlLJKIDiErq
15gFy2NeQfmlZQHdftMwHXfHguLdHSifpzOPaVM5GGYrUILcfQE1TcNLXYRy3UCIABoLoT9o3Lt6
CpfTXMnG0YhKYzyYL6xZbkXlPrUAKzvPxLbkN67LZJYD1pNg0V/AGMCZ5h4LGBmuTOyL/KdaT1wM
VnZuHjmUqGfAEgmKABgA+qDnnz0vgLQlYYfOBInSOgPAIMZg1VSdBYVFx0+eoUhx3ITWmYETutxu
HsZtO3TkGJAGd+5H7vG7YRChr4Z4YWXgCigmt+/eh+IBGUqLi/FZaatiN3z2gkKuAZDwFZBLZDY+
c/ZCnz5JLMgd4gQASx/kLhiHjL610d/x87ZFXV5uuPxB7KsL02QX4TFuwWK4LitnYTaBCUlTNEuL
pdHVyOkmnw/4OWHiFIC2SVOmKVUe+T0joRZekITt82LPS8eNnyhchBodQggVmh5yAlU592nMpdjc
osFnev4YeWlyrGgsBqsjQe6tqtlAzHx6dCzkVlWwZPVXw1hlaRozSvPIytNnyUWoBLlbjILcdRYs
bQRVooio+CPleueg/kyzDOx2s9rP8fWk9da1xJY2fpAAVu7CxRFmgwnzbFjh9raoTAaqH7xVlNdV
jqtOYU0yOTl8VS/RDTVameSU5KJSilFR1lRvWdGsIlTSNPAYrGTmIhQAK0SJuMQ95Zhro0kdEySA
feQn1cwC2ZklUsgYcgzeCSLIfaBwEcZWEeqipznAIgtWh2KwpFLWUT0EkVbktGpEYBAMtaZWCk1r
k21yYimuMcA6fCyoj8J2m8VgRQ39gAIYUW4agnoR1QItr/wFSQjZryEbkbc2FBcgG5LHVKSZUNI0
UAyW2v6gYfU6s7hmw3VnbhOpnChkPmDcgYY+So3fKi4c3mgVoWrB6kiaBjH0oruU6jex0Y8SkTSo
i2RFmm5JUjQLAhOQSzcj4sIZo1KuUSUGS5+mQZdE1HgxpkEmCwOQGtSPr4EJMGCaed+wNqIOghut
ImzVTUZjPCAjEJmLatiO7G0Px0UjkOsmKjz+shCUPfXx2aaisiVeFARj5U3DlMl9sKfaqViwvtak
aYjnjHLGQk3ghbCCCnyjSW4uXl5inXEWrFgMFgdYpWWKpafVPORcje2IO0HlPiG5Z/F349adE6fO
AsMqootOg5CgIs3t7SlDhmXzVYRtLKYm0tpqQNAxjhO/+k9zpsgQrZegGvrQpFUkC1mcKFVchDP1
ACscD/jkxLWxQOOYUSEONZJ0jMVeSCQoYjIoHkXTsSfOnB87YXKVw1Vhc1odXpBNma26osr5tKj4
t+/8+r2//PV5YUmxtarMWm2v9pRYq4sqHcWVzrjN5uQHaWNHlHNsfKs03BzqaQ72aVPuIx+X9mMX
FkkHY6fZ5NOUncIqd4XLV1rpuPPo+c6fDwNC4ZwiO3s7S5Wr1FqFd7RUuYstVdZqD+BjhbUqIzN3
ftZCFqPUSuKzPRKOST6NPJP7UPyksYhIUKlV1ow1pCIHksvlCmQTkWAHGlgm3HBiFWGffjxNQ7VH
BLn3U+uvUXG0hsYmp8tD1tmAmpQOjamqdjQ2NoqU8QHonF4vHg0NjXLK5yxclJO7CJQm51b1eLzk
4aq02SnxDDGQurp63F8QLdRTp5I/j+UBbo209u+ffPzYKa/DTasIzXLqCIClxGCpAEukB9T0uQYh
mWmGoj+LiktpDfXho8eOnzwtcIng2mKg9QDFwEVoYIbhLkKTNA36P6/Xt3vPLxrMKv4AAin12shR
aRTCr+GoiTLw6fJ4xcVgGS3dDxpmBDCsaR0f3Rw0E9jaks8Bg/xMRpH12iSuuuJ3JriQx2C5fTEX
oWrBEllw9ZxcjrrDjJAnsijAgDl7596DSLxPVta0MWswobw+/x2eM48ep3gbdUhCYgg8Y3g0ymsR
5pp2oHH6sYBZuizThAsxkGpU59s4MMu4SA4NSlBXMMcsTYMAOhqKNQw91Ot7clfL9pHYCk1dJ2v8
tnr7rh5yKXgjGqu8fI6vImQuwnLDNA3xaMYMwksyICSYfpOa0lNvcIpn+hxgzSMX4THhIhRIU0Yq
eteDFH4eqxtPj5ZDZYnQcRXdDQ1ooa7ntQhZnHJbG6VpGDtuorwuVH5QS/xrQnLIbNTMwM7KifEa
KZrZpTHLh1VjA32NFbdRLFhagCV7MeSliCJqVRhR2uLVcY3VWogc5jZqbZU1b43hmi7MP3Vm7PhJ
5RZbmc1RVMEKEVocXku150lh8Z/f/fPvf/27x88Li8nyVFFVZuO+wir2STsW9avyWU07Lou0XxE7
wSVfpWzVyt00myX2IJe079bfIa5JykPdhVbni1Krxe4sKrF89XXXORnZRWWWcqsduIpDK2a+ojOL
LY4yu7vCyjK5s1I5LEiFqppIpWnUlXFyZ6qFkqJysIuYwMJfo9EolACgeG8aL18Tt/7UsLICtScc
XzaHZqicpkFZRchchP7DB48mJQ/k86W1piYwcdLk3EVLv+3cNW/x0ukz5wwcNIRKFGTnLho8ZFja
mLH19Q0PHj7GTwsyc5IHpOQtXjZuwiSchnOWrVj96aefp4+bMDptLPDT1Ws35mdmz5g1t7CoZNLk
aaPHjO36Xfd79x/i64RJU3LzlnTt2g2QBS+178Ch5AGDcDeeK6GVxUSqLkLoggGX1+fwGQT6iDxY
yirCGxoXIXU7ZBglNUUXOpyugsJiALt1Gzaj5dDBCLKsXrsBL4ifqLu27/wJXw8cOkK5ab79tktd
fb3T5S7jMRInT5/NzMo9eDi/hcdFFRaXXLh0hSXmKSySjNwywFLzYOlEPt/0aRoSrTJuaGjEiGDQ
nz57gfZjmF4UFgl787kLl77//scXBYWpQ0csWbZyybIVV6/fJH547sLl7Nw86orEGC7ORRizYJk4
7AxyTRmJXqNkmJqk6kF9fE+CtO9uSWa7E6V+CGqWLsZjBWHBCvA8WMlGQe5yERVhWKL5dff+wwkT
p8TLWvYTwFOXLt85WO7KiOxnoD8KvVi7ftPzgsKFi5YIoSZDBI3RkWYx1b+D8IhLNOrxmxgXTfrT
4zeOhTc0EhumhDWzO2oq8HiMSxzK5aX1Qe7ReLElRyLquZ/IpScuARgQAQDyVXpUI0eU0rpaksua
84WOKptX5OXPIoCVyndiOisA6+FTyUUYjcVgaXxkIooiFIrVImSF4iXvIV0lqnSZOUQ43JHTNMQS
jWohVLO2WIHSBfG+7YiutUJEaZBpmGeiamUIJtoaVlyEWbl5Y8dNiKoWeEObmeoqDevWzUYp/jeu
kBw9S60x5/MHSKzK46Hxn4bUBd7KE+MyuS8FGKWDssymeY5NY8nQeDBb2F9I/kmFrVpEFQzWyFYH
2b516vzlcROnlVmrK+yeUpuntMpncfhBPE+Ky//6l/c++Ov7T4sqCiqdFdU+a5W3uNJdgf1Kp4Vv
FepmsSmfbJNOoK/6ky3SVRXSmRXyaezTEf9Ve47mfIt8WrXfUu0vs1Q7HJ68Rctf+1WnXr373r51
p6zSARBWWFbJAFa1T0FXVV6r3ckAVnYerxYJUgkL8C0GRWAdHKRoKsljG5bjfkR4MkS+PxCIqBPb
cBZojKl0GoCO8NlRzkyZbltU6m1UkvWHlTQN52MWLHIRAsQMSR3Gw31CPp/nk48/efK84OCRY//8
x0egngVZuctXsvylQEjgMoBQuXmL7z989O///RgkvWHz1tFp6Zgac+YtuHb95uatO374sSctdgF8
+XnfQfyKBgOQkRHop72/rN+4BTLp439/4vcH9h88DNCGKQzsBYFkrbRNnTazsbGeB7lH+/dPVoPc
fQGXSaAJW2AYVBON3mSJRsMKwFKs6eEw4FSPHr0IJi7Iylm1Zj1eCm8BVEerrKfNmIX2U74SlmZ5
2Yq0MeMuX72eMjj1waMnczMy//b+32pqavFGkIXPnhf07Zt0+uz5yVOm45yGxsb3//r+mnUbAWV6
9+nXrNoa24xjsAxdYN5+/UwTjer/0FF4NGgGzwW6WrZiFfpcUMLGzduAcU+eOjtk6PD+SQPwjv/6
6H8tPDPq4CFDIdTHT5xcwAFZYgtWVHURKgDLsJqvO6Hx4yVJrXRJmAwQm8nafrd5Oi4D84lZ8JAU
g0UuQh3AouwbBKlBOcdPnqGhOXn6HEjol/0HMdc2bdmOuVBeYcU+CB6ngZAItXfu3HXdxs2AuUBR
mJ6YL7t+2gsg/vT5Cwawzl7AbAJ9FhWXYKJBtcjMXogJQmU2iopLDxw6CloFRNu5ey92KLxSKUgc
iWzfsTszM9fr9BomqQpq8ojqXbT6OpIGUVMdG0r5oSbRWjobZGw6S5nc4wCWoRpABi2qCBkIBmVL
PykYMj6hO1TaqrhnX6m4IPup5AU6GrnM71/TIKE3EV0TlioSSmtilMmLiQyAxfJgUaLRrySARZnc
6TGiaoe+UpjEtSOy/U3WmGWzOVm8JMuq7CIEwFJWMFFkX7xfs93QjG+IQzULglrVms2xTqRuZZXq
2yK8qckDB4Pvp48dz1fNKE7AFo4i9WnlNM3QNEm2RQGsLF2+CugK8+2nvfs0vReJB8jia7MIfpRc
hFIeLMXUFIkPnJLWZmpDXjQmUI1TWQ4gwBvPnbfA5fZoEtzRE4+ePDtm3CRrlavc5gIoAYQqslSX
Vrqellh+9+vfvvPGWwBYxXZPRbW3xOIssrjKKl2lVmdZpdhc0r6T/+SK/0n5Wqrsu9R906/sEbo7
06/xx126J7Jb0d0qnDXlVf4KvJTFfuvW3d/95nevv9Lpk48/Xr9l17OicrvTC6SFM0usjvIqT7HV
bbU552Rkg3SZMznc0t4WalOX3cpUCnoHDUCejRiZJjzssjIkrsLxDZu2yrmbhdlVH0aNOxAlFxYV
Q5zjHJAWLWCWiVNQUSzgWqW6VjXIXViwlBisw8f69x9AcxAA67PPPg/W1l25fjMpeSBVU1izbsO6
DZt79uqzfOWa6TPnZOfm3bx9lzJsAVFBfuDRi5cuv3Xn3qKly7NyFvKkdBdGjkrbvfcXKnuAE27f
ubdj956Ro8ds2rLtzr0H5JQ8e/4i7lNbV4dnAbssWrIc4r+uroapOq2tVCoHrIpisIKGyrGbAJY3
KGKw1DQNMiuYn5m9cs06DAewiMvlxnPvP3hUXFI2cNCQmtraCZOmAFo9evwUYBePvn7z9oVLVwBK
Jk2ZdvvufXztz+vToXnLV63ZuXsPVQO8ffceTgAn/OKLr3BhQ0Pj119/SwsdNDFY8Znc4z1rHoNE
o4nz5FmsldNnzg4Egl999bXP78e07fpdd4/XS2SAX6dMmwG8hTHFKKAlAwYOvnHrDiAvxDleeV5G
5uq1GxJHgor280zuA2MxWG6DZfYJK7HoPVOBoD4cKkFEdqIAo4CBfYXL8qAcLuY2x1siTYM7BrCE
i1BIIhBD9+4/ApuOGJUGerh77wHmLLr0xx699h04vHjpCqgij588A3hiJ/BqRS8KisD/cTwrJw9S
oEfP3hgpnAn9AfCrb78k0Mn5i5dBk1A2cNWxE6d79+6HGTQ/MweaAG7+m7ffAcACZX788afbdrBi
3nPmzufyngOscGTL1h2AI4kSr+vrMZuZG3UmKG3+9/i1AkHD1Awek0I6L8vuoViwdKsIpboCsWAk
QaI3b92BVhY2wgm8jp2ivm7auh08B4i2JT5+Q0EIkqVfuHfAJRYtWdbU1ATIC56Am2hsPYrXTgq8
01mwBigAi1mwvo1P06AqxODjaBYYK8a+oLA4Oyfv4OGj5HHbtefnFavWUAJ3r88HYjp34RI4aWl5
BVRSkBSFUmnYhOQyM040KjJHC1QE9RGPBl+Avkh3ePrsRWZ27t5f9rfwUP+Hj580NjYBH4BMKYwD
VAsxAGx77/5DtGTvLwcIC7KlASR7uIswzHuHxWDlLpo4aSpbSRe/uAMkTosEwX/xUDxl+86foGFQ
UlO0c9/Bw5gMlL4M7OzosZPQaSg24ur1m3/74G+4A6ZKeYUFnQZunrEgG3yZ+uTx02eFxSXrNmw6
ceqM3gGsWLCmzTxx6hxzEcZbsOSTbfYqtG3VmnX7Dx2hfoOozlm4CKKXzFHQtqHp4tVwGvSnCkvl
k2fPV6xei1cDq0X/rFm/kerAYyZX2uwhaWW+MIadPHdpzNiJlXYnUEd5la/Y6rI6A5Yq751HT//2
wYd/e/+DRy9KXliqgUIsdm9Zlb/E7imxudmnnX0W29y0lYjNTptH/erRfxar+8W2+JuoVxXHHqE9
XqzeVr6Wnan5qTrwwuIstnlKKx2V1a5ho8a89kqnV3/1q1dfefUfH/172cp1RaWWChswVrWlysMw
VqkFAGvhkhWscnZTA7P4MrzbpkmbBHa8YtXapctXgifaq6qtlXayXxYUFmFagT5BckePncB4gTbA
ag8fPY75UlLKCiRDOpaUlUPfAsGA0lauXufzB0DYoGGAqrzFSy1WGwb3s8++wMhaK220NAYzEYMO
6mriyUceP31OiW2hGcu5ElSAdYksWCrA8p04fhpwh4P1sNvt/PrrbxqbWy5cugrQA3IFYMKE2vPz
vlGj03EOZACABd4Rij5eYduO3YAdlILryrUba9dvmjqdlX8+cOgIdnAV1dG7dv3m+AmT8S7gIYBr
mBos8UxzM94REAfUOCiFfdbW1h07caqpqb6NT9Ikpdizt4ajKJ1TQ2H6casIpSB3NTt8hNZpjkpL
3/nT3slTp7ez0shZlNNkcOowSjpPlRO//bZLtcOJ09Cerdt3Qo4CSuKV0RW8ZOwijAgwMRWkgkxN
GzMOkrJbt++h7OLtvvmmM42IQS1COZO71n7jM0s0avhXXe3AW0Ar7tbtB6fLDXXuyy++orQskARo
P70jQKGamC0FGBHMiqVcvnsf4JL4c2IXYZsKsLi08JmWu3EbhjabrDeMNz6Z1rnTRLXrfIKmpQZf
ih6Mco3yWoQ+AliGQe7owJOnz4KjYmI2NDT4fH5weEwxAKz1G7fcuXu/V+++ZFmEWgXlYfCQoZeu
XMOc/fzzL3l8M7ObgrpA8+DYYBSQFKvWrL989Tpo6dr1WyNHjcG4fPLxp0BgDx4+xizDeOHmIAOw
C7o5TgavEBas9ijLdZmVledzeROvDNCHyhklfTVMxKDLgG8cLB8wXt3pMUn1rsO76ipCNdGoFOQu
WzHIBUTr35cuXwUlYfCQYS5e7ZcsPpTKAFABPIeq55WVW9B7h47kg0NW8GWARWDi1sr6+ga2zvrc
RfArWmVfV18PvoQ5AhGJwf37h3/HfSCjMV6MexQWgWmDwWLsMMVwHCAbg0VPNHQRxgCWvhYh93xF
wVOGDh8J3DlJyj8AAIAASURBVNCnb3+8CaAAIDZEAiv5B36Rf/yHH3pgVoOi3nrtdYCP5StX/+tf
/wvACI48e+58eX2NiIIyrEUoVhFqyk0A04CywTHxqmgDAAGYV+rQ4SC1SZOnoRPRTRAGUBTAYsDa
QP0gdwAFaBIg0LHjJx4/eSZ93AQcVAwD5IYD8sAOpfsaNnJ+Vs7YcRPaVBsDNRV3TksfR5ZeiIr0
sRPQm7PmZKA3Pv/8CwARjB/IHSMBDgs5d+XqDVb85PrN7t//eCT/BEbi7Tfe2HfgEIQcNjQMv6ID
cR/0EiX7HjZ8JNoJhg5JKcSAEvIlLFhUKicnFuQeYhkdYx5JcMzvvusOJgjVGboUJTXFW4MaqEIZ
eg/3F7WPNm3Z/uOPPfFekN+45HD+cVb5dRqTiOPGTyJi0v+dPH1u9JhxVdUuq81Zaqlmth+b02p3
Pi8p+/Wbb/353T+9KC4rqqwusznt1d5yu6esyo2tVPpkO3a2j0/xa6k4qD3Zo27yJR7NJ7vWTr96
1NM88k1ij5afa4+1pNDqLKvyFlkdpXZncYV1z/5Dr3d67bVXXn3j1dfefO31V3/VqVv3Hjt+2ldQ
Um6tclZUVlVYq6bPypg7P5vMT6ysPbNXR2RjLTQNcEb0GGbH0GEj7/DSe6z44LUbczMy0fMsc+/t
u5hcOBOTHOQEVjsvI3MhKzUTgfYGxgHJ/e7v/oA5hUuoXjLkOihwy/adXbp8N2nK9I/++a8Tp85C
yYGwBLvv3acfqA4AAvwCYgDcAXfbsm0HZg1le1IMZmomd7GKkAe5+44cPiaEisNR3aVLV68/cPnq
DVzOQ6/yVq5eC6Hes2dvzMRvv+0MJereg0dkgtr108+AfWTBwqQDc4DmffBwPpoEVR5wiugQXGLM
2PH4BL8DUsRPZABD+1OGsAw0mEcg5mUrV2OOYC5SDBZEOwCWz+mu4SjKTEtWXYSJ8mABCwJUff9D
j/sPHwMMDR8xup5LSgwEGC7mC6/zGvmu2/dUuJOSR+NumNR4L0xYvCNOg7LHX2pRU3Mz+gFDgB7G
HATQwez76qtvvKoFy7jYs3EWA68myD2xBQtsEC0EHgX3wKeHu6KgR1EoCX5NHzueYAGlq2Z1Fe/c
AwKmpGt4Bapf2xGARasIg5SmwWO8Gj9ovJI/YFAWOmFCh/gVf7oqxQbpBsxrFOorDxrZaZRSOZ6Y
i1AGWMLSnDwgBbOV1nxA5IEAevbss27D5kEpqZi86FsyemH29es/ANoIePv1G7cgmLryLO34CYBg
2ozZmFBEHlDUMQq4EHNBWHNZ1c7lK7/t3BVK+8VLVwcMHAyRBIBFhuTjJ09TeuFQS1Mo1NQajmzd
vis3Z7HX6TEOkNIhoaCm6LVx4e2EVbQNFyd6zIsSehLXNwxIqwhZJvdYolEpiEJjqTlz7iJ4CGRc
t+4/gMFC/5nK680DFWQsyAaWguKHCQsFCdIZaPeTTz6D1KMKwpiqi5Ysg+r74NHjP/7h3V17fp49
J2PajFmYC0BXjMFu2wmxuGnLNjCxjZu3AcmAbwdravBEsO4x6ePBnDHN//mPjziD3dm3b5KobxEX
5N5vQMxFKAe5i2LPUC4xrvsPHgGFoWVHj58kLn/g8NEePXv/cuBQYVEJcAmI7OHjJ3hV/ApKQguo
0A20VUx4CGy9zKamiESjBw4f18dghXiKdsp3CslBKcjB+PBKAArPXhSABEG7pWXlEGZ4biAQBK9p
bmlZsWotuh73QcM2b91Oyj0kHF6H2QZ4gCqQFPMPtrGMxgBYOXmLgckikbAmHhzvPnTYCHwF6wc2
gkR59OQZmBcehH20BBIUg0oeAYAYjDRQMIRf3uJlwHOdu3TFcFLN7O07d0NlwWnAiORrwPCT7QpT
7vzFK+KhCnhSYrBUF6FiwYpoVvm285rcs2bPoxT+mN7bdu5mBcsKi/YfOgKmD1k7kidSw5v2Txrw
8NETyIPM7Fxcix6DFEQLt+3YDe6AUYYMIFVA4+Rli6eOHJkyZVpJcUlRScWzgpKnL4qeF2K//O6j
x+/9+a8fvvfB9Vt3npdWPC0ofv6i+NGL4mcF2EqeFZbwnWK2w/ZpU48UqKcpn9IJ2l/jt0LpzrFN
c7DE4KqCEs35hcXlT14UPSssffS84ElB0eNnBR/96+PXO3V6/Ve/ev2VTm+9/sbbb7z12iudfuzZ
+8ixU0BZpRX27IVLM7IWNodispM6SizLSBszFkiXavSiYzGgo9PGgp6hcoCZAnlDBkO8UWYX/Apc
C0YMbEEhSoAjy1asuvfgIfHcU2fOYQrU1taBZdNqvouXr/60dx/VhViybAUgC0ZwJqcBi9XWo0fv
4tIyTA3MQQiDL7/8GrpHbIVvnIswVuz51Ikz4EpsKWtbpKmpYceuXS2hcLml8tCRY5THCw8F+Cgo
LALx5B8/iWaDkvGCLML33gPMAio7Aw0erA3iB6QIwYD5+OjJ0xs3b1MX4fx1GzaBCKHc40ygE9y8
pLSMjK+BYBC/QvBgirVGQkzAg2i5i5AAFtRcs4SKLNGo2ye5CFtjybSk2EfMOIgoYtYZC7IGDU4F
NBw7biLIHjARwBedjFHACeAeYKl42QkTp1y+ct3pdGHU0HKoahgddMXwEaPA6zCyHo+3obERaBKj
A9mJHWIIBsWeGcAKGBSZMQJYiS1YaPD8zGyobZTDFvQDalEDdFgIPBgXOMO4CZMwNBisUaPHYFwg
GNA5oEnonBQp29EYLFHs2WNYYdBg0Z/Z2n6tRcpA3geM82x5zJf9uxPWNtavNNQZ3mIWLJdXE4NF
AwGWPm9+ZiTSCk0D4n/kqDEgGDBVKOFg7/fus9kKGoYK8fDxU+xAa8UcB2FAEgM/obehjeMIlIe9
+w6EIxEq2IBpBXyGy3nllkuEhjdt3Q7V6MHDx0pNyQsKwMKs4eVcWhQiaWOrCNU8WLHeC+rWARgs
7vMYhq4nTGolD5/bvGK3xzwXv1u3yEAdDuEiBI6fL60iFHigWSqSi04Gx8AJR/KPQzfDHAd5o1vm
ZiwAg937ywGooOhYr89PVhUoqOCBmNcYRHzNxZxfserBoydkDgRuxnCDRWD2U4E7MC5ITCiTPE38
arA14LM58+aT8x3gB6yPFCpMQFmhMrZgGWRyV+eYKP2DlqEdoBswF9AH7g40feMmow9wQ9ANSAFM
B9N+0uRp5LeaOn0mmNSIkWkAjDSZ4wvwsTxY+kSj+uWXYFhk5UY3gSLRg2BqQFp49P0Hj/BEyBK/
P1BTWwtZQi0kZyKeC4CPW6GF02fMxouMGp0+dcYsq80OxhtqCVGahkFDhvFM7hOV1QRqoCieDj4F
MQZ4B2UXLAwqyMxZcyEk8ESIHFo8ApEAkYaJAVg9dvzEX/YfBL4BiAGywTBDYqHrMIUgb6hGtdPl
GpI6jLL+i7Iq1MlySQRtLcKcWC1CEVhGf5ATIBicvHDREjxozfqNUF7RP5BqtDxqFKsz8IhqsEAW
4i2yc1lLwAgg2qFFZWblUt0lyIBKm12z8JX2R44aBdjx7u//8Obrb/72N797tdNrv//9u692evWt
t95+/ZVXXv/VK3/84586vfIqfnr91dd//evf/vrtd379lry9rfvKt7fjfn1HOk3af1u6RPvrO/HH
Y+e/rb3EqBnv/Oatt9967Y3f/+4Pb7/59m/e+c3vfvt7HHyz06t4o7deex2fBLO437DTe+//bdSY
CcNGpectWQH8wbJxtvKFouE4WUimKYgnfHLk2oYxopJkj58+w1cgfmhL4JWbuAIAcF/f0ACABQgO
zrswD0rs6pvcxMW9jcyDBuE9cNBgcAHMMpA6KJzMP2AVOBMKGa1Cgm6NuVlYXNK1a3eeXSEIbVhN
fNAuA6w+/QZItQh9cpqGSLhFqUXY3q7JdmiYaNRwhaywmbXoUuiFdeswBPcUamsbY0QsPgIAS0nT
IOfB0tWnU1YR6mKwRHQF2cUBNSitKy0s4lHJYUxtagA4JhiXCMRk/eL34ycqRwFAjB4FK6NsFJga
FRYr1XTHr5R7AneDTG1RF5NqVxESwDJYJK+sIuy4ixBiBu3AcFBVHPxRAwQPQTsBr3mCaIb7qWQh
hZYCh1GzX2bBiuXBUjK5G/nagnJos+fli/6M05hJC/7jnIYeXQ2cBDlIPX7T2PaXRd/HLFgmmdwb
G5s2bNo6c/ZcQB+Q0KPHT6fNmLVtx67VazcAadXW1UE8QWEAS584eerW7TvXb9oC9ovehm4Plotf
Dxw+CsoHg83NWzJj5hwot7gtRNjRYydeFBThIGgvO3fR3IxM8HMMH3jFgkxWlhfwC0oXsAIg17z5
WUr+kVAzFJAdO3/KyMgyz9EQMK7PqA1sDyRKQpbYseg2jb4K6pcs6O4ZjC0yEDFY3vnxxZ5FFnth
xwKnunT5Gimf/ZNYDANnsHnQiDAuoOpnzwuAPSCIt2zbSdV4MWvRw+he/IrOBIOFiASDxa9kQfer
DJYmPtS/zp27Yi6vXL0OkhTnQ2jiQdCdvv7629KyCmAAkIHH62WrRNWQAG2QO2Vyj4vBisZK5VD5
DsLU4P5kblm+cg12AHHIwQnSwStduXaDID+ehJcB60H7QFIJrdwxF6FqwWoVLkJ58qMNVKNt0pTp
167fhEKGjkAbS8rK0V9oNjoCmOnu/Qd///DvgLFo4cnT51jYEFv0kcsdfEeh3ysZ+ZQg9wh3EfI8
WKnDcR802zC7FYDRt992Idfb559/AW0bvOnjf38CqbZ56w60B/xr8tQZgDWA1YeO5IOJjxw9hnLq
A9uCnwE4o5du3roLnYasGlTEnmp681qSKQTX4lYXyrUIpTQNGkMXvqLxEK7oagBzvPutO/cASdEq
zGQqmw2Mi5npdns++uhf2AEAxZkE5CdPnc5quWzeRp4gtJBy1MbVveJRLDNmznr1V68MTh3eN2lQ
3+SUvkkp+Ow3YHCf/skERPonp/TokzQgZWjywNQ+SYPwVd76JQ3qJw6qO3RQbJpL6ATNp/xVe4nm
uO58/U2wsdb2H5Q0KLXvgJTkQan9kwf96d0/cXT12hudgK5eeQNg65VOAFi/fuc3vfoN2LH34LhJ
04DdWQxfpCXERyTSHJKTwGH0qZ43yA/zH2MNUvzLH/8MpAsOCzUUzJeyAAwdPpLB6MnTMFeXLFsJ
+I6bcIBOOvEACucigh+Vll5WbgGE6tK1G2gP0B/EBuq6fvP2tRu3aAKCWUMZcLndIFoALNwW7ACX
xBbDxvJgyaVylMBefakc2VAvUorr8yppsm6GdAtE9NVC9KnJNfxBzeTOSuUEeAxWrFSOWxu9y8Kz
XF6l2HMHahGaF5iLA3+iwRoW/9IcB8alchIVe9anaWiLC6eVkC4Rm7xaRVTjjg1K/K9xrYpb5qLN
oBhLTczyAjYTwOrXL9nrdGsEbVBfDNhjUoDFk7AKoUfnxjIrOKgJDDIDUlJ7gmapIuJ3ar0MoItM
7skdqEX4/8ufmogxnCiTu8ck7+tL8+C7E5gndT5BtwZFGVWYTrBWUZ9olBV7VvNgqQArolYJlZEu
WOUcHoA0PzMbIAlCHyjlD7/9HVgfxXqu3bCJQhdGjEqjqnHBmtpVa9cD14KJgcEyr+5dFqLAw7mu
sljSSAQSvLCoxF5VDUQBcNyt+w/QrACgwYGvXr85JHUYT4N3fPQYZrQGwALYgq77becubh77aAyw
ykUMlq4WIVA5YAfAE9oEhRuCAbB62YrVEOHFJWWQ4imDh4K/owMAeiDFeZkOK96Z7Vgr56gxWKYA
i7sILZVxLkLB2ggP4RP6Pd4Q/AV35oAmBBUf3TpsxKhbt++Sda1Hj14YkqTkQeh9dK4IL5g7b0Ha
mHHMcsOz4MurCBm64u85WAFYEw1L5VgqbT/+2JOqAwEn/fBDD/QARBF64/7DRymDU8eOmzh+wuSG
hkagaRwHTB41Oh0CElh4+IhROQsXAZtikNAeXD5ocOqQ1OGUkh/tB8DCuGL4z124RJVWY6YpE4Cl
4fJNTU1r128ky+fipcvxXFAb2gCGiBG5cZNZsPYdONSnbxKkfs9efQCw1qzbCBxGg4Uj6F6Q3djx
E3HhvIxMB/cyyJlLqUlnzp6dPnNWWWlFZZWzvNJhsbGQcGuV82lh0Xt//uvf/vrek2cFFoe7zGIr
r7BZqj32KqeNbQ7+6bSrm009Lh1x2NUz1R2HTTouXeiIv9BpM7g89pN0c6fcDHayXXkEXsRW5S4u
t+K9SsotzwsK//bBh79+8y1Aqzdfe42g1RuvvTFk6Mjzl67bHe7npdYF2YuATSOhcEu4OdwaoYUu
six0utzpY8djtmMCj+GhMCDjjz/+FGAdZFDtcKYOGwHKSR06gqrfQGfFFAW07d2735x5C0AYW7fv
un3nHuiqJRQC+AZFMcZx4xau6tGz95H84+UVViAnwCzoyqfPXqDRx+NwT2hmeApuBXTl9njAO4Tn
KMJTrcgWLDVNA8WdxErlRLkFK6pLVkKCWV5TQ6m55CURmuW3Yt0GaYeEvSgsLDF/iGgyubt9rNiz
x7DsXYAVe+YA68bVDpXKSWwcko1qIote3Lpdlhw40sFEnVqAZeCoUjK56wGWnBRQrMLWVqNXk7lr
8gXKiW01qRdpyORcHkp6WynkhTkcOEC8cOHywAEpriqHp9ptmOsoESTSF2bR5gL1G6cS1T/CDMmZ
SX2ziDEDWw4FufuFi7DjtQj/vwZYitLLxiWqKfbs0aeeChinsXC/zK/3H8WxGafCMs+nZTAWAY0F
i7kIjcyrRL1gsJBuI0eN6dsvKS19HHXLv//9CRhshNsIoXyCxw4YNJiK2Myek+H3B0rKyvv06Q8G
O3TYyG07dj9+8mzosBGUigwgAZQPqIPbQojv+Zmt+k8dOnzq9FkQpmDFENPg+Tgfv+JCsNa+fZP8
gSBa0j9pgGLBkhONMoA1IBhnwfLG5cGiRkMJptnLTM18HjY1NxNzDASDwHoi6QAeSdOVrXjisxRo
LKEJWpsHKyoFucsMXTg48ESR5BqtJaO3yArDVnb4/fRcajOYSH1DA7qbEpAqFeMFwGpTAFZK6vCc
hYu5BcsAYIFt0docEg/Yx059fUOAVzvHy4r7U+YSOpnM9UCoaDxALnlIcYnNXo1v1D8iORZdEitH
RV65aFyahqzcxTLAUmqF8l7yBwLUNrw11WDH/d0eLy1dIY8nHoFmYODQVDSgrq6eh7i1Ytdqs2O/
obERIlOMMktvpmbooM/jp86MGTfBVu2ssFUXVdhZyedqlu78RWn522+8+e5vf19YVlFidxZbbFZe
VcZa5a6sdldWua1VLvqkDQfZT9rjtOOulHbE5VbpcuUm2hPijtOjpePx58RfVW5zllY68C7lVrvF
atu0Zfs7QFe/6vRGp1df+1Wnj/718fzM3DPnL9v4nUst7MVBtKxac1s03BpqiYSJSjSoAhSCPkeH
EyVUWCrBCygJUyMbhBbMHR9PkQWSRrdzlBJp4bXcfWroAM1bYGhQDtEkoJLI5hIIBF0uNxvTJiVF
Hp5IMQQ4RAFedBoRv2zBJQuWDLDUUjltqnQPU1U9kdOLsuaikfRGmpo5cpZ5KXtqSCMYMBFwuajR
lNjC3aqpReiOcxFqcym5WQyWUirn/waw5HytUibDJjlJnpLMsKn5P7JgHaYgd+OFVCyTu95FKNfl
0KQU15S6EmlZaLCkVEARvb2NJrjGz6tJrkgxG2DGp8+cT04e5HN5DMOZtR49j0GcjankNpa+RkkZ
YnnA/YahPAE9ODMqSByMP1kEffNahP6At1YplTPwvxtgKRasNuNSOR1ZWJDApetJmCTWLPVGgiJI
7pcflAGWbMESWaY06Y1AsdZKGw6Si/zJ0+d9+vaHLFZqlnMGK7znwZpamqpgPpCDYM6YHvjERrOg
hnvM8Yc7UAAlCVbgCsw4nEbsjgVd1daKXyk7AzitVEhQF4MlLFiaWoSyAifWrNHUVQ5Szi7+E2U3
oAqLcgGBl1iwmIswy1IZVyrHUJuU03vKKdoNk+IL3doweWuci1BYsACwJkwyq0UYS6GrNkbDrTSZ
VOPlSlSmD40EErk9iLuJbEbsNCUGS03ToFqw5ITdoVAcGyVaEZ96r4GczExVhZU3FbRomN8LTzl1
/lLa2AnWKkdRua2i2sNcS3Z3ud354HnBP/7+0ft/ff9JYckLaxV+sthdZdU+tTwzEIybNu3XSuWr
4Sf9ql4Su5XJPeOukk8Tv4qD8uXYinEJ2uzwWuwOq636hx59AK3efv2N1199PX385Ft3HwJalZTb
cOcKyvJlrZ41NzN34WJWCaClWQVYbZr6GJrOzMrJ27F7jz5WiYZAjGYskDMc1hghlBpkKmVqysrK
8E6fqjQupa1UKqfcJkrlMKEiA6yoCrA0pZ8uXLqyY9ceYbUiia6R8XRJs1TRgYxe9C6z5syDptgR
/iCKPeerxZ4VC5aR14lbsCgG68bw/xvAEixOs+QFWHbt+o179x3ogH8zsYswoE9sHaRSOedNY7BE
6nBe5C6sD2t7UVC0feduypFG5BHmCJF0a1b9vcKCaQ4tn3Ky0AvSONJgaWiJYjZACefOX+rXLxlD
4CYLlqcDq8MMnYmJgFTg5cLYLJ2VUWZ/Y7+VIQKTY7CYi9Cb/19vwZJdhFlZefrK2cH4eLWgYVp8
j27h4UurOBuvKzTMEJvQTenRu2i5i1DOg9UWV3eoRTLHiiyVYgoAkO3cvZcsHWE1GkFTOUPmSHKN
YMF1Rd16oUfhMc1SeRghUuvVBSIyE9C4CPv1G2CcpkGIXZ4Jvklfa0Wfl8IwXjKsi4c1cxHKQe6i
O5qk11Z4dGxBQYvWzhS/VijMEhmE9JCCVTAUAKtNSdNAMVisFqGRi1DK96rUS5dL8Ui1EeNqIGrC
I+QAlBjcUfuHSdb4Sp/s5qLY80kp0WhbRGQWllGg3NUt0t00OFWlrUhcmv5Q3LWy8I5KcSf5J8+m
j59ksTmKLFXlDj9wSYGlqqjCfv95wZ/e/dNv3n7nSWFpodUBgFVqdZZX+0ptrtJKF//kWT3VnRL2
6VKO0Dl0xKbu8J/U0+Tj0pk2V+ye4kFik5+rbHIzXLGDNryFA60tKKusqKw+f+naq690evvNt778
4uuD+afsTl8lq6jjBbSyVPtKrM5iq6Pc7po7PyeHF3tu5cWeWZc2tegCWcL6klVkBGrXVUkXJaf0
VEcJixUpqKox+mT9NKz6HL9yiLoCvKRizwrAqnS6eC3CAVKx56ga5B4fgR6FMud0uvCghsZGaI2X
rlwT9HPx8tWbt+7gnCCL/fQRaXk8XhBVbV3dmXMXKVfIi8Iiyi33snJ4VOy5XbVgqTFYxjm+AwJg
sTxY/4cYLKUndUXNsLN5647s3LyS0jKyULab1OFO4CI8LNI06Au3mRR7VuGR1gqlSJ2WmDezrNyy
/+BhgCeW0NLnZ8kSlaIrEVrgOWz4SGDE3Xt+Bldvjrc46ottqIWrQ7TmvFevPjxNQ7x5w6jYXyIP
VHxBwGBcZUAzya3LWeU2S69lniDe7X/pGjfFgiWKPf+3W7Ai2hisxIH8Hr+pe1Tfjf9RCn7Py5YQ
GlTOMagOrmRyZ7/65FqEWl0x3nwbzyrDGuQkc5hYRVfObOXSJjHvVqRVjrYUCdwNoy1FXKlYVmJc
Ksc4k7sRTpK5CTVIVFYSJxBDF9gosQsgK3fxHO4iVGKwWlvNCFpToFBDbYrgiS9io1HoRWfpXYTc
gmUKsDSJ7AU61tRIksvPyRVvxOp9/RvJObfa44vYKzFYAFjT4tM0tEV094nqI0XkaH1NVVqcI0fp
in1RaCnezBYRePfE2QtjJ06prAI6qS6zewCwGJaqdNx/VvDnP/75vT//9Vlx+eMSS5nNWenwldhZ
Tk5sZWyHpcWirYyO09cqdYt9Vc+kHfFrlXqtOE359IqDyoPET/xrmXx+7DSpJVUe1lSHv9Rabaty
T5+V8fqrb6RPmFJQUsaMW5bqcrvbUu0tqXQVltvxvng7YMrZ8zIzsxcyioxGALDYXI20qobDkKEp
S68SaPgF6UyydkWOeA0L0EB/OROsGGW52JEoEa9fRdhbBVjCRQitXRPkHtVNB6CoLdt2Pi8o7Nq1
25p1G/r07b985Wo0ePHS5dNmzJoxc87ho8efPn+BX11uz+y581k25ObmYcNHzZw9Nyl50L37D3Ea
hL1h/XhTF6ESgyVchPHBy3ynhtI08FI5/0eAJexVy1eumZuRmZu3GKNTU1M7OHVYxoJscsLKufo6
bMGSEo3qLApmFqz6hoY16zdOnzmbMmKcPnv++s3bGND9B488fvLM5XZn5eTNnD3v9p17NnvV+YuX
j+Qff+8v723bsctaaeN1JGcvXroCHDJn4aJ//uOjh4+enDpzrq6u3uvzU4FIWqt06Ej+vgMsO/Sq
NetF+LwghvMXLvfu3Q+ST05oGdSuUAskSqEUt2rMMBlVwLianjthgiu3URS2cSKoQOJ84hxg+RKs
IvyvdBGqAMsQ4ngMAY1JkJxZNJXhKGirRprZCM0NYDo/L7kIa7xBAljCgqUx04QjsWq8BDbkOBa5
hF2rlAherIWXFU6Zo4oARJJ3MkrT2y9EERQB4/QAiwW5MwuWArDiXISUB6uxsQmzVB+LKqs+8roh
vfDogAWL0jSQBSuFLNKxOm5qX4j3pEjzFh481BJvDQqrdRKDNTXbduxmyawjreRniTlTOAaiRIsa
gKXEYBkBrPZYFcKQ3oOmxorGyszFr3eAvvjLgUNHhQFJmO7lSjXgoeKtY1w7ygEWt2BlSTFYVAWJ
BytHZfmKv4OH80Xa7vh6TBFhMNOsyJBSjrVqRD4FnQhb6ymeyb3cYiu3OoA8yph/0F1QVvmsqPQP
v/39b95651lBSVGlo8LuLrNUldqocrOLbXaXYZFm000+X+wbHlT2XYnuENuMbwukWFhmt1Z5Hj8v
6tG738lzlyrsjhcleEuv1eHBCSXWKl6X0PuizFrOKkC75y7IZanJeQwWS9WAjg0bJB3WONcEDaja
UkT0tgaaC0OssIqLIoMtLS2GK/hERJRiIaMVE5IBXBTHFLUIqVSOqEWYH7+KkEU+cEu2HCiN7xDw
q9duuHX7Lq1UPXfh0vARox88evLtt11u3r578PDRzp27AuGtXL32m286U+3nA4eO0HoXEGdJadmQ
1OFnzl2ora0Dw0mYiinmIjxGmdw9RgBLm2hUAKz/ly5CrnREaUXLvPmZeP09P+9bsWotjgCsYF8q
yRr6fxPk7jZS4o0tWG20doGWpACkHjtxqtJmR88DbH355deAsBiyI/knSkrLJ0+ZzvOlDauwWPET
WOX2nT/t2LUHN5kzb/6VazeOHjvRt19SeYUF2Bedv3DR0n0HDjWxTIeDCotKcPMVq9bU1zf06Nn7
wsUrEgPHKLSwYs+8VI7P5TM2exhGlJvlVtCUuksgzhNHZHcgZFtX4DmgW/smBbmrxZ7z/4tXEUYN
VxF6OtwtZrmv3CaLPbVp2wI601cgYULRQKLnxiUKFrUIfWoMVpuhw0cvo+UlIBomLBcNpHhW4TGQ
tVlxf+FM0JTl0TgT4yFQVO8ilIo9213xqwhD5CF0uthKb8qgpYk2IAkhKgHrM9wYLnUxjMFSAVYs
yF0feSDC2KFvyW+rr33LotVqasF9hBImpFqsp+gqFkXeHr+KcJLGKKV33MZ7wdv0QVoaX9vGzdtS
hw4nXGg2VUwzDFEMlskqQk1vU2QrGCjl1JDzaYWk2o66skXM9SAaL7+j1+crK68Q5NjOM7mnj5tk
r3bZHL7SSqATT2ml02J3Pn5R/Od3//Ten/7yrLC01O6CtGZFlKv9oKtyu7Pc5mSfdhffUT/lTT6B
9m3qppyj7FTEXRI7Ll0rPTH26ZJuKLbYQYuDFfyx2l0vCkofPyuyVLlKbNVlDg/OsVS5iyvslmrs
A1PaK6pwfjW+zp6XxfJcRKOhcHOolXVvqKnFMC7QzANoYNk2CujRjJqmFqmRnTWkmX36OKE4C5ad
XIQOp0Nxi4hVhG2Si1C+84lTZ9as23D33gOSQKC3ESPTbt6688knn61eux6gZOv2XXijQDD44Qcf
Hj56DM3YvnM38KhoyaCUIVA5hg4b+cF7H0D9SAiwwiJNA8Vg6VyEUkEVVirHGyv2/H8Lcsff1Okz
aTY9efocIBIzZfnK1SdPn5V7/qUuQtWCFREAyzhrgIdK5cRbsCiJzODUwUOGgfUBV63bsAkzfV5G
5uuvdLp99z4tEaclohggtHbwkKE4+M033wYCQUDq/OMngc+AdO/cvQ/4i56vq6sHAgaTxNtZK23t
PKX7xctXR4wcTan4kpIHXrpyDZh49pwM7kysJ2kBgOWucpo5m4wMToG4PA5uc8eiYV2dBGHaZtYa
t5FZxdx3FoxP8/HSPFj/NRYsGWDxIPesPMM066ZZwTqYPcFsxZ/ZzQ3T8bvlxKcB+bgmRz8AVpDS
NHi0tQg11gfNUtmIGjVFR2SfjOC6ZHDR814lnEPPJOWgVV1IqxwGrVq8Iu36TO79BxgVe2YxWMyC
5fP7v/rqmynTZoxOG3sk/zhZpzdv2wF9qLauDkrVmPTxczMyA0FWk/XA4aObtmwHqyWDM241e25G
2phxh44ck2sixr+eaS1Cw789P+//+ONPoSvj9Q7nHx81eszsufPxdOjE6zZsbm5uwbZp6/bikrIz
5y7iEQ8fPUkfNwGNvycSNJB8kl2EUdmCNTFmjetQkL6C22ICLxoFChkxKm38xMnPXhSgA3v37guW
5/cHEif0M5lJ8YlGJYB18HB+Wvo4Ucrj7v2HeCIwYvfuP4I5okkrV6/Di0PaoW3QSqF2r1m/cfQY
lrpszbqNwHyU0uzOvQcTJk4ZNTr9+MnTkfj0Oeg9WsIqSmCiV9MnTAI6KbO5rFUeq80FqFFic/0/
xH0He9zWmXX+SOKsnU12v2zifNlvN/Fmk03i2Cq2ZRWrU4WiJKr33hvFTkpUs6qLLKsXqheK6r13
tmGZ4cwAmBnMsHfqOxcXwFwA92Lo7D7P6sEzwmAADIAhXpz7vuc951lJ+W9+9T4w1suS8lItM1Tl
k0kxzhuMTwBe7Fvb5KPcc+ua9k0kusTj463pkyzr2+Y1EKZ/i/6R+Y3irbgzPqm2NrB2febAL4Zl
5GzIzN2YlVeAKT07Pyt3A5lyNthnzLe2j3I2ZGNz8yNzytuYkZOPHWaS3ebhK/LyC7Zs3YZfMwfr
Z+fl5hdk5eTnbtiUSb50o31zbefxPedaluM1J78gJ3/TpGmzRidPoH2UFVU+X0A56SgRmgCri+HX
nzpz7ssduwGwqAhqUfHVscnjPZXVeGzjL83rq/1yxy4ELAxy/vnnv5gybQYe88dOnJw5ey7+hPB3
i0gyfsIkQAGEPCADV7EGR4lQselgWR4MutCoDrB+WAaLaTjo0vN8nZ2Llyw/ffYCvb+mTZ9Jk0nn
LhTFe3hbdZ/XLqa/iSVLkVGOVWiUcLBknlmeLJRpGDN23Lf79mNPQEjUiH3d+kwArBcvX0djsU8/
7RcMSvUNDbjxz124lJwyIRqr++yzz7Fk34FDk6dMR8BctGTZrTv3NKsfwK96fBqNxuYtWEQBFrDv
jVt3gOGKr1zHWeNnvXbj1tHjhcsIwDrY1NRA6x0cgMWiJUUkRqXaBS1tSRGXjAvr2Zwg48I14Esk
02D9K4qGYpKfFEDDQfnUyTPDh43E79dKcsmd/0NTG0ZkZNIwd2eH+UD8YfvRNqTJ7HYcIQDW6jXp
aigqVLdSHAx3hWcIrfDQlSz4HbnqGzKvHGljX8lCLa5YSA0TobVQWAplZuYNGjQkP78gOyc/J3dD
DgloG+IzeRuzmSU57Ed0ytuY4/iUrJCdl5WVR7bNyd9YsAVPyeycPETXXKzPbIK3tiU9nHK1TbDz
TZu3TZw4OXXi5IiskAyWDWDREqGsKP/xwR8uXb7iq/XjJqcSERs3bcXoB7ffUi2ZBIizacuXjY2N
GM6+KSm7//BR376fEjeGKdP27T8UCocBgwDLzKBDEUkcYMW9CBMDrOs3b48anQxsh0AwYuRoxIi9
+/anTibCYrNmz1ublp63oWDVmnUI8RiNlXsqBw8Zdu/Bw4ePnuBThEKb0CKbwdKFRufMcyl3Jmo7
IvC5usY3b/4iXC5cBwQsPDzmzFswd/6iH7o3PsAyOFieyioER78/8OTZc8DfWn8Af4t4BmCc/U//
+HMs3P3VtytXr8W3A0vhrwQR+YPff0AMmR49/tMf/wujVYx9+30+ICjJOGUMbXHAQ4eOiKhRU8ge
I3WMtnv37rt2XTouMj27Cxcvz5hNAVYQAKtKA1jlPunpm7L3/+XXAFgv3pSX6QALryETkbDwyAJo
nCAp/qlk+9Rj29xEVBbY5NiPz2hF5CwXHwwL2oyFJrDz+gK37jz4/uDRE6fOfbf/MGYOHS3cf/i4
fTpCZ45pM8cwf+CI7SN9IsuNdTDt23/wAFnnBOaxZwxRli1f+fN335s1b9G+A0eOHD918Gjh94eO
7Tt09LsDhw+aX32E2b+xK/508Mjho4WHjp08de5SVS3J+RGY5Q2e5HGwurrf2vpucPft2vM1/oQm
pk55q5l/TZ46HTNffbN34qQpuPEB1olI3tARJWXlgPJff7vvLTEbWD9j5hx8ClA1d97C6zdutydq
wdMzWJTkbgAs0kUo8xvH4jpYN273pIvQViun3ESTP4qPLly6PGz4SIQv3G4YXWCF/I2baZrnrSOx
h22dVEuN49hhN3vmSHHSkT1fyR3wdMjQ4YeOHO/dq8+b0rInT59j7ISRJBWSTkvPwuAKg9s169YX
FV9LmZCK8Ptff/ozfgVE5szsXITNXr1639Tsh//ylw9v3Lw9ZMgwjP0OHDoK1Lv/4OHhI5IQQ3DF
qJoazYIb7Pg2KuuPe38UKRGGI1KYg5mUH9iib7d5Fuu/i1reZI7iJdubGeX004ntd/SZaDRUF5Ej
QZ//7FliG0XE7ru6/6cyT7ihmpsa8GpWfkg3euffsf9OjWrSgj+uttb27Tv2ZGTm1tbUivsoLcgp
KqoYOi+RU9PV6fLk3vLp/I1kXr+ntppG7wsHvbV4ffns1Ynjp86dvXj0yInjxwqPHz95/NjJE3gl
M4UnzLf6fKEx6fN0BWOJsdrRwlOFp48eOV544vSpU2enT5/1y3/6PwBY+IjZiba+sWd258Y+zT0X
Ggemv54+de7woWOYOXb0ROGJUwhZ165cJwCLcrB6W2UaurUsFO5MJRTG30Fmdh4e1dNnzKJ6mPX1
9ccLT+MG7tWrD4JOOKLOX7gYvzpW7tev/6vXJR991GvhoqUrVq4ZMGDQlzt3m2weWzLN4UXoBrAw
3kKke0sc97IwlMTXBYISxs1UKwjhhgqt4rARZah9G9s6Z6Ici9Co9uc9zgRYAg6WuNuo3eR+4RwR
hXGV6FsEU1WNZuXkY4DoLpbjArCoDtaZc5fYDBaGqv37D8TwetHiZQiLmtvdOLoFcDACKAa4I0aO
Wrc+I3ncBARfHAauUigURrz4298+Ju4psVhfTbi/qrpmy7btQMnkrVYLBhJF1N60ZRuO/89//gsu
9cHDR2n9EY8WAKwKA2DpGSwWYJUAYBFiE7CXlsFyYBorgvGwIIlFMyz6MfNPXomTBvNJtvwW841S
4qQUbzJzXR4L4AuaKK2s0kuFtap8wfIqn6fGj5kqpl5Z4XWbZ0+WXWjOV3n9Nb6Ap9pfVllb7ZMw
/9U33/30x++kZW3waEdSWk2o96U1QaDbMuOYnd/iiaNSFiBKVdU+fEWF11/pJ6uVVPrwk3kDIRvJ
vauzjWZmdPmZODOvqaGxEW/rGxo0WZYO1ZCjw58WLVfF6vQuQqwZCAbpHYH7l0rI4JXtTf7BJHeB
JYhRIozoJcIeZLDYyGByH9mqH0YjmnfsKXOMR5XMWN1OVuDAUcfhmT0L6ETUKsfpRdipyTivXptG
3a4A+ICV3moOE4CwmPlm7/cYEeGCV3t9h48ep1nG/I2b8FtgPHzkWCEOm1Izt+/cffrshb37DmAQ
hSEnZhDYaRYc42HKZDh09PjrklL9LPQRLxEaHTZ0RJSS3F1Mb2SxTY3I00ax5cBUt2ZAUfqEx7Ky
GyMqPLUCJuMSIfWpWDREPIvOnrnw2/f/7+gxySNHjgbSMicswT1CJ33JaHPJWOfy+ApjkocPT8Ko
e1zKBEzDh4/EX/XYsePG8PZm3W2y8b36AYwYPjI5eTw9kqFDhgNMZ2bm85lnzryULGggcDYf6KBf
5fHVBBDKeW25YyGFr+IRDoZw8RW/HAoowPFKQMZ8OKhEAOs1ZE8mfSYUn2df2RlCFrQsiWKJ9laV
8UWR7Oz8d3/yzuWiq9oKIf2V7tnclv2i+P5D9u+S6W4jxmohieZ65QjOguhgUZK7Tckdw5revftS
+LKeYJqNGDlRO/G1aRl4tN+8fXfO3AUAWHX19bPnzKc0qX6fD6isqgbwevT4KcJreUUlvW9bDGGJ
5jhNzORg+XuSwSIuhwsWAQFk526gfkyIIH36fNLQ0BCU5A//+jf8/XVqoqA4zjPnLhrGagg357GC
A2B1WLoI/64Mlq36e6noCvX4w/zMWXPxKEL8Imzov7PYTgHWEh1gGRksAJ3lK1e3tLQC1+KC4+3I
pNFapbITp4wfZcWqtQidjU1NXl9taVkFHnufftovFI5g/c/69QfSwhMROPj5i1cAZNt27EL4Hjps
BC4mOwSnZUf8amYBlACsOfPNDBae/RRgPSspf/9X7/+WZrA05ngVgVkhHo5h0A+LjeIZpqBHVOlj
8JZlE0suSpwesyM8O54Tf2/QlveqBHaskUo8taRU6g8RTQqfJrLl0yZzhvvWXGK8lnuZdbS3NbXY
W7CSdEeGSisJetv9zb5/+MlP0/O2YgUqFVFeSzofAWdfV/krvPw922b0L8L+/VJNQCmt9r3y+N6Q
zYm+F14dAEsvEbL6fibp3kwJdzsMZFqNhgmWEGbKkGJDtjenZ1Y5Y+wcLN6gmZLcY6ZMQ0dPARbb
BM1S6Mwmm3ajt8h2tCY9gJVyMCnwbzlehEviXYSys45DOFhcL0JTQowO1VgISJfQ4kBbW5tNhC/O
6jVOwdZ+YdhEdpvo2cIr7dQLUkWXrwwZPEzzInQtycliTxVbU4IiUAS1YCNVKN/A8SdWeR9Z81gy
j2odP+ZoKBii897KGtwOp0+dO1l4BjOYTmIqPHNSmzeXFFon9yVFl4rnzFnw8394b8OGLUUXi0+f
Onv86KnCE2cKHVuRDQvteztpHsaJU8B/GHJgD5jBQb549krPLLI4lZOjUoV4l7mYUc5OVL7FkLCp
UxV2QrjmNZWAEgvHAOLxQ+CMJF+QACOCevVJVfBap79VYvyP2HX0GfKqWWkRDI1hK3ZbULDtvXd+
euliMd2Pau5Ncf0uy5fWsUtCwQheI3JUW16nBMJYgrfxEmFcB0uTaVCj0b/+9UOMk06cPJM0agyG
bhgXUoA1bfqsdesznz1/mTJ+Yk7ehoaGRgAs3Ix4hH+u1Z4ALFatXofB1pJlK7CaU5ZJu8NZknti
gCUroeRx4zEUe1NaphmPFwNJAPcBAg4eMuzA4aO79nwDkISBMnBDOBKZMHGSZiSyF1tRLXhaoOzk
ZbDSM3Nmz5nX3TPuKpuKY+lvGERqFp6F23fuoY7XaemZ2HNPNAl5OWVdaJSS3M0uwlisDpf9eOEp
jFYLNm+rb2iYkDp52/ad+w8e/qef/SOGuRcuFWOodPnKNYxfcVmi0RiAMn5NHB5+HVwZ/EwDBgy6
defewIGD8YOePX+xnwa8KA6mYRp4C1/BPgtpBosyxAGhTA7W0zdllIMVLxF6tRIhm0Ni8zdOxOME
N85UltcOehx5GgdiYwuI1hqix8cpWXrsZUo+LgScAsohU02QyFUQ6a9QeQ3hpdX4Ffa1xh+qMd6y
E7vE+Wl5jR87rPRHPLXhcq9S6SUA692fvpuVv7US3wV0i4tfqxBUVBMEvLNtru+WHoAxb9l/da2H
EPnJ5CFfFK4ORDxeyegi7LYBLLP9wmxFNolTlJ5v9i3joxbGMoF92LMcfF2GVC9CtScAWNYSYR2J
aCo3TDMZrFuIVN2JABbVlGHhBduWax62eYQmRjS11M0NbcqurFqKHWDpOlgqTwibXyKMdzkxenVO
4q3tYpoDWvYIbfL6JmnMpsL/1mLg3dnd1aExdonQKLHKcef0cM0HRQ91Di2aQz+3gy17qoankOl+
hLx1CNkrRGQCwhrMioYioYBkpCviuY2IngWJZziYTEnI+qktxaLk5W1698fvXDxfFA4qSoCkalQ5
al9Tsm5rS6Vo+5FqAwHc1X7gDyVCDjWKvbnBUKcAlWIRJBPVcIXGhSJSvDOz6NKoaE1SalgqCoCF
qS4c09juKnmrRGOySl6dE5bTjwj/UqVvzRl2BSxUpUh9uB4YKOiTcOVzcgoAsM6fK4qaKzv2GWM/
YmaixmQsJzP4KYHJgKswAVeFgvilcI6xuNCoQ6ah6atvv/vu+4PpmdmPnz7D/bb/4JGycg/FOtu2
78KEhy4e5E1NzafOnMfdXldf/+133zeT8nDXV6R1KIfmn80WAMpyMAIBX2jUZbh58PAxKqP88NET
HBWOBwuLiq9ihpKHCP324WMgBnwLgMWuPV8XbN4KdMXamvZEpqFnAKudFe2k0erR46d5GzYB2fhq
/Xh75dqN6zdv/z0M97cCL8Jusqs3JaVZOfkbCrbQ/KKihLZs237g0JF9+w96KqtIj9jlK8B2R44V
UkVEoEwcQzQW+/rbfcQqp76epLgam3B42M/5i5eBpXDAjnhtAYUmwDIyWLJJciclwl+9D4Blktwr
iRKVZM8A2ZFTkMNtZ4pZfITkTCxxJsnOoHdms7ySnV8vIuBbefFvKmtxdpjKiWq8jFcgrTeknKeB
Tq9kvlYb8+ZE1yHJP9tCn0xnqjTgiGtYUuUn6ApAyhsAwPrH936WnlVQWe2vrgl4qsnk84fKKn36
D+HYG/u99m+sld9U+kqBDmvlV5V+AERvIOwLcMyeqUwDq6dn1gppXsRmJMz+wbCdPtxeyLeakVRP
S4RmBkuJifrCNIDFWOX0oETIwincJjqC1F5bSe6203azt/HgYDvTTG1m+GgqqMtOcme8CDnc8JDI
7LnDaAVn5RDbmfR5l5Uq1MrkDtm3zhWcLdIsnYO1ysGvECH1QUc5L2GV0KXjT464MaA55T+RepbK
62TkGBRGzdyYAxbgiQ6wEgrqUhR4Gw3RnZNcBZFvUGLsPE1UkLehGLuEzNMlxnI6yf5gQcG2d3/8
k6JLVwge0tCD7JfiOw9ZvyJk+S5zBQpBMGEPYS1xFQvpb/kqryJnG4UvbeWEoVEW5op+dK70hpP4
xTkq/bcgBUFy/xKMpeo/hPZbSBHnFJUiFDOJpqisrxA11g8HQhieAf1ofQyhrCxSIsRvEQnGvyJm
3US1znDfqsaRAFFJtTLNaYUlkhCNSJGAN0gzWJwSoWHn125XRWq3d5Wz96RtAPfW6tZujbA6yZ2a
PQ9PinsRutTjTAsRc3BpDuxottymoG/TdSVxM26VYyG5s0KjPbP60ZWHzOOx6Y9RLSJDrf/vyWDR
EqGti5Be3g6ruhKlgpljU9uToNOVW2YWF5y9k6wVDy0RUg5WFX2o6yR3CrDiGaxKPYPFSTslSFnZ
uFAcsrm4JuhkdBkQysNtM7Suw8+o+RzZL4DLQKgmGNb5UkCTtKJXK3lJykpmXhVvQJ+0bJa+nHmr
r0OWB+IrV9diz4HyGpIYq/YrFVXeXV/t/emP38nM21xDrm3QU+PHRcZhEI2J+E4Ur5/9Ojn+FX72
G7UNfVI50aeIEKnVmmBVTbDGZ3KwulkOVldcrKTVbIGmyU5b8qm8orKyqrrDkJAJhyNvSsuisboX
L18jsNBOXuzE6L9r7YkQcSc1ex45+tTJs8AfcaFRC8OGyWDJeonwh1rlUHU6xDGLgg5zz5rq/G81
O0Wb+oZNBtnM8HVxS4TWfAzz7HHINHRxZGjoQjao2jzazBmTjEH7HJ1gix0ZthM43c1qfBBJP8Ps
uejy1TFjNLPngCL0Y+b7AIoIOi49hmIVckUAywQrRF3ERR1IIkQ4QERJPKJDMQJrJD/5q9MnxZhk
wYxsXcJOSiQSCBZs3PLej9+5fLFY8vqishLyS6ok2H98h2HbPpVamUABhRjLRIKKisMmKCTUs6Sd
IK3I7fTkLhcCYrVHB2ArAVv+YKJhSaWFNoAVLSFE8kB1xAcaUzQ+aaJl2kJzuTZvLjc/VdT4p9oM
wXBhFUOFvLxN//jTdwGwLCsozH4UNf51zi/S56P6vAZDzYmeHf1zAsCyc7BMDSWbkp7NTsFIOLey
OMagJbWxSsds2GJCKs1g9UjJ3RZlHNSHDidr1SbVytfB6o4ruVtkGnrAwTJjHCuo7VzISnD9fRws
C8DqNqOh3k/ezUFF7U5cZcsodDhkvcyEHHtJmawDaaqaTjNYPsnMYJVTDta/0BJhGZvBEhbabIoJ
HC62JM5RSc7MlseuvCDQfXCCMAf73sNl4tv3GSirqgUAIjALMIhI2wdKSU7Ij6kME1bQJrpEX6hN
tiWl2srmEjrjDeDyBjWyF/FArPb5v/3u+5/+5J112fme2mBpta8qIGM1j18u9wVLawJlxpeae4vv
nPlG81uAz8qrCUR7XeGr1KqNXp9S61OouKKpg6V3ETowUDiizpg5m9qTm24EbzUvsLT0TBMB3Hvw
8Oz5i9dukGrd85evMrPzsHDNuvXPXrwUSdkJSoSaDhYpEZpWOXwfNJrBiirhW9dvT5qcWMndvD2B
h54+f9HU1FR46uzR4yedEYBVF6yvbyi+et308mOHOqYZ/IqVa8LaChwvQpPkbiG70FMQcrCsQhLd
bL21U08okq8+ffa8mRRst6qhmmwzM0v36PHTWn/g5as3BZu3mb+a06+po6NVk2m4PGJEEumiVwSC
4ArHmJnXwy/m69Bnkh1pqULWvMwrHcouugwqRyye+Rat0KZoiStS7pH9itZXGDOevtaJfRJbnsEq
53mvLQSi2pi/6d0f/+RK0VXM14UiDWosHJA4e1as84oFKETlmCYZFW1QG2O4HSQCQerDMZ40g+rW
yMlt9FME8mbOSqIjJRYVyZsprrQ54yeQAyGSAiQZu2hIitD5iIxTw10foa/OCctFH5krkJkwIGlY
qQ1gGBMKyEFv7YYNm977yTsXzl+KKiG6gn2Tnu9cm8IAuzJ2LmEoGCFTuC4CyKjEldy1oEkAlnYH
2keoTi1K1k/NtIUxn9CtDllVxtGMDvjiSu4swGL9Ym2UzA4G2Jn67Czbw/R+0bJIFjgYz3vRsNja
2qXRsLC3cRMm4QEwe878tjYLF4FV2WZTUA5/wzYb5CLRzS7paZd+ZnkbNjFZfU2mizCNZ5XjHLPq
F4FxKmSF15yq9+zgWyeoGb+pebXNzJyRwQpYSoRmBssi0yA7ZBoSlAUZyCXAQ1yNBv7eJJ7ClqMP
kcsAc+s35GEyfu0y2CNs5+P3RZZp3QPeWgWXsVwDcLu/2fveOz/NzCvQgZdfIcivVqb+0+b5OhTC
+Nff1GjVEST5NSWvX9bNnrvjGawO68iAvsOfwS/e+1lO3kZAjXVpGVOnz1yydIWmV7lp9JjkpctX
bSjYjLdVNV48wm/duZc8brw/EDx/sejx02cf/P6DZctX7fn6W9pjeOnylRs3b/+AEiFilgaworwe
fsYq55aT5O711Z45d5GaTNPb5MatO1ev38TMy1evJ6ZOxk2EdYKSjPMyqN9d0VgMUctX6z9x8vSr
1yWaGH353/720avXb2jbDVn+psSseBZdvnrvwaOBAwdrfFZeBosCLL5keWj48FHFV651tBNM096u
W8zevH3X9MaORmMXLl7GcdK+gYbGxvsPH+NE8La8wvPhhziwkqam5kBQun33PtZ//uJV4akzbwx3
h3Akgmte4/UhzqxctXb/wSM45gqNVEBbJoG36M3e0NCIHQJXqSp+qc7z5y8ljRyNh5NUKwl772Vh
G6ALMzrKyXUlUgdVBOQel4pkD32pFVd7Y35bnCrUlbCDvGheXgHpXLt0JSIBWzWHCYwIu56mACQp
PIsbS+dgD6RWOd8lqiQK5MoUx4wzDWlTcndx4+H8CaluToiKO7tOtZU4Y7Kq+UkTTyTca7m5G98j
JcJiG4cvasur9cTVUeihSXb1I8TZ569LP+79icnB0rBFl6UCJeCi6vlqq4q0TWCGHapa2e4mB8tP
AZZZIjSVQlgMYY7hzEIY9tmhjclYHQTbmJiSIcwMP6HotrQQdRocSbfOwRqfOmXNuvQ5c+e3MkPV
FhPVMfDFVEjXC3/GmQLtmY3ZJrIxIakFVxEX6vYuqwY9V5Ke1cFKy4iXCLn2RCwb3bSJpBk1UZKg
XaOPsb+jE7qxCvUMBysuNGpksEyZBkcGiwOSJDuo4hDbueU5SVhndK029oC2JdCAEO3KRUbLRqL3
uapFONJ12LCUFv585DKWkUIhANZ3P/vpP2TmFtQAYBHTHiLiqgGsoAawgpxeSzHaM6XwTTUKCrCo
2bMzg2W79+/ef/gfH/wH/hgOHDqSnbsBj/nUSVP37tsP2PT7331QWl4xIXXynq/3Xr95e8euPXj2
p06agid3yoRUT2XVwEGDDx89PmnKtC3bduBvbOjQEZevXPtBOliGVY7dM1gTGqUAy272TNiH0RgO
Misnf9AXQzZv3U77oMcmp+BIVq1Jw5L3/+VXADG79nyzfefujZu2bP1yJ7aKRFSsc+5C0ZAhwzAA
A3zBuW/9cgeekdu276ysqh4ydDiA5vgJqYCSVKF+5eq1E1On4HYAlBGWCAXFLIyAhw9LukDEqPTe
PVx5fO/UaTMnTZ5K/ARbWoFWFy1ZPjJpNIDU/YePho9I2rTly08/7bfrq2+27dj183ffA8AdP2HS
gkVLdu7++sixE7jgeRs2DRgwCMARmCll/MQ5cxfgIpw+ewEfjU0ej19q3vxFRFV16XJ80biUiQcO
HVWj0QEDv0jPzAHunDFzVmNj3eXia8OHJxGzZy7Fx2KJo7qQ3KM8nYWovds/IuTFc2tYLk9rGxYX
HRhPFyrqoMBzBA5cXH0UZ7aGAKz3iDQAAFaEAqxYWKT8KX6W2+rj3JY9pUeNBSoHTKhuRDrrylFu
m6dL2tINqfA0t+w6Harw5+Ok4uxmlDaAlZdLfouii5dtuCrqVMRVHG2t7tjOemqEg/XgyYuPe/eN
qCrxTu8m8VQOhXGXhsMRtn2Gzb6w7h+so+3Bw8cePn5CWVkmsGAV7plnNjF7pjINthIhIALhS7Xp
RvE7dn2FuICBV6fDJo+1dkFMN/NYLEnLdCPS65jdGkQD/ujobNGQ2aixKZk5+bNmz8WRmUa5rDck
ZVOxyzEix8k+f/lq1ep19EuJd72Bzyj7weTJYtSIEM8tttJLhFh2594DM2mkfxdTIrRZ5bCZQnzX
w8dPM7JybDDO2RNkVhbYmmlTc7N5oSh3hLWCtpPcHRksC8CydxG6ghU7/hB0+fGJU0E3eVLnrhzI
xiOifDFrmuJbHs764hQaV8rLy9Qxfa7qpt5gmYZcawi9nRQfPWYGiwIsb6BSU8n3+LQMFrGv5olN
cLGmqctF8ZnxtrqWaEMUWq1yWCV3FmPJsvLJJ59JsoyFL1+9uXXn3uAhwwBNcvML8GeMP92z5y9O
mz4LyAnABYhkyrQZd+7ep7LvkyZPe/2m9PqN28OGjSwpK+/ff6DtvuBa5YzSAJbKehHyqD96idAk
uTMZrOoaL9U7PXK8MDllQgWg3sAvEEPq6uq379yDQ5ozbwGtcm7ctLXCUwnkhJti/8EjQDO4Mb/7
/iDOa+myldm5+bjHAWjIhrv2ZGbnYrVTZ86tXpuGuEcFjZ+9eAkAGi8RdjvMnhWelyKBAuGkpLEX
LxW3tTXTTWJ1dbPmzGtsaiqvqPz2u++/P3iYxKju7q++/W7p8pW3795fuGgpDuDMuQu4vMBPn332
OWI4fkRqfopdATXiZ1q7Lh0z2HzGzDk4JEDhW7fvFmzeht8IZwdAVlVdAxCGkPL02Qv8mrX+QNKo
sdFYzO8P9OrVu74+du36zRHDk1Q5LJli7k7NJE6J0JapEmh5u9T+HPmAqGgPMk+RXE4kR+5uRcw1
qBbgs2hiPQI9g1V0qZgCrAhRDQibly4qZKQlwoj8tJZrQs7JVHPmYKxgRSguymkeVO06HdxeQqG8
ljhlZfxp8XLY4qq0nuHWAJbmiYR7LVcDWJc0gBUVFUA5+bkE7ZDOP4wfIYg/f13Wq/cnkiTjrg4p
0pWrN+7cf4iBjpbTeosweuLkaSohiPiCgd39B49ocxwtNmGceuXaDRqFta60IkpWwAzir6ZG2I5w
htCDoR4jn2OS3A0dLC2DxVa1gFFevSkZNTr5waMn+BRB+ejxwjJN6w9IqK6+/tyFS0A5RB/vyPHp
M2ZTTPDs+UsEHRwATYZhTRwGgkhpWQVO5OkLsj4QCjHrbSNAZNLUGevWZyI+koBuPE4wBkUAunnr
jtmdjtPEEuwWB/C3v33s9dXi+mB03tzc0kibhrq6YrG6Fi11jwO4q+kBYuyI8Edz70oojGElDphi
RwRQPHuev3iFoWTxlessGCXH0KWZPS9aSs2ezRIhW6ykycKr12/ikfDw0RP8ClioqlEcJL0UdCSN
o8KX4slHtIm1f/jSs+cv0U/xMKDHjx8Xg1c2b0cThPQKxJXcCblb18GKK7lrXYREaBQYiwqN+iSP
CP2IZEU5slUOTXYnQrLILggKczzul4tilkdYxZNcK4ASV2RLWCLk0cX0DJYBsLQM1t73fkpKhDSD
VelnAJZP4SQCRbqsFlVS2XwLgEUzWCwHi8g0dFkym50aVxqQ6K9//Rtw+eUr11esWlt46uzESVN2
f/UNoMnatAz6dwIQc/P23W3bd+K+mzR56sWi4pQJqRRg0X7klPETx4wdt2bt+sRK7i46WJZSkapn
sBwkd5yDJhyTm5O3Yf7CxdNmzLpcfG1scgrlGOBO9NX6MX6jCsZUx25cykQc+crV6zA0qvBUrV67
Hjhs2PCRW7ZtRzD5+KNeCGKAj1h+4NAR4BXAl8xsYsGBqxcKhfv2/ZS299o4WLrQqOIEBOSxIdcG
hw1LQhygJUKMdRFygfzM4WtGVi6gEhX2mzJ1Or5UyyC2IQQlj5sAaNWnzye4wXFtL12+iiMs91Su
W5+xacuXo8eMe/L0ORBVemY2zc1j4Je3cRNiOH6myVOmYw8jk8ZQcZaBgwaTiDRuPL4Xo9Y+ffo2
NtZfvnx1yBBNB0uOREWmyxwcwJN65yIV9ne04wyO4DhHnJ1L83JmaLjPTr4pspqYJO5uQW2vuGkA
i3QREoAVDTXFM1g2bXRbmc9FstVFwFPhNSLYYauzm1J1aMBG3OFXVCBnyqNtqW6FYMVV8sN2NZx9
Em4u4JpOnpnB0gGWUSKUE5VfZVfmPh+JxqE5ERp9+PRl776f4eGKe2n8+AkrV68dP3HS//vtv+Iu
LTx1ZsTIUfkbN0+ZOgNP7kdPnv3lL39FYJ06bSZeEVDS0jMRN2fPXYDxH2BB3oZNiKe47YcNT1q8
dDnGQ1u/3Al0hXHVkmUrsWeafDKV3BkdrGRaIrRJGmJk/Nvf/N+vvvkOt33yuPE5eRsBbih1Y8LE
SQhAw0ckfb133/SZs//8X39BgED0+WLw0FWr16WMT8W3AOUMHjx09Zq0GbPm4BgKNm8dNSYZUK+t
ubm7s0snuU+YhME39mCSvRCnsNvFS5Z/odUUsCRtfSZw0vKVaxCCEbPefeedg4ePYhC5dPkqROHt
O3fTo8UKwFKIaKvWpOEwvtyx+9r1W1gZ3wswijgOAIrg/v2Bw0B+GVk5OAVsghWuG2SUeN6om2f2
3N3hLCZeuHT5N79+H8F00KAhO3Z9hWfD5KnT8du9ePkaV6zGW4ugOXvOfJzOxNTJOEeMuXFs+Pmm
aCYneEisTUvHOX71zd5lK1Y7baE7TA4Wl+SudxG+b3oRVtoyWNx6mQgPcXVBHYKiHueaPskuW+qC
rpxZK2eNzw6qesbfstUQWVzII4c5E2xlRL+UACy9RGjjYGkAS0dINUGazaoQCYx5OW2SdoBFhLUk
L81gjXZksLpt4gudGFfgQV5SWoaY8P3Bw0S99rPPN23Zhjv0Dx/8oay8YvKUaccLTwH0b9m2496D
RwgOwP24d/AHiT8/6uUHvIKhPIYEPSC5MyVCnYPFj866DlbIXiLEfbehYDOglfanfnRcygRgJtwp
GITgbx5hDfBiwaKl+LPHvYk4gIWnz57HAVOJYNxBuKdwIeYtWAxQgrET8BMGJF/u2LV565dYobKq
GieImwi3GA4Yo7vf/fvvKAfLJjTKWOVwXURCI0aMKrp8FSu3tRELvOaWFsBBfBeuKtDhd98fnD2X
yA1+/e0+GnbyNhRQv22M0BoaGj/9tF+srh7h+mLRFW2sm7f3+wNaUFqN8IKh3cxZpI8HgRqb4NcB
RMNynCAuyAAtpffqdQniHt7S4BmUpL4EYNVdu35z1KixmtCoKqzQOctnSiTqQthSOHUcAaRQ+Us4
Upkql0Qf5drj2MpAQq6S2oPMig2jqBx+vRLNzdtoKxHiz9WBFVSVlZOwqaS6Qzq5BxQ0UZWT6xWd
gLKmCqVERfbStnPhYZeoyy+S4DRVl/aLqGxksDQ/6bxcLZt4sZjn/y3WoFfEjtcCppqug/WXDz8G
pjly7NjMWbPx7H/89DlJdIcjuNOo4ylGS/sPHQFe6dWrDwZ/FDPhph01Orm5uSVWVzdw4Bd+fwCB
APetJMkbCrZgK4RaDItx8//lz39FJKINL6wOllNo1MQNtOJWVe1duHgZIteNW3fOXbhEXe4xGis8
fZamrAC8Dh05jii5aPEyvEWAePLsBcLQrDnzgA6BNvr3H0i90nAusVhdUFFwPFQHq7WF6GqmTJi0
Lj1z3vxFOACqvFDt9QEpasd/GkNtWQkh4GJbrH3i5GlPZdXnnw/ATvCl4ydMwthx2vSZ+GoME1ev
TQsEgkCBOEecO62MYECvRmP7Dx6hevcIx6mTp7549XrQoMFAogigH374Ec7OpM/rObxuXomwu8NM
L1FOOtbEYSA+YgmuD9AbgiwG2RiXHzpybN36TBzJf/3pzwBbWAF4VPtFkp9rabxZmhkZINeE1Mk4
clyo129K2aqiOXrGVSJmz8QqJ+DxWThYVqscw+xZ5wZJiRxpONQoD7euZ4FWtobEoDAZ5nSJ9kmc
1JFV/cGTmMvlOH4+s8qRtHPn+xsZLA1gEUvH8pqgpza4+5vvaIlQI7kbHCysbJLcnbaMdj3VIKOV
b1xhuo5OcldoBiuu5M7oYNFcpvnHsDYtA3ilwlO5YOGS7Nz8jZu2Hj1eWHjq7IpVaxYsWoJ7E388
9x88Onn6HNAGUAuGHFRuF/cpIEJTUxNCAcBEIgspWwYrZOFgOUonOsk9FLGZPVNXQTrSw3hm3PiJ
WALwhHsQIQIDJ0Q5YnV89ToQyXrtLsP4Cjc4ca1u78BWg74YAjjSr19/YEqcWv8BgwAQy8o9uF9W
rFyDmxo4kqblEKnGT0j9zz/8UedgOTNYTiX3ePElLjTa2dmG693S2oqLOXnK9EmTp279cgcuF44f
0Q8Q6k1JGQ4YwzZczMtXro1MGo24gMiclp6FmIOPqGwhNgS4/OijXhjmYW+I2IhyQ4YOD4Uju7/6
NmVC6nffH0AEQzyn5hxjx43ft/8QgjnWRIRXlNCnn36mqpErV6+PHDFKCUhutsqiPjU5ktjguSeM
Zq6bHtfW0MmC50IfhUUzAvdDpce5Out1iHIyLmaJ8EpEVs0SoRt6c4c1IvFPF8kxJeLmzO2uZ+Go
XdqgUtQFcytcup4YFblT3FwKds4DZmRcbCVCHWApLgk/nvqX+Po42gXIhrqS++cDvqhvaMjMzsnI
zATACkeiAwYMwkMadxruvczsPEwkpXzrDgUNGBfS7AtJlmgPYzy2Ab8wli0qvopdYbyFTaZNn4UA
oUajvXv1ARDBqHHZilUzZs45cfIM5WBZvAgNDhbrzYxjQFDGWwRlRMDNW7cjViLAIfAhStIRMF4x
nlu2fFUoFMYwjubnEdlxAA8ePRk2fCQiHb4db4HJ5i9aQtBGp0bA6ibBLHXyNAQmoA1AFxqSo7G6
XXu+zsjKmT5j1sTUKa/elOBEzI5oxJ3evfvW1dfjgowcORoLMQ4GbEIUxlnjUDHEBB4FmqH2iIBo
GPjiOfTFF0PyCzbjMPZ8vRdBH+NOepqImIAv9j5NwsHqjgOsdAsHy6za4LF3qegKvoKOZTHQJP3w
a9fjYbA+Iwunj+Ps1as37avHwxAHhnAc0Aq+OGs6ZD964uTP333v8NHjCLVLl6+cNGXazj1f0xoK
YK7ZRThdA1gWL0JvXKbBzGBV+agXobPvTxKmr1xqfD1Jd3m59UQxzuDqYDkwioU4JaI3cdJgkqDm
aEto8dlpOgdLI7kbXYQayZ3tImRJ7uy1daburMemtxAyAFEDWDIFWKzQqF4iNLiV9I/BkLtsY9Oc
VF7ObG0xqYesuwvGLbqOXVsbnt+5+QW4HRL5PRsk95GjbV2E3EBMzZ41odFbTh0sjChwdwCO0JEG
DuPx02dYQgcSuMHv3L2PuEGFlDWZiUd+f5ASRm/cvPPw8VPcQXTbN6Vl1NACoQlDGspwJ6R4NXr+
YhFwJ/ZsEiE4JULrk958SoUlZVTS2HPnL9H0Fd0EKAdBhgKmDu0rEF29vlogPxwPQiK+AZHt6fOX
mKmqrgHYevTkGfATHShevX4TJ454VV3jw5kiLGPz6hovjhbr4I7Gib/UOiJxwLfv3se2XRoPlZ5p
Y2Pj/QcPcCRnzl5IShqtymGFiI8LNLtFlimKQLbK6R/M9clRIkJiu+JOfOZgC1t9M2rLVbhkVpSI
wMRQFZeTbLRxneReZOki5BC8orxcYOJcTkK5L0VQ/+qJm6RsFc0XeUe6JLS4+Ujuj8vllimOPgPO
VzskKqwDME08zABYORvfdS8RutcEXWrltgwWLRF+3PsTgIDDR49Omz6DxpcPfv8fkYiaPG48rV4V
X7mOyHLj1p1+nw+gg7yU8alnz18E3Glra29oaBwyZJhmHrwD6+B12oxZdBSFYTEAFkZ7kkwMAQPB
IOKCZvtKZBqoDpZNyV2XKtZiH8LBQi2BD+hAyZsLFi3dtOXL44WnMRpD0Cmv8MyZu+DMuQtYDesT
NtLjp13d3TNnzz16/OS9+w/HJqdg+eMnz6i6+k5N3r0BB9BNMlgEACWPB86YOWuO5jb9lrLOabbp
wKGjGOdhw+HDk6hVLVDd9Ru3gD4bG5s07gIBWBi+j0uZMGHiZCUUArKZOWsuQCc9d5wFriG2/f7A
YdrQHo6oGMq/el2Ca9Lc0oL9fPxxbz2Gas2SenNfF19o1JR4MDEonhNJo4gPI+I+RVovX735y5//
ioCOnSMQf/jhR1XVXpLBmrsAh4rjefL0Od7OJBksIoIPEDl/4eJBgwZjZYTjGq+PUu7YCk5cB8sb
rOJmsN44zJ75Ku0WNOBxs3AWF+nsloJurHMP15TQupB1XE5sC51IasEurGU5Qp5vD3NGVKZBy2DJ
5QRIBffoAGsTAFY56SIMGRysYJzkzldn4P0ExOhQspLceRmszjbWi9Ds7TXN71iTPlv/qc3jxaZX
BxCzPiNbCYU7EjgcmF6EFh2sqPPRq3cR6lY5ug4WA7Bwp7DNv/R4dC29jg57T3QHRwnFKd3Oqtuz
uiemkY5QB0uQnMAJjh497lIRBlrttLDIrZ86RfVMiRxd553RAjQgb5tNnI9zUoYkMqtRrMXDzra2
5itXryO8K35JNNC3wyNZoH7E5VNz6Vk9TJUpiZ9wPF1TNweYKL/Ap/JgmSr0+3OqUchMBstWInRv
jVR43DI50iMtAztVvwdsOUEXnoCMZQGaUSE7zeFoxDP/jrpZ/Vh+xyhX04GPF1UTYBldhNF4ButS
Md/32tYEwBWY4CJsB9f+R6VV/qcvS/p80q/WH8DtlJIyfu68heMnTvq3f/033HWnzpz79NN+CIgL
Fi0JhcJ37z34P7/4J2osk5O3ETfhqjXrpk6fSZLt6Zm4e7Hw2o1bGAz16tUnf+OmiZOmjJ8wKRyJ
9O1LrXjizf8tHW1pmbnLV6dV1vgOHDk+QmNZajoRmnoCRT/dbz2eKtJI3N5RsGkrcMDGgi2f9P2M
5Orb2lPGT0TMwv4PHDr26MmLAQMHvyktP3X2/NBhI5cuX52SMhE7uXz56ujRyR1t7ecvFH3xxRBs
njQ6+dHT53oQ1EyBksenrlufOXvufLO9DmiyT59PMM6eNGVailZToCn0xUuXZ+fmE/vkzz4/erzw
yrUbwFXkXFpbsf6yFauwJk7/o496ZeXkY0NALnwK0IMDBn4FoFm6fBUWfrtvP+1aGjU6GRf2/V/9
mgIsUy6LzHQxXoQZRgaru8Om44w1SeJqdDLFQGOSU+hOALmmz5hNHRI/+P0H8xYsXrV6HVAjPi08
dQawePXatNRJU7ACfrLM7Dx8aXpmNq6n6HEXJ7l7NS9Cg4PFAixTaNRjcoOEkChoL6XxXHQ8LlaG
QtqWxNUs8Dj9pH2SSzcfh63lk1zVECQ7xPFxdCU8IkBmrG8ALKWKkNyDOsnd6CLUclosyV1O0Jbo
SN3pJcJahoOlyTScPnWOonORDtYPFsrVmuj+GzvobG9v00uEGgeLyFVLQjkfRM9wQAbAun3zzsTU
yRq7nSaQTKuudqcqXpfWwyGCenrjrVWowlROZ/GKmbIye4q79H/tVKuzubl5+YrVR46c4Lej616E
FqFRG8AytGY6nEqEHVaBZdOpkFVaNpebdtRmC0MHY2fEqhBrxq0E6uHex7HpZs/clIZYf5LnJKja
qUsibSQrxInyWe2qoCCYCJ8p4v411/67qEuqTHHSiSw6WO8ZXYQ2kjsHKPQkcaVYkI2VKW/Ljalu
whZshwGfaqZGubaSTqwpEpW15jujIszN+935sFgA1kV8O5bkrmok93d//JNLhkwDvx+Cb+no6sLp
OHGSwbr36FnfTz9XozHEAkUOXr5yrayi8unzl4SrpGXXz124VOGppIoDgC937j149vylGVYoWZKO
BWu8PlqNevz02Y1bd2J1dY+fPkeEAuTCyjRDo4smdLYRHaw1aZXV3oNHC5PGjGtrbelqa2rv6KRD
Z0zNrW0IAo+fvcBrY3PL9Zt3nr98HQjKeEWQwKdFxdcePX7S1EiO8+q1Gx5PJaIGMTy+WBSN1bW2
t8uh8KMnz7tIkaLlxas3xwpPP33+yoxY+CZ83fjUKWnpRMmdjWU4QRx/RI0+fPSERiucAk4zFCYa
ia9LSnERVDVKygFam+TTZy/KKyrpmk+fv7h5604oHHn24mVraysuHa4bTj8QlM6ev0hko5ubaSzD
Dl+9Lrn34FEsVsca0NrNnjM4QqOm/EREaz7A3nC3PnrylFYWgHm3frmDti4C3RYVX711555pf4Rj
wJFEY7FWUit5TrEvfqz7mqUJH2AxZs+sFyEBWHGzZ9laInTUB/kISeIke9wzW5xymCQ0FnTy313E
I4SmOkE+Ad9mnuhNxH/3JlA3ZbsIDZL7d++ZJULaRUjzXqYOlk/Ug+kUIJUMHSwryd0vHz92ctSo
MR2dnZYM1g8HSKx2mukY0/33IC3tqd/VPWrUWJ2DJbMcLNXe/09MwQgHCwBr/ITUNl2IuJOq5jo1
2Z3/AEfYDJzZ8hJfwQHRzBPkKg9raIagq9bWJpo/1vQm+E5wUcVu9mwq6rVZRZs7HB4+pm2XmZOz
XXBTRthc3pNfBFt0GwBLKxGGOCqvIgoLl6CjcOWmrAqZvDKZoLSnCl2NZXszl7CpjcvmUVxpQE7p
KU4x1DmjdxEaJHcALDWug+VWpVLdpBaURL1vbqhRFebweqKbIOw8UIW0epf2CMWttutWPRSJmVkV
rfQMlsbBojpYbAYr6kxGOgupXBTFb1hhABbCLh6NH/Xq6w8EiWpLVxtxazZS+vTeNlv/AAgmTZ5m
6qSTvHR7PCXeYlXMMkNDu9W+EJvToVVaetbyVetqvLWHjp1MGp1M42lbZzumlva2ts6OWEM9XjE1
tDThtaWjDTOtne3a2/amthbMdGshjIrHNNbHaGzC27YuuhX21oE16X6a21oRMtrbWupj6tuOdiIn
1dFBrHLSs+bMnW+Lv1S8wEQ8wCLNzS02Axyn1KdzW9Fjqk33UqQZ/m42uJPnHNfs2So0ajPqoXEz
GJRmzJqzYNFSWtME3h2ZNAY/rsGMsRduWK6xi2diXAfLAFjAUnwdLNPsmSmNeXwCxreX12fnVj1k
1R94qSaRwqdQPYuv/+nxJWKMuaTNuPhMpORu3X+ZTWjUruRulghNkjvjL8TFi3Z6vpnB0i8ylWk4
WXhmzBg9g4V7xOwi/DsSVz1cmDiD1YabuHPkyFEnCTc8ZJFpYDNAip7BikqhUFC+ee0WzWBhF6Wl
JSVl5TYpL8oYM0JTB9XjNVdgdOC6Ta3jNqMYSpfQ60KdZ9q1aMjCOBoraPIKUYdiLHIvz1+kexHy
lZNCDqucbhtoY+ERWwQ0bS1M9hsL8hAHqD7O4yfPJFk25Zdtus1UPI+qN+shpVPPYF28BIA1Ji40
Knp+c5NMCSpfqnhvrg3/9kSgqzapgIMllAZwF3PnVdY4zXHWJE1EVvPydN4P5i0ZLBsiVMS5QJkn
j+6U5VRcBEsdaSqnfY2I081vqRNXhxVemZJHkHfTZxdYY4lNfrifqhahUa2LkBEaVV37BAV/pda6
YZTrda1EflRS6Xv2qrTPJ/002g0CAsFS3UyahA0cgCA019LCODrTvjaRcSGNBZ3GP4rJtLu3Kz0z
Z+XqtBovERodqbGzOxDvujF1trW3ImSZM5gA9ugSTK1tLd3GR0Qc9a3+SuStyGBRm9HWxzoInnjF
Vi0tzXilMjNdiHpdJH+ldWJPyMjMnjVnnvNJQHN4bICmtQZWWd4YVlqcU1nEQ0OYKU/PQtIOqz+0
5YHEKLnbOFi2AajBJo47T3t9tW1GGyBCJrVOM8fZ5i9lVBC6DaTV7PK4owDLKdOglQjfZ2UaqnxU
poHHUuJ23nGqhFIPC2oMvpE4ltK22qLTRtrLqzAmol55OK2CQYt+hI0f5hSYELdY2kqEHprB0kuE
kkFyN2Qa4kruAvEtuz12kCW5e9guwuOn8BDV7lH87bRiENL53ysR/rf/UbPntySDpcs0aMb1gkE5
AVhyOCKH7t66RwFWfX1DVk5uZnauO8Jji270rsHNZUIQ0zBKZJC15+u9VH/OYPG3sxx/k4OFyLl4
yXLD7JlbVSEZLKvZc5cZYYyCYxd7k1KpP9spsB5idGCMh3i/fv3xiktx/+FjM3Cx3Lh2prYQ92+1
Aiwtg8WrxQhqTw6FJAGyFEg1Ru1lKdXeS6+4JqK4nfYimxcuvFOEPC3RF9kBhAVKRmlZigIsq0yD
a82RkW/g1+xcslmKq92Nu4sOl3LkJvflqnnBkY3tgQa96KgUF9tp/snqJHfFKBGaJHfF0d4oR3rA
XhcoOziuJ5FpePj05Ue9+siKQsBHVztiAQavLPPAzNxoNSxLlcpm+dfc0mJ29rFVfxMWxD1kOjqy
8zasWrO+uqb28LGTw0aOxgiqtZmkrro6dSYW7nu8EhhEjZm7uhuBeAhD621baxtVCqUdT20tTXht
bm7s6mzrbG9taW7UP9W20uhcOq+rXbOhwGqY79KGucnjU9dnZM/WABab829sbLSEG8PTptUKJdsN
NU5LpG5ro3ruND/EWmI7Maj5pdhD3ITR8CIU6WA590AzcCbFOA7jjNyYToNlUmXNRtKuqbnZPV9h
V3I3ughZmYZSgRehR5TmcS5PQMwKenwJzQd5iM3oJfTYyPVchriLZyL/6yS74pRAHd6StBPk2IgO
VsAEWEYGy7TK4XURemxwk6uGZZyyx+uQadBKhKeYDJaug/W/DbBMmYaTehdhxKKDZRV3phksYvZ8
4w7p3tVu7fUZmVR54dnzlytXr6WiJHj76Mkz3MVAUQ8fPaH87u++P7By9TpAJXrXfH/gcGZWLlUz
wZLiq9czsnK+/nYftsK2VLDXU1n19NmLOXMXFGzeClgTCkc2b92+cdNW6rSIUc2XO3dnZGXfu3+/
pYVEktlz5hcWnhFwTbQM1gi+2TO9l/F234FDWTn5GAnjLbXQvnzlGtU3fvHqNU2cl5ZXIOY8efb8
wqViHA9wVSgc7tWrjxqNlpZVyEro9ZvSm7fv5m3YVFJWrqW62o8cO4E179y9jyM3W0SN7LgOsDQO
VohPc+arEohVBhTXapHwKau6pXZYwQUXpx1FjKLEdPVoQu9q0elbTpPhYMk8L0JFLBSu8LJcClcF
SnXz0ZPFnHqhhKbK0yAQ79wGB/nIT2xYaftzUhIS4Bw4W+HL31tKhJSDZSi5czQjHEgryv17cLds
UgwO1tOXJR993EcTx+ts02JBtzbuuXvvAQKKYTXY7iRY4JFMB0myrDx4+JilfJpNOmauyy5709W9
Ni1j6fLV1V7/kcIzn/QbcPbSlctXb1y8ePny5auXLhXj9dw5vLmKJRcuFNGZoqIrmKefnj17obj4
2sWiK1dv3L589fqV67fOXyo+e/7S2QuXrly7iZUxYc3z5y+ZO8Hm54uuXrh89cy5CwiaRcXXCs9c
HDR4eFZeAQAWwlY4HCmv8NAiAh0Osp7WJoRqM7xo2HGtyWy19FVp6T1TTIheBwrdTD4sv8HH6CK0
mT2z9oidxs5tLFdzxsSCrYy1Ed0cz4b6hgbb4N7lkXo+TnIPOjJYupJ7qV0Hi5t2kvhsJxdpBruU
aAJWFl/YXTTjc2hfWdhLksVN2SnfJaobeiU3sXhbdyRLcveaZs8myT3OwSqnXoS62bMjg+Vm3SMw
e/bpQqMnjhPZNrOLkFTSNYZiV/xfNx1jGO/0f5yPuiyrOBfaVuF+pCMMVqZBLxGqHEEdOaLUypGg
EpFDRGh08rROjRqZnpGZk7exxuubNXvevQePNm7akp6RHY3G+vb9FHiIzmBYsmvPN0BXCAjTps8C
7MjKyVuxag0iydBhI7At7pSJqZMxwEhLz8TC+QsWf/XNd7g64yek7j90ZOr0mVje0NAI/HToyLHj
hadnzJqDWxtvsZNr16/v3L2ns5OglkWLlx07dlKMP+wcLFuEWb5yzZp16/fuO7B4yXIgv9Fjko8X
nkqdNOXwsRNVNd7UyVNxg/tq/QsWLqmrr//Df/znjl1f4bzGpUwIBKU+fT5BPJ88ZTqOEGBrz9d7
v9t/cMjQ4YgbJzWrn9NnL3z0Ua8Dh46y7mfdJsC6eJmaPbvpFyiueQXnY9ICmFS3vjmxFBOvjVF8
VNzqngiBWbFOlEPVdzfkcRa2GC9Co0TIAVis37DikBBzyaglEOR07dB0Y1ypDmSjJlQz5ySEWIBo
F7lQE6twCbnzaiLhftVilUNJ7rJRIqRmz846r6hC6i7mznNIJFY5j569/HzgYEmWMZZ7S7gXnV3d
RKkB97MJJliCJEISvfkxSkM0UdXok6fP0zOzKZZqZRydzU3iTKbWNlOJIC09a216Tk2tfLbo+ojR
KSNGjR00ZPiw4aOGjxgzeMjIYcNHk2nE6KHakqHDRg0ZOpLOfDF4+JChSSNGjsU84NEv/vEXP3v3
Z58P+GJk0tgRI8eMSBqLhXgdOiwJexgyLGlkUjLWxPqYhieNwX6+0FYYNHhY0uhxY1Imbd6+Z7qm
K4EwmpO3wUwOmdkgk3DKZb+ahUKWTmthrFNilmb2t/f7A1/u2M1aVsfzfySN1GV0ODIZrAxLBss0
KRK1PpltRPSCdxnZRJPrigND/KXcdnokekgVU191HSwv4WBpXYT2DNbLkjjJXc9g8VU9XeWvLOsL
1BmseMtjp3OJFNVFuIdTrPSIljgtq50lOZuaPKdqKfFMfvStTC9C1uxZ42Bt0jNYtUwGS9itybHH
9vhMhrsh06CXCAkH69TJM0RVRKMNdXd1AGCRJPL/egar++3oUWNPGyVChoNlj7+0RBhVItev3pwy
dbqWgOvOzMretOVL4IwhQ4YDFWXn5gNEVtd4+w8YRFI7mmwe4t7yFaurqmvwlYBc1TW+Tz75zOur
JXpy69KxOTY8deYcbpympibcJqfPnh8xctSLV68RQdo074obt+48e/7y17/81c7dX2/fuefDD//2
4NGT/I2bgd527NotyUHKWJ+/YJFFaNT+VLZnsMyhF14Bknr37osbFm/r6xvWrc9Yo9nmYKCIk338
9Pn0mbNxXwclaf7CJRFV/dOf/gsDRdzwY8aOO3KscNCgwRE1Cph4+OgJXAotrRUB6sL5Iu49efac
nuyuPV+z1K4uEvM7tAxWcTyD5UadUZ28JV5HPU+HSUBhSSzqrfCJ8G4Igwfy+F1ycqIioyOTKnwM
y1aAFW6yyDSIWNVc4XW3upu4wpgoNciR3VdEZjUqP1Fnw81ChKcKC5qW1oeE3+gKGa3fy8o04C+Z
ZrA0oVGV5z4eETPx1R6JwRqrUSX3V4SD5Q9Ss2et77cLsKm0rAJPYgx61qZlHDtxkt57GDwBS23Z
tiMWq7tz78Fvfv0+Rn4NjY2vXpeQQBAIYpiYv3ETghee6G9KSl++elOweRu1HbX1sBAl9zXrX5R6
8NiuDsil5R5vrR94y1Pjr66VMENtaKt8QbzW+MnbKm8Qb+nyypoAVnvxquQ3v/nX99//7ZvSiuqa
WjJ5/V5fAKtpK5DNMdF9VnoDVV6sUFvj9fv9UnW1t6q6Fnu+UHxj8pRpOMLzFy9n525AaH71+s26
9ZnffX+Q1t3uP3xMq2klpeV0BmuuWbv+ItGtIWzWg4ePrl67HqiUXiUgTmx+4PDRtrY2jIARmhGz
EB8RlzHWnDlrLk3vYf+4mK80rT9Eva1f7szKyS8qvqqZhPDNnk3QZoo1sE3mtNsR8Rd7pjKkr9+U
4OBz8zcSn92bt9dnZFd4qgj/t7yCEk0wCl+1Ju3KtRvuFSHaRaiVCC1K7rrQqMbB0kjumheh7pFn
qUaJoInHJ/EJW15bJkmc63J19+O0JfokF6F2j7XM5+E79khOe0SPvQVScveu8fB0R21mzwzAKmAA
lmQRGvVKQuNFx7XSYRYluZtCo7WE5D5s2AgMmQAI/P5aTD5/sDYg4dFOJ38giLtbfxsI+rXJ/JQu
1FcLSkEJf+whRQlJkmwuNNf3M/sJBB370T/y+wOBWDQ2ZPCwwhOn4xwsvhdhXKbhpqaDRUuEaevT
t2zbTmT5ps+6fede8ZXrDx89wY0G6BPGf2oUSAuRavHS5UBdlHOJmxELFW3skZGVu3nr9m3bd+GP
n9LbcVoYBQFtzJ2/kBYfES5w79y5d/+zfv0vX7l25eoNxATaa/zw8dM1a9f17t2nrLwMmy9ctFTL
YAlyM3J4xAi+TAO2xWUE7KMOPNg5DgxxA2HqwqXilPGpb0rKJqROpk3cCxcvwxn17z8wSLxl345L
mbD/4JFhw0bW1dWPn5C6T0tcAV3h9AEucQ2mz5hNe4dxIoCSbA8NAVhdOsAiXYRK2FGOUW2UGo7F
r8zjHSs8RxRF7K7j9IF2GBRyanay6yNZSQTaZAdhSBETnviCFHYld9Mqx8hgCZyDXXUZonZKu8rp
/BCV+XgXM+rsHBSm6MQ4w4HJbLIRbq2FovZMWZyfc/oqymJHagvAUuMAi2awOH+fql3tQrGSArls
d16HJgFYT1686dWH6lQReniXpg519vylKdNmHDx8DDckntkZWTnAW9FYLGX8RMQR3JbAE+cvFOEo
Dx09Dvw0LmUiwMSsOfMwhtMcHqbhRsUtjZmjx09++OFHb0rLTJ47BQPrM7OXr1pHmtG8UqU/VKmV
RfjJDCeR2Xj9ITpMGke4loAAPFfw9KoGRKjxe3zB88U3cZzUbSa/YHOsrm7Y8CQEytVr09IzczBk
/PijXghJADez587HQ4jaU2BlvAI/IQrPmDUHwGjCxMm1eFxI8sikMQcOHQGQwqBw2oxZe/ftx4lv
3LR1x649w4cnJY8bj+iJt8tWrMJORo0eixHznq/3Imrff/Bo/oLFCJRvuztFQqOiJnO8Vngq585b
iN9r2fJV1F7jd//27xi4YyD+61/+C84FA+uBgwYT2cNFSwik275z5uy5+K3/+J9/Kq+odMFYJgeL
tcrRMljlv7HLNMiGF6HEw0ySsJ7FNQS0lfz4VTZxIVLQKsjfJ/+oxJ45Pgd7TJiHE1RFHeiNKRGa
XYSa0CjLwdJLhBIrNOrhugY5zhE/kE7G0qWwMOQI+gKhmzfu9u8/iPxxjk0ZPTp5zOjksWNTRiWN
xbw+jXLMMB+NGjUWE+ZHjUoeOXJMSkpq3z6fvv+rX/f/fCCWjB2TQtck64yyb2tZMspYbXRy8tjx
I4Yn9f980LUrt6IkLEZiZPTJ6ck3uwip0GjqJANgpWfgLsO4ArdnNBp78OgJxjCAGr169bl77wGA
Ef7s6xsaCjZv3bn7awQ3rHz4KPHz+f7AIdzHOAyMIXFfL1+xOhyJHC88nZtP7P/yNm5C3LtICOlv
c/I2YAgKyPJ5/4HPnr/EzZ+ZlYv7F2uWlJbFYuqgLwbfvnsHt/+ChUuOA2AJ2viJTMOI0VaSezy3
3dTcPH3GrG+/24/x6pJlK06dOZc0agyA1JKlKzYUbAE6HDFydHWN79SZ8zNmzlGjsQ9+/wGGxE+e
vUD0LikrB5bC6SN0A2wNHUpgNBBkv379Gxubduz66qtv9gI4Dh48dO++Ayy505RpiJPcZTdWu5uM
p1PwUxZ4CctWkSQHL8pRXnRScFQ3Pz6utU4Cxawe8Irsoly2kpOqdRESaQC2RBgLR6IJNQhknumh
UCtVtRpmcxlsqgvZSFzzdaFyC7JTsghpuXG/3IwjZa73EQ98O9aMk9y1DBYtEeocLNmlUdS13Oxs
pHAY7OhehABYCgVY3e0aG+ItwsrE1ClFxdf+44M/rE/Pevn6DU1B3XvwCNPatAygBNy0uHUx7LtB
tGcm3bx1F1iB3qJAHohNWId6P48YOQqgxOQwUY4FhoAAWFUAWIRrEsJwvMoncsYVdsvrOkwaB0h7
wEtxHSZnx5n2gDGeMQRglVX7K30SANZEbQh4/mIRIg4wYr/PB3zz3fc4zd69+5aWlePZQ0eEc+Yu
ABLFyWJUhxEtUBeWA0dWAxK9fbtufSYiOFALTeDHYnVNTc1nz19EmAPWAXLCKwJiVk4+rsAf//OP
iMUYNSLS4UsREHExMeCmGaa4kvtZu1WOuO2qE1Bv9Jjkb/buW7NuPcWCH3/cGwNfHCdG7RgH06cL
3s6ZtyBAoKBy49Yd4OM///mv9IGRCGAF9RKhDrCCutmzSXL3SXGzZ4vagkB0iuvf7OISzTDKPXap
J0mo3i72w7FR7D1ilQePUzmCSVnZaogejoCW/TpwrwzxIgwwAMsfJ7lTmQaG5G54EXKwIE843msA
LOsl0gCWEpEUT2lFKCjXVvtkv+Sv8flran1V3gDJKvvwSma8PpIc1ubp2/h8jTkfkP1B7Cc7O/eX
v/jn7Kw87A0L6QraHmrZvZmTuRNj3u+vCcTCseqKmriUogmwnExeKRLySwRgEQ7W1LbmVtxr+w8c
pKDhwKGjqZOmrFy9FjdXe0cHRjW4hXHrrVi5BgALd/T6jKxp02fh9iHKJpK8YtWaqdNnAlFR/uKO
3V8Boq1YtRY3DrHWeV2Cuwz7x5DyybPnkyZP89X6sRB3HMZIDzXznLv3H06aMm3+wkVHjx+nlogY
+Zw9e5F9ukQtKthCoVFavq+sql61eh3Ggc9fvEIoPnHyNHDk5q1fUp4lwg5GSt/s/X7Xnm9wRrjr
V61Zh4MB5kMQwHCLOhRduXoDQ0YlFEbQxrnTmZy8jQjFGBzu23+I5Xg4hEZDfIwiu8lyiqnfYmKQ
IvLxtTxQRY3xbhbUfDECgb6AcENXHr0IkRhK7lYOlki+PFG7gIhg7kQ27g2SfOMglXPiSs/cr2Wx
woWSoJxndw1y8QfsiWyEdeVY3OyZZrCoF+HlqAWSqm6FbzmR1hePZfgjj08HWPEMlgZ/gIeGj0gC
hkDswN370UcfX7p85U1J2dChw9MzcxYtWQb4hTsZmADDIHyUOnnq9Ru3x4wdRxuAxyan3Lx9d/zE
SdS3C0jr3IUiKyWrc31mjp7BwqPCH64k2j88/UlXz10eByiewXLynav8sv6M0fjC5QbAmjBxEo4c
MIKSNhBucPw4eKDJyuoazeqHCKjOmDkbAWvM2BSsSUkbGCAiWGO8i2iblp61ZdsO7AEBq0tTWK7w
VCKEDRj4RXbuhmUrVlMBd4x6W1paevfug+Hy1Ws3i69er6quwaVG6MQz4MMPP3r85Jku02DqYOlK
7p3uACszOxcDXAAmHPmLl6+B8PADqbidQ+HPPvscv1dEjX762ec4hQWLlvj9xJcaQ2Fgvk8++QwD
fZvWhpODFSe5M1Y5vzEAbtyL0KeYmMnDl32S3MSi3FjhEo+95Ew4udvdSMLkmT3NZq+1eRyiqR6f
JPaHFglTSTz+vi7TUB0IUaucuNBo3OyZ5WAxZs82LCsScyfYV67UfxddBR43nS8QAqAhQTYUBRii
yXDMYwpLobAUxmtECtOJzofjb/WJvgUkkmqDdRG1oGALxohZWXkAPaGgvkk4yO7Httv4frAcQSro
C9JoJfmC2CeWu2gmEbNnyTR7ntLZ1qFRIRud2gp0mNfu0EYxb6IWhkVqttnqDjmdnY1NTUAq8w3P
AysX065TRQFKawupxS9ctPTAgSNiBSanDhYnnWx2zHRaiQEsYTSoEbZINdMq7EdXMBUoKJBapfVO
1voD2nD6qkNo1CwRMhksx/MvmiD7oiYmzXB5Tu4EbaUHhtOKSAzTzWQmKlJaUpz4UoAynck5w+z5
8qUrFiV3d2Bq14VPZPYnu1liC0GbkqgZUOEJtNpKkxwLRTUhquNznthUpez6y7r7hTMYN272rFvl
WL0InXjOib9Fjtqc1grVItNAS4S0i/BtVxvVXb5YVIwR0s7dXwFptbW1b9m2fdeer/Eyb/6itvb2
3V99mzRqLKDDX//6t6Ak44kOCBWORAYNGoyRVll5xeefD4ioKmDW+YtFNKEFgGVGNy0i6ACrSgdY
WonQToURKzQab2mJ6re0RKU9PCq9ViVxayasqlYHWLQhq7xGB1iTtBLhhUvFX+7YdevOvWHDRzY1
NZdXeDKycgBTELBevnpTXeMFHInG6vI3bsJAEOtv3Lx1zbr0WbPnHTpyjOa3bmlUj5Txqdgcl4Xa
j2Tl5P/zz3+xbfvO1ta2jKzctWnpuAIp4ycePHwMFxuA7N79hwBbb0pKafHu6vWbcZmGs1qJsAcZ
LERMYLXVa0lrwvOXrzBAD2mJKwAsnAJm8EsBaWF0i1NYtGT5sxevMP/i1euGhoY///kv5EsTcbC4
AMvMYLFCo7pouNOMz+ZM7JVENTiPj6M+6qZU7uB0c81qeFSqoIixlBjz2VJWAjF3jyMZJuLUl+Hy
6kKjcZkGavZcY3YRml6ErNkzrwPAyUKr1IjtzJcG8EW+gAJghLgAAEQwkBzBq1QrRUOAWbGoEouG
6rQpZkzm2zrtU32hSuZVxS/J/mB+/qZf//JfNmzYDIAVIfRzc8OYsU8yqebmimXP9WpDXaQeyAwH
VheO4VWooGhwsKjQ6I1rN1NTp7S3ULFNTXiPUUJnhc5pt42pLGXT7O3osEMcirFwzyLWYUSEEZTZ
Lm1TyUKUMwaTnaYX4aLFS4lMg8hXhAAsThcho7HCsRSkPUM2+fi6unqM5ahaBG1hYRVk2Lc4o7IK
D8LX5CnT9+0/xH4jm8EiJcKRLAerJzqiKsfTzal+nkBkklfGEnKqVPvj356mErtQczQCVGHDIKcO
pfagHc/uRRiR1HgXocIrkLlUMGVXya6etBPK4jJcAt1Xp9GNq8m37Hp4Sg86BzlOAKqQ2iVQpdK7
CG0ZLF0HS406e1p7KCbiIuKlrUZkGh4/f927r5HBMkqEt+/ez8rJKykrB5JYuXotQEBdfT0e2GvW
rs/bsGn/wcO0xzB/4+YNm7bcvHUnPTOHuETff7hqzbrlK9dgc5qtefz0GUJYZnbu4yfPOrRONnPc
RUuEeIRoHKywViIUUJjFPnSm0KUOsFiz4XieI/4gZ0qEQTaDlTp5Kk3sA+g0N7cUnjqLEWdmdl65
5hF04uTpufMX7t23Pzt3QzQawwrAmouXLt++c0+srh6DRZw+3mJbGu9Onj67eMlysnmFR5PMqf63
//dv9x8+wvyDh49nzpoblAgReNWatKXLVx45Vki/evWatNVr03bs+oow620Ai6eD5Rzd4vWbvfsW
Ll4GSFfhqWpsbMI8xtz4cVesWkNwVn09fk38jtt37gbwOl54CiscOnI8LT0LAMvFf9ckuVMOVpWN
5G4FWHwOnF07VBKRrmzNfR4fT0TU6/TbkTjgiWvMLGzlCwqto20FOP5CQTlS7AbtBIKsTANjlUNJ
7lJcB8u0yuEK03slXjE0GOdgmcJgtEToVzSaiFaDMwJK0BfU4k40PsnRCJH61OfN5WShMU9SUHI4
HJSzsvLe/fE7eXmbyJ5JRipq2ZVi2ZxO5rfgVQngkCJa1ipCM1s4Ntkv8xvagQgDYQqw7ty6O236
TKKfRwBUm9PcRnc1ZgSfaNsvi1QwOqKfmu5SrNF1l5GgsrYAt7BmNcaMqYTciYAQJ7kbj9JovA3e
LjTqFBOm97jTVNEUMWbHWnH5PeN4WF0YMxnWyuzZIXfsILm7WwLLETcE5t7lLgtUyN09AR3k6yi3
FCVKwMhcySs16m7JwvH3Va22P1xcEs9gheMk97DNDTAB41sWiJ0mOGVB9q5njtoOZVeBBJcbAlbd
lDIUgciCkkA7VNCays+QRVkldwAsi9Cow+zSvYdUdpU5tWIvUiK0kNy1LsIuptfPHDwZ2qF2PQJW
YIlqBJjyx+ZQiSoUxN21aInQ5GAJAZZUwZHGtjzD9BKVheTOcLAc1B8WYFEOFiW5T5g4iVWoZ+dp
6GQlVW0RrUP7xw7+9GKE9hZoJm9DQcqEVIeEdNy1hl4ZqsKs79ZWIsxInMFih6cdVgFY2l7AKng5
PdRsNtLiLkJGaNRq9kwBlplBtLrlOLIsTgzNSxolUkwIJioFCmyPnX7MNuF1+zHYbXw8YqEpfoGS
kz+znDvdZ1zJ3adxE+NWOZpMA8lghWgbYLkFYLm4H1qwqQVgMST3ukhdLBQNBRQgm3AwRKuEZEbL
S5E8k2LkmfSEFpN8YqZYpCFE9qDk5xMmeEHBNpJ8sme/zEyVJQFGJ5XuX4tcsl/C8ZAj0QCWeIis
IoCSEqEmNDp+fGpLU7ORQLJgDhZh0DvCxB/m/W7WEA31u3YTjXWTrFU7KzLXbTgt2vemI7MWk7E+
b/5C3YuQDx00kvsljpI768BjU3W2BRPNw6zTcJLotjl9sTZfbMarnVF1YR1RmQwWkWkwrXKiwlZ8
gSakXQnJnZjlIHgpXFkEN1Y1nzLl5sSn2hUfRAkMl/5ExU0tiZLczS5Cq5K7K7fJBZE4L7I79U3M
e3P7TTlyG2rP01RRlwKxQ3fKBHNRfrOt6uogqQq7JTgcrI1UByvKpfzb7HEUgSAIH+ZaToqWCB0c
rO63NnVQU3vTGU2Yo5eiowAAgABJREFU0VWnTeKcHXJhV6YkMY0SaQBYq9NoF2GVP+wxOVgcbSTJ
aloX/zROsn5jVRIXSGybJUI9g2WWCCdPM6kMTQ7TGHN0a7MC1G0WrRl4ekF0qVJNOGfM2HEVxIi6
y+bbauNStBuSY9Qqh+tF6J6+4r61DUz1WGxYqpmmOu64za7kbhMaZb0IGZkGjva6CAkJBbFsSEty
8rF4ORs+D8njRFEiofaewDgnm15oVi25tyua+2G7CKnQ6B4mgxUvEWoyDbpnMwsBfbzEHoNKNYAV
pH2IWhosQDlYqgwQQx4DiP5KICTVynpWSSSBLeilAlQKa4rqAFjAhRs3bpVqpVAw7EY95rXtRLWS
pQbOdDYYSV8pjImKNfwRmQa/TDlYU6ZMp12EWvYoPiZkhoKdToE6+u/KtRtXr980vXHY+8KS8Wpt
1QdF2grXbtyiKvB2nWHNmItysIjQ6NFCEXXDSXJnx2/OWMS6oHYYA7mtX+6srvECS2HSWKHtOKqb
t+92MNk7E0d2MFp6JoJs1nzoGZkGw+yZkNzDQoNeme/IG3WxwlUENnMiOU05IiD6JEo22BNdDmly
Zw7JXgJT1YTiEXJCSXezRFjMAKxw4hySIkhcuRk8/8A2TweWjYpPJCp0lhSTtNz7E2WBCpeLxLwS
SSAV5kjyGRmsMDV7ZmQanLQzR5OyEknA0Bdl/hQ13kVokWlgbmB6vzF5dev4z2GSanI8WYcc9jFv
RDeG5E5lGnyGTEMC/WvLCm4kd9tj2GfKNMg6l0jPYEmaTMN0im9YDql5zO2GSRk7xmWBlA3HsCku
mplnB5SGCWAXKxBvuD4bBAviwNhtFxp1zWB1GGKwrGs1WwqxlmjthAyX9FVcaNTqRRgXGo13cbIA
17UFz4au3It0PnETolMg3gm/rGkej7NCZyWbe+w7t9b7OHmvoODvjet7KLnQszSrnJCZwfJYOVgV
NQHdi9AEWCL3Q347pBSXafAZMg0+WiLUM0lSraJlp6JhidTsokokFiITndFftcmciU+EbhXVgksk
V2uE3rBhayhI6oMxYxPbVjFjw/gU0kf2il4QVGura2n8IhVDwRAZ0VPy+rGhycEyVOnfWuuD5uii
q8bro60q7DrrM7Ip2wFABGCloaFRy1phu/b6hgbNsFW/ZTBf6w/Qbdetz8zMzrN5iNEDaGlpoocx
f8Hik6ZVDgdkOGUaupxDJsY/p4MKX4W0xkYc3+y585etWFVXX09XWLiY2L1n527AsUVjsfr6BnNb
HHk0GmNNwNiRIcPB6jK7CEmJ0CY0KkqHWEpmYp0nFx0pp567IpYD4CqIuvCKZIGmqEh9XolE3TjO
qlC2wIoDTJkGK8DiMYqUSGKxCVmE/wSdAXbZi56spvKMnFXBEKsHXofceq5I6cqN3Kb21KKH2Tau
g2UDWLKgXZSryC/Gf1Hb37wx86NKX+DZy9e9evWJhCMdLU2dZMiF8NCq3eQdDElTn9qaGomv39v2
pqYYARKtDW/bWro6O51ruk8Acghky1enlVbXvq6qLa8NlVX5a2wPZmHTfny5xgGyP+AtAMu6Ez2D
5SPPqmqNg0VLhEQ7R+wV02bwHkwCrM15RoS0uMNfE626tQR2dbd2dM1fvOz8haK0dBL0yXC8q+OH
Xuf/qQlBdvbsedU+f2mNvxzP+NrQmwpvtU8R6pA5kA1TmRLLQVn0GpwOOQ79KqdwOZ9xFXSbRDu0
VjA9Lhk4kSS9gZ88Pr43oqM0adfB8tQGdZkGrURYXhNwehHy1NtdS4RePYMVB1gBBWO7GAlD2iRH
zHl+XzT3EUgDjZZwUpXQhg2kRLhh45aIRFjzwicT9zmXoCnM2aIV7yK8dYN0EXbpw4a4sbHNegG3
bVHx1REjR9l6ANMzszOzc/Hp6rVpU6fNTBo19umzF1j/0ZNnI0aOHjU6eW1aBu7+PV9/OzF1ypCh
w3PyNtKtMrJy25jhk149JACF3rNvFyxczFdy1+d71EXI/tuybQeOJ3nchNdvSoAUf/V/fjl5yrRw
RG1pIVnz3/3771atScO59O7dd/ac+UOGDC8tq6BYcPSYZKCxQFDq7HQbU1nNnq0ZLK5mlWxt9Xdp
8hJJlttUxRVx239Coz130Xleo5lQR15kOJhAKMuSjbOWCFW70ChX10B28q/Fvs4i+QBRdyQ372Xl
BXKvv+2niYoNnqNcsVAXbXoujLYlolw6HkRJLG2HBGApRonQYvasuv2tCjx/rH2dInityTSUVHlf
vC7t3eez6mrv2w7istzZ3dHQ0iy+7YgncUtzY2dXB9ZtbW1qayOWzD/YCaOre3Vaxoo168u9fjyY
S2qksqqAN6AKTVEEj2QALIvQpabSZOEA+SzillVap6HHp1dbdJL7lZsTJ03hAiw2icUNeQhbV67q
HrE2glpra6sNRVGG7FtNBcO9a69Lc4Scs2DxufOX0tKz1meQUXVne8v/lnFJ0eUr06bPqqklj/zX
Vf7XVQE84L2BiK5DZgIsev19Ct++xoFOPD5JoLdu1UrglgI5wrOSW+JTxIjy8ZJkPolLEneUGiW+
UrwL98trt9axdhFqHCwfobJpACuu5E5lGswSYbnFi9DFQjtozeAyQqOaGpwOsJSIBWABb8kUYKli
TW1OuAe6imkAi3KwNIAVjvDJtipn8K2IzXRF41pFb8OO4pg1gDVp0tRuI03OHSw1t7QUbN46afLU
jz/uvWZd+vGTp81P12dkFWzepnkeZOFGxkdTpk7H8vETUo8cKwRkmjV73uOnzwGn6hsaSkrLk0aN
0TTfczCZAURPUROAZY6ISAbLCrBUK6ogJUKXDJbtX2VV9eQp03GEwFIATFjSv//AA4eO0nx5U1Mz
8B/WAcCiqy1cvHSb1h89bcYsvP32u/3LNdUYd4BlkNwZL0J+v5saTZAdUcUeMjySlrMwpwhyGAmc
UiJuSpLOVI1Igz6hmIKIP+4oEQJgGSR3lZYIo5aeRzWhU1DUXVNKEYuMK+Jkngi+KAlTR4nMBN37
BPmS7j04Na49IofMYJVp0EnuYZ2DdbHYRZQrmpC8n5DqDoBVHQw/flXWp2+/2fMWzpo9H68z5iyY
vWApXuk0c+6Cmdqr9nb+jNnzZs9bNH3mXMwkjUmeMXv+3AVLZs3V17RsZW4yxzZDPpo7b3H/gYPT
svIq/VK5T67whz140tQwbh4+UfuV5dFo5QCxJSqJK31kKxGaHKxUAcBi2a8IW89evGSJ/0BdZ89f
pPaFLS0toVAY40KG29EYCkcaNGtnBLVoNIZPKasjDWPe3A0uI8h2YrbbPX/R0tNnL2Rk5a1Zn9ml
1wGJkZExdbNTJ33t0qb48i72I7zVXm1TF7sHdok5c/5S8ey5CyuqfQDEFXi61yp4uvuCAFjlTInW
woHzuCR7LGkhcROcs3/Q1pDokwSlOq5cgsRXyfK5ao26Z8JE/YDOvz2fqyK8saG1RBhgSoRGBquW
kWmoVfia9U48akwGwDKvvE5y13BVWM9jMdkslWujIUzRsxmszVqJcLO9ricqGymJlRWjrFmYNdel
kdx1JXcgpy4GYLE3NTAPbsCmpqbNW7cDavzxP/8IIHXy9FlzBdyWGzdt3bJtxzd7v8fKoXB4zNgU
r6/28/4Dg0HJZETcvf9wz9d7sTJxJGxrX5+RTQGZMdDqcANYCte4N2TrInQHWGfPX6LJs1p/AEfY
3tExavRYqhWsEcja5i1YVF/fQEVEqe3PhoIt23ftGTx4aP7GTQsXLUUIspml8gCWVcndzghWxTke
tQeSTrzOdhGpnFuSE1RwomJFb77UQkKU1kPejwtJ0WqVI+RgyQLnacXukxN1kaqSudXSRDx6JWJv
plNcOgFV7ndFrQmhqEj6wY6E1ATm2Vw9UkVsVuP4fa0yDYYO1sXLifW0euiNLTBu+lFJNQnW95+8
uv/o+b0HT5+9Krl9//GtB08ePH6OJeZkvr197/HDxy9evi7Zu+/Az9792dIVa56/LDE/ZbeyzbPr
PHj0/NHjZ4+eviyr8iLiv6qoKakKlFfbSh4uuQFWB6tMlwl4w8gEWEsnLBOZVXKv0kuECQAWHY8i
ZnkqqxctWcayzRDLzl8s2lCwWTNtPD5m7DiMJg8cOoIg/vzFqyFDh49Lmbh6bRpxJ3z2HEEKw0r6
RRjvUsEqN91QjYN1/mJx7sat/fp/sTY9Ky0zJw2hPDNHmxDTs8lb41Wf8JG2xLYwvoTuxNyPsU6a
9VX7IroaeU0enwokXeULGMhDJrpl/pCVAydpSvpMidaeSpEquOqjnLyL9AOKenZJLUczoNDgWXJr
TuQmokTKES55LK8AJtptDXWAZXQRMl6EGsCyKLkTfjoVGuUBTXE10xxd6PytmgCVaTCgVcRAWnGA
xUu6CCsymkKpqpcIf/wTksGSjQyWi1GGSJGZ1xPOUyYEwIpSgHXz+q1Jk6ZaS4RE8pcllVIFrKLi
q2OTU5q0fsOGBl2SFAOfrV/u/HrvPrxS7ymsE4vVDRj4RUlZOZYcPnpizbr0GbPmVFbXPH76fOiw
EViYm18AgGWWI20cpniJ8Pgpvn+IJjQ6YsQPyGBdu34Lh4qZsvIKHCFWRvC5WHTFXGH6zNmNjU2Z
2XkINfgUt/CmLdsQmqZMnYG3L1+9Oa8JE7oBLFw4DSBSkrvZRZiobssjfSuJZJzkRDJOCZ1kXFjJ
LkbOwpKla5ZCEds8C5/EFiV3axehqGNOVMp0KZ46dTFUMa5VE7Yp2Ln/sutXK4nkuxL+PfD2HHWe
jlvdmcejIjFNJVY5utlzmOhg/fgnlIMVtY0ZXDJhruKuPOCu/qjCHy4jtQa5tLK2xOOr9EllVbUe
wlUKkckfqiZTGDN4W03yTHJ5lc/rD545X/QPP303LSu/ulYqrfTTdbCyuaaxubatX9+VufD/s/cm
flIUad44/8fv1QbBcS5F3dl9353dfXfffd/ZuRxdZxwPEERuEG9FQcQbFbmapptDdJzxQO5TkPtG
QMdbgYbqo6q7qzKrKqubhu6uqu7i90RGZmQcT0QWzAjdkvHJT3VmdmZkZGQc33iO71NXl2hMkIjO
x2NxmDNgUjlBMFYLxvqd1Dl2xRiTuDvBm2IR+vd6TO6iinCrXkVI4dQZd8k7bfpzv/zlr1+a8eo7
y5Yzr+kPtmybW7kgk83eeefQ+oZGWFBS2nfAUivXrIPbpz397ImTp2A0XLZ8JYzsd9419PCRj+dV
VcOgbFxBEueghx6d/MGHO7ft3j/9+ZenPz/j6WdffOa5l6b72zNkm+Fu9JDuz5geHLLLvEP/96Xp
z77E7cyYzmXLcvYOnyXbtGdeen/V+niLHXPn5uP1TQRjERssV0V77fUBDxkvQUwYWKBEhz4tKDFZ
FBm1gVjIZ4zbMxzDaaNKJ2MGjgmTk6Nacu/8CVcJ6HsRtnA0DYGK0JPv+gBL5q+XCiZiXNkGq5GT
YNnZQI7lC7GM3ImIWoF4/JEzREXIJFhZS2NiJU4tzLGLl1GFhY1zRAlWhgR7lgFWD5Ut8UsjAA+W
nf7rZ1/winu4YMbLM19+dZaTywFA2bp91333P1hZVQ3rpfkLFo4ZO/79Fav/ePudy1euATSzZ9+B
V2bOBuDV0dk5a07lC250LNEIQpBgBQDLRmOcZc5LggUjEpQNVrkPP/L4izNegTNDhg7fsXOPz9RQ
eOSxJ957fwVdO7nAcdbsuZXJlPW7392yeu2G8RMm/fntd8sEWJ6KULLB0inXNDwaZdFgoqwHZhai
UGtoO1waIYiFsP2yaDNtU0wYIRZhyhGN3MtUPoZo2QSOA0tj/ITYbmss5XWmaWVRcuCDA64G1S20
JHmkWXpkhcQGaGUqQtfIfU5ANOqI6mkHIaY3RmDk8VlOMWLrV9vQfLIxebwucSpu1TVnjgHMqmuq
bWipc6dPsrnKoDpXYgE7xxpa6pushkTzlq07+l9Z8fKsyli85UQjjPjC9cEhtx+jmbgXwPxR3wSz
NQF2kCFxSWtsaWjJYAoXWTnIm0tzKsJaRIKiuOsHRu4+0Shv5F5SqKGoR2T7mTPz5ldPnTb997+/
7fkXZ/zlnWVMggUACxa7n33+5e133EXPjBw1dtkKElTVTqeJMtFFUQC8li1fBfdCab/48mvAZJQL
XqsizHfCvPDI408uW7GmkZBLtcD82tiUbEi0NCZa6C/d8fabxN+m4Brp+kbxfIN4r5B/U3BZIplt
bLKPnYrDt2toSceImJB8dNGLkJMgovQEqlWWhq4MkwaltEboKHWC30Ji5pwRs60UboAlw8EwW/uE
zp3QVBs0FqHL5E5VhEnOizAVGLm7RKOMpgHHdkg4ap0NVlq0wfKlWSLvCxK8Qlk1UkqFQIIFAMvK
8BNhTnVHQkKlGoOpYXNwoCLcTwGW1gZLF2aKeq7s3X9w776D+Xz+0EdHoLcyqybAWGvWbXht9ryv
vv4WDteu3wSQ5ZO/fkbVi7v27Nu9dz9TDjIGQV6CxasIMcOa87PBgnTs+IkZr8x8113swXMB9sEC
j9mA7jtwaNGSpTBKHzp8FJDSth27Dhw67NqMngTItWrN+rxRP8iXnw/2nEM8y/TB+CyjgY4mbreg
cTbTvhuUYrZZTKUxHscjChsoCQzSXGkCFm2wMmddU3cjAYFlVj85Wq2ibaR1KA90Iq9m64WOts4v
wTGaB8iCnxzOjyDCVgMhhVJIZkqVw2IRkmDPONc/UviczvLPCP2JF2E8mT4Wi5P5sjnNqKIBb5Et
4W5x/xfwUGOyvil14lTdps1br6oY8MqsebX1cTgZXMxvcYvlc5IM8Vxu7k69y87gwjLrBGCdJisk
Yp2iS0JtsAIvNkUvwyRYxAarJU3mMKIi3E81dyrA4n0AGxoTjzw2WeIt3Pzh9qrqRTDswqKWRq6A
ne079wDeomGbYQj+YMvW+yY9sGTpnz7/8qvf/Oamjz/5FBbEVHSvH96KJZcH6+33VsAUCEDwOHyj
eEssoWjZUGNtnVGOpBpDQQwGQY7XNQMaBvBNgDL5cDbdEB4sXoJoZOHntcCxEB6pJPJqKte/lI9O
5afTACqljcnntTyoMa1EDdV7pnAOMGbkHthgJd+kKsLZHA+WJ8Hy4xImNEwWGFuYToKVY2pBDl21
2qjk3NHNN14EQ/Kb8Yzc51V7NlgW4nKoVUxoZtOcxpHeB1heLELJBgvDDT08pTDtyygtAm8l2RlE
Qe5hnsU++2jeJw7sENdmIsBau1Ef0sRVEZbtRcjTevl4rkS5G+ghfSkeRVFyCveyAotIWJ4Ea5dI
0+DIUfl04US0sXLl+U/n946wW9lmNjXHBJgMiFAl20TdBrU8mY5WScepCAeKKkISi1CCYqEWZjom
gnLcKssNZegYedWVKISGCEioaBMNIy1+OImlLGfmoTAY0rFQOQxg8TQN23ZpY3Ujq4gyVLRKI+nX
6Bp2nGxsOtGQAJxU6zsoxXx7WGa05DITWq4Rrt0Qb9q8ZeuAK/sDwIrFm483wExg1XEbvZ7l4Mqu
rBjbIXNw+mQcpupUPUwSrlSstqGZ0UxLrNkGnm5eRegDrJRME8ABsno0VM7uAwaARYctQt/X1fXt
sRM8SxaMQQCeAC3BmDV+4qQFNYvnVi6gwrB586tHjxm3Zev2oXcPP/LxXwFvVS9csnrt+mt//BNY
+MJ/YQVsGkNLxa6zZydPfXrZyrX1zYGpzUmoN7ol7JNNhC4h2PF+2X/T9JD98of+TnCjcN69nb+s
rjl7ogHm/nRjc/pkfbOHTZssYuTuBnv26p/GgmQM4wbuK9yX0ICEUibbprIuS2KhkfWQVB81GSf2
LGdDNYNcE6VG7nGo8HhKVBFWcTxYSYQHK7S23WIrEiwv2LOPrgQXwlY7q3UyEgVROSYe9yVYvIoQ
4enWGjUH53OhETN4FQChaUi3pn0bLB9gUbY5Kofmo/hR20qePJn3GubiyQhm8tIOH16GhzKMX6pU
UlSEikLHrxZTqJzQxBih4S5GHMMo7ng0xpczlKaBlt+naUjnzESguoA2FsI+EO4VKIlL7XK0Qhrm
Ap2pu4bByxBazuRJp+rNhYv1RKNqmD+jqCkn9Q6DgZSl0aKiUYxC7f11iNasHtXhJFtDAKFjokcU
nfiqTCJgy/k2WAxgycGe7TJCmKPRliyUY0woTD8NB6MsKwoEJ3HP9nbjlu39r6h49bW5dfGWEwnZ
m6m8GQhT1ogTIW7jwmWOMbmnJBusmAqw6Nqdi0U43o1FqCOvYtSdAc2xH4/sRO0pSriQTFnVCxfP
X1DjUrYSo/h1Gz54ccarn37+BYy03xw7PnPW3F179gHk+uqbbz86cnTv/oPUWkINWUMpCuH3kclT
3l+13lVoBuSQMVTDlUihYYw17E0pkzGTzn0P+5R8qCIX4KZkCVY5Vk1xxEY7lkhpoxmK5vAxg8QO
U/PFUJt31MTeUIZ4ShtmETOKj2HyV1VyxnsRUpqGN//8ziDfyB2TYCF8YzFFasj6dZ1fElYkV4Jl
iwQNmUCCZekdxGxEwEABlsfkLngROhjPoSEwiNYHPoc5HnoqQkrToJFg8TGvJHZNHmrQPi7JePjQ
hOyQAReeRZkXLOlVhKrFbvp8AZZnrS8G6eJjSKgMfIz3WJXPYaNfQNMwdKgvwZJC2dhYTEBLE8xO
VuE5igBDsX/iss2pJAtaStIsauVtpBTXsEtYGC+Xgd5JR8Jp52bPqZQAlifBkpGZg5OEWTqrJsR0
KYey3mPLGC1JFe4y6YRIyELcIBwt7AtjTcuV6dyHUnnZjkc06qsI5zAVoZVF+FQNvKY6nnrVpI9K
sPTTp2LDS53Y45YPsLYNuNIFWI0ttYk0wmDEm0yJ81ZMbywSCxUwiIfeBC8QjaZUJnE2BTIB20mX
aJQxuVOAhdpgMVN0NQQYymVPYRMMtVKMC2qPRUX3bEkthAAT4q2S+GUuwFpX51Z74PllQqtliIJk
uvMyPPx1fgbEycAnehWcDNIhvAaoNtOg3VN0XjEVh+FQKYmIrBBbew2RhMHeK6GYasUNWkKFNR6j
b4glZJoGP1TOgECC1cSY3FN+exCjJcZTqvI0CJXjBngWbLAYwOIEV0ygZaQBRGROAcCiRKOIkbsy
B9hZk3JBeWhO8iS3vQGU8mAd2HdonGKD1dnZVeA6Y5HFGSwWUWOsHj/4BPTWtrbTbnf2Ass4uRyN
GZoXhwVmd6VTEU5+YqqsIhTejgAsnmi0TAkWlIzFKIRytra2wUovm3Xomfb2dttON7ckYSrPuJzv
PFNXGTxYPNFoWktiaYdQqOPWezKNlkaqodq522GmMNpwxQ4e/9gyhC90cNaDcugehCs5L0IXYHk2
WLjHgyH+TGgxNIpOzGQbIanHDeTDbJ7M4NXSkxVb+i8YSqaqDU+J2Ev5TO4ZAFhMguUBrFCZHG7F
72i1xtzJfupyXw1tK6zF6UzflNy4ZfuAK/vPfG1eXRwAlq01H0YnG1VRojhDxXDPLHnexY2sJX4g
bjIOVIQBwEpu3U1iEVI7BsUUo5sFogmsMTo7SSD6ri4WApbCJj4YGb+fJ/FiC9ztQZR7VUtIaKa7
u0UJlsJIqfVcE0UsfGRiA05CgwaisitFDUeY9K8dfKPqxWmwl1K5EnS+eFrBWxLPDRUOmYPbJDQ0
WqgfooaR65RWoJUKk93Kz6VehEyC5dI0uEbus+c3MB6shAewBKLRcl6KN3JnNA1MRWhhRKPaAchB
PQpdgMXZYMk0DahXkWpk6qAE38qQGghFqIqQGrmPGy9IsFTlnSrLgc64ZOmbRz/5VA0OXbPodcov
RWHWtOnP7t1/kF9Z6ZZkCk3DVCLBsrM4/aYCsMw2WACqWJxpphasb4zf+vvbfvObm2666eZ1GzZB
MV5/460br78RDn/1q1//27/+752797JFHb90DGFyZ7EIOaSimsXkcFosvZjH1pg0WSE2LjlzAGYF
jmtnYgvFGVktC5SsQ8RpSBHxm0g0qoTK0av2bI2yrAy9Z04rYnFCmDyF9Y9WTaZKiXI4o70xciIK
zdHvi9IL69qM0n6EYM92Zo4byEuIRWige9BTeeVQZjXuTD/MRDdlULLEfNMQXkVYm7BPia5bpnkx
js9JMZXjUSM14WdWOsFLsQg5CZYck8RjcqdBQjgbLCbBUhV2AKeYYMkNstGthnZm43iB+5VGYZ0y
go9LKATL6el5dPJUCrBcXJvypA6oPksnhjFHdZREWTpeTfyhMg+Zz+SeigkM42pLSMUkY3aTfEjR
HaPm7UaNntZ8XtfecM5ShVnNbNIehmhPYQ2+NkGN3C1qg8WpCDkmdwawmjCaBsXuil+0MDPHwMhd
ZXJnGMsuwylactjmbLCYkXvWKiMTAx22znufF55ZYqgcUUUI0IgaJLUkU5s2f/jV199CN2xvb6fd
82xHRzbr3HHnkDXrNtI+u33nbgBbtFe+NnsuDVlopzOwTIrV1be2tsF/2tvPfLhtxzfHjlNRNOTw
wZatn3/5Fd+7SxIPFgFYOr/I9NAh5+dFyBZpTIJ1/4MPL1u+EsDWzl1777xrKLzjq6/Nefa5F+GN
2tpOr167YfKTU8s0wFJC5dwjB3vWcVfaKlOAg3CjW+U5tfEI29awOmntoA0GPU65hOM64xudabxO
vEEkWJUMYOUyZz0bLDQ2tuTkiIuOHEN8GJTtPafVdmEOKLbeRD2UYQFjhMLdQi1MmxnC8qWXk1la
GoVWmcl9fmCDhbpG2ij7hqNlote4V/fDluApvU97klMREgkWAKx6AFge71EKm49TWExfvZWP2Yte
mbC9WIQBTYMPsCSxDRcqxLPBircQS+3ABmsSCnR4yROzeODZRwWMlQ84BunY19nZdebsWT5Qq6Q3
lCxCYBrwl85URTh1+Wpig+WrCM2+gaYAxqdkMyDUNjxVnqouABxyqBxeRYgpH2MI97qo5MJD1ijE
7jooxtkYaaypeL1eymCKXoYMNYyqXqaPT4XZvCcVJvckk2A1+jZYMWaD5QVs1mvS47IqNgBYkgRL
CkTo+xJqDWV05NEcTcNAKVSOhZl06JbIlp6DFMNhOVdFGNA0+ACLufVBR2tta5sw8f5nn3/ptj/e
sXzlmunPPJ9oaoYeOntu5YKaxYOvvW7suAlw2cxZc+5/4OFRo8cBOjlz5kxlVQ3grbfffX/M2PGQ
zyOPTf7kr5+9+dbbY8dPnDWn8tZb/9Dc3AJ33TfpwZdengnXwJUaolFeRejI1t9uLMLthCm0XIDF
ZFF058yZs489/uQ77y0/fbodTgIQhF/K5E7HJSj2qNFjfVv/0nkArG0ck7tVNhhCXb20IVkcjQub
XjGtOvHxZl6hsXgtNd6wE0J6iYiv9LpCOQdXgnXFldSL0I9FmDGBPMzgWpASlWPApDcmwzlQ7Cyu
KLRNLqIh0jKclEujXrTxoIc6LJXTxZ8WN9EGi4XK2RnGpO/glBPCV8AGRuZFWE5A3Bhnb+4BrCYf
YM2cG6gIlchxWkCAYSkZDxlwnmiDJdEEeF5scdwJn/MiBIBFQuUQHqzdB8bpjdyZioHBKWpeumjJ
G1989Q2ze2WSrYWLly5aspSpCJ9/8eWP//opXdFSy1N6C1UyMjyniOuJEYYPsHzDoyYr3LbJYF2k
89oT9WIxg1hIgC8UYJ0UaTJSIk2G3lxdJ4XSiTDN0MSkTETYHLTEUbqszPItJNogIl+MmS3xfSN3
Phahx+TueRH6NA1eqByqIkTAJZ+hpFYWJFgMYBEmd55olLPBUkO22QhDIxvsWjmi0askI3c0wqCt
DvcOzsaphqsTB1AKsIgXoWLkTs3baxYtefqZ52GF0xhPfP3NsWnTn61euMTJtT7+xFToiYCo9u0/
+NU3395++11URXjXXXefqD21cMnSf//3//PAg48ATAFccsedQ45+8mn1oiXLV62BM7Pnzt+3/9B7
768YMmTYx3/97C/vLLvlllsdJ6flwZK8zEQj9/OywWIBu5hhaNvp0zWLXp90/0N3D7sHcB4MQVXV
i370g2vGjJvwn//n/wKA++TTz5mHY3k2WAFNQ8DkXq7RjIPzIKBWd6aY4kbsgsqibD1nFWrRbJll
RRo3OhtX8OWwkIIB0eh2j6YhsMEysa06iD7OzmpFPlqKV8cU7cdSdF4q66aVDbedCiHKR9ZmOR1X
rcERMpRZDWsevg0Wo2kgYNc3cjda/qlSWAOIVOqhn9asRJntYpyKMOYBLGbkbpcFkgzWyujkhBvZ
CAFGOAmWoiLEgsrV8xIs3waLqQglIuZCoZjNOrB+/eyLL1371laAQXTlB6vhP/7xzlVr1tPF8aHD
Rzd/uB3WjjDkvTJzFqx94Xw80QQDX6yuAQY+uL69/cyefQe++PJratGVy7Xu2LXn2IlaGqYDzuQD
xWJRBliN2AytAyKiTxmq2ivTlkuPbFioopPMyYAFew5UtJIWDPEe1Tgtlvmm8fDgMIHtWhkOrSYs
qBVEpcLoJFAshUdOVHiwfBWhK8GSaBoCGyxUWyrFXqQAi3yRwIUwxtM08GZYjGjUoMfBhE8eD5ad
4QFW1ipDM2j2frcwd2h+iU95sFwm93EckzszY+/qyrtB019jK6VtO3YNGz4C1kLPPPciZUI/cOgw
bDR2MqTbbrv98y++WvT6G//xH/8JqAt6MZykrCuVVTVbtm6Hw5mz5sItgGOGDB0GcG323Mo//eUd
eqVr0MlJsCYLNA2KtEC1wSqZXQgZAgOcB/un29sB3tFHw8jz6GNPwC+8Lyzw2s+cmTVn3mOPPwkD
S4e/uuPXhGai0a3bAqJRrZ27LsoKiqRRLCWFaFQ/tJ1FRCB6W2PeGSKHTu2hc7ONCL0QZ367HMkH
UREO5IhGMzzACg3gaOuD8dk69zdN+EVdEBg00rOluqRo1fc5gwG7TmOrFU6HjRh2GYGVbEWCZQU2
WCKTu4Z/wSojFJKtrEK5mu8X4i+mjN1UguUCLNeL0JNgpY0znGpAndQiAyS0HBbs2f+XC7AGI0SX
CsFEEIvQnWMkHiwJYFEWBoBTo8eOf/iRx++8a+jaDZtgAH3rL+/Af5ctX/n7P/zxn//XP0964KEu
F1FNvO8BWBDTeGQw5s6ZN//9FavHjCUah4cfffyvn37+1l/e/cNtt782e95//dev9u4jRrLjJtz3
4oxXYN0MOVOMRQVjogRrCgCsOhdgxZjdDK6rSuE8mTIjeQpxNMMwQQxjIFMRngdwOSeDunjKC5Uj
PcJsUx+C53CkFdO7lyIk7FqjNBm4x8x5qhgxrlhoqWb16kkFaFIvQi4WYdLzIqzo7wEsKRZhk42H
QVR4UFnxZKJRBrA4uyuZB0vLfuSocEGIRcgDLJ2FhzqEIRSCjmxdq4T1YKFyDu4TVIQ8K9V77698
6OHHYOdE7amx4yYA7BgyZNitv79t2YpVLnK6Z9+BQw2NiZtv/m/oj62tbdDrT56qq164GNZF0FWn
Tnumq6tr5KixgKgWLln64badsCiaNafy4KHD0IVHjxkHmaTTmXfeW06xkUvUqRq54xpSj8l9+/nZ
YPHXdHR03vbHO2DJB7AJEOQDDz785dffzK2sgtGJWibcPeyepW++RddvofpBlAfLRATFCahwWBPG
LYlFrNPHbNExFRli5hgnYJMVoK1n41ThBS9kFaRHHA8WIxpNKwEJdCbVFuYTgJk0IYEguerKIepX
1M5MChbk4FRh4REkzyd8ss5ywBy20kBEbGMqQo8HSzRyN4szDfwyqkGe+Nx+GmSjDXbrA6zkxg99
CZbLgxVL6OKHpPQL/ZROzqRh/U6qE3YgQVG92DBr4jouVE5Ds6ci3OoTjUrWVEuW/omahR47Ubt7
7/5PP/viiSefgkMYnXfu3jt2/MQdu/a0trXd/+DDrW1k4fjgw4/Wnowtfv3N668b/MBDj2RcZ2kY
1w4f+RiWvM88+wIcvjTjVVjvrly97o47hnzy6edvvvX27353C2SiDJrUi3AqBVgCTYM6PeNeY6ky
Ta1l4jHlQ8TQylRUtF79xwOi15iBkF2V3xgCF4aSOyiippjkTYnG28Eo38LpTxNokEFcghVLoNF1
tDpcSYLl0zQERKOMdfakz+QuyykROBvUgEw0isQiDPSDrXbZwx9m5D4QkWA5OjoGbE4KUxZw4yCM
nnZTMpO0D+w7OHbcROg9vIqQmoF3dnbB4ufZ51+c/uwLVP70xp/+csPgG5Ipi4Z5hrXQ6dPt7y5b
Ab3+iSnT/vz2e3AeeisALBgQ7hkx8tvjJ8ZPmATdFm6Evg//nb9g4f4DhyD/mbPmTH1q+rPPv7T5
w23cGNLdXcxTcdSTU55as2aDYVIZOmT4h1t39BQLvskB7PaUw9RAHZzPnD377bHjE+67f+KkB0bc
O+rVmbM6OjqqqhfOnjvfdTPsrm9ovP+Bh1KWrfKmoinf1VUsdEHht+/YfeedQzwbLJSeSlWZGSLq
+FbwOTQinvLFkVi8Kv2VZZZ1ZY0hBR0E85kdFa2wqMaIM5ovwdruGrl7NlhmpniTTCgnGZyZga/R
ck4b7tM2r4vwiJC50LjI4QGqw9CMmYIYI7BQbbCu4m2wbIErJIePPI6Jnp6/V7bB0jk3YQHUfBVh
0pVg9Ve9CJEc4qlyNVAqwlN5HMTyeBKsazEbLEzXIzG51/pG7jTYM8+/VygUYMx96eWZDHVBmvTA
Q8uWrxp693AYs+4dOQZQV9bJPfzI4/S/T06ZduijIwsXL/3pj34MwzGsgyHDYcNHHP34rzDMvTiD
BB986eVX51YuAOh22223Vy9aAuvjxa+/AWvKs2c7eIQnGblzNlgaXzZdIBqDYjEREt2PoRODzRYa
KodKsGJmgWgcdRI0B9RLYnfpVIQphINKZN1EGrwO5GHvIoblSWlIXzE7fb1FP42U4AOspGeD5cci
lL0IE3YIlTzXg2KSDRavImy2A8N2W1AUOtr4gzipOguVE8QiTKXxEdnWMP0YrDqUOY8NhWTSSnlG
7uPGeV6EhUInT2JOMZZl2ykXUVFt/uQnn6J8DXBZPNHU7Wrqk3CFZdNbcrB4am+nVgGwnSa+h0Xo
2oQiuKcHQAzVyp09e7apucVxcjQ3yQarp1SCtRkBWJpZIZ20hg+7d9fuveeI4q9b8n0pM3V2dsJL
JZqac64xg+v5mOaDArUkU13coZEavqPHJYvp6jq7Y+eeoUOHQ91azXYIDZVtjIxra5g8bb3AUic1
KSeAtEka5JgC+9hlcMQbvD1s2QgdWqkY7DnLG7nndCI6JE6LI3ve6UQvYvhhbSXYpih+Wl5+MzW8
GY3pSA2ssICPIfpo/eezVSP3dOBFaA5IgHH058xsq2Ih+8nzhOoeL054VJRSh9hgpULN2BW1kYl5
MhZKAh5IUFQvNlvnCscTjXJM7vvHT5wkUyF3di5fueahRx6jdO0jR42l6r9f/vLXsE4lRhtDhsEq
FgbBMWMnUGHVY5OnxOrqAT+9NnsewKlnnnsBsrp72AhY8s6bv4DK6l+dOXve/OoPtmydMPF+GOwy
mew77y3nDVp9Bx9PgvV+IMFK0RDLGCZIGSyTYgmN9goXwBjJC2QgkkJVtHXMi9DMgCC2EEXYk8Kp
pExNNKnj94pp/SRSYZF8UnqJV1JdD8hE6jyaxPBrTPxqvgTLC/bshsphsQg5CZZng2VJXy2mui6K
L87Et5yRe8pXEWYCjCUALER5l5M4QgMbLEdr5C5xvksmq2qgEp2EA5taXB4sQtOwf++BcaIEq+Am
yfmOOqnceusfAI5QCy3a6z1yLJ8pivHbUZE2QyfUhYXnxuMp9JjrYj7fQQEWJABY69d/oBPOZS17
yF13b9+xq/Nse6lECIk9M6lCZyHfUch3Bhs501nqKfR05+EXtu5iF5x0zxDM1+W73Zw5c6bkvi2g
LvhXvgswU6Gz8wzcCFu+62wPYUT2MuQ28jjyFsT9uauz48zOHbtu/+Md2aRNPqVttKdRlXc2FihQ
SwcgiaPCGJtsjVG8mXnc0jk5OloeTtQQUGv27mB23EKoHNmL0NZHb9TGS3aUiEMogZYT9tZy/8qh
3KRWWTVmEuPZ2fNAyWoAeK3sqhwCWIfSNOSsjKwitLBoYIj4M0wshwZ8dI3c8TC3uGO8OyX4Eqzt
/akNVqNP06Au01HXelyNlTplilmLWnR5EiyOyT2lC9XCuDrrOC9CCrCIkfuuA6NdH2w+CAZdsz74
8KOvvjb7iSlP/eWdZSRG/f5DP77mh7v27IP9Rx9/4qWXZ57t6ADA9NwLM2bPrZwzrwpurKyqqV64
pCufv+222498/NeHHn7syNFPFi1ZCqgL7po9dz5cAE+Z9MBDrsLipT+//S6jhygKTO4e0WhdYE9m
xczEUcZ4yTHMy0wjkhHEOTFcxcapaEWAS2kyBKbycG501ExKK8uM6SgJ8GpBECQeNltpgTGzu6sC
v2Kq9hYFmrgmN0V5sOJMRdjkE43yPFiCF6GehRVbkNQxd2CP4oGjaeAlWEGwZwfx9NYvghUj92rK
n5QzmG6oAVIMprgaRpw2uzVHRGWZfXv2T5gwiQEsXnwFIAmgD1vMZLLZttOnz5w5K0VlYKTtvHpR
Io5iYf6onTjLE1ZlXZ6ncJd/U97dAGBNXU9D5WD+7TDX3nXX3Tt27SoUoDwF4ruc76SEw+hWIsHg
i1T/SA/pg1yxE3F85mIBFTybzp5iR8cZ2KGKv7AtYKIhRu5DiZG71ZQyBdw1SbCw8IuqdYttkoXk
VJsnnaG3pVF1GaZ2dcFgZ8sQDjlmwQlXSJ+mYbtH0+B6EWZMDoAy4nHU0ENGQ/tw+YpKoIWzpSPq
e9SZ0UECgWvDtDtaijuVK9XG9MI60SZWJwCwWm0u2PMsjqbBRGevEb/ZOpmc/Gn6If7kkoG5tOzm
eLD6MwlWUzrcW17H8x5ubpXUzqzCBF/LvAhVG6zAi7A5YHL3ARZREU7wJVh0kOWivRaTKaupuYXu
b92+86abboZhOu/Gfo7V1cMwBDsNjYlkKkW9wXO51vYzxGi9tbXNTqfhv4QN68xZGM2JTqGzkxLV
tLefaYwnLNsWbb/yWoDFXOvNcqZ4Cv+ImvAsBp+DmE7jxn0mn0nfl2AlUkj961STOmmWjgIeQ0Ix
sz2WckaW52FEFaZii/gpprgUxDSysVgiNKIOVRES00AqwaKxCN8QjNyTjMn9ZGMyxniwNCJeNWZi
EIuwyQdYcZQHK4swuevDbwX0TqoXIQNYIWtihfbQMlo8KEasmRYrk7QP7j80YeL9xTwNVkW52rt5
CRblPSdCHS7oAuvynb7ISorp7uns6DWdnTRDnn9YcvGjz+W9CB95dPKa1et1c3/WsgnA2kl4sDo7
Trt4qKenOwQGEX0mkTYFZ+C1SQjBnpIbyrqHHHreiPw1ne7wUjDk7A5rXqW5NA33EA6OzGmV41ET
p0+jMNKzb6haIUTGaaYqtfUW6yaGKgeTQOhj+dlhJkS4NMUjGhWDPWcRrGBgu9BxTISGEkLJyUIV
u1bZluy2hpVKw9ef06sIc6grgxqwCI2ZY2kFnzA+BADL5ohGyyd9sHX0VybtZD+tH7tmggyM3Fks
woAHy2hDY/LwSsoRcsKVNR6GIDxMvpG7GCoHnTV9L8J4ktlguRKs/WPHTWAEV2KowSAi/UeHj95y
y600UIZqHuFFMWOUoSymvbvDIhjSBS59lr9cLtH1Il0rc0buAU1DQDSa0BplY+wMBpaspOwuh7sj
aOk6Y56TgRTsWVHRagmo9KZXqNDIZJyeNBG4JxQDKY00TsKOsUTKYKCmiQqFK1IRKaDmQ/ChcgIb
LB9guXrttB+LMBkwucs1rKX1V7wIqYpQ4sHyqbBIdBRebO7gcdwUmgZRRZjWu/E7eLgM3E3MMRiB
taVbM82Wy+T+0bjxE7vzRcmLEHoci8TMYsvASWZwSfsmLH4+++KrohKjkI/WwDoy3P7ZF18C3uLZ
7Jj5FNXOAY7p7DwDF09+YuoGqiLE4sJmU/Y994xavmJ1e1tbNptOWbA0y9g22YE1mOXukH331z2Z
ttOZdCYLyz/Y4Az9zTpOoqm5Md5k2xlYwsH1mUy2JQmXZ+A8XNCSTKUz3o00Q/iftwWZk6enLPKI
0+3t7y1bMWrUuGwqk2qytJTouvjBqL22NmCfkWDd1ljNh3J1GrCILvQKSn2kBqezxUDUtoY/gguV
s8PnwfKCPdvZ8AkeNdKysSjXOtWV1NE0JuE5nTeixCyPIhuegN7OmsNWSgZqWrN6XZgj3BLOZI7G
MbnnWLDnHYwHC7eiC1M0h5qm2U4/rReVxs6dAKzABqv/TN+LEF+ym9mwDIoYszqJm4wxJvFUjJ94
xOknkGBRL0LfBmvCxEkMWlGoxOJ8UeJj6ggNI48aD4eqAzyCGS7EPSN2p5ItZs9BQRtDYKrLNPU/
ojxY7/MAS5VglSUiSmmvL4MrIWaCPilPRSuFypFiEeIUUylcFmUm8lAiJCpMBCYVcyyR0gYQ1Nlm
hdt7aW5BP4eOD9YvDLXBigtM7h7RaIPP5B7QNHALm5hZ+st7EbJgz0xF2GwH6ErUEkojSM6wsue8
CKkEayCTYNmhUyDmlh8qNuPKBqNnNmm7RKOHCOW6qyLs6jrLh2CXdmj/ZTbgtM9u/nDb8HtGCkpA
UY5FM1y4eOl2Im06t2Tpm4BUKIZj6IoOIK4VFJFFAcCCf02Z+vTq1et1k1NrpnX8uPv+7V/+7Ve/
/PVvfnPTr3/9m9/+9new/+tf/ZZsv/7tb359E92h2y//69f/9Ytf3XTTze5lv6H/hRt/6d4OJ3/x
//7rZzf+7D//8/9BVnASsrrptzfDNb/4BWT6W7jgdzfd8qtf/cbL+ddBznAI23/94pe//S3JHHL7
l5//6/jxkzLJNJFg6QIG2+Up5kJxla3h7tcpvAy22JYoH7L15u06HZ+NkUfoOHK5toqZlueo55rH
5O7yYBGAFRZCKmc05c4ZwyqEBKXW2jkZ+ahQiaAuiqiB9VSVXNoGEi/Uh9QYRlBEcsTI3daEyuEq
JGcmFC0Hb4mYvp+KqGIYaxE/WFOAtcmlaSDBnhtdHiyDICSeMjpkmc2JjHSaTIJy7fVEguXaV9X7
XoSxBKL9pOiqzvci9Jjcdx0YO26CxKju0+eUJFMMuoplIQt1hMtsgKZms5I+gkE03uSLnvFXyVSC
NYUauSNBYBKqk2BKFEaqTm0p3JsPrXPkUAXQAcDlYkGm/GDbyOdGjMD0HBC4rRKCXczcnhqtnBw3
M2WMyhwWHFPLCK+Rw6kiPZVo1O1oHk3DbOpF6AZ7ZhKshK2PVI1xQwhehDxNg61GIfSY3E3L0Kwu
3rNk5J4NkUnoB1YrjKjQDiRY6aYkkWDtI16E54iOLF9XX7ds+crXZs8bP2HSt8dPwEJox649L708
8/kXZ8D+a7PnTrjv/gU1i2iPmzd/wf0PPDz5ian3jhwNhx9s2ZZ1iOfK+o2b29vPQDevrKoB6LZo
yRsNjfHbb78TABP08W07dp3t6ICJcspTT9836UHKPPzFV1+vXL1uxiszH3n0sYbGeipIe+zxJ1wj
d3yATrekWxLJk8dPHv/627pTdbXHT544VnvyROzkiZNw8uSJU7DBSdinv7GTdd989S25Bm755jic
PP7tidrjtadq4YITzfHEkiVvVPx/V8x4eWayqfnEt8fgv6dqYyeOnYBb4F64BXbo7eQRJP8gc5J/
7Sm4C7I6cexYQ6wuXh9Pt9h2Swb3DbRRCZOD2NhZGIE7EgjP0VrnWBqXPTOvlZUtMyowblKNAf2c
6nKBEVIwFeFspiKkNliWQ3iwLI0qTWdUZJdN66UGSrfDCJxCdJ1Gyn6dPSXKN4FojTE1LibByiHe
MGYplyNKsKgXYSVONIpag2nJsRxjJTjMBsuw9pWtdGM+wbQLsFwJFsfkrjB3p0KMjhNhO7gGhAdY
npH718cVLzZsCg+Y3BtbOAmWR9PAyf/zvMm5ug5m9q1w5dffHmM2GQXXQrYorpKZvzf8HvroiJ3O
QIbU3IrmTNEYXUwzmwlGNCqHyhFlErFEyuQZkBA5ylUGDZX3EpWy8HImDjQwCdbXxxUjdx1SV0O4
4PSnSSRit1miiWIvgzmX2eTcZKmGNWmVoTSuqu24qFPYooJXEfo2WJ6RuwewKE2Da+Qe8KLpMHFC
ZpujKnIPonnBnlNeqByLoxhVbbDMnt5M4M9JsAQvQssYFBabCHOokxTCiOhJsOymJKxNDx04PHqM
J8Haf+AAYNPV6zbs3rv/D3+4Hc6MHjNu1Zp13xw7/qc/vwMwq+306ZGjxmzYtBnw0LjxE1tb2yZM
nDR06HDowo9NntLckiwWi48+/kTWyS1bvgqubEmmHnjoEbj3yanTAG9BZ3988pRs1nliylOz5lSe
itXffMutdfUNq9duuPnm/47VNcyeO2/h4iXErrzYPWXqtLWUyd3si8TNNDmUWtpoy5xLt7pnMu+9
t3zglRVz5lRlU2n/JB7OTxtXWDY0xk3Ic6GRm20DzZU5RooaozAMLth6inY7DKtZ+tDmqJ2WpRCd
W1rPR4mmwQ+Vk5GbOvoIlYJOtRgz8x3YWpSZ00Yf13NiKVbtOB2XjYEwHGmF05/mVKcEs8WYLRMR
80SjcwKiUUe7YEAl6AZeXFWWSVSEqkUzyjCJGbkzJvcTCVtrXCVbvRghlM7UGrEaTvk8TLyRu6Ii
VOKl1Es0DY2ukTthcp/Eya5KfFRmX/7v+RZR8EThEew3xpuemDKNYTLVZ5tevPTNP1cvXAKZwLr5
8NFPVOkXde2mHkzuvR7Aen+VxIOVxLEsTgcQRpKkgNeYllAKp4z3jdwHQ/1raDJ0AEWGdLEQmjSN
mZHEW6GVmSW1Pqq6isJcGvmg1LgTQEKBg1psh1xQ6wEsSyAaJSpC6kVImdx5G6yU7HlgNGoMjNwT
lFONehHaOT+6MwewMq2WUU2D2dm4AMtBJFh47DOMmRBdnqqzvuRpRZnciQ3WoTFjJwDAgtXOjp07
f/+HP9KOec+IkQCznnr6GcA9NOKNG5fm3Padu6dOmz523ATYgRFgx649w4aPoDbpjfEEdRbOZLIj
7h21bccuQFROrpX6Am/avBV2AFp9+vkXt976h5TLm/Xyq6/NmVe1cs06Gixrw6ZNlfMXdHV1uBKs
Jzd4EiwjupJ8oLBpO6dGmGH1kG5z5YVpAFhXXXHl3Lmk/uGkyRrdMFdJljcofb8OPBkkH3J8Ekcf
qEQ/y6KPRom5DRpAyU/WNprPS3BTBBA8yFD1egxg7aBEo16onAxOsoBz34dxhskUA5gZnFjynFZz
iplL4sZSjlZ1K9PAOhg3eva8c8a8SpH4SyIcbGUAK+15EULvEJjczWpHxHZNAwptNNhzGCF44NPu
0jQoPFhprXhAa3eFQgGTajKWQNieCA8TShOgGtzwXoRxj1KIqQjHuDQNMJJu/GDLwsVLn3vBY2Te
uXvv62+8NW9+tePkFr/+5jPPvbBoyRtU4DS3cgEsW6c/+wIlGl29dn3tqRiM0avWrG9oJENz9cLF
06Y/u2Tpn2Dhe/vtd41yg2ms2/ABDNx2OgNj8Qsvvgyr59Pt7XDBkjf+BM+d9vSzX379jQu8fC9C
JBahnqHAbIKj47XSQIFYeJhCiWjU4kLlyI0qltA5MehN9FAPU4P6OJ4qI7J1GKzHmpk54AGnVU/p
/A1PmQOfc16EogQr+caf36ZG7g1qLELJ1lBLJJsSaBoCI3c/2HPAgyX5EmZCogcqQ7ls5F5ZnbUY
wNLLYzDya5STJqfxn8q0ZAAjZlKEyX38+PtgeQJrlZ27d9PAgtArASEd/OgIACxAQnA4ctTYLVu3
Qxfbun0ndNJJDzz04bYdcCX83j1sRGdn19RpzySamuHKRx9/Mp3JjB03kQ4ItSdP/fWzLwBgbdlK
rn/8iamff/HVzTf/N3RhgHQzXnmtZtHry1asgpGhK5/fsnXrrDlzqYrwiSenbtiwWUsFZGCJ1GIX
cdrzaDJaXYBFJFhXUQkW+YitWtc/CSTZGgJrjelSTuZcCPerkg2VDDQNOL24g3NomYkrVWskibRT
Bz3t7HmFmtbGunFpGgaqEqzwviDFrtErE1H7IRTLolQXZTgJysGn9XJErciKK0wunCpWq4jM6ez2
NBZaAU1D2pNgcTZYcrFzIYTyRsWuSJPWT8OUrYuP66kImQSL2GDFRR6sEJZ2nRchFmwkHh57GGUS
D3iwlEz8WIRkamloSTMerIn33Q/jY9bJ/cMNN773/kpAOQ889AgMkUOGDntxxisnak+9/e77944c
nclmR44as3b9RhidJ056AAZrGGphNQwj9fB7Rn64bSeMpHcNGfbR4aMrVq+FKwFLPfjwo3/68zuw
Dr7/wYfdlfSoI0c/gYH+tdnzYFAeO35ifUPjvgOHfve7W+ApANomTJxEJVjMixDhwYqnEGaNcAKC
pEmmlZAizOhNvxUJ1o3XXS+HKtKHFESsxOIas7wEIujCxWw8xImr9uNlmKujFYho/bR1GzM4eCK4
MDB5jAkAK8UDLOpF6KsIXYSkBntGzdpQX9E4C5XD2WApACuH22CF+XLbWZ4Hi49FGGITikWNzamy
E9REhq1QCQ9Wxm5OHdr/EYChfEcXVRFCGQ4dPrprz767h91DxFGPPUGZRd986+0XXnrl9On2kaPH
wiJn+ao10LuTKWvS/Q/SK8dPuA8QFWCy//7v37e2tb23fOWo0eOgwz459WlYOMEq6/0Vq4vF7sce
f9LJ5Z5+5nnoznUNjb+96XfQnQFgUVbhrdu3z5w1m0qjJz8xlagIrTCGRkvHnYgal0hCL1dF6Eqw
3n2XAKy5c3wJlq2XDurd63IodwY6rWIypxwaxVIvYsFJhszIXmuL7YRP24gIzTGFfNGxSCA4RjUn
z6kqwta0aofk6H0qHaNa2SBJ0siDVd0iZs2GoA3B0EpPnKGxFcuFMiNgHzGH+2bqoY/4UInJnQKs
7YwHy9aEtrTCCSBwi36/uvrJYQGFWQRZAfuhchjAEoM9I/SeYeF7Q2LkJVXBAD+/Biqq4yJNAG5o
zxGNBjxYJBYhACwYEAEw3TfpQeruN3PWXBpwcM++A11deQBG23bsAhAGKGrifQ8sXLx00+YP4bKm
5haAYjTmIFxJdw4cOjxm7Hi6Js65OgUYcF96mYTKGTZ8xKo162774x2UW+vlV2fNmVd1+OgnMP4S
ypkdu+j4LjG5M4CF1mdMpevUUAaEha9RqRlCWAkITYYowdLykBmCJMZF9vM4qu/T65TDoI+WSUsb
hycZRu+O0JbGytHMmgzCSA7UBkskGqWhcqoaAoDFGbljrp24q6MSizDGAyyRnYGpCzWB3rR+1z42
ciVYNFSOlcGZe9ToYyrNoKX3crKF9TShaU5l0i3WoQMAsCbQUDm79uz57W9/99wLMwAVHTtRC3gI
gBHtd9CRoYOPGTth/oKFtL/D2mb0mPGAuighMPREgFxv/Okvr8ycfbq9Ha6vWfQ6dHzKEgwjA3Tw
5pbkoiVLiSuYnZ46bTosjWDp5WoGNy9bvgqWZ0c//njVmrUFQsBSeHzyFGLkHsqCbdavWXpaKU9F
20pDR7/3LrHBclWEog2WWV+jpV/XKEcUaoYcSrUgm4E7OEeArbAS6PjKUetygyGOwZIPVT3bmvC9
uAovTNThqQgreZoG19Q9Y7QyxOV2ORwY6S3EbWPMHwMpnWXk0Lf1yENxqzShap0DIMruYeuZXDSi
cXpBwOTu0jT4sQh3oWJgqfZyZgtCI0FGv5hqu4Ouy4OVPZNg8bEI0yZ6BZUs28zrGMrow8kJvAne
NXL3aQIsWUXFTep8sOeAB2s3MXIvFArxRNODDz9KjaJmzak89NGRMcQ4Yw8sQEeMHE0DxG7dthOW
uTAuU/xUe/LU409Mobhqx8491LwDFr5wzcYPtsAhjM6QLeT26mtzzp49C8vrd99fcdeQu+10pqOj
Y8Yrry1Z+qfde/dPfvIpKMDOXXupCQgFWI+yWISNKZysUhJUqAGPUXPvUKSld0SIocGeXSZ9TbDt
VAwBQCjdVApHPEbRmmpiFTOwridSWuYqVdmqcbmIqVWKWH0hTbcMjtMkZXJvTFiyBMtVEQY8WJSm
gZKOJowRJ0WUHKgIvbfgJVjZAGOJAEvrZIRZycg0DbwXoWJChJM1o3SCxmApdPRsdW2wxro2WJB2
7d49avRYwE+e9WSx2ydMyVOrSsbrW/DZ23nTSep0IvGU8m4u6r7kLExi+XWe9b0In/RiEWr90bJa
mjFLF01I8bHybLAIwAKA6xq5+ypCxJpKIyBEPopjMpIz2Iab9KGOSV6l0hAgCBsxkMqZPeAso3eF
peeUR1nUQynpAzGPRzTKJFg+0aiDLyfw716GMbsu6GcZNGAmA6NQna9WXYs6UmgiF9l6llRdFMhQ
Ig+EB4sEe0ZD5XCY3jFJpxSJmk7ZqnoRSrw+ij9XHAVYdgxl0pIjo5WtrgrRcwVzGwNYX6lehKpa
Jwj27HkRsmDPE1wJVi7X+vN//jkgqi++/JrKpWAVu2PXHhgu//LOstFjxzu53Ih7R6/bsAkWuPeM
GAkgCVa0d911N1w5YeL9b7719uGjn9w4+Ab4XbVmPaxxYbk8ZerTb/757cqq6unPPg/5jLh31P6D
H02b/uysOfOyWQfW0MeOnzh46PDkJ4kEC5AWZMszuQsqQs7IPabjjtIxOHBfJ4bGbxFaQkq2Z8fd
CZOYk4EHsGJoaBqDKEsXstDMfq5XHyuvnMToQJN4ZB4EaakOgJoFQyJliquNc9On+FiEccEGKzBy
P8lssAjA8iVYOvIIzNHE58HivQi5YM9WVjDDsoyMzDYi7UeZ3LO4JYc5UJpClyyH8hD9zK0cACw3
FiG1wSJA5/iJ48tXruHhEWOtE3xQuAv8+DAFyQ1FQU7EH4XxEue58A/sXhe9dfsYi9A0bGASLHWJ
bxnVHzZGha9GAg5ssDwVIbXB8vWGBs9zfdBAy2gFrCcHymkdyvRP1Cm/7Gy4RESyRdN4TigUWQgC
yxnt3ENmev7pQuYCwMplzgY2WGUozVUYir5IDvVktMOEWKguz8YM1MKiJOUkfautEWgJGmRHy3gn
OLp6dlc5VTOOeiGIxROY3HmApQtuaCtACos/nZO53eUm0U8buIZpajC+bxj3fZqGeR5NAxZhF5mi
BBmAIt/SRGjW2G+lXC9CjQRFzcdnsq5rokzuvJH7/nET7oNBsK6+cdz4+wAJTX5i6uEjH8MY+sJL
r3zy6eeEniqfr6peNHrMuPkLFtIhe868qnHjJ8IFcAbGWcBJ9z/w0NI3//z09Oe++ubbnlJp4ZKl
kO3Cxa8Xu7s//fyL8RMnNbckX5k5+7Mvvmw7fXrKU0+PHTcRJgD475GP/7poyRswiMPOjJdncsGe
pwTBnl3DZCGeIE9aplpYy7wMOLd+DHUX1SmLeaaGhFf/aixC0QZOo9DUctsmw91LE6lw18iQYAAq
1MP9EGMYVVssoVi4oyaDqv+Bgokl4S4ArIYWT4J10pdgBUbuAU2DSDSaQGNbIZZYpPELX1yRYMmx
CMN0WJKpRNqTYAG0ukolGtUN4mbGHfN5ukK1PaJRAFgTJkwqeORzBQlXUZEV7b95IXCCx7rCR19g
fsQUM1GBFuMHltjeWRxDHoSxYM/EHP7xJz0VYTmMTRI1tmW0OOEVIr6K8N133/dUhNTI3cQNYRBQ
aYigdASVqOjLbB9j1hkZQguHBrEx2Xob9VPl8BSoYgyjDxpv5J7hgz3bGomdapMXwqnh4EGvtWIh
DSY2A02NpC1n8oTIav0czWRmNhpjUawHRIGI0956ACsI9lwZ2GCh8QZsjWW9HUbnIVpN9NNxNCCc
17wXYbPHg0VpGmoTtjm0nDpJ42opXJGUNHAgMYDF8TC5RKMaW+PahmbAVdSLkIIVKsEa5/JgNTW3
PPLYZBZb45w+deXzRZfgHbZCdzfsd5d68sViV1eBZ3kouCHRzl1AKhEy00cef3LZijUN/oRa35TF
XP80rpeIs4LGP46HYhgmMPjoqU4GdXFGNOp9+hjunZo0EdKGSqcU+BJD0bnZWt8Ay7QQTR+fB5XR
4oyvmhqgsQhbApoGKsGiKsJG5kWYEIlGEVGllp6Xt8HyVIRuLEKfpiEjBMyxjdxX2CSEhcqRVYRl
EU8jsgrHIHppS7e2pZ10S+qATzRKwuIUu86323khbsR4z2pcrDKSGyuwyHiDzz02+ckNGzYZfdwc
XAum1fs4MqEl0c+24TxYOoYLlQDC0lAwcNqTXLhhlh5whAcH1JtAGbRmls7KHmGxyvH2W5bREcwK
9xxE1IiIOkwwcg8Alk6MZPKddCRAljPFQAxraVqBqFFdaAog7YRF7HFk2ZitRity9DheoXdHQhjJ
0tNWjgeL2mDJKsIyjeFCVJOy6UI/WcKBGMQIM2XMk2ARFWEQ7DlhI/GhFZlHLJHCDbEVmZlG+ZWS
OCMCFSFTUdFgw7xETZTuwKRF6BzrEzHOo3DLrv3j3WDPrW1tH2zZ5i1zXYREQJQbLcf9pWFzevgB
V8fkztNiwQqY3VtyE3/YE+QfpO4uWDAXHn7syVVrN9YnXN1Qwq5vymiZx1Ei1lBmzjhGMYpH1sNh
RKCi9VWEHsBKpFQJEEqcUZ7uGAXoKT1mSiGSUa21WRKF/ojWG5dRBWKtWCKlh3Q8KEzFEii3quxF
GGvyebB8mob65nTMIxoNaBpi2oBU8ju6DT7JO0xwKkKRB8tWVISW0RfazORuozFTjdEGeXWArfgu
SRqfFBk6M0lr/94DY8ZMAIDV4wIs1q1oR5O7Hpfov2iiAi0aqdCMrno0icZLplGl6WWPTZ6yceMH
glpBR2WkJ4Iy09nnAi9C1wZLMHLXcCKYFbWWkVrd0pjImH3fdLZBupkVUec5JlIDSxO+UCEsyIUx
LYWYZiPRf/XvwtM08EbuVlZLBK8R0eVkI6HQQmbLELA5OPmWZYyfjRjwZcsKNWNrhHY4ZYljanIY
z6qqTw9ssHwVoSfBwoNmOiFLQYmk19aS7/fDxSGiaQivU2CxCGmonIAHy2Cvg87oZYXDQ+11BFmX
IEFpsowqKo9o1AVYTXW+DYof7Hl8d6HzXKlwrid/rqfgbSX/tyTuk//CCN5TgpVuIe9Gtc/DWhXQ
VqHrbKm7y7udMDiTfT9nfsuLh8pz3VH+0clTV6xefyLWCKWtrW8+UdeiNU7CnddSOFOAIV4hgldS
WlopRvQqqGi5WIRoxEk0MqAuDI4eHsUShjcS9ae6hqRCcEMEJ522USuRKi/Gjni7D7As2YvQVxHW
qzQNmHNJTAOL63wtsyfBYjZYIq5illgmyQHGmIAALCuDxQ8R5Ac51anNHJFNpdK2ck4ynbMzNNhz
TzcVQnf6Grpytx4SKrTQQ3BVN8VfeVjoFPLnm08+30Wyyne5q6VSV2dh8hNTV61aE8LkbuLCzuIG
SYzVwlPRKjZYqQwnwXJUAUYZbvMOEoLXNpJ4oeGVUI2PeQ42xJNGadbRuV/3poi0w9EKfjSWWLKu
CrdncrxQOVdc6Ru5nw0AlqVXv+qZzcPK5phDTmkXNqFSHDODKwo4yvOBNZFmmZ0rrXDaEY8Hy2IS
LJfJnQAsB3FfMNggGoJBYdaH/fAJTPVB8ychZuTuqQhRolE1lgvKGx5Phfixo2F9RVlLwMMUBBtG
jKxjgZGvqxZsSrmQpYl6EW7dc3DifZNgWOzoaPdk+9151wqqoB+Ie3qKBUBQgISIQqG7myr12AWw
djXnELK5esZHJk9ZsWZDg+tZdjyWqKMSLDxgH2blZph3cXVVGSbz4n+9WIQuwKrl61+XVSivOk6Y
mcLt0BPagmlxjEFDbbbH0pj5Y+6ZWqlYCAEv48FKEEFgLRbsmVMRpgSiUQW9ofjVd6H1V02w5OBj
ESrRcrQObjJ1UCCRokzu8+a5XoSV1TIPltkTyhCwwjKFyoEBNN1sAcA6sO/Q+PH3Fb1IoBfQ9TwL
qmK353JIpdEwIKCbLp+iGxaahRyFHABgrVmzXmt2prFlVlSHxhmI1L8HsDgvwjRlcg/RzOJxSxyt
5NI20wqINKS2IiGw9U1CjfJmNpYyEEyEKrUl8xodFYjydXJl8mzZggSLA1jEizCIRWiOGWxnQ4yZ
zJRdobwVdqj3YvC+6o5ete2E41RDfepVnDlcLGp6Sk6SYM1yVYTbdmkkeU5IaFRbVnT69DRiuGhm
g6UzeVFt1RmTeyDB8ohGk9qR3eASmEBd1TRyrIQaEsRncmcTfJNC0yDeC4UnnoPuOp7IsVyNyYe7
DowcNbqnO9/TXSgWYOkJ68+zxSLswFq2UOohG91hZ4ibUndPIV/o7OgksivAQ6VS19lOQFTMsjXf
xUxcu9178z1+Vj1eVnn6UJazv5/vPHu2p6f0wMOPv7di9alGUuBvAWA1Z81YISZzBKT0wYllIs1Y
OczpSpViNnCuilaVimmNn0KiKOLID6uEmDbaj4kxNWaIPYDzXOijHZiYtFJ6s7OgwMTIvVk2cudj
EdY32wFNQ8LGfUV1fc1FwHU8KvV4sLhgz5KRu84qBaVxsgMj94DJPZUxsTCUMzFYYdpJX0Xo2Jn9
ew6MHj0OVjtdnZ3Ql89bguXrBzlPwHMXhNWCiO8EsZVKjz3+5Eaeyd3GCEWRQLmO3qQdMzdmoXIE
CVabLj5drkxLZIMttm0UhJhEMvzMZLZlMcYWxJVHDlarmKTHzobAL4QFXhHEmt0tRS/CTMDkHhbW
xtLALExyjBm6hVE3qeT7Kpu5TluHBsbWRVEsRyiIxwLSiHXLYe3ndMEB0agLsAjRKAuVY4c5Sdiq
OtjBg7Eqbqr9FAeo1CmjoQyVYMHCeuOW7f39WIQMYMVMmh2TbS96ARYPWA4XQ2yAKMDiiEYFmgZe
/OaSALlmWC0nG5rd3Ig91pad+x94+NHW0+095851dHbBbx6G2J4SoCb442093i+c7/bNMvzAzMTK
qhNudIfnsx2d1ES2q1CAiwvFbppDt5+Dtyn7ROXY4z0OEFu+UHzo0SdWrdsEM+LxuoQrlkvjLOFm
qkyDYXVCr8xCpmqEv4MFe+aJRr1gzwYb80RKa6uXMHAfpLThltUym2g/tbwJsUQqLIqirCTVwr6y
PBwRHqyGljQjGqXBnqkNVmNA00AkWCcbfTuqREofZSglma8JKsLAi9CWg+TwTO6SWlDn4eXFwlOM
3K1MuRREuB20ow+8GswHZAC1nebGxNHDn4wbN7HTEz51+yaPPYIxlm8M6f9ydpZEMVgirinFbmZG
SZm0RBtK74Cd5g00Oc/EHiLEKp0rdBUefPCRTZu2OIgAQPEFE41LcnjsPxwVsVA5REV4hW/kbrdi
mjUj9bnBjF0HpLRcBmWgZxtzkre13I9CfHE0DLDMgKovsxXGCa73XXXQ0IQ4NnUBFpnUPRuswMi9
zIUEEoqxjCjpUmAi7dfXMwkbojjoGpWOBNXMyB+qm9PJ9izF80NpDB7AIkSjAZP7Dt6LEKfJdUyN
ytJHdvKz6ndKF94O9+xLMS9CPthzbcLWxZ7Tc4RiXO1G82qUG5NIsHwbLJymQeTioioSymFNl/K1
DU37j372kx//ZMTIscNGjLpr6PChw++9Z+SYocNG3HHX3bAPO3fDr7sFO/eMpDtw/e13Dh12z8iR
o8eRu4bfO3LM+NvuGAI7kJt72ci77r7HzYdsXg7DvHy8bdgIlv/d7uFdcM+IUT//l39bvmaDq9C0
4aWIBEtvrxZLpPTYKKmN34diLIzADIuanJIBViJVHxi5p8JRhRLsUgtuEmFCLF1omkTKELImZnAq
1PkVJsrwQEQj7aAASCxhrcTkTiRYbzMvQp9o1IVWrgQrhtKX6D+Z4EXoAayUJ8FSDLBaZQ9qBxlr
pMhufrBnj6aBSLDSWv5Agx20zFKIhskLrrSbLNcBO3v40JGf/6+f3zty9JChw4YMvXvY8BF0Gw79
EX7vuZdsw2Eb4f7e651n+8NG3H77XSPuHQ2X3TXk7jHjJsA2avQ4OO9tw/3f4SPuHnYPvZ3l4D0C
evGwe4YMGXY3DB13Dx86dDic/Pf//R8bNm4pw6wEncOw4HGYoyVvg0VoGqgEi9E02GEk5mZ//nDC
Do1WxezmJhHBSwxDliZaok5lg/ohmuz3w3Rndtbk66cyo6qrETurhsqRvQgN2dqYaszKhnggagJC
I1wMRqp0E2mWbSQf1lJbGfW2hkBGob1Gb3IuSrAkJncDT5gTQouqdaH1mnQ/jbmulnfKD5WTdAFW
f1FFmFK4PRGOgJjeJEUrwEjoTIu4UC2eBCuFxiIMQstRzynXHL6OiAGIDda3p+Kbt+5cvmo9bKvW
bly1btOK1etXrt24et2mlWs2wrZizQbYVnLb6rXrV61Zv37j5lVr1sG2+cNtr86ae1X/qx58ZPK6
jR+u3bD5/ZXrICvIZ9XaTfR2lon7u1E8dLe13rPgd9XKlWvWrFuzblNtXeO3pxrrmu2TTekYscEy
Mq/KBFeIsMdkWh5PhdMWiPZzHg8WwkOGaCERKhBZ5iTSvusCJ+s8Ig1BA89L1ISEDDJBK22QHLG2
Yyi5qNjjTsSTDb4XIQVYb/pEoz7AYkbunA0W4oWAR632SOC4jyLEIuSZGrxgz0rce3XQ59ZtrRhN
A27UjAaeMzNwWlpXJhg9s8k0DJ12S2rL5g83f/DhunXrN2/evH7dpvXrP8B/+R1/27B+46ZNm9et
27Bhw6bdu/c++9yLt9x865Ilb2zcsHmDv210N7oT3Mtydnc2bvwA8lm/bsP69Zs2bPgAto0bP2ys
a8BBKmYengsNV2IhEW9YLEIS7JnaYFl+LEIblSA6ZpYyXCOms50yTL1mu2w8yooT7uVgl0GgFaLs
cwzUULiToxUW8RBp1Z4XIS7BsvWU7qhZmEGFqmXGx+yydb1M10IMki0DzRVKW6UNDIAxlKomX7Y+
IrhK5cVssPxgz7NnVXLBno0uAlZ5RGsaK9J+uIEzTgJJDr9taD6VSDYkmjdt3kpUhLMrTzYkjtc3
GZUgKZQOMRamMNIKHridr74+NvjawbB99c2xk/Hm443Nx+sTpxqbtQIbTTlh6jqPjVzfdKopVduY
PEmIi9L18SaokKsq+s94rfJUfVOsoamhyTpRlzjZ0AwYrpb88jl4jyPPjXP7yoPck0npTAyhfi2D
Ojyu8FHhIfxSiBBLmrA53PClUv/H6hOxeHNIBEBMF4xSr+m84XBMY0ZLOrmpVpdtLLAuwk/CHEka
7WL8i7fUxluOE+dWCxpPQ6LlzbfeHlgx4JU5C+oAb8VbmlJZGkCTyKI8LislcrbWj8QLFQUoDRpt
YzNx+QSAFW9JuzxS4ma3lnvS34ifTuZ0a6Y1m7Lnuuv1efOqyUDDXYDe5f7m0EewW1qNj9YVMgeD
bIpYaMEvDLLejn/GP083B/azqZxjtQFMySTtdEuKRlTcsW2Hf5lDL3PooZ8bPenlE5wU/+vehVea
v+GvfD4fAuofxvdsKv3OO8vcYM9VZPmeOV1u1Wm+jvil1N+cWjbd9yr3O9qtF1zmcl6Kr1u+8sXL
chdcXVKeTjJVOa+a0DRs251tsdwFDLSlrOH11Zo3VaN9fpVsuACtDfmjY59YqtLzKImtPTS3B92H
Q64EUGtlT2dIxFInmZ43l8jXd2zdecFNtNUO6Sa0zP1ONqZOEqEUxQr+DpxsTHJbyjsDFzRn6pph
ed2y+UNig/XK7PkEBDSlvdvdHLxfem+c3/EziXM73vkUcsidpKWqDfLxti++PnbdtYOvIxP8CVju
1yZSJxOWS9GeDC4T8kwKZ/zDuuZ0XXMmRqREZIfu05Pur3wy1pSqS2ZjRF9jNTRnYCLc9AEArAEv
z17Q0GTXET5umAgJeZWrL7O5TNJ1/iP8zFnO3n9jxIYJ5k7rJCHFSJF9ukMM4MRXEOqHe2W2Hxfr
XPg6wb/g9lr2sfiL+Y/If0H/QV9+w9V/E1f/QibKhyjvsJYVWPheSaHRNkoNLMU3OVYttWr5pUYY
F6tUbfyNUrUoDVXKjS98XKxwKVuuf9U1W6eg9hIWNIZTjal4c+rNt96BdvXK7AWEYMxVEdbWN7vM
/pbXHoRiI32HP6TtykXbFmRS15isT1iNzQCwYC5x2mx3gx16GPzSHbbl3Mv8W+gF7r3EnhRGsXSG
rtcrK2vo2s670RY3dmOQp5i5n23wXOFKdjLHTwDieJ3LEQ/tXKuLjVrpPjvpbcF+zj4N6Kot207Z
pAAgwkC8a+dulgm7N8gBOeT2uYe6E7YjVEXwUg5XmdLbqSexHNxDIkEkW5bxYNF1vKZK/ZoUPor0
ZcVS2cqhUHjx4yKfm3+XHHKv8HTpxbGqkN7FXKW2+HT5xpxQIWqTU19QqgG1uvyt1c7Mr6wGsL57
516Y4+EamOzl+vc6GrfJT+RfEGsSpkYiFVXs3Tb2jmj921IHxF7ZNte8I4wb6MhgiyVPox9F991z
+AW2055tI33EzlTOW0C+xY49egglfl+kZhy55FjN9wtmbvfXG3/5LW6d8kdzMuU3ZeDKWENi4+Zt
FVdUvPzaPIARLoYIoADdggz5HNh+QtyR/qVewArAA46E9flX3/oT/HGiYUlYta7WQ8gwjj0Cyxwp
ZMJ/qHje5XewTibsEw0pd6JqhgoBxPnyLJgIk7X1AK0sQHx0IjzZmEIeJ1aslD+FehScxVwDrBgx
uLHlssWxCuQ+AV/yk3HsuQklQ/G/LIegnXAnP5PrP3WCr/9EWIWrxdY1DF0h0fOJoKmc5HITQQbX
SuMWj2KRFsjlgLQZ9cqEeGUiyFnK4aT8dil3xQII1QYgVR9veeOtd4kufk41wCDC5t+cJsCdGOSl
1Wag9mKpd0OjgtZIWiwlB24kKvV4C4nilyMKPhKAttXd93cy3nnb39LiZmeCu9JZNzBLxvUiJCa9
c+dWZZKW3Wzl0srt/OPog9hJ28/Wv4Y9KyiGHeST87mgvFDT/Oadob6NTiv7Df5F/+vtZ1MOIdom
QiA7m0rPcUNW79yxi/63lfslt9iO8FzxWX5YxuDQfXqWf01Wsa18/djBmyKVIN7INq/+U+lMynbs
9LvvLnON3OdD/WeSdvClbLVWxTNyxXr/bU2j3ysj3ytm3qr/vqyNcVWRCQpgIx+dXdMqt1LpWcqh
nZUeJz8iOImWwT+f1rygjWYbnKFWiQOINHRXNmk5boDObCrD12pQNr6Fs/IEO8Jl0l3IW9tqm8kg
r8+9XSvXr4MvnlYewQ8X3LeQhwtbfIotN2Y+n1apm8uvw1pdRqphruNkWqX6d/sFDSHl9es5VZQy
QxgxhL6cMbWBtPJGfHmCjpbpB+Ost5Ep3KL7bIfuk8MmcgEZlJszMDo3Nllbtu/pf2X/V2ZX1RGz
3LR0vXdLwhZ+xcz5p/DF4P7L5SPd4pfnq2MnYXa/fvD1Xx+rJQQ/BIuQ4tW5V0qPEN6lSSmAnyd3
3vL25fM2sZEnqhaAm+Qw3pT64MOdBGDNXlBPJVgwRza01BPrNG8+Ewovlso9IxSG+hPQX7jd2/dr
Qyh5k1hpTcp/WVU02UiFKx8O/0BNyqd0d74+fsqt/xu+OVZLnAaa06T+lS+rfGtLzVAsofTpLfwt
muTyIE2uyUa/Mtry8esTQYOhzVIuQ0JTBqRtW1w+cqdzNzdcZrNrb9eYjDdbb/5lGZVgAcACMATt
CtpDQ0u2gVC6y58sqOom+ZBdQxsVCQzgsm1BPk0pABa2Y6Xd0Ydu/L70L2lLu//1LoBhpc3JtWWz
c+fOh+lk3rz5uTTMJWkuT/bLNu+k9BR6SH6583BIt5Di+Wcc4sPoYT7YyL301z0JO+LJtDvCZlsz
jjuwEjkcmRS37/TycTcvK/8W92SaPcjbLOFx7n7GEeqBL3nar0ZbrBabvayjVAL3pYT6z2Wypx3n
vffedwEuqX9CB2AFFe7drv/cQuVjNax+Av+aNPov4RruAu7iNFYS5N35a9gTy2il2jdVm41Yt3Il
6LuJ6cXbMtCWqgb8D0INQCbgjIvpvfneNlS1Uvi02IPMPdTQ3nRVkUb7ETkfUjBdKxJyEM8I92It
PK15hbR6r7GD2BQntWVbKWJzOcnIwgkrj20eW8L6gvDffg3xZCOxqXJ/42TH2+JJ719sh17TZMOq
ujHR8sGHOyr+R8XLM+c0wmGT3ZjwrqEXs+tZtvJ/48LjGrmdRvGMd2U8uLeRO/nVtyeu/eng6356
3bffHK+PN59KuHYqyl3SL/8sutU3Ntc3trgbERsEh/EW7jA4GauPwyFkEnOVLPF48oMt2/pfceWM
V+c0NDYTGyxyTaKhKUVNZ7jbSf51ZL+ZZcgdsqdLO97WKBa7QfPVGpUXbNRc4N0eF6paviAufD7+
Grf+r+PqPwkvm0i08JkE3wJrIWoBGjUlkYokZBtHXrNB/O7qjY2GJ4qZq/WD3J6QK0feF3uBVJ90
q2tIuA2MdLRYQ0uiKfXGW2/3v6LildfmQUerayDtoa6hqZGo6ZPQtNQ3VcspPKUpBRfAvY1NqcYE
bMmmZiuZyhbzBbJ1FbpJQE1vP/jlD+kGl+XFM+69XZ1066qqXnTVlRULqhd3dRQ7z0oZFunF3rO6
hGcFJ+m++mhp84pRdLdu8pvv9rYu/pf+19/3fwtdxQJ3S1dHgZS/o9hxtqvzbFdlVQ28xd59B1m2
Bf8u/xHu7V6G3fJOXthx78IKnxerndsJzos1I2fiVxcUvuNsHup/5eq1Ayv6z1+wkL6OWoFC5au5
Kfvq0/kc2JfqxhqG0LT4JqR7LlZOVhXyGV35pdbLXRC0K83r4AXG6hx5lzxShq6zHfPdtrRv38Gu
jnyhs5jvLMCvUHt5rLRdhZAyoF9K9+5iq9Pl1u33UDlD7N3d/yL1aSpkXuzveeOAg48/yI6hSec7
oMLJBpVPv8VA+BZ7D8qjhLvj9VOllsRmUzS3W3q+X3tnd3tHN/nt7D7jbu0dRe9MB90vngn2u0+f
Lbadybee7ti579CAK/vPmV/TdrrjLLve/fXy8ffbaZ7+yTPys4rB9cGN3kODy1huQnmKdYnmGwbf
cMPg65uamnNnurJn8m1nujo6CuyJZ/iny69TDC44WzhNtry7Fdq9fcgnOOnv5OFkW3tna3tXa0d3
tq0r51bIrj37CbPf/Bpyb0fx9Jmu1vaOtq7uVthxM+eyErZ2/7/0ofSQVaBQb1z5gwvY9xLr1vAJ
/BuDT8/XebtyL/8JpMO6eBPU/42Db2huaoE3dfz6lz9fB9e0+K8Z5M/t+N9FbhWd3XxrOSOeCa5R
/sXKzL++8I60SGg9cGXmz3OVUFS/1JmgOxTRj8J3E/4XehO0gdyZQq69kG3rgHb13vurBg0YUFm9
6ExHAZoctA2o4fZ8CRpV69mCuWdxfbnoncz3tMFT4JoucgjPOtvV3dXtBiFwyXKFX287F5zkN/Yv
/r9+aM7qmoUDKyoW1CwmdHHdPdyV54TMhQfxmZ8T9oXrzwVn+EOpSPRfLiEw2Wc7bD/4Fz3j/ooJ
AAp06oOHDnOZlIR7+Qx7xH+hTwyKek583xLyCYK3O6dU/jm5Mv1/URauVWvWXnXllVB+l6+vhDyr
JD60hH3iHvGCnrD2gH4CvpHwjcr7iOfk2iiVhO/L/7ckXoBUCFZCqbFJLyXVrfSBSmJ7ExobV3J0
X/yyVawtuVn1FLvlFyxx1YV+I6lrqM8K/Zol5Suonwn/iGqLPYd89JLaYM5hJzX78uCjPFEqSUnf
8HqwqvP3Cdi94krvW/ToO0IJ65I9JbEBlOS2yu30K7oxt2CjO4z6srtU8v9Vovv0kHBvuvv7Dh4c
AB24emGPmx27RZcP3ScZ8k/s4a8MiuFdyeWjXENKBbe3pK0bBg++4brBGTtd6DlHKD7dF5Nukd5R
zRzGJHlj9ckdeu3Qjd5KB67OQjc8t9hd2n/gAMwoVaRCCGVoD4m20QP/IvTtPX6Fs9tLWP7cDleZ
JfbKQR0KH0Xekfa5eihJZ9Svz6qFryL0W9DzLXbqxuuvF+r/nBtJSGw2ylcoqSWUyikVWGhU2GtK
zYY9wmsqwnmkBliDVJ5bQvuI+FF6+AcphUSLKr2sV1qPNbynRCsT2tWKVasH9e+/oGZRIQ/Lou4C
LJxI8PBzHfl8Xulihmqhh/nuHliedRaKpH3CYQGWbIVzf7/kBkeGYaKwoBrW61dWLagmh5qA6L0/
BQCrjyT42N3kqxdWrlpNAFbVAkaGHKXe0JYO+G3JHEQ8St9hH+npnr+ghv8W313qd96hJArdbrT5
7oMfHbyqggygMKa6K7/uS7KlM9aNBGBdl7GSbgiwght9mZWn+B09t6eYJ4EIXRRFO8rBQwcG9q+o
nF/VU+xyIQaJe0NmnGJXT0m6vfjdFezi1/8NXP13k/ovXML20Oc3t10RinAi9SBT44pVKwf1B+Be
Q6KGuwEuAT75cV10+WhbV0kOeZk/d8HhMvUhYmBnQU0NLMAW1BAJCh0xvuNNO5j2+KCPhnBmZzj+
dS+uM4ko6mbl7nAA66MjPd7tPexessNvNBPxJM2cv/ci1IM7c3evWr16wJVXkGZzgaF+LtpWvEy6
NrSlAVdcCW2JAayenlI04l2cze/rXuyFyqpq8i0OHTIsFf8uW78LAoBk3Af0B0NPVfWiS4tGs1nn
RldFmMlm/aH8ogHhHn7nIFchnnzrMlijZLIOVD58Alr/0bLs755WrFozqP+A+dUMqZzrEzKJ6oWL
iQ3WwsUXuVd+JxIsf1LsIwt00gdXrl7XG8bnKLFUVR1JsHpPv64ZWNH/IvTrfhfcgaFwvQVgXX8D
bJnMJQNY9KF8hfgT4fe/C2UdAnBZ/Uf6iL97Wr6SAKwqF2D1IeC+oMYFWNQGq892BEmt0ycSHXxW
rll3VUUFxeVR6h0AaxFM6qwt9d1Vx/cCYF2khdOFAyxfgnWJO3CGSbDoBH8RWy3rITzAolall48E
iwJcqP90JpJgfSdpxao1MC73OcmoB7AWfh8AVl+UYK1as85tNhHA6kUAi29L0VAZASxNBy71IhUh
VVFdEhWhCrCoX/S5y0qCxSSIF73+LxuAtXZg//6CBKsvVDIBWBWRBOsSAqz1RIK1IAJYvQlgVQQO
ExHAuqT9+uIZuV8gsKAA65KLoLkJ3jl3sVWEJblCKkQV4WWANqiKMJAgRqPG3zstX7kGAFafk4x+
XyRYNX1YRXhlBLB6U1uqFjxSI2uKS75w6hMqwkttg+U4lIeJAqyLOZTLRu6uBMuTNLhjXOkyAVjX
8zZYEcD6ewMsV0XY5ySj3ycJVh9TEbqNZNWayMi9dyXJyD0S9l/ifl3RWyVYAcCq6BUqwks1wctG
7hzivHxUhJyK1jkXAazvAmBxRu4RwLr4A/HF8Tb6O6ZSBLB6KcByVYR+W4oA1uWwcPqbABZbWF/C
RGkaLpGKUAuw6L8uCwmWaAMXyb2/C4Dl2mD1MeD+/ZFgVfRRG6x1vWEBHCUBYEVG7r2lX9fwHp29
EWAd7CUAy7lkRtbsWTxvxfzqy8/IfXBQ/9Go8fcHWKuoBKuPAXfCg/V9AFg1vNShDwGsiAerl0pN
IiP3XvMtejfA4vDEpQVYN3ASrIspQZEA1gGEaPQykWDdcMPgyIvwOwNYK10brIgH6xJOin1WRRgZ
ufeeFEmwIoB1fgCrl0iwBIB1aSRYPNHownOXk4owI3pxRirC7wRgBUSjfUdF6DK5V/d5JveavhWL
MAJYvRhgRUzul93C6cJ5sHoJwMrIRJeXLlSOArAuCwmWQ+v/hsjI/TsEWMw7tadv2WD1/56oCPuW
DZZP0xARjfYygLUoAli9JFX2fh4sgid8guleMMFffwlD5ahW/5eRkbvjxiKMaBq+s0SY3Pv3SSb3
gd8HgNVXVYQrPS/CCGD1LoDFqQgjYf8l7dcVvR9g9QIRtBcLb/Clj0WIEI1eJrEIIyb37zItXxVI
sPqYF+GVkRfhJQNYEU1D7wNYAliPhspLmHq1BItXEfaSUDm9gQfLB1iXXSxCStMQxSL8jhKVYPU5
yej3RUXYh2MRRjZYva0t8Zxq0VB5OfTrv4Wm4UjvoWkIbIBKvcQG6zKLRRh5EX6nAKuPehFGRKOX
GmBFKsLekyIJVm/q1zUXp1/3u7DbisWiF4vw0hu5Z2GC/6d//CcnlysUChdzKO/u7ma1AfuHDh+F
CqmsqqFnzl0eWnZa///zH/+n4+TgraNlWVmI/HzG1uUr11x91UAmKmaZ0DbWOxP0xAU1i5gXYR9K
TAlL65kqOvcf/KjPNbb3V64e1H8ADEdsmIrSpe37VTWLYFLft/9gVBuXauylfSGfL0C/uHrAVReh
X18IwILRE34/OvKxK8Gq4aHGxU+Aq677yU+v/fFPso7DhsiLM/fQUbjbTbDDS7DkCfX7CzucXOt1
P732p1D/WYe9LADOqEtLKFxtPCU39bh7PX7iG0yhUGSiCBgRaL/jM+zs7OydAAV+oSPA+FCz6HUX
C3a7b+q9Zil43xKferiz4o5wKJ3kE6tPJYegkuUHCXnKHZZ6EcJAjDyde4se9H24R9PXZzmw50pl
44vkZese8mUWSoK9VMFd56xcvdYFuEvYSKVWFnuK+GqGVMIzMt4o1RvfEuTblTYgdBDuZVkm8oeW
70Ku0bU09sn0l8kfWi2V+nFpUaHbzl+w8JqBg+iknodJ3u3OagtXuwPLRH602vKVzmX89PgQpKsi
qcmxutU9RfoK6PXooa414p1Lzkf+1nzXLriyENiBcQlGJ8AwvRJgufCFGbnT/iy9T8n4GYTqEAYL
XeVqV/yAq/7pH//phsHXO06On9LUz6JrOuKzSiWl8Un9mSZJzEsBFiwZoULybs+h2EtCY2iHkc5w
XbSktJuSpi9Jw5+2+xnu4hqu2mFKBoAL9X/j4Bu09W8c13RjtzqgKLebRhn1s+KPU5prSZz2kGFO
mZL59hAKx0MBN+1NPEJdtWa9ay2+iMOvxd4vllhQsxjWiPALhS30YmGbOQGuHXRRVrp/dykpbTZz
KxdEEqxekmBqgLbEG1ZH8v5LteIFgHVxIjT0u7AODGtrqiKkK6RLmCw7/bMb/+HG628EpEVnu4s5
oFA4DE/s6uo6cPAjqJCaRUsk7PX9HuBI/f/Dz9z6zzGRXtSNdQCL1g90H53Mhl4MzYmKRQGawEwJ
C9/Kqmp6Gbug174pXZpXL1pC1xvC62PYVCehMZ/pMUJwSeqgLJZwSQCt3q6u/DlfjQsAi3obSXnq
l/Ilg7xEEX31mOUr6LujS3x+eUZFhtBsrr5qIJUgQivSrMpKJY0cTrpAWXqV1OVZj3bhJ96CyZxQ
8ZVxPSavNtFWUd5ay/QU/63lFZ1moa59IpXpQlv66PBR6Nr5fIHZ6fZohLihAkXdSlsS5skrZ237
EZaRqGgNFSnh4sMyZEu63JSmWEKXu/pvV1LX4TAo5fN5b9YuFmFc+uGgq3uvDRY0kcNHPu4NbsCn
T7f/+JofXveTn+ZyrXRw5yeq73qlyGt2P4IKqaiYN7+ax1Xfe2VZ2+nTP77mR6T+W9so8qZtOkJU
f8sCK18oMJzK+9sz/Mo0cb3wFbrcgazaZXKnJgR9aKUurRDmzV/Q52IR0qT6RkTpkkuw+pxH6vcp
8YZDVPXfG2kaGHyBwv3oB9fAwlqz5FI0gyo8Fy0SsItL6vUSXE1Z9j/ccOO//PxfkynrnK++POfb
uJhWMJLeUKtJLKEGHPyM2NlJxAm79uyDCoF5hQ7QLtTo4e2adYtmzfKxxC/O8bVaKdz6oYSptNB1
fwmTLqAXSPV/4/Wk/mGHSS9YO9EsfFUrAf9dEPMF8UqxhZjNEWSbA+3aXbZH0VkGqJYfupU0306Y
Uo/mQI32DABLov9YuXrdNYOuBuDuCyeKfUJGCAWGlU/1wiWsSfStBOtdd6Vb848/+8fde/f3rcJ3
deXfeW/5dT+5ds68qmhm7Q3p7NmzALB+9g8/49tSBHwvKsByR2DoGvBLJdOHj37SGyVYdMRctmIV
rJDuGTFq4eLXFy5eCitsstUsWlCzeAH5pdtiep7suGfcfe9Ket7fFgVXeueDi7nLFgOCCQ4XLp5b
WfWjq68BZDNrzryaRa97xaheSO9dEJQnyJZ/Insuu54vLSs/d4GXz9zKBdBhSHkWLYHfJUvfnPLU
0/DNRo0eC8WoWfw6nHQvIHfBMC1UBcszyJCvE/6Vg1LxJaxCXs39Vw37F/8IvmL9R2AvWFUjVwgr
M17/NYthBP/R1T+A+n9t9lx4cam0/KvR6+UaQA6FX++lgq/JtSXuvaqQigoKKX1i/h2FNlCjvrh8
yLUcoUmj9QP7z73w0vRnX3h6+nNPPwPb89OmPzdt+rNPPQ3bM9PI77NwyDY4CduUp6ZPnUb+O3Xa
9OnPPj9s+AhYbEHdtp0+zQMvXmPY2yRwFGBBd7j99jufee5F9prui7vvPt17d/L7tPDL1YZ3kl7v
bfI1z/DX+znjJ9kTvfJw9f+U/3Soc9iBT/bMcy889/xLf7jtdqj8SQ88RPPxi/QMWuDg0U8HGbJH
8x9dKgBfFdOeFsoTVIVYzqewf8F5GIVgH1rdyFFjSP3fcddzL8x4atoz7ImsDoUzXLU8pWZurDGx
Yp+hW/CxlO8ovOx0pBhSG+DfV60uqTakliPUpF/aaXIBnuG/mu7RaJML7uJqQGohdOf5F1+GbwFf
ZMLESaRHTHsmaNhPy6062OeqV/5w05WmgjYJ9MvqH4c2quDDPc1/zaBho5UvPfcp8V7/1Z6ZJv5X
ykp+CtZmhIaNDhSkX0yndQ5D8QsvvXzLLbf+5Ic/2r1nf68DWHRpfs5niBnUf8DVA66CdkP3B/bv
z3bc3wFwCL+DvB35v4Pov4Ir2QXeLd6NFf3hETDS0V96xjt5pXdy0ICr4MwPrhoIh1dfNZBe4D/X
z1Dc8YpBL3CfHjxUuLK/vwW3DHLfmr44LQmcvwp2KioAbZAyuBfQUkF5gqwquK2/8LKsJKwYbONf
Z5BaWv5lvfftH5TcfxafJ/sufBWxC4IbuacHte1/BfJFvI9CboQdUv8V5Fd4zSDbAUJj6N9/EPeh
g/Irh9x7CRUSNJgKIbeBalbSvf6nHMQ3QulxYoUPktoMV1f03b06ubKC1RXsXDPoalZptLRejfnV
KLUivhj0Xz+8+gd33jX0s8+/5PTORSYT7bWKTkCEV9POCF2gv1At7MXl2lA2/hZhEFBz4ypNaqv8
55Br28+TlYT1ZfqxoPLVMgh38Y+rCN5L7i/8Se6t1cuEaqkQsr1KeOX+cpEqvEGYz4Qe0g/B1x5+
qKkutWBSdbFf5Hv55ReGizI+N6tetQ6lh0oNCa1SqbRqC0HeukIsRgXS2AYiX4GbraSHul2bTgrw
e83AQeYPIbxRRXjlIOOzri9UaPqXrg4rNJ1R7VOaHPhaDXqB5krpM4W8KVpvFXJpyeDvz8jw++Nr
fvjo409QrUuvk2DRUf7Q4aOVVTWVVdWwfIeVOi+7EuUNgnimqobb0UgLqGxAFW/wohpuf7Ei9FrM
pBpVqtijmpfKCNIdWX6mCGAkiVeVKAyTHs3lKQtUxBeUiiQL82T5GZdbVQ0i+GFyrCpJiMVJX2Bb
tGQpYHlo5f/3//5iydI/8fI5XIxUjQu31CriJT1MVCZ9OP4TVIXVHi+EU8RRiwWRUrX6xMWiUJBv
MNKnF2qsCiutJKDVf+WgWt5+9/29+w9CZ9l34NCBQ4cPfnQEfmGDM7DB4SHY6I77S68h++41cBcc
1jc09hU5PFMIwovA+LBs+crDRz/xXsp/R7qxtz7k/oudZPvqIb8d8jf+jLR/CLtLKgnd94qhFA+/
ly8Dy4fbOYQVgD1FzoQvSVjh+YuFxqO55aDyILXepHqW9qXLdPWMPiWoDfruXDuXy6ZWoNQ7uIo9
JFWpkqFQJ+oHkp4rZnUIaxVqI9l/8COWyc7de2EKv+2Pd3z8yacH9d9d+nYHlXc0fzu+MOpX4At5
UPm4B9UGr4w8eJvHHndQU8mHuHo7iHVPNzdT61IbCTo4SKXSvTJ/O/leh4/SsRcG5CNHP2lJpi7C
eHghAKvT92Big2kxchzrg2nXnn2Df3rt2HETOjo6o9r4zqxhhM6CsZkI1DtMTsxYr3oh2VWomaYr
Zuum7nj8WxuodzROXsw2DvEMKpVKKr2IanRo9hETqbMQ9iylwGj5ERfF8l3AMCNRMyFLUCf4g7R8
KxqasRDyGoSNSGe1WeZbI8aOJcUsEmdRKancVyg1mvqaMv2YxgrW0Cz5EhaLRdpJbTt9/XWDR9w7
Op/Pm/3jJDIwlW4GrUytU2fwlUvGqtbkqWk55blVan0nUTIwqbVoq4jPU8OsZGxvJd2zJAOGi2bG
2u9vvB9aWIc7AVDT3WK3NsG/qH1usSifF6/B70VO+pcWNU9l5/kruZOmW4Qicf8qFuVLaJ7lFLuo
3syylTJU8mdvUVTyL3KZcG9alMsv3njOZzIbOWrMOc55Slvbxi+LfGXNf/Ga6Q7/KFw9lFUqtT5D
3ytoG8rX575FEW1dRU2ZeYvp8+xZ3vX5QqE3kzKgTjD8+MW8o6MUpe9ZojO3k2v90Q+uGTJ0WFQh
vV++fpHNKs4bYBUDN73Sue87ydP3WrKSP3T46NUDrhozdjybzqOv+V1YIwHW6lGYaY0ARYjW0sem
HI7+LQqdFKXvcb+mw2Y+X8hknet+8tNhw0dE1dJrE7++BZhFh6aLMDr1+7vkArO1IHVUKM401AAl
XfQGUfoXHuiAJ4JDdRA4c4RIJVAyuPGHiExNcQPMotFyogeUo3SQ89cH02DM4zR44j33jmK4irqw
6gIvmLgTNRcrShwt3YPh63M1bKK0wMjudIqPUjlfs4yvr6Fy4ArPgyqe3cqQmEy74Osg+uKynk8w
CUVDfJS+rymTzf7oB9fcM2JkVBV9aFA6d1FoMi7QyJ3h92KfDYIRNbgDhw4P6j9g1OhxUW18pxId
pnstU0BIzTvKlHj1zpU9pZxxGavzkRArSt/LxHTf6Uzmh1f/4N5RY6Km3vtTV1cXJcuk1iy9EWBB
w+LHfVimRzCrL6aDbrCjkaPG0mYX2cpctHE5lGgUPgcdrPsoJ343pxU9F6meo/R9TLRVw8CZyWZ/
+uOfAMDqc/4ol9vHktaxF+G5/S64oAAD6ZQcuRD20USDJ44ZN4FN5NGn/LsnKbjNuTB9GbWLZ/YB
fRSasBUXM9WPUpS+Z/26x+f7zbW2uSrCUVG19ObE/LJ9/dvFsFvoF9X75QuwXBXhyNFjz0VBG6IU
pShF6YKQlpPL/fDqH4y4d3RUG1GKAFaUBIA1KgJYUYpSlKJ0QalUKjm51ghgRSkCWFFCAda4CGBF
KUpRitIFAiwn98NBV987MgJYUYoAVpQigBWlKEUpSn+PFKkIoxQBrCgh6eBHRwZW9KdehBHAilKU
ohSl802lUimXa/3hoKtH3BsZuUcpAlhRYgDrkAuwXBusPkoHEKUoRSlKlzC5EizXBitSEUYpAlhR
YunAocMDIy/CKEUpSlG6cIDlSrCIijCSYEUpAlhR8tPBj44QmoZIRRilKEUpShcIsHwJVgSwohQB
rCixRCRYFf0jmoYoRSlKUfobAFYuAlhRigBWlIREjdwjgBWlKEUpShcMsHKRDVaUIoAVJSlRGywP
YEVG7lGKUpSidGEAa1BE0xClCGBFiUsHCcDyJFiRF2GUohSlKF0AwCIqwoimIUoRwIqSALAiHqwo
RSlKUfobksfkHqkIoxQBrCjxdqaAAABmC0lEQVTxiRq5U4AVSbCiFKUoRel8E5FgOZGRe5QigBUl
MREJls+DFQGsKEUpSlE63xRIsCIbrChFACtKEsCKvAijFKUoRenCAZbrRRgFe45SBLCiFCQ/2HMk
wYpSlKIUpQsGWLkIYEUpAlhREpIrwYp4sKIUpShF6QJTRDQapQhgRQkDWBGTe5SiFKUo/W0Ay+XB
ujqSYEUpAlhRwgFWpCKMUpSiFKULAFi+BCsCWFGKAFaU/ERtsCIerChFKUpRurAES1MqwYoAVpQi
gBUlAWBFEqwoRSlKUfpbAFZkgxWlCGBFSU4eD5YnwYoAVpSiFKUoXSDAimywohQBrCjJACsyco9S
lKIUpQtLgQ1WBLCiFAGsyzMVi938YXc3OTx85GOmIqRn+Aso5IKdQqEQVWCUohSlyzN15fPeTlee
rUXz/kk4zDq5HwwcxCRYxWLx/2fvPfybONL/8T/j9/1cwEW26SQE7nLJ5XLpdAJp9G4DAUKHEJpt
9WrZBtPTSaipl4TgJmmbZJNOQu8J1RXbKlul38yOtFo1J7mYC+Tmec1rXs8+OzO7Wu0+855nnnkm
Ilu2kObEY1cMsDD9aUn9kYsyASYUCgEJSXtlgLVA1hfJKApIUoWYMGHC9L+kPwUZWrHqoSnKJZkA
c6ujoyBXM3PW3KQyyLFVgCTiJ4kBFqY/s44IxXREKMSiERjtbUADL2WMJYXDSDuorVY81A9YQWDC
hOl/kbiYMgQqVEZLQiTmtAogVDAYam5pGdR/YGHRfE4mZTYArxzChAHWn58UB3Zk1gY5+vJ9jV/m
5+TOmj03hsOiegQN12RYJSJoxcs6BRMmTJj+10ixVykSpD8VINXa1oZWEQoxPRkIBpFGRbOKmDDA
wvQnBlhSIBBEmAlZsxB5SFqTlT1vwcKIavYQYSkZXEXVRyjEKg4HmDBhwvS/Q4JqbAkAU9z1SmWd
unGzaWC//sjXQplMTNsCJgywMP3pdIQMlb7/4Xj7rQ6EpZCaiMXBWqCogGAwBAZnly7//POVq6gk
GIGJeH4QEyZM/9v6s7OrKyLPEn76+RcH3/+osxMeAkUKhq+AHzxg4JSp02Mj0hDUt8d+NFls585f
wAALAyxMf1pSLNuffPr55CnTtmzdAXAV0Ai8IDR++TUAWHML50XklTKXf/q5tt7zyqvrlyxdceny
T5GYtxZeSIgJE6b/WVKs+8g69f0PPz799IgH/vrAug3FNbWutrb2pqbmewcOmjUbBhr99vsf3nzn
3YWLXgaS7TtfU1rAjxEDLEx/0hGYgBbCcO/tP6jJygZp9OixO3a9vu/Aob75BYVFC3yNXy5dvvKv
Q4dpsrOHDhl67IfjilKAbgR4fhATJkz/88NUxRX1x+Mnh90/tECTBwaofx3218UvLwNKdcyYcTNn
zSnI1QBhfk7uy0uXo8J4dIoBFqY/L7qKDZ4QTlr08lKEsUDqX9AH5EAj9NHkAWiFVMPhI7XBIDRx
oxgNOIgLJkyYMCXR23v2Ii2K1CZgQI6YPnn5f/vr306fOaca4mILFgZYmP7EMEuIhmZxExT4/qFe
AKAKKIhsyPRBfFb2y0uWB2UHAgVXYfMVJkyYMKVoVGHR4iVAZ/bNy4fQKienb36Bgrd27Ho9de0h
JgywMP0JCQXEC8sEmKptO/vJtqv8XA2ycgOl0L9PXwCzvv72+4gqgF4kNlGYujQGEyZMmP6XCQxW
wQC1n4yrkEZFadnylcgFPoK9rzDAwo/gz008INl1QAnp3tXlf/75FwvkaUHoLpCrQfZto8kaUW0B
Iah82/E4DBMmTJgUQnpy4aIlaFoQzQbk5eQMufe+EydPywV4RW3iiKMYYGH6cxKK1xKOhWhHdOiD
j9G0YH5OLjRx5+Q+8s9/Xbt+I0GDxNAVDoKFCRMmTMkYi+cpxtc3vwBhLDRF+Mqr68Epv9+vHpdi
HywMsDD9mQmFZkEWKZZlATNn7jzFEwsArNfffEcZbLFcQuwrZeNnTJgwYcKkJqvdqTi5g7zxy6+B
toyFa0ab6khYf2KAhenPSTwvKNuORlQ+AfVuIqoUsrMnTZ6KvKyStsThOA7vQogJEyZMSYQM/GCk
evHS5b8OHYYU6cLFS9B2hBFV9CxsvsIAC9OflhRoBYZTaCCFPviW1rYRw0eiAA37D76f5IwJ8BYq
jPYxxLOEmDBhwpQ8fAVKNRzeWFyKpgIIikFyoDyRzsRBsDDAwnRnfrscAEcA3oSEcCfcSVDkQ6GI
FOakCEq8KqVKMiWlWIDlt2zflZuV89dhfzt59gInS1JLcr/UDmBCgsSKksL7WYGV0ZqgjOHkHHt6
3gnkFyIC7/cLYmdI2HPgwzKrtsxhdzgrHGVyclZGGYWPSewyb1fOqlNqLaVKEq8umXwqXctpSyZc
ukJ9e0ntZ7qoPdMlMvyQX1s9tYD66cl5mcNpc9hsZQ6Lw2kp22y3W8rsRse21zs6OiMxj0k8o9QD
JIZEESgkqKO6QmwYPFIpLHJ8d9os/BuUaogXgcKEapMTfjx1Njcre/LUGf4Q92t0r1rCCpJyCmhR
0CyQQDloKRwJhrhwbNoBj3IxwMLUgwBL5FhOBB8bz4XDMS8o8M1JbETiMiRWdbabYtF09crlIYMH
r1y5Kiyyv6Z8+mYjXFgKgQQYkCSg14RAJMwqYWCUnecxwLozOh5JYv3hMBdob391zZo9zpWf7C75
5DXd57vXw7Rr/WGYrwOMkgPJ4fip9bFD+awsieeIgafWqfnDcR6ViTKHd8dyVCV+rfillYpIfjh+
xXVKdcQk8Koqcgvxq0QZVZmEU7vVF1J+iLpWrLXYY4n/5Hgt9RNTXWX3+k+3bfhs9/rPdm34bNem
j7dvdL25cW/5ihFPPt7a1oahVY++5wIfCvIcG2KDYfnBQmOSKEGVFVaprzD3W9RpTBJGFdEhy7P+
F55/4aOPPvqNypNF+jMSYWEKwxRVpGEWanpoIRP5GK7CER8wwMLUYxSGuiAsCRLLdgGAdauzKxIO
h4LQlNUjKRTyg1yrN9TV18OPVwCfsQC0UE+1LwhCABreokZyFBce0x/f73C8ELgFlTjLLZ5fdPbT
0qBHzxJaidbDRMVyOYnqQ1o+jPKGaPmkWnTyqWgLSt14sQReTCeETVGJzapaEKn0V0yorpYnpVhT
8Usn/S4qnZBOKp+UDGmEiT+Hc5s5xiiSoE0j6zFJROm1GsOIJx+72dSM/R17kKC9RxQlgRX4oBQW
O/0BaEoXpJ7Sb/JIBW4kJiMf7uN/f9rUdIPjfrN+BioeJDUPmpUlkdh+0iyG3RhgYephCvEiAFgs
3G451NrWtHT56rmF82bNmjlrTtGsOfNmzimaKTOz5s6LMkgyd57CJyVZHi0P0pyiBbML5z/7/MTp
M+eAwxmzC8Gp6TPnxtuMlVSaTTicGy02fdZckED1aJo1F8inzZxTWLRgzdp1ra1tSrcRDodxF/KH
E/SpCwsdLNDj4aWLF1+psUiUiSf0EmNXksjY1Idysol0qjChQLRurFi6RpLK21KrKzxoR24qoRHV
PdjQJVLuytb9FWN3ZUv9sd3/QHQ2qXrqHaraSbl5dHVvWbjRFnRDvMUzls660ovV1lEjRty4eVMx
UeAOtQcmACR5fQ8fDEvst98dm1M4b25h0Zw5c9X6UMUXzVIJk1TfzASVG5XPmFUIcqDogBadPHXG
/IUvAzUI+AS1rNKTsxJUcZJmLlKKzZS16MzZRXPnFr6ydl1T801JAqNfHi7lxjMAGGBh6inq7Ori
QkKoKxAJB1tamx7+x8Oa3r2HDurbT5PbV5XQYb88Tb8UYUKxPLlMniZ2qNH0ugcIHxh6f5/cnEF9
+4DD/vl5/WPt9NMklI+1kNwsSgMK8vvmaQb0KeirgVUG9++X17uXJiv7gb8+gCY+8K4Rd5AFC/wX
knArBP3kVq1Yefozc4iwSIxZYiwiDRhrNKl5VUJl4iWTqsQOxQzVY6dSzqqEqktYUsrEeVF1OXXj
iZfO+IvS34bqzuMFMv4WS6a6sbOWRAYmljCKPhPn0bGuEslr5Cn9+WrLqOHDbzY1Kx8IQAb4Rf2d
1BUQAv6uMAft9EzD0fycXE3vXgPyc6LKLUE3apI0W5IkrWoFavPe/v0G9ikAkoF9+wAdWJCT3Tc3
R9WCBmndtDpTrbFRGVgYSXJzQFN5Wb3//rcHmpubImFe4PmoCsX/KwZYmHpmBCayfIiDTgMR7npT
U//8PnOmvniReK2l3hpLNpjq4oetSAJ4RViHillbVTkU1lnb3fbWemtTraW5ztrmsoEcpFaXqnpd
lInWUjcrC1FqqrXKuQUIo424HZcPG+8bfO+w+4e1tLZxHIeiP6C9evA/+8eS4A9GhFBAXjCxctmS
s59pBdooUSUiYxQZg8AYACPnMAk0TOhUXBIrhkoiCToUGaWwUa4YZ1BTsdaMsVoGpZHY1aMtoJKK
PHrdWFOKUH0hFZ9YN/5DEvL4701sQblJJSkPIX7/TOqvjpeMnU24Z/QTgh5TuNEmeR2cxxgiTRxj
PHfENvwpCLDi3z5eetYTFiyODUoCjP/nIr25vXuvWTrvZ/qdVpWeVPShWjEipRpXekr5OrUWtd2o
MQOl1yozQG1erzYDLdrmipdUtRA/bE1uPK5pUbMgByr0Zq1l+JNP3jtwYNPNawIX5EJ+hK5CLPZz
xwALU08Qx90CkEQICQE2dKWpbVC//rMnT7hFOnjKylEWkPOxXD5EvJJSJbCWktBhZ70xRJgB73eD
kbSVJc0gqcurW1NqwUNaZuRcoG1yXXTWKk+C2Ftq9IP6Dxh2/9A22YIV7drx/OAdQHDNEh/sCnZF
BGnV8qU/H9FLXotI6UOMXU62JIb1yrmKRwwrCyGTWajUZWMtJLTpjZ9iY4fo0kqbodTrqtv0JghD
iU2p81ibtpCqYpr7iZaxKXeb0KDqV2S6pVDKjSX8QK9d8DoCjF30buYoZ0u92U+aTh+2jR4x+sbN
plSAhQck/zEFQ2xYAACLDfGii27oo8ldt3R2c71Drc34uE6zAm2WokKRMKl8XIUqerLLZQS5rEst
iqZNKRlvJC5EF6VtnJwjYYiw+N2m0SNHDO7fv63lRkTiwiInyfFyRBG/DxhgYeqZnrBD9noUQ4J0
ra2jT65mxotjQ4RO8prTJUsGOUxhnwWkJCFPGZGco4zgUGTMSg6Tz5KpqSSJQJvA1VnCIDGANwuM
RfJZb1aXDhsydPCAga2tbZG4nzsefv3x5BfA4J7r4FhJlFYuX37mU5PfUyYylQAWQ1chL0wIJUcl
MWFUzqjOelW+R96EknF3pdRmuxeqr5jUrLr9tHfrTSnA2JMbV51Kqhh3GkutwqQ8lpTfm+YSqfcM
GqGNQXdJqN4swQ7VJDG6n6r1Y0eOVAMsZa4QRaHD9B8QGJwCaMKGQiE+XEt6NVm9SlbNYUlTqgZL
qx6ThHE+xgBVyZJgXGpEh0CLIkUKS6ZrMKkppUDYZ5W1t5IDpGUOkcaRTz81ZNDAlqZr8kpDEShP
8C4IIp4kxAALU49YsER5UXEYLu1rbbvZN7/P7CnPyxrZir7DpHTLZQ4fLWdpC0/oedIoUCbWYwAf
Le/RA1UuectYxsl7nQLoJGhz2GuSSDPLOLooG8fYgx4TEEqUSWh0gpE3XOtE64OkiSdkBMYYebcp
5HOEgAZhrAJdHiKdgs8WbjSwrmLkXyLQFpBEudNiaWtLnXHI4HuHDbm/tbVZXiCT3HNg6ilC06+K
fzTCskmzsUpQaRGFBpJVdlCQVq1Y/tPnBjCkltV97F1SvWAiY0mSJCdGdZZJrp58ypvow6Rcgolf
K3rF1Isy3V6OSWrcoq4rKi5QaX9L4i0p95OhZaWW7CimLsxY09+5N6Euz9jhNwUd4a08gFy06Xq1
ZfSoUQBgRYNgybkgCEG4ZPiuIbV9OsmHTHn9lE1j/jPLXNIqGfSIzl+4mHAbsbDpAI6EYcDkoMAG
Kd/RvJzcjSsKQ4Q5zX8q8yHCxDMm6B7H6EEeBGqTAejHFmDMQdIqUVaWMoR8tqCvDCg6ntR2UWWA
57wWgTSybqOftreTNslXxlKbecYZoEwtLi3QpX7CypPgbbS0E3YAvDo8YGRr7vRYWj1lks/GMw6R
SX67QPsACI4a/vR9gwa1NLfIv0UUJLhcMYLxNgZYmHoGYElCRAzDgZgotbYCgFUAARY0F6X0bYhp
dHbUGYJuUMAeoqyC1yHQ1qDHHKDsAUIeLVE6zrWBJUpDlDkAB9Zm1mvzE5YgAeBXOQRJpK6LMgYJ
C0tAN5Fwo5MlrAHSHPCaBW9Z0GMB8E72MjEDZQTdooFy8UY7M9DTgATQG7gox9hkgDU4FWCFMcC6
LYP1sBpjsSpLYVJPxsmBFqMAi1cAllUeTGcGLpkQVUaMZUlEVBYxEfGkgVxea/qerxus1n11b8ot
eVPuLR0AUiQxWGaJo0wm889PhGXJv1fxgmcsvPzpqQCW8foR88iRI5tkJ3dJCqsdsO6uAQnA+uAl
bGtrR3iLSwngBH4OkMtbSvQAUkChrdasXff1N9/B1172T4rtPyHxQG+GIzD6jMgRTGNuVtaGZXNZ
MgVqK/9pQ0XAbZBoQ3udXqQcfredpZwCHJrqQqQ1QG32004w5gx6dHAk6XWwhJkDOtBnBkNTjjCL
cCAKGDBSBU3ZpAaTbOuyc7RdanCItCEAp//04AUIkWDcaw4BNMaYgLIVGdX7FmOAgh01AgGsVgSw
xCjAwggLAyxMPQawYCgsoI3a2hIBVrrOT/Dagm5jW7053FgRouytdSbwDbOMA4yTWEIX9sG1Syxt
E3xlYFzVRegFxszCT9rsdxmAKhGhN4C+izSIpJ0nnCHCEfRYAQ9UEuu1cBRcdh4iAbSC654kxgjQ
FUeag14HXLfFWJAFKwqw6IwAS8JuWLejY5MNBgA7tcgTsurNkZJsDLD/jgGskCCtXLEsDrAYa0aM
lQ6ypLf0pCQxydKT1gb2C2jJkt4S5k0LZSwZESHzS0gxMzBK80BS7jbB2pcWbMnleVoGWHC2EXyz
EGBdO2IelThFqFhi2LvHqRkhG4Cltm7f9dnhI0mgv0faB28vygFJMHoBxGqHPvz4vsH3vv/hJ2g/
e+VzQIE6ofIROQ/ty8/N1a5ZwJEZ3+oA4wQfQsClg1O3RJlAl0s+J+suYWmzSJok+I2AgatFbCiT
Gis6PEAfmnkaOmxwACSRZoExhBuMIm3mPaU8qeVAokwAeIEUbrCypE5qsAddJfBlAPqTLOVIA0cZ
5WGwRVINU5EFCwKs4U+lAVh4yhgDLEw9DLBEOEXYryA2RehNP5TnCQMYb4kN5SB11gMejK5sfrdJ
lEMd8qQeHN5yGQMeaH9iKSO0Y4PxVgOQG2+RTjCW4rwQMAVdOp4q93tsoJbgMUADOA39q1hCC2rB
IR1l46ErA0Bslk7CrkwRykjLDgAWqwCs+wHAasFThLeV0PwLeLCtrW2r17z6lTyaT4RfvLKHNxzZ
qwHW8mUJFiwmxX7jzWxS8lozGgOYzGe9meGON3kCLgFgMb9k90qc04wxGVBgIuhJ/9PSzWwmo6hM
s6Jpe3EEsJgYwGKiAOv6EfOI4TAOlhoTK9BKhhNhhC0Qg+AFQhqSwkuKLEoxOBIVxgtHz0qxYlIS
H68SyzO0LymgR20oPfbDcaCsNmwq6ejsVD555XcBBryO6mYzXjecQJne/6bm5n8+/E9NVva4ceMZ
XyMCpvCLkDGWwLOyBauhQKPZuKKwrUafCei3u3VSowP8L2AMKTEmHkaF1fJEKVCSAmUUKT3nKpEI
rUQaA/UGCQgZMwcnCu3X6yqCZDkoKVBa1lvRQTg7SYffIzu8e60sYeAZaN+SvCage5tc5c2usk4X
QGxGAOZEMOJVh/aQX5JEgJU0RYgBFgZYmHoEYIk88iMQpXBr640owKJNaR0I5GQWATwiIaiCLlaM
IeQG4yTwrRpa3RUN+6zVb+i/fN/cQTqguxX4hpnyTrdRokuClOnEF1taPBWsW9tFggHW+nNfWH+u
L2upL22qNVyptV2ssVw6Yrnprugk4DqXABi9ASTHGDjGGKLs0ahFyA0LWrBs0IJVb4I+WPdjC9Z/
lda8si4/V/Pu3gNomgnkylwMGu5H5OXrsSlCcdWK5Zc/ByNpS9SC1Y2dJh2SSDZiJdSydOeSlXZy
LZO/FJPoDaa4WHVjOWMygCRvtxiR6XaekemmBcsvT7DGJAhgsbQ8KEIAq9oyauRIFKaBlSlyF64f
RCg/AkMJsKNHj9VkZz/99Ahf45dowhrlAOgjO9N/EIdCPauo+HIhmlM4Ly87Jy8n5x8PPVyxeWtr
GwxuDNQmDM0Jh6kQYOVmZW1aUQSnCDO8KhxtCJBgUOrgGWPYB3BVaSvhbHzfuXH1kllTX5w++XnD
usXkXlMXUc659XAG0GsH5am9emfxUt8BMM40cqTOt99o3bjMWbK07u3SW6SD9VpYEq7SlXxlnFt7
/N/2Ct2KSuOaA5vXSg2VcuQ5sxALt6Z8TektWGEO+2BhgIWpRwFWzILVFnVyfy4OsFJnQxiL4HV0
ui0cXNBnYOuLg5T9+GeO9cvn3T+oXx9Njiard1527+FPPPLJjuK2WriMnPOCYbTO/cb6IQP7bjcu
l2g9yxi/eMf80N//ft/gwQU59+T2+kv/goIBfftpsnNmT33+g23r/aAWbe4iLCHonQDhFArDGJsi
hE7uAGC1ygBr6JAhKRYsDLBuV/cGOjY3QYGhPOhsNpVoW1UBMhQCnbfagrUqdYqQ+RVTaUwGdNLt
lKK6gJjJKJUyoZbR+Sl1KjDT1GFiO8kOVWlnPJkMV0+RINfDX/BUSzzL0SqAxUQtWKNHjbpy9VqS
lVeZdEsiQYgziFckUXlSMTEjZSojJPJC/HJC0g0opEwIAuGKVWv6aPL65uUP7NffZLFHjXOxHd+F
2LKMbm4s9TaSAJYagL7+5jsIYIGXv3+fvo888q+P//0Z8sGC1+GCbtoHAF/xyiIYUzeD+x0YnYoU
0GZWkTR0uY0X6jYvmPmi5p6/aLKy7h0wsF9BgSarV4EmZ9WiwnPVVSxVKjGOIG3bbFyh6fV/lbqV
AmUKEcYt+mX5OblAbc6cPL6FqgoxlnCDCQxBgy4LGJTaNy0Bp4Aenj/z+U6yXHbwssYtWKpXUXZy
hwCrWbZgheEUIYenCDHAwtTTU4RhxQerTxond7X6pkxBwiyrbyvn0QJ09dkb+r/d178gJ3v54qI9
O4x7qkp3O0qeHTsyr/c9q1e83OGWF864Suj9VvDNbzGsEdwl7TUb6H1WTa+spx9/vFK3rKJk+Wbt
GmfJCuPaRf3zc4cN7r/TuKQDurEbJZ9T1kdGFKhajCa7oAJY2Afrv4yxgsHgc8+9APo20NM8/I9/
Oiu2HD9xCp2Ne6gkAKzlmaYI088PMhlQVzezfr/kpJXGjSnN4OHXzCpmWFfozWxj+0WMyGRwFOt+
YaM386NjoqsIWWgDhstBwBd0o9o8dswYAIj9gYAyj6aglruF0JpH5MZ+9KtvAOIBmAakvJzchx58
qFRnPHnqTFy5/faILUneBWoj1rXrNx579PGCXA2EWdkQZgFsN3XajKptO3/48YewwDZ89S0Qvrpk
dtSClbg2FkFknqkQKDPv0fpd5oZDzqf+9VDuPf/PaVj3wye6m7Uwjiixt2Tl4tmaXr1sG1cCBCaS
Fr/HvNW0StO712bDWtZVGnSVVOpW5GbnPvnYY7n3/H9HD1n9JGjWyNNmkS4LUJUvjh/Vv2/fnKzs
eTNfCBAOv8sU8hiEhB0FLKpVhABgDW6OTRFGARaeIsQAC1PPWrBEKeqDNWeqKkxDipYXaROMX+d1
glEa0COX66se/+cDQ4YMbTywEQAv1qWTSF37kY0X6rc8M+pJMCzbY1/CkjaJ0Na/Z83pnVWuXc16
4B601H4dUBmzpz7XTtv8Hh3002KKJXoT8fnbQwYNevqxRy7Vlfk9xTxhFjwWaCqPuWcqYRpiU4SD
Uy1YeBXh7SD12vWdu98ArwroTgpkmPXEE0/tP/gBy3FhOAqGFoh0AMuS4OTO/JK7N/ML7t7dzc0l
OTN5U6b8MgGvXwnyunei/zUY6Nf82CQvLm+306mJJdEUYYiSDRUAZlHGmzXWsWPHfvr5F1u376ys
2rZ1x64tW3ds3Q7y7QAiVG3bIec7gTCWxxM43IJyNbN1R6xirExUEm1HaSrGJ5VRLrSzKqFNtXyn
uiJI23e+VrEZ/ILXQCqvrBrYrz96D9GrCHDP0PvuX/vqhh27Xi+vBHe6W6mYdBuw5XT3ozyH6NVj
ZTZXbd/9+ltjxz4DLgGuCPL+BX0RDy49dMj9JpPl7fcO5OXkbFg+V94VKv3LAE1KjF4gNrTSWxfM
mQZ04GvODTfrtAJt5gkHR5g73cXn6rc+O3Y0AF51e0sF2tpeo60yrsjLyqoybwi5tSJRskW3DOCn
ja+uAWXesq/2E3aR0rOEXvLavzpg0PT6v4kTJ+dp8gqnPw+qy3HXbDEnd9VEhGqKUGXBwj5YGGBh
6nkLViQ2RViQ0QcLTT0QNpYydXjAgEkfIvSGDSs1vXt/sHU9D2ATDVU5LEyV+Inig1teyc/qNXvS
2DaiTPSUkm+V5mfnbtavDtUXS5TOe9Ce3Tt7zrRJktcJqnQRdoClJKaCI4t1axcBvUPut4F2eLJE
jgdjSIqDJTu5W5EFa/CAAe232gSBVWYQMMDqcUJOwVHrlCBcuHipT14+3HktKxvm2bB7Gz/+2Tff
3tPZ2QXKBDgYgFGSeOTkfvFTvRxL2pgRWGQAPTBSudsEN4qG74C+w71JIoslsjRE2VnGCXi+foPk
NXaQ9rBXD4bynZRRojbyBHijtCGmhPMYbtQY1q8oaq7Tim7jLaayw2MLuUFXZAy4deFGZ5DZJnhA
SWM7oStZu8j3vlPyaAVC7yccPGUQ3aUwUAhZDN0NaTvn0UuUgSPN7QTcbET0Vcj3ZvSTBt5jlrwm
AX4gdol2hMAQxWeGrsqkXSAMHS6H1FBe+46hy2NpqdGtXTyzzWURiQ236gyC1wFa472WWx6HRJeA
n9BKVQThBwg3xu5wWcH4hKW3/IJrlzc5yBYPByFmvzxXJfocMsCyTJw4sVRnBN84+L/Av6ZYYvJl
qwyQoIT4vBivTnFJSmE5wRm0hKZyVNVRmdjZOBO7VrRxOYdz0PLb1UeGTYgHreXn5kbhVK4G2q6y
sgf07Rf9FbGKMGVnK02BBBpBvxG2EL9QjurmEaO+8/jPVxjwziPDLUj98gtk+5l8q/BOsoYN+1tu
VlbJqvkwDlaGKW+RsAgNZV20+cIX9oF9+4wbM+qWywKUJ1zrwxg6aQdP6kL16z7dXbqscMpXh7QA
G7GkdotueV5WjlO/GryKYHS6Rb8it/c9n71lfmjY/dMnTewA0Iq2BBin6NGZStZoev3Fpl2hyc4q
nDEFhoymbAHCEp0i9GZycm9NAFh4ihADLEw9QqzKB0tZRcghC1a6XlCkYaSGEA1QlK6pxvT4ww+O
eOqJZnelBLtPc6fHJDU4Ra8JKIUbbie5v+JCbRXoVAJubeNBi6Z39ubSFaH6EpbUke9uys3qtWDO
FNBjBV2beDh5pOMILVtX6tSvycvqReyFofNCtCPIVAikSaKjZu3oFCEK01Bvuv/e+4YNud9mL9uy
dRsYcW6u2la5ZWvl5q3KuFPFIH67MpYFI+HNW6NyyFdtVxWLllRL1OXRoVImsX10qMh3qMvEJKrb
qFJfcbu6BSSEdVWNR4XxG07TWvrfkvjbExtU30ZCO4qksmrbNtnssX3na86KLU888RTq/+AgHvVn
cnr2uRe27th1uKa+tfkGUNYBXlyzeuXlz/TJFixviid7OntPiIJhzXmvA3RaNzxbzrl2NO7Tkgfs
rS6n5621xB6AruDmS9eInaH69X6mssXl5GhDF1HlfttU80ZpG1HeQm0e9fjDPx2x+6ly73uvHtm+
wk9Zb9WDjsfeWa+VvCV+qozZs/HYx9bZU1+of2O9v774eq3lo52bvnu/uI2oanXZf661n/1MW/36
xhYXePmdXWTZdx+U1ry2pt1l66rVA6h302X3vL3xm0+sN1zmAGEOEuZbpOW629Hksn2x69WG/Zs6
vJvBmGTBzBePf2LtqDMcet3aWbupg6ok3y11v7le+mqrRBVfOWy6Xlfm2aNl9lnaXXa2vpiFs+Tg
ORg42tzdbGk6nIosWDB2pRymQaAM14+Yn50w4ZNPD8uGK2Q0grYr2Yi1Q23BSjU4qe1MUQvTtuQC
UePWtgQDWEySbLVSG6iSryWXAXclp52VW7ahu63YvLVq+84du14H8kmTpyJciF68vnn5CGxBVJSb
i6xKAEdOmjS1vLIK6ATli4h9s9vVvzTZFJdskIveM7jusPuHKj5YCKQCgDV0yNBFi5fU1tR+8vkR
cOk1i2ZwZDfGy7IOD/hfDJ/t3pSXleUwrA8BdEUbgx6bSFlZX3kQjBDITR305mvkriAMVQMBVpV+
BQBY5YbV8ujCsEW3QpPVmzno2LB8/sN/f+CqywGUquS1caRt1PAnnxn51MFd2sH9+8+dPomjtEBj
s5Qt1YcvdRUhBlgYYGG6PVOEsUju8VWEKf4fMb9dM4BQvNfGukp//NCS2+svSxfOvVWrl7xOljbz
YKDvK5O38jB2uo1dHkcIjPsJA9AgzF4dUExV+pVgQB8gdN59JUBHFM6a0lZr7HQZOuC6Qi3vKb1w
ZPuIxx/559+Hnf/cAcZet9xlHUS5RJvEBCf3eByshx/6Bxg7Fmg0IEfTBHC0mpOrDGSjjOyUjdw1
osLEU9GzqFhW/FSSUD1ETiimCJOuqGYyNZXuMOMlUqtkR8frSnk1n3RLSq3YT85JvZBi2FDfFezM
AJzKy0eNgw5GaUeW56GRPXjyBXLJGbPmMgwNlDUrRZYvWwKnCOlEH6z0awaTZ/FYjwmgK6GhHMD0
g9u1MyZNKC9ZPHvKc7OnTy5ZNee5cSM/fs3ges9YOGOS5DORe3QvzZ4SIk36tYuLpr24dtkC7cq5
N2rNY0aN7XAZrBuXL50/tXjNQvP6xbfcZjDcl45WdpIbTRtXFk57vnT1Qk3v3o37ik9UVzw7ZmR5
6eqXZr3Q8HHVLcI+ZviTpnWL509/YcH8uYJr3f7dtqnPj7FsXFw47bmrxNZWl3HhnEmla+bNnfqM
cd0CGIPX59SumNH4YfnMF0cVr5o/Y+IzVZYNxOtrQU9mXz//Frl51tRJTV8YSjesXTh3ytLCicY1
8wO1JTstaxYWzbKtK3p2zBPHPnFKlJGjTRzsHXU8XZrONz9djImYhIXAFE4RIguWQBqufmEaM3p0
c3OL2lVcHfo8OVZCSugEJfKClBL+QB2IIbm1xGANaWM3pAZQ4HlecQ5T7x/Q0dm5cvVa9PoVFs0f
M2Zc/4K+ihFOeSEXvbz06JdfR1Kivaudq5JiRqSEiki4f3APPx4/Cd7/qMlWBnP98gvWbyo9efos
ioPlprxAf5auXtBZb8w0kGBpS4CysO7SbcaVoJ0jb9skT0kIvIqMnSd1QfCPg7+StnS6zB0eoAAN
cQtWdo5TvwoCLMoILVjZ2Q17Da539Jpe9zR8XMG51guE0bfPUJCbW2VY5Xvf0i8vf8akZ0UveHNs
sjnTkhI0Do5MYpHcW/EUIQZYmG4nwBITAVZqjKLox2kKQp9KuArG845Z07vXhtWLYBwX0gn6A9Fr
4AgrR8hx7XzGoGsTyMM+s0Do69/aBGBQlXENR1q6SJ333Y2599wzfdKL5Du6ox/Yq98xAe3w2c5N
Lz47QdP7HmfJEtnMbmZJW5Cy85ROccxMCNNQZxw8YMCDD/z9s88PH/3yS9rbwHgbKNpLkDTjawSH
KAGhcgh5b6NariQaHXpjktjZmFzVSExIJ7aQpjW5YtrC8dtLajaWaFVKfwPeNLeXzKuupWbUV4lf
V5Gn/EDwVEFO0l5fI3zOtfXuJ594Cij9AhnOKuarAX37vbp+45mz5wIcH5GVdWeQW71qBXJyTxPA
lukusCec6qKsfgquhgu5it92vjp/2vMcU/nBtuKNK+a3uqyHdjkqixd8ecg0a9pk1r3B9ZZ29rSJ
N2tNixfMvnDYdIu0Hdxlvvip9rkJE6gD1snPTTj1qbXZXT5x/IhjH+pBJwf6pG8+Khs/8im/p6St
vvSpRx/17reXlSwybVrVWmfeU7Xp1UXTW2s2jBz+1MUjhnaX9enHHrpaW/ns+DE1b64XGeOS+TP3
Vmxor9HOmzPpenXl1Wrn6pcLO2vMxw4WF82a/OMnZZW6lc1u66HtxbMmjuaJ4pXLFlw9om2tK50w
bqRnj37icxOCcPOTsvGjh1+tKdtiXPGWdeXVLwzGV1+qfqO0o7aYJY1NcJNsW3T/uHTxJtIEnkgK
NIpCNlDGa1+YRwwfnrSK8I6NGIeW7yle6oFAUBAEgA5nzJwNXrm/P/D3w0dqrl2/8fjjT/aRzVcD
+vZHQwUAreQ4VYKyOrKnbsnmcKLBBhpmzF+wCHwMLC9I4QjPhSQ+RPmO5mZlRZ3cM0X5pw3ho2Vd
1esqtcs1vbOYvWaJKOF9aFdmXYjW+eE4pEz02kMw7qhJBlg6ALDyFYBFQoCVr8n/cp+utdaYe8//
mTetlIhirl5r3fgyuL3GA+YvD5bmZWUXTQejjtJg1KfCkjJgtiqrCGNxsARswcIAC9NtmCKMAay+
yMld7ggTfH5jmkJgjCEZYIHv3LvPVpCdvXbFAonSsqSTp41BQisxDpFydsExnB7ojpCrpKuuFGgK
Zr9ek5VVpVsp0uZ2d6nnPVN+Xp/srJzBfTW5ve/R5OTkZ2dBS0zve0peWXirYbtE6fzQgcB8y6WX
fLo0Tu7yVjn3DRp878CBHR3taKV5dGyKfbBuD4VCLGK++/4HNDMYNRZmZw/s139TsRZAK9SxBTmB
Z/1w+1gpsnrl8ktwijBlqxzmlyMyCBQM8Q/3BnBvetux2vrqS6xLX/3aRtv6lwJ1Gz993bHDtNR3
yDR90gsdNZtq3jTOnj75ZrVxzUsvikfB27jR7ym/+YVuwtjR5JtrR40cvmrZwkXz5q5ctuibQ1qJ
tnW4zTVvaudMnwqjuNWVzJ7yAvNuiWH9ommTJq5bOnfFwpllxStuuY2jn3ry7L/NF6p3Pv/shJMf
bhz+5GPLFhWtemlG4ZxZ+7eVtJPOpQvnQBxDrNOtnd94yL5du3DDqvmdTNlbFcWrFkx79pkxs6ZP
CbotL80runLY3lxtem78uP1b1k6fMlEg9X7CNOn5Zxr3FZdrlx5529hWr3cULz7yRkkA9K9flnNk
mUTZWcLaXXiLdGsFlK1yoAujHAfrRrVl5IgRLS2tkcTwV3dsKCy0qAJAK3STzS2tM2bOAchm2vSZ
Z8+dB6/Z+x99onhfgfy551/86JPPUHwvtfVLDSLVroS/laZNn9U3H0aTeeyxx+vdRBSnhiMsjLYl
CmzARXnBh7Bh+VyOtKTbDQliLDAWlY6WS0TpTvOq/Jwczx5TsK6Y89k662ySz8aBv8znCLrNnS5D
F2kU3SWJPlirRGITtGDpVmT3zvbuhQ7vL82ZPH7MSL/HKHlMMyY///gj/2yqsR7dvxE8kIVzprFU
SQB8d2gvwsRPL9XJHa8ixAAL020CWOFkC1aGMIk8aQw3OMGoKOQqvXSkoiA7a95s0HmYONIeIvTy
/jZ2yefkKDPrdbS4yzvoLUHCIlBG3wFjblb2Zu1yiTTwlMG7d2NO715TJj3v3avzvKev22dzv6en
D9i+/Xd5O70Z9C4iYwIwrstjFuEch1mKBhpNWEXYWm+6/777hg0Z0t7eKgicopRxmIYeJ3XMRtBp
rVz1iuIE89CD/9iydceNm01KV83z8irCcDySu8oHy9J9DIKkIOY8aQKdR4h2sJT1Tcdq0yvz2uvM
NW8UV5a+fKumuOYt4+aS+d8cKH3xmVFiY8X+irVzJr/YRu0omvrMxSOWoLeyYuMizzvaF8Y/wxyw
Tn1+zOW6yibXll2WVZeOWEJu6Fn87SHjC2OfullnaiGdDz/44Ffvl9lfnVupX3OjWuvdb/qkan0b
ZX9mzIjLNTo/Xf704//6ua5s0oQRrneMHS77x7t1jQeNN+qsqxfPDnqsYXrjh9vXzp87c1HRrBM1
W3foChcVzWymqt6oKJ724hiB0C5fOPPyEWuzyzZ+3Gh6v2H6i2ObaozX62xTnh99+lPjDuuqw7s3
hDxG6/oFX7xeAl5v2f5kC3qMKJxVd88tZW1m0l6EyMldDjTapPyVyj4zCIWo94dJmv5LnBlMiN6e
YX5NSmknHE4XET79XGTM+KRM8F25em38hOfAK7dk6YquLj8qsOClxXARa3b21GkzfI1fArnqdRW6
t12lRpDv5icA5tSZswBd3X/vkLfeeQ9tFYWeGws3MBBlgBUkvY198vLXo70IkyKfxf4gjtQJPqdI
at3vGjRZvTdrVwqEqYsE30UZUJIsUHpeG+s23qiveH/rq6c+sykAS7ZgxZ3cwa/2HTCL9es/3K3L
y+r97QeW9npHQW528cp5QY/Ju3cTeFbzZ03u8ug5xgEaEVM+NASwRst7EaoAFp4ixAALUw9OEUpC
LJI73OxZBlixQKNpt1GjofkKxg6l9J1u26inHnvi0UdaiS3yN4y2Z7bztCVImS7WbZ496ZmlhROv
1NhCbp1vnx4ArK3G1Zxby3l0zAFjTlbW3OkTQ25DoH5TiDLyZAnrLg0SoNvTdcIoxuUBxhmExnaL
wJQpYYjVPlgAYA3o0/evQ4c2Nd9Uh2lAEwQq9Z28U0eq24d6a440biUJ5eUGkzxIUvYASdHU8a1F
0nufpKsezixM69SS1GFk7jMSf07GbiYsqbZPicQCtYPebuiQoWgh1boNm348fjL22EUlumOQFyQh
JEm8n+XXrFpx9YgpRJhZ0pgwz/VrNlqGe4mYApSjtd6yb/MrzuIFfqby8x1ry0sWthNlR14r3qJ9
+apnxzOjnta9uqho2nOzprwQYCpM6xcXTZtQuuYlw9pFN+udY4c/2VSjtW9YNGfqMyWrCk1r57UR
dpHUhY86b1EOw7qXZ0wcv27p3P4F+eRe/dmayvGjn9auWbC4cMrRg8brtcbRTz56rX7zjS+0o5/6
V3vN2o/ftE4Y+YR2VdHCWeOv1NuuHdGtWjCN99gDbkOTq3zsiCfXLpnXUmete6d05JP/qjKsWDZv
2qzJzwpMxfqlcypL5l9zVY184l9Xa52WjUsWzZ2yqHCyaf2iLo/dtmHR+7vMnEtftmHev3duCFF2
2bUR7hblV5b9p0bVymDW4mm4ihCt6kWBRhHAun7j5t1hK2VZ9eErr67Py8mZOGlKe/stJGlrb3/k
n4/kZefoDWa/H0b2QiGyIiq/K7R3E3qtYwan/9CCtXX7LoDwzp6/oOC26BcBv5EIiuRe56HBR1Gy
ap7sg5VpGwBLhwv+j9frbQ8MvXfcyKfb3RVByhby6HlCC9QmR4GhiPHIO/a+muzSlYUirViwsstl
gIV8sDS9e7n3Wti6Td9/ZND0ztppXffNB9bc3r1qXgMYXe9+pzQ3K6twxiSWsgveMjCWEFPemQxh
GnCgUQywMPUgwIIWrNhWOWkjuSfpcbosRJoCMEidLujRlRnW5+dkH9y8VnRpgRKH00Bwf1ljS01x
7R6zplev58eNbGO2t9cUM3vBiC17i2GV6NHyHgOxR9c3P79w+iSJMEuEvstjgVvrUHbRZ+FJvUhZ
ONIOtQNtFt0GialMDdOAfLCGDbl/yL33tre3Ar0ADSfy6BzvRXhbTVl7DxxCG4Z88NEnqZ7IiOGl
CABY0MldjKxcvvTSZ3roVKdMEXYb5irBlZsG75WFZxxB0n76U+PJw6b2Gm1zvenUp5YAYb5RXXr+
sJlz6y5VVzB7iq9UO459ZGhzlQRI25cflVW/VtJWaw15Ld73DQFvZYfLTOzVVb9R2k7Y4aIKrzPg
LuEoQ8BtpA+av3u/tOF9Z1utKeQpPf+57ZPdxT+8XyoQmzopa+MH5V0EXBt79JA5xDhu1Zu/PGT5
fHfJrXpLV72+w7v1x4+N8lo/HegpvXtLL3xukMhNLG1u/MBW+xa4Q8v3H+nFulfOV1fWv1Vys87W
+L4t4DLxbgO118Ls0bXUmER36blP7U21FpHQnf3Cea66nKPLJK8DXJQjSoOQ/xURuZiEQKM8bYxF
codxsNAUIQJYCILEgpbdoeZexUvs6Fdf3zf4XpC+P/Yjcn4Hwk8//+IfD/1DmaqLbw4o1+I4Pr7N
oipYaNLuN5ksW2rffHRkL6tA+2RH25f1jCCKIY6Ds4RsEAAs0nc0Pyd33dI5LGHp5m/ye+xSg8NP
6F8qmq7J6v2WZQl4bYAaDHoMHBhJ0oaW6o0vjnta07v34f2bFYCVn51TnhimoXavXSJNV+sMjzz8
yNxpL1rWzfvbsGHtLqPfrfPsMxdoNHPA8JVycrQTNC4mBVSDX5k1I8DC+AoDLEw9CbDkHbXiAIsy
Zdq+Q6TNnMcke7JbwMd/3bVl8rOj+hb0Pbhtw/Vas+jZEKxb3+Uyf/qG6YGh92lyct/fsoKnbQKh
d+9z5PTKKtetAboe9EauPcbcrJy5MybLcfDKeG8FGMDxlC1thEbZzJ4u0Cjc7DnNXoTYB+v2dXiA
ps+YtWbt+nPnL3SHwxIDjaIpwrDPknH9YPdRPVPeiuhyBzlsR5SBfHQ78PjZGJO4fipuXRDUhRlL
pkORSSipnFXKZApPz1NmlLgYI6c0l0OSDFusWLqL586kCT2q3otQ9DnQVjkjR45EKOHO34IQQUAA
mFrb2saPf7aPJu+jTz5VQDzLcQDcnzx1Gv2Q/8KAKhAIpo0LL0GYJaFVhB6mIS87Z+PywijAShel
rItyhChzyKNjSfM37xufevRBTVbWslWvfn1A3+ExXTy86dCOTdMnTwRDU/2aBUFfmUAbA6S1XLtS
0ztrh20T59ooULoK7fKcrJz6vU7OVRyi7ZtWLQKHYMyzcdVLAlHKUSWe/TZQfsHsGbcIO+vZwDVs
FlOGNIoF696BKYFGsQULAyxMPUKKD1YMYCUGGk3pDlm3nocO5g7JZwtCU4H9k9d0g/vkgu95/OgR
+g3LtjpKFhTOysvq3VeTbS5decsFRmBm1lVM7oNLDit1q7j6ks66EmavPj8np3DGC36XjnUZecYp
UHpBntFIdq5Xbesb7ZYYm8CoNntO3SoHA6zbgcU5MG7nQQ9dXetCrsRA8GsA1srlcC/C6GbP3exq
/Eu7Pqs3PE6CJkkwJY66mASAlXppBSeJ8bpWVfU4YhO7hWLpg9HH27cKKY0kSUT1faYNcMV0G2I0
sUAcYDEwDhayYClThHfLBwLu0+Gs7CvPRCvoCk0Ftt+69V99+VVhIyLyVGMagEX7IMpZXsiRlkzb
louNFX6PWWoA74O5i3D4DtqADszt9X8FmryCXE1/uBdh79x7/p929fxmdwVXs0GkDaC8PCd4z2bD
Kr5+o0Trt5lWaHrdQ75nEt2bBMLw0S79AFA/6y+fvWEUPaUirXe9C+O5F057IUDaJLrUT5cnvFox
XZoUBws7uWOAhen2ACwpnZM7k3Zcbgkx9naPTfBaJFrHE1ruaOXR980LC2cPGTQAaIG+GgC2ek15
YfwH2zb4CXuQKpOOOiWfof6NtUMG9tmmXypROo4x+/aX5mf9ZUnRxHCDRaLMAcom+cxB9R5eSb7P
GeJgRTd7bsNb5dxeihsPWBZNxygrCrsHWEE+utlzHGD9YlByb+bdAFXARVQAdzprUFJK3oBZha6E
dNBK1XI6a1lKsUyoUQXdVFgteucJ6E1kMm8clGEeMOOm17G9CJGTu+CLbvYMANaNuwRggdcM3OTx
E6eGDhmal53D+BqV21bm/rqH+LcV9sXnHNMBrDRO7rH/pb3OhM6ytFkgjZ0u801X+ZHXNqxeMn/W
1InTJj5v3LCCPmBrJ8ok2hTyGMVGS9BjpN8pdWxaQu3VS0SpRBuY/YaKkkXnPzPCAFqk7kqNY6d5
WaV28eXPLTz05dKd/dxWUbr0g6p1cC6C0nWQZfHNnlVfUJopwjAGWBhgYbptACtmwcq41UOI0AdI
i5+yQ93tNQY9pTylZylrh8v88xGLb5++/m3d0YOWNneF6DH5azYFKXuXxyAxJUHKeuKLra2eCs5T
GmIsXW7TqZqdV91VEqntcmmlBnuI0PnJRC3AJIX/iXWE3liYhnrjfdG9CLEF67aP4JF/G5qUAf0f
2+1Out1t9pwUvSmVT2PK6m5qL9UalIyBaEv6PQ0Za/ewLAn9pLGQ0RksZJmCravWcCUYyVKnGpNR
puUX5lKTpiaVVYTeqAXrerX57rJggfdNqzNqsrLXvLJOca5CQJ/jOEEQFEd4tLTij7GxJQCsBgiw
VqRYsBJye8gjB7gCAIsB41izQOi6aoslShukDZ1gqAkRuVEiDSxp5Bvs/FGbSBpZj7Wp3uGnHQBd
iV5LJ+Vodllkb1cwLoUrirpom5+wSuAT81lFwhCiy667HJ0kqAvGwEbeVxkHWKopQjnQaMJWOQKe
IsQAC9PtAFhwirAVAazn0kwRKuMeQi/QVqnBydIOAXzPsKQFKJQgHEsVAyAlMkYgD9RDJy2pwcIx
DgiwGvRAlbS4nEHCxjKmLrgHrbXVU+6nysJeE8eY4YonQscy6c1XUswHK9mCJW/2LPtgtWCA9V/A
WKjbUx4vy7K/BWCpfLAyYKy07kSZLFjqqb1ME4VKSr/gjsnog5XJwJbWoJUcxfFXbAKdCq3SALVu
tpdOtY6knyK0oSlCaMGqjvtg3RUfyE8/Xxl2/9A+mrxvvjuW9Gkry1qT+NsOp1IuFAdYQsyCtSJm
wcoAuGF4fZ8j4DHBvQ189iChhzqQMrfXFwfpTeGGUriRpdchMea2uuJbhIEljBJtFShDAJT0WQSv
JUAYAK7iKAsY1oKBq5/QcZRWIPVA8QpwK1jwVtgDtCFIalm4g6e1i7AlY3cmwYLVgjd7xgAL023p
NeM+WNHNnqOBRlPNSPGRtIOl7DB4He3gKDsHPdMdkq8M6IhOgKUa4SgqSJk5L9x5l4X7CYKeQx9w
aQG6ksNZGds9JoE0BkkTdOQiTGAExtPGgEsfPuqIe9MzaaxZcR+sOMC6d1iqBQvHweppUoK4osNQ
KNR9r5YIsJapt8pJg6hUodu7Q1pelTUrgy9UPCUBoLSxIeLrUlW+UEzKlKI3reUpMyBLa1tKRHiZ
3LnSe7InLTRJvbGUqXyOjsfBQk7uyAfrxt1jwaqurddkZb+8dLnyyimwXrV5jiD8tz72tCEepHCi
k7syRcikB8pBaM63Qg3mK+O9jgBhCXjMAGyFqC1SQwWEX6AAQEg0VIySD2hROLYUodepKUjq+Rik
5hhLpwuGL2G9DhgykNaHYIgH9JLbwg12ngFfnFaAh/Yuj1lIMeIqAOveBB8sbMHCAAtTz1qwJLiK
MHEvQnPG8XFDmQQHxFaONPNAfcN1LtbOeiNHWoBOD9HOIGkN1BdLjC7cCEZaRslr4bx2P2GB/lWw
sFmiDJ0k1CACpZMVQZkf1EXbSzc60mwukThFqIRpYGlrFGDdn+rkjgHWbSG1+UoderR7gIWc3Hm1
k3sKMkh+2TK4eCvFUnBVRptQdIqQSW8ESoVKKkCWZiOaTM5YacKpp+5jnbAa15LW7T19dKsUfJnR
QS1xFSHaKiduwRox4m6xYAE4tXL12rzsnNp6t+JgDvIwDImcHBnkD1wUGYahsOI+WJrs7AQfLCbZ
TBs+WhbwGLpc4HMwh+BiQztcMNRYLhJGkUIeijC4qCQPILvgnhm2AAFQl1mSF4R2eExdMCiaPeg2
drqMgs8u+qBxiyUMktfW5QGvEFDLFvCtsbQZqN8ulxEuaYRTBMkAPdHJPXGKEFuwMMDC1JMWLCVM
QyzQqKIRklyDOwlbp8cSboTqO+jR+d36IPy2zRJ0irJ3UdYgZRW9TpEu4wl7kC7jPAYwUPNTDhiM
G3oJmENundAAgFS5RGkl2hSknEFvGUuZgYrp9BjTryNjFC8cOXmjAKtVniIcOmRIC/bBut3D98RH
irq0bnxfOAiw2PRThJlCYSVAK0t3KwrVFqB0MRRSJ/4yAbuMPlsZpvbEDC5fGeOqM8krYWOdnDXt
ysf0UdqZRB8sJvPsarowDVGAdQQArLvGB+v7Yz/CLcNnzlbWUiA4FXUBlP3/4gFFef4P+y7CKU7u
aacIY39ZkDIBXScwJjjZRxrgP0XbRNIseI1BytjqNvhpG1ymDR0W7QHKKhBGjikLkGUwgDNlhQqW
tvMeq0QDFWoLuLUCrQODWNZjCrhN8ujXLHptLGUFWpcFY1cCfh1hn0lM2UY9YYpQ3kAJR3LHAAtT
T5PIS7wY6LoF+sQbN5sH9uk3a/JzHYSR99ph8jnAhyrzjqgEMFEhYuxRPlZMSBama0GuK/hQYaUd
e0r5OM8yNjmHxYDWCJBWULe5zjSo/4AHH3iwqbk5qmq79bzG9F+jzq5ARAqC16stwK1asfTHj6G7
XhD6XJsTk0lO5rCKVzFmRRJOrBL2mVGKFTbJvCIxJ7ZgSmFUTSVdSG5BZKKXYEkDapmHcXSNyuVU
DSZUjP+i+P2YEwuYlftXngM8TGjQlNpU0nVVl0vzEAJeIwuGK5S5i7AIDBCWXKh1jhw+SpkilKRw
pEf3Qv4dZtEoTkJLAhFqdzgr8rJz3nrnPQVgSeHwHwikMt+9KO9YEAxLvIfyaXpnl6xaAAaoKt1l
z6AP7am6DulDpEJVeWI7isSn1quO+FmfI1l1+1RaNCYP0TagRUc89cTf//bXlqbrcNdQtGlS1KsM
EwZYmH4/vhIBwoqIYS4s+pubWvsX9Jk99bku2gC3aobJICe95DWkHBrCiUJwKEuUuvo0vDdePZ68
6qb0iS1H64rwlqI5T+k4EozbjM21JUMG33ff4HubmluSnIQw/bEU5ISIxHJckJMia1YuufSFLeQu
kRqsrGzpVHKUAK9O0bN0GrmqeqaKcbmaycSnvTRKoPsJUvCGQVcEUur9JF0i6XdluG2lbpp7SC2W
3Kx8G5menvpCAcYsUnaJdggNFXDJrbv4/Bdl40aNQVOEypeibCbzhxtHwZ0oM30cx40bN75fQZ8f
j59AEiFxz+Y7iMJhuK+5GGTZTpLxabKyNy6fGyJ0Kr2nqLuoZgunaD/lbDT3xtVmTBPGmYSSqhbC
6bVoQkmRjt8S4EOEdtTwpwb169t085oIhqYy5pbkhAkDLEw90RHyfFCMcCIAWJ3tbc394CrC8c1u
o0SaJNIswtwExsEJCckhYxLlBHi5ZPSscgrx6jKxinF5QvWYXMnRtUASCCNkojdgEuDo3NJarb3/
viGDBw5Cm5FB/wxZTd+xu3/87xAL/gE+IApwqnDxS4U/HbGH6jZJtDHjjsWZt3+WEsM3pAkW1Q3D
WDN5X3UXXMprlT3Gok5XyqwlT5l/OVgXk+Imlfbm0/5kb3f+Z4ow2ck9XSgsvsEqkHDnUM7r6Kw3
SGTJdU/50088ngSw7oRhCcJVyhpVkH/3/Q952Tnjxz+XFJ3hDqSQEO7ipZDACkJn45df9dFoAMBq
r9cn60xFoaVI1AowSZJURTlMe0ppQc3Ei6mUMxIKhInzGMeNGT2of7/OjnYEsACQFUTs4o4BFqae
UhDBQJAXQzwXlgLNzS198/JfnDDGs89IvKcn3tWT78FEyCnKK8J3dSApPPlecmFYIKVukhBVRG0m
NKgUiBVz79EC3vOujtpr8OyJHta+WTKo/4CB/fp3dHamjbOM6Q97r3gxIoFOk+MFae2Kl08f3tJF
OG/WOQXSKJAGOU+b5FOEIbGYIZYSCotJteJMmkMxoTziE69FJLQP44/QJtYDekpTyK0HCUooY8Y7
J1LukDCo5Yl3a0jzQ2J3Isb5xKZSH1TST1ZdMcCYeNLCEkbWaw0QRoHWnvpUN37UEzebmhWH8Tvh
PUnaHBBtR1O1bUeBJm/DppJIYljRO3CKMBTiwACVFYVIOEiStKZ31uKi6d6DZkUfJijGdxP1YVSo
i6nBZAWoVoNEXFvGyquE6qsoupeMtx9TvKjwXgMq49mjffzRRwf169fR0S6oQraKEo81GAZYmHqC
BF4Sw11+fyQstLW0PfLIo5qsrL65vYGm0GRlKykvhYGpd1aeLMlLkqdLeSmN5Kna0SQ2q2byVOXz
YheV8xzA5PbOeujBhwA0ROYrRHii8E7oOEWBAzi3I8AWFRY+O+bpF8Y9XTjjhRkTJ8yY9CzMUUI8
yJWkyNWS7oslnUorySRMOgUZyE97Yfzk58YWTp84c/JzRTMmTXl+HGCmvvBMUvnpSXcb5TNfKKHk
hPS/N/VnphSYnnrRxDIvPjtm1pQX5kx7YfqkCdPh2fFTJz334IP/aG1rv6MAVlr72dzC+eB7P/TB
x4p7lhL+6o570aGHRYQXRJEFAIsp0OQD/VmQfU+SKkujHmPKLZN2zUunEn+xQKrezkvXviLP7dXr
b8OGtbS0Irc8tPm3KLBYg2GAhakntFsoIPE8xwlg2HLz+s3Fy1bNnFNUVLSgcB5Mc+fNn1s0X2ZQ
mh+XFM1HCZ2NlV+gPgUKx+rOL1SdKlSVnysLVZdQNRI7K190wRyQCkHJl4AQ8IXzF0Lh3KI1r6xT
nNwx3TEdTwh1Pn4+/NXX39XXHqmr/vyL6i9q6lw1de7aejdgQK4k5RAydQlyUF5OCeUTKkYbVCQZ
W4tfqA617FIOkwrUu4k6lwfc8YgRo/buP4ROAaFSK34/dbFLK40kXzHerLqWurpyVt1y8r3VJfw6
5UnGf7v6wVbX1tW46mpqPv/8syOfV1cfqamr/sLn+zIQCKL/Rx2o8w8e4gkicmxHBqqr167//W8P
5OdqzsZ2E7+TZwmFkF8AKBA8TEH6+utvZ82dP2M2GFAUIVWp0nJIxUXzjPqwaL6idWN6b368llpP
FiW0oBROEhbG9ed85brxNovmz5w5e9Wata2tbcq6B2jAErEFCwMsTD2jITgxLAV5UQ43GmntCgY4
SeIFSQiFhZAkp7DISjEeycOinMfOoqQ+G2NYhZFTclPRs0pKbEe5NKzIcyLHSjwXEfiIKEjyYURW
BJ1dXeinKJu3YB+sPx64s13gb2JFKSTA9yoihUEn2R4Ef1uYFaRoEmEOJSLMOZjDFC+QlMRoFbVE
KZ/QsirF5dHLxfn4oZB4XXDbPESHH/7789ys7O273wA8kAfYhPtPvWJS48k/UykjJp9V7k1+Dpl+
SIZriSk/FnaRgsByAstDqOvnAALgOR5+13InGlbFzOT/uH1mIrE47GoI5SaovOycqdNmoOlCxSB9
h7phCUFWhFHfJKCOJK7dH+rkwgFWiCvGuBaNa1T1WZUiRSkmFKOKVKkeq5XQiJSgJ9kEvZ2holoJ
h8Nipz8Ani8bYoNBVn7U4EmHsAbDAAtTjwwfuYAgBgRJZP0C2xkOh4JsCHSHQGWkJi6d8DclLrER
Lh2T6Sqg24BMOBLt7TjoQY3ULppKABoZTw7eOQiL57gQJ4lyGFtRAON8KSBEED6GOWRUKekw+ZQg
J16VCyklVafStCaoriIk54LqMMbzoeCMGbP65ec/+fiTrc1NQBjF9PG6Se0nNZV6b0k/NvVXCIm/
VMjQgvqUkPYBsvJ3FIQft5+D347Ace3gQ0GYBoxAlC/lTgMu+w4cKtDkmSz2iCqcxB3rVRkSuLYA
5xfCXFdrhGvnJbHNH+IlLpN+U3guRStyv0Jh8v9pmYyaXACvdTjEyYGBBTAMAonn+QBWYBhgYcKE
CdPvJWQp4eLmzyhY//Lrb/Kyc6DDSk7uV19/K/f30dhRanQi4n2ZfucYTxVBFFB5ZVV+rqam1qVe
4YifMyZMGGBhwoTpbiL1wjRlihmBrfUbS/rm5Wuys0FasmwFDv9xu/4ClQMWyJcuXwke+Nlz59FZ
ta8YxliYMGGAhQkTpruJYhPNPOjO0UTz8ZOnBg8YmJedk5+rAUmTle32UBGVKQWuVk00vWD6D0gJ
04AeZjAYGj16zEMPPhQIBBShYi8U/lB3MUyYMMDChAkTpt/czSOrlWIm2VSshfOD2Tl98/IRwFr8
8rJo4RiiutPiHdzVzx8x12/cBLh2buE8tb0Kb9KACRMGWJgwYbrLSHGoUkcK8JD0gL798nNyAcZC
RixwCDDW3v2HUHkuMeIlxli/k2JucHzD0a/Ac9YbLcojlVcZhhUEjAkTJgywMGHCdBeQMsEHGBQ0
vP3WrSlTp0Pf9uycglyNJju7b35BgSZPk53z2KOPX7x0WcFhGFf9fopuRCg/TwChDhz6EDzw9/Yd
VOxVCq7C2zNgwoQBFiZMmO4yjMVxvNLZ73lvP0BXAFSBHOKqWPDrwQMHAci1Y9drwWBQAQd43up3
UhJIrdq2Iz9XQ9JeRaIEc8eECRMGWJgwYbqbSA2SbjY1jxw5GkVnuG/QvcPuH5qXk/vYY4/fK6Mr
IPzr0GHHfjiu9hDCGKtHKBSCwS2NZht44N99/0Mk5uGOiGXh5i3YyR0TJgywMGHCdHcQ6sVR/x0M
BqdMnaHJzh49eqzDWXnu/IUtW3eAwx27Xm9pbd1ctQ3IAcz61yOPXv7pZwVd4VWEPUK8IPA8X1g0
Hzzh9lu38APBhAkDLEyYMN3dpGwGUKo1gA7+s8PVgWAQwaaqbTs1WdnllVtQSY7jKMY3e07hSwtf
vtXRGfMfwmaV34GrwOOToRU6nD5j1rD7hzW3tOIngwkTBliYMGG6iwmBJE7u5o+fPMWyrDL3ByRV
23YM6j8A5EAIIJdy6uy5C+23boUT4zVg+o8JebJ3dnb965FHJzz7PH4gmDBhgIUJE6a7mxT7k2JE
UTv6VG3bmZedA3J1FTYaMSusVMezhL8T4CJqamruo8mbM3cefiyYMGGAhQkTpruegsGgYoJCkRqQ
QQUgrS1b4aI2ALCARL0FIdrdRQnpjp/h7yFBtg6CZ9vR0dm/oM+cuUU45BUmTBhgYcKE6e4mVrXH
M3J1R4SwFPLB2rZzdxRX8bwYdYrn1JsY4oWEv/dfAH8Dx7W1tffv03f2nEL8QDBhwgALEyZMfwZK
2pUFhQwAtHP363nZOZVbtgUCwUhsWlBdC+AsjK5+D/GqB3ju/IX8XM3CxUvwY8GECQMsTJgw3d0k
yJs2qzGW2hmr8cuvLbayL7/+JhWKqXfLEbCT++8gBLDAgyVpLwBYm0p0+JlgwoQBFiZMmP4o4rhg
x88/X7x580pT07Vr1366cv3KlRtXbzY1K6kpljfFePWp6NlmVcnm+NkbN0HW3H6rIxAIdHZ2NTW3
XL9xE5WJNdWE+KbUK6ravBmTJB1ev37hxo2bP1+5fu3mNU7oDLF+hO7ufrTEBlk2xEu8FAlyAUkK
BrraI1JYCovqFIa5EJYZnmdBDSD0kFR+Tm5xqVYQeXQ2sRaSCHJStyM3wrHglYhEghHJLwlBNtQV
Doc6/E34O8GEARYmTJgw/SYSKyu3PvzQw2NGjh3x1IiRw0eNGTV2xPDRo0eOGT1CziED06gRo0Ea
LecyM0bJU0+hukgImLGjxo0b8wxoGbQ/4umRqM14RfkqSY2o02jlcrE2lVNjRo4Z/uTw0SPHjhs3
4eq1n8ORSCjISjx/9/8v8CcEgpwE8kBH1bbtzrLNdpvTUVbhcFai3A7yWCpzVjortljtzrLyzQaj
5ZlxE5YtX+Us32xXyqMUq+tQ1Y02JQvtdqfVWgZyh6O8sqLK6dxcU+cC8A5/J5gwwMKECROm30As
G7JYnevWlh51ff21+wfmyFFv9VH6iNdb/Y0PpBqYQ77mW8BHhdXfKGfVEq9Krkgaar4FCR0yR77y
Vn8NDhtrv/PGikXzxAbjTalOqQ+VYg1HmC/rvyOPfDWvaPG1q00CL/LcnwBdRUQ+BO1VoigKbNPN
67NmzHlr5553dx96Z9eBPSDtlnPIHAQ5EL6zc/+7uw++s2v/Wzv2vff6++/v+fcH73765va90bO7
YuWVWnLFaK5mXj/03usH975+aN+bH72z69CmdYaKyirZpoUJEwZYmDBhwvSrKRzm9AbL+le033lO
HnOfPU6cO+O9fK7xp1P02VMUTCdBDnj63EnEKxKZURKQqBlQHlU/Tpw6QZ4BCTAgoXZOkKfRWfVV
YtXPnYpdSCkTP5tc+OwZ+twZ+uIp3+WXFy6/cOESx3JSOMLxd7/FhWfBfxMJ8wIfvHrl2vzCRT/S
J38kL56kL51kLsE8xpygofAEdfEHzzkk/N59BjDHyfOqwhfjtZBQfahq8xhx8nv38WOeUz8S579z
nXxrx/7KiiqeC+AvBRMGWJgwYcL0mwCW32yxr3+l9Afi9Bnm0lnm0hnq4ve1P5zzXT7rvXQOJIUB
wMt3GeZeWYJ4Xyx5o4dy4VgB3+VT1PlzMR6dBek0fUE5VJ9Vt3Y2SS5XVNpX5OfpiycALiRPL3t5
1eVLFyWJ5fmAIHbd9X8MwIlSWOCCPNt1/er1pYtWHKfPnSDPn/WeO8ucO6fkMoPSKer0WVmC5CeI
k+e84OHHikHmfLxWtIXz0TwmOeW9cNp7+TRz6RR9/jh5cd+bHzmdlWHJj78UTBhgYcKECdNvIJZr
s9mcxesNx4gToP8+LyOYM8z5kwRMp0iQn4MJMAoP0/loHhemSOQqp8gLp6mLZ+iLZ1AeTZeUKqei
LZ+PXgLx6rOE+rrn5DZjVyEhPgD3fIo5CwDW1auXJSkUiXCC0Hm3/y/xGKFh/vKln5YvWf2d+/hJ
6uJZ38VzIDVcgrlPyaPprPfiKfpc7PDiKQryZxPLpNaK1pWFP3hOHSfOniLPnaIvfu86uWfXPoej
Avq8Y8KEARYmTJgw/RYSzSbrxle137mOnYDd6qWT9IUfydNnvGdBOs2cOS0z0UMVn3qoSNTyU6AF
BrSDmDNKm4iPV0GnYil29fTtq0+dpi6cpC996/5hyaIVly5f4NkAtP1E7vpwD7wAQ4ZKcvCFixcv
rVy25oT35CkGTgWCdJy8cJyKJiQ55jkLpwXlwx+J8z+i+UEalY+WidZNc3hBkZ9iAIa7APLT3svH
PCfefe1AWRkAWCz+TjBhgIUJEyZMvwlfSQadqXSD8QRzGnSrp7yXTzf8dNILOtrLoDsHh1EmOUHh
ycRDNaOcOklfjJ6CTUGHoTRVkq9yOZYr96C6ovfyyXj7stB76XvqzPJlr/x0+WdJkMAvigh3P8CS
RH8oFGB5gLF+vnxl4YIl3xPfnfaePxlLJ1Q8PGRQfg7kx8hT4BDwx+VDJIwVS+BPJAoB84MLoNhL
J6nzp32XjhGn9rx2yOEoZ9kQ/lAwYYCFCRMmTL+BpHDEbDZvelV7nLp4mr5w1nsB+t8gRxzZFyfq
kQMYOZ0/+vNx8txx6uzZhosnyZM/EifO+S58X/vdaeo8qHuWOXWKvnjMdeY0YLwXjxOnz3gv/0ic
PQ6dps+C6md9l8/4Lp+iT5+iL8kWqdMnyNPHodv7KdCvA6H6oko6hSQy0kooIDtmgVoAKCxZtOLK
lZ8jcDO+P4MFC8LESAj8FFEK//zzpaUvrzxBnjmrPI2UB3KCvACe7Q/us+iJAYQE/qYz/397Z/Yc
xZWl8X9kevrBMw8dE+OZnu6OiYnoGA9tt+k2uG0WCQkQxmCwBEKAcCNshA0SWsFgE7gZC2yDwCwC
QYNYhJAqK3etteW+Vwk8ju556QesDVVp7s2sLNUmRwg/WXO+yMi4eTPzFmSGIn9xznfPRReTtuuE
U3QOxyZ1fMpR3ADV/IPNGhNTF41zhQaLLfMXz3Yd//iTZAqWiQQBYIFAINCiAGsOA1b9gcMS5eis
Mw9Y2SiT2dh4LKihz7M+OG4MjqNDxE/hfskcHLdRD2YdSXcvE0kRXaMiuqJMY8iWadkcSWj8eDQg
aZyu8ap7jYWoS6YMlbHEoIna6Nuf/Vt5jRy64tJt/KO0gwCrumrPk28QYM0tHcBKYcB6NptMAxbt
Apb3HHIb+EXwtkRjJEIvSGUlnZcVRhGCusqhp6pIJDo0REpDz18kJZGS8xA285AzgGVyOMnY2XHt
+IlPkymosA8CwAKBQKDFR7DqDxxBgIUn92GXdFYEq2ATgyriJJHEn2EJ7SkbUVEsoFtD4zg0Qkte
HhB/4FkcKVExk+kqa+p8QkBwxmCvD9rLlOr6fix79InCWrjEAO2oXA5gqQXxs7y4mubOK8QRLN7G
gPXkMa4dtZQiWHM5ESw9lzXVLDyKBqUoIYuM/eWfLm4qf6t0VelH7zeGyUi4Hz184/bVnrc2bF5f
uqH63d23Lt8TGWeeUzNDuY9U4Sz0gly/vBvBQoAFESwQABYIBAI9H2DhFCFla4wfwWLt/FSd31Aw
HmE3tFddSeXiMVKTKC38SJWCpjlshvpjMi3rI0ooIEcIKxo0ZdaWOD0W1EIDeiSooetH+2WZkRXG
FAgVYYFAiCofl2lTovQctCqMWuX+Y9DZNGBxVnUmRTi7BAFr1869mQhWXvLUe0QSlxBo+bOTHSWr
yjo7rvV0Payp2lu2doPKW+R97tVlr3ac/vLGxZ4TLad/+eK/3fj61vyzzX3R2Ik1nyJ0EGAdA8AC
AWCBQCDQogFrbq6ltTU7RTgfwcoOIPkNY3DcBSwrRuoqp/XeJF5dtvxB9wOZtlXOOX38zN2r/X23
iH//+a86Tp2X2YTCmdfOX/vFP//L55+ecyLxivJN5SUbK8or3lyx6usvrsqsFgvK5miicuuOlsPH
FdbI/G5+1CoL9bJNSAZ2ZDueB+vxk/El5cFKTaTwAthuBGtnLaJPIzctmB3Si5I6cZdd+buVQ4GR
0ECUfxCOMcalc9ejpHr7ysOK8rf4/pEoKYWDEvtouLf7XjbFZo/jA5aTG8GCFCEIAAsEAoEWDVhe
BMs3uWOnuZMJjah5NiwugegKG614J0LEeq73vvB3f7+/tk4gJYFUmg+337jQ8/BW4IWf/LS+7ohA
G5Gg/N+nOv7hJz9tb/okFAxVvrNzLMgLrNjTdefVZb8dIyJRQurtHthYtundLVVjA5HiH/5swMql
LpNPYMDi7eodbopwKXmw3AhWGrA8kzuXmyfNIq3h3tC183/euK5ComMCrRsjT6KEGh4QhntlhUu0
HT2x+g9rS9eU7d753pdnLsVoM//x+qO5gJWbIgQPFggACwQCgX5IBKtwFmER8xNtutWYLI1PhAei
XRduVazftKe6trPjSjgQOXKw+ebX9+9cvbfmzTV1tfVc30g4aBw+2LRl0zvHmj8ZGQjvqqzh+zj+
YejS2Qtla9eLnCFz1qG6hitfXT3RevrO1b48flLz2gXxG9dZ75rcd+zBEayl58HyAcuLYOVTpv98
xKB+50rv6pWrVE4UKF1mLInUhh6NxKhYf3dgpF8YfSTwD8OXzl1f88bao4fbigziA1bag8WaCgsR
LBAAFggEAv0AwPLKNOiMY3Ke/dkp5ih3U0ikbg6NC0EDYxbrfH3uxvYtVfe7H7y54o2hvqG2xhM3
L93rOt9dtf3d/bXvd3Zcpe6H6947eLj+cOOHrWPB0Bsr3qjcVr2vZv9vl73S1nhsuE/k+6IVZRV8
3+DFs12tDSfyQ1YFk93U3EOT803u6QjWUivT4KcIXQ9W0ahe+r3gqZrbNm87d6pDY+3YgBm4Ra1c
vuJm592Ln1+pqdwdCkRjQTUSEE62nd729vYiecacFGE6ggWzCEEAWCAQCPRDAcubRZgGrEK68vKD
jK2wcYmxdd4OB6LXO2+Xr10vUtG2pk+3bak88mHzjUvd3ZfvbN287cyps/v27P/izKWGQy3Hmz/9
8EDDGBGr3fVeKCAJlDlCRFb+fuW9G329twf+9Z9efP2115f9529eW/5aNCiIpCjRhupGZTQ+IZCm
unDG0K+DlTWLcAmZ3F0PVjJtcqdyAEvNDWUZeL0gk73PbSit+MPvX99YXvFfv37pT6fOSpw9Gojs
3rHvFy/+fPPGzctfXr5i+Yre7t6cQbLrabGmRNk5gPXxJykALBAAFggEAi0OsFLZKULHTFfAcrRi
DmhvL1IWIh590FE5/Ubn7Y3rKhReVYa0LZu2/+yFf+y91Xfj4p/frthK9ATLS8rXrSnv6uw6+lFL
85H20cBw1bZd+ogeIsZCVGTF8tfvXe+tr2u4ebmH62XlQbm6sub0sTMaj4jKkWlch0l13WC4MOYC
bvf5WYRVex4vvQiW58F6ggFLypRpKDr7j7Ik0lAoJUJG0VPt/Pxy8D4bIiIC6QiUE6XUgdv0hTOX
ersJgTGihJL/PP12jgeLTXuwALBAAFggEAj0HBGstMk9u9CoH9vITdK5+TjNrQkukLo+aF39orty
y06RkSOESNzlXvqPX/fdCt7rGtha8Y7CKZVbq1556WVlSGw90t7a8LHARNatLqup2lNb/ceSVaUN
9c1jRHj721UCqwtB7JH/6rPL1dtqBEpRWW81PVwZy8WsBd3uphfByqQIl44HK5VtcvcAy8ia1JlX
JMzi4hafwAtpc5bK6uEBQWYtgTIwk7GOgouWWULQkNFTpd1SZ8UoLaeSO5cu0wAeLBAAFggEAj0n
YLkRLFtnnByTe26Qw/uQi6SJlyxE6MOYGmfpg/boQMxbx1AMyuFANBKIjj6MKDz6TqvhQDhMKqEB
MUrpIUJROGv4UZS6O8TcHw0TkUggLJBiJChHA7LGJ2JB7O4aC8QUxsBkwOM1B1EnrvBe4OnOAIHn
wZK8Su5LbxZhKh3B8j1YRezt6RQh7VjYmR6PBVRcZJ9LxAgdF2LlDJXWpKCi0SYiMI1xsItuMN8s
n50izPZgQaFREAAWCAQCPTdgtfplGvw6WGxBJXf/S6wzNvp+xwKKSOoKaykM4i0zRkgKY2ksrs+O
C2XRlkxZJq7trgqEJZG2RJki6eiDeKgooWm4toIpUZbGOwikYgEZL1Do0hsaIRqQjKFxd5aili5n
ylr5dbD8f1VWoVF3FuESLdOQjmAVnXngLZVDm+isjh4UbRgcgl1dIS03dShotGSwhsZYMmlIhKrR
qkgIRQtw+ClCtw4Wm/ZgHYMIFggACwQCgRYNWKl5wJpPEbL2Qh4dmTLdOIqDKEp3Heh4PRzcj21S
KqMLhKIxOG0XI1SdN2XGwmsXIooilBhpIGwS8ZJ5pkSa+DLakdwJiTrvKJQukarCGDKDLfbo6y5S
+CcUnJE0s5Eiu9im6S/27HqwxpfaWoRzWWsReh6swgUEPfDlLGPQlmlNJlWNtW1Et5SB6NMZeSwj
FMZvzdGZOJ4oyif0hSOCsgdYg2kPFpjcQQBYIBAI9LyA1eJ7sPwUoTeLUC02a0+hDTdSEheCuo6+
627kSWFsibZFylRoXSRVibbceqQmtqszukKrIqW6BIAgDAfAov1+BIVP4CV60CD40NIHE9jPju91
RBzfSngbDo/lWsHmPVjoXn+x58dLahZhKr/QqJciXGA2pcxgbMVzPGlLdaOMQlAzeFwVFrGvu0yk
7bqv0OONS5RZdNJAvgeLjV882wWABQLAAoFAoMUD1py32HN+oVF1gSrq6AKF0jUGh7u8pQldPxZm
LFxMgTeNQfT9ttFoCs4zIrpCH343EMXgtKNEWugW9OEXKR2nF1EPZcqsI1BuXQbKdEkLjRZHtyAU
EL0aDXw+Dajz/554VopwKa1FmMqug+Wb3AtKg84v0pwQ6Th+5hiqnAwBuz42Q8XJXE0ftGRGQ205
A6wFpbDyKrl3ggcLBIAFAoFAz6FnkxPNzW1H6htlWsHow8VNHkc7Cle7K6yi/n1rBeatmrfQWjds
vHBwtaCaqFboFvI7LcQctC0xTs3OvePx8enJKTe5lvrRg29qdnpmEr+g6WnHcmpr3pMoTccvKGG4
WOluONmXPnTDiun+3IaePpXIXDZ/ZUGPRtkmhzOJGutECa2z4/Kx4yfnUk/hLwUEgAUCgUCLi5Q0
HW09uP+jKKFIQctLHulcvLDEqFq4Cl6BSUvNW6e5uGGouPvn+2gsg1xc/pjY0E0aMm9W79j7zf88
wSnPZGp6avrH/2JmZqYRLuL/yLff/GXXjj0iLcqufU2mDW/z2ti15rb9QzP3bP4t/pZ/i7ePEZpE
GWJQEUgtRqkXOq6dPHl6enoa/lBAAFggEAi0CE1PTbW1Hf+g7rCIPre4ULspM5pEWxJryawtsba7
t9zNTncyVqbHO0x3elum3917Dbff9resofJP2bkjWFk/7R5mfsLfK7SksnaUkffV1jmOmUzNziZT
S2HWW3IK0y/+v8yNP35SsnbdB/sPffjB0UPvH60/0Ij2XsNre43699P7zDU5Z4udmj/0T31U33Sw
rqH+QMOhA2jf+FbFO+3tJ1PwdwICwAKBQKDFfcdnU03Nbfv2fjBKSFxvhOrhhx+F2Adj/MMIOizc
+N7i/emzD6Pc915QeA069H6roH/Bu7y2dyP/gB3uD48Gw9U7dycS5tSMt0DyzBJA34nJyakphFhz
f/3fb788/1VjY0tLc3tL6zG0NbfgRnNr+tBtH2tZYCs8hW73RvAvaM+Mibamppa29vamlvajTa2t
bccZln32DFKEIAAsEAgEWowmJr89d+6zV17+zfp1G9esWruhfGPJ6tKykrKy0vLy0vVoKyspR5vX
KHc73VPlmQtyOksy7fXp20u9u/x7S+bbWfv0VuaOUJYeJ/uW+V/xD9026iwpX7XyzZJV61avXjs5
8bfJqQmEJJPTEz/29zIz8x3aI8B6OjE582zy6dO/zc7Mzs3MJmeTyWdo723JFDpMt2f9djKrPZvb
Tvq3z+9TXmd6qORcMjUzOTGXnJ599mxuNvnd0+9SyZlkcgL+UkD/H/R/W2Si8fd91lgAAAAASUVO
RK5CYII=
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2014-01-17 10:44:18 +0000" MODIFIED_BY="Greet Hermans" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. Red (-) = high risk of bias; green (+) = low risk of bias; yellow (?) = unclear risk of bias (not shown).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAdoAAAJKCAIAAAAECBMmAAAgfklEQVR42u3dMW7kONqHcR/AwQR9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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2013-12-13 12:31:49 +0000" MODIFIED_BY="Greet Hermans" NO="3" REF_ID="CMP-001.01" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_MORE_DECIMALS:NO;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Intensive insulin therapy (IIT) versus conventional insulin therapy (CIT), outcome: 1.1 Occurrence of CIP/CIM.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArYAAAFQCAMAAAB9KM3cAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2014-01-17 10:44:19 +0000" MODIFIED_BY="Greet Hermans" NO="4" REF_ID="CMP-002.01" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_MORE_DECIMALS:NO;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Corticosteroids versus placebo, outcome: 2.1 Occurrence of CIP/CIM.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAxMAAAEwCAMAAAD7I9zTAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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==
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2013-12-12 08:32:11 +0000" MODIFIED_BY="Greet Hermans" NO="5" REF_ID="CMP-003.01" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_MORE_DECIMALS:NO;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 EarIy physical therapy versus control, outcome: 6.1 Occurence of CIP/CIM.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAyYAAAEwCAMAAAB1+ZWvAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2014-01-17 10:44:19 +0000" MODIFIED_BY="Greet Hermans" NO="6" REF_ID="CMP-004.01" SETTINGS="SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_MORE_DECIMALS:NO;SHOW_EFFECT_SIZE_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 4 Elecrical magnetic stimulation versus control, outcome: 4.1 Occurrence of CIP/CIM.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAqgAAAEwCAMAAABMu3PdAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2013-01-08 15:53:21 +0000" MODIFIED_BY="Angela Gunn">
<APPENDIX ID="APP-01" MODIFIED="2013-01-08 15:53:21 +0000" MODIFIED_BY="Angela Gunn" NO="1">
<TITLE MODIFIED="2012-10-01 12:19:02 +0100" MODIFIED_BY="Angela Gunn">CENTRAL search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2012-03-08 08:00:51 +0000" MODIFIED_BY="Angela Gunn">
<P>#1Polyneuropath* or Muscle Weakness or Rhabdomyolysis or Quadriplegia or Paresis<BR/>#2quadriplegia or weakness or neuromyopath* or "motor syndrome" or "muscle function" or "muscle strength" or "respiratory failure"<BR/>#3(#1 OR #2)<BR/>#4"Intensive Care" or "Critical Illness" or "intensive care" or "ventilator weaning" or (respiration NEAR/2 artificial)<BR/>#5(critical NEXT/2 illness) or (critically NEAR/2 ill)<BR/>#6(#4 OR #5)<BR/>#7therapeutic* or "enteral nutrition" or "enteral feeding" or "enteral nutrition" or "parenteral nutrition" or "parenteral feeding" or "parenteral nutrition" or glucocorticoid* or exercise therapy" or kinesiotherap* or "diet therapy"<BR/>#8(therapies NEAR/2 investigational) or "experimental therap*" "or "investigational therap*" or "amino acid*" or arginine or arg or glutamine or glu or antioxidant* or "anti oxidant*" or acetylcysteine or n-acetylcycteine or NAC or glutathione or "growth hormone" or GH<BR/>#9androgens* or testosterone or oxandrolone "Insulin-Like Growth Factor I" or "insulin-like growth factor" or igf-1 or immunoglobulin* or insulin or iit or (insulin NEAR/5 therapy) or (insulin NEAR/5 treatment)<BR/>#10physiotherapy or "physical therap*" "electric stimulation" or electrostimulation or (electrical NEAR/2 stimulation) or rehabilitation or "breathing exercise*" or magnesium<BR/>#11(#7 OR #8 OR #9 OR #10)<BR/>#12(#3 AND #6 AND #11)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2013-01-08 15:53:21 +0000" MODIFIED_BY="Angela Gunn" NO="2">
<TITLE MODIFIED="2012-10-01 12:19:22 +0100" MODIFIED_BY="Kate Jewitt">MEDLINE (OvidSP) search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2012-08-28 15:25:14 +0100" MODIFIED_BY="Angela Gunn">
<P>1 randomized controlled trial.pt.<BR/>2 controlled clinical trial.pt.<BR/>3 randomized.ab.<BR/>4 placebo.ab.<BR/>5 drug therapy.fs.<BR/>6 randomly.ab.<BR/>7 trial.ab.<BR/>8 groups.ab.<BR/>9 or/1-8<BR/>10 exp animals/ not humans.sh.<BR/>11 9 not 10<BR/>12 polyneuropathies/<BR/>13 muscle Weakness/<BR/>14 rhabdomyolysis/<BR/>15 quadriplegia/<BR/>16 paresis/<BR/>17 neuromuscular manifestation$1.tw.<BR/>18 (polyneuropath$ or myopath$).tw.<BR/>19 polyneuromyopath$.tw.<BR/>20 neuromuscular disorder$.tw.<BR/>21 neuromuscular disease$.tw.<BR/>22 paresis.tw.<BR/>23 quadriplegia.tw.<BR/>24 weakness.tw.<BR/>25 neuromyopath$.tw.<BR/>26 motor syndrome.tw.<BR/>27 muscle function.tw.<BR/>28 muscle strength/<BR/>29 (muscle strength or respiratory failure).tw.<BR/>30 or/12-29<BR/>31 intensive Care/<BR/>32 critical Illness/<BR/>33 intensive care.tw.<BR/>34 critical$ ill$.tw.<BR/>35 ventilator weaning/<BR/>36 respiration, artificial/<BR/>37 or/31-36<BR/>38 therapeutics/<BR/>39 enteral nutrition/ or enter$ feed$.tw. or enter$ nutrition.tw.<BR/>40 parenteral nutrition/ or parenter$ feed$.tw. or parenter$ nutrition.tw.<BR/>41 glucocorticoids/ or glucocorticoids.tw.<BR/>42 exercise therapy/ or kinesiotherap$.tw.<BR/>43 diet therapy/<BR/>44 pc.fs.<BR/>45 rh.fs.<BR/>46 therapies investigational/ or experimental therap$.tw. or investigational therap$.tw.<BR/>47 amino acids/ or amino acids.tw.<BR/>48 arginine/ or arginine.tw. or arg.tw.<BR/>49 glutamine/ or glutamine.tw. or glu.tw.<BR/>50 antioxidants/ or antioxidant$.tw. or anti oxidant$.tw.<BR/>51 acetylcysteine/ or n-acetylcycteine.tw. or NAC.tw. or glutathione.tw.<BR/>52 growth hormone/ or growth hormone.tw. or GH.tw.<BR/>53 androgens/ or androgen$.tw. or testosterone.tw. or oxandrolone.tw.<BR/>54 Insulin-Like Growth Factor I/ or insulin-like growth factor.tw. or igf-1.tw.<BR/>55 immunoglobulins/ or immunoglobulin$.tw.<BR/>56 insulin/ or insulin.tw.<BR/>57 iit.mp.<BR/>58 (insulin adj5 therapy).tw.<BR/>59 (insulin adj5 treatment).tw.<BR/>60 physical therapy modalities/ or physiotherap$.tw. or physical therap$.tw.<BR/>61 electric stimulation therapy/ or electrostimulation.mp. or (electric$ adj2 stimulation).tw.<BR/>62 rehabilitation.tw. or rehabilitation/<BR/>63 breathing exercises/<BR/>64 breathing exercise$.tw.<BR/>65 magnesium.mp.<BR/>66 or/38-65<BR/>67 11 and 30 and 37 and 66</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2013-01-08 15:53:18 +0000" MODIFIED_BY="Angela Gunn" NO="3">
<TITLE MODIFIED="2012-10-01 12:19:12 +0100" MODIFIED_BY="Kate Jewitt">EMBASE (OvidSP) search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2012-03-08 08:00:51 +0000" MODIFIED_BY="Angela Gunn">
<P>1 crossover-procedure/ <BR/>2 double-blind procedure/ <BR/>3 randomized controlled trial/ <BR/>4 single-blind procedure/ <BR/>5 (random$ or factorial$ or crossover$ or cross over$ or cross-over$ or placebo$ or (doubl$ adj blind$) or (singl$ adj blind$) or assign$ or allocat$ or volunteer$).tw. <BR/>6 or/1-5 <BR/>7 exp animals/ <BR/>8 exp humans/ <BR/>9 7 not (7 and 8) <BR/>10 6 not 9 <BR/>11 limit 10 to embase <BR/>12 polyneuropathy/ <BR/>13 muscle weakness/ <BR/>14 RHABDOMYOLYSIS/ <BR/>15 QUADRIPLEGIA/ <BR/>16 PARESIS/ <BR/>17 neuromuscular manifestation$1.mp. <BR/>18 (polyneuropath$ or myopath$).mp. <BR/>19 polyneuromyopath$.mp. <BR/>20 neuromuscular disorder$.mp. <BR/>21 neuromuscular disease$.mp. <BR/>22 paresis.mp. <BR/>23 quadriplegia.mp. <BR/>24 muscle weakness.mp. <BR/>25 neuromyopath$.mp. <BR/>26 motor syndrome.mp. <BR/>27 muscle function.mp. <BR/>28 muscle strength/ <BR/>29 muscle force/ <BR/>30 respiratory failure/ <BR/>31 (muscle strength or respiratory failure or muscle dysfunction or muscle force or acquired weakness).mp. <BR/>32 or/12-31 <BR/>33 intensive care/ <BR/>34 critical illness/ <BR/>35 intensive care.mp. <BR/>36 intensive care.mp. <BR/>37 ventilator weaning.mp. <BR/>38 artificial ventilation/ <BR/>39 or/33-38 <BR/>40 therapy/ <BR/>41 enteric feeding/ or enter$ feed$.tw. or enter$ nutrition.mp. <BR/>42 parenteral nutrition/ or parenter$ feed$.mp. or parenter$ nutrition.mp. <BR/>43 glucocorticoids/ or glucocorticoids.mp.<BR/>44 kinesiotherapy/ or kinesiotherap$.mp. or exercise therapy.mp. <BR/>45 diet therapy/ or diet therapy.mp. <BR/>46 (pc or rh).fs. <BR/>47 experimental therapy/ or (experimental therap$.tw. or investigational therap$).mp. <BR/>48 amino acid/ or amino acids.mp. <BR/>49 arginine/ or arginine.mp. <BR/>50 glutamine/ or glutamine.mp. <BR/>51 antioxidant/ or antioxidant$.tw. or anti oxidant$.mp. <BR/>52 acetylcysteine/ or (n-acetylcycteine or NAC or glutathione).mp. <BR/>53 growth hormone/ or (growth hormone or GH).mp. <BR/>54 androgen/ or (androgen$ or testosterone or oxandrolone).mp. <BR/>55 somatomedin C/ or (insulin-like growth factor or igf-1).mp. <BR/>56 immunoglobulin/ or immunoglobulin$.mp. <BR/>57 insulin/ or insulin.mp. <BR/>58 iit.mp. <BR/>59 (insulin adj5 therapy).mp. <BR/>60 (insulin adj5 treatment).mp. <BR/>61 physiotherapy/ or (physiotherap$ or physical therap$).mp. <BR/>62 electrostimulation/ <BR/>63 (electric$ adj2 stimulation).mp. <BR/>64 62 not 63 <BR/>65 electrostimulation/ or electrostimulation.mp. <BR/>66 rehabilitation/ or rehabilitation.mp. <BR/>67 breathing exercise/ or breathing exercise.mp. <BR/>68 corticosteroid$.mp. <BR/>69 magnesium.mp. <BR/>70 or/40-69 <BR/>71 11 and 32 and 39 and 70</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>